drugbank_id	DRUG_ID	DRUG_NAME	TYPE	CLASS_SOURCE_ID	CLASS	SOURCE
DB00014	1327	goserelin	EPC	N0000175655	Gonadotropin Releasing Hormone Receptor Agonist	FDA
DB00014	1327	goserelin	MoA	N0000175654	Gonadotropin Releasing Hormone Receptor Agonists	FDA
DB00014	1327	goserelin	PA	D000970	Antineoplastic Agents	MeSH
DB00014	1327	goserelin	PA	D018931	Antineoplastic Agents, Hormonal	MeSH
DB00035	817	desmopressin	EPC	N0000175916	Factor VIII Activator	FDA
DB00035	817	desmopressin	PE	N0000175914	Increased Coagulation Factor VIII Activity	FDA
DB00035	817	desmopressin	PE	N0000175915	Increased Coagulation Factor VIII Concentration	FDA
DB00035	817	desmopressin	EPC	N0000175905	Vasopressin Analog	FDA
DB00035	817	desmopressin	Chemical/Ingredient	N0000006320	Vasopressins	FDA
DB00035	817	desmopressin	has role	CHEBI:59727	vasopressin receptor agonist	CHEBI
DB00035	817	desmopressin	has role	CHEBI:35846	renal agent	CHEBI
DB00035	817	desmopressin	has role	CHEBI:33295	diagnostic agent	CHEBI
DB00050	583	cetrorelix	PE	N0000008638	Decreased GnRH Secretion	FDA
DB00050	583	cetrorelix	EPC	N0000175839	Gonadotropin Releasing Hormone Antagonist	FDA
DB00050	583	cetrorelix	MoA	N0000175084	Gonadotropin Releasing Hormone Receptor Antagonists	FDA
DB00050	583	cetrorelix	has role	CHEBI:59229	GnRH antagonist	CHEBI
DB00050	583	cetrorelix	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00050	583	cetrorelix	PA	D005300	Fertility Agents, Female	MeSH
DB00050	583	cetrorelix	PA	D006727	Hormone Antagonists	MeSH
DB00050	583	cetrorelix	PA	D012102	Reproductive Control Agents	MeSH
DB00091	760	ciclosporin	EPC	N0000175457	Calcineurin Inhibitor Immunosuppressant	FDA
DB00091	760	ciclosporin	MoA	N0000182141	Cytochrome P450 3A4 Inhibitors	FDA
DB00091	760	ciclosporin	MoA	N0000185503	P-Glycoprotein Inhibitors	FDA
DB00091	760	ciclosporin	PA	D000890	Anti-Infective Agents	MeSH
DB00091	760	ciclosporin	has role	CHEBI:35842	antirheumatic drug	CHEBI
DB00091	760	ciclosporin	has role	CHEBI:50177	dermatologic drug	CHEBI
DB00091	760	ciclosporin	has role	CHEBI:35705	immunosuppressive agent	CHEBI
DB00091	760	ciclosporin	has role	CHEBI:49167	anti-asthmatic drug	CHEBI
DB00091	760	ciclosporin	PA	D000935	Antifungal Agents	MeSH
DB00091	760	ciclosporin	PA	D018501	Antirheumatic Agents	MeSH
DB00091	760	ciclosporin	PA	D065095	Calcineurin Inhibitors	MeSH
DB00091	760	ciclosporin	PA	D003879	Dermatologic Agents	MeSH
DB00091	760	ciclosporin	PA	D004791	Enzyme Inhibitors	MeSH
DB00091	760	ciclosporin	PA	D007155	Immunologic Factors	MeSH
DB00091	760	ciclosporin	PA	D007166	Immunosuppressive Agents	MeSH
DB00104	1980	octreotide	EPC	N0000175904	Somatostatin Analog	FDA
DB00104	1980	octreotide	MoA	N0000000194	Somatostatin Receptor Agonists	FDA
DB00104	1980	octreotide	has role	CHEBI:51060	hormone agonist	CHEBI
DB00104	1980	octreotide	PA	D000970	Antineoplastic Agents	MeSH
DB00104	1980	octreotide	PA	D018931	Antineoplastic Agents, Hormonal	MeSH
DB00104	1980	octreotide	PA	D005765	Gastrointestinal Agents	MeSH
DB00136	466	calcitriol	Chemical/Ingredient	N0000006996	Cholecalciferol	FDA
DB00136	466	calcitriol	EPC	N0000175908	Vitamin D3 Analog	FDA
DB00136	466	calcitriol	has role	CHEBI:50733	nutraceutical	CHEBI
DB00136	466	calcitriol	has role	CHEBI:50748	antipsoriatic	CHEBI
DB00136	466	calcitriol	has role	CHEBI:50846	immunomodulator	CHEBI
DB00136	466	calcitriol	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00136	466	calcitriol	has role	CHEBI:50646	bone density conservation agent	CHEBI
DB00136	466	calcitriol	PA	D050071	Bone Density Conservation Agents	MeSH
DB00136	466	calcitriol	PA	D002120	Calcium Channel Agonists	MeSH
DB00136	466	calcitriol	PA	D002317	Cardiovascular Agents	MeSH
DB00136	466	calcitriol	PA	D006133	Growth Substances	MeSH
DB00136	466	calcitriol	PA	D049990	Membrane Transport Modulators	MeSH
DB00136	466	calcitriol	PA	D018977	Micronutrients	MeSH
DB00136	466	calcitriol	PA	D014662	Vasoconstrictor Agents	MeSH
DB00136	466	calcitriol	PA	D014815	Vitamins	MeSH
DB05314	466	calcitriol	Chemical/Ingredient	N0000006996	Cholecalciferol	FDA
DB05314	466	calcitriol	EPC	N0000175908	Vitamin D3 Analog	FDA
DB05314	466	calcitriol	has role	CHEBI:50733	nutraceutical	CHEBI
DB05314	466	calcitriol	has role	CHEBI:50748	antipsoriatic	CHEBI
DB05314	466	calcitriol	has role	CHEBI:50846	immunomodulator	CHEBI
DB05314	466	calcitriol	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB05314	466	calcitriol	has role	CHEBI:50646	bone density conservation agent	CHEBI
DB05314	466	calcitriol	PA	D050071	Bone Density Conservation Agents	MeSH
DB05314	466	calcitriol	PA	D002120	Calcium Channel Agonists	MeSH
DB05314	466	calcitriol	PA	D002317	Cardiovascular Agents	MeSH
DB05314	466	calcitriol	PA	D006133	Growth Substances	MeSH
DB05314	466	calcitriol	PA	D049990	Membrane Transport Modulators	MeSH
DB05314	466	calcitriol	PA	D018977	Micronutrients	MeSH
DB05314	466	calcitriol	PA	D014662	Vasoconstrictor Agents	MeSH
DB05314	466	calcitriol	PA	D014815	Vitamins	MeSH
DB00146	464	calcifediol	has role	CHEBI:50646	bone density conservation agent	CHEBI
DB00146	464	calcifediol	has role	CHEBI:50733	nutraceutical	CHEBI
DB00146	464	calcifediol	PA	D050071	Bone Density Conservation Agents	MeSH
DB00146	464	calcifediol	PA	D006133	Growth Substances	MeSH
DB00146	464	calcifediol	PA	D018977	Micronutrients	MeSH
DB00146	464	calcifediol	PA	D014815	Vitamins	MeSH
DB00153	2838	ergocalciferol	Chemical/Ingredient	N0000006337	Ergocalciferols	FDA
DB00153	2838	ergocalciferol	EPC	N0000175909	Provitamin D2 Compound	FDA
DB00153	2838	ergocalciferol	has role	CHEBI:50733	nutraceutical	CHEBI
DB00153	2838	ergocalciferol	has role	CHEBI:50646	bone density conservation agent	CHEBI
DB00153	2838	ergocalciferol	has role	CHEBI:33288	rodenticide	CHEBI
DB00169	2840	colecalciferol	Chemical/Ingredient	N0000006277	Vitamin D	FDA
DB00169	2840	colecalciferol	PA	D050071	Bone Density Conservation Agents	MeSH
DB00169	2840	colecalciferol	PA	D006133	Growth Substances	MeSH
DB00169	2840	colecalciferol	PA	D018977	Micronutrients	MeSH
DB00169	2840	colecalciferol	PA	D014815	Vitamins	MeSH
DB00175	2239	pravastatin	EPC	N0000175589	HMG-CoA Reductase Inhibitor	FDA
DB00175	2239	pravastatin	has role	CHEBI:35821	anticholesteremic drug	CHEBI
DB00175	2239	pravastatin	PA	D000924	Anticholesteremic Agents	MeSH
DB00175	2239	pravastatin	PA	D000963	Antimetabolites	MeSH
DB00175	2239	pravastatin	PA	D004791	Enzyme Inhibitors	MeSH
DB00175	2239	pravastatin	PA	D019161	Hydroxymethylglutaryl-CoA Reductase Inhibitors	MeSH
DB00175	2239	pravastatin	PA	D000960	Hypolipidemic Agents	MeSH
DB00176	1230	fluvoxamine	EPC	N0000175696	Serotonin Reuptake Inhibitor	FDA
DB00176	1230	fluvoxamine	PA	D014151	Anti-Anxiety Agents	MeSH
DB00176	1230	fluvoxamine	has role	CHEBI:50949	serotonin uptake inhibitor	CHEBI
DB00176	1230	fluvoxamine	has role	CHEBI:35474	anxiolytic drug	CHEBI
DB00176	1230	fluvoxamine	has role	CHEBI:35469	antidepressant	CHEBI
DB00176	1230	fluvoxamine	PA	D000928	Antidepressive Agents	MeSH
DB00176	1230	fluvoxamine	PA	D018687	Antidepressive Agents, Second-Generation	MeSH
DB00176	1230	fluvoxamine	PA	D002491	Central Nervous System Agents	MeSH
DB00176	1230	fluvoxamine	PA	D002492	Central Nervous System Depressants	MeSH
DB00176	1230	fluvoxamine	PA	D065609	Cytochrome P-450 CYP1A2 Inhibitors	MeSH
DB00176	1230	fluvoxamine	PA	D065689	Cytochrome P-450 CYP2C19 Inhibitors	MeSH
DB00176	1230	fluvoxamine	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB00176	1230	fluvoxamine	PA	D004791	Enzyme Inhibitors	MeSH
DB00176	1230	fluvoxamine	PA	D049990	Membrane Transport Modulators	MeSH
DB00176	1230	fluvoxamine	PA	D018377	Neurotransmitter Agents	MeSH
DB00176	1230	fluvoxamine	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB00176	1230	fluvoxamine	PA	D011619	Psychotropic Drugs	MeSH
DB00176	1230	fluvoxamine	PA	D018490	Serotonin Agents	MeSH
DB00176	1230	fluvoxamine	PA	D017367	Serotonin Uptake Inhibitors	MeSH
DB00176	1230	fluvoxamine	PA	D014149	Tranquilizing Agents	MeSH
DB00177	2806	valsartan	MoA	N0000000070	Angiotensin 2 Receptor Antagonists	FDA
DB00177	2806	valsartan	EPC	N0000175561	Angiotensin 2 Receptor Blocker	FDA
DB00177	2806	valsartan	PA	D047228	Angiotensin II Type 1 Receptor Blockers	MeSH
DB00177	2806	valsartan	PA	D057911	Angiotensin Receptor Antagonists	MeSH
DB00177	2806	valsartan	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00177	2806	valsartan	has role	CHEBI:61016	angiotensin receptor antagonist	CHEBI
DB00177	2806	valsartan	PA	D000959	Antihypertensive Agents	MeSH
DB00177	2806	valsartan	PA	D002317	Cardiovascular Agents	MeSH
DB00180	1201	flunisolide	PA	D018927	Anti-Asthmatic Agents	MeSH
DB00180	1201	flunisolide	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00180	1201	flunisolide	has role	CHEBI:35705	immunosuppressive agent	CHEBI
DB00180	1201	flunisolide	has role	CHEBI:35472	anti-inflammatory drug	CHEBI
DB00180	1201	flunisolide	has role	CHEBI:49167	anti-asthmatic drug	CHEBI
DB00180	1201	flunisolide	PA	D019141	Respiratory System Agents	MeSH
DB00181	282	baclofen	MoA	N0000000196	GABA A Agonists	FDA
DB00181	282	baclofen	MoA	N0000000116	GABA B Agonists	FDA
DB00181	282	baclofen	EPC	N0000175759	gamma-Aminobutyric Acid-ergic Agonist	FDA
DB00181	282	baclofen	has role	CHEBI:51371	muscle relaxant	CHEBI
DB00181	282	baclofen	has role	CHEBI:35488	central nervous system depressant	CHEBI
DB00181	282	baclofen	has role	CHEBI:51373	GABA agonist	CHEBI
DB00181	282	baclofen	PA	D002491	Central Nervous System Agents	MeSH
DB00181	282	baclofen	PA	D018682	GABA Agents	MeSH
DB00181	282	baclofen	PA	D018755	GABA Agonists	MeSH
DB00181	282	baclofen	PA	D058786	GABA-B Receptor Agonists	MeSH
DB00181	282	baclofen	PA	D009125	Muscle Relaxants, Central	MeSH
DB00181	282	baclofen	PA	D009465	Neuromuscular Agents	MeSH
DB00181	282	baclofen	PA	D018377	Neurotransmitter Agents	MeSH
DB00182	195	amfetamine	EPC	N0000175739	Central Nervous System Stimulant	FDA
DB00182	195	amfetamine	PE	N0000175729	Central Nervous System Stimulation	FDA
DB00182	195	amfetamine	PA	D018663	Adrenergic Agents	MeSH
DB00182	195	amfetamine	PA	D018759	Adrenergic Uptake Inhibitors	MeSH
DB00182	195	amfetamine	has role	CHEBI:35524	sympathomimetic agent	CHEBI
DB00182	195	amfetamine	has role	CHEBI:48560	dopaminergic agent	CHEBI
DB00182	195	amfetamine	has role	CHEBI:37962	adrenergic agent	CHEBI
DB00182	195	amfetamine	has role	CHEBI:51039	dopamine uptake inhibitor	CHEBI
DB00182	195	amfetamine	has role	CHEBI:35640	adrenergic uptake inhibitor	CHEBI
DB00182	195	amfetamine	PA	D002491	Central Nervous System Agents	MeSH
DB00182	195	amfetamine	PA	D000697	Central Nervous System Stimulants	MeSH
DB00182	195	amfetamine	PA	D015259	Dopamine Agents	MeSH
DB00182	195	amfetamine	PA	D018765	Dopamine Uptake Inhibitors	MeSH
DB00182	195	amfetamine	PA	D049990	Membrane Transport Modulators	MeSH
DB00182	195	amfetamine	PA	D018377	Neurotransmitter Agents	MeSH
DB00182	195	amfetamine	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB00182	195	amfetamine	PA	D013566	Sympathomimetics	MeSH
DB01576	195	amfetamine	EPC	N0000175739	Central Nervous System Stimulant	FDA
DB01576	195	amfetamine	PE	N0000175729	Central Nervous System Stimulation	FDA
DB01576	195	amfetamine	PA	D018663	Adrenergic Agents	MeSH
DB01576	195	amfetamine	PA	D018759	Adrenergic Uptake Inhibitors	MeSH
DB01576	195	amfetamine	has role	CHEBI:35524	sympathomimetic agent	CHEBI
DB01576	195	amfetamine	has role	CHEBI:48560	dopaminergic agent	CHEBI
DB01576	195	amfetamine	has role	CHEBI:37962	adrenergic agent	CHEBI
DB01576	195	amfetamine	has role	CHEBI:51039	dopamine uptake inhibitor	CHEBI
DB01576	195	amfetamine	has role	CHEBI:35640	adrenergic uptake inhibitor	CHEBI
DB01576	195	amfetamine	PA	D002491	Central Nervous System Agents	MeSH
DB01576	195	amfetamine	PA	D000697	Central Nervous System Stimulants	MeSH
DB01576	195	amfetamine	PA	D015259	Dopamine Agents	MeSH
DB01576	195	amfetamine	PA	D018765	Dopamine Uptake Inhibitors	MeSH
DB01576	195	amfetamine	PA	D049990	Membrane Transport Modulators	MeSH
DB01576	195	amfetamine	PA	D018377	Neurotransmitter Agents	MeSH
DB01576	195	amfetamine	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB01576	195	amfetamine	PA	D013566	Sympathomimetics	MeSH
DB00185	584	cevimeline	MoA	N0000000104	Cholinergic Muscarinic Agonists	FDA
DB00185	584	cevimeline	EPC	N0000175884	Cholinergic Receptor Agonist	FDA
DB00185	584	cevimeline	has role	CHEBI:38325	muscarinic agonist	CHEBI
DB00185	584	cevimeline	PA	D018678	Cholinergic Agents	MeSH
DB00185	584	cevimeline	PA	D018679	Cholinergic Agonists	MeSH
DB00185	584	cevimeline	PA	D018721	Muscarinic Agonists	MeSH
DB00185	584	cevimeline	PA	D018377	Neurotransmitter Agents	MeSH
DB00185	584	cevimeline	PA	D010277	Parasympathomimetics	MeSH
DB00186	1606	lorazepam	EPC	N0000175694	Benzodiazepine	FDA
DB00186	1606	lorazepam	Chemical/Ingredient	N0000007542	Benzodiazepines	FDA
DB00186	1606	lorazepam	PA	D014151	Anti-Anxiety Agents	MeSH
DB00186	1606	lorazepam	PA	D000927	Anticonvulsants	MeSH
DB00186	1606	lorazepam	PA	D000932	Antiemetics	MeSH
DB00186	1606	lorazepam	PA	D002491	Central Nervous System Agents	MeSH
DB00186	1606	lorazepam	PA	D002492	Central Nervous System Depressants	MeSH
DB00186	1606	lorazepam	PA	D018682	GABA Agents	MeSH
DB00186	1606	lorazepam	PA	D018757	GABA Modulators	MeSH
DB00186	1606	lorazepam	PA	D005765	Gastrointestinal Agents	MeSH
DB00186	1606	lorazepam	PA	D006993	Hypnotics and Sedatives	MeSH
DB00186	1606	lorazepam	PA	D018377	Neurotransmitter Agents	MeSH
DB00186	1606	lorazepam	PA	D011619	Psychotropic Drugs	MeSH
DB00186	1606	lorazepam	PA	D014149	Tranquilizing Agents	MeSH
DB00187	1054	esmolol	EPC	N0000175556	beta-Adrenergic Blocker	FDA
DB00187	1054	esmolol	PA	D018663	Adrenergic Agents	MeSH
DB00187	1054	esmolol	PA	D018674	Adrenergic Antagonists	MeSH
DB00187	1054	esmolol	PA	D058671	Adrenergic beta-1 Receptor Antagonists	MeSH
DB00187	1054	esmolol	PA	D000319	Adrenergic beta-Antagonists	MeSH
DB00187	1054	esmolol	has role	CHEBI:35530	beta-adrenergic antagonist	CHEBI
DB00187	1054	esmolol	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB00187	1054	esmolol	PA	D018377	Neurotransmitter Agents	MeSH
DB00188	391	bortezomib	MoA	N0000175075	Proteasome Inhibitors	FDA
DB00188	391	bortezomib	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00188	391	bortezomib	has role	CHEBI:52726	proteasome inhibitor	CHEBI
DB00188	391	bortezomib	PA	D000970	Antineoplastic Agents	MeSH
DB07475	391	bortezomib	MoA	N0000175075	Proteasome Inhibitors	FDA
DB07475	391	bortezomib	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB07475	391	bortezomib	has role	CHEBI:52726	proteasome inhibitor	CHEBI
DB07475	391	bortezomib	PA	D000970	Antineoplastic Agents	MeSH
DB00189	1078	ethchlorvynol	has role	CHEBI:35717	sedative	CHEBI
DB00189	1078	ethchlorvynol	PA	D002491	Central Nervous System Agents	MeSH
DB00189	1078	ethchlorvynol	PA	D002492	Central Nervous System Depressants	MeSH
DB00189	1078	ethchlorvynol	PA	D006993	Hypnotics and Sedatives	MeSH
DB00190	496	carbidopa	EPC	N0000175754	Aromatic Amino Acid Decarboxylation Inhibitor	FDA
DB00190	496	carbidopa	MoA	N0000175755	DOPA Decarboxylase Inhibitors	FDA
DB00190	496	carbidopa	PA	D018726	Anti-Dyskinesia Agents	MeSH
DB00190	496	carbidopa	has role	CHEBI:66956	antidyskinesia agent	CHEBI
DB00190	496	carbidopa	has role	CHEBI:48407	antiparkinson drug	CHEBI
DB00190	496	carbidopa	has role	CHEBI:48560	dopaminergic agent	CHEBI
DB00190	496	carbidopa	PA	D000978	Antiparkinson Agents	MeSH
DB00190	496	carbidopa	PA	D065105	Aromatic Amino Acid Decarboxylase Inhibitors	MeSH
DB00190	496	carbidopa	PA	D002491	Central Nervous System Agents	MeSH
DB00190	496	carbidopa	PA	D015259	Dopamine Agents	MeSH
DB00190	496	carbidopa	PA	D004791	Enzyme Inhibitors	MeSH
DB00190	496	carbidopa	PA	D018377	Neurotransmitter Agents	MeSH
DB00191	2140	phentermine	PE	N0000175372	Appetite Suppression	FDA
DB00191	2140	phentermine	PE	N0000175651	Increased Sympathetic Activity	FDA
DB00191	2140	phentermine	EPC	N0000175423	Sympathomimetic Amine Anorectic	FDA
DB00191	2140	phentermine	PA	D018663	Adrenergic Agents	MeSH
DB00191	2140	phentermine	has role	CHEBI:48560	dopaminergic agent	CHEBI
DB00191	2140	phentermine	has role	CHEBI:37962	adrenergic agent	CHEBI
DB00191	2140	phentermine	has role	CHEBI:35524	sympathomimetic agent	CHEBI
DB00191	2140	phentermine	has role	CHEBI:50507	appetite depressant	CHEBI
DB00191	2140	phentermine	has role	CHEBI:35470	central nervous system drug	CHEBI
DB00191	2140	phentermine	has role	CHEBI:35337	central nervous system stimulant	CHEBI
DB00191	2140	phentermine	PA	D019440	Anti-Obesity Agents	MeSH
DB00191	2140	phentermine	PA	D001067	Appetite Depressants	MeSH
DB00191	2140	phentermine	PA	D002491	Central Nervous System Agents	MeSH
DB00191	2140	phentermine	PA	D000697	Central Nervous System Stimulants	MeSH
DB00191	2140	phentermine	PA	D018377	Neurotransmitter Agents	MeSH
DB00191	2140	phentermine	PA	D013566	Sympathomimetics	MeSH
DB00193	2711	tramadol	MoA	N0000175684	Full Opioid Agonists	FDA
DB00193	2711	tramadol	EPC	N0000175690	Opioid Agonist	FDA
DB00193	2711	tramadol	PA	D000700	Analgesics	MeSH
DB00193	2711	tramadol	PA	D000701	Analgesics, Opioid	MeSH
DB00193	2711	tramadol	has role	CHEBI:35640	adrenergic uptake inhibitor	CHEBI
DB00193	2711	tramadol	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00193	2711	tramadol	has role	CHEBI:35482	opioid analgesic	CHEBI
DB00193	2711	tramadol	has role	CHEBI:51177	antitussive	CHEBI
DB00193	2711	tramadol	has role	CHEBI:55322	mu-opioid receptor agonist	CHEBI
DB00193	2711	tramadol	has role	CHEBI:59282	kappa-opioid receptor agonist	CHEBI
DB00193	2711	tramadol	has role	CHEBI:50949	serotonin uptake inhibitor	CHEBI
DB00193	2711	tramadol	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB00193	2711	tramadol	has role	CHEBI:48878	nicotinic antagonist	CHEBI
DB00193	2711	tramadol	PA	D002491	Central Nervous System Agents	MeSH
DB00193	2711	tramadol	PA	D002492	Central Nervous System Depressants	MeSH
DB00193	2711	tramadol	PA	D009294	Narcotics	MeSH
DB00193	2711	tramadol	PA	D018689	Sensory System Agents	MeSH
DB00194	2818	vidarabine	PA	D000890	Anti-Infective Agents	MeSH
DB00194	2818	vidarabine	PA	D000963	Antimetabolites	MeSH
DB00194	2818	vidarabine	PA	D000998	Antiviral Agents	MeSH
DB00194	2818	vidarabine	PA	D009676	Noxae	MeSH
DB00640	2818	vidarabine	PA	D000890	Anti-Infective Agents	MeSH
DB00640	2818	vidarabine	PA	D000963	Antimetabolites	MeSH
DB00640	2818	vidarabine	PA	D000998	Antiviral Agents	MeSH
DB00640	2818	vidarabine	PA	D009676	Noxae	MeSH
DB03528	2818	vidarabine	PA	D000890	Anti-Infective Agents	MeSH
DB03528	2818	vidarabine	PA	D000963	Antimetabolites	MeSH
DB03528	2818	vidarabine	PA	D000998	Antiviral Agents	MeSH
DB03528	2818	vidarabine	PA	D009676	Noxae	MeSH
DB00194	90	adenosine	EPC	N0000178375	Adenosine Receptor Agonist	FDA
DB00194	90	adenosine	MoA	N0000175788	Adenosine Receptor Agonists	FDA
DB00194	90	adenosine	PA	D000700	Analgesics	MeSH
DB00194	90	adenosine	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB00194	90	adenosine	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB00194	90	adenosine	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00194	90	adenosine	has role	CHEBI:35480	analgesic	CHEBI
DB00194	90	adenosine	PA	D002317	Cardiovascular Agents	MeSH
DB00194	90	adenosine	PA	D002491	Central Nervous System Agents	MeSH
DB00194	90	adenosine	PA	D018377	Neurotransmitter Agents	MeSH
DB00194	90	adenosine	PA	D058906	Purinergic P1 Receptor Agonists	MeSH
DB00194	90	adenosine	PA	D018689	Sensory System Agents	MeSH
DB00194	90	adenosine	PA	D014665	Vasodilator Agents	MeSH
DB00640	90	adenosine	EPC	N0000178375	Adenosine Receptor Agonist	FDA
DB00640	90	adenosine	MoA	N0000175788	Adenosine Receptor Agonists	FDA
DB00640	90	adenosine	PA	D000700	Analgesics	MeSH
DB00640	90	adenosine	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB00640	90	adenosine	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB00640	90	adenosine	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00640	90	adenosine	has role	CHEBI:35480	analgesic	CHEBI
DB00640	90	adenosine	PA	D002317	Cardiovascular Agents	MeSH
DB00640	90	adenosine	PA	D002491	Central Nervous System Agents	MeSH
DB00640	90	adenosine	PA	D018377	Neurotransmitter Agents	MeSH
DB00640	90	adenosine	PA	D058906	Purinergic P1 Receptor Agonists	MeSH
DB00640	90	adenosine	PA	D018689	Sensory System Agents	MeSH
DB00640	90	adenosine	PA	D014665	Vasodilator Agents	MeSH
DB03528	90	adenosine	EPC	N0000178375	Adenosine Receptor Agonist	FDA
DB03528	90	adenosine	MoA	N0000175788	Adenosine Receptor Agonists	FDA
DB03528	90	adenosine	PA	D000700	Analgesics	MeSH
DB03528	90	adenosine	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB03528	90	adenosine	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB03528	90	adenosine	has role	CHEBI:35620	vasodilator agent	CHEBI
DB03528	90	adenosine	has role	CHEBI:35480	analgesic	CHEBI
DB03528	90	adenosine	PA	D002317	Cardiovascular Agents	MeSH
DB03528	90	adenosine	PA	D002491	Central Nervous System Agents	MeSH
DB03528	90	adenosine	PA	D018377	Neurotransmitter Agents	MeSH
DB03528	90	adenosine	PA	D058906	Purinergic P1 Receptor Agonists	MeSH
DB03528	90	adenosine	PA	D018689	Sensory System Agents	MeSH
DB03528	90	adenosine	PA	D014665	Vasodilator Agents	MeSH
DB00195	356	betaxolol	EPC	N0000175556	beta-Adrenergic Blocker	FDA
DB00195	356	betaxolol	PA	D018663	Adrenergic Agents	MeSH
DB00195	356	betaxolol	PA	D018674	Adrenergic Antagonists	MeSH
DB00195	356	betaxolol	PA	D058671	Adrenergic beta-1 Receptor Antagonists	MeSH
DB00195	356	betaxolol	PA	D000319	Adrenergic beta-Antagonists	MeSH
DB00195	356	betaxolol	has role	CHEBI:66991	sympatholytic agent	CHEBI
DB00195	356	betaxolol	has role	CHEBI:35530	beta-adrenergic antagonist	CHEBI
DB00195	356	betaxolol	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00195	356	betaxolol	PA	D000959	Antihypertensive Agents	MeSH
DB00195	356	betaxolol	PA	D002317	Cardiovascular Agents	MeSH
DB00195	356	betaxolol	PA	D018377	Neurotransmitter Agents	MeSH
DB00195	356	betaxolol	PA	D013565	Sympatholytics	MeSH
DB00196	1187	fluconazole	EPC	N0000175487	Azole Antifungal	FDA
DB00196	1187	fluconazole	Chemical/Ingredient	N0000008217	Azoles	FDA
DB00196	1187	fluconazole	MoA	N0000182140	Cytochrome P450 2C19 Inhibitors	FDA
DB00196	1187	fluconazole	MoA	N0000182141	Cytochrome P450 3A4 Inhibitors	FDA
DB00196	1187	fluconazole	MoA	N0000185504	Cytochrome P450 2C9 Inhibitors	FDA
DB00196	1187	fluconazole	PA	D058888	14-alpha Demethylase Inhibitors	MeSH
DB00196	1187	fluconazole	PA	D000890	Anti-Infective Agents	MeSH
DB00196	1187	fluconazole	PA	D000935	Antifungal Agents	MeSH
DB00196	1187	fluconazole	PA	D065689	Cytochrome P-450 CYP2C19 Inhibitors	MeSH
DB00196	1187	fluconazole	PA	D065688	Cytochrome P-450 CYP2C9 Inhibitors	MeSH
DB00196	1187	fluconazole	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB00196	1187	fluconazole	PA	D004791	Enzyme Inhibitors	MeSH
DB00196	1187	fluconazole	PA	D006727	Hormone Antagonists	MeSH
DB00196	1187	fluconazole	PA	D065088	Steroid Synthesis Inhibitors	MeSH
DB00197	2767	troglitazone	has role	CHEBI:50427	platelet aggregation inhibitor	CHEBI
DB00197	2767	troglitazone	has role	CHEBI:50249	anticoagulant	CHEBI
DB00197	2767	troglitazone	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00197	2767	troglitazone	has role	CHEBI:35526	hypoglycemic agent	CHEBI
DB00197	2767	troglitazone	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00197	2767	troglitazone	has role	CHEBI:35623	anticonvulsant	CHEBI
DB00197	2767	troglitazone	PA	D065701	Cytochrome P-450 CYP3A Inducers	MeSH
DB00197	2767	troglitazone	PA	D007004	Hypoglycemic Agents	MeSH
DB08607	2767	troglitazone	has role	CHEBI:50427	platelet aggregation inhibitor	CHEBI
DB08607	2767	troglitazone	has role	CHEBI:50249	anticoagulant	CHEBI
DB08607	2767	troglitazone	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB08607	2767	troglitazone	has role	CHEBI:35526	hypoglycemic agent	CHEBI
DB08607	2767	troglitazone	has role	CHEBI:35620	vasodilator agent	CHEBI
DB08607	2767	troglitazone	has role	CHEBI:35623	anticonvulsant	CHEBI
DB08607	2767	troglitazone	PA	D065701	Cytochrome P-450 CYP3A Inducers	MeSH
DB08607	2767	troglitazone	PA	D007004	Hypoglycemic Agents	MeSH
DB00201	463	caffeine	PE	N0000175729	Central Nervous System Stimulation	FDA
DB00201	463	caffeine	EPC	N0000175790	Methylxanthine	FDA
DB00201	463	caffeine	Chemical/Ingredient	N0000008118	Xanthines	FDA
DB00201	463	caffeine	has role	CHEBI:35471	psychotropic drug	CHEBI
DB00201	463	caffeine	has role	CHEBI:35498	diuretic	CHEBI
DB00201	463	caffeine	has role	CHEBI:64047	food additive	CHEBI
DB00201	463	caffeine	has role	CHEBI:60809	adjuvant	CHEBI
DB00201	463	caffeine	has role	CHEBI:35337	central nervous system stimulant	CHEBI
DB00201	463	caffeine	PA	D002491	Central Nervous System Agents	MeSH
DB00201	463	caffeine	PA	D000697	Central Nervous System Stimulants	MeSH
DB00201	463	caffeine	PA	D004791	Enzyme Inhibitors	MeSH
DB00201	463	caffeine	PA	D018377	Neurotransmitter Agents	MeSH
DB00201	463	caffeine	PA	D010726	Phosphodiesterase Inhibitors	MeSH
DB00201	463	caffeine	PA	D058914	Purinergic Antagonists	MeSH
DB00201	463	caffeine	PA	D058915	Purinergic P1 Receptor Antagonists	MeSH
DB00202	2489	suxamethonium	EPC	N0000175719	Depolarizing Neuromuscular Blocker	FDA
DB00202	2489	suxamethonium	PE	N0000175733	Neuromuscular Depolarizing Blockade	FDA
DB00202	2489	suxamethonium	has role	CHEBI:51371	muscle relaxant	CHEBI
DB00202	2489	suxamethonium	has role	CHEBI:88188	drug allergen	CHEBI
DB00202	2489	suxamethonium	has role	CHEBI:51372	neuromuscular agent	CHEBI
DB00202	2489	suxamethonium	PA	D009465	Neuromuscular Agents	MeSH
DB00202	2489	suxamethonium	PA	D009466	Neuromuscular Blocking Agents	MeSH
DB00202	2489	suxamethonium	PA	D009467	Neuromuscular Depolarizing Agents	MeSH
DB00203	2441	sildenafil	EPC	N0000175599	Phosphodiesterase 5 Inhibitor	FDA
DB00203	2441	sildenafil	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00203	2441	sildenafil	PA	D002317	Cardiovascular Agents	MeSH
DB00203	2441	sildenafil	PA	D004791	Enzyme Inhibitors	MeSH
DB00203	2441	sildenafil	PA	D058986	Phosphodiesterase 5 Inhibitors	MeSH
DB00203	2441	sildenafil	PA	D010726	Phosphodiesterase Inhibitors	MeSH
DB00203	2441	sildenafil	PA	D064804	Urological Agents	MeSH
DB00203	2441	sildenafil	PA	D014665	Vasodilator Agents	MeSH
DB00204	942	dofetilide	EPC	N0000175426	Antiarrhythmic	FDA
DB00204	942	dofetilide	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB00204	942	dofetilide	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB00204	942	dofetilide	PA	D002317	Cardiovascular Agents	MeSH
DB00204	942	dofetilide	PA	D049990	Membrane Transport Modulators	MeSH
DB00204	942	dofetilide	PA	D026902	Potassium Channel Blockers	MeSH
DB00205	2332	pyrimethamine	EPC	N0000175934	Dihydrofolate Reductase Inhibitor Antimalarial	FDA
DB00205	2332	pyrimethamine	MoA	N0000000191	Dihydrofolate Reductase Inhibitors	FDA
DB00205	2332	pyrimethamine	PA	D000890	Anti-Infective Agents	MeSH
DB00205	2332	pyrimethamine	has role	CHEBI:38068	antimalarial	CHEBI
DB00205	2332	pyrimethamine	has role	CHEBI:35820	antiprotozoal drug	CHEBI
DB00205	2332	pyrimethamine	PA	D000962	Antimalarials	MeSH
DB00205	2332	pyrimethamine	PA	D000977	Antiparasitic Agents	MeSH
DB00205	2332	pyrimethamine	PA	D000981	Antiprotozoal Agents	MeSH
DB00205	2332	pyrimethamine	PA	D004791	Enzyme Inhibitors	MeSH
DB00205	2332	pyrimethamine	PA	D005493	Folic Acid Antagonists	MeSH
DB00206	2370	reserpine	EPC	N0000175640	Catecholamine-depleting Sympatholytic	FDA
DB00206	2370	reserpine	PE	N0000175650	Decreased Sympathetic Activity	FDA
DB00206	2370	reserpine	PA	D018663	Adrenergic Agents	MeSH
DB00206	2370	reserpine	PA	D018759	Adrenergic Uptake Inhibitors	MeSH
DB00206	2370	reserpine	has role	CHEBI:65190	first generation antipsychotic	CHEBI
DB00206	2370	reserpine	has role	CHEBI:35640	adrenergic uptake inhibitor	CHEBI
DB00206	2370	reserpine	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00206	2370	reserpine	PA	D000959	Antihypertensive Agents	MeSH
DB00206	2370	reserpine	PA	D014150	Antipsychotic Agents	MeSH
DB00206	2370	reserpine	PA	D002317	Cardiovascular Agents	MeSH
DB00206	2370	reserpine	PA	D002491	Central Nervous System Agents	MeSH
DB00206	2370	reserpine	PA	D002492	Central Nervous System Depressants	MeSH
DB00206	2370	reserpine	PA	D049990	Membrane Transport Modulators	MeSH
DB00206	2370	reserpine	PA	D018377	Neurotransmitter Agents	MeSH
DB00206	2370	reserpine	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB00206	2370	reserpine	PA	D011619	Psychotropic Drugs	MeSH
DB00206	2370	reserpine	PA	D014149	Tranquilizing Agents	MeSH
DB00208	2657	ticlopidine	PE	N0000008832	Decreased Platelet Aggregation	FDA
DB00208	2657	ticlopidine	has role	CHEBI:48676	fibrin modulating drug	CHEBI
DB00208	2657	ticlopidine	has role	CHEBI:50248	hematologic agent	CHEBI
DB00208	2657	ticlopidine	has role	CHEBI:50427	platelet aggregation inhibitor	CHEBI
DB00208	2657	ticlopidine	has role	CHEBI:50249	anticoagulant	CHEBI
DB00208	2657	ticlopidine	PA	D002317	Cardiovascular Agents	MeSH
DB00208	2657	ticlopidine	PA	D065689	Cytochrome P-450 CYP2C19 Inhibitors	MeSH
DB00208	2657	ticlopidine	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB00208	2657	ticlopidine	PA	D004791	Enzyme Inhibitors	MeSH
DB00208	2657	ticlopidine	PA	D005343	Fibrinolytic Agents	MeSH
DB00208	2657	ticlopidine	PA	D006401	Hematologic Agents	MeSH
DB00208	2657	ticlopidine	PA	D018377	Neurotransmitter Agents	MeSH
DB00208	2657	ticlopidine	PA	D010975	Platelet Aggregation Inhibitors	MeSH
DB00208	2657	ticlopidine	PA	D058914	Purinergic Antagonists	MeSH
DB00208	2657	ticlopidine	PA	D058919	Purinergic P2 Receptor Antagonists	MeSH
DB00208	2657	ticlopidine	PA	D058921	Purinergic P2Y Receptor Antagonists	MeSH
DB00209	2776	trospium	EPC	N0000175700	Cholinergic Muscarinic Antagonist	FDA
DB00209	2776	trospium	MoA	N0000000125	Cholinergic Muscarinic Antagonists	FDA
DB00209	2776	trospium	PA	D018678	Cholinergic Agents	MeSH
DB00209	2776	trospium	PA	D018680	Cholinergic Antagonists	MeSH
DB00209	2776	trospium	PA	D018727	Muscarinic Antagonists	MeSH
DB00209	2776	trospium	PA	D018377	Neurotransmitter Agents	MeSH
DB00209	2776	trospium	PA	D010276	Parasympatholytics	MeSH
DB00209	2776	trospium	PA	D064804	Urological Agents	MeSH
DB00210	87	adapalene	EPC	N0000175607	Retinoid	FDA
DB00210	87	adapalene	Chemical/Ingredient	N0000007700	Retinoids	FDA
DB00210	87	adapalene	PA	D000700	Analgesics	MeSH
DB00210	87	adapalene	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00210	87	adapalene	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00210	87	adapalene	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00210	87	adapalene	has role	CHEBI:50177	dermatologic drug	CHEBI
DB00210	87	adapalene	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00210	87	adapalene	PA	D018501	Antirheumatic Agents	MeSH
DB00210	87	adapalene	PA	D003879	Dermatologic Agents	MeSH
DB00210	87	adapalene	PA	D018689	Sensory System Agents	MeSH
DB00211	1803	midodrine	PA	D018663	Adrenergic Agents	MeSH
DB00211	1803	midodrine	PA	D000322	Adrenergic Agonists	MeSH
DB00211	1803	midodrine	PA	D058646	Adrenergic alpha-1 Receptor Agonists	MeSH
DB00211	1803	midodrine	PA	D000316	Adrenergic alpha-Agonists	MeSH
DB00211	1803	midodrine	has role	CHEBI:50266	prodrug	CHEBI
DB00211	1803	midodrine	has role	CHEBI:35569	alpha-adrenergic agonist	CHEBI
DB00211	1803	midodrine	has role	CHEBI:35524	sympathomimetic agent	CHEBI
DB00211	1803	midodrine	has role	CHEBI:50514	vasoconstrictor agent	CHEBI
DB00211	1803	midodrine	PA	D002317	Cardiovascular Agents	MeSH
DB00211	1803	midodrine	PA	D018377	Neurotransmitter Agents	MeSH
DB00211	1803	midodrine	PA	D013566	Sympathomimetics	MeSH
DB00211	1803	midodrine	PA	D014662	Vasoconstrictor Agents	MeSH
DB00212	4696	remikiren	PA	D000959	Antihypertensive Agents	MeSH
DB00212	4696	remikiren	PA	D002317	Cardiovascular Agents	MeSH
DB00212	4696	remikiren	PA	D004791	Enzyme Inhibitors	MeSH
DB00212	4696	remikiren	PA	D011480	Protease Inhibitors	MeSH
DB00213	2054	pantoprazole	EPC	N0000175525	Proton Pump Inhibitor	FDA
DB00213	2054	pantoprazole	has role	CHEBI:49201	anti-ulcer drug	CHEBI
DB00213	2054	pantoprazole	PA	D000897	Anti-Ulcer Agents	MeSH
DB00213	2054	pantoprazole	PA	D004791	Enzyme Inhibitors	MeSH
DB00213	2054	pantoprazole	PA	D005765	Gastrointestinal Agents	MeSH
DB00213	2054	pantoprazole	PA	D054328	Proton Pump Inhibitors	MeSH
DB00214	2708	torsemide	PE	N0000175366	Increased Diuresis at Loop of Henle	FDA
DB00214	2708	torsemide	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00214	2708	torsemide	has role	CHEBI:77608	loop diuretic	CHEBI
DB00214	2708	torsemide	PA	D000959	Antihypertensive Agents	MeSH
DB00214	2708	torsemide	PA	D002317	Cardiovascular Agents	MeSH
DB00214	2708	torsemide	PA	D004232	Diuretics	MeSH
DB00214	2708	torsemide	PA	D049990	Membrane Transport Modulators	MeSH
DB00214	2708	torsemide	PA	D045283	Natriuretic Agents	MeSH
DB00214	2708	torsemide	PA	D049994	Sodium Potassium Chloride Symporter Inhibitors	MeSH
DB00215	1053	escitalopram	EPC	N0000175696	Serotonin Reuptake Inhibitor	FDA
DB00215	1053	escitalopram	MoA	N0000000109	Serotonin Uptake Inhibitors	FDA
DB00215	1053	escitalopram	has role	CHEBI:35469	antidepressant	CHEBI
DB01175	1053	escitalopram	EPC	N0000175696	Serotonin Reuptake Inhibitor	FDA
DB01175	1053	escitalopram	MoA	N0000000109	Serotonin Uptake Inhibitors	FDA
DB01175	1053	escitalopram	has role	CHEBI:35469	antidepressant	CHEBI
DB00215	663	citalopram	has role	CHEBI:50949	serotonin uptake inhibitor	CHEBI
DB00215	663	citalopram	PA	D000928	Antidepressive Agents	MeSH
DB00215	663	citalopram	PA	D018687	Antidepressive Agents, Second-Generation	MeSH
DB00215	663	citalopram	PA	D002491	Central Nervous System Agents	MeSH
DB00215	663	citalopram	PA	D049990	Membrane Transport Modulators	MeSH
DB00215	663	citalopram	PA	D018377	Neurotransmitter Agents	MeSH
DB00215	663	citalopram	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB00215	663	citalopram	PA	D011619	Psychotropic Drugs	MeSH
DB00215	663	citalopram	PA	D018490	Serotonin Agents	MeSH
DB00215	663	citalopram	PA	D017367	Serotonin Uptake Inhibitors	MeSH
DB01175	663	citalopram	has role	CHEBI:50949	serotonin uptake inhibitor	CHEBI
DB01175	663	citalopram	PA	D000928	Antidepressive Agents	MeSH
DB01175	663	citalopram	PA	D018687	Antidepressive Agents, Second-Generation	MeSH
DB01175	663	citalopram	PA	D002491	Central Nervous System Agents	MeSH
DB01175	663	citalopram	PA	D049990	Membrane Transport Modulators	MeSH
DB01175	663	citalopram	PA	D018377	Neurotransmitter Agents	MeSH
DB01175	663	citalopram	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB01175	663	citalopram	PA	D011619	Psychotropic Drugs	MeSH
DB01175	663	citalopram	PA	D018490	Serotonin Agents	MeSH
DB01175	663	citalopram	PA	D017367	Serotonin Uptake Inhibitors	MeSH
DB00216	995	eletriptan	MoA	N0000175763	Serotonin 1b Receptor Agonists	FDA
DB00216	995	eletriptan	MoA	N0000175764	Serotonin 1d Receptor Agonists	FDA
DB00216	995	eletriptan	EPC	N0000175765	Serotonin-1b and Serotonin-1d Receptor Agonist	FDA
DB00216	995	eletriptan	has role	CHEBI:35941	serotonergic agonist	CHEBI
DB00216	995	eletriptan	has role	CHEBI:50514	vasoconstrictor agent	CHEBI
DB00216	995	eletriptan	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00216	995	eletriptan	PA	D018377	Neurotransmitter Agents	MeSH
DB00216	995	eletriptan	PA	D018490	Serotonin Agents	MeSH
DB00216	995	eletriptan	PA	D017366	Serotonin Receptor Agonists	MeSH
DB00217	359	betanidine	PA	D018663	Adrenergic Agents	MeSH
DB00217	359	betanidine	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00217	359	betanidine	has role	CHEBI:37887	adrenergic antagonist	CHEBI
DB00217	359	betanidine	PA	D000959	Antihypertensive Agents	MeSH
DB00217	359	betanidine	PA	D002317	Cardiovascular Agents	MeSH
DB00217	359	betanidine	PA	D018377	Neurotransmitter Agents	MeSH
DB00217	359	betanidine	PA	D013565	Sympatholytics	MeSH
DB00218	1854	moxifloxacin	EPC	N0000175937	Quinolone Antimicrobial	FDA
DB00218	1854	moxifloxacin	Chemical/Ingredient	N0000007606	Quinolones	FDA
DB00218	1854	moxifloxacin	PA	D000900	Anti-Bacterial Agents	MeSH
DB00218	1854	moxifloxacin	PA	D000890	Anti-Infective Agents	MeSH
DB00218	1854	moxifloxacin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00218	1854	moxifloxacin	PA	D000970	Antineoplastic Agents	MeSH
DB00218	1854	moxifloxacin	PA	D004791	Enzyme Inhibitors	MeSH
DB00218	1854	moxifloxacin	PA	D059005	Topoisomerase II Inhibitors	MeSH
DB00219	2039	oxyphenonium	PA	D018678	Cholinergic Agents	MeSH
DB00219	2039	oxyphenonium	PA	D018680	Cholinergic Antagonists	MeSH
DB00219	2039	oxyphenonium	PA	D018727	Muscarinic Antagonists	MeSH
DB00219	2039	oxyphenonium	PA	D009184	Mydriatics	MeSH
DB00219	2039	oxyphenonium	PA	D018377	Neurotransmitter Agents	MeSH
DB00219	2039	oxyphenonium	PA	D010276	Parasympatholytics	MeSH
DB00220	1893	nelfinavir	EPC	N0000175889	Protease Inhibitor	FDA
DB00220	1893	nelfinavir	PA	D019380	Anti-HIV Agents	MeSH
DB00220	1893	nelfinavir	PA	D000890	Anti-Infective Agents	MeSH
DB00220	1893	nelfinavir	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00220	1893	nelfinavir	PA	D000998	Antiviral Agents	MeSH
DB00220	1893	nelfinavir	PA	D004791	Enzyme Inhibitors	MeSH
DB00220	1893	nelfinavir	PA	D017320	HIV Protease Inhibitors	MeSH
DB00220	1893	nelfinavir	PA	D011480	Protease Inhibitors	MeSH
DB05251	1893	nelfinavir	EPC	N0000175889	Protease Inhibitor	FDA
DB05251	1893	nelfinavir	PA	D019380	Anti-HIV Agents	MeSH
DB05251	1893	nelfinavir	PA	D000890	Anti-Infective Agents	MeSH
DB05251	1893	nelfinavir	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB05251	1893	nelfinavir	PA	D000998	Antiviral Agents	MeSH
DB05251	1893	nelfinavir	PA	D004791	Enzyme Inhibitors	MeSH
DB05251	1893	nelfinavir	PA	D017320	HIV Protease Inhibitors	MeSH
DB05251	1893	nelfinavir	PA	D011480	Protease Inhibitors	MeSH
DB00221	1491	isoetarine	PA	D018663	Adrenergic Agents	MeSH
DB00221	1491	isoetarine	PA	D000322	Adrenergic Agonists	MeSH
DB00221	1491	isoetarine	PA	D058666	Adrenergic beta-2 Receptor Agonists	MeSH
DB00221	1491	isoetarine	PA	D000318	Adrenergic beta-Agonists	MeSH
DB00221	1491	isoetarine	PA	D018927	Anti-Asthmatic Agents	MeSH
DB00221	1491	isoetarine	PA	D001993	Bronchodilator Agents	MeSH
DB00221	1491	isoetarine	PA	D018377	Neurotransmitter Agents	MeSH
DB00221	1491	isoetarine	PA	D019141	Respiratory System Agents	MeSH
DB00222	1300	glimepiride	EPC	N0000175608	Sulfonylurea	FDA
DB00222	1300	glimepiride	Chemical/Ingredient	N0000008054	Sulfonylurea Compounds	FDA
DB00222	1300	glimepiride	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB00222	1300	glimepiride	has role	CHEBI:35526	hypoglycemic agent	CHEBI
DB00222	1300	glimepiride	PA	D002317	Cardiovascular Agents	MeSH
DB00222	1300	glimepiride	PA	D007004	Hypoglycemic Agents	MeSH
DB00222	1300	glimepiride	PA	D007155	Immunologic Factors	MeSH
DB00222	1300	glimepiride	PA	D007166	Immunosuppressive Agents	MeSH
DB00223	4485	diflorasone diacetate	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00223	4485	diflorasone diacetate	PA	D005938	Glucocorticoids	MeSH
DB00223	4485	diflorasone diacetate	PA	D006728	Hormones	MeSH
DB00224	1437	indinavir	PA	D019380	Anti-HIV Agents	MeSH
DB00224	1437	indinavir	PA	D000890	Anti-Infective Agents	MeSH
DB00224	1437	indinavir	PA	D000998	Antiviral Agents	MeSH
DB00224	1437	indinavir	PA	D004791	Enzyme Inhibitors	MeSH
DB00224	1437	indinavir	PA	D017320	HIV Protease Inhibitors	MeSH
DB00224	1437	indinavir	PA	D011480	Protease Inhibitors	MeSH
DB00226	1339	guanadrel	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00226	1339	guanadrel	has role	CHEBI:37887	adrenergic antagonist	CHEBI
DB00226	1339	guanadrel	PA	D000959	Antihypertensive Agents	MeSH
DB00226	1339	guanadrel	PA	D002317	Cardiovascular Agents	MeSH
DB00227	1612	lovastatin	EPC	N0000175589	HMG-CoA Reductase Inhibitor	FDA
DB00227	1612	lovastatin	has role	CHEBI:50266	prodrug	CHEBI
DB00227	1612	lovastatin	has role	CHEBI:35821	anticholesteremic drug	CHEBI
DB00227	1612	lovastatin	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00227	1612	lovastatin	PA	D000924	Anticholesteremic Agents	MeSH
DB00227	1612	lovastatin	PA	D000963	Antimetabolites	MeSH
DB00227	1612	lovastatin	PA	D004791	Enzyme Inhibitors	MeSH
DB00227	1612	lovastatin	PA	D019161	Hydroxymethylglutaryl-CoA Reductase Inhibitors	MeSH
DB00227	1612	lovastatin	PA	D000960	Hypolipidemic Agents	MeSH
DB00228	1009	enflurane	PE	N0000175975	General Anesthesia	FDA
DB00228	1009	enflurane	EPC	N0000175681	General Anesthetic	FDA
DB00228	1009	enflurane	PA	D000777	Anesthetics	MeSH
DB00228	1009	enflurane	PA	D018685	Anesthetics, Inhalation	MeSH
DB00228	1009	enflurane	has role	CHEBI:38867	anaesthetic	CHEBI
DB00228	1009	enflurane	PA	D002491	Central Nervous System Agents	MeSH
DB00228	1009	enflurane	PA	D002492	Central Nervous System Depressants	MeSH
DB00229	548	cefotiam	PA	D000900	Anti-Bacterial Agents	MeSH
DB00229	548	cefotiam	PA	D000890	Anti-Infective Agents	MeSH
DB00229	548	cefotiam	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00230	2255	pregabalin	PA	D000700	Analgesics	MeSH
DB00230	2255	pregabalin	PA	D014151	Anti-Anxiety Agents	MeSH
DB00230	2255	pregabalin	has role	CHEBI:35623	anticonvulsant	CHEBI
DB00230	2255	pregabalin	PA	D000927	Anticonvulsants	MeSH
DB00230	2255	pregabalin	PA	D002121	Calcium Channel Blockers	MeSH
DB00230	2255	pregabalin	PA	D002317	Cardiovascular Agents	MeSH
DB00230	2255	pregabalin	PA	D002491	Central Nervous System Agents	MeSH
DB00230	2255	pregabalin	PA	D002492	Central Nervous System Depressants	MeSH
DB00230	2255	pregabalin	PA	D049990	Membrane Transport Modulators	MeSH
DB00230	2255	pregabalin	PA	D011619	Psychotropic Drugs	MeSH
DB00230	2255	pregabalin	PA	D018689	Sensory System Agents	MeSH
DB00230	2255	pregabalin	PA	D014149	Tranquilizing Agents	MeSH
DB00231	2585	temazepam	EPC	N0000175694	Benzodiazepine	FDA
DB00231	2585	temazepam	Chemical/Ingredient	N0000007542	Benzodiazepines	FDA
DB00231	2585	temazepam	PA	D014151	Anti-Anxiety Agents	MeSH
DB00231	2585	temazepam	PA	D002491	Central Nervous System Agents	MeSH
DB00231	2585	temazepam	PA	D002492	Central Nervous System Depressants	MeSH
DB00231	2585	temazepam	PA	D018682	GABA Agents	MeSH
DB00231	2585	temazepam	PA	D018757	GABA Modulators	MeSH
DB00231	2585	temazepam	PA	D006993	Hypnotics and Sedatives	MeSH
DB00231	2585	temazepam	PA	D018377	Neurotransmitter Agents	MeSH
DB00231	2585	temazepam	PA	D011619	Psychotropic Drugs	MeSH
DB00231	2585	temazepam	PA	D014149	Tranquilizing Agents	MeSH
DB00232	1759	methylclothiazide	PE	N0000175359	Increased Diuresis	FDA
DB00232	1759	methylclothiazide	EPC	N0000175419	Thiazide Diuretic	FDA
DB00232	1759	methylclothiazide	Chemical/Ingredient	N0000166469	Thiazides	FDA
DB00232	1759	methylclothiazide	PA	D004232	Diuretics	MeSH
DB00232	1759	methylclothiazide	PA	D049990	Membrane Transport Modulators	MeSH
DB00232	1759	methylclothiazide	PA	D045283	Natriuretic Agents	MeSH
DB00232	1759	methylclothiazide	PA	D049993	Sodium Chloride Symporter Inhibitors	MeSH
DB00233	2050	aminosalicylic acid	PA	D000900	Anti-Bacterial Agents	MeSH
DB00233	2050	aminosalicylic acid	PA	D000890	Anti-Infective Agents	MeSH
DB00233	2050	aminosalicylic acid	has role	CHEBI:33231	antitubercular agent	CHEBI
DB00233	2050	aminosalicylic acid	PA	D000995	Antitubercular Agents	MeSH
DB00235	1809	milrinone	EPC	N0000175598	Phosphodiesterase 3 Inhibitor	FDA
DB00235	1809	milrinone	has role	CHEBI:50427	platelet aggregation inhibitor	CHEBI
DB00235	1809	milrinone	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00235	1809	milrinone	has role	CHEBI:38147	cardiotonic drug	CHEBI
DB00235	1809	milrinone	PA	D002316	Cardiotonic Agents	MeSH
DB00235	1809	milrinone	PA	D002317	Cardiovascular Agents	MeSH
DB00235	1809	milrinone	PA	D004791	Enzyme Inhibitors	MeSH
DB00235	1809	milrinone	PA	D006401	Hematologic Agents	MeSH
DB00235	1809	milrinone	PA	D058987	Phosphodiesterase 3 Inhibitors	MeSH
DB00235	1809	milrinone	PA	D010726	Phosphodiesterase Inhibitors	MeSH
DB00235	1809	milrinone	PA	D010975	Platelet Aggregation Inhibitors	MeSH
DB00235	1809	milrinone	PA	D020011	Protective Agents	MeSH
DB00235	1809	milrinone	PA	D014665	Vasodilator Agents	MeSH
DB00237	439	secbutabarbital	PA	D002491	Central Nervous System Agents	MeSH
DB00237	439	secbutabarbital	PA	D002492	Central Nervous System Depressants	MeSH
DB00237	439	secbutabarbital	PA	D006993	Hypnotics and Sedatives	MeSH
DB00238	1904	nevirapine	EPC	N0000175463	Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor	FDA
DB00238	1904	nevirapine	Chemical/Ingredient	N0000175460	Non-Nucleoside Analog	FDA
DB00238	1904	nevirapine	MoA	N0000009948	Non-Nucleoside Reverse Transcriptase Inhibitors	FDA
DB00238	1904	nevirapine	MoA	N0000190118	Cytochrome P450 3A Inducers	FDA
DB00238	1904	nevirapine	MoA	N0000187064	Cytochrome P450 2B6 Inducers	FDA
DB00238	1904	nevirapine	PA	D019380	Anti-HIV Agents	MeSH
DB00238	1904	nevirapine	PA	D000890	Anti-Infective Agents	MeSH
DB00238	1904	nevirapine	has role	CHEBI:36044	antiviral drug	CHEBI
DB00238	1904	nevirapine	PA	D000998	Antiviral Agents	MeSH
DB00238	1904	nevirapine	PA	D065701	Cytochrome P-450 CYP3A Inducers	MeSH
DB00238	1904	nevirapine	PA	D004791	Enzyme Inhibitors	MeSH
DB00238	1904	nevirapine	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB00238	1904	nevirapine	PA	D018894	Reverse Transcriptase Inhibitors	MeSH
DB00239	3408	oxiconazole	EPC	N0000175487	Azole Antifungal	FDA
DB00239	3408	oxiconazole	Chemical/Ingredient	N0000008217	Azoles	FDA
DB00239	3408	oxiconazole	PA	D000890	Anti-Infective Agents	MeSH
DB00239	3408	oxiconazole	has role	CHEBI:35441	antiinfective agent	CHEBI
DB00239	3408	oxiconazole	PA	D000935	Antifungal Agents	MeSH
DB00240	4493	alclometasone dipropionate	EPC	N0000175576	Corticosteroid	FDA
DB00240	4493	alclometasone dipropionate	MoA	N0000175450	Corticosteroid Hormone Receptor Agonists	FDA
DB00240	4493	alclometasone dipropionate	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00240	4493	alclometasone dipropionate	has role	CHEBI:35472	anti-inflammatory drug	CHEBI
DB00240	4493	alclometasone dipropionate	PA	D005938	Glucocorticoids	MeSH
DB00240	4493	alclometasone dipropionate	PA	D006728	Hormones	MeSH
DB00241	441	butalbital	EPC	N0000175693	Barbiturate	FDA
DB00241	441	butalbital	Chemical/Ingredient	N0000008016	Barbiturates	FDA
DB00241	441	butalbital	has role	CHEBI:35717	sedative	CHEBI
DB00241	441	butalbital	has role	CHEBI:35480	analgesic	CHEBI
DB00243	2359	ranolazine	EPC	N0000175427	Anti-anginal	FDA
DB00243	2359	ranolazine	MoA	N0000190114	Cytochrome P450 3A Inhibitors	FDA
DB00243	2359	ranolazine	MoA	N0000185503	P-Glycoprotein Inhibitors	FDA
DB00243	2359	ranolazine	MoA	N0000182137	Cytochrome P450 2D6 Inhibitors	FDA
DB00243	2359	ranolazine	MoA	N0000187061	Organic Cation Transporter 2 Inhibitors	FDA
DB00243	2359	ranolazine	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB00243	2359	ranolazine	PA	D002317	Cardiovascular Agents	MeSH
DB00243	2359	ranolazine	PA	D049990	Membrane Transport Modulators	MeSH
DB00243	2359	ranolazine	PA	D026941	Sodium Channel Blockers	MeSH
DB00244	1710	mesalazine	EPC	N0000175781	Aminosalicylate	FDA
DB00244	1710	mesalazine	Chemical/Ingredient	N0000005760	Aminosalicylic Acids	FDA
DB00244	1710	mesalazine	PA	D000700	Analgesics	MeSH
DB00244	1710	mesalazine	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00244	1710	mesalazine	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00244	1710	mesalazine	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00244	1710	mesalazine	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00244	1710	mesalazine	PA	D018501	Antirheumatic Agents	MeSH
DB00244	1710	mesalazine	PA	D018689	Sensory System Agents	MeSH
DB00245	333	benzatropine	EPC	N0000175574	Anticholinergic	FDA
DB00245	333	benzatropine	EPC	N0000175750	Antihistamine	FDA
DB00245	333	benzatropine	MoA	N0000000207	Histamine Receptor Antagonists	FDA
DB00245	333	benzatropine	PA	D018726	Anti-Dyskinesia Agents	MeSH
DB00245	333	benzatropine	has role	CHEBI:66956	antidyskinesia agent	CHEBI
DB00245	333	benzatropine	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00245	333	benzatropine	has role	CHEBI:48407	antiparkinson drug	CHEBI
DB00245	333	benzatropine	has role	CHEBI:50370	parasympatholytic	CHEBI
DB00245	333	benzatropine	PA	D000978	Antiparkinson Agents	MeSH
DB00245	333	benzatropine	PA	D002491	Central Nervous System Agents	MeSH
DB00245	333	benzatropine	PA	D018678	Cholinergic Agents	MeSH
DB00245	333	benzatropine	PA	D018680	Cholinergic Antagonists	MeSH
DB00245	333	benzatropine	PA	D015259	Dopamine Agents	MeSH
DB00245	333	benzatropine	PA	D018765	Dopamine Uptake Inhibitors	MeSH
DB00245	333	benzatropine	PA	D049990	Membrane Transport Modulators	MeSH
DB00245	333	benzatropine	PA	D018727	Muscarinic Antagonists	MeSH
DB00245	333	benzatropine	PA	D018377	Neurotransmitter Agents	MeSH
DB00245	333	benzatropine	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB00245	333	benzatropine	PA	D010276	Parasympatholytics	MeSH
DB00246	2865	ziprasidone	EPC	N0000175430	Atypical Antipsychotic	FDA
DB00246	2865	ziprasidone	has role	CHEBI:35471	psychotropic drug	CHEBI
DB00246	2865	ziprasidone	has role	CHEBI:37956	histamine antagonist	CHEBI
DB00246	2865	ziprasidone	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00246	2865	ziprasidone	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB00246	2865	ziprasidone	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB00246	2865	ziprasidone	has role	CHEBI:35476	antipsychotic agent	CHEBI
DB00246	2865	ziprasidone	PA	D014150	Antipsychotic Agents	MeSH
DB00246	2865	ziprasidone	PA	D002491	Central Nervous System Agents	MeSH
DB00246	2865	ziprasidone	PA	D002492	Central Nervous System Depressants	MeSH
DB00246	2865	ziprasidone	PA	D015259	Dopamine Agents	MeSH
DB00246	2865	ziprasidone	PA	D018492	Dopamine Antagonists	MeSH
DB00246	2865	ziprasidone	PA	D018377	Neurotransmitter Agents	MeSH
DB00246	2865	ziprasidone	PA	D011619	Psychotropic Drugs	MeSH
DB00246	2865	ziprasidone	PA	D018490	Serotonin Agents	MeSH
DB00246	2865	ziprasidone	PA	D012702	Serotonin Antagonists	MeSH
DB00246	2865	ziprasidone	PA	D014149	Tranquilizing Agents	MeSH
DB00247	1775	methysergide	has role	CHEBI:66991	sympatholytic agent	CHEBI
DB00247	1775	methysergide	has role	CHEBI:50514	vasoconstrictor agent	CHEBI
DB00247	1775	methysergide	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB00247	1775	methysergide	PA	D002317	Cardiovascular Agents	MeSH
DB00247	1775	methysergide	PA	D018377	Neurotransmitter Agents	MeSH
DB00247	1775	methysergide	PA	D018490	Serotonin Agents	MeSH
DB00247	1775	methysergide	PA	D012702	Serotonin Antagonists	MeSH
DB00247	1775	methysergide	PA	D014662	Vasoconstrictor Agents	MeSH
DB00248	460	cabergoline	Chemical/Ingredient	N0000007618	Ergolines	FDA
DB00248	460	cabergoline	EPC	N0000175827	Ergot Derivative	FDA
DB00248	460	cabergoline	PA	D018726	Anti-Dyskinesia Agents	MeSH
DB00248	460	cabergoline	has role	CHEBI:51065	dopamine agonist	CHEBI
DB00248	460	cabergoline	has role	CHEBI:48407	antiparkinson drug	CHEBI
DB00248	460	cabergoline	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00248	460	cabergoline	PA	D000970	Antineoplastic Agents	MeSH
DB00248	460	cabergoline	PA	D000978	Antiparkinson Agents	MeSH
DB00248	460	cabergoline	PA	D002491	Central Nervous System Agents	MeSH
DB00248	460	cabergoline	PA	D015259	Dopamine Agents	MeSH
DB00248	460	cabergoline	PA	D018491	Dopamine Agonists	MeSH
DB00248	460	cabergoline	PA	D018377	Neurotransmitter Agents	MeSH
DB00250	782	dapsone	EPC	N0000175881	Sulfone	FDA
DB00250	782	dapsone	Chemical/Ingredient	N0000008053	Sulfones	FDA
DB00250	782	dapsone	PA	D000900	Anti-Bacterial Agents	MeSH
DB00250	782	dapsone	PA	D000890	Anti-Infective Agents	MeSH
DB00250	782	dapsone	has role	CHEBI:38068	antimalarial	CHEBI
DB00250	782	dapsone	has role	CHEBI:35816	leprostatic drug	CHEBI
DB00250	782	dapsone	has role	CHEBI:35441	antiinfective agent	CHEBI
DB00250	782	dapsone	has role	CHEBI:35472	anti-inflammatory drug	CHEBI
DB00250	782	dapsone	PA	D000962	Antimalarials	MeSH
DB00250	782	dapsone	PA	D000977	Antiparasitic Agents	MeSH
DB00250	782	dapsone	PA	D000981	Antiprotozoal Agents	MeSH
DB00250	782	dapsone	PA	D004791	Enzyme Inhibitors	MeSH
DB00250	782	dapsone	PA	D005493	Folic Acid Antagonists	MeSH
DB00250	782	dapsone	PA	D007917	Leprostatic Agents	MeSH
DB00251	2599	terconazole	EPC	N0000175487	Azole Antifungal	FDA
DB00251	2599	terconazole	Chemical/Ingredient	N0000008217	Azoles	FDA
DB00251	2599	terconazole	PA	D000890	Anti-Infective Agents	MeSH
DB00251	2599	terconazole	PA	D000935	Antifungal Agents	MeSH
DB00252	2152	phenytoin	EPC	N0000175753	Anti-epileptic Agent	FDA
DB00252	2152	phenytoin	PE	N0000008486	Decreased Central Nervous System Disorganized Electrical Activity	FDA
DB00252	2152	phenytoin	MoA	N0000191266	Cytochrome P450 1A2 Inducers	FDA
DB00252	2152	phenytoin	MoA	N0000187064	Cytochrome P450 2B6 Inducers	FDA
DB00252	2152	phenytoin	MoA	N0000187063	Cytochrome P450 2C8 Inducers	FDA
DB00252	2152	phenytoin	MoA	N0000185607	Cytochrome P450 2C19 Inducers	FDA
DB00252	2152	phenytoin	MoA	N0000191267	Cytochrome P450 2D6 Inducers	FDA
DB00252	2152	phenytoin	MoA	N0000190118	Cytochrome P450 3A Inducers	FDA
DB00252	2152	phenytoin	MoA	N0000185507	Cytochrome P450 2C9 Inducers	FDA
DB00252	2152	phenytoin	PA	D000927	Anticonvulsants	MeSH
DB00252	2152	phenytoin	PA	D002317	Cardiovascular Agents	MeSH
DB00252	2152	phenytoin	PA	D002491	Central Nervous System Agents	MeSH
DB00252	2152	phenytoin	PA	D065694	Cytochrome P-450 CYP1A2 Inducers	MeSH
DB00252	2152	phenytoin	PA	D049990	Membrane Transport Modulators	MeSH
DB00252	2152	phenytoin	PA	D026941	Sodium Channel Blockers	MeSH
DB00252	2152	phenytoin	PA	D061567	Voltage-Gated Sodium Channel Blockers	MeSH
DB00253	1662	medrysone	EPC	N0000175576	Corticosteroid	FDA
DB00253	1662	medrysone	MoA	N0000175450	Corticosteroid Hormone Receptor Agonists	FDA
DB00253	1662	medrysone	PA	D005938	Glucocorticoids	MeSH
DB00253	1662	medrysone	PA	D006728	Hormones	MeSH
DB00254	961	doxycycline	EPC	N0000175882	Tetracycline-class Drug	FDA
DB00254	961	doxycycline	Chemical/Ingredient	N0000007948	Tetracyclines	FDA
DB00254	961	doxycycline	PA	D000900	Anti-Bacterial Agents	MeSH
DB00254	961	doxycycline	PA	D000890	Anti-Infective Agents	MeSH
DB00254	961	doxycycline	has role	CHEBI:38068	antimalarial	CHEBI
DB00254	961	doxycycline	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00254	961	doxycycline	PA	D000962	Antimalarials	MeSH
DB00254	961	doxycycline	PA	D000977	Antiparasitic Agents	MeSH
DB00254	961	doxycycline	PA	D000981	Antiprotozoal Agents	MeSH
DB00255	875	diethylstilbestrol	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00255	875	diethylstilbestrol	PA	D002273	Carcinogens	MeSH
DB00255	875	diethylstilbestrol	PA	D004967	Estrogens	MeSH
DB00255	875	diethylstilbestrol	PA	D004968	Estrogens, Non-Steroidal	MeSH
DB00255	875	diethylstilbestrol	PA	D006728	Hormones	MeSH
DB00255	875	diethylstilbestrol	PA	D009676	Noxae	MeSH
DB00257	719	clotrimazole	EPC	N0000175487	Azole Antifungal	FDA
DB00257	719	clotrimazole	Chemical/Ingredient	N0000008217	Azoles	FDA
DB00257	719	clotrimazole	PA	D058888	14-alpha Demethylase Inhibitors	MeSH
DB00257	719	clotrimazole	PA	D000890	Anti-Infective Agents	MeSH
DB00257	719	clotrimazole	PA	D000891	Anti-Infective Agents, Local	MeSH
DB00257	719	clotrimazole	has role	CHEBI:35441	antiinfective agent	CHEBI
DB00257	719	clotrimazole	PA	D000935	Antifungal Agents	MeSH
DB00257	719	clotrimazole	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB00257	719	clotrimazole	PA	D004791	Enzyme Inhibitors	MeSH
DB00257	719	clotrimazole	PA	D006727	Hormone Antagonists	MeSH
DB00257	719	clotrimazole	PA	D065088	Steroid Synthesis Inhibitors	MeSH
DB00259	2521	sulfanilamide	PA	D000900	Anti-Bacterial Agents	MeSH
DB00259	2521	sulfanilamide	PA	D000890	Anti-Infective Agents	MeSH
DB00260	759	cycloserine	PA	D000900	Anti-Bacterial Agents	MeSH
DB00260	759	cycloserine	PA	D000890	Anti-Infective Agents	MeSH
DB00260	759	cycloserine	PA	D000892	Anti-Infective Agents, Urinary	MeSH
DB00260	759	cycloserine	has role	CHEBI:64571	NMDA receptor agonist	CHEBI
DB00260	759	cycloserine	has role	CHEBI:35441	antiinfective agent	CHEBI
DB00260	759	cycloserine	has role	CHEBI:33231	antitubercular agent	CHEBI
DB00260	759	cycloserine	PA	D000904	Antibiotics, Antitubercular	MeSH
DB00260	759	cycloserine	PA	D000963	Antimetabolites	MeSH
DB00260	759	cycloserine	PA	D000995	Antitubercular Agents	MeSH
DB00260	759	cycloserine	PA	D009676	Noxae	MeSH
DB00261	209	anagrelide	PE	N0000175972	Decreased Platelet Production	FDA
DB00261	209	anagrelide	EPC	N0000175638	Platelet-reducing Agent	FDA
DB00261	209	anagrelide	MoA	N0000175086	Phosphodiesterase 3 Inhibitors	FDA
DB00261	209	anagrelide	has role	CHEBI:50249	anticoagulant	CHEBI
DB00261	209	anagrelide	has role	CHEBI:50427	platelet aggregation inhibitor	CHEBI
DB00261	209	anagrelide	has role	CHEBI:48675	antifibrinolytic drug	CHEBI
DB00261	209	anagrelide	has role	CHEBI:35554	cardiovascular drug	CHEBI
DB00261	209	anagrelide	PA	D002317	Cardiovascular Agents	MeSH
DB00261	209	anagrelide	PA	D005343	Fibrinolytic Agents	MeSH
DB00261	209	anagrelide	PA	D006401	Hematologic Agents	MeSH
DB00261	209	anagrelide	PA	D010975	Platelet Aggregation Inhibitors	MeSH
DB00262	512	carmustine	MoA	N0000000236	Alkylating Activity	FDA
DB00262	512	carmustine	EPC	N0000175558	Alkylating Drug	FDA
DB00262	512	carmustine	PA	D000477	Alkylating Agents	MeSH
DB00262	512	carmustine	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00262	512	carmustine	PA	D000970	Antineoplastic Agents	MeSH
DB00262	512	carmustine	PA	D018906	Antineoplastic Agents, Alkylating	MeSH
DB00262	512	carmustine	PA	D009676	Noxae	MeSH
DB00263	2529	sulfafurazole	EPC	N0000175504	Sulfonamide Antimicrobial	FDA
DB00263	2529	sulfafurazole	Chemical/Ingredient	N0000008048	Sulfonamides	FDA
DB00263	2529	sulfafurazole	PA	D000890	Anti-Infective Agents	MeSH
DB00263	2529	sulfafurazole	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00264	1786	metoprolol	EPC	N0000175556	beta-Adrenergic Blocker	FDA
DB00264	1786	metoprolol	PA	D018663	Adrenergic Agents	MeSH
DB00264	1786	metoprolol	PA	D018674	Adrenergic Antagonists	MeSH
DB00264	1786	metoprolol	PA	D058671	Adrenergic beta-1 Receptor Antagonists	MeSH
DB00264	1786	metoprolol	PA	D000319	Adrenergic beta-Antagonists	MeSH
DB00264	1786	metoprolol	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB00264	1786	metoprolol	has role	CHEBI:35530	beta-adrenergic antagonist	CHEBI
DB00264	1786	metoprolol	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00264	1786	metoprolol	PA	D000959	Antihypertensive Agents	MeSH
DB00264	1786	metoprolol	PA	D002317	Cardiovascular Agents	MeSH
DB00264	1786	metoprolol	PA	D018377	Neurotransmitter Agents	MeSH
DB00264	1786	metoprolol	PA	D013565	Sympatholytics	MeSH
DB00266	867	dicoumarol	has role	CHEBI:50249	anticoagulant	CHEBI
DB00266	867	dicoumarol	PA	D000925	Anticoagulants	MeSH
DB00266	867	dicoumarol	PA	D004791	Enzyme Inhibitors	MeSH
DB00266	867	dicoumarol	PA	D006401	Hematologic Agents	MeSH
DB00266	867	dicoumarol	PA	D014475	Uncoupling Agents	MeSH
DB00267	538	cefmenoxime	PA	D000900	Anti-Bacterial Agents	MeSH
DB00267	538	cefmenoxime	PA	D000890	Anti-Infective Agents	MeSH
DB00267	538	cefmenoxime	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00268	2402	ropinirole	EPC	N0000175768	Nonergot Dopamine Agonist	FDA
DB00268	2402	ropinirole	PA	D018726	Anti-Dyskinesia Agents	MeSH
DB00268	2402	ropinirole	has role	CHEBI:51065	dopamine agonist	CHEBI
DB00268	2402	ropinirole	has role	CHEBI:35470	central nervous system drug	CHEBI
DB00268	2402	ropinirole	has role	CHEBI:66956	antidyskinesia agent	CHEBI
DB00268	2402	ropinirole	has role	CHEBI:48407	antiparkinson drug	CHEBI
DB00268	2402	ropinirole	PA	D000978	Antiparkinson Agents	MeSH
DB00268	2402	ropinirole	PA	D002491	Central Nervous System Agents	MeSH
DB00268	2402	ropinirole	PA	D015259	Dopamine Agents	MeSH
DB00268	2402	ropinirole	PA	D018491	Dopamine Agonists	MeSH
DB00268	2402	ropinirole	PA	D018377	Neurotransmitter Agents	MeSH
DB00269	610	chlorotrianisene	has role	CHEBI:50739	estrogen receptor modulator	CHEBI
DB00269	610	chlorotrianisene	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00269	610	chlorotrianisene	PA	D000970	Antineoplastic Agents	MeSH
DB00269	610	chlorotrianisene	PA	D018931	Antineoplastic Agents, Hormonal	MeSH
DB00269	610	chlorotrianisene	PA	D004967	Estrogens	MeSH
DB00269	610	chlorotrianisene	PA	D004968	Estrogens, Non-Steroidal	MeSH
DB00269	610	chlorotrianisene	PA	D006728	Hormones	MeSH
DB00270	1511	isradipine	MoA	N0000000069	Calcium Channel Antagonists	FDA
DB00270	1511	isradipine	EPC	N0000175421	Dihydropyridine Calcium Channel Blocker	FDA
DB00270	1511	isradipine	Chemical/Ingredient	N0000007556	Dihydropyridines	FDA
DB00270	1511	isradipine	PA	D000959	Antihypertensive Agents	MeSH
DB00270	1511	isradipine	PA	D002121	Calcium Channel Blockers	MeSH
DB00270	1511	isradipine	PA	D002317	Cardiovascular Agents	MeSH
DB00270	1511	isradipine	PA	D049990	Membrane Transport Modulators	MeSH
DB00270	1511	isradipine	PA	D014665	Vasodilator Agents	MeSH
DB00272	357	betazole	has role	CHEBI:35678	histamine agonist	CHEBI
DB00272	357	betazole	has role	CHEBI:33295	diagnostic agent	CHEBI
DB00272	357	betazole	has role	CHEBI:55324	gastrointestinal drug	CHEBI
DB00272	357	betazole	PA	D005765	Gastrointestinal Agents	MeSH
DB00272	357	betazole	PA	D018494	Histamine Agents	MeSH
DB00272	357	betazole	PA	D017442	Histamine Agonists	MeSH
DB00272	357	betazole	PA	D018377	Neurotransmitter Agents	MeSH
DB00273	2706	topiramate	PE	N0000008486	Decreased Central Nervous System Disorganized Electrical Activity	FDA
DB00273	2706	topiramate	MoA	N0000185506	Cytochrome P450 3A4 Inducers	FDA
DB00273	2706	topiramate	MoA	N0000182140	Cytochrome P450 2C19 Inhibitors	FDA
DB00273	2706	topiramate	has role	CHEBI:35623	anticonvulsant	CHEBI
DB00273	2706	topiramate	PA	D019440	Anti-Obesity Agents	MeSH
DB00273	2706	topiramate	PA	D000927	Anticonvulsants	MeSH
DB00273	2706	topiramate	PA	D002491	Central Nervous System Agents	MeSH
DB00273	2706	topiramate	PA	D018696	Neuroprotective Agents	MeSH
DB00273	2706	topiramate	PA	D020011	Protective Agents	MeSH
DB00274	539	cefmetazole	PA	D000900	Anti-Bacterial Agents	MeSH
DB00274	539	cefmetazole	PA	D000890	Anti-Infective Agents	MeSH
DB00274	539	cefmetazole	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00275	1985	olmesartan medoxomil	PA	D047228	Angiotensin II Type 1 Receptor Blockers	MeSH
DB00275	1985	olmesartan medoxomil	PA	D057911	Angiotensin Receptor Antagonists	MeSH
DB00275	1985	olmesartan medoxomil	PA	D000959	Antihypertensive Agents	MeSH
DB00275	1985	olmesartan medoxomil	PA	D002317	Cardiovascular Agents	MeSH
DB00277	2620	theophylline	EPC	N0000175790	Methylxanthine	FDA
DB00277	2620	theophylline	Chemical/Ingredient	N0000008118	Xanthines	FDA
DB00277	2620	theophylline	PA	D018927	Anti-Asthmatic Agents	MeSH
DB00277	2620	theophylline	has role	CHEBI:51371	muscle relaxant	CHEBI
DB00277	2620	theophylline	has role	CHEBI:35523	bronchodilator agent	CHEBI
DB00277	2620	theophylline	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00277	2620	theophylline	has role	CHEBI:50846	immunomodulator	CHEBI
DB00277	2620	theophylline	has role	CHEBI:67079	anti-inflammatory agent	CHEBI
DB00277	2620	theophylline	has role	CHEBI:49167	anti-asthmatic drug	CHEBI
DB00277	2620	theophylline	PA	D001993	Bronchodilator Agents	MeSH
DB00277	2620	theophylline	PA	D002316	Cardiotonic Agents	MeSH
DB00277	2620	theophylline	PA	D002317	Cardiovascular Agents	MeSH
DB00277	2620	theophylline	PA	D004791	Enzyme Inhibitors	MeSH
DB00277	2620	theophylline	PA	D018377	Neurotransmitter Agents	MeSH
DB00277	2620	theophylline	PA	D010726	Phosphodiesterase Inhibitors	MeSH
DB00277	2620	theophylline	PA	D020011	Protective Agents	MeSH
DB00277	2620	theophylline	PA	D058914	Purinergic Antagonists	MeSH
DB00277	2620	theophylline	PA	D058915	Purinergic P1 Receptor Antagonists	MeSH
DB00277	2620	theophylline	PA	D019141	Respiratory System Agents	MeSH
DB00277	2620	theophylline	PA	D014665	Vasodilator Agents	MeSH
DB01223	2620	theophylline	EPC	N0000175790	Methylxanthine	FDA
DB01223	2620	theophylline	Chemical/Ingredient	N0000008118	Xanthines	FDA
DB01223	2620	theophylline	PA	D018927	Anti-Asthmatic Agents	MeSH
DB01223	2620	theophylline	has role	CHEBI:51371	muscle relaxant	CHEBI
DB01223	2620	theophylline	has role	CHEBI:35523	bronchodilator agent	CHEBI
DB01223	2620	theophylline	has role	CHEBI:35620	vasodilator agent	CHEBI
DB01223	2620	theophylline	has role	CHEBI:50846	immunomodulator	CHEBI
DB01223	2620	theophylline	has role	CHEBI:67079	anti-inflammatory agent	CHEBI
DB01223	2620	theophylline	has role	CHEBI:49167	anti-asthmatic drug	CHEBI
DB01223	2620	theophylline	PA	D001993	Bronchodilator Agents	MeSH
DB01223	2620	theophylline	PA	D002316	Cardiotonic Agents	MeSH
DB01223	2620	theophylline	PA	D002317	Cardiovascular Agents	MeSH
DB01223	2620	theophylline	PA	D004791	Enzyme Inhibitors	MeSH
DB01223	2620	theophylline	PA	D018377	Neurotransmitter Agents	MeSH
DB01223	2620	theophylline	PA	D010726	Phosphodiesterase Inhibitors	MeSH
DB01223	2620	theophylline	PA	D020011	Protective Agents	MeSH
DB01223	2620	theophylline	PA	D058914	Purinergic Antagonists	MeSH
DB01223	2620	theophylline	PA	D058915	Purinergic P1 Receptor Antagonists	MeSH
DB01223	2620	theophylline	PA	D019141	Respiratory System Agents	MeSH
DB01223	2620	theophylline	PA	D014665	Vasodilator Agents	MeSH
DB00278	239	argatroban	EPC	N0000175980	Anti-coagulant	FDA
DB00278	239	argatroban	EPC	N0000175518	Direct Thrombin Inhibitor	FDA
DB00278	239	argatroban	MoA	N0000009963	Thrombin Inhibitors	FDA
DB00278	239	argatroban	PA	D000925	Anticoagulants	MeSH
DB00278	239	argatroban	PA	D000991	Antithrombins	MeSH
DB00278	239	argatroban	PA	D004791	Enzyme Inhibitors	MeSH
DB00278	239	argatroban	PA	D006401	Hematologic Agents	MeSH
DB00278	239	argatroban	PA	D010975	Platelet Aggregation Inhibitors	MeSH
DB00278	239	argatroban	PA	D011480	Protease Inhibitors	MeSH
DB00278	239	argatroban	PA	D015842	Serine Proteinase Inhibitors	MeSH
DB00279	1585	liothyronine	EPC	N0000175946	l-Triiodothyronine	FDA
DB00279	1585	liothyronine	Chemical/Ingredient	N0000006165	Triiodothyronine	FDA
DB01583	1585	liothyronine	EPC	N0000175946	l-Triiodothyronine	FDA
DB01583	1585	liothyronine	Chemical/Ingredient	N0000006165	Triiodothyronine	FDA
DB00280	926	disopyramide	EPC	N0000175426	Antiarrhythmic	FDA
DB00280	926	disopyramide	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB00280	926	disopyramide	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB00280	926	disopyramide	PA	D002317	Cardiovascular Agents	MeSH
DB00280	926	disopyramide	PA	D049990	Membrane Transport Modulators	MeSH
DB00280	926	disopyramide	PA	D026941	Sodium Channel Blockers	MeSH
DB00280	926	disopyramide	PA	D061567	Voltage-Gated Sodium Channel Blockers	MeSH
DB00281	1579	lidocaine	EPC	N0000175682	Amide Local Anesthetic	FDA
DB00281	1579	lidocaine	Chemical/Ingredient	N0000007681	Amides	FDA
DB00281	1579	lidocaine	EPC	N0000175426	Antiarrhythmic	FDA
DB00281	1579	lidocaine	PE	N0000175976	Local Anesthesia	FDA
DB00281	1579	lidocaine	PA	D000777	Anesthetics	MeSH
DB00281	1579	lidocaine	PA	D000779	Anesthetics, Local	MeSH
DB00281	1579	lidocaine	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB00281	1579	lidocaine	has role	CHEBI:88188	drug allergen	CHEBI
DB00281	1579	lidocaine	has role	CHEBI:36333	local anaesthetic	CHEBI
DB00281	1579	lidocaine	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB00281	1579	lidocaine	PA	D002317	Cardiovascular Agents	MeSH
DB00281	1579	lidocaine	PA	D002491	Central Nervous System Agents	MeSH
DB00281	1579	lidocaine	PA	D002492	Central Nervous System Depressants	MeSH
DB00281	1579	lidocaine	PA	D049990	Membrane Transport Modulators	MeSH
DB00281	1579	lidocaine	PA	D018689	Sensory System Agents	MeSH
DB00281	1579	lidocaine	PA	D026941	Sodium Channel Blockers	MeSH
DB00281	1579	lidocaine	PA	D061567	Voltage-Gated Sodium Channel Blockers	MeSH
DB05291	1579	lidocaine	EPC	N0000175682	Amide Local Anesthetic	FDA
DB05291	1579	lidocaine	Chemical/Ingredient	N0000007681	Amides	FDA
DB05291	1579	lidocaine	EPC	N0000175426	Antiarrhythmic	FDA
DB05291	1579	lidocaine	PE	N0000175976	Local Anesthesia	FDA
DB05291	1579	lidocaine	PA	D000777	Anesthetics	MeSH
DB05291	1579	lidocaine	PA	D000779	Anesthetics, Local	MeSH
DB05291	1579	lidocaine	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB05291	1579	lidocaine	has role	CHEBI:88188	drug allergen	CHEBI
DB05291	1579	lidocaine	has role	CHEBI:36333	local anaesthetic	CHEBI
DB05291	1579	lidocaine	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB05291	1579	lidocaine	PA	D002317	Cardiovascular Agents	MeSH
DB05291	1579	lidocaine	PA	D002491	Central Nervous System Agents	MeSH
DB05291	1579	lidocaine	PA	D002492	Central Nervous System Depressants	MeSH
DB05291	1579	lidocaine	PA	D049990	Membrane Transport Modulators	MeSH
DB05291	1579	lidocaine	PA	D018689	Sensory System Agents	MeSH
DB05291	1579	lidocaine	PA	D026941	Sodium Channel Blockers	MeSH
DB05291	1579	lidocaine	PA	D061567	Voltage-Gated Sodium Channel Blockers	MeSH
DB00282	2048	pamidronic acid	EPC	N0000175579	Bisphosphonate	FDA
DB00282	2048	pamidronic acid	Chemical/Ingredient	N0000007707	Diphosphonates	FDA
DB00282	2048	pamidronic acid	PA	D050071	Bone Density Conservation Agents	MeSH
DB00283	671	clemastine	PA	D018926	Anti-Allergic Agents	MeSH
DB00283	671	clemastine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB00283	671	clemastine	has role	CHEBI:50857	anti-allergic agent	CHEBI
DB00283	671	clemastine	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00283	671	clemastine	has role	CHEBI:59683	antipruritic drug	CHEBI
DB00283	671	clemastine	PA	D000982	Antipruritics	MeSH
DB00283	671	clemastine	PA	D003879	Dermatologic Agents	MeSH
DB00283	671	clemastine	PA	D018494	Histamine Agents	MeSH
DB00283	671	clemastine	PA	D006633	Histamine Antagonists	MeSH
DB00283	671	clemastine	PA	D006634	Histamine H1 Antagonists	MeSH
DB00283	671	clemastine	PA	D018377	Neurotransmitter Agents	MeSH
DB00284	39	acarbose	MoA	N0000000166	alpha Glucosidase Inhibitors	FDA
DB00284	39	acarbose	EPC	N0000175559	alpha-Glucosidase Inhibitor	FDA
DB00284	39	acarbose	has role	CHEBI:35526	hypoglycemic agent	CHEBI
DB00284	39	acarbose	PA	D004791	Enzyme Inhibitors	MeSH
DB00284	39	acarbose	PA	D065089	Glycoside Hydrolase Inhibitors	MeSH
DB00284	39	acarbose	PA	D007004	Hypoglycemic Agents	MeSH
DB00285	2813	venlafaxine	MoA	N0000000102	Norepinephrine Uptake Inhibitors	FDA
DB00285	2813	venlafaxine	EPC	N0000175749	Serotonin and Norepinephrine Reuptake Inhibitor	FDA
DB00285	2813	venlafaxine	MoA	N0000000109	Serotonin Uptake Inhibitors	FDA
DB00285	2813	venlafaxine	has role	CHEBI:50949	serotonin uptake inhibitor	CHEBI
DB00285	2813	venlafaxine	has role	CHEBI:35640	adrenergic uptake inhibitor	CHEBI
DB00285	2813	venlafaxine	has role	CHEBI:51039	dopamine uptake inhibitor	CHEBI
DB00285	2813	venlafaxine	has role	CHEBI:35480	analgesic	CHEBI
DB00285	2813	venlafaxine	has role	CHEBI:35469	antidepressant	CHEBI
DB00285	2813	venlafaxine	PA	D000928	Antidepressive Agents	MeSH
DB00285	2813	venlafaxine	PA	D018687	Antidepressive Agents, Second-Generation	MeSH
DB00285	2813	venlafaxine	PA	D002491	Central Nervous System Agents	MeSH
DB00285	2813	venlafaxine	PA	D049990	Membrane Transport Modulators	MeSH
DB00285	2813	venlafaxine	PA	D018377	Neurotransmitter Agents	MeSH
DB00285	2813	venlafaxine	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB00285	2813	venlafaxine	PA	D011619	Psychotropic Drugs	MeSH
DB00285	2813	venlafaxine	PA	D000068760	Serotonin and Noradrenaline Reuptake Inhibitors	MeSH
DB00286	4857	estrone sulphate	PA	D003270	Contraceptive Agents	MeSH
DB00286	4857	estrone sulphate	PA	D012102	Reproductive Control Agents	MeSH
DB04574	4857	estrone sulphate	PA	D003270	Contraceptive Agents	MeSH
DB04574	4857	estrone sulphate	PA	D012102	Reproductive Control Agents	MeSH
DB00287	2716	travoprost	EPC	N0000175454	Prostaglandin Analog	FDA
DB00287	2716	travoprost	Chemical/Ingredient	N0000007706	Prostaglandins	FDA
DB00287	2716	travoprost	has role	CHEBI:66981	ophthalmology drug	CHEBI
DB00287	2716	travoprost	has role	CHEBI:39456	antiglaucoma drug	CHEBI
DB00287	2716	travoprost	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00287	2716	travoprost	has role	CHEBI:50266	prodrug	CHEBI
DB00287	2716	travoprost	PA	D000959	Antihypertensive Agents	MeSH
DB00287	2716	travoprost	PA	D002317	Cardiovascular Agents	MeSH
DB00288	150	amcinonide	EPC	N0000175576	Corticosteroid	FDA
DB00288	150	amcinonide	MoA	N0000175450	Corticosteroid Hormone Receptor Agonists	FDA
DB00288	150	amcinonide	has role	CHEBI:35472	anti-inflammatory drug	CHEBI
DB00288	150	amcinonide	PA	D005938	Glucocorticoids	MeSH
DB00288	150	amcinonide	PA	D006728	Hormones	MeSH
DB00289	256	atomoxetine	EPC	N0000175695	Norepinephrine Reuptake Inhibitor	FDA
DB00289	256	atomoxetine	MoA	N0000000102	Norepinephrine Uptake Inhibitors	FDA
DB00289	256	atomoxetine	PA	D018663	Adrenergic Agents	MeSH
DB00289	256	atomoxetine	PA	D018759	Adrenergic Uptake Inhibitors	MeSH
DB00289	256	atomoxetine	has role	CHEBI:35640	adrenergic uptake inhibitor	CHEBI
DB00289	256	atomoxetine	has role	CHEBI:35469	antidepressant	CHEBI
DB00289	256	atomoxetine	PA	D049990	Membrane Transport Modulators	MeSH
DB00289	256	atomoxetine	PA	D018377	Neurotransmitter Agents	MeSH
DB00289	256	atomoxetine	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB00292	1109	etomidate	PE	N0000175975	General Anesthesia	FDA
DB00292	1109	etomidate	EPC	N0000175681	General Anesthetic	FDA
DB00292	1109	etomidate	PA	D000777	Anesthetics	MeSH
DB00292	1109	etomidate	PA	D018686	Anesthetics, Intravenous	MeSH
DB00292	1109	etomidate	has role	CHEBI:38877	intravenous anaesthetic	CHEBI
DB00292	1109	etomidate	has role	CHEBI:35717	sedative	CHEBI
DB00292	1109	etomidate	PA	D002491	Central Nervous System Agents	MeSH
DB00292	1109	etomidate	PA	D002492	Central Nervous System Depressants	MeSH
DB00292	1109	etomidate	PA	D006993	Hypnotics and Sedatives	MeSH
DB00294	1110	etonogestrel	Chemical/Ingredient	N0000011301	Progesterone Congeners	FDA
DB00294	1110	etonogestrel	EPC	N0000175602	Progestin	FDA
DB00294	1110	etonogestrel	has role	CHEBI:49323	contraceptive drug	CHEBI
DB00294	1110	etonogestrel	has role	CHEBI:49324	female contraceptive drug	CHEBI
DB00294	1110	etonogestrel	PA	D003270	Contraceptive Agents	MeSH
DB00294	1110	etonogestrel	PA	D003271	Contraceptive Agents, Female	MeSH
DB00294	1110	etonogestrel	PA	D012102	Reproductive Control Agents	MeSH
DB00295	1845	morphine	MoA	N0000175684	Full Opioid Agonists	FDA
DB00295	1845	morphine	EPC	N0000175690	Opioid Agonist	FDA
DB00295	1845	morphine	PA	D000700	Analgesics	MeSH
DB00295	1845	morphine	PA	D000701	Analgesics, Opioid	MeSH
DB00295	1845	morphine	has role	CHEBI:55322	mu-opioid receptor agonist	CHEBI
DB00295	1845	morphine	has role	CHEBI:35482	opioid analgesic	CHEBI
DB00295	1845	morphine	PA	D002491	Central Nervous System Agents	MeSH
DB00295	1845	morphine	PA	D002492	Central Nervous System Depressants	MeSH
DB00295	1845	morphine	PA	D009294	Narcotics	MeSH
DB00295	1845	morphine	PA	D018689	Sensory System Agents	MeSH
DB00296	2403	ropivacaine	EPC	N0000175682	Amide Local Anesthetic	FDA
DB00296	2403	ropivacaine	Chemical/Ingredient	N0000007681	Amides	FDA
DB00296	2403	ropivacaine	PE	N0000175976	Local Anesthesia	FDA
DB00296	2403	ropivacaine	PA	D000777	Anesthetics	MeSH
DB00296	2403	ropivacaine	PA	D000779	Anesthetics, Local	MeSH
DB00296	2403	ropivacaine	has role	CHEBI:36333	local anaesthetic	CHEBI
DB00296	2403	ropivacaine	PA	D002491	Central Nervous System Agents	MeSH
DB00296	2403	ropivacaine	PA	D002492	Central Nervous System Depressants	MeSH
DB00296	2403	ropivacaine	PA	D018689	Sensory System Agents	MeSH
DB00297	432	bupivacaine	EPC	N0000175682	Amide Local Anesthetic	FDA
DB00297	432	bupivacaine	Chemical/Ingredient	N0000007681	Amides	FDA
DB00297	432	bupivacaine	PE	N0000175976	Local Anesthesia	FDA
DB00297	432	bupivacaine	PA	D000777	Anesthetics	MeSH
DB00297	432	bupivacaine	PA	D000779	Anesthetics, Local	MeSH
DB00297	432	bupivacaine	has role	CHEBI:37887	adrenergic antagonist	CHEBI
DB00297	432	bupivacaine	has role	CHEBI:36333	local anaesthetic	CHEBI
DB00297	432	bupivacaine	PA	D002491	Central Nervous System Agents	MeSH
DB00297	432	bupivacaine	PA	D002492	Central Nervous System Depressants	MeSH
DB00297	432	bupivacaine	PA	D018689	Sensory System Agents	MeSH
DB01002	432	bupivacaine	EPC	N0000175682	Amide Local Anesthetic	FDA
DB01002	432	bupivacaine	Chemical/Ingredient	N0000007681	Amides	FDA
DB01002	432	bupivacaine	PE	N0000175976	Local Anesthesia	FDA
DB01002	432	bupivacaine	PA	D000777	Anesthetics	MeSH
DB01002	432	bupivacaine	PA	D000779	Anesthetics, Local	MeSH
DB01002	432	bupivacaine	has role	CHEBI:37887	adrenergic antagonist	CHEBI
DB01002	432	bupivacaine	has role	CHEBI:36333	local anaesthetic	CHEBI
DB01002	432	bupivacaine	PA	D002491	Central Nervous System Agents	MeSH
DB01002	432	bupivacaine	PA	D002492	Central Nervous System Depressants	MeSH
DB01002	432	bupivacaine	PA	D018689	Sensory System Agents	MeSH
DB00298	781	dapiprazole	EPC	N0000175553	alpha-Adrenergic Blocker	FDA
DB00298	781	dapiprazole	PA	D018663	Adrenergic Agents	MeSH
DB00298	781	dapiprazole	PA	D000317	Adrenergic alpha-Antagonists	MeSH
DB00298	781	dapiprazole	PA	D018674	Adrenergic Antagonists	MeSH
DB00298	781	dapiprazole	has role	CHEBI:37890	alpha-adrenergic antagonist	CHEBI
DB00298	781	dapiprazole	has role	CHEBI:51068	miotic	CHEBI
DB00298	781	dapiprazole	has role	CHEBI:35476	antipsychotic agent	CHEBI
DB00298	781	dapiprazole	has role	CHEBI:66981	ophthalmology drug	CHEBI
DB00298	781	dapiprazole	PA	D014150	Antipsychotic Agents	MeSH
DB00298	781	dapiprazole	PA	D002491	Central Nervous System Agents	MeSH
DB00298	781	dapiprazole	PA	D002492	Central Nervous System Depressants	MeSH
DB00298	781	dapiprazole	PA	D018377	Neurotransmitter Agents	MeSH
DB00298	781	dapiprazole	PA	D011619	Psychotropic Drugs	MeSH
DB00298	781	dapiprazole	PA	D014149	Tranquilizing Agents	MeSH
DB00299	2079	penciclovir	MoA	N0000020060	DNA Polymerase Inhibitors	FDA
DB00299	2079	penciclovir	EPC	N0000175468	Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor	FDA
DB00299	2079	penciclovir	Chemical/Ingredient	N0000175459	Nucleoside Analog	FDA
DB00299	2079	penciclovir	PA	D000890	Anti-Infective Agents	MeSH
DB00299	2079	penciclovir	has role	CHEBI:36044	antiviral drug	CHEBI
DB00299	2079	penciclovir	PA	D000998	Antiviral Agents	MeSH
DB00302	2713	tranexamic acid	EPC	N0000175634	Antifibrinolytic Agent	FDA
DB00302	2713	tranexamic acid	PE	N0000175632	Decreased Fibrinolysis	FDA
DB00302	2713	tranexamic acid	has role	CHEBI:50248	hematologic agent	CHEBI
DB00302	2713	tranexamic acid	has role	CHEBI:48675	antifibrinolytic drug	CHEBI
DB00302	2713	tranexamic acid	PA	D000933	Antifibrinolytic Agents	MeSH
DB00302	2713	tranexamic acid	PA	D003029	Coagulants	MeSH
DB00302	2713	tranexamic acid	PA	D006401	Hematologic Agents	MeSH
DB00302	2713	tranexamic acid	PA	D006490	Hemostatics	MeSH
DB00303	1046	ertapenem	Chemical/Ingredient	N0000011294	Carbapenems	FDA
DB00303	1046	ertapenem	EPC	N0000175496	Penem Antibacterial	FDA
DB00303	1046	ertapenem	PA	D000900	Anti-Bacterial Agents	MeSH
DB00303	1046	ertapenem	PA	D000890	Anti-Infective Agents	MeSH
DB00303	1046	ertapenem	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00304	818	desogestrel	Chemical/Ingredient	N0000011301	Progesterone Congeners	FDA
DB00304	818	desogestrel	EPC	N0000175602	Progestin	FDA
DB00304	818	desogestrel	has role	CHEBI:49323	contraceptive drug	CHEBI
DB00304	818	desogestrel	has role	CHEBI:49326	synthetic oral contraceptive	CHEBI
DB00304	818	desogestrel	PA	D003270	Contraceptive Agents	MeSH
DB00304	818	desogestrel	PA	D003271	Contraceptive Agents, Female	MeSH
DB00304	818	desogestrel	PA	D003276	Contraceptives, Oral	MeSH
DB00304	818	desogestrel	PA	D003280	Contraceptives, Oral, Synthetic	MeSH
DB00304	818	desogestrel	PA	D006728	Hormones	MeSH
DB00304	818	desogestrel	PA	D011372	Progestins	MeSH
DB00304	818	desogestrel	PA	D012102	Reproductive Control Agents	MeSH
DB00307	361	bexarotene	EPC	N0000175607	Retinoid	FDA
DB00307	361	bexarotene	Chemical/Ingredient	N0000007700	Retinoids	FDA
DB00307	361	bexarotene	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00307	361	bexarotene	PA	D016588	Anticarcinogenic Agents	MeSH
DB00307	361	bexarotene	PA	D000970	Antineoplastic Agents	MeSH
DB00307	361	bexarotene	PA	D020011	Protective Agents	MeSH
DB00310	625	chlortalidone	PE	N0000175359	Increased Diuresis	FDA
DB00310	625	chlortalidone	EPC	N0000175420	Thiazide-like Diuretic	FDA
DB00310	625	chlortalidone	PA	D000959	Antihypertensive Agents	MeSH
DB00310	625	chlortalidone	PA	D002317	Cardiovascular Agents	MeSH
DB00310	625	chlortalidone	PA	D004232	Diuretics	MeSH
DB00310	625	chlortalidone	PA	D049990	Membrane Transport Modulators	MeSH
DB00310	625	chlortalidone	PA	D045283	Natriuretic Agents	MeSH
DB00310	625	chlortalidone	PA	D049993	Sodium Chloride Symporter Inhibitors	MeSH
DB08046	625	chlortalidone	PE	N0000175359	Increased Diuresis	FDA
DB08046	625	chlortalidone	EPC	N0000175420	Thiazide-like Diuretic	FDA
DB08046	625	chlortalidone	PA	D000959	Antihypertensive Agents	MeSH
DB08046	625	chlortalidone	PA	D002317	Cardiovascular Agents	MeSH
DB08046	625	chlortalidone	PA	D004232	Diuretics	MeSH
DB08046	625	chlortalidone	PA	D049990	Membrane Transport Modulators	MeSH
DB08046	625	chlortalidone	PA	D045283	Natriuretic Agents	MeSH
DB08046	625	chlortalidone	PA	D049993	Sodium Chloride Symporter Inhibitors	MeSH
DB00311	1089	ethoxzolamide	has role	CHEBI:35498	diuretic	CHEBI
DB00311	1089	ethoxzolamide	has role	CHEBI:39456	antiglaucoma drug	CHEBI
DB00311	1089	ethoxzolamide	PA	D002257	Carbonic Anhydrase Inhibitors	MeSH
DB00311	1089	ethoxzolamide	PA	D004232	Diuretics	MeSH
DB00311	1089	ethoxzolamide	PA	D004791	Enzyme Inhibitors	MeSH
DB00311	1089	ethoxzolamide	PA	D045283	Natriuretic Agents	MeSH
DB00312	2095	pentobarbital	PA	D000759	Adjuvants, Anesthesia	MeSH
DB00312	2095	pentobarbital	PA	D002491	Central Nervous System Agents	MeSH
DB00312	2095	pentobarbital	PA	D002492	Central Nervous System Depressants	MeSH
DB00312	2095	pentobarbital	PA	D018682	GABA Agents	MeSH
DB00312	2095	pentobarbital	PA	D018757	GABA Modulators	MeSH
DB00312	2095	pentobarbital	PA	D006993	Hypnotics and Sedatives	MeSH
DB00312	2095	pentobarbital	PA	D018377	Neurotransmitter Agents	MeSH
DB00315	2869	zolmitriptan	MoA	N0000175763	Serotonin 1b Receptor Agonists	FDA
DB00315	2869	zolmitriptan	MoA	N0000175764	Serotonin 1d Receptor Agonists	FDA
DB00315	2869	zolmitriptan	EPC	N0000175765	Serotonin-1b and Serotonin-1d Receptor Agonist	FDA
DB00315	2869	zolmitriptan	has role	CHEBI:35941	serotonergic agonist	CHEBI
DB00315	2869	zolmitriptan	has role	CHEBI:50514	vasoconstrictor agent	CHEBI
DB00315	2869	zolmitriptan	has role	CHEBI:35472	anti-inflammatory drug	CHEBI
DB00315	2869	zolmitriptan	PA	D018377	Neurotransmitter Agents	MeSH
DB00315	2869	zolmitriptan	PA	D058825	Serotonin 5-HT1 Receptor Agonists	MeSH
DB00315	2869	zolmitriptan	PA	D018490	Serotonin Agents	MeSH
DB00315	2869	zolmitriptan	PA	D017366	Serotonin Receptor Agonists	MeSH
DB00316	52	paracetamol	PA	D000700	Analgesics	MeSH
DB00316	52	paracetamol	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00316	52	paracetamol	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB00316	52	paracetamol	has role	CHEBI:35493	antipyretic	CHEBI
DB00316	52	paracetamol	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00316	52	paracetamol	PA	D058633	Antipyretics	MeSH
DB00316	52	paracetamol	PA	D002491	Central Nervous System Agents	MeSH
DB00316	52	paracetamol	PA	D018689	Sensory System Agents	MeSH
DB00317	1282	gefitinib	EPC	N0000175605	Kinase Inhibitor	FDA
DB00317	1282	gefitinib	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00317	1282	gefitinib	PA	D000970	Antineoplastic Agents	MeSH
DB00317	1282	gefitinib	PA	D004791	Enzyme Inhibitors	MeSH
DB00317	1282	gefitinib	PA	D047428	Protein Kinase Inhibitors	MeSH
DB00318	725	codeine	PA	D000700	Analgesics	MeSH
DB00318	725	codeine	PA	D000701	Analgesics, Opioid	MeSH
DB00318	725	codeine	has role	CHEBI:51177	antitussive	CHEBI
DB00318	725	codeine	has role	CHEBI:60606	opioid receptor agonist	CHEBI
DB00318	725	codeine	has role	CHEBI:50266	prodrug	CHEBI
DB00318	725	codeine	has role	CHEBI:35482	opioid analgesic	CHEBI
DB00318	725	codeine	PA	D000996	Antitussive Agents	MeSH
DB00318	725	codeine	PA	D002491	Central Nervous System Agents	MeSH
DB00318	725	codeine	PA	D002492	Central Nervous System Depressants	MeSH
DB00318	725	codeine	PA	D009294	Narcotics	MeSH
DB00318	725	codeine	PA	D019141	Respiratory System Agents	MeSH
DB00318	725	codeine	PA	D018689	Sensory System Agents	MeSH
DB00319	2187	piperacillin	PA	D000900	Anti-Bacterial Agents	MeSH
DB00319	2187	piperacillin	PA	D000890	Anti-Infective Agents	MeSH
DB00319	2187	piperacillin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00320	888	dihydroergotamine	EPC	N0000175766	Ergotamine Derivative	FDA
DB00320	888	dihydroergotamine	Chemical/Ingredient	N0000007621	Ergotamines	FDA
DB00320	888	dihydroergotamine	PA	D000700	Analgesics	MeSH
DB00320	888	dihydroergotamine	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00320	888	dihydroergotamine	has role	CHEBI:35941	serotonergic agonist	CHEBI
DB00320	888	dihydroergotamine	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB00320	888	dihydroergotamine	has role	CHEBI:50514	vasoconstrictor agent	CHEBI
DB00320	888	dihydroergotamine	has role	CHEBI:51065	dopamine agonist	CHEBI
DB00320	888	dihydroergotamine	has role	CHEBI:66991	sympatholytic agent	CHEBI
DB00320	888	dihydroergotamine	PA	D002317	Cardiovascular Agents	MeSH
DB00320	888	dihydroergotamine	PA	D002491	Central Nervous System Agents	MeSH
DB00320	888	dihydroergotamine	PA	D015259	Dopamine Agents	MeSH
DB00320	888	dihydroergotamine	PA	D018491	Dopamine Agonists	MeSH
DB00320	888	dihydroergotamine	PA	D018377	Neurotransmitter Agents	MeSH
DB00320	888	dihydroergotamine	PA	D018689	Sensory System Agents	MeSH
DB00320	888	dihydroergotamine	PA	D014662	Vasoconstrictor Agents	MeSH
DB00321	180	amitriptyline	EPC	N0000175752	Tricyclic Antidepressant	FDA
DB00321	180	amitriptyline	PA	D018663	Adrenergic Agents	MeSH
DB00321	180	amitriptyline	PA	D018759	Adrenergic Uptake Inhibitors	MeSH
DB00321	180	amitriptyline	PA	D000700	Analgesics	MeSH
DB00321	180	amitriptyline	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00321	180	amitriptyline	has role	CHEBI:35469	antidepressant	CHEBI
DB00321	180	amitriptyline	has role	CHEBI:35640	adrenergic uptake inhibitor	CHEBI
DB00321	180	amitriptyline	PA	D000928	Antidepressive Agents	MeSH
DB00321	180	amitriptyline	PA	D000929	Antidepressive Agents, Tricyclic	MeSH
DB00321	180	amitriptyline	PA	D002491	Central Nervous System Agents	MeSH
DB00321	180	amitriptyline	PA	D049990	Membrane Transport Modulators	MeSH
DB00321	180	amitriptyline	PA	D018377	Neurotransmitter Agents	MeSH
DB00321	180	amitriptyline	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB00321	180	amitriptyline	PA	D011619	Psychotropic Drugs	MeSH
DB00321	180	amitriptyline	PA	D018689	Sensory System Agents	MeSH
DB00322	1184	floxuridine	EPC	N0000180853	Antimetabolite	FDA
DB00322	1184	floxuridine	Chemical/Ingredient	N0000007770	Deoxyuridine	FDA
DB00322	1184	floxuridine	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00322	1184	floxuridine	has role	CHEBI:36044	antiviral drug	CHEBI
DB00322	1184	floxuridine	PA	D000963	Antimetabolites	MeSH
DB00322	1184	floxuridine	PA	D000964	Antimetabolites, Antineoplastic	MeSH
DB00322	1184	floxuridine	PA	D000970	Antineoplastic Agents	MeSH
DB00322	1184	floxuridine	PA	D009676	Noxae	MeSH
DB00323	2697	tolcapone	EPC	N0000175757	Catechol-O-Methyltransferase Inhibitor	FDA
DB00323	2697	tolcapone	PA	D018726	Anti-Dyskinesia Agents	MeSH
DB00323	2697	tolcapone	has role	CHEBI:48407	antiparkinson drug	CHEBI
DB00323	2697	tolcapone	PA	D000978	Antiparkinson Agents	MeSH
DB00323	2697	tolcapone	PA	D065098	Catechol O-Methyltransferase Inhibitors	MeSH
DB00323	2697	tolcapone	PA	D002491	Central Nervous System Agents	MeSH
DB00323	2697	tolcapone	PA	D004791	Enzyme Inhibitors	MeSH
DB00324	1208	fluorometholone	EPC	N0000175576	Corticosteroid	FDA
DB00324	1208	fluorometholone	MoA	N0000175450	Corticosteroid Hormone Receptor Agonists	FDA
DB00324	1208	fluorometholone	PA	D018926	Anti-Allergic Agents	MeSH
DB00324	1208	fluorometholone	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00324	1208	fluorometholone	has role	CHEBI:35472	anti-inflammatory drug	CHEBI
DB00324	1208	fluorometholone	PA	D005938	Glucocorticoids	MeSH
DB00324	1208	fluorometholone	PA	D006728	Hormones	MeSH
DB00327	1393	hydromorphone	MoA	N0000175684	Full Opioid Agonists	FDA
DB00327	1393	hydromorphone	EPC	N0000175690	Opioid Agonist	FDA
DB00327	1393	hydromorphone	PA	D000700	Analgesics	MeSH
DB00327	1393	hydromorphone	PA	D000701	Analgesics, Opioid	MeSH
DB00327	1393	hydromorphone	has role	CHEBI:35482	opioid analgesic	CHEBI
DB00327	1393	hydromorphone	has role	CHEBI:55322	mu-opioid receptor agonist	CHEBI
DB00327	1393	hydromorphone	PA	D002491	Central Nervous System Agents	MeSH
DB00327	1393	hydromorphone	PA	D002492	Central Nervous System Depressants	MeSH
DB00327	1393	hydromorphone	PA	D009294	Narcotics	MeSH
DB00327	1393	hydromorphone	PA	D018689	Sensory System Agents	MeSH
DB00328	1440	indomethacin	Chemical/Ingredient	N0000175721	Nonsteroidal Anti-inflammatory Compounds	FDA
DB00328	1440	indomethacin	EPC	N0000175722	Nonsteroidal Anti-inflammatory Drug	FDA
DB00328	1440	indomethacin	PA	D000700	Analgesics	MeSH
DB00328	1440	indomethacin	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00328	1440	indomethacin	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00328	1440	indomethacin	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00328	1440	indomethacin	has role	CHEBI:35480	analgesic	CHEBI
DB00328	1440	indomethacin	has role	CHEBI:35845	gout suppressant	CHEBI
DB00328	1440	indomethacin	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00328	1440	indomethacin	PA	D018501	Antirheumatic Agents	MeSH
DB00328	1440	indomethacin	PA	D002317	Cardiovascular Agents	MeSH
DB00328	1440	indomethacin	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB00328	1440	indomethacin	PA	D004791	Enzyme Inhibitors	MeSH
DB00328	1440	indomethacin	PA	D006074	Gout Suppressants	MeSH
DB00328	1440	indomethacin	PA	D012102	Reproductive Control Agents	MeSH
DB00328	1440	indomethacin	PA	D018689	Sensory System Agents	MeSH
DB00328	1440	indomethacin	PA	D015149	Tocolytic Agents	MeSH
DB00330	1073	ethambutol	EPC	N0000175483	Antimycobacterial	FDA
DB00330	1073	ethambutol	PA	D000900	Anti-Bacterial Agents	MeSH
DB00330	1073	ethambutol	PA	D000890	Anti-Infective Agents	MeSH
DB00330	1073	ethambutol	has role	CHEBI:33231	antitubercular agent	CHEBI
DB00330	1073	ethambutol	PA	D000995	Antitubercular Agents	MeSH
DB00331	1725	metformin	EPC	N0000175565	Biguanide	FDA
DB00331	1725	metformin	Chemical/Ingredient	N0000007698	Biguanides	FDA
DB00331	1725	metformin	has role	CHEBI:35526	hypoglycemic agent	CHEBI
DB00331	1725	metformin	PA	D007004	Hypoglycemic Agents	MeSH
DB00332	1475	ipratropium	EPC	N0000175574	Anticholinergic	FDA
DB00332	1475	ipratropium	PA	D018927	Anti-Asthmatic Agents	MeSH
DB00332	1475	ipratropium	PA	D001993	Bronchodilator Agents	MeSH
DB00332	1475	ipratropium	PA	D018678	Cholinergic Agents	MeSH
DB00332	1475	ipratropium	PA	D018680	Cholinergic Antagonists	MeSH
DB00332	1475	ipratropium	PA	D018377	Neurotransmitter Agents	MeSH
DB00332	1475	ipratropium	PA	D019141	Respiratory System Agents	MeSH
DB00333	1728	methadone	MoA	N0000175684	Full Opioid Agonists	FDA
DB00333	1728	methadone	EPC	N0000175690	Opioid Agonist	FDA
DB00333	1728	methadone	PA	D000700	Analgesics	MeSH
DB00333	1728	methadone	PA	D000701	Analgesics, Opioid	MeSH
DB00333	1728	methadone	has role	CHEBI:35482	opioid analgesic	CHEBI
DB00333	1728	methadone	has role	CHEBI:55322	mu-opioid receptor agonist	CHEBI
DB00333	1728	methadone	PA	D000996	Antitussive Agents	MeSH
DB00333	1728	methadone	PA	D002491	Central Nervous System Agents	MeSH
DB00333	1728	methadone	PA	D002492	Central Nervous System Depressants	MeSH
DB00333	1728	methadone	PA	D009294	Narcotics	MeSH
DB00333	1728	methadone	PA	D019141	Respiratory System Agents	MeSH
DB00333	1728	methadone	PA	D018689	Sensory System Agents	MeSH
DB00334	1982	olanzapine	EPC	N0000175430	Atypical Antipsychotic	FDA
DB00334	1982	olanzapine	has role	CHEBI:37956	histamine antagonist	CHEBI
DB00334	1982	olanzapine	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00334	1982	olanzapine	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB00334	1982	olanzapine	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB00334	1982	olanzapine	has role	CHEBI:50919	antiemetic	CHEBI
DB00334	1982	olanzapine	has role	CHEBI:50949	serotonin uptake inhibitor	CHEBI
DB00334	1982	olanzapine	has role	CHEBI:65191	second generation antipsychotic	CHEBI
DB00334	1982	olanzapine	PA	D000932	Antiemetics	MeSH
DB00334	1982	olanzapine	PA	D014150	Antipsychotic Agents	MeSH
DB00334	1982	olanzapine	PA	D002491	Central Nervous System Agents	MeSH
DB00334	1982	olanzapine	PA	D002492	Central Nervous System Depressants	MeSH
DB00334	1982	olanzapine	PA	D005765	Gastrointestinal Agents	MeSH
DB00334	1982	olanzapine	PA	D049990	Membrane Transport Modulators	MeSH
DB00334	1982	olanzapine	PA	D018377	Neurotransmitter Agents	MeSH
DB00334	1982	olanzapine	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB00334	1982	olanzapine	PA	D011619	Psychotropic Drugs	MeSH
DB00334	1982	olanzapine	PA	D018490	Serotonin Agents	MeSH
DB00334	1982	olanzapine	PA	D017367	Serotonin Uptake Inhibitors	MeSH
DB00334	1982	olanzapine	PA	D014149	Tranquilizing Agents	MeSH
DB00335	255	atenolol	EPC	N0000175556	beta-Adrenergic Blocker	FDA
DB00335	255	atenolol	PA	D018663	Adrenergic Agents	MeSH
DB00335	255	atenolol	PA	D018674	Adrenergic Antagonists	MeSH
DB00335	255	atenolol	PA	D058671	Adrenergic beta-1 Receptor Antagonists	MeSH
DB00335	255	atenolol	PA	D000319	Adrenergic beta-Antagonists	MeSH
DB00335	255	atenolol	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB00335	255	atenolol	PA	D000959	Antihypertensive Agents	MeSH
DB00335	255	atenolol	PA	D002317	Cardiovascular Agents	MeSH
DB00335	255	atenolol	PA	D018377	Neurotransmitter Agents	MeSH
DB00335	255	atenolol	PA	D013565	Sympatholytics	MeSH
DB06987	255	atenolol	EPC	N0000175556	beta-Adrenergic Blocker	FDA
DB06987	255	atenolol	PA	D018663	Adrenergic Agents	MeSH
DB06987	255	atenolol	PA	D018674	Adrenergic Antagonists	MeSH
DB06987	255	atenolol	PA	D058671	Adrenergic beta-1 Receptor Antagonists	MeSH
DB06987	255	atenolol	PA	D000319	Adrenergic beta-Antagonists	MeSH
DB06987	255	atenolol	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB06987	255	atenolol	PA	D000959	Antihypertensive Agents	MeSH
DB06987	255	atenolol	PA	D002317	Cardiovascular Agents	MeSH
DB06987	255	atenolol	PA	D018377	Neurotransmitter Agents	MeSH
DB06987	255	atenolol	PA	D013565	Sympatholytics	MeSH
DB00337	2168	pimecrolimus	EPC	N0000175457	Calcineurin Inhibitor Immunosuppressant	FDA
DB00337	2168	pimecrolimus	PA	D000700	Analgesics	MeSH
DB00337	2168	pimecrolimus	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00337	2168	pimecrolimus	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00337	2168	pimecrolimus	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00337	2168	pimecrolimus	PA	D018501	Antirheumatic Agents	MeSH
DB00337	2168	pimecrolimus	PA	D065095	Calcineurin Inhibitors	MeSH
DB00337	2168	pimecrolimus	PA	D003879	Dermatologic Agents	MeSH
DB00337	2168	pimecrolimus	PA	D004791	Enzyme Inhibitors	MeSH
DB00337	2168	pimecrolimus	PA	D007155	Immunologic Factors	MeSH
DB00337	2168	pimecrolimus	PA	D007166	Immunosuppressive Agents	MeSH
DB00337	2168	pimecrolimus	PA	D018689	Sensory System Agents	MeSH
DB00338	1990	omeprazole	EPC	N0000175525	Proton Pump Inhibitor	FDA
DB00338	1990	omeprazole	MoA	N0000182140	Cytochrome P450 2C19 Inhibitors	FDA
DB00338	1990	omeprazole	has role	CHEBI:49201	anti-ulcer drug	CHEBI
DB00338	1990	omeprazole	has role	CHEBI:35623	anticonvulsant	CHEBI
DB00338	1990	omeprazole	PA	D000897	Anti-Ulcer Agents	MeSH
DB00338	1990	omeprazole	PA	D004791	Enzyme Inhibitors	MeSH
DB00338	1990	omeprazole	PA	D005765	Gastrointestinal Agents	MeSH
DB00338	1990	omeprazole	PA	D054328	Proton Pump Inhibitors	MeSH
DB00736	1990	omeprazole	EPC	N0000175525	Proton Pump Inhibitor	FDA
DB00736	1990	omeprazole	MoA	N0000182140	Cytochrome P450 2C19 Inhibitors	FDA
DB00736	1990	omeprazole	has role	CHEBI:49201	anti-ulcer drug	CHEBI
DB00736	1990	omeprazole	has role	CHEBI:35623	anticonvulsant	CHEBI
DB00736	1990	omeprazole	PA	D000897	Anti-Ulcer Agents	MeSH
DB00736	1990	omeprazole	PA	D004791	Enzyme Inhibitors	MeSH
DB00736	1990	omeprazole	PA	D005765	Gastrointestinal Agents	MeSH
DB00736	1990	omeprazole	PA	D054328	Proton Pump Inhibitors	MeSH
DB00339	2328	pyrazinamide	EPC	N0000175483	Antimycobacterial	FDA
DB00339	2328	pyrazinamide	PA	D000900	Anti-Bacterial Agents	MeSH
DB00339	2328	pyrazinamide	PA	D000890	Anti-Infective Agents	MeSH
DB00339	2328	pyrazinamide	has role	CHEBI:33231	antitubercular agent	CHEBI
DB00339	2328	pyrazinamide	has role	CHEBI:50266	prodrug	CHEBI
DB00339	2328	pyrazinamide	PA	D000995	Antitubercular Agents	MeSH
DB00340	1780	metixene	has role	CHEBI:48407	antiparkinson drug	CHEBI
DB00340	1780	metixene	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00340	1780	metixene	has role	CHEBI:37956	histamine antagonist	CHEBI
DB00341	581	cetirizine	MoA	N0000000190	Histamine H1 Receptor Antagonists	FDA
DB00341	581	cetirizine	EPC	N0000175587	Histamine-1 Receptor Antagonist	FDA
DB00341	581	cetirizine	PA	D018926	Anti-Allergic Agents	MeSH
DB00341	581	cetirizine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB00341	581	cetirizine	has role	CHEBI:50857	anti-allergic agent	CHEBI
DB00341	581	cetirizine	PA	D018494	Histamine Agents	MeSH
DB00341	581	cetirizine	PA	D006633	Histamine Antagonists	MeSH
DB00341	581	cetirizine	PA	D006634	Histamine H1 Antagonists	MeSH
DB00341	581	cetirizine	PA	D039563	Histamine H1 Antagonists, Non-Sedating	MeSH
DB00341	581	cetirizine	PA	D018377	Neurotransmitter Agents	MeSH
DB00342	2600	terfenadine	PA	D018494	Histamine Agents	MeSH
DB00342	2600	terfenadine	PA	D006633	Histamine Antagonists	MeSH
DB00342	2600	terfenadine	PA	D006634	Histamine H1 Antagonists	MeSH
DB00342	2600	terfenadine	PA	D039563	Histamine H1 Antagonists, Non-Sedating	MeSH
DB00342	2600	terfenadine	PA	D018377	Neurotransmitter Agents	MeSH
DB00343	897	diltiazem	MoA	N0000000069	Calcium Channel Antagonists	FDA
DB00343	897	diltiazem	EPC	N0000175566	Calcium Channel Blocker	FDA
DB00343	897	diltiazem	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00343	897	diltiazem	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00343	897	diltiazem	PA	D000959	Antihypertensive Agents	MeSH
DB00343	897	diltiazem	PA	D002121	Calcium Channel Blockers	MeSH
DB00343	897	diltiazem	PA	D002317	Cardiovascular Agents	MeSH
DB00343	897	diltiazem	PA	D049990	Membrane Transport Modulators	MeSH
DB00343	897	diltiazem	PA	D014665	Vasodilator Agents	MeSH
DB00344	2320	protriptyline	EPC	N0000175752	Tricyclic Antidepressant	FDA
DB00344	2320	protriptyline	PA	D018663	Adrenergic Agents	MeSH
DB00344	2320	protriptyline	PA	D018759	Adrenergic Uptake Inhibitors	MeSH
DB00344	2320	protriptyline	has role	CHEBI:35469	antidepressant	CHEBI
DB00344	2320	protriptyline	PA	D000928	Antidepressive Agents	MeSH
DB00344	2320	protriptyline	PA	D000929	Antidepressive Agents, Tricyclic	MeSH
DB00344	2320	protriptyline	PA	D002491	Central Nervous System Agents	MeSH
DB00344	2320	protriptyline	PA	D049990	Membrane Transport Modulators	MeSH
DB00344	2320	protriptyline	PA	D018377	Neurotransmitter Agents	MeSH
DB00344	2320	protriptyline	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB00344	2320	protriptyline	PA	D011619	Psychotropic Drugs	MeSH
DB00346	115	alfuzosin	EPC	N0000175553	alpha-Adrenergic Blocker	FDA
DB00346	115	alfuzosin	PA	D018663	Adrenergic Agents	MeSH
DB00346	115	alfuzosin	PA	D058668	Adrenergic alpha-1 Receptor Antagonists	MeSH
DB00346	115	alfuzosin	PA	D000317	Adrenergic alpha-Antagonists	MeSH
DB00346	115	alfuzosin	PA	D018674	Adrenergic Antagonists	MeSH
DB00346	115	alfuzosin	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00346	115	alfuzosin	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00346	115	alfuzosin	has role	CHEBI:37890	alpha-adrenergic antagonist	CHEBI
DB00346	115	alfuzosin	PA	D018377	Neurotransmitter Agents	MeSH
DB00346	115	alfuzosin	PA	D064804	Urological Agents	MeSH
DB00347	2751	trimethadione	EPC	N0000175753	Anti-epileptic Agent	FDA
DB00347	2751	trimethadione	PE	N0000008486	Decreased Central Nervous System Disorganized Electrical Activity	FDA
DB00347	2751	trimethadione	PA	D000927	Anticonvulsants	MeSH
DB00347	2751	trimethadione	PA	D002491	Central Nervous System Agents	MeSH
DB00348	1944	nitisinone	EPC	N0000175809	Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor	FDA
DB00348	1944	nitisinone	MoA	N0000175808	Hydroxyphenylpyruvate Dioxygenase Inhibitors	FDA
DB00348	1944	nitisinone	PA	D004791	Enzyme Inhibitors	MeSH
DB00349	682	clobazam	EPC	N0000175694	Benzodiazepine	FDA
DB00349	682	clobazam	Chemical/Ingredient	N0000007542	Benzodiazepines	FDA
DB00349	682	clobazam	MoA	N0000182137	Cytochrome P450 2D6 Inhibitors	FDA
DB00349	682	clobazam	has role	CHEBI:35623	anticonvulsant	CHEBI
DB00349	682	clobazam	has role	CHEBI:35474	anxiolytic drug	CHEBI
DB00349	682	clobazam	has role	CHEBI:50268	GABA modulator	CHEBI
DB00349	682	clobazam	PA	D000927	Anticonvulsants	MeSH
DB00349	682	clobazam	PA	D002491	Central Nervous System Agents	MeSH
DB00350	1814	minoxidil	PE	N0000175379	Arteriolar Vasodilation	FDA
DB00350	1814	minoxidil	EPC	N0000175564	Arteriolar Vasodilator	FDA
DB00350	1814	minoxidil	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00350	1814	minoxidil	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00350	1814	minoxidil	PA	D000959	Antihypertensive Agents	MeSH
DB00350	1814	minoxidil	PA	D002317	Cardiovascular Agents	MeSH
DB00350	1814	minoxidil	PA	D014665	Vasodilator Agents	MeSH
DB00352	2632	thioguanine	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00352	2632	thioguanine	PA	D000963	Antimetabolites	MeSH
DB00352	2632	thioguanine	PA	D000964	Antimetabolites, Antineoplastic	MeSH
DB00352	2632	thioguanine	PA	D000970	Antineoplastic Agents	MeSH
DB00352	2632	thioguanine	PA	D009676	Noxae	MeSH
DB00353	1764	methylergometrine	Chemical/Ingredient	N0000007618	Ergolines	FDA
DB00353	1764	methylergometrine	EPC	N0000175827	Ergot Derivative	FDA
DB00353	1764	methylergometrine	PA	D010120	Oxytocics	MeSH
DB00353	1764	methylergometrine	PA	D012102	Reproductive Control Agents	MeSH
DB00354	416	buclizine	has role	CHEBI:50919	antiemetic	CHEBI
DB00354	416	buclizine	has role	CHEBI:48873	cholinergic antagonist	CHEBI
DB00354	416	buclizine	has role	CHEBI:37956	histamine antagonist	CHEBI
DB00354	416	buclizine	has role	CHEBI:36333	local anaesthetic	CHEBI
DB00354	416	buclizine	has role	CHEBI:35488	central nervous system depressant	CHEBI
DB00354	416	buclizine	PA	D018494	Histamine Agents	MeSH
DB00354	416	buclizine	PA	D006633	Histamine Antagonists	MeSH
DB00354	416	buclizine	PA	D018377	Neurotransmitter Agents	MeSH
DB00355	279	aztreonam	EPC	N0000175493	Monobactam Antibacterial	FDA
DB00355	279	aztreonam	Chemical/Ingredient	N0000011311	Monobactams	FDA
DB00355	279	aztreonam	PA	D000900	Anti-Bacterial Agents	MeSH
DB00355	279	aztreonam	PA	D000890	Anti-Infective Agents	MeSH
DB00355	279	aztreonam	has role	CHEBI:88188	drug allergen	CHEBI
DB00355	279	aztreonam	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00356	626	chlorzoxazone	PE	N0000175730	Centrally-mediated Muscle Relaxation	FDA
DB00356	626	chlorzoxazone	has role	CHEBI:51371	muscle relaxant	CHEBI
DB00356	626	chlorzoxazone	has role	CHEBI:35717	sedative	CHEBI
DB00356	626	chlorzoxazone	PA	D002491	Central Nervous System Agents	MeSH
DB00356	626	chlorzoxazone	PA	D009125	Muscle Relaxants, Central	MeSH
DB00356	626	chlorzoxazone	PA	D009465	Neuromuscular Agents	MeSH
DB00357	164	aminoglutethimide	EPC	N0000175928	Adrenal Steroid Synthesis Inhibitor	FDA
DB00357	164	aminoglutethimide	MoA	N0000175921	Adrenal Steroid Synthesis Inhibitors	FDA
DB00357	164	aminoglutethimide	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00357	164	aminoglutethimide	has role	CHEBI:37962	adrenergic agent	CHEBI
DB00357	164	aminoglutethimide	has role	CHEBI:35623	anticonvulsant	CHEBI
DB00357	164	aminoglutethimide	PA	D000970	Antineoplastic Agents	MeSH
DB00357	164	aminoglutethimide	PA	D018931	Antineoplastic Agents, Hormonal	MeSH
DB00357	164	aminoglutethimide	PA	D047072	Aromatase Inhibitors	MeSH
DB00357	164	aminoglutethimide	PA	D004791	Enzyme Inhibitors	MeSH
DB00357	164	aminoglutethimide	PA	D004965	Estrogen Antagonists	MeSH
DB00357	164	aminoglutethimide	PA	D006727	Hormone Antagonists	MeSH
DB00357	164	aminoglutethimide	PA	D065088	Steroid Synthesis Inhibitors	MeSH
DB00359	2500	sulfadiazine	EPC	N0000175503	Sulfonamide Antibacterial	FDA
DB00359	2500	sulfadiazine	Chemical/Ingredient	N0000008048	Sulfonamides	FDA
DB00359	2500	sulfadiazine	PA	D000890	Anti-Infective Agents	MeSH
DB00359	2500	sulfadiazine	has role	CHEBI:35818	coccidiostat	CHEBI
DB00359	2500	sulfadiazine	has role	CHEBI:35441	antiinfective agent	CHEBI
DB00359	2500	sulfadiazine	has role	CHEBI:35820	antiprotozoal drug	CHEBI
DB00359	2500	sulfadiazine	PA	D000977	Antiparasitic Agents	MeSH
DB00359	2500	sulfadiazine	PA	D000981	Antiprotozoal Agents	MeSH
DB00359	2500	sulfadiazine	PA	D003049	Coccidiostats	MeSH
DB00359	4142	sulfadiazine silver	PA	D000891	Anti-Infective Agents, Local	MeSH
DB00359	4142	sulfadiazine silver	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00360	2612	sapropterin	EPC	N0000190483	Phenylalanine Hydroxylase Activator	FDA
DB00360	2612	sapropterin	MoA	N0000190482	Phenylalanine Hydroxylase Activators	FDA
DB00360	2612	sapropterin	has role	CHEBI:33295	diagnostic agent	CHEBI
DB02692	2612	sapropterin	EPC	N0000190483	Phenylalanine Hydroxylase Activator	FDA
DB02692	2612	sapropterin	MoA	N0000190482	Phenylalanine Hydroxylase Activators	FDA
DB02692	2612	sapropterin	has role	CHEBI:33295	diagnostic agent	CHEBI
DB03918	2612	sapropterin	EPC	N0000190483	Phenylalanine Hydroxylase Activator	FDA
DB03918	2612	sapropterin	MoA	N0000190482	Phenylalanine Hydroxylase Activators	FDA
DB03918	2612	sapropterin	has role	CHEBI:33295	diagnostic agent	CHEBI
DB00361	2827	vinorelbine	EPC	N0000175612	Vinca Alkaloid	FDA
DB00361	2827	vinorelbine	Chemical/Ingredient	N0000007780	Vinca Alkaloids	FDA
DB00361	2827	vinorelbine	has role	CHEBI:47868	photosensitizing agent	CHEBI
DB00361	2827	vinorelbine	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00361	2827	vinorelbine	PA	D000970	Antineoplastic Agents	MeSH
DB00361	2827	vinorelbine	PA	D000972	Antineoplastic Agents, Phytogenic	MeSH
DB00362	4357	anidulafungin	EPC	N0000175507	Echinocandin Antifungal	FDA
DB00362	4357	anidulafungin	Chemical/Ingredient	N0000175508	Lipopeptides	FDA
DB00362	4357	anidulafungin	PA	D000890	Anti-Infective Agents	MeSH
DB00362	4357	anidulafungin	PA	D000935	Antifungal Agents	MeSH
DB00363	722	clozapine	EPC	N0000175430	Atypical Antipsychotic	FDA
DB00363	722	clozapine	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB00363	722	clozapine	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB00363	722	clozapine	has role	CHEBI:37887	adrenergic antagonist	CHEBI
DB00363	722	clozapine	has role	CHEBI:37956	histamine antagonist	CHEBI
DB00363	722	clozapine	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00363	722	clozapine	has role	CHEBI:65259	GABA antagonist	CHEBI
DB00363	722	clozapine	has role	CHEBI:65191	second generation antipsychotic	CHEBI
DB00363	722	clozapine	PA	D014150	Antipsychotic Agents	MeSH
DB00363	722	clozapine	PA	D002491	Central Nervous System Agents	MeSH
DB00363	722	clozapine	PA	D002492	Central Nervous System Depressants	MeSH
DB00363	722	clozapine	PA	D018682	GABA Agents	MeSH
DB00363	722	clozapine	PA	D018756	GABA Antagonists	MeSH
DB00363	722	clozapine	PA	D018377	Neurotransmitter Agents	MeSH
DB00363	722	clozapine	PA	D011619	Psychotropic Drugs	MeSH
DB00363	722	clozapine	PA	D018490	Serotonin Agents	MeSH
DB00363	722	clozapine	PA	D012702	Serotonin Antagonists	MeSH
DB00363	722	clozapine	PA	D014149	Tranquilizing Agents	MeSH
DB00364	4106	sucralfate	EPC	N0000175801	Aluminum Complex	FDA
DB00364	4106	sucralfate	Chemical/Ingredient	N0000007683	Organometallic Compounds	FDA
DB00364	4106	sucralfate	PA	D000897	Anti-Ulcer Agents	MeSH
DB00364	4106	sucralfate	PA	D005765	Gastrointestinal Agents	MeSH
DB00365	1330	grepafloxacin	PA	D000900	Anti-Bacterial Agents	MeSH
DB00365	1330	grepafloxacin	PA	D000890	Anti-Infective Agents	MeSH
DB00365	1330	grepafloxacin	PA	D000970	Antineoplastic Agents	MeSH
DB00365	1330	grepafloxacin	PA	D004791	Enzyme Inhibitors	MeSH
DB00365	1330	grepafloxacin	PA	D059005	Topoisomerase II Inhibitors	MeSH
DB00366	962	doxylamine	has role	CHEBI:37956	histamine antagonist	CHEBI
DB00366	962	doxylamine	has role	CHEBI:48873	cholinergic antagonist	CHEBI
DB00366	962	doxylamine	has role	CHEBI:35717	sedative	CHEBI
DB00366	962	doxylamine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB00366	962	doxylamine	has role	CHEBI:51177	antitussive	CHEBI
DB00366	962	doxylamine	has role	CHEBI:50919	antiemetic	CHEBI
DB00366	962	doxylamine	has role	CHEBI:50857	anti-allergic agent	CHEBI
DB00366	962	doxylamine	PA	D000932	Antiemetics	MeSH
DB00366	962	doxylamine	PA	D002491	Central Nervous System Agents	MeSH
DB00366	962	doxylamine	PA	D005765	Gastrointestinal Agents	MeSH
DB00366	962	doxylamine	PA	D018494	Histamine Agents	MeSH
DB00366	962	doxylamine	PA	D006633	Histamine Antagonists	MeSH
DB00366	962	doxylamine	PA	D006634	Histamine H1 Antagonists	MeSH
DB00366	962	doxylamine	PA	D018377	Neurotransmitter Agents	MeSH
DB00367	1572	levonorgestrel	PE	N0000175830	Inhibit Ovum Fertilization	FDA
DB00367	1572	levonorgestrel	Chemical/Ingredient	N0000011301	Progesterone Congeners	FDA
DB00367	1572	levonorgestrel	EPC	N0000175602	Progestin	FDA
DB00367	1572	levonorgestrel	EPC	N0000175832	Progestin-containing Intrauterine Device	FDA
DB00367	1572	levonorgestrel	has role	CHEBI:49323	contraceptive drug	CHEBI
DB00367	1572	levonorgestrel	has role	CHEBI:49326	synthetic oral contraceptive	CHEBI
DB00367	1572	levonorgestrel	has role	CHEBI:49324	female contraceptive drug	CHEBI
DB00367	1572	levonorgestrel	PA	D003270	Contraceptive Agents	MeSH
DB00367	1572	levonorgestrel	PA	D003271	Contraceptive Agents, Female	MeSH
DB00367	1572	levonorgestrel	PA	D003276	Contraceptives, Oral	MeSH
DB00367	1572	levonorgestrel	PA	D003280	Contraceptives, Oral, Synthetic	MeSH
DB00367	1572	levonorgestrel	PA	D012102	Reproductive Control Agents	MeSH
DB00368	1960	norepinephrine	EPC	N0000175570	Catecholamine	FDA
DB00368	1960	norepinephrine	Chemical/Ingredient	N0000007715	Catecholamines	FDA
DB00368	1960	norepinephrine	PA	D018663	Adrenergic Agents	MeSH
DB00368	1960	norepinephrine	PA	D000322	Adrenergic Agonists	MeSH
DB00368	1960	norepinephrine	PA	D000316	Adrenergic alpha-Agonists	MeSH
DB00368	1960	norepinephrine	PA	D002317	Cardiovascular Agents	MeSH
DB00368	1960	norepinephrine	PA	D018377	Neurotransmitter Agents	MeSH
DB00368	1960	norepinephrine	PA	D013566	Sympathomimetics	MeSH
DB00368	1960	norepinephrine	PA	D014662	Vasoconstrictor Agents	MeSH
DB00369	639	cidofovir	PA	D000890	Anti-Infective Agents	MeSH
DB00369	639	cidofovir	PA	D000998	Antiviral Agents	MeSH
DB00370	1816	mirtazapine	PA	D018663	Adrenergic Agents	MeSH
DB00370	1816	mirtazapine	PA	D000317	Adrenergic alpha-Antagonists	MeSH
DB00370	1816	mirtazapine	PA	D018674	Adrenergic Antagonists	MeSH
DB00370	1816	mirtazapine	has role	CHEBI:37890	alpha-adrenergic antagonist	CHEBI
DB00370	1816	mirtazapine	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB00370	1816	mirtazapine	has role	CHEBI:37956	histamine antagonist	CHEBI
DB00370	1816	mirtazapine	has role	CHEBI:35474	anxiolytic drug	CHEBI
DB00370	1816	mirtazapine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB00370	1816	mirtazapine	PA	D000928	Antidepressive Agents	MeSH
DB00370	1816	mirtazapine	PA	D000929	Antidepressive Agents, Tricyclic	MeSH
DB00370	1816	mirtazapine	PA	D002491	Central Nervous System Agents	MeSH
DB00370	1816	mirtazapine	PA	D018494	Histamine Agents	MeSH
DB00370	1816	mirtazapine	PA	D006633	Histamine Antagonists	MeSH
DB00370	1816	mirtazapine	PA	D006634	Histamine H1 Antagonists	MeSH
DB00370	1816	mirtazapine	PA	D018377	Neurotransmitter Agents	MeSH
DB00370	1816	mirtazapine	PA	D011619	Psychotropic Drugs	MeSH
DB00371	1704	meprobamate	PA	D014151	Anti-Anxiety Agents	MeSH
DB00371	1704	meprobamate	PA	D000927	Anticonvulsants	MeSH
DB00371	1704	meprobamate	PA	D002491	Central Nervous System Agents	MeSH
DB00371	1704	meprobamate	PA	D002492	Central Nervous System Depressants	MeSH
DB00371	1704	meprobamate	PA	D006993	Hypnotics and Sedatives	MeSH
DB00371	1704	meprobamate	PA	D009125	Muscle Relaxants, Central	MeSH
DB00371	1704	meprobamate	PA	D009465	Neuromuscular Agents	MeSH
DB00371	1704	meprobamate	PA	D011619	Psychotropic Drugs	MeSH
DB00371	1704	meprobamate	PA	D014149	Tranquilizing Agents	MeSH
DB00372	2630	thiethylperazine	has role	CHEBI:37930	phenothiazine antipsychotic drug	CHEBI
DB00372	2630	thiethylperazine	has role	CHEBI:37956	histamine antagonist	CHEBI
DB00372	2630	thiethylperazine	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00372	2630	thiethylperazine	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB00372	2630	thiethylperazine	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB00372	2630	thiethylperazine	has role	CHEBI:50919	antiemetic	CHEBI
DB00372	2630	thiethylperazine	PA	D000932	Antiemetics	MeSH
DB00372	2630	thiethylperazine	PA	D002491	Central Nervous System Agents	MeSH
DB00372	2630	thiethylperazine	PA	D015259	Dopamine Agents	MeSH
DB00372	2630	thiethylperazine	PA	D018492	Dopamine Antagonists	MeSH
DB00372	2630	thiethylperazine	PA	D005765	Gastrointestinal Agents	MeSH
DB00372	2630	thiethylperazine	PA	D018377	Neurotransmitter Agents	MeSH
DB00373	4061	timolol	PA	D018663	Adrenergic Agents	MeSH
DB00373	4061	timolol	PA	D018674	Adrenergic Antagonists	MeSH
DB00373	4061	timolol	PA	D000319	Adrenergic beta-Antagonists	MeSH
DB00373	4061	timolol	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB00373	4061	timolol	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00373	4061	timolol	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB00373	4061	timolol	has role	CHEBI:35530	beta-adrenergic antagonist	CHEBI
DB00373	4061	timolol	has role	CHEBI:39456	antiglaucoma drug	CHEBI
DB00373	4061	timolol	PA	D000959	Antihypertensive Agents	MeSH
DB00373	4061	timolol	PA	D002317	Cardiovascular Agents	MeSH
DB00373	4061	timolol	PA	D018377	Neurotransmitter Agents	MeSH
DB00374	2720	treprostinil	EPC	N0000175416	Prostacycline Vasodilator	FDA
DB00374	2720	treprostinil	Chemical/Ingredient	N0000011280	Prostaglandins I	FDA
DB00374	2720	treprostinil	PE	N0000009909	Vasodilation	FDA
DB00374	2720	treprostinil	has role	CHEBI:50427	platelet aggregation inhibitor	CHEBI
DB00374	2720	treprostinil	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00374	2720	treprostinil	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00374	2720	treprostinil	has role	CHEBI:35554	cardiovascular drug	CHEBI
DB00374	2720	treprostinil	PA	D000959	Antihypertensive Agents	MeSH
DB00374	2720	treprostinil	PA	D002317	Cardiovascular Agents	MeSH
DB00376	2745	trihexyphenidyl	PA	D018726	Anti-Dyskinesia Agents	MeSH
DB00376	2745	trihexyphenidyl	PA	D000978	Antiparkinson Agents	MeSH
DB00376	2745	trihexyphenidyl	PA	D002491	Central Nervous System Agents	MeSH
DB00376	2745	trihexyphenidyl	PA	D018678	Cholinergic Agents	MeSH
DB00376	2745	trihexyphenidyl	PA	D018680	Cholinergic Antagonists	MeSH
DB00376	2745	trihexyphenidyl	PA	D018727	Muscarinic Antagonists	MeSH
DB00376	2745	trihexyphenidyl	PA	D018377	Neurotransmitter Agents	MeSH
DB00377	2046	palonosetron	MoA	N0000175817	Serotonin 3 Receptor Antagonists	FDA
DB00377	2046	palonosetron	EPC	N0000175818	Serotonin-3 Receptor Antagonist	FDA
DB00377	2046	palonosetron	has role	CHEBI:50919	antiemetic	CHEBI
DB00377	2046	palonosetron	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB00377	2046	palonosetron	PA	D018377	Neurotransmitter Agents	MeSH
DB00377	2046	palonosetron	PA	D018490	Serotonin Agents	MeSH
DB00377	2046	palonosetron	PA	D012702	Serotonin Antagonists	MeSH
DB00378	975	dydrogesterone	PA	D006728	Hormones	MeSH
DB00378	975	dydrogesterone	PA	D011372	Progestins	MeSH
DB00379	1794	mexiletine	EPC	N0000175426	Antiarrhythmic	FDA
DB00379	1794	mexiletine	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB00379	1794	mexiletine	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB00379	1794	mexiletine	PA	D002317	Cardiovascular Agents	MeSH
DB00379	1794	mexiletine	PA	D049990	Membrane Transport Modulators	MeSH
DB00379	1794	mexiletine	PA	D026941	Sodium Channel Blockers	MeSH
DB00379	1794	mexiletine	PA	D061567	Voltage-Gated Sodium Channel Blockers	MeSH
DB07129	1794	mexiletine	EPC	N0000175426	Antiarrhythmic	FDA
DB07129	1794	mexiletine	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB07129	1794	mexiletine	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB07129	1794	mexiletine	PA	D002317	Cardiovascular Agents	MeSH
DB07129	1794	mexiletine	PA	D049990	Membrane Transport Modulators	MeSH
DB07129	1794	mexiletine	PA	D026941	Sodium Channel Blockers	MeSH
DB07129	1794	mexiletine	PA	D061567	Voltage-Gated Sodium Channel Blockers	MeSH
DB00382	2551	tacrine	EPC	N0000175723	Cholinesterase Inhibitor	FDA
DB00382	2551	tacrine	PA	D002491	Central Nervous System Agents	MeSH
DB00382	2551	tacrine	PA	D018678	Cholinergic Agents	MeSH
DB00382	2551	tacrine	PA	D002800	Cholinesterase Inhibitors	MeSH
DB00382	2551	tacrine	PA	D004791	Enzyme Inhibitors	MeSH
DB00382	2551	tacrine	PA	D018377	Neurotransmitter Agents	MeSH
DB00382	2551	tacrine	PA	D018697	Nootropic Agents	MeSH
DB00382	2551	tacrine	PA	D010277	Parasympathomimetics	MeSH
DB00384	2728	triamterene	PE	N0000008859	Decreased Renal K+ Excretion	FDA
DB00384	2728	triamterene	PE	N0000175359	Increased Diuresis	FDA
DB00384	2728	triamterene	EPC	N0000175418	Potassium-sparing Diuretic	FDA
DB00384	2728	triamterene	PA	D004232	Diuretics	MeSH
DB00384	2728	triamterene	PA	D062686	Epithelial Sodium Channel Blockers	MeSH
DB00384	2728	triamterene	PA	D049990	Membrane Transport Modulators	MeSH
DB00384	2728	triamterene	PA	D045283	Natriuretic Agents	MeSH
DB00384	2728	triamterene	PA	D026941	Sodium Channel Blockers	MeSH
DB00385	2805	valrubicin	PA	D000970	Antineoplastic Agents	MeSH
DB00385	2805	valrubicin	PA	D004791	Enzyme Inhibitors	MeSH
DB00385	2805	valrubicin	PA	D059005	Topoisomerase II Inhibitors	MeSH
DB00387	2276	procyclidine	EPC	N0000175574	Anticholinergic	FDA
DB00387	2276	procyclidine	PA	D018726	Anti-Dyskinesia Agents	MeSH
DB00387	2276	procyclidine	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00387	2276	procyclidine	has role	CHEBI:48407	antiparkinson drug	CHEBI
DB00387	2276	procyclidine	has role	CHEBI:66956	antidyskinesia agent	CHEBI
DB00387	2276	procyclidine	PA	D000978	Antiparkinson Agents	MeSH
DB00387	2276	procyclidine	PA	D002491	Central Nervous System Agents	MeSH
DB00387	2276	procyclidine	PA	D018678	Cholinergic Agents	MeSH
DB00387	2276	procyclidine	PA	D018680	Cholinergic Antagonists	MeSH
DB00387	2276	procyclidine	PA	D018727	Muscarinic Antagonists	MeSH
DB00387	2276	procyclidine	PA	D018377	Neurotransmitter Agents	MeSH
DB00388	2146	phenylephrine	EPC	N0000186105	alpha-1 Adrenergic Agonist	FDA
DB00388	2146	phenylephrine	MoA	N0000009917	Adrenergic alpha1-Agonists	FDA
DB00388	2146	phenylephrine	PA	D018663	Adrenergic Agents	MeSH
DB00388	2146	phenylephrine	PA	D000322	Adrenergic Agonists	MeSH
DB00388	2146	phenylephrine	PA	D058646	Adrenergic alpha-1 Receptor Agonists	MeSH
DB00388	2146	phenylephrine	PA	D000316	Adrenergic alpha-Agonists	MeSH
DB00388	2146	phenylephrine	has role	CHEBI:38147	cardiotonic drug	CHEBI
DB00388	2146	phenylephrine	has role	CHEBI:50513	mydriatic agent	CHEBI
DB00388	2146	phenylephrine	has role	CHEBI:50267	protective agent	CHEBI
DB00388	2146	phenylephrine	has role	CHEBI:50514	vasoconstrictor agent	CHEBI
DB00388	2146	phenylephrine	has role	CHEBI:35524	sympathomimetic agent	CHEBI
DB00388	2146	phenylephrine	has role	CHEBI:77715	nasal decongestant	CHEBI
DB00388	2146	phenylephrine	has role	CHEBI:35569	alpha-adrenergic agonist	CHEBI
DB00388	2146	phenylephrine	PA	D002316	Cardiotonic Agents	MeSH
DB00388	2146	phenylephrine	PA	D002317	Cardiovascular Agents	MeSH
DB00388	2146	phenylephrine	PA	D009184	Mydriatics	MeSH
DB00388	2146	phenylephrine	PA	D014663	Nasal Decongestants	MeSH
DB00388	2146	phenylephrine	PA	D018377	Neurotransmitter Agents	MeSH
DB00388	2146	phenylephrine	PA	D020011	Protective Agents	MeSH
DB00388	2146	phenylephrine	PA	D019141	Respiratory System Agents	MeSH
DB00388	2146	phenylephrine	PA	D013566	Sympathomimetics	MeSH
DB00388	2146	phenylephrine	PA	D014662	Vasoconstrictor Agents	MeSH
DB00389	497	carbimazole	has role	CHEBI:50266	prodrug	CHEBI
DB00389	497	carbimazole	has role	CHEBI:50671	antithyroid drug	CHEBI
DB00389	497	carbimazole	PA	D013956	Antithyroid Agents	MeSH
DB00389	497	carbimazole	PA	D006727	Hormone Antagonists	MeSH
DB00390	882	digoxin	EPC	N0000175568	Cardiac Glycoside	FDA
DB00390	882	digoxin	Chemical/Ingredient	N0000008157	Cardiac Glycosides	FDA
DB00390	882	digoxin	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB00390	882	digoxin	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB00390	882	digoxin	has role	CHEBI:38147	cardiotonic drug	CHEBI
DB00390	882	digoxin	PA	D002316	Cardiotonic Agents	MeSH
DB00390	882	digoxin	PA	D002317	Cardiovascular Agents	MeSH
DB00390	882	digoxin	PA	D004791	Enzyme Inhibitors	MeSH
DB00390	882	digoxin	PA	D020011	Protective Agents	MeSH
DB00392	1086	profenamine	PA	D018663	Adrenergic Agents	MeSH
DB00392	1086	profenamine	PA	D018674	Adrenergic Antagonists	MeSH
DB00392	1086	profenamine	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00392	1086	profenamine	has role	CHEBI:48407	antiparkinson drug	CHEBI
DB00392	1086	profenamine	has role	CHEBI:37956	histamine antagonist	CHEBI
DB00392	1086	profenamine	has role	CHEBI:37887	adrenergic antagonist	CHEBI
DB00392	1086	profenamine	has role	CHEBI:66956	antidyskinesia agent	CHEBI
DB00392	1086	profenamine	PA	D018678	Cholinergic Agents	MeSH
DB00392	1086	profenamine	PA	D018680	Cholinergic Antagonists	MeSH
DB00392	1086	profenamine	PA	D018494	Histamine Agents	MeSH
DB00392	1086	profenamine	PA	D006633	Histamine Antagonists	MeSH
DB00392	1086	profenamine	PA	D018727	Muscarinic Antagonists	MeSH
DB00392	1086	profenamine	PA	D018377	Neurotransmitter Agents	MeSH
DB00393	1937	nimodipine	MoA	N0000000069	Calcium Channel Antagonists	FDA
DB00393	1937	nimodipine	EPC	N0000175421	Dihydropyridine Calcium Channel Blocker	FDA
DB00393	1937	nimodipine	Chemical/Ingredient	N0000007556	Dihydropyridines	FDA
DB00393	1937	nimodipine	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00393	1937	nimodipine	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00393	1937	nimodipine	has role	CHEBI:35554	cardiovascular drug	CHEBI
DB00393	1937	nimodipine	PA	D000959	Antihypertensive Agents	MeSH
DB00393	1937	nimodipine	PA	D002121	Calcium Channel Blockers	MeSH
DB00393	1937	nimodipine	PA	D002317	Cardiovascular Agents	MeSH
DB00393	1937	nimodipine	PA	D049990	Membrane Transport Modulators	MeSH
DB00393	1937	nimodipine	PA	D014665	Vasodilator Agents	MeSH
DB00396	2279	progesterone	Chemical/Ingredient	N0000005934	Progesterone	FDA
DB00396	2279	progesterone	has role	CHEBI:49323	contraceptive drug	CHEBI
DB00396	2279	progesterone	has role	CHEBI:70709	progesterone receptor agonist	CHEBI
DB00396	2279	progesterone	PA	D006728	Hormones	MeSH
DB00396	2279	progesterone	PA	D011372	Progestins	MeSH
DB00398	2459	sorafenib	EPC	N0000175605	Kinase Inhibitor	FDA
DB00398	2459	sorafenib	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00398	2459	sorafenib	has role	CHEBI:48422	angiogenesis inhibitor	CHEBI
DB00398	2459	sorafenib	PA	D000970	Antineoplastic Agents	MeSH
DB00398	2459	sorafenib	PA	D004791	Enzyme Inhibitors	MeSH
DB00398	2459	sorafenib	PA	D047428	Protein Kinase Inhibitors	MeSH
DB00399	2868	zoledronic acid	has role	CHEBI:50646	bone density conservation agent	CHEBI
DB00399	2868	zoledronic acid	PA	D050071	Bone Density Conservation Agents	MeSH
DB00400	1331	griseofulvin	PE	N0000008732	Decreased Mitosis	FDA
DB00400	1331	griseofulvin	PE	N0000175085	Microtubule Inhibition	FDA
DB00400	1331	griseofulvin	EPC	N0000175848	Tubulin Inhibiting Agent	FDA
DB00400	1331	griseofulvin	PA	D000890	Anti-Infective Agents	MeSH
DB00400	1331	griseofulvin	PA	D000935	Antifungal Agents	MeSH
DB00401	1942	nisoldipine	EPC	N0000175421	Dihydropyridine Calcium Channel Blocker	FDA
DB00401	1942	nisoldipine	Chemical/Ingredient	N0000007556	Dihydropyridines	FDA
DB00401	1942	nisoldipine	MoA	N0000000069	Calcium Channel Antagonists	FDA
DB00401	1942	nisoldipine	PE	N0000178477	Decreased Blood Pressure	FDA
DB00401	1942	nisoldipine	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00401	1942	nisoldipine	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00401	1942	nisoldipine	has role	CHEBI:50427	platelet aggregation inhibitor	CHEBI
DB00401	1942	nisoldipine	has role	CHEBI:35554	cardiovascular drug	CHEBI
DB00401	1942	nisoldipine	PA	D000959	Antihypertensive Agents	MeSH
DB00401	1942	nisoldipine	PA	D002121	Calcium Channel Blockers	MeSH
DB00401	1942	nisoldipine	PA	D002317	Cardiovascular Agents	MeSH
DB00401	1942	nisoldipine	PA	D049990	Membrane Transport Modulators	MeSH
DB00401	1942	nisoldipine	PA	D014665	Vasodilator Agents	MeSH
DB00402	2873	zopiclone	has role	CHEBI:35488	central nervous system depressant	CHEBI
DB00402	2873	zopiclone	has role	CHEBI:35717	sedative	CHEBI
DB00402	2873	zopiclone	PA	D002491	Central Nervous System Agents	MeSH
DB00402	2873	zopiclone	PA	D002492	Central Nervous System Depressants	MeSH
DB00402	2873	zopiclone	PA	D006993	Hypnotics and Sedatives	MeSH
DB01198	2873	zopiclone	has role	CHEBI:35488	central nervous system depressant	CHEBI
DB01198	2873	zopiclone	has role	CHEBI:35717	sedative	CHEBI
DB01198	2873	zopiclone	PA	D002491	Central Nervous System Agents	MeSH
DB01198	2873	zopiclone	PA	D002492	Central Nervous System Depressants	MeSH
DB01198	2873	zopiclone	PA	D006993	Hypnotics and Sedatives	MeSH
DB00403	579	ceruletide	has role	CHEBI:33295	diagnostic agent	CHEBI
DB00403	579	ceruletide	has role	CHEBI:55324	gastrointestinal drug	CHEBI
DB00404	136	alprazolam	EPC	N0000175694	Benzodiazepine	FDA
DB00404	136	alprazolam	Chemical/Ingredient	N0000007542	Benzodiazepines	FDA
DB00404	136	alprazolam	PA	D014151	Anti-Anxiety Agents	MeSH
DB00404	136	alprazolam	has role	CHEBI:51373	GABA agonist	CHEBI
DB00404	136	alprazolam	has role	CHEBI:35474	anxiolytic drug	CHEBI
DB00404	136	alprazolam	has role	CHEBI:35623	anticonvulsant	CHEBI
DB00404	136	alprazolam	has role	CHEBI:51371	muscle relaxant	CHEBI
DB00404	136	alprazolam	has role	CHEBI:35717	sedative	CHEBI
DB00404	136	alprazolam	PA	D002491	Central Nervous System Agents	MeSH
DB00404	136	alprazolam	PA	D002492	Central Nervous System Depressants	MeSH
DB00404	136	alprazolam	PA	D018682	GABA Agents	MeSH
DB00404	136	alprazolam	PA	D018757	GABA Modulators	MeSH
DB00404	136	alprazolam	PA	D006993	Hypnotics and Sedatives	MeSH
DB00404	136	alprazolam	PA	D018377	Neurotransmitter Agents	MeSH
DB00404	136	alprazolam	PA	D011619	Psychotropic Drugs	MeSH
DB00404	136	alprazolam	PA	D014149	Tranquilizing Agents	MeSH
DB00405	830	dexbrompheniramine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB00405	830	dexbrompheniramine	has role	CHEBI:50857	anti-allergic agent	CHEBI
DB00405	830	dexbrompheniramine	PA	D018494	Histamine Agents	MeSH
DB00405	830	dexbrompheniramine	PA	D006633	Histamine Antagonists	MeSH
DB00405	830	dexbrompheniramine	PA	D006634	Histamine H1 Antagonists	MeSH
DB00405	830	dexbrompheniramine	PA	D018377	Neurotransmitter Agents	MeSH
DB00835	830	dexbrompheniramine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB00835	830	dexbrompheniramine	has role	CHEBI:50857	anti-allergic agent	CHEBI
DB00835	830	dexbrompheniramine	PA	D018494	Histamine Agents	MeSH
DB00835	830	dexbrompheniramine	PA	D006633	Histamine Antagonists	MeSH
DB00835	830	dexbrompheniramine	PA	D006634	Histamine H1 Antagonists	MeSH
DB00835	830	dexbrompheniramine	PA	D018377	Neurotransmitter Agents	MeSH
DB00405	408	brompheniramine	PA	D018926	Anti-Allergic Agents	MeSH
DB00835	408	brompheniramine	PA	D018926	Anti-Allergic Agents	MeSH
DB00408	1613	loxapine	has role	CHEBI:35476	antipsychotic agent	CHEBI
DB00408	1613	loxapine	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB00408	1613	loxapine	PA	D014150	Antipsychotic Agents	MeSH
DB00408	1613	loxapine	PA	D002491	Central Nervous System Agents	MeSH
DB00408	1613	loxapine	PA	D002492	Central Nervous System Depressants	MeSH
DB00408	1613	loxapine	PA	D015259	Dopamine Agents	MeSH
DB00408	1613	loxapine	PA	D018492	Dopamine Antagonists	MeSH
DB00408	1613	loxapine	PA	D018377	Neurotransmitter Agents	MeSH
DB00408	1613	loxapine	PA	D011619	Psychotropic Drugs	MeSH
DB00408	1613	loxapine	PA	D014149	Tranquilizing Agents	MeSH
DB00409	2365	remoxipride	PA	D014150	Antipsychotic Agents	MeSH
DB00409	2365	remoxipride	PA	D002491	Central Nervous System Agents	MeSH
DB00409	2365	remoxipride	PA	D002492	Central Nervous System Depressants	MeSH
DB00409	2365	remoxipride	PA	D015259	Dopamine Agents	MeSH
DB00409	2365	remoxipride	PA	D018492	Dopamine Antagonists	MeSH
DB00409	2365	remoxipride	PA	D018377	Neurotransmitter Agents	MeSH
DB00409	2365	remoxipride	PA	D011619	Psychotropic Drugs	MeSH
DB00409	2365	remoxipride	PA	D014149	Tranquilizing Agents	MeSH
DB00410	1857	mupirocin	EPC	N0000175515	RNA Synthetase Inhibitor Antibacterial	FDA
DB00410	1857	mupirocin	MoA	N0000175516	RNA Synthetase Inhibitors	FDA
DB00410	1857	mupirocin	PA	D000900	Anti-Bacterial Agents	MeSH
DB00410	1857	mupirocin	PA	D000890	Anti-Infective Agents	MeSH
DB00410	1857	mupirocin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00410	1857	mupirocin	PA	D004791	Enzyme Inhibitors	MeSH
DB00410	1857	mupirocin	PA	D011500	Protein Synthesis Inhibitors	MeSH
DB00411	488	carbachol	PA	D000700	Analgesics	MeSH
DB00411	488	carbachol	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00411	488	carbachol	has role	CHEBI:47958	nicotinic acetylcholine receptor agonist	CHEBI
DB00411	488	carbachol	has role	CHEBI:38325	muscarinic agonist	CHEBI
DB00411	488	carbachol	has role	CHEBI:38147	cardiotonic drug	CHEBI
DB00411	488	carbachol	has role	CHEBI:51068	miotic	CHEBI
DB00411	488	carbachol	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB00411	488	carbachol	PA	D002316	Cardiotonic Agents	MeSH
DB00411	488	carbachol	PA	D002317	Cardiovascular Agents	MeSH
DB00411	488	carbachol	PA	D002491	Central Nervous System Agents	MeSH
DB00411	488	carbachol	PA	D018678	Cholinergic Agents	MeSH
DB00411	488	carbachol	PA	D018679	Cholinergic Agonists	MeSH
DB00411	488	carbachol	PA	D008916	Miotics	MeSH
DB00411	488	carbachol	PA	D018377	Neurotransmitter Agents	MeSH
DB00411	488	carbachol	PA	D020011	Protective Agents	MeSH
DB00411	488	carbachol	PA	D018689	Sensory System Agents	MeSH
DB00412	2405	rosiglitazone	EPC	N0000180186	Peroxisome Proliferator Receptor gamma Agonist	FDA
DB00412	2405	rosiglitazone	MoA	N0000175374	Peroxisome Proliferator-activated Receptor Activity	FDA
DB00412	2405	rosiglitazone	Chemical/Ingredient	N0000170119	PPAR gamma	FDA
DB00412	2405	rosiglitazone	EPC	N0000180190	Thiazolidinedione	FDA
DB00412	2405	rosiglitazone	Chemical/Ingredient	N0000011272	Thiazolidinediones	FDA
DB00412	2405	rosiglitazone	has role	CHEBI:50864	insulin-sensitizing drug	CHEBI
DB00412	2405	rosiglitazone	PA	D007004	Hypoglycemic Agents	MeSH
DB00413	2233	pramipexole	EPC	N0000175768	Nonergot Dopamine Agonist	FDA
DB00413	2233	pramipexole	PA	D018726	Anti-Dyskinesia Agents	MeSH
DB00413	2233	pramipexole	has role	CHEBI:48407	antiparkinson drug	CHEBI
DB00413	2233	pramipexole	has role	CHEBI:51065	dopamine agonist	CHEBI
DB00413	2233	pramipexole	has role	CHEBI:66956	antidyskinesia agent	CHEBI
DB00413	2233	pramipexole	PA	D000975	Antioxidants	MeSH
DB00413	2233	pramipexole	PA	D000978	Antiparkinson Agents	MeSH
DB00413	2233	pramipexole	PA	D002491	Central Nervous System Agents	MeSH
DB00413	2233	pramipexole	PA	D015259	Dopamine Agents	MeSH
DB00413	2233	pramipexole	PA	D018491	Dopamine Agonists	MeSH
DB00413	2233	pramipexole	PA	D018377	Neurotransmitter Agents	MeSH
DB00413	2233	pramipexole	PA	D020011	Protective Agents	MeSH
DB00414	57	acetohexamide	has role	CHEBI:35526	hypoglycemic agent	CHEBI
DB00414	57	acetohexamide	PA	D007004	Hypoglycemic Agents	MeSH
DB00415	198	ampicillin	EPC	N0000175497	Penicillin-class Antibacterial	FDA
DB00415	198	ampicillin	Chemical/Ingredient	N0000011281	Penicillins	FDA
DB00415	198	ampicillin	PA	D000900	Anti-Bacterial Agents	MeSH
DB00415	198	ampicillin	PA	D000890	Anti-Infective Agents	MeSH
DB00415	198	ampicillin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00416	908	dimethyltubocurarinium	PA	D009465	Neuromuscular Agents	MeSH
DB00416	908	dimethyltubocurarinium	PA	D009466	Neuromuscular Blocking Agents	MeSH
DB00416	908	dimethyltubocurarinium	PA	D003473	Neuromuscular Nondepolarizing Agents	MeSH
DB01336	908	dimethyltubocurarinium	PA	D009465	Neuromuscular Agents	MeSH
DB01336	908	dimethyltubocurarinium	PA	D009466	Neuromuscular Blocking Agents	MeSH
DB01336	908	dimethyltubocurarinium	PA	D003473	Neuromuscular Nondepolarizing Agents	MeSH
DB00417	2083	phenoxymethylpenicillin	EPC	N0000175497	Penicillin-class Antibacterial	FDA
DB00417	2083	phenoxymethylpenicillin	Chemical/Ingredient	N0000011281	Penicillins	FDA
DB00417	2083	phenoxymethylpenicillin	PA	D000900	Anti-Bacterial Agents	MeSH
DB00417	2083	phenoxymethylpenicillin	PA	D000890	Anti-Infective Agents	MeSH
DB00418	2428	secobarbital	PA	D000759	Adjuvants, Anesthesia	MeSH
DB00418	2428	secobarbital	has role	CHEBI:60807	anaesthesia adjuvant	CHEBI
DB00418	2428	secobarbital	has role	CHEBI:50268	GABA modulator	CHEBI
DB00418	2428	secobarbital	has role	CHEBI:35717	sedative	CHEBI
DB00418	2428	secobarbital	PA	D002491	Central Nervous System Agents	MeSH
DB00418	2428	secobarbital	PA	D002492	Central Nervous System Depressants	MeSH
DB00418	2428	secobarbital	PA	D018682	GABA Agents	MeSH
DB00418	2428	secobarbital	PA	D018757	GABA Modulators	MeSH
DB00418	2428	secobarbital	PA	D006993	Hypnotics and Sedatives	MeSH
DB00418	2428	secobarbital	PA	D018377	Neurotransmitter Agents	MeSH
DB00419	1807	miglustat	EPC	N0000175783	Glucosylceramide Synthase Inhibitor	FDA
DB00419	1807	miglustat	MoA	N0000020019	Glucosylceramide Synthase Inhibitors	FDA
DB00419	1807	miglustat	PA	D019380	Anti-HIV Agents	MeSH
DB00419	1807	miglustat	PA	D000890	Anti-Infective Agents	MeSH
DB00419	1807	miglustat	PA	D000998	Antiviral Agents	MeSH
DB00419	1807	miglustat	PA	D004791	Enzyme Inhibitors	MeSH
DB00419	1807	miglustat	PA	D065089	Glycoside Hydrolase Inhibitors	MeSH
DB00419	1807	miglustat	PA	D007004	Hypoglycemic Agents	MeSH
DB00420	2284	promazine	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB00420	2284	promazine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB00420	2284	promazine	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00420	2284	promazine	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB00420	2284	promazine	has role	CHEBI:37930	phenothiazine antipsychotic drug	CHEBI
DB00420	2284	promazine	has role	CHEBI:50919	antiemetic	CHEBI
DB00420	2284	promazine	PA	D000932	Antiemetics	MeSH
DB00420	2284	promazine	PA	D014150	Antipsychotic Agents	MeSH
DB00420	2284	promazine	PA	D002491	Central Nervous System Agents	MeSH
DB00420	2284	promazine	PA	D002492	Central Nervous System Depressants	MeSH
DB00420	2284	promazine	PA	D015259	Dopamine Agents	MeSH
DB00420	2284	promazine	PA	D018492	Dopamine Antagonists	MeSH
DB00420	2284	promazine	PA	D005765	Gastrointestinal Agents	MeSH
DB00420	2284	promazine	PA	D018377	Neurotransmitter Agents	MeSH
DB00420	2284	promazine	PA	D011619	Psychotropic Drugs	MeSH
DB00420	2284	promazine	PA	D014149	Tranquilizing Agents	MeSH
DB00421	2475	spironolactone	EPC	N0000175557	Aldosterone Antagonist	FDA
DB00421	2475	spironolactone	MoA	N0000011310	Aldosterone Antagonists	FDA
DB00421	2475	spironolactone	has role	CHEBI:35498	diuretic	CHEBI
DB00421	2475	spironolactone	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00421	2475	spironolactone	PA	D004232	Diuretics	MeSH
DB00421	2475	spironolactone	PA	D006727	Hormone Antagonists	MeSH
DB00421	2475	spironolactone	PA	D000451	Mineralocorticoid Receptor Antagonists	MeSH
DB00421	2475	spironolactone	PA	D045283	Natriuretic Agents	MeSH
DB00422	1767	methylphenidate	PE	N0000175729	Central Nervous System Stimulation	FDA
DB00422	1767	methylphenidate	has role	CHEBI:37962	adrenergic agent	CHEBI
DB00422	1767	methylphenidate	has role	CHEBI:35640	adrenergic uptake inhibitor	CHEBI
DB00422	1767	methylphenidate	has role	CHEBI:51039	dopamine uptake inhibitor	CHEBI
DB00422	1767	methylphenidate	has role	CHEBI:35337	central nervous system stimulant	CHEBI
DB00422	1767	methylphenidate	has role	CHEBI:35524	sympathomimetic agent	CHEBI
DB00422	1767	methylphenidate	has role	CHEBI:35471	psychotropic drug	CHEBI
DB00422	1767	methylphenidate	PA	D002491	Central Nervous System Agents	MeSH
DB00422	1767	methylphenidate	PA	D000697	Central Nervous System Stimulants	MeSH
DB00422	1767	methylphenidate	PA	D015259	Dopamine Agents	MeSH
DB00422	1767	methylphenidate	PA	D018765	Dopamine Uptake Inhibitors	MeSH
DB00422	1767	methylphenidate	PA	D049990	Membrane Transport Modulators	MeSH
DB00422	1767	methylphenidate	PA	D018377	Neurotransmitter Agents	MeSH
DB00422	1767	methylphenidate	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB06701	1767	methylphenidate	PE	N0000175729	Central Nervous System Stimulation	FDA
DB06701	1767	methylphenidate	has role	CHEBI:37962	adrenergic agent	CHEBI
DB06701	1767	methylphenidate	has role	CHEBI:35640	adrenergic uptake inhibitor	CHEBI
DB06701	1767	methylphenidate	has role	CHEBI:51039	dopamine uptake inhibitor	CHEBI
DB06701	1767	methylphenidate	has role	CHEBI:35337	central nervous system stimulant	CHEBI
DB06701	1767	methylphenidate	has role	CHEBI:35524	sympathomimetic agent	CHEBI
DB06701	1767	methylphenidate	has role	CHEBI:35471	psychotropic drug	CHEBI
DB06701	1767	methylphenidate	PA	D002491	Central Nervous System Agents	MeSH
DB06701	1767	methylphenidate	PA	D000697	Central Nervous System Stimulants	MeSH
DB06701	1767	methylphenidate	PA	D015259	Dopamine Agents	MeSH
DB06701	1767	methylphenidate	PA	D018765	Dopamine Uptake Inhibitors	MeSH
DB06701	1767	methylphenidate	PA	D049990	Membrane Transport Modulators	MeSH
DB06701	1767	methylphenidate	PA	D018377	Neurotransmitter Agents	MeSH
DB06701	1767	methylphenidate	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB00422	836	dexmethylphenidate	EPC	N0000175739	Central Nervous System Stimulant	FDA
DB06701	836	dexmethylphenidate	EPC	N0000175739	Central Nervous System Stimulant	FDA
DB00423	1747	methocarbamol	PE	N0000175730	Centrally-mediated Muscle Relaxation	FDA
DB00423	1747	methocarbamol	has role	CHEBI:51371	muscle relaxant	CHEBI
DB00423	1747	methocarbamol	PA	D002491	Central Nervous System Agents	MeSH
DB00423	1747	methocarbamol	PA	D009125	Muscle Relaxants, Central	MeSH
DB00423	1747	methocarbamol	PA	D009465	Neuromuscular Agents	MeSH
DB00424	1402	hyoscyamine	PA	D000759	Adjuvants, Anesthesia	MeSH
DB00424	1402	hyoscyamine	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB00424	1402	hyoscyamine	PA	D018927	Anti-Asthmatic Agents	MeSH
DB00424	1402	hyoscyamine	PA	D001993	Bronchodilator Agents	MeSH
DB00424	1402	hyoscyamine	PA	D002317	Cardiovascular Agents	MeSH
DB00424	1402	hyoscyamine	PA	D002491	Central Nervous System Agents	MeSH
DB00424	1402	hyoscyamine	PA	D018678	Cholinergic Agents	MeSH
DB00424	1402	hyoscyamine	PA	D018680	Cholinergic Antagonists	MeSH
DB00424	1402	hyoscyamine	PA	D018727	Muscarinic Antagonists	MeSH
DB00424	1402	hyoscyamine	PA	D009184	Mydriatics	MeSH
DB00424	1402	hyoscyamine	PA	D018377	Neurotransmitter Agents	MeSH
DB00424	1402	hyoscyamine	PA	D010276	Parasympatholytics	MeSH
DB00424	1402	hyoscyamine	PA	D019141	Respiratory System Agents	MeSH
DB00572	1402	hyoscyamine	PA	D000759	Adjuvants, Anesthesia	MeSH
DB00572	1402	hyoscyamine	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB00572	1402	hyoscyamine	PA	D018927	Anti-Asthmatic Agents	MeSH
DB00572	1402	hyoscyamine	PA	D001993	Bronchodilator Agents	MeSH
DB00572	1402	hyoscyamine	PA	D002317	Cardiovascular Agents	MeSH
DB00572	1402	hyoscyamine	PA	D002491	Central Nervous System Agents	MeSH
DB00572	1402	hyoscyamine	PA	D018678	Cholinergic Agents	MeSH
DB00572	1402	hyoscyamine	PA	D018680	Cholinergic Antagonists	MeSH
DB00572	1402	hyoscyamine	PA	D018727	Muscarinic Antagonists	MeSH
DB00572	1402	hyoscyamine	PA	D009184	Mydriatics	MeSH
DB00572	1402	hyoscyamine	PA	D018377	Neurotransmitter Agents	MeSH
DB00572	1402	hyoscyamine	PA	D010276	Parasympatholytics	MeSH
DB00572	1402	hyoscyamine	PA	D019141	Respiratory System Agents	MeSH
DB00424	260	atropine	EPC	N0000175574	Anticholinergic	FDA
DB00424	260	atropine	EPC	N0000175700	Cholinergic Muscarinic Antagonist	FDA
DB00424	260	atropine	MoA	N0000000125	Cholinergic Muscarinic Antagonists	FDA
DB00424	260	atropine	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB00424	260	atropine	has role	CHEBI:60807	anaesthesia adjuvant	CHEBI
DB00424	260	atropine	has role	CHEBI:50513	mydriatic agent	CHEBI
DB00424	260	atropine	has role	CHEBI:50370	parasympatholytic	CHEBI
DB00424	260	atropine	has role	CHEBI:35523	bronchodilator agent	CHEBI
DB00424	260	atropine	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00572	260	atropine	EPC	N0000175574	Anticholinergic	FDA
DB00572	260	atropine	EPC	N0000175700	Cholinergic Muscarinic Antagonist	FDA
DB00572	260	atropine	MoA	N0000000125	Cholinergic Muscarinic Antagonists	FDA
DB00572	260	atropine	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB00572	260	atropine	has role	CHEBI:60807	anaesthesia adjuvant	CHEBI
DB00572	260	atropine	has role	CHEBI:50513	mydriatic agent	CHEBI
DB00572	260	atropine	has role	CHEBI:50370	parasympatholytic	CHEBI
DB00572	260	atropine	has role	CHEBI:35523	bronchodilator agent	CHEBI
DB00572	260	atropine	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00425	2870	zolpidem	EPC	N0000175759	gamma-Aminobutyric Acid-ergic Agonist	FDA
DB00425	2870	zolpidem	MoA	N0000000196	GABA A Agonists	FDA
DB00425	2870	zolpidem	Chemical/Ingredient	N0000007570	Pyridines	FDA
DB00425	2870	zolpidem	PE	N0000175728	Central Nervous System Depression	FDA
DB00425	2870	zolpidem	has role	CHEBI:35488	central nervous system depressant	CHEBI
DB00425	2870	zolpidem	has role	CHEBI:51373	GABA agonist	CHEBI
DB00425	2870	zolpidem	has role	CHEBI:35717	sedative	CHEBI
DB00425	2870	zolpidem	PA	D002491	Central Nervous System Agents	MeSH
DB00425	2870	zolpidem	PA	D002492	Central Nervous System Depressants	MeSH
DB00425	2870	zolpidem	PA	D018682	GABA Agents	MeSH
DB00425	2870	zolpidem	PA	D018755	GABA Agonists	MeSH
DB00425	2870	zolpidem	PA	D058785	GABA-A Receptor Agonists	MeSH
DB00425	2870	zolpidem	PA	D006993	Hypnotics and Sedatives	MeSH
DB00425	2870	zolpidem	PA	D018377	Neurotransmitter Agents	MeSH
DB00426	1128	famciclovir	MoA	N0000020060	DNA Polymerase Inhibitors	FDA
DB00426	1128	famciclovir	EPC	N0000180187	Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor	FDA
DB00426	1128	famciclovir	Chemical/Ingredient	N0000175459	Nucleoside Analog	FDA
DB00426	1128	famciclovir	PA	D000890	Anti-Infective Agents	MeSH
DB00426	1128	famciclovir	has role	CHEBI:50266	prodrug	CHEBI
DB00426	1128	famciclovir	has role	CHEBI:36044	antiviral drug	CHEBI
DB00426	1128	famciclovir	PA	D000998	Antiviral Agents	MeSH
DB00427	2763	triprolidine	PA	D018926	Anti-Allergic Agents	MeSH
DB00427	2763	triprolidine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB00427	2763	triprolidine	PA	D018494	Histamine Agents	MeSH
DB00427	2763	triprolidine	PA	D006633	Histamine Antagonists	MeSH
DB00427	2763	triprolidine	PA	D006634	Histamine H1 Antagonists	MeSH
DB00427	2763	triprolidine	PA	D018377	Neurotransmitter Agents	MeSH
DB00429	502	carboprost	EPC	N0000175454	Prostaglandin Analog	FDA
DB00429	502	carboprost	Chemical/Ingredient	N0000007706	Prostaglandins	FDA
DB00429	502	carboprost	PA	D000020	Abortifacient Agents, Nonsteroidal	MeSH
DB00429	502	carboprost	has role	CHEBI:36063	oxytocic	CHEBI
DB00429	502	carboprost	has role	CHEBI:50691	abortifacient	CHEBI
DB00429	502	carboprost	PA	D010120	Oxytocics	MeSH
DB00429	502	carboprost	PA	D012102	Reproductive Control Agents	MeSH
DB00430	552	cefpiramide	PA	D000900	Anti-Bacterial Agents	MeSH
DB00430	552	cefpiramide	PA	D000890	Anti-Infective Agents	MeSH
DB00430	552	cefpiramide	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00431	1583	lindane	has role	CHEBI:33288	rodenticide	CHEBI
DB00431	1583	lindane	has role	CHEBI:33286	agrochemical	CHEBI
DB00431	1583	lindane	has role	CHEBI:24127	fungicide	CHEBI
DB00431	1583	lindane	has role	CHEBI:38706	pediculicide	CHEBI
DB00431	1583	lindane	PA	D007306	Insecticides	MeSH
DB00431	1583	lindane	PA	D010575	Pesticides	MeSH
DB00433	2274	prochlorperazine	EPC	N0000175746	Phenothiazine	FDA
DB00433	2274	prochlorperazine	Chemical/Ingredient	N0000007544	Phenothiazines	FDA
DB00433	2274	prochlorperazine	has role	CHEBI:50919	antiemetic	CHEBI
DB00433	2274	prochlorperazine	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB00433	2274	prochlorperazine	has role	CHEBI:37890	alpha-adrenergic antagonist	CHEBI
DB00433	2274	prochlorperazine	has role	CHEBI:48873	cholinergic antagonist	CHEBI
DB00433	2274	prochlorperazine	has role	CHEBI:65190	first generation antipsychotic	CHEBI
DB00433	2274	prochlorperazine	PA	D000932	Antiemetics	MeSH
DB00433	2274	prochlorperazine	PA	D014150	Antipsychotic Agents	MeSH
DB00433	2274	prochlorperazine	PA	D002491	Central Nervous System Agents	MeSH
DB00433	2274	prochlorperazine	PA	D002492	Central Nervous System Depressants	MeSH
DB00433	2274	prochlorperazine	PA	D015259	Dopamine Agents	MeSH
DB00433	2274	prochlorperazine	PA	D018492	Dopamine Antagonists	MeSH
DB00433	2274	prochlorperazine	PA	D005765	Gastrointestinal Agents	MeSH
DB00433	2274	prochlorperazine	PA	D018377	Neurotransmitter Agents	MeSH
DB00433	2274	prochlorperazine	PA	D011619	Psychotropic Drugs	MeSH
DB00433	2274	prochlorperazine	PA	D014149	Tranquilizing Agents	MeSH
DB00434	765	cyproheptadine	PA	D018926	Anti-Allergic Agents	MeSH
DB00434	765	cyproheptadine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB00434	765	cyproheptadine	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB00434	765	cyproheptadine	has role	CHEBI:59683	antipruritic drug	CHEBI
DB00434	765	cyproheptadine	has role	CHEBI:50857	anti-allergic agent	CHEBI
DB00434	765	cyproheptadine	has role	CHEBI:55324	gastrointestinal drug	CHEBI
DB00434	765	cyproheptadine	PA	D000982	Antipruritics	MeSH
DB00434	765	cyproheptadine	PA	D003879	Dermatologic Agents	MeSH
DB00434	765	cyproheptadine	PA	D005765	Gastrointestinal Agents	MeSH
DB00434	765	cyproheptadine	PA	D018494	Histamine Agents	MeSH
DB00434	765	cyproheptadine	PA	D006633	Histamine Antagonists	MeSH
DB00434	765	cyproheptadine	PA	D006634	Histamine H1 Antagonists	MeSH
DB00434	765	cyproheptadine	PA	D018377	Neurotransmitter Agents	MeSH
DB00434	765	cyproheptadine	PA	D018490	Serotonin Agents	MeSH
DB00434	765	cyproheptadine	PA	D012702	Serotonin Antagonists	MeSH
DB00435	1948	nitric oxide	PE	N0000009909	Vasodilation	FDA
DB00435	1948	nitric oxide	EPC	N0000175940	Vasodilator	FDA
DB00435	1948	nitric oxide	PA	D018927	Anti-Asthmatic Agents	MeSH
DB00435	1948	nitric oxide	has role	CHEBI:35523	bronchodilator agent	CHEBI
DB00435	1948	nitric oxide	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00435	1948	nitric oxide	PA	D000975	Antioxidants	MeSH
DB00435	1948	nitric oxide	PA	D001993	Bronchodilator Agents	MeSH
DB00435	1948	nitric oxide	PA	D002317	Cardiovascular Agents	MeSH
DB00435	1948	nitric oxide	PA	D045462	Endothelium-Dependent Relaxing Factors	MeSH
DB00435	1948	nitric oxide	PA	D016166	Free Radical Scavengers	MeSH
DB00435	1948	nitric oxide	PA	D064426	Gasotransmitters	MeSH
DB00435	1948	nitric oxide	PA	D018377	Neurotransmitter Agents	MeSH
DB00435	1948	nitric oxide	PA	D019141	Respiratory System Agents	MeSH
DB00435	1948	nitric oxide	PA	D014665	Vasodilator Agents	MeSH
DB00436	305	bendroflumethiazide	PE	N0000175359	Increased Diuresis	FDA
DB00436	305	bendroflumethiazide	EPC	N0000175419	Thiazide Diuretic	FDA
DB00436	305	bendroflumethiazide	Chemical/Ingredient	N0000166469	Thiazides	FDA
DB00436	305	bendroflumethiazide	has role	CHEBI:35498	diuretic	CHEBI
DB00436	305	bendroflumethiazide	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00436	305	bendroflumethiazide	PA	D000959	Antihypertensive Agents	MeSH
DB00436	305	bendroflumethiazide	PA	D002317	Cardiovascular Agents	MeSH
DB00436	305	bendroflumethiazide	PA	D004232	Diuretics	MeSH
DB00436	305	bendroflumethiazide	PA	D049990	Membrane Transport Modulators	MeSH
DB00436	305	bendroflumethiazide	PA	D045283	Natriuretic Agents	MeSH
DB00436	305	bendroflumethiazide	PA	D049993	Sodium Chloride Symporter Inhibitors	MeSH
DB00437	124	allopurinol	EPC	N0000175698	Xanthine Oxidase Inhibitor	FDA
DB00437	124	allopurinol	MoA	N0000000206	Xanthine Oxidase Inhibitors	FDA
DB00437	124	allopurinol	has role	CHEBI:35845	gout suppressant	CHEBI
DB00437	124	allopurinol	PA	D000963	Antimetabolites	MeSH
DB00437	124	allopurinol	PA	D000975	Antioxidants	MeSH
DB00437	124	allopurinol	PA	D018501	Antirheumatic Agents	MeSH
DB00437	124	allopurinol	PA	D004791	Enzyme Inhibitors	MeSH
DB00437	124	allopurinol	PA	D016166	Free Radical Scavengers	MeSH
DB00437	124	allopurinol	PA	D006074	Gout Suppressants	MeSH
DB00437	124	allopurinol	PA	D009676	Noxae	MeSH
DB00438	559	ceftazidime	PA	D000900	Anti-Bacterial Agents	MeSH
DB00438	559	ceftazidime	PA	D000890	Anti-Infective Agents	MeSH
DB00438	559	ceftazidime	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00438	559	ceftazidime	has role	CHEBI:88188	drug allergen	CHEBI
DB00439	577	cerivastatin	PA	D000924	Anticholesteremic Agents	MeSH
DB00439	577	cerivastatin	PA	D000963	Antimetabolites	MeSH
DB00439	577	cerivastatin	PA	D004791	Enzyme Inhibitors	MeSH
DB00439	577	cerivastatin	PA	D019161	Hydroxymethylglutaryl-CoA Reductase Inhibitors	MeSH
DB00439	577	cerivastatin	PA	D000960	Hypolipidemic Agents	MeSH
DB00440	2755	trimethoprim	EPC	N0000175489	Dihydrofolate Reductase Inhibitor Antibacterial	FDA
DB00440	2755	trimethoprim	MoA	N0000000191	Dihydrofolate Reductase Inhibitors	FDA
DB00440	2755	trimethoprim	MoA	N0000187062	Cytochrome P450 2C8 Inhibitors	FDA
DB00440	2755	trimethoprim	MoA	N0000187061	Organic Cation Transporter 2 Inhibitors	FDA
DB00440	2755	trimethoprim	PA	D000890	Anti-Infective Agents	MeSH
DB00440	2755	trimethoprim	PA	D000892	Anti-Infective Agents, Urinary	MeSH
DB00440	2755	trimethoprim	has role	CHEBI:88188	drug allergen	CHEBI
DB00440	2755	trimethoprim	PA	D000962	Antimalarials	MeSH
DB00440	2755	trimethoprim	PA	D000977	Antiparasitic Agents	MeSH
DB00440	2755	trimethoprim	PA	D000981	Antiprotozoal Agents	MeSH
DB00440	2755	trimethoprim	PA	D065687	Cytochrome P-450 CYP2C8 Inhibitors	MeSH
DB00440	2755	trimethoprim	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB00440	2755	trimethoprim	PA	D004791	Enzyme Inhibitors	MeSH
DB00440	2755	trimethoprim	PA	D005493	Folic Acid Antagonists	MeSH
DB03125	2755	trimethoprim	EPC	N0000175489	Dihydrofolate Reductase Inhibitor Antibacterial	FDA
DB03125	2755	trimethoprim	MoA	N0000000191	Dihydrofolate Reductase Inhibitors	FDA
DB03125	2755	trimethoprim	MoA	N0000187062	Cytochrome P450 2C8 Inhibitors	FDA
DB03125	2755	trimethoprim	MoA	N0000187061	Organic Cation Transporter 2 Inhibitors	FDA
DB03125	2755	trimethoprim	PA	D000890	Anti-Infective Agents	MeSH
DB03125	2755	trimethoprim	PA	D000892	Anti-Infective Agents, Urinary	MeSH
DB03125	2755	trimethoprim	has role	CHEBI:88188	drug allergen	CHEBI
DB03125	2755	trimethoprim	PA	D000962	Antimalarials	MeSH
DB03125	2755	trimethoprim	PA	D000977	Antiparasitic Agents	MeSH
DB03125	2755	trimethoprim	PA	D000981	Antiprotozoal Agents	MeSH
DB03125	2755	trimethoprim	PA	D065687	Cytochrome P-450 CYP2C8 Inhibitors	MeSH
DB03125	2755	trimethoprim	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB03125	2755	trimethoprim	PA	D004791	Enzyme Inhibitors	MeSH
DB03125	2755	trimethoprim	PA	D005493	Folic Acid Antagonists	MeSH
DB00441	1283	gemcitabine	MoA	N0000000233	Nucleic Acid Synthesis Inhibitors	FDA
DB00441	1283	gemcitabine	EPC	N0000175595	Nucleoside Metabolic Inhibitor	FDA
DB00441	1283	gemcitabine	PA	D000890	Anti-Infective Agents	MeSH
DB00441	1283	gemcitabine	has role	CHEBI:47868	photosensitizing agent	CHEBI
DB00441	1283	gemcitabine	has role	CHEBI:50266	prodrug	CHEBI
DB00441	1283	gemcitabine	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00441	1283	gemcitabine	has role	CHEBI:36044	antiviral drug	CHEBI
DB00441	1283	gemcitabine	has role	CHEBI:35705	immunosuppressive agent	CHEBI
DB00441	1283	gemcitabine	PA	D000963	Antimetabolites	MeSH
DB00441	1283	gemcitabine	PA	D000964	Antimetabolites, Antineoplastic	MeSH
DB00441	1283	gemcitabine	PA	D000970	Antineoplastic Agents	MeSH
DB00441	1283	gemcitabine	PA	D000998	Antiviral Agents	MeSH
DB00441	1283	gemcitabine	PA	D004791	Enzyme Inhibitors	MeSH
DB00441	1283	gemcitabine	PA	D007155	Immunologic Factors	MeSH
DB00441	1283	gemcitabine	PA	D007166	Immunosuppressive Agents	MeSH
DB00441	1283	gemcitabine	PA	D009676	Noxae	MeSH
DB00441	1283	gemcitabine	PA	D011838	Radiation-Sensitizing Agents	MeSH
DB00442	1019	entecavir	PA	D000890	Anti-Infective Agents	MeSH
DB00442	1019	entecavir	has role	CHEBI:36044	antiviral drug	CHEBI
DB00442	1019	entecavir	PA	D000998	Antiviral Agents	MeSH
DB00443	824	dexamethasone	EPC	N0000175576	Corticosteroid	FDA
DB00443	824	dexamethasone	MoA	N0000175450	Corticosteroid Hormone Receptor Agonists	FDA
DB00443	824	dexamethasone	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00443	824	dexamethasone	has role	CHEBI:50919	antiemetic	CHEBI
DB00443	824	dexamethasone	has role	CHEBI:37962	adrenergic agent	CHEBI
DB00443	824	dexamethasone	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00443	824	dexamethasone	has role	CHEBI:35705	immunosuppressive agent	CHEBI
DB00443	824	dexamethasone	has role	CHEBI:35472	anti-inflammatory drug	CHEBI
DB00443	824	dexamethasone	PA	D000932	Antiemetics	MeSH
DB00443	824	dexamethasone	PA	D000970	Antineoplastic Agents	MeSH
DB00443	824	dexamethasone	PA	D018931	Antineoplastic Agents, Hormonal	MeSH
DB00443	824	dexamethasone	PA	D002491	Central Nervous System Agents	MeSH
DB00443	824	dexamethasone	PA	D005765	Gastrointestinal Agents	MeSH
DB00443	824	dexamethasone	PA	D005938	Glucocorticoids	MeSH
DB00443	824	dexamethasone	PA	D006728	Hormones	MeSH
DB01234	824	dexamethasone	EPC	N0000175576	Corticosteroid	FDA
DB01234	824	dexamethasone	MoA	N0000175450	Corticosteroid Hormone Receptor Agonists	FDA
DB01234	824	dexamethasone	PA	D000893	Anti-Inflammatory Agents	MeSH
DB01234	824	dexamethasone	has role	CHEBI:50919	antiemetic	CHEBI
DB01234	824	dexamethasone	has role	CHEBI:37962	adrenergic agent	CHEBI
DB01234	824	dexamethasone	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB01234	824	dexamethasone	has role	CHEBI:35705	immunosuppressive agent	CHEBI
DB01234	824	dexamethasone	has role	CHEBI:35472	anti-inflammatory drug	CHEBI
DB01234	824	dexamethasone	PA	D000932	Antiemetics	MeSH
DB01234	824	dexamethasone	PA	D000970	Antineoplastic Agents	MeSH
DB01234	824	dexamethasone	PA	D018931	Antineoplastic Agents, Hormonal	MeSH
DB01234	824	dexamethasone	PA	D002491	Central Nervous System Agents	MeSH
DB01234	824	dexamethasone	PA	D005765	Gastrointestinal Agents	MeSH
DB01234	824	dexamethasone	PA	D005938	Glucocorticoids	MeSH
DB01234	824	dexamethasone	PA	D006728	Hormones	MeSH
DB00443	348	betamethasone	PA	D018927	Anti-Asthmatic Agents	MeSH
DB00443	348	betamethasone	has role	CHEBI:65023	anti-asthmatic agent	CHEBI
DB00443	348	betamethasone	PA	D019141	Respiratory System Agents	MeSH
DB01234	348	betamethasone	PA	D018927	Anti-Asthmatic Agents	MeSH
DB01234	348	betamethasone	has role	CHEBI:65023	anti-asthmatic agent	CHEBI
DB01234	348	betamethasone	PA	D019141	Respiratory System Agents	MeSH
DB00444	2590	teniposide	EPC	N0000175609	Topoisomerase Inhibitor	FDA
DB00444	2590	teniposide	MoA	N0000000176	Topoisomerase Inhibitors	FDA
DB00444	2590	teniposide	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00444	2590	teniposide	PA	D000970	Antineoplastic Agents	MeSH
DB00444	2590	teniposide	PA	D004791	Enzyme Inhibitors	MeSH
DB00444	2590	teniposide	PA	D059005	Topoisomerase II Inhibitors	MeSH
DB00447	1603	loracarbef	PA	D000900	Anti-Bacterial Agents	MeSH
DB00447	1603	loracarbef	PA	D000890	Anti-Infective Agents	MeSH
DB04293	1603	loracarbef	PA	D000900	Anti-Bacterial Agents	MeSH
DB04293	1603	loracarbef	PA	D000890	Anti-Infective Agents	MeSH
DB00448	4162	dexlansoprazole	EPC	N0000175525	Proton Pump Inhibitor	FDA
DB00448	4162	dexlansoprazole	PA	D000897	Anti-Ulcer Agents	MeSH
DB00448	4162	dexlansoprazole	PA	D004791	Enzyme Inhibitors	MeSH
DB00448	4162	dexlansoprazole	PA	D005765	Gastrointestinal Agents	MeSH
DB00448	4162	dexlansoprazole	PA	D054328	Proton Pump Inhibitors	MeSH
DB00448	1547	lansoprazole	PE	N0000009724	Inhibition Gastric Acid Secretion	FDA
DB00448	1547	lansoprazole	has role	CHEBI:49201	anti-ulcer drug	CHEBI
DB00449	922	dipivefrine	EPC	N0000175883	Adrenergic Receptor Agonist	FDA
DB00449	922	dipivefrine	PA	D018663	Adrenergic Agents	MeSH
DB00449	922	dipivefrine	PA	D000322	Adrenergic Agonists	MeSH
DB00449	922	dipivefrine	has role	CHEBI:50266	prodrug	CHEBI
DB00449	922	dipivefrine	has role	CHEBI:37886	adrenergic agonist	CHEBI
DB00449	922	dipivefrine	has role	CHEBI:35524	sympathomimetic agent	CHEBI
DB00449	922	dipivefrine	has role	CHEBI:39456	antiglaucoma drug	CHEBI
DB00449	922	dipivefrine	has role	CHEBI:66981	ophthalmology drug	CHEBI
DB00449	922	dipivefrine	PA	D018377	Neurotransmitter Agents	MeSH
DB00450	966	droperidol	MoA	N0000175799	Dopamine D2 Antagonists	FDA
DB00450	966	droperidol	EPC	N0000175800	Dopamine-2 Receptor Antagonist	FDA
DB00450	966	droperidol	PA	D000759	Adjuvants, Anesthesia	MeSH
DB00450	966	droperidol	has role	CHEBI:50919	antiemetic	CHEBI
DB00450	966	droperidol	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB00450	966	droperidol	has role	CHEBI:60807	anaesthesia adjuvant	CHEBI
DB00450	966	droperidol	has role	CHEBI:65190	first generation antipsychotic	CHEBI
DB00450	966	droperidol	PA	D000932	Antiemetics	MeSH
DB00450	966	droperidol	PA	D014150	Antipsychotic Agents	MeSH
DB00450	966	droperidol	PA	D002491	Central Nervous System Agents	MeSH
DB00450	966	droperidol	PA	D002492	Central Nervous System Depressants	MeSH
DB00450	966	droperidol	PA	D015259	Dopamine Agents	MeSH
DB00450	966	droperidol	PA	D018492	Dopamine Antagonists	MeSH
DB00450	966	droperidol	PA	D065127	Dopamine D2 Receptor Antagonists	MeSH
DB00450	966	droperidol	PA	D005765	Gastrointestinal Agents	MeSH
DB00450	966	droperidol	PA	D018377	Neurotransmitter Agents	MeSH
DB00450	966	droperidol	PA	D011619	Psychotropic Drugs	MeSH
DB00450	966	droperidol	PA	D014149	Tranquilizing Agents	MeSH
DB00451	2646	levothyroxine	EPC	N0000175945	l-Thyroxine	FDA
DB00451	2646	levothyroxine	Chemical/Ingredient	N0000007632	Thyroxine	FDA
DB00509	2646	levothyroxine	EPC	N0000175945	l-Thyroxine	FDA
DB00509	2646	levothyroxine	Chemical/Ingredient	N0000007632	Thyroxine	FDA
DB01583	2646	levothyroxine	EPC	N0000175945	l-Thyroxine	FDA
DB01583	2646	levothyroxine	Chemical/Ingredient	N0000007632	Thyroxine	FDA
DB00454	1690	pethidine	MoA	N0000175684	Full Opioid Agonists	FDA
DB00454	1690	pethidine	EPC	N0000175690	Opioid Agonist	FDA
DB00454	1690	pethidine	PA	D000759	Adjuvants, Anesthesia	MeSH
DB00454	1690	pethidine	PA	D000700	Analgesics	MeSH
DB00454	1690	pethidine	PA	D000701	Analgesics, Opioid	MeSH
DB00454	1690	pethidine	PA	D002491	Central Nervous System Agents	MeSH
DB00454	1690	pethidine	PA	D002492	Central Nervous System Depressants	MeSH
DB00454	1690	pethidine	PA	D009294	Narcotics	MeSH
DB00454	1690	pethidine	PA	D018689	Sensory System Agents	MeSH
DB00455	1605	loratadine	PA	D018926	Anti-Allergic Agents	MeSH
DB00455	1605	loratadine	PA	D000982	Antipruritics	MeSH
DB00455	1605	loratadine	PA	D003879	Dermatologic Agents	MeSH
DB00455	1605	loratadine	PA	D018494	Histamine Agents	MeSH
DB00455	1605	loratadine	PA	D006633	Histamine Antagonists	MeSH
DB00455	1605	loratadine	PA	D006634	Histamine H1 Antagonists	MeSH
DB00455	1605	loratadine	PA	D039563	Histamine H1 Antagonists, Non-Sedating	MeSH
DB00455	1605	loratadine	PA	D018377	Neurotransmitter Agents	MeSH
DB00456	574	cefalotin	PA	D000900	Anti-Bacterial Agents	MeSH
DB00456	574	cefalotin	PA	D000890	Anti-Infective Agents	MeSH
DB00456	574	cefalotin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00457	4209	prazosin	EPC	N0000175553	alpha-Adrenergic Blocker	FDA
DB00457	4209	prazosin	PA	D018663	Adrenergic Agents	MeSH
DB00457	4209	prazosin	PA	D058668	Adrenergic alpha-1 Receptor Antagonists	MeSH
DB00457	4209	prazosin	PA	D000317	Adrenergic alpha-Antagonists	MeSH
DB00457	4209	prazosin	PA	D018674	Adrenergic Antagonists	MeSH
DB00457	4209	prazosin	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00457	4209	prazosin	has role	CHEBI:37890	alpha-adrenergic antagonist	CHEBI
DB00457	4209	prazosin	PA	D000959	Antihypertensive Agents	MeSH
DB00457	4209	prazosin	PA	D002317	Cardiovascular Agents	MeSH
DB00457	4209	prazosin	PA	D018377	Neurotransmitter Agents	MeSH
DB00458	1427	imipramine	EPC	N0000175752	Tricyclic Antidepressant	FDA
DB00458	1427	imipramine	PA	D018663	Adrenergic Agents	MeSH
DB00458	1427	imipramine	PA	D018759	Adrenergic Uptake Inhibitors	MeSH
DB00458	1427	imipramine	has role	CHEBI:35640	adrenergic uptake inhibitor	CHEBI
DB00458	1427	imipramine	has role	CHEBI:35469	antidepressant	CHEBI
DB00458	1427	imipramine	PA	D000928	Antidepressive Agents	MeSH
DB00458	1427	imipramine	PA	D000929	Antidepressive Agents, Tricyclic	MeSH
DB00458	1427	imipramine	PA	D002491	Central Nervous System Agents	MeSH
DB00458	1427	imipramine	PA	D049990	Membrane Transport Modulators	MeSH
DB00458	1427	imipramine	PA	D018377	Neurotransmitter Agents	MeSH
DB00458	1427	imipramine	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB00458	1427	imipramine	PA	D011619	Psychotropic Drugs	MeSH
DB00459	78	acitretin	EPC	N0000175607	Retinoid	FDA
DB00459	78	acitretin	Chemical/Ingredient	N0000007700	Retinoids	FDA
DB00459	78	acitretin	has role	CHEBI:50176	keratolytic drug	CHEBI
DB00459	78	acitretin	PA	D003879	Dermatologic Agents	MeSH
DB00459	78	acitretin	PA	D007641	Keratolytic Agents	MeSH
DB00461	1863	nabumetone	Chemical/Ingredient	N0000175721	Nonsteroidal Anti-inflammatory Compounds	FDA
DB00461	1863	nabumetone	EPC	N0000175722	Nonsteroidal Anti-inflammatory Drug	FDA
DB00461	1863	nabumetone	PA	D000700	Analgesics	MeSH
DB00461	1863	nabumetone	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00461	1863	nabumetone	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00461	1863	nabumetone	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00461	1863	nabumetone	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB00461	1863	nabumetone	has role	CHEBI:50266	prodrug	CHEBI
DB00461	1863	nabumetone	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00461	1863	nabumetone	PA	D018501	Antirheumatic Agents	MeSH
DB00461	1863	nabumetone	PA	D052246	Cyclooxygenase 2 Inhibitors	MeSH
DB00461	1863	nabumetone	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB00461	1863	nabumetone	PA	D004791	Enzyme Inhibitors	MeSH
DB00461	1863	nabumetone	PA	D018689	Sensory System Agents	MeSH
DB00462	1757	methscopolamine	EPC	N0000175574	Anticholinergic	FDA
DB00462	1757	methscopolamine	MoA	N0000175370	Cholinergic Antagonists	FDA
DB00462	1757	methscopolamine	PA	D010276	Parasympatholytics	MeSH
DB00465	1529	ketorolac	Chemical/Ingredient	N0000175721	Nonsteroidal Anti-inflammatory Compounds	FDA
DB00465	1529	ketorolac	EPC	N0000175722	Nonsteroidal Anti-inflammatory Drug	FDA
DB00465	1529	ketorolac	EPC	N0000175939	Cyclooxygenase Inhibitor	FDA
DB00465	1529	ketorolac	PA	D000700	Analgesics	MeSH
DB00465	1529	ketorolac	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00465	1529	ketorolac	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00465	1529	ketorolac	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00465	1529	ketorolac	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00465	1529	ketorolac	has role	CHEBI:35480	analgesic	CHEBI
DB00465	1529	ketorolac	PA	D018501	Antirheumatic Agents	MeSH
DB00465	1529	ketorolac	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB00465	1529	ketorolac	PA	D004791	Enzyme Inhibitors	MeSH
DB00465	1529	ketorolac	PA	D018689	Sensory System Agents	MeSH
DB00467	1013	enoxacin	PA	D000900	Anti-Bacterial Agents	MeSH
DB00467	1013	enoxacin	PA	D000890	Anti-Infective Agents	MeSH
DB00467	1013	enoxacin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00467	1013	enoxacin	PA	D000970	Antineoplastic Agents	MeSH
DB00467	1013	enoxacin	PA	D065609	Cytochrome P-450 CYP1A2 Inhibitors	MeSH
DB00467	1013	enoxacin	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB00467	1013	enoxacin	PA	D004791	Enzyme Inhibitors	MeSH
DB00467	1013	enoxacin	PA	D059005	Topoisomerase II Inhibitors	MeSH
DB00470	4109	dronabinol	EPC	N0000175782	Cannabinoid	FDA
DB00470	4109	dronabinol	Chemical/Ingredient	N0000008010	Cannabinoids	FDA
DB00470	4109	dronabinol	PA	D000700	Analgesics	MeSH
DB00470	4109	dronabinol	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00470	4109	dronabinol	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB00470	4109	dronabinol	has role	CHEBI:35499	hallucinogen	CHEBI
DB00470	4109	dronabinol	PA	D063386	Cannabinoid Receptor Agonists	MeSH
DB00470	4109	dronabinol	PA	D063385	Cannabinoid Receptor Modulators	MeSH
DB00470	4109	dronabinol	PA	D002491	Central Nervous System Agents	MeSH
DB00470	4109	dronabinol	PA	D006213	Hallucinogens	MeSH
DB00470	4109	dronabinol	PA	D006728	Hormones	MeSH
DB00470	4109	dronabinol	PA	D018377	Neurotransmitter Agents	MeSH
DB00470	4109	dronabinol	PA	D011619	Psychotropic Drugs	MeSH
DB00470	4109	dronabinol	PA	D018689	Sensory System Agents	MeSH
DB00471	1836	montelukast	EPC	N0000175777	Leukotriene Receptor Antagonist	FDA
DB00471	1836	montelukast	MoA	N0000000083	Leukotriene Receptor Antagonists	FDA
DB00471	1836	montelukast	PA	D018927	Anti-Asthmatic Agents	MeSH
DB00471	1836	montelukast	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB00471	1836	montelukast	has role	CHEBI:49167	anti-asthmatic drug	CHEBI
DB00471	1836	montelukast	has role	CHEBI:49159	leukotriene antagonist	CHEBI
DB00471	1836	montelukast	PA	D065694	Cytochrome P-450 CYP1A2 Inducers	MeSH
DB00471	1836	montelukast	PA	D006727	Hormone Antagonists	MeSH
DB00471	1836	montelukast	PA	D020024	Leukotriene Antagonists	MeSH
DB00471	1836	montelukast	PA	D019141	Respiratory System Agents	MeSH
DB00472	1209	fluoxetine	EPC	N0000175696	Serotonin Reuptake Inhibitor	FDA
DB00472	1209	fluoxetine	has role	CHEBI:88188	drug allergen	CHEBI
DB00472	1209	fluoxetine	has role	CHEBI:50949	serotonin uptake inhibitor	CHEBI
DB00472	1209	fluoxetine	has role	CHEBI:35480	analgesic	CHEBI
DB00472	1209	fluoxetine	has role	CHEBI:35469	antidepressant	CHEBI
DB00472	1209	fluoxetine	PA	D000928	Antidepressive Agents	MeSH
DB00472	1209	fluoxetine	PA	D018687	Antidepressive Agents, Second-Generation	MeSH
DB00472	1209	fluoxetine	PA	D002491	Central Nervous System Agents	MeSH
DB00472	1209	fluoxetine	PA	D065690	Cytochrome P-450 CYP2D6 Inhibitors	MeSH
DB00472	1209	fluoxetine	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB00472	1209	fluoxetine	PA	D004791	Enzyme Inhibitors	MeSH
DB00472	1209	fluoxetine	PA	D049990	Membrane Transport Modulators	MeSH
DB00472	1209	fluoxetine	PA	D018377	Neurotransmitter Agents	MeSH
DB00472	1209	fluoxetine	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB00472	1209	fluoxetine	PA	D011619	Psychotropic Drugs	MeSH
DB00472	1209	fluoxetine	PA	D018490	Serotonin Agents	MeSH
DB00472	1209	fluoxetine	PA	D017367	Serotonin Uptake Inhibitors	MeSH
DB08472	1209	fluoxetine	EPC	N0000175696	Serotonin Reuptake Inhibitor	FDA
DB08472	1209	fluoxetine	has role	CHEBI:88188	drug allergen	CHEBI
DB08472	1209	fluoxetine	has role	CHEBI:50949	serotonin uptake inhibitor	CHEBI
DB08472	1209	fluoxetine	has role	CHEBI:35480	analgesic	CHEBI
DB08472	1209	fluoxetine	has role	CHEBI:35469	antidepressant	CHEBI
DB08472	1209	fluoxetine	PA	D000928	Antidepressive Agents	MeSH
DB08472	1209	fluoxetine	PA	D018687	Antidepressive Agents, Second-Generation	MeSH
DB08472	1209	fluoxetine	PA	D002491	Central Nervous System Agents	MeSH
DB08472	1209	fluoxetine	PA	D065690	Cytochrome P-450 CYP2D6 Inhibitors	MeSH
DB08472	1209	fluoxetine	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB08472	1209	fluoxetine	PA	D004791	Enzyme Inhibitors	MeSH
DB08472	1209	fluoxetine	PA	D049990	Membrane Transport Modulators	MeSH
DB08472	1209	fluoxetine	PA	D018377	Neurotransmitter Agents	MeSH
DB08472	1209	fluoxetine	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB08472	1209	fluoxetine	PA	D011619	Psychotropic Drugs	MeSH
DB08472	1209	fluoxetine	PA	D018490	Serotonin Agents	MeSH
DB08472	1209	fluoxetine	PA	D017367	Serotonin Uptake Inhibitors	MeSH
DB08544	1209	fluoxetine	EPC	N0000175696	Serotonin Reuptake Inhibitor	FDA
DB08544	1209	fluoxetine	has role	CHEBI:88188	drug allergen	CHEBI
DB08544	1209	fluoxetine	has role	CHEBI:50949	serotonin uptake inhibitor	CHEBI
DB08544	1209	fluoxetine	has role	CHEBI:35480	analgesic	CHEBI
DB08544	1209	fluoxetine	has role	CHEBI:35469	antidepressant	CHEBI
DB08544	1209	fluoxetine	PA	D000928	Antidepressive Agents	MeSH
DB08544	1209	fluoxetine	PA	D018687	Antidepressive Agents, Second-Generation	MeSH
DB08544	1209	fluoxetine	PA	D002491	Central Nervous System Agents	MeSH
DB08544	1209	fluoxetine	PA	D065690	Cytochrome P-450 CYP2D6 Inhibitors	MeSH
DB08544	1209	fluoxetine	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB08544	1209	fluoxetine	PA	D004791	Enzyme Inhibitors	MeSH
DB08544	1209	fluoxetine	PA	D049990	Membrane Transport Modulators	MeSH
DB08544	1209	fluoxetine	PA	D018377	Neurotransmitter Agents	MeSH
DB08544	1209	fluoxetine	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB08544	1209	fluoxetine	PA	D011619	Psychotropic Drugs	MeSH
DB08544	1209	fluoxetine	PA	D018490	Serotonin Agents	MeSH
DB08544	1209	fluoxetine	PA	D017367	Serotonin Uptake Inhibitors	MeSH
DB00474	1748	methohexital	EPC	N0000175693	Barbiturate	FDA
DB00474	1748	methohexital	Chemical/Ingredient	N0000008016	Barbiturates	FDA
DB00474	1748	methohexital	PA	D000777	Anesthetics	MeSH
DB00474	1748	methohexital	PA	D018686	Anesthetics, Intravenous	MeSH
DB00474	1748	methohexital	has role	CHEBI:38877	intravenous anaesthetic	CHEBI
DB00474	1748	methohexital	PA	D002491	Central Nervous System Agents	MeSH
DB00474	1748	methohexital	PA	D002492	Central Nervous System Depressants	MeSH
DB00475	594	chlordiazepoxide	EPC	N0000175694	Benzodiazepine	FDA
DB00475	594	chlordiazepoxide	Chemical/Ingredient	N0000007542	Benzodiazepines	FDA
DB00475	594	chlordiazepoxide	PA	D000759	Adjuvants, Anesthesia	MeSH
DB00475	594	chlordiazepoxide	PA	D014151	Anti-Anxiety Agents	MeSH
DB00475	594	chlordiazepoxide	has role	CHEBI:60807	anaesthesia adjuvant	CHEBI
DB00475	594	chlordiazepoxide	has role	CHEBI:35717	sedative	CHEBI
DB00475	594	chlordiazepoxide	has role	CHEBI:35474	anxiolytic drug	CHEBI
DB00475	594	chlordiazepoxide	PA	D002491	Central Nervous System Agents	MeSH
DB00475	594	chlordiazepoxide	PA	D002492	Central Nervous System Depressants	MeSH
DB00475	594	chlordiazepoxide	PA	D018682	GABA Agents	MeSH
DB00475	594	chlordiazepoxide	PA	D018757	GABA Modulators	MeSH
DB00475	594	chlordiazepoxide	PA	D006993	Hypnotics and Sedatives	MeSH
DB00475	594	chlordiazepoxide	PA	D018377	Neurotransmitter Agents	MeSH
DB00475	594	chlordiazepoxide	PA	D011619	Psychotropic Drugs	MeSH
DB00475	594	chlordiazepoxide	PA	D014149	Tranquilizing Agents	MeSH
DB00476	972	duloxetine	MoA	N0000000102	Norepinephrine Uptake Inhibitors	FDA
DB00476	972	duloxetine	EPC	N0000175749	Serotonin and Norepinephrine Reuptake Inhibitor	FDA
DB00476	972	duloxetine	MoA	N0000000109	Serotonin Uptake Inhibitors	FDA
DB00476	972	duloxetine	PA	D000700	Analgesics	MeSH
DB00476	972	duloxetine	has role	CHEBI:35469	antidepressant	CHEBI
DB00476	972	duloxetine	PA	D000928	Antidepressive Agents	MeSH
DB00476	972	duloxetine	PA	D002491	Central Nervous System Agents	MeSH
DB00476	972	duloxetine	PA	D015259	Dopamine Agents	MeSH
DB00476	972	duloxetine	PA	D049990	Membrane Transport Modulators	MeSH
DB00476	972	duloxetine	PA	D018377	Neurotransmitter Agents	MeSH
DB00476	972	duloxetine	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB00476	972	duloxetine	PA	D011619	Psychotropic Drugs	MeSH
DB00476	972	duloxetine	PA	D018689	Sensory System Agents	MeSH
DB00476	972	duloxetine	PA	D000068760	Serotonin and Noradrenaline Reuptake Inhibitors	MeSH
DB00477	621	chlorpromazine	EPC	N0000175746	Phenothiazine	FDA
DB00477	621	chlorpromazine	Chemical/Ingredient	N0000007544	Phenothiazines	FDA
DB00477	621	chlorpromazine	has role	CHEBI:50919	antiemetic	CHEBI
DB00477	621	chlorpromazine	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB00477	621	chlorpromazine	has role	CHEBI:37930	phenothiazine antipsychotic drug	CHEBI
DB00477	621	chlorpromazine	PA	D000932	Antiemetics	MeSH
DB00477	621	chlorpromazine	PA	D014150	Antipsychotic Agents	MeSH
DB00477	621	chlorpromazine	PA	D002491	Central Nervous System Agents	MeSH
DB00477	621	chlorpromazine	PA	D002492	Central Nervous System Depressants	MeSH
DB00477	621	chlorpromazine	PA	D015259	Dopamine Agents	MeSH
DB00477	621	chlorpromazine	PA	D018492	Dopamine Antagonists	MeSH
DB00477	621	chlorpromazine	PA	D005765	Gastrointestinal Agents	MeSH
DB00477	621	chlorpromazine	PA	D018377	Neurotransmitter Agents	MeSH
DB00477	621	chlorpromazine	PA	D011619	Psychotropic Drugs	MeSH
DB00477	621	chlorpromazine	PA	D014149	Tranquilizing Agents	MeSH
DB00478	2383	rimantadine	EPC	N0000175543	Influenza A M2 Protein Inhibitor	FDA
DB00478	2383	rimantadine	MoA	N0000175542	M2 Protein Inhibitors	FDA
DB00478	2383	rimantadine	PA	D000890	Anti-Infective Agents	MeSH
DB00478	2383	rimantadine	PA	D000998	Antiviral Agents	MeSH
DB00478	2383	rimantadine	PA	D004791	Enzyme Inhibitors	MeSH
DB00478	2383	rimantadine	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB00480	3317	lenalidomide	EPC	N0000184014	Thalidomide Analog	FDA
DB00480	3317	lenalidomide	PA	D020533	Angiogenesis Inhibitors	MeSH
DB00480	3317	lenalidomide	has role	CHEBI:48422	angiogenesis inhibitor	CHEBI
DB00480	3317	lenalidomide	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00480	3317	lenalidomide	has role	CHEBI:50846	immunomodulator	CHEBI
DB00480	3317	lenalidomide	PA	D000970	Antineoplastic Agents	MeSH
DB00480	3317	lenalidomide	PA	D006131	Growth Inhibitors	MeSH
DB00480	3317	lenalidomide	PA	D006133	Growth Substances	MeSH
DB00480	3317	lenalidomide	PA	D007155	Immunologic Factors	MeSH
DB00481	2351	raloxifene	EPC	N0000175826	Estrogen Agonist/Antagonist	FDA
DB00481	2351	raloxifene	has role	CHEBI:50646	bone density conservation agent	CHEBI
DB00481	2351	raloxifene	has role	CHEBI:50739	estrogen receptor modulator	CHEBI
DB00481	2351	raloxifene	has role	CHEBI:50837	estrogen antagonist	CHEBI
DB00481	2351	raloxifene	PA	D050071	Bone Density Conservation Agents	MeSH
DB00481	2351	raloxifene	PA	D004965	Estrogen Antagonists	MeSH
DB00481	2351	raloxifene	PA	D020847	Estrogen Receptor Modulators	MeSH
DB00481	2351	raloxifene	PA	D006727	Hormone Antagonists	MeSH
DB00481	2351	raloxifene	PA	D020845	Selective Estrogen Receptor Modulators	MeSH
DB00482	568	celecoxib	Chemical/Ingredient	N0000175721	Nonsteroidal Anti-inflammatory Compounds	FDA
DB00482	568	celecoxib	EPC	N0000175722	Nonsteroidal Anti-inflammatory Drug	FDA
DB00482	568	celecoxib	PA	D000700	Analgesics	MeSH
DB00482	568	celecoxib	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00482	568	celecoxib	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00482	568	celecoxib	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00482	568	celecoxib	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB00482	568	celecoxib	PA	D018501	Antirheumatic Agents	MeSH
DB00482	568	celecoxib	PA	D052246	Cyclooxygenase 2 Inhibitors	MeSH
DB00482	568	celecoxib	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB00482	568	celecoxib	PA	D004791	Enzyme Inhibitors	MeSH
DB00482	568	celecoxib	PA	D018689	Sensory System Agents	MeSH
DB00483	1273	gallamine	PA	D018678	Cholinergic Agents	MeSH
DB00483	1273	gallamine	PA	D018680	Cholinergic Antagonists	MeSH
DB00483	1273	gallamine	PA	D009465	Neuromuscular Agents	MeSH
DB00483	1273	gallamine	PA	D009466	Neuromuscular Blocking Agents	MeSH
DB00483	1273	gallamine	PA	D003473	Neuromuscular Nondepolarizing Agents	MeSH
DB00483	1273	gallamine	PA	D018377	Neurotransmitter Agents	MeSH
DB00483	1273	gallamine	PA	D018733	Nicotinic Antagonists	MeSH
DB00484	395	brimonidine	PA	D018663	Adrenergic Agents	MeSH
DB00484	395	brimonidine	PA	D000322	Adrenergic Agonists	MeSH
DB00484	395	brimonidine	PA	D058647	Adrenergic alpha-2 Receptor Agonists	MeSH
DB00484	395	brimonidine	PA	D000316	Adrenergic alpha-Agonists	MeSH
DB00484	395	brimonidine	has role	CHEBI:37886	adrenergic agonist	CHEBI
DB00484	395	brimonidine	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00484	395	brimonidine	has role	CHEBI:35569	alpha-adrenergic agonist	CHEBI
DB00484	395	brimonidine	PA	D000959	Antihypertensive Agents	MeSH
DB00484	395	brimonidine	PA	D002317	Cardiovascular Agents	MeSH
DB00484	395	brimonidine	PA	D018377	Neurotransmitter Agents	MeSH
DB00485	866	dicloxacillin	EPC	N0000175497	Penicillin-class Antibacterial	FDA
DB00485	866	dicloxacillin	Chemical/Ingredient	N0000011281	Penicillins	FDA
DB00485	866	dicloxacillin	PA	D000900	Anti-Bacterial Agents	MeSH
DB00485	866	dicloxacillin	PA	D000890	Anti-Infective Agents	MeSH
DB00485	866	dicloxacillin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00486	1862	nabilone	EPC	N0000175782	Cannabinoid	FDA
DB00486	1862	nabilone	Chemical/Ingredient	N0000008010	Cannabinoids	FDA
DB00486	1862	nabilone	PA	D014151	Anti-Anxiety Agents	MeSH
DB00486	1862	nabilone	PA	D000932	Antiemetics	MeSH
DB00486	1862	nabilone	PA	D002491	Central Nervous System Agents	MeSH
DB00486	1862	nabilone	PA	D002492	Central Nervous System Depressants	MeSH
DB00486	1862	nabilone	PA	D005765	Gastrointestinal Agents	MeSH
DB00486	1862	nabilone	PA	D011619	Psychotropic Drugs	MeSH
DB00486	1862	nabilone	PA	D014149	Tranquilizing Agents	MeSH
DB00489	2464	sotalol	EPC	N0000175426	Antiarrhythmic	FDA
DB00489	2464	sotalol	PE	N0000008330	Cardiac Rhythm Alteration	FDA
DB00489	2464	sotalol	PA	D018663	Adrenergic Agents	MeSH
DB00489	2464	sotalol	PA	D018674	Adrenergic Antagonists	MeSH
DB00489	2464	sotalol	PA	D000319	Adrenergic beta-Antagonists	MeSH
DB00489	2464	sotalol	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB00489	2464	sotalol	has role	CHEBI:35530	beta-adrenergic antagonist	CHEBI
DB00489	2464	sotalol	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB00489	2464	sotalol	PA	D002317	Cardiovascular Agents	MeSH
DB00489	2464	sotalol	PA	D018377	Neurotransmitter Agents	MeSH
DB00489	2464	sotalol	PA	D013565	Sympatholytics	MeSH
DB00490	437	buspirone	PA	D014151	Anti-Anxiety Agents	MeSH
DB00490	437	buspirone	has role	CHEBI:35941	serotonergic agonist	CHEBI
DB00490	437	buspirone	has role	CHEBI:35717	sedative	CHEBI
DB00490	437	buspirone	has role	CHEBI:35474	anxiolytic drug	CHEBI
DB00490	437	buspirone	PA	D002491	Central Nervous System Agents	MeSH
DB00490	437	buspirone	PA	D002492	Central Nervous System Depressants	MeSH
DB00490	437	buspirone	PA	D018377	Neurotransmitter Agents	MeSH
DB00490	437	buspirone	PA	D011619	Psychotropic Drugs	MeSH
DB00490	437	buspirone	PA	D018490	Serotonin Agents	MeSH
DB00490	437	buspirone	PA	D017366	Serotonin Receptor Agonists	MeSH
DB00490	437	buspirone	PA	D014149	Tranquilizing Agents	MeSH
DB00491	1806	miglitol	MoA	N0000000166	alpha Glucosidase Inhibitors	FDA
DB00491	1806	miglitol	EPC	N0000175559	alpha-Glucosidase Inhibitor	FDA
DB00491	1806	miglitol	PA	D004791	Enzyme Inhibitors	MeSH
DB00491	1806	miglitol	PA	D065089	Glycoside Hydrolase Inhibitors	MeSH
DB00491	1806	miglitol	PA	D007004	Hypoglycemic Agents	MeSH
DB00493	546	cefotaxime	EPC	N0000175488	Cephalosporin Antibacterial	FDA
DB00493	546	cefotaxime	Chemical/Ingredient	N0000011161	Cephalosporins	FDA
DB00493	546	cefotaxime	PA	D000900	Anti-Bacterial Agents	MeSH
DB00493	546	cefotaxime	PA	D000890	Anti-Infective Agents	MeSH
DB00493	546	cefotaxime	has role	CHEBI:88188	drug allergen	CHEBI
DB00493	546	cefotaxime	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00494	1018	entacapone	EPC	N0000175757	Catechol-O-Methyltransferase Inhibitor	FDA
DB00494	1018	entacapone	PA	D018726	Anti-Dyskinesia Agents	MeSH
DB00494	1018	entacapone	has role	CHEBI:35470	central nervous system drug	CHEBI
DB00494	1018	entacapone	has role	CHEBI:66956	antidyskinesia agent	CHEBI
DB00494	1018	entacapone	has role	CHEBI:48407	antiparkinson drug	CHEBI
DB00494	1018	entacapone	PA	D000978	Antiparkinson Agents	MeSH
DB00494	1018	entacapone	PA	D065098	Catechol O-Methyltransferase Inhibitors	MeSH
DB00494	1018	entacapone	PA	D002491	Central Nervous System Agents	MeSH
DB00494	1018	entacapone	PA	D004791	Enzyme Inhibitors	MeSH
DB00495	2861	zidovudine	EPC	N0000175462	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor	FDA
DB00495	2861	zidovudine	Chemical/Ingredient	N0000175459	Nucleoside Analog	FDA
DB00495	2861	zidovudine	MoA	N0000009947	Nucleoside Reverse Transcriptase Inhibitors	FDA
DB00495	2861	zidovudine	PA	D019380	Anti-HIV Agents	MeSH
DB00495	2861	zidovudine	PA	D000890	Anti-Infective Agents	MeSH
DB00495	2861	zidovudine	has role	CHEBI:36044	antiviral drug	CHEBI
DB00495	2861	zidovudine	PA	D000963	Antimetabolites	MeSH
DB00495	2861	zidovudine	PA	D000998	Antiviral Agents	MeSH
DB00495	2861	zidovudine	PA	D004791	Enzyme Inhibitors	MeSH
DB00495	2861	zidovudine	PA	D009676	Noxae	MeSH
DB00495	2861	zidovudine	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB00495	2861	zidovudine	PA	D018894	Reverse Transcriptase Inhibitors	MeSH
DB00496	784	darifenacin	EPC	N0000175700	Cholinergic Muscarinic Antagonist	FDA
DB00496	784	darifenacin	MoA	N0000000125	Cholinergic Muscarinic Antagonists	FDA
DB00496	784	darifenacin	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00496	784	darifenacin	has role	CHEBI:53784	antispasmodic drug	CHEBI
DB00496	784	darifenacin	PA	D018678	Cholinergic Agents	MeSH
DB00496	784	darifenacin	PA	D018680	Cholinergic Antagonists	MeSH
DB00496	784	darifenacin	PA	D018727	Muscarinic Antagonists	MeSH
DB00496	784	darifenacin	PA	D018377	Neurotransmitter Agents	MeSH
DB00496	784	darifenacin	PA	D064804	Urological Agents	MeSH
DB00497	2029	oxycodone	MoA	N0000175684	Full Opioid Agonists	FDA
DB00497	2029	oxycodone	EPC	N0000175690	Opioid Agonist	FDA
DB00497	2029	oxycodone	PA	D000700	Analgesics	MeSH
DB00497	2029	oxycodone	PA	D000701	Analgesics, Opioid	MeSH
DB00497	2029	oxycodone	has role	CHEBI:35482	opioid analgesic	CHEBI
DB00497	2029	oxycodone	has role	CHEBI:55322	mu-opioid receptor agonist	CHEBI
DB00497	2029	oxycodone	has role	CHEBI:51177	antitussive	CHEBI
DB00497	2029	oxycodone	PA	D002491	Central Nervous System Agents	MeSH
DB00497	2029	oxycodone	PA	D002492	Central Nervous System Depressants	MeSH
DB00497	2029	oxycodone	PA	D009294	Narcotics	MeSH
DB00497	2029	oxycodone	PA	D018689	Sensory System Agents	MeSH
DB00498	2130	phenindione	has role	CHEBI:50249	anticoagulant	CHEBI
DB00498	2130	phenindione	PA	D000925	Anticoagulants	MeSH
DB00498	2130	phenindione	PA	D006401	Hematologic Agents	MeSH
DB00499	1223	flutamide	MoA	N0000000243	Androgen Receptor Antagonists	FDA
DB00499	1223	flutamide	EPC	N0000175560	Androgen Receptor Inhibitor	FDA
DB00499	1223	flutamide	PA	D000726	Androgen Antagonists	MeSH
DB00499	1223	flutamide	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00499	1223	flutamide	has role	CHEBI:35497	androgen antagonist	CHEBI
DB00499	1223	flutamide	PA	D000970	Antineoplastic Agents	MeSH
DB00499	1223	flutamide	PA	D018931	Antineoplastic Agents, Hormonal	MeSH
DB00499	1223	flutamide	PA	D006727	Hormone Antagonists	MeSH
DB00500	2699	tolmetin	Chemical/Ingredient	N0000175721	Nonsteroidal Anti-inflammatory Compounds	FDA
DB00500	2699	tolmetin	EPC	N0000175722	Nonsteroidal Anti-inflammatory Drug	FDA
DB00500	2699	tolmetin	PA	D000700	Analgesics	MeSH
DB00500	2699	tolmetin	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00500	2699	tolmetin	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00500	2699	tolmetin	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00500	2699	tolmetin	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00500	2699	tolmetin	PA	D018501	Antirheumatic Agents	MeSH
DB00500	2699	tolmetin	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB00500	2699	tolmetin	PA	D004791	Enzyme Inhibitors	MeSH
DB00500	2699	tolmetin	PA	D018689	Sensory System Agents	MeSH
DB00501	645	cimetidine	MoA	N0000000151	Histamine H2 Receptor Antagonists	FDA
DB00501	645	cimetidine	EPC	N0000175784	Histamine-2 Receptor Antagonist	FDA
DB00501	645	cimetidine	has role	CHEBI:37961	H2-receptor antagonist	CHEBI
DB00501	645	cimetidine	has role	CHEBI:35480	analgesic	CHEBI
DB00501	645	cimetidine	has role	CHEBI:60809	adjuvant	CHEBI
DB00501	645	cimetidine	has role	CHEBI:49201	anti-ulcer drug	CHEBI
DB00501	645	cimetidine	PA	D000897	Anti-Ulcer Agents	MeSH
DB00501	645	cimetidine	PA	D065609	Cytochrome P-450 CYP1A2 Inhibitors	MeSH
DB00501	645	cimetidine	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB00501	645	cimetidine	PA	D004791	Enzyme Inhibitors	MeSH
DB00501	645	cimetidine	PA	D005765	Gastrointestinal Agents	MeSH
DB00501	645	cimetidine	PA	D018494	Histamine Agents	MeSH
DB00501	645	cimetidine	PA	D006633	Histamine Antagonists	MeSH
DB00501	645	cimetidine	PA	D006635	Histamine H2 Antagonists	MeSH
DB00501	645	cimetidine	PA	D018377	Neurotransmitter Agents	MeSH
DB00502	1353	haloperidol	EPC	N0000180182	Typical Antipsychotic	FDA
DB00502	1353	haloperidol	PA	D018726	Anti-Dyskinesia Agents	MeSH
DB00502	1353	haloperidol	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB00502	1353	haloperidol	has role	CHEBI:66956	antidyskinesia agent	CHEBI
DB00502	1353	haloperidol	has role	CHEBI:50919	antiemetic	CHEBI
DB00502	1353	haloperidol	has role	CHEBI:65190	first generation antipsychotic	CHEBI
DB00502	1353	haloperidol	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB00502	1353	haloperidol	PA	D000932	Antiemetics	MeSH
DB00502	1353	haloperidol	PA	D014150	Antipsychotic Agents	MeSH
DB00502	1353	haloperidol	PA	D002491	Central Nervous System Agents	MeSH
DB00502	1353	haloperidol	PA	D002492	Central Nervous System Depressants	MeSH
DB00502	1353	haloperidol	PA	D015259	Dopamine Agents	MeSH
DB00502	1353	haloperidol	PA	D018492	Dopamine Antagonists	MeSH
DB00502	1353	haloperidol	PA	D005765	Gastrointestinal Agents	MeSH
DB00502	1353	haloperidol	PA	D018377	Neurotransmitter Agents	MeSH
DB00502	1353	haloperidol	PA	D011619	Psychotropic Drugs	MeSH
DB00502	1353	haloperidol	PA	D014149	Tranquilizing Agents	MeSH
DB00503	2391	ritonavir	EPC	N0000191001	Cytochrome P450 3A Inhibitor	FDA
DB00503	2391	ritonavir	EPC	N0000175889	Protease Inhibitor	FDA
DB00503	2391	ritonavir	MoA	N0000190114	Cytochrome P450 3A Inhibitors	FDA
DB00503	2391	ritonavir	PA	D019380	Anti-HIV Agents	MeSH
DB00503	2391	ritonavir	PA	D000890	Anti-Infective Agents	MeSH
DB00503	2391	ritonavir	has role	CHEBI:36044	antiviral drug	CHEBI
DB00503	2391	ritonavir	PA	D000998	Antiviral Agents	MeSH
DB00503	2391	ritonavir	PA	D065692	Cytochrome P-450 CYP3A Inhibitors	MeSH
DB00503	2391	ritonavir	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB00503	2391	ritonavir	PA	D004791	Enzyme Inhibitors	MeSH
DB00503	2391	ritonavir	PA	D017320	HIV Protease Inhibitors	MeSH
DB00503	2391	ritonavir	PA	D011480	Protease Inhibitors	MeSH
DB00503	2391	ritonavir	MoA	N0000182137	Cytochrome P450 2D6 Inhibitors	FDA
DB00503	2391	ritonavir	MoA	N0000185607	Cytochrome P450 2C19 Inducers	FDA
DB00503	2391	ritonavir	MoA	N0000190118	Cytochrome P450 3A Inducers	FDA
DB00503	2391	ritonavir	MoA	N0000185503	P-Glycoprotein Inhibitors	FDA
DB00503	2391	ritonavir	MoA	N0000190113	Breast Cancer Resistance Protein Inhibitors	FDA
DB00503	2391	ritonavir	MoA	N0000182141	Cytochrome P450 3A4 Inhibitors	FDA
DB00504	1560	levallorphan	PA	D002491	Central Nervous System Agents	MeSH
DB00504	1560	levallorphan	PA	D009292	Narcotic Antagonists	MeSH
DB00504	1560	levallorphan	PA	D018689	Sensory System Agents	MeSH
DB00505	2737	tridihexethyl	has role	CHEBI:49201	anti-ulcer drug	CHEBI
DB00505	2737	tridihexethyl	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00505	2737	tridihexethyl	has role	CHEBI:53784	antispasmodic drug	CHEBI
DB00507	1943	nitazoxanide	EPC	N0000175485	Antiprotozoal	FDA
DB00507	1943	nitazoxanide	PA	D000890	Anti-Infective Agents	MeSH
DB00507	1943	nitazoxanide	PA	D000977	Antiparasitic Agents	MeSH
DB00508	2742	triflupromazine	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB00508	2742	triflupromazine	has role	CHEBI:50919	antiemetic	CHEBI
DB00508	2742	triflupromazine	has role	CHEBI:65190	first generation antipsychotic	CHEBI
DB00508	2742	triflupromazine	PA	D000932	Antiemetics	MeSH
DB00508	2742	triflupromazine	PA	D014150	Antipsychotic Agents	MeSH
DB00508	2742	triflupromazine	PA	D002491	Central Nervous System Agents	MeSH
DB00508	2742	triflupromazine	PA	D002492	Central Nervous System Depressants	MeSH
DB00508	2742	triflupromazine	PA	D015259	Dopamine Agents	MeSH
DB00508	2742	triflupromazine	PA	D018492	Dopamine Antagonists	MeSH
DB00508	2742	triflupromazine	PA	D005765	Gastrointestinal Agents	MeSH
DB00508	2742	triflupromazine	PA	D018377	Neurotransmitter Agents	MeSH
DB00508	2742	triflupromazine	PA	D011619	Psychotropic Drugs	MeSH
DB00508	2742	triflupromazine	PA	D014149	Tranquilizing Agents	MeSH
DB00511	67	acetyldigitoxin	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB00511	67	acetyldigitoxin	has role	CHEBI:38147	cardiotonic drug	CHEBI
DB00513	163	aminocaproic acid	EPC	N0000175634	Antifibrinolytic Agent	FDA
DB00513	163	aminocaproic acid	PE	N0000175632	Decreased Fibrinolysis	FDA
DB00513	163	aminocaproic acid	has role	CHEBI:48675	antifibrinolytic drug	CHEBI
DB00513	163	aminocaproic acid	has role	CHEBI:50248	hematologic agent	CHEBI
DB00513	163	aminocaproic acid	PA	D000933	Antifibrinolytic Agents	MeSH
DB00513	163	aminocaproic acid	PA	D003029	Coagulants	MeSH
DB00513	163	aminocaproic acid	PA	D006401	Hematologic Agents	MeSH
DB00513	163	aminocaproic acid	PA	D006490	Hemostatics	MeSH
DB00517	223	octatropine methylbromide	has role	CHEBI:49201	anti-ulcer drug	CHEBI
DB00517	223	octatropine methylbromide	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00517	223	octatropine methylbromide	has role	CHEBI:50370	parasympatholytic	CHEBI
DB00518	103	albendazole	EPC	N0000175481	Antihelminthic	FDA
DB00518	103	albendazole	PA	D000871	Anthelmintics	MeSH
DB00518	103	albendazole	PA	D000890	Anti-Infective Agents	MeSH
DB00518	103	albendazole	has role	CHEBI:35443	anthelminthic drug	CHEBI
DB00518	103	albendazole	PA	D000923	Anticestodal Agents	MeSH
DB00518	103	albendazole	PA	D050256	Antimitotic Agents	MeSH
DB00518	103	albendazole	PA	D000977	Antiparasitic Agents	MeSH
DB00518	103	albendazole	PA	D000980	Antiplatyhelmintic Agents	MeSH
DB00518	103	albendazole	PA	D000981	Antiprotozoal Agents	MeSH
DB00518	103	albendazole	PA	D050257	Tubulin Modulators	MeSH
DB00518	103	albendazole	MoA	N0000191624	Cytochrome P450 1A Inducers	FDA
DB00519	2712	trandolapril	EPC	N0000175562	Angiotensin Converting Enzyme Inhibitor	FDA
DB00519	2712	trandolapril	PA	D000806	Angiotensin-Converting Enzyme Inhibitors	MeSH
DB00519	2712	trandolapril	PA	D000959	Antihypertensive Agents	MeSH
DB00519	2712	trandolapril	PA	D002317	Cardiovascular Agents	MeSH
DB00519	2712	trandolapril	PA	D004791	Enzyme Inhibitors	MeSH
DB00519	2712	trandolapril	PA	D011480	Protease Inhibitors	MeSH
DB00520	2977	caspofungin	EPC	N0000175507	Echinocandin Antifungal	FDA
DB00520	2977	caspofungin	Chemical/Ingredient	N0000175508	Lipopeptides	FDA
DB00520	2977	caspofungin	PA	D000890	Anti-Infective Agents	MeSH
DB00520	2977	caspofungin	has role	CHEBI:35441	antiinfective agent	CHEBI
DB00520	2977	caspofungin	PA	D000935	Antifungal Agents	MeSH
DB00521	520	carteolol	EPC	N0000175556	beta-Adrenergic Blocker	FDA
DB00521	520	carteolol	PA	D018663	Adrenergic Agents	MeSH
DB00521	520	carteolol	PA	D018674	Adrenergic Antagonists	MeSH
DB00521	520	carteolol	PA	D000319	Adrenergic beta-Antagonists	MeSH
DB00521	520	carteolol	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB00521	520	carteolol	has role	CHEBI:35530	beta-adrenergic antagonist	CHEBI
DB00521	520	carteolol	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00521	520	carteolol	has role	CHEBI:66991	sympatholytic agent	CHEBI
DB00521	520	carteolol	has role	CHEBI:39456	antiglaucoma drug	CHEBI
DB00521	520	carteolol	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB00521	520	carteolol	PA	D000959	Antihypertensive Agents	MeSH
DB00521	520	carteolol	PA	D002317	Cardiovascular Agents	MeSH
DB00521	520	carteolol	PA	D018377	Neurotransmitter Agents	MeSH
DB00521	520	carteolol	PA	D013565	Sympatholytics	MeSH
DB00523	2722	tretinoin	EPC	N0000175607	Retinoid	FDA
DB00523	2722	tretinoin	Chemical/Ingredient	N0000007700	Retinoids	FDA
DB00523	2722	tretinoin	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00523	2722	tretinoin	has role	CHEBI:50176	keratolytic drug	CHEBI
DB00523	2722	tretinoin	has role	CHEBI:67079	anti-inflammatory agent	CHEBI
DB00523	2722	tretinoin	has role	CHEBI:67198	retinoic acid receptor agonist	CHEBI
DB00523	2722	tretinoin	PA	D000970	Antineoplastic Agents	MeSH
DB00523	2722	tretinoin	PA	D003879	Dermatologic Agents	MeSH
DB00523	2722	tretinoin	PA	D007641	Keratolytic Agents	MeSH
DB00755	2722	tretinoin	EPC	N0000175607	Retinoid	FDA
DB00755	2722	tretinoin	Chemical/Ingredient	N0000007700	Retinoids	FDA
DB00755	2722	tretinoin	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00755	2722	tretinoin	has role	CHEBI:50176	keratolytic drug	CHEBI
DB00755	2722	tretinoin	has role	CHEBI:67079	anti-inflammatory agent	CHEBI
DB00755	2722	tretinoin	has role	CHEBI:67198	retinoic acid receptor agonist	CHEBI
DB00755	2722	tretinoin	PA	D000970	Antineoplastic Agents	MeSH
DB00755	2722	tretinoin	PA	D003879	Dermatologic Agents	MeSH
DB00755	2722	tretinoin	PA	D007641	Keratolytic Agents	MeSH
DB00982	2722	tretinoin	EPC	N0000175607	Retinoid	FDA
DB00982	2722	tretinoin	Chemical/Ingredient	N0000007700	Retinoids	FDA
DB00982	2722	tretinoin	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00982	2722	tretinoin	has role	CHEBI:50176	keratolytic drug	CHEBI
DB00982	2722	tretinoin	has role	CHEBI:67079	anti-inflammatory agent	CHEBI
DB00982	2722	tretinoin	has role	CHEBI:67198	retinoic acid receptor agonist	CHEBI
DB00982	2722	tretinoin	PA	D000970	Antineoplastic Agents	MeSH
DB00982	2722	tretinoin	PA	D003879	Dermatologic Agents	MeSH
DB00982	2722	tretinoin	PA	D007641	Keratolytic Agents	MeSH
DB00523	1508	isotretinoin	PA	D009676	Noxae	MeSH
DB00523	1508	isotretinoin	PA	D013723	Teratogens	MeSH
DB00755	1508	isotretinoin	PA	D009676	Noxae	MeSH
DB00755	1508	isotretinoin	PA	D013723	Teratogens	MeSH
DB00982	1508	isotretinoin	PA	D009676	Noxae	MeSH
DB00982	1508	isotretinoin	PA	D013723	Teratogens	MeSH
DB00524	1783	metolazone	PE	N0000175359	Increased Diuresis	FDA
DB00524	1783	metolazone	EPC	N0000175420	Thiazide-like Diuretic	FDA
DB00524	1783	metolazone	has role	CHEBI:35498	diuretic	CHEBI
DB00524	1783	metolazone	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00524	1783	metolazone	PA	D000959	Antihypertensive Agents	MeSH
DB00524	1783	metolazone	PA	D002317	Cardiovascular Agents	MeSH
DB00524	1783	metolazone	PA	D004232	Diuretics	MeSH
DB00524	1783	metolazone	PA	D049990	Membrane Transport Modulators	MeSH
DB00524	1783	metolazone	PA	D045283	Natriuretic Agents	MeSH
DB00524	1783	metolazone	PA	D049993	Sodium Chloride Symporter Inhibitors	MeSH
DB00527	859	cinchocaine	EPC	N0000185508	Standardized Chemical Allergen	FDA
DB00527	859	cinchocaine	PE	N0000175629	Increased Histamine Release	FDA
DB00527	859	cinchocaine	PE	N0000184306	Cell-mediated Immunity	FDA
DB00527	859	cinchocaine	Chemical/Ingredient	N0000171131	Allergens	FDA
DB00527	859	cinchocaine	PA	D000777	Anesthetics	MeSH
DB00527	859	cinchocaine	PA	D000779	Anesthetics, Local	MeSH
DB00527	859	cinchocaine	has role	CHEBI:48425	topical anaesthetic	CHEBI
DB00527	859	cinchocaine	PA	D002491	Central Nervous System Agents	MeSH
DB00527	859	cinchocaine	PA	D002492	Central Nervous System Depressants	MeSH
DB00527	859	cinchocaine	PA	D018689	Sensory System Agents	MeSH
DB00528	4157	lercanidipine	PA	D000959	Antihypertensive Agents	MeSH
DB00528	4157	lercanidipine	PA	D002121	Calcium Channel Blockers	MeSH
DB00528	4157	lercanidipine	PA	D002317	Cardiovascular Agents	MeSH
DB00528	4157	lercanidipine	PA	D049990	Membrane Transport Modulators	MeSH
DB00529	1241	foscarnet	MoA	N0000020060	DNA Polymerase Inhibitors	FDA
DB00529	1241	foscarnet	Chemical/Ingredient	N0000175469	Pyrophosphate Analog	FDA
DB00529	1241	foscarnet	EPC	N0000175470	Pyrophosphate Analog DNA Polymerase Inhibitor	FDA
DB00529	1241	foscarnet	PA	D000890	Anti-Infective Agents	MeSH
DB00529	1241	foscarnet	PA	D000998	Antiviral Agents	MeSH
DB00529	1241	foscarnet	PA	D004791	Enzyme Inhibitors	MeSH
DB00529	1241	foscarnet	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB00529	1241	foscarnet	PA	D018894	Reverse Transcriptase Inhibitors	MeSH
DB00530	1045	erlotinib	EPC	N0000175605	Kinase Inhibitor	FDA
DB00530	1045	erlotinib	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00530	1045	erlotinib	PA	D000970	Antineoplastic Agents	MeSH
DB00530	1045	erlotinib	PA	D004791	Enzyme Inhibitors	MeSH
DB00530	1045	erlotinib	PA	D047428	Protein Kinase Inhibitors	MeSH
DB00532	1695	mephenytoin	EPC	N0000175753	Anti-epileptic Agent	FDA
DB00532	1695	mephenytoin	PE	N0000008486	Decreased Central Nervous System Disorganized Electrical Activity	FDA
DB00532	1695	mephenytoin	PA	D000927	Anticonvulsants	MeSH
DB00532	1695	mephenytoin	PA	D002491	Central Nervous System Agents	MeSH
DB00533	2397	rofecoxib	PA	D000700	Analgesics	MeSH
DB00533	2397	rofecoxib	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00533	2397	rofecoxib	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00533	2397	rofecoxib	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00533	2397	rofecoxib	has role	CHEBI:35480	analgesic	CHEBI
DB00533	2397	rofecoxib	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00533	2397	rofecoxib	PA	D018501	Antirheumatic Agents	MeSH
DB00533	2397	rofecoxib	PA	D052246	Cyclooxygenase 2 Inhibitors	MeSH
DB00533	2397	rofecoxib	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB00533	2397	rofecoxib	PA	D004791	Enzyme Inhibitors	MeSH
DB00533	2397	rofecoxib	PA	D018689	Sensory System Agents	MeSH
DB00535	533	cefdinir	EPC	N0000175488	Cephalosporin Antibacterial	FDA
DB00535	533	cefdinir	Chemical/Ingredient	N0000011161	Cephalosporins	FDA
DB00535	533	cefdinir	PA	D000900	Anti-Bacterial Agents	MeSH
DB00535	533	cefdinir	PA	D000890	Anti-Infective Agents	MeSH
DB00535	533	cefdinir	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00537	659	ciprofloxacin	EPC	N0000175937	Quinolone Antimicrobial	FDA
DB00537	659	ciprofloxacin	Chemical/Ingredient	N0000007606	Quinolones	FDA
DB00537	659	ciprofloxacin	PA	D000900	Anti-Bacterial Agents	MeSH
DB00537	659	ciprofloxacin	PA	D000890	Anti-Infective Agents	MeSH
DB00537	659	ciprofloxacin	has role	CHEBI:35441	antiinfective agent	CHEBI
DB00537	659	ciprofloxacin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00537	659	ciprofloxacin	PA	D000970	Antineoplastic Agents	MeSH
DB00537	659	ciprofloxacin	PA	D065609	Cytochrome P-450 CYP1A2 Inhibitors	MeSH
DB00537	659	ciprofloxacin	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB00537	659	ciprofloxacin	PA	D004791	Enzyme Inhibitors	MeSH
DB00537	659	ciprofloxacin	PA	D059005	Topoisomerase II Inhibitors	MeSH
DB05488	659	ciprofloxacin	EPC	N0000175937	Quinolone Antimicrobial	FDA
DB05488	659	ciprofloxacin	Chemical/Ingredient	N0000007606	Quinolones	FDA
DB05488	659	ciprofloxacin	PA	D000900	Anti-Bacterial Agents	MeSH
DB05488	659	ciprofloxacin	PA	D000890	Anti-Infective Agents	MeSH
DB05488	659	ciprofloxacin	has role	CHEBI:35441	antiinfective agent	CHEBI
DB05488	659	ciprofloxacin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB05488	659	ciprofloxacin	PA	D000970	Antineoplastic Agents	MeSH
DB05488	659	ciprofloxacin	PA	D065609	Cytochrome P-450 CYP1A2 Inhibitors	MeSH
DB05488	659	ciprofloxacin	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB05488	659	ciprofloxacin	PA	D004791	Enzyme Inhibitors	MeSH
DB05488	659	ciprofloxacin	PA	D059005	Topoisomerase II Inhibitors	MeSH
DB00539	2709	toremifene	EPC	N0000175826	Estrogen Agonist/Antagonist	FDA
DB00539	2709	toremifene	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00539	2709	toremifene	has role	CHEBI:50837	estrogen antagonist	CHEBI
DB00539	2709	toremifene	has role	CHEBI:50646	bone density conservation agent	CHEBI
DB00539	2709	toremifene	has role	CHEBI:50739	estrogen receptor modulator	CHEBI
DB00539	2709	toremifene	PA	D000970	Antineoplastic Agents	MeSH
DB00539	2709	toremifene	PA	D018931	Antineoplastic Agents, Hormonal	MeSH
DB00539	2709	toremifene	PA	D050071	Bone Density Conservation Agents	MeSH
DB00539	2709	toremifene	PA	D020847	Estrogen Receptor Modulators	MeSH
DB00539	2709	toremifene	PA	D006727	Hormone Antagonists	MeSH
DB00539	2709	toremifene	PA	D020845	Selective Estrogen Receptor Modulators	MeSH
DB00540	1971	nortriptyline	EPC	N0000175752	Tricyclic Antidepressant	FDA
DB00540	1971	nortriptyline	PA	D018663	Adrenergic Agents	MeSH
DB00540	1971	nortriptyline	PA	D018759	Adrenergic Uptake Inhibitors	MeSH
DB00540	1971	nortriptyline	has role	CHEBI:35469	antidepressant	CHEBI
DB00540	1971	nortriptyline	has role	CHEBI:35640	adrenergic uptake inhibitor	CHEBI
DB00540	1971	nortriptyline	has role	CHEBI:35480	analgesic	CHEBI
DB00540	1971	nortriptyline	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00540	1971	nortriptyline	PA	D000928	Antidepressive Agents	MeSH
DB00540	1971	nortriptyline	PA	D000929	Antidepressive Agents, Tricyclic	MeSH
DB00540	1971	nortriptyline	PA	D002491	Central Nervous System Agents	MeSH
DB00540	1971	nortriptyline	PA	D049990	Membrane Transport Modulators	MeSH
DB00540	1971	nortriptyline	PA	D018377	Neurotransmitter Agents	MeSH
DB00540	1971	nortriptyline	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB00540	1971	nortriptyline	PA	D011619	Psychotropic Drugs	MeSH
DB00541	2825	vincristine	EPC	N0000175612	Vinca Alkaloid	FDA
DB00541	2825	vincristine	Chemical/Ingredient	N0000007780	Vinca Alkaloids	FDA
DB00541	2825	vincristine	PA	D050256	Antimitotic Agents	MeSH
DB00541	2825	vincristine	PA	D000970	Antineoplastic Agents	MeSH
DB00541	2825	vincristine	PA	D000972	Antineoplastic Agents, Phytogenic	MeSH
DB00541	2825	vincristine	PA	D050257	Tubulin Modulators	MeSH
DB00542	299	benazepril	EPC	N0000175562	Angiotensin Converting Enzyme Inhibitor	FDA
DB00542	299	benazepril	PE	N0000178477	Decreased Blood Pressure	FDA
DB00542	299	benazepril	PA	D000806	Angiotensin-Converting Enzyme Inhibitors	MeSH
DB00542	299	benazepril	has role	CHEBI:35457	EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor	CHEBI
DB00542	299	benazepril	has role	CHEBI:50266	prodrug	CHEBI
DB00542	299	benazepril	PA	D000959	Antihypertensive Agents	MeSH
DB00542	299	benazepril	PA	D002317	Cardiovascular Agents	MeSH
DB00542	299	benazepril	PA	D004791	Enzyme Inhibitors	MeSH
DB00542	299	benazepril	PA	D011480	Protease Inhibitors	MeSH
DB00543	191	amoxapine	EPC	N0000175752	Tricyclic Antidepressant	FDA
DB00543	191	amoxapine	PA	D018663	Adrenergic Agents	MeSH
DB00543	191	amoxapine	PA	D018759	Adrenergic Uptake Inhibitors	MeSH
DB00543	191	amoxapine	has role	CHEBI:35469	antidepressant	CHEBI
DB00543	191	amoxapine	has role	CHEBI:35640	adrenergic uptake inhibitor	CHEBI
DB00543	191	amoxapine	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB00543	191	amoxapine	has role	CHEBI:50949	serotonin uptake inhibitor	CHEBI
DB00543	191	amoxapine	PA	D000928	Antidepressive Agents	MeSH
DB00543	191	amoxapine	PA	D018687	Antidepressive Agents, Second-Generation	MeSH
DB00543	191	amoxapine	PA	D002491	Central Nervous System Agents	MeSH
DB00543	191	amoxapine	PA	D015259	Dopamine Agents	MeSH
DB00543	191	amoxapine	PA	D018492	Dopamine Antagonists	MeSH
DB00543	191	amoxapine	PA	D049990	Membrane Transport Modulators	MeSH
DB00543	191	amoxapine	PA	D018377	Neurotransmitter Agents	MeSH
DB00543	191	amoxapine	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB00543	191	amoxapine	PA	D011619	Psychotropic Drugs	MeSH
DB00543	191	amoxapine	PA	D018490	Serotonin Agents	MeSH
DB00543	191	amoxapine	PA	D017367	Serotonin Uptake Inhibitors	MeSH
DB00544	26	fluorouracil	MoA	N0000000233	Nucleic Acid Synthesis Inhibitors	FDA
DB00544	26	fluorouracil	EPC	N0000175595	Nucleoside Metabolic Inhibitor	FDA
DB00544	26	fluorouracil	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00544	26	fluorouracil	has role	CHEBI:35705	immunosuppressive agent	CHEBI
DB00544	26	fluorouracil	PA	D000963	Antimetabolites	MeSH
DB00544	26	fluorouracil	PA	D000964	Antimetabolites, Antineoplastic	MeSH
DB00544	26	fluorouracil	PA	D000970	Antineoplastic Agents	MeSH
DB00544	26	fluorouracil	PA	D007155	Immunologic Factors	MeSH
DB00544	26	fluorouracil	PA	D007166	Immunosuppressive Agents	MeSH
DB00544	26	fluorouracil	PA	D009676	Noxae	MeSH
DB00545	2330	pyridostigmine	EPC	N0000175723	Cholinesterase Inhibitor	FDA
DB00545	2330	pyridostigmine	PA	D018678	Cholinergic Agents	MeSH
DB00545	2330	pyridostigmine	PA	D002800	Cholinesterase Inhibitors	MeSH
DB00545	2330	pyridostigmine	PA	D004791	Enzyme Inhibitors	MeSH
DB00545	2330	pyridostigmine	PA	D018377	Neurotransmitter Agents	MeSH
DB00546	93	adinazolam	has role	CHEBI:35469	antidepressant	CHEBI
DB00546	93	adinazolam	has role	CHEBI:35717	sedative	CHEBI
DB00546	93	adinazolam	has role	CHEBI:35474	anxiolytic drug	CHEBI
DB00546	93	adinazolam	has role	CHEBI:35623	anticonvulsant	CHEBI
DB00546	93	adinazolam	PA	D000928	Antidepressive Agents	MeSH
DB00546	93	adinazolam	PA	D002491	Central Nervous System Agents	MeSH
DB00546	93	adinazolam	PA	D011619	Psychotropic Drugs	MeSH
DB00547	819	desoximetasone	EPC	N0000175576	Corticosteroid	FDA
DB00547	819	desoximetasone	MoA	N0000175450	Corticosteroid Hormone Receptor Agonists	FDA
DB00547	819	desoximetasone	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00547	819	desoximetasone	has role	CHEBI:35472	anti-inflammatory drug	CHEBI
DB00547	819	desoximetasone	has role	CHEBI:59683	antipruritic drug	CHEBI
DB00547	819	desoximetasone	PA	D005938	Glucocorticoids	MeSH
DB00547	819	desoximetasone	PA	D006728	Hormones	MeSH
DB00549	2855	zafirlukast	EPC	N0000175777	Leukotriene Receptor Antagonist	FDA
DB00549	2855	zafirlukast	MoA	N0000000083	Leukotriene Receptor Antagonists	FDA
DB00549	2855	zafirlukast	MoA	N0000185504	Cytochrome P450 2C9 Inhibitors	FDA
DB00549	2855	zafirlukast	PA	D018927	Anti-Asthmatic Agents	MeSH
DB00549	2855	zafirlukast	has role	CHEBI:49159	leukotriene antagonist	CHEBI
DB00549	2855	zafirlukast	has role	CHEBI:65023	anti-asthmatic agent	CHEBI
DB00549	2855	zafirlukast	PA	D006727	Hormone Antagonists	MeSH
DB00549	2855	zafirlukast	PA	D020024	Leukotriene Antagonists	MeSH
DB00549	2855	zafirlukast	PA	D019141	Respiratory System Agents	MeSH
DB00550	2308	propylthiouracil	EPC	N0000175918	Thyroid Hormone Synthesis Inhibitor	FDA
DB00550	2308	propylthiouracil	MoA	N0000175917	Thyroid Hormone Synthesis Inhibitors	FDA
DB00550	2308	propylthiouracil	has role	CHEBI:50671	antithyroid drug	CHEBI
DB00550	2308	propylthiouracil	has role	CHEBI:49020	hormone antagonist	CHEBI
DB00550	2308	propylthiouracil	has role	CHEBI:74529	antidote to paracetamol poisoning	CHEBI
DB00550	2308	propylthiouracil	PA	D000963	Antimetabolites	MeSH
DB00550	2308	propylthiouracil	PA	D013956	Antithyroid Agents	MeSH
DB00550	2308	propylthiouracil	PA	D006727	Hormone Antagonists	MeSH
DB00550	2308	propylthiouracil	PA	D009676	Noxae	MeSH
DB00551	58	acetohydroxamic acid	EPC	N0000175611	Urease Inhibitor	FDA
DB00551	58	acetohydroxamic acid	MoA	N0000175087	Urease Inhibitors	FDA
DB00551	58	acetohydroxamic acid	PA	D004791	Enzyme Inhibitors	MeSH
DB00552	2098	pentostatin	MoA	N0000000233	Nucleic Acid Synthesis Inhibitors	FDA
DB00552	2098	pentostatin	EPC	N0000175595	Nucleoside Metabolic Inhibitor	FDA
DB00552	2098	pentostatin	PA	D058892	Adenosine Deaminase Inhibitors	MeSH
DB00552	2098	pentostatin	PA	D000970	Antineoplastic Agents	MeSH
DB00552	2098	pentostatin	PA	D004791	Enzyme Inhibitors	MeSH
DB00554	2210	piroxicam	Chemical/Ingredient	N0000175721	Nonsteroidal Anti-inflammatory Compounds	FDA
DB00554	2210	piroxicam	EPC	N0000175722	Nonsteroidal Anti-inflammatory Drug	FDA
DB00554	2210	piroxicam	PA	D000700	Analgesics	MeSH
DB00554	2210	piroxicam	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00554	2210	piroxicam	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00554	2210	piroxicam	has role	CHEBI:35842	antirheumatic drug	CHEBI
DB00554	2210	piroxicam	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00554	2210	piroxicam	has role	CHEBI:35480	analgesic	CHEBI
DB00554	2210	piroxicam	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00554	2210	piroxicam	PA	D018501	Antirheumatic Agents	MeSH
DB00554	2210	piroxicam	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB00554	2210	piroxicam	PA	D004791	Enzyme Inhibitors	MeSH
DB00554	2210	piroxicam	PA	D018689	Sensory System Agents	MeSH
DB00555	1540	lamotrigine	EPC	N0000175753	Anti-epileptic Agent	FDA
DB00555	1540	lamotrigine	PE	N0000008486	Decreased Central Nervous System Disorganized Electrical Activity	FDA
DB00555	1540	lamotrigine	EPC	N0000175751	Mood Stabilizer	FDA
DB00555	1540	lamotrigine	has role	CHEBI:35623	anticonvulsant	CHEBI
DB00555	1540	lamotrigine	has role	CHEBI:35477	antimanic drug	CHEBI
DB00555	1540	lamotrigine	has role	CHEBI:35469	antidepressant	CHEBI
DB00555	1540	lamotrigine	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB00555	1540	lamotrigine	PA	D000927	Anticonvulsants	MeSH
DB00555	1540	lamotrigine	PA	D002121	Calcium Channel Blockers	MeSH
DB00555	1540	lamotrigine	PA	D002317	Cardiovascular Agents	MeSH
DB00555	1540	lamotrigine	PA	D002491	Central Nervous System Agents	MeSH
DB00555	1540	lamotrigine	PA	D018691	Excitatory Amino Acid Antagonists	MeSH
DB00555	1540	lamotrigine	PA	D049990	Membrane Transport Modulators	MeSH
DB00555	1540	lamotrigine	PA	D018377	Neurotransmitter Agents	MeSH
DB00555	1540	lamotrigine	PA	D026941	Sodium Channel Blockers	MeSH
DB00555	1540	lamotrigine	PA	D061567	Voltage-Gated Sodium Channel Blockers	MeSH
DB00557	1400	hydroxyzine	EPC	N0000175750	Antihistamine	FDA
DB00557	1400	hydroxyzine	MoA	N0000000207	Histamine Receptor Antagonists	FDA
DB00557	1400	hydroxyzine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB00557	1400	hydroxyzine	has role	CHEBI:35474	anxiolytic drug	CHEBI
DB00557	1400	hydroxyzine	has role	CHEBI:50177	dermatologic drug	CHEBI
DB00557	1400	hydroxyzine	has role	CHEBI:59683	antipruritic drug	CHEBI
DB00557	1400	hydroxyzine	PA	D000982	Antipruritics	MeSH
DB00557	1400	hydroxyzine	PA	D003879	Dermatologic Agents	MeSH
DB00557	1400	hydroxyzine	PA	D018494	Histamine Agents	MeSH
DB00557	1400	hydroxyzine	PA	D006633	Histamine Antagonists	MeSH
DB00557	1400	hydroxyzine	PA	D006634	Histamine H1 Antagonists	MeSH
DB00557	1400	hydroxyzine	PA	D018377	Neurotransmitter Agents	MeSH
DB00558	2859	zanamivir	EPC	N0000175524	Neuraminidase Inhibitor	FDA
DB00558	2859	zanamivir	MoA	N0000175436	Neuraminidase Inhibitors	FDA
DB00558	2859	zanamivir	PA	D000890	Anti-Infective Agents	MeSH
DB00558	2859	zanamivir	has role	CHEBI:52425	EC 3.2.1.18 (exo-alpha-sialidase) inhibitor	CHEBI
DB00558	2859	zanamivir	PA	D000998	Antiviral Agents	MeSH
DB00558	2859	zanamivir	PA	D004791	Enzyme Inhibitors	MeSH
DB00559	392	bosentan	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00559	392	bosentan	has role	CHEBI:51451	endothelin receptor antagonist	CHEBI
DB00559	392	bosentan	PA	D000959	Antihypertensive Agents	MeSH
DB00559	392	bosentan	PA	D002317	Cardiovascular Agents	MeSH
DB00559	392	bosentan	PA	D065128	Endothelin Receptor Antagonists	MeSH
DB00561	953	doxapram	PE	N0000009393	Increased Medullary Respiratory Drive	FDA
DB00561	953	doxapram	EPC	N0000175716	Respiratory Stimulant	FDA
DB00561	953	doxapram	has role	CHEBI:35337	central nervous system stimulant	CHEBI
DB00561	953	doxapram	PA	D002491	Central Nervous System Agents	MeSH
DB00561	953	doxapram	PA	D000697	Central Nervous System Stimulants	MeSH
DB00561	953	doxapram	PA	D019141	Respiratory System Agents	MeSH
DB00562	332	benzthiazide	has role	CHEBI:35498	diuretic	CHEBI
DB00562	332	benzthiazide	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00563	1751	methotrexate	EPC	N0000175584	Folate Analog Metabolic Inhibitor	FDA
DB00563	1751	methotrexate	MoA	N0000000111	Folic Acid Metabolism Inhibitors	FDA
DB00563	1751	methotrexate	PA	D000020	Abortifacient Agents, Nonsteroidal	MeSH
DB00563	1751	methotrexate	has role	CHEBI:35705	immunosuppressive agent	CHEBI
DB00563	1751	methotrexate	has role	CHEBI:50691	abortifacient	CHEBI
DB00563	1751	methotrexate	has role	CHEBI:50177	dermatologic drug	CHEBI
DB00563	1751	methotrexate	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00563	1751	methotrexate	has role	CHEBI:35842	antirheumatic drug	CHEBI
DB00563	1751	methotrexate	PA	D000963	Antimetabolites	MeSH
DB00563	1751	methotrexate	PA	D000964	Antimetabolites, Antineoplastic	MeSH
DB00563	1751	methotrexate	PA	D000970	Antineoplastic Agents	MeSH
DB00563	1751	methotrexate	PA	D018501	Antirheumatic Agents	MeSH
DB00563	1751	methotrexate	PA	D003879	Dermatologic Agents	MeSH
DB00563	1751	methotrexate	PA	D004791	Enzyme Inhibitors	MeSH
DB00563	1751	methotrexate	PA	D005493	Folic Acid Antagonists	MeSH
DB00563	1751	methotrexate	PA	D007155	Immunologic Factors	MeSH
DB00563	1751	methotrexate	PA	D007166	Immunosuppressive Agents	MeSH
DB00563	1751	methotrexate	PA	D009676	Noxae	MeSH
DB00563	1751	methotrexate	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB00563	1751	methotrexate	PA	D012102	Reproductive Control Agents	MeSH
DB00564	489	carbamazepine	EPC	N0000175753	Anti-epileptic Agent	FDA
DB00564	489	carbamazepine	PE	N0000008486	Decreased Central Nervous System Disorganized Electrical Activity	FDA
DB00564	489	carbamazepine	EPC	N0000175751	Mood Stabilizer	FDA
DB00564	489	carbamazepine	MoA	N0000185506	Cytochrome P450 3A4 Inducers	FDA
DB00564	489	carbamazepine	MoA	N0000191266	Cytochrome P450 1A2 Inducers	FDA
DB00564	489	carbamazepine	MoA	N0000187064	Cytochrome P450 2B6 Inducers	FDA
DB00564	489	carbamazepine	MoA	N0000185507	Cytochrome P450 2C9 Inducers	FDA
DB00564	489	carbamazepine	MoA	N0000185607	Cytochrome P450 2C19 Inducers	FDA
DB00564	489	carbamazepine	PA	D000700	Analgesics	MeSH
DB00564	489	carbamazepine	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00564	489	carbamazepine	has role	CHEBI:88188	drug allergen	CHEBI
DB00564	489	carbamazepine	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB00564	489	carbamazepine	has role	CHEBI:35480	analgesic	CHEBI
DB00564	489	carbamazepine	has role	CHEBI:35477	antimanic drug	CHEBI
DB00564	489	carbamazepine	has role	CHEBI:35623	anticonvulsant	CHEBI
DB00564	489	carbamazepine	has role	CHEBI:64370	glutamate transporter activator	CHEBI
DB00564	489	carbamazepine	PA	D000927	Anticonvulsants	MeSH
DB00564	489	carbamazepine	PA	D018692	Antimanic Agents	MeSH
DB00564	489	carbamazepine	PA	D002491	Central Nervous System Agents	MeSH
DB00564	489	carbamazepine	PA	D002492	Central Nervous System Depressants	MeSH
DB00564	489	carbamazepine	PA	D065701	Cytochrome P-450 CYP3A Inducers	MeSH
DB00564	489	carbamazepine	PA	D011619	Psychotropic Drugs	MeSH
DB00564	489	carbamazepine	PA	D018689	Sensory System Agents	MeSH
DB00564	489	carbamazepine	PA	D014149	Tranquilizing Agents	MeSH
DB00565	661	cisatracurium	PE	N0000175732	Neuromuscular Nondepolarizing Blockade	FDA
DB00565	661	cisatracurium	EPC	N0000175720	Nondepolarizing Neuromuscular Blocker	FDA
DB00565	661	cisatracurium	has role	CHEBI:51371	muscle relaxant	CHEBI
DB00565	661	cisatracurium	has role	CHEBI:48878	nicotinic antagonist	CHEBI
DB00565	661	cisatracurium	PA	D009465	Neuromuscular Agents	MeSH
DB00565	661	cisatracurium	PA	D009466	Neuromuscular Blocking Agents	MeSH
DB00732	661	cisatracurium	PE	N0000175732	Neuromuscular Nondepolarizing Blockade	FDA
DB00732	661	cisatracurium	EPC	N0000175720	Nondepolarizing Neuromuscular Blocker	FDA
DB00732	661	cisatracurium	has role	CHEBI:51371	muscle relaxant	CHEBI
DB00732	661	cisatracurium	has role	CHEBI:48878	nicotinic antagonist	CHEBI
DB00732	661	cisatracurium	PA	D009465	Neuromuscular Agents	MeSH
DB00732	661	cisatracurium	PA	D009466	Neuromuscular Blocking Agents	MeSH
DB00565	259	atracurium	PA	D018678	Cholinergic Agents	MeSH
DB00565	259	atracurium	PA	D018680	Cholinergic Antagonists	MeSH
DB00565	259	atracurium	PA	D003473	Neuromuscular Nondepolarizing Agents	MeSH
DB00565	259	atracurium	PA	D018377	Neurotransmitter Agents	MeSH
DB00565	259	atracurium	PA	D018733	Nicotinic Antagonists	MeSH
DB00732	259	atracurium	PA	D018678	Cholinergic Agents	MeSH
DB00732	259	atracurium	PA	D018680	Cholinergic Antagonists	MeSH
DB00732	259	atracurium	PA	D003473	Neuromuscular Nondepolarizing Agents	MeSH
DB00732	259	atracurium	PA	D018377	Neurotransmitter Agents	MeSH
DB00732	259	atracurium	PA	D018733	Nicotinic Antagonists	MeSH
DB00567	571	cefalexin	EPC	N0000175488	Cephalosporin Antibacterial	FDA
DB00567	571	cefalexin	Chemical/Ingredient	N0000011161	Cephalosporins	FDA
DB00567	571	cefalexin	PA	D000900	Anti-Bacterial Agents	MeSH
DB00567	571	cefalexin	PA	D000890	Anti-Infective Agents	MeSH
DB00567	571	cefalexin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00569	1236	fondaparinux	EPC	N0000175637	Factor Xa Inhibitor	FDA
DB00569	1236	fondaparinux	MoA	N0000175635	Factor Xa Inhibitors	FDA
DB00569	1236	fondaparinux	PA	D000925	Anticoagulants	MeSH
DB00569	1236	fondaparinux	PA	D006401	Hematologic Agents	MeSH
DB00571	2303	propranolol	EPC	N0000175556	beta-Adrenergic Blocker	FDA
DB00571	2303	propranolol	PA	D018663	Adrenergic Agents	MeSH
DB00571	2303	propranolol	PA	D018674	Adrenergic Antagonists	MeSH
DB00571	2303	propranolol	PA	D000319	Adrenergic beta-Antagonists	MeSH
DB00571	2303	propranolol	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB00571	2303	propranolol	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00571	2303	propranolol	has role	CHEBI:35530	beta-adrenergic antagonist	CHEBI
DB00571	2303	propranolol	has role	CHEBI:35474	anxiolytic drug	CHEBI
DB00571	2303	propranolol	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB00571	2303	propranolol	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00571	2303	propranolol	PA	D000959	Antihypertensive Agents	MeSH
DB00571	2303	propranolol	PA	D002317	Cardiovascular Agents	MeSH
DB00571	2303	propranolol	PA	D018377	Neurotransmitter Agents	MeSH
DB00571	2303	propranolol	PA	D014665	Vasodilator Agents	MeSH
DB03322	2303	propranolol	EPC	N0000175556	beta-Adrenergic Blocker	FDA
DB03322	2303	propranolol	PA	D018663	Adrenergic Agents	MeSH
DB03322	2303	propranolol	PA	D018674	Adrenergic Antagonists	MeSH
DB03322	2303	propranolol	PA	D000319	Adrenergic beta-Antagonists	MeSH
DB03322	2303	propranolol	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB03322	2303	propranolol	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB03322	2303	propranolol	has role	CHEBI:35530	beta-adrenergic antagonist	CHEBI
DB03322	2303	propranolol	has role	CHEBI:35474	anxiolytic drug	CHEBI
DB03322	2303	propranolol	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB03322	2303	propranolol	has role	CHEBI:35620	vasodilator agent	CHEBI
DB03322	2303	propranolol	PA	D000959	Antihypertensive Agents	MeSH
DB03322	2303	propranolol	PA	D002317	Cardiovascular Agents	MeSH
DB03322	2303	propranolol	PA	D018377	Neurotransmitter Agents	MeSH
DB03322	2303	propranolol	PA	D014665	Vasodilator Agents	MeSH
DB00573	1154	fenoprofen	Chemical/Ingredient	N0000175721	Nonsteroidal Anti-inflammatory Compounds	FDA
DB00573	1154	fenoprofen	EPC	N0000175722	Nonsteroidal Anti-inflammatory Drug	FDA
DB00573	1154	fenoprofen	PA	D000700	Analgesics	MeSH
DB00573	1154	fenoprofen	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00573	1154	fenoprofen	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00573	1154	fenoprofen	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00573	1154	fenoprofen	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00573	1154	fenoprofen	has role	CHEBI:35493	antipyretic	CHEBI
DB00573	1154	fenoprofen	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB00573	1154	fenoprofen	PA	D018501	Antirheumatic Agents	MeSH
DB00573	1154	fenoprofen	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB00573	1154	fenoprofen	PA	D004791	Enzyme Inhibitors	MeSH
DB00573	1154	fenoprofen	PA	D018689	Sensory System Agents	MeSH
DB00575	704	clonidine	MoA	N0000009918	Adrenergic alpha2-Agonists	FDA
DB00575	704	clonidine	EPC	N0000175554	Central alpha-2 Adrenergic Agonist	FDA
DB00575	704	clonidine	PA	D018663	Adrenergic Agents	MeSH
DB00575	704	clonidine	PA	D000322	Adrenergic Agonists	MeSH
DB00575	704	clonidine	PA	D058647	Adrenergic alpha-2 Receptor Agonists	MeSH
DB00575	704	clonidine	PA	D000316	Adrenergic alpha-Agonists	MeSH
DB00575	704	clonidine	PA	D000700	Analgesics	MeSH
DB00575	704	clonidine	has role	CHEBI:66991	sympatholytic agent	CHEBI
DB00575	704	clonidine	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00575	704	clonidine	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB00575	704	clonidine	has role	CHEBI:35569	alpha-adrenergic agonist	CHEBI
DB00575	704	clonidine	PA	D000959	Antihypertensive Agents	MeSH
DB00575	704	clonidine	PA	D002317	Cardiovascular Agents	MeSH
DB00575	704	clonidine	PA	D002491	Central Nervous System Agents	MeSH
DB00575	704	clonidine	PA	D018377	Neurotransmitter Agents	MeSH
DB00575	704	clonidine	PA	D018689	Sensory System Agents	MeSH
DB00575	704	clonidine	PA	D013565	Sympatholytics	MeSH
DB00576	2512	sulfamethizole	PA	D000890	Anti-Infective Agents	MeSH
DB00576	2512	sulfamethizole	has role	CHEBI:35441	antiinfective agent	CHEBI
DB00577	2798	valaciclovir	MoA	N0000020060	DNA Polymerase Inhibitors	FDA
DB00577	2798	valaciclovir	EPC	N0000180187	Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor	FDA
DB00577	2798	valaciclovir	EPC	N0000180188	Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor	FDA
DB00577	2798	valaciclovir	EPC	N0000175468	Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor	FDA
DB00577	2798	valaciclovir	Chemical/Ingredient	N0000175459	Nucleoside Analog	FDA
DB00577	2798	valaciclovir	PA	D000890	Anti-Infective Agents	MeSH
DB00577	2798	valaciclovir	PA	D000998	Antiviral Agents	MeSH
DB00578	492	carbenicillin	EPC	N0000175497	Penicillin-class Antibacterial	FDA
DB00578	492	carbenicillin	Chemical/Ingredient	N0000011281	Penicillins	FDA
DB00578	492	carbenicillin	PA	D000900	Anti-Bacterial Agents	MeSH
DB00578	492	carbenicillin	PA	D000890	Anti-Infective Agents	MeSH
DB00578	492	carbenicillin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00579	1640	mazindol	PA	D018663	Adrenergic Agents	MeSH
DB00579	1640	mazindol	PA	D018759	Adrenergic Uptake Inhibitors	MeSH
DB00579	1640	mazindol	PA	D002491	Central Nervous System Agents	MeSH
DB00579	1640	mazindol	PA	D000697	Central Nervous System Stimulants	MeSH
DB00579	1640	mazindol	PA	D015259	Dopamine Agents	MeSH
DB00579	1640	mazindol	PA	D018765	Dopamine Uptake Inhibitors	MeSH
DB00579	1640	mazindol	PA	D049990	Membrane Transport Modulators	MeSH
DB00579	1640	mazindol	PA	D018377	Neurotransmitter Agents	MeSH
DB00579	1640	mazindol	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB00580	2799	valdecoxib	PA	D000700	Analgesics	MeSH
DB00580	2799	valdecoxib	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00580	2799	valdecoxib	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00580	2799	valdecoxib	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00580	2799	valdecoxib	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB00580	2799	valdecoxib	has role	CHEBI:35842	antirheumatic drug	CHEBI
DB00580	2799	valdecoxib	has role	CHEBI:35493	antipyretic	CHEBI
DB00580	2799	valdecoxib	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00580	2799	valdecoxib	PA	D018501	Antirheumatic Agents	MeSH
DB00580	2799	valdecoxib	PA	D052246	Cyclooxygenase 2 Inhibitors	MeSH
DB00580	2799	valdecoxib	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB00580	2799	valdecoxib	PA	D004791	Enzyme Inhibitors	MeSH
DB00580	2799	valdecoxib	PA	D018689	Sensory System Agents	MeSH
DB00582	2846	voriconazole	EPC	N0000175487	Azole Antifungal	FDA
DB00582	2846	voriconazole	Chemical/Ingredient	N0000008217	Azoles	FDA
DB00582	2846	voriconazole	MoA	N0000182141	Cytochrome P450 3A4 Inhibitors	FDA
DB00582	2846	voriconazole	MoA	N0000182140	Cytochrome P450 2C19 Inhibitors	FDA
DB00582	2846	voriconazole	MoA	N0000185504	Cytochrome P450 2C9 Inhibitors	FDA
DB00582	2846	voriconazole	PA	D058888	14-alpha Demethylase Inhibitors	MeSH
DB00582	2846	voriconazole	PA	D000890	Anti-Infective Agents	MeSH
DB00582	2846	voriconazole	PA	D000935	Antifungal Agents	MeSH
DB00582	2846	voriconazole	PA	D065692	Cytochrome P-450 CYP3A Inhibitors	MeSH
DB00582	2846	voriconazole	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB00582	2846	voriconazole	PA	D004791	Enzyme Inhibitors	MeSH
DB00582	2846	voriconazole	PA	D006727	Hormone Antagonists	MeSH
DB00582	2846	voriconazole	PA	D065088	Steroid Synthesis Inhibitors	MeSH
DB00584	1005	enalapril	EPC	N0000175562	Angiotensin Converting Enzyme Inhibitor	FDA
DB00584	1005	enalapril	PE	N0000178477	Decreased Blood Pressure	FDA
DB00584	1005	enalapril	PA	D000806	Angiotensin-Converting Enzyme Inhibitors	MeSH
DB00584	1005	enalapril	has role	CHEBI:50266	prodrug	CHEBI
DB00584	1005	enalapril	has role	CHEBI:35457	EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor	CHEBI
DB00584	1005	enalapril	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00584	1005	enalapril	PA	D000959	Antihypertensive Agents	MeSH
DB00584	1005	enalapril	PA	D002317	Cardiovascular Agents	MeSH
DB00584	1005	enalapril	PA	D004791	Enzyme Inhibitors	MeSH
DB00584	1005	enalapril	PA	D011480	Protease Inhibitors	MeSH
DB00585	1955	nizatidine	MoA	N0000000151	Histamine H2 Receptor Antagonists	FDA
DB00585	1955	nizatidine	EPC	N0000175784	Histamine-2 Receptor Antagonist	FDA
DB00585	1955	nizatidine	has role	CHEBI:49201	anti-ulcer drug	CHEBI
DB00585	1955	nizatidine	has role	CHEBI:37961	H2-receptor antagonist	CHEBI
DB00585	1955	nizatidine	has role	CHEBI:38323	cholinergic drug	CHEBI
DB00585	1955	nizatidine	PA	D000897	Anti-Ulcer Agents	MeSH
DB00585	1955	nizatidine	PA	D005765	Gastrointestinal Agents	MeSH
DB00585	1955	nizatidine	PA	D018494	Histamine Agents	MeSH
DB00585	1955	nizatidine	PA	D006633	Histamine Antagonists	MeSH
DB00585	1955	nizatidine	PA	D006635	Histamine H2 Antagonists	MeSH
DB00585	1955	nizatidine	PA	D018377	Neurotransmitter Agents	MeSH
DB00586	865	diclofenac	PE	N0000008836	Decreased Prostaglandin Production	FDA
DB00586	865	diclofenac	Chemical/Ingredient	N0000175721	Nonsteroidal Anti-inflammatory Compounds	FDA
DB00586	865	diclofenac	EPC	N0000175722	Nonsteroidal Anti-inflammatory Drug	FDA
DB00586	865	diclofenac	PA	D000700	Analgesics	MeSH
DB00586	865	diclofenac	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00586	865	diclofenac	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00586	865	diclofenac	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00586	865	diclofenac	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB00586	865	diclofenac	has role	CHEBI:35493	antipyretic	CHEBI
DB00586	865	diclofenac	has role	CHEBI:88188	drug allergen	CHEBI
DB00586	865	diclofenac	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00586	865	diclofenac	PA	D018501	Antirheumatic Agents	MeSH
DB00586	865	diclofenac	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB00586	865	diclofenac	PA	D004791	Enzyme Inhibitors	MeSH
DB00586	865	diclofenac	PA	D018689	Sensory System Agents	MeSH
DB00587	648	cinalukast	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB00587	648	cinalukast	has role	CHEBI:49167	anti-asthmatic drug	CHEBI
DB00587	648	cinalukast	has role	CHEBI:49159	leukotriene antagonist	CHEBI
DB00589	1588	lisuride	PA	D018726	Anti-Dyskinesia Agents	MeSH
DB00589	1588	lisuride	has role	CHEBI:48407	antiparkinson drug	CHEBI
DB00589	1588	lisuride	has role	CHEBI:35941	serotonergic agonist	CHEBI
DB00589	1588	lisuride	has role	CHEBI:51065	dopamine agonist	CHEBI
DB00589	1588	lisuride	has role	CHEBI:66956	antidyskinesia agent	CHEBI
DB00589	1588	lisuride	PA	D000978	Antiparkinson Agents	MeSH
DB00589	1588	lisuride	PA	D002491	Central Nervous System Agents	MeSH
DB00589	1588	lisuride	PA	D015259	Dopamine Agents	MeSH
DB00589	1588	lisuride	PA	D018491	Dopamine Agonists	MeSH
DB00589	1588	lisuride	PA	D018377	Neurotransmitter Agents	MeSH
DB00589	1588	lisuride	PA	D018490	Serotonin Agents	MeSH
DB00589	1588	lisuride	PA	D017366	Serotonin Receptor Agonists	MeSH
DB00590	954	doxazosin	EPC	N0000175553	alpha-Adrenergic Blocker	FDA
DB00590	954	doxazosin	PA	D018663	Adrenergic Agents	MeSH
DB00590	954	doxazosin	PA	D058668	Adrenergic alpha-1 Receptor Antagonists	MeSH
DB00590	954	doxazosin	PA	D000317	Adrenergic alpha-Antagonists	MeSH
DB00590	954	doxazosin	PA	D018674	Adrenergic Antagonists	MeSH
DB00590	954	doxazosin	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00590	954	doxazosin	has role	CHEBI:37890	alpha-adrenergic antagonist	CHEBI
DB00590	954	doxazosin	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00590	954	doxazosin	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00590	954	doxazosin	has role	CHEBI:59844	antihyperplasia drug	CHEBI
DB00590	954	doxazosin	PA	D000959	Antihypertensive Agents	MeSH
DB00590	954	doxazosin	PA	D002317	Cardiovascular Agents	MeSH
DB00590	954	doxazosin	PA	D018377	Neurotransmitter Agents	MeSH
DB00591	1204	fluocinolone acetonide	EPC	N0000175576	Corticosteroid	FDA
DB00591	1204	fluocinolone acetonide	MoA	N0000175450	Corticosteroid Hormone Receptor Agonists	FDA
DB00591	1204	fluocinolone acetonide	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00591	1204	fluocinolone acetonide	has role	CHEBI:59683	antipruritic drug	CHEBI
DB00591	1204	fluocinolone acetonide	has role	CHEBI:35472	anti-inflammatory drug	CHEBI
DB00591	1204	fluocinolone acetonide	PA	D005938	Glucocorticoids	MeSH
DB00591	1204	fluocinolone acetonide	PA	D006728	Hormones	MeSH
DB00591	1205	fluocinonide	PA	D018926	Anti-Allergic Agents	MeSH
DB00593	1087	ethosuximide	EPC	N0000175753	Anti-epileptic Agent	FDA
DB00593	1087	ethosuximide	PE	N0000008486	Decreased Central Nervous System Disorganized Electrical Activity	FDA
DB00593	1087	ethosuximide	has role	CHEBI:35623	anticonvulsant	CHEBI
DB00593	1087	ethosuximide	PA	D000927	Anticonvulsants	MeSH
DB00593	1087	ethosuximide	PA	D002491	Central Nervous System Agents	MeSH
DB00594	158	amiloride	PE	N0000008859	Decreased Renal K+ Excretion	FDA
DB00594	158	amiloride	PE	N0000175359	Increased Diuresis	FDA
DB00594	158	amiloride	EPC	N0000175418	Potassium-sparing Diuretic	FDA
DB00594	158	amiloride	PA	D062646	Acid Sensing Ion Channel Blockers	MeSH
DB00594	158	amiloride	has role	CHEBI:35498	diuretic	CHEBI
DB00594	158	amiloride	PA	D004232	Diuretics	MeSH
DB00594	158	amiloride	PA	D062686	Epithelial Sodium Channel Blockers	MeSH
DB00594	158	amiloride	PA	D049990	Membrane Transport Modulators	MeSH
DB00594	158	amiloride	PA	D045283	Natriuretic Agents	MeSH
DB00594	158	amiloride	PA	D026941	Sodium Channel Blockers	MeSH
DB00598	1531	labetalol	EPC	N0000175556	beta-Adrenergic Blocker	FDA
DB00598	1531	labetalol	PA	D018663	Adrenergic Agents	MeSH
DB00598	1531	labetalol	PA	D058668	Adrenergic alpha-1 Receptor Antagonists	MeSH
DB00598	1531	labetalol	PA	D000317	Adrenergic alpha-Antagonists	MeSH
DB00598	1531	labetalol	PA	D018674	Adrenergic Antagonists	MeSH
DB00598	1531	labetalol	PA	D000319	Adrenergic beta-Antagonists	MeSH
DB00598	1531	labetalol	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00598	1531	labetalol	has role	CHEBI:66991	sympatholytic agent	CHEBI
DB00598	1531	labetalol	has role	CHEBI:37890	alpha-adrenergic antagonist	CHEBI
DB00598	1531	labetalol	has role	CHEBI:35530	beta-adrenergic antagonist	CHEBI
DB00598	1531	labetalol	PA	D000959	Antihypertensive Agents	MeSH
DB00598	1531	labetalol	PA	D002317	Cardiovascular Agents	MeSH
DB00598	1531	labetalol	PA	D018377	Neurotransmitter Agents	MeSH
DB00598	1531	labetalol	PA	D013566	Sympathomimetics	MeSH
DB00599	2633	thiopental	PA	D000777	Anesthetics	MeSH
DB00599	2633	thiopental	PA	D018686	Anesthetics, Intravenous	MeSH
DB00599	2633	thiopental	has role	CHEBI:88188	drug allergen	CHEBI
DB00599	2633	thiopental	has role	CHEBI:35623	anticonvulsant	CHEBI
DB00599	2633	thiopental	has role	CHEBI:35717	sedative	CHEBI
DB00599	2633	thiopental	has role	CHEBI:38877	intravenous anaesthetic	CHEBI
DB00599	2633	thiopental	PA	D000927	Anticonvulsants	MeSH
DB00599	2633	thiopental	PA	D002491	Central Nervous System Agents	MeSH
DB00599	2633	thiopental	PA	D002492	Central Nervous System Depressants	MeSH
DB00599	2633	thiopental	PA	D018682	GABA Agents	MeSH
DB00599	2633	thiopental	PA	D018757	GABA Modulators	MeSH
DB00599	2633	thiopental	PA	D006993	Hypnotics and Sedatives	MeSH
DB00599	2633	thiopental	PA	D018377	Neurotransmitter Agents	MeSH
DB00600	1834	monobenzone	PE	N0000175851	Depigmenting Activity	FDA
DB00600	1834	monobenzone	EPC	N0000175853	Depigmenting Agent	FDA
DB00600	1834	monobenzone	MoA	N0000175850	Melanin Synthesis Inhibitors	FDA
DB00600	1834	monobenzone	has role	CHEBI:50177	dermatologic drug	CHEBI
DB00600	1834	monobenzone	has role	CHEBI:64933	melanin synthesis inhibitor	CHEBI
DB00602	3972	ivermectin	EPC	N0000175484	Antiparasitic	FDA
DB00602	3972	ivermectin	EPC	N0000181811	Pediculicide	FDA
DB00602	3972	ivermectin	PA	D000890	Anti-Infective Agents	MeSH
DB00602	3972	ivermectin	has role	CHEBI:73333	scabicide	CHEBI
DB00602	3972	ivermectin	has role	CHEBI:35443	anthelminthic drug	CHEBI
DB00602	3972	ivermectin	has role	CHEBI:35820	antiprotozoal drug	CHEBI
DB00602	3972	ivermectin	has role	CHEBI:35444	antinematodal drug	CHEBI
DB00602	3972	ivermectin	has role	CHEBI:24852	insecticide	CHEBI
DB00602	3972	ivermectin	PA	D000977	Antiparasitic Agents	MeSH
DB00602	3972	ivermectin	PA	D007306	Insecticides	MeSH
DB00602	3972	ivermectin	PA	D010575	Pesticides	MeSH
DB00603	1659	medroxyprogesterone	Chemical/Ingredient	N0000011301	Progesterone Congeners	FDA
DB00603	1659	medroxyprogesterone	EPC	N0000175602	Progestin	FDA
DB00603	1659	medroxyprogesterone	has role	CHEBI:49323	contraceptive drug	CHEBI
DB00603	1659	medroxyprogesterone	has role	CHEBI:49326	synthetic oral contraceptive	CHEBI
DB00603	1659	medroxyprogesterone	PA	D000970	Antineoplastic Agents	MeSH
DB00603	1659	medroxyprogesterone	PA	D018931	Antineoplastic Agents, Hormonal	MeSH
DB00603	1659	medroxyprogesterone	PA	D003270	Contraceptive Agents	MeSH
DB00603	1659	medroxyprogesterone	PA	D003271	Contraceptive Agents, Female	MeSH
DB00603	1659	medroxyprogesterone	PA	D003272	Contraceptive Agents, Male	MeSH
DB00603	1659	medroxyprogesterone	PA	D003276	Contraceptives, Oral	MeSH
DB00603	1659	medroxyprogesterone	PA	D003280	Contraceptives, Oral, Synthetic	MeSH
DB00603	1659	medroxyprogesterone	PA	D012102	Reproductive Control Agents	MeSH
DB00604	660	cisapride	has role	CHEBI:35941	serotonergic agonist	CHEBI
DB00604	660	cisapride	has role	CHEBI:49201	anti-ulcer drug	CHEBI
DB00604	660	cisapride	has role	CHEBI:55324	gastrointestinal drug	CHEBI
DB00604	660	cisapride	PA	D000897	Anti-Ulcer Agents	MeSH
DB00604	660	cisapride	PA	D005765	Gastrointestinal Agents	MeSH
DB00604	660	cisapride	PA	D018377	Neurotransmitter Agents	MeSH
DB00604	660	cisapride	PA	D018490	Serotonin Agents	MeSH
DB00604	660	cisapride	PA	D017366	Serotonin Receptor Agonists	MeSH
DB00605	2534	sulindac	Chemical/Ingredient	N0000175721	Nonsteroidal Anti-inflammatory Compounds	FDA
DB00605	2534	sulindac	EPC	N0000175722	Nonsteroidal Anti-inflammatory Drug	FDA
DB00605	2534	sulindac	PA	D000700	Analgesics	MeSH
DB00605	2534	sulindac	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00605	2534	sulindac	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00605	2534	sulindac	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00605	2534	sulindac	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB00605	2534	sulindac	has role	CHEBI:35480	analgesic	CHEBI
DB00605	2534	sulindac	has role	CHEBI:35493	antipyretic	CHEBI
DB00605	2534	sulindac	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00605	2534	sulindac	has role	CHEBI:50266	prodrug	CHEBI
DB00605	2534	sulindac	has role	CHEBI:66993	tocolytic agent	CHEBI
DB00605	2534	sulindac	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00605	2534	sulindac	PA	D000970	Antineoplastic Agents	MeSH
DB00605	2534	sulindac	PA	D018501	Antirheumatic Agents	MeSH
DB00605	2534	sulindac	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB00605	2534	sulindac	PA	D004791	Enzyme Inhibitors	MeSH
DB00605	2534	sulindac	PA	D018689	Sensory System Agents	MeSH
DB00606	761	cyclothiazide	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00606	761	cyclothiazide	has role	CHEBI:35498	diuretic	CHEBI
DB00606	761	cyclothiazide	PA	D000959	Antihypertensive Agents	MeSH
DB00606	761	cyclothiazide	PA	D002317	Cardiovascular Agents	MeSH
DB00606	761	cyclothiazide	PA	D004232	Diuretics	MeSH
DB00606	761	cyclothiazide	PA	D045283	Natriuretic Agents	MeSH
DB00607	1869	nafcillin	EPC	N0000175497	Penicillin-class Antibacterial	FDA
DB00607	1869	nafcillin	Chemical/Ingredient	N0000011281	Penicillins	FDA
DB00607	1869	nafcillin	PA	D000900	Anti-Bacterial Agents	MeSH
DB00607	1869	nafcillin	PA	D000890	Anti-Infective Agents	MeSH
DB00607	1869	nafcillin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00609	1083	ethionamide	EPC	N0000175483	Antimycobacterial	FDA
DB00609	1083	ethionamide	PA	D000900	Anti-Bacterial Agents	MeSH
DB00609	1083	ethionamide	PA	D000890	Anti-Infective Agents	MeSH
DB00609	1083	ethionamide	has role	CHEBI:33231	antitubercular agent	CHEBI
DB00609	1083	ethionamide	has role	CHEBI:35679	antilipemic drug	CHEBI
DB00609	1083	ethionamide	has role	CHEBI:35816	leprostatic drug	CHEBI
DB00609	1083	ethionamide	has role	CHEBI:50266	prodrug	CHEBI
DB00609	1083	ethionamide	PA	D000963	Antimetabolites	MeSH
DB00609	1083	ethionamide	PA	D000995	Antitubercular Agents	MeSH
DB00609	1083	ethionamide	PA	D054872	Fatty Acid Synthesis Inhibitors	MeSH
DB00609	1083	ethionamide	PA	D000960	Hypolipidemic Agents	MeSH
DB00610	1721	metaraminol	PA	D018663	Adrenergic Agents	MeSH
DB00610	1721	metaraminol	PA	D000322	Adrenergic Agonists	MeSH
DB00610	1721	metaraminol	PA	D058646	Adrenergic alpha-1 Receptor Agonists	MeSH
DB00610	1721	metaraminol	PA	D000316	Adrenergic alpha-Agonists	MeSH
DB00610	1721	metaraminol	has role	CHEBI:35569	alpha-adrenergic agonist	CHEBI
DB00610	1721	metaraminol	has role	CHEBI:50514	vasoconstrictor agent	CHEBI
DB00610	1721	metaraminol	has role	CHEBI:35524	sympathomimetic agent	CHEBI
DB00610	1721	metaraminol	PA	D002317	Cardiovascular Agents	MeSH
DB00610	1721	metaraminol	PA	D018377	Neurotransmitter Agents	MeSH
DB00610	1721	metaraminol	PA	D013566	Sympathomimetics	MeSH
DB00610	1721	metaraminol	PA	D014662	Vasoconstrictor Agents	MeSH
DB00611	454	butorphanol	MoA	N0000175686	Competitive Opioid Antagonists	FDA
DB00611	454	butorphanol	EPC	N0000175692	Opioid Agonist/Antagonist	FDA
DB00611	454	butorphanol	MoA	N0000175685	Partial Opioid Agonists	FDA
DB00611	454	butorphanol	PA	D000700	Analgesics	MeSH
DB00611	454	butorphanol	PA	D000701	Analgesics, Opioid	MeSH
DB00611	454	butorphanol	has role	CHEBI:51177	antitussive	CHEBI
DB00611	454	butorphanol	has role	CHEBI:35482	opioid analgesic	CHEBI
DB00611	454	butorphanol	has role	CHEBI:55322	mu-opioid receptor agonist	CHEBI
DB00611	454	butorphanol	has role	CHEBI:59282	kappa-opioid receptor agonist	CHEBI
DB00611	454	butorphanol	PA	D000996	Antitussive Agents	MeSH
DB00611	454	butorphanol	PA	D002491	Central Nervous System Agents	MeSH
DB00611	454	butorphanol	PA	D002492	Central Nervous System Depressants	MeSH
DB00611	454	butorphanol	PA	D009292	Narcotic Antagonists	MeSH
DB00611	454	butorphanol	PA	D009294	Narcotics	MeSH
DB00611	454	butorphanol	PA	D019141	Respiratory System Agents	MeSH
DB00611	454	butorphanol	PA	D018689	Sensory System Agents	MeSH
DB00612	380	bisoprolol	EPC	N0000175556	beta-Adrenergic Blocker	FDA
DB00612	380	bisoprolol	PA	D018663	Adrenergic Agents	MeSH
DB00612	380	bisoprolol	PA	D018674	Adrenergic Antagonists	MeSH
DB00612	380	bisoprolol	PA	D058671	Adrenergic beta-1 Receptor Antagonists	MeSH
DB00612	380	bisoprolol	PA	D000319	Adrenergic beta-Antagonists	MeSH
DB00612	380	bisoprolol	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00612	380	bisoprolol	has role	CHEBI:35530	beta-adrenergic antagonist	CHEBI
DB00612	380	bisoprolol	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB00612	380	bisoprolol	has role	CHEBI:66991	sympatholytic agent	CHEBI
DB00612	380	bisoprolol	PA	D000959	Antihypertensive Agents	MeSH
DB00612	380	bisoprolol	PA	D002317	Cardiovascular Agents	MeSH
DB00612	380	bisoprolol	PA	D018377	Neurotransmitter Agents	MeSH
DB00612	380	bisoprolol	PA	D013565	Sympatholytics	MeSH
DB00615	2376	rifabutin	EPC	N0000175501	Rifamycin Antimycobacterial	FDA
DB00615	2376	rifabutin	Chemical/Ingredient	N0000007911	Rifamycins	FDA
DB00615	2376	rifabutin	PA	D000900	Anti-Bacterial Agents	MeSH
DB00615	2376	rifabutin	PA	D000890	Anti-Infective Agents	MeSH
DB00615	2376	rifabutin	has role	CHEBI:33231	antitubercular agent	CHEBI
DB00615	2376	rifabutin	PA	D000904	Antibiotics, Antitubercular	MeSH
DB00615	2376	rifabutin	PA	D000995	Antitubercular Agents	MeSH
DB00619	1423	imatinib	EPC	N0000175605	Kinase Inhibitor	FDA
DB00619	1423	imatinib	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00619	1423	imatinib	PA	D000970	Antineoplastic Agents	MeSH
DB00619	1423	imatinib	PA	D004791	Enzyme Inhibitors	MeSH
DB00619	1423	imatinib	PA	D047428	Protein Kinase Inhibitors	MeSH
DB00620	2725	triamcinolone	EPC	N0000175576	Corticosteroid	FDA
DB00620	2725	triamcinolone	MoA	N0000175450	Corticosteroid Hormone Receptor Agonists	FDA
DB00620	2725	triamcinolone	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00620	2725	triamcinolone	has role	CHEBI:50857	anti-allergic agent	CHEBI
DB00620	2725	triamcinolone	has role	CHEBI:35472	anti-inflammatory drug	CHEBI
DB00620	2725	triamcinolone	PA	D005938	Glucocorticoids	MeSH
DB00620	2725	triamcinolone	PA	D006728	Hormones	MeSH
DB00621	2011	oxandrolone	PA	D045930	Anabolic Agents	MeSH
DB00621	2011	oxandrolone	PA	D000728	Androgens	MeSH
DB00621	2011	oxandrolone	PA	D006728	Hormones	MeSH
DB00622	1909	nicardipine	MoA	N0000000069	Calcium Channel Antagonists	FDA
DB00622	1909	nicardipine	EPC	N0000175421	Dihydropyridine Calcium Channel Blocker	FDA
DB00622	1909	nicardipine	Chemical/Ingredient	N0000007556	Dihydropyridines	FDA
DB00622	1909	nicardipine	PA	D000959	Antihypertensive Agents	MeSH
DB00622	1909	nicardipine	PA	D002121	Calcium Channel Blockers	MeSH
DB00622	1909	nicardipine	PA	D002317	Cardiovascular Agents	MeSH
DB00622	1909	nicardipine	PA	D049990	Membrane Transport Modulators	MeSH
DB00622	1909	nicardipine	PA	D014665	Vasodilator Agents	MeSH
DB00623	1212	fluphenazine	EPC	N0000175746	Phenothiazine	FDA
DB00623	1212	fluphenazine	Chemical/Ingredient	N0000007544	Phenothiazines	FDA
DB00623	1212	fluphenazine	has role	CHEBI:37930	phenothiazine antipsychotic drug	CHEBI
DB00623	1212	fluphenazine	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB00623	1212	fluphenazine	PA	D014150	Antipsychotic Agents	MeSH
DB00623	1212	fluphenazine	PA	D002491	Central Nervous System Agents	MeSH
DB00623	1212	fluphenazine	PA	D002492	Central Nervous System Depressants	MeSH
DB00623	1212	fluphenazine	PA	D015259	Dopamine Agents	MeSH
DB00623	1212	fluphenazine	PA	D018492	Dopamine Antagonists	MeSH
DB00623	1212	fluphenazine	PA	D018377	Neurotransmitter Agents	MeSH
DB00623	1212	fluphenazine	PA	D011619	Psychotropic Drugs	MeSH
DB00623	1212	fluphenazine	PA	D014149	Tranquilizing Agents	MeSH
DB00624	2607	testosterone	EPC	N0000175824	Androgen	FDA
DB00624	2607	testosterone	MoA	N0000000146	Androgen Receptor Agonists	FDA
DB00624	2607	testosterone	Chemical/Ingredient	N0000008241	Androstanes	FDA
DB00624	2607	testosterone	PA	D000728	Androgens	MeSH
DB00624	2607	testosterone	PA	D006728	Hormones	MeSH
DB07768	2607	testosterone	EPC	N0000175824	Androgen	FDA
DB07768	2607	testosterone	MoA	N0000000146	Androgen Receptor Agonists	FDA
DB07768	2607	testosterone	Chemical/Ingredient	N0000008241	Androstanes	FDA
DB07768	2607	testosterone	PA	D000728	Androgens	MeSH
DB07768	2607	testosterone	PA	D006728	Hormones	MeSH
DB00625	989	efavirenz	EPC	N0000175463	Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor	FDA
DB00625	989	efavirenz	Chemical/Ingredient	N0000175460	Non-Nucleoside Analog	FDA
DB00625	989	efavirenz	MoA	N0000009948	Non-Nucleoside Reverse Transcriptase Inhibitors	FDA
DB00625	989	efavirenz	MoA	N0000190118	Cytochrome P450 3A Inducers	FDA
DB00625	989	efavirenz	MoA	N0000187064	Cytochrome P450 2B6 Inducers	FDA
DB00625	989	efavirenz	MoA	N0000185504	Cytochrome P450 2C9 Inhibitors	FDA
DB00625	989	efavirenz	MoA	N0000182140	Cytochrome P450 2C19 Inhibitors	FDA
DB00625	989	efavirenz	MoA	N0000182141	Cytochrome P450 3A4 Inhibitors	FDA
DB00625	989	efavirenz	PA	D000890	Anti-Infective Agents	MeSH
DB00625	989	efavirenz	has role	CHEBI:36044	antiviral drug	CHEBI
DB00625	989	efavirenz	PA	D000998	Antiviral Agents	MeSH
DB00625	989	efavirenz	PA	D065695	Cytochrome P-450 CYP2B6 Inducers	MeSH
DB00625	989	efavirenz	PA	D065689	Cytochrome P-450 CYP2C19 Inhibitors	MeSH
DB00625	989	efavirenz	PA	D065688	Cytochrome P-450 CYP2C9 Inhibitors	MeSH
DB00625	989	efavirenz	PA	D065701	Cytochrome P-450 CYP3A Inducers	MeSH
DB00625	989	efavirenz	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB00625	989	efavirenz	PA	D004791	Enzyme Inhibitors	MeSH
DB00625	989	efavirenz	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB00625	989	efavirenz	PA	D018894	Reverse Transcriptase Inhibitors	MeSH
DB00627	2835	nicotinic acid	EPC	N0000175594	Nicotinic Acid	FDA
DB00627	2835	nicotinic acid	Chemical/Ingredient	N0000007641	Nicotinic Acids	FDA
DB00627	2835	nicotinic acid	has role	CHEBI:75769	B vitamin	CHEBI
DB00627	2835	nicotinic acid	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00627	2835	nicotinic acid	has role	CHEBI:50247	antidote	CHEBI
DB00627	2835	nicotinic acid	has role	CHEBI:35679	antilipemic drug	CHEBI
DB00627	2835	nicotinic acid	PA	D000963	Antimetabolites	MeSH
DB00627	2835	nicotinic acid	PA	D002317	Cardiovascular Agents	MeSH
DB00627	2835	nicotinic acid	PA	D006133	Growth Substances	MeSH
DB00627	2835	nicotinic acid	PA	D000960	Hypolipidemic Agents	MeSH
DB00627	2835	nicotinic acid	PA	D018977	Micronutrients	MeSH
DB00627	2835	nicotinic acid	PA	D014665	Vasodilator Agents	MeSH
DB00627	2835	nicotinic acid	PA	D014803	Vitamin B Complex	MeSH
DB00627	2835	nicotinic acid	PA	D014815	Vitamins	MeSH
DB00628	711	clorazepate	EPC	N0000175694	Benzodiazepine	FDA
DB00628	711	clorazepate	Chemical/Ingredient	N0000007542	Benzodiazepines	FDA
DB00628	711	clorazepate	PA	D014151	Anti-Anxiety Agents	MeSH
DB00628	711	clorazepate	has role	CHEBI:50266	prodrug	CHEBI
DB00628	711	clorazepate	has role	CHEBI:35623	anticonvulsant	CHEBI
DB00628	711	clorazepate	has role	CHEBI:35474	anxiolytic drug	CHEBI
DB00628	711	clorazepate	has role	CHEBI:50268	GABA modulator	CHEBI
DB00628	711	clorazepate	PA	D000927	Anticonvulsants	MeSH
DB00628	711	clorazepate	PA	D002491	Central Nervous System Agents	MeSH
DB00628	711	clorazepate	PA	D002492	Central Nervous System Depressants	MeSH
DB00628	711	clorazepate	PA	D018682	GABA Agents	MeSH
DB00628	711	clorazepate	PA	D018757	GABA Modulators	MeSH
DB00628	711	clorazepate	PA	D018377	Neurotransmitter Agents	MeSH
DB00628	711	clorazepate	PA	D011619	Psychotropic Drugs	MeSH
DB00628	711	clorazepate	PA	D014149	Tranquilizing Agents	MeSH
DB00629	3952	guanabenz	MoA	N0000009918	Adrenergic alpha2-Agonists	FDA
DB00629	3952	guanabenz	EPC	N0000175554	Central alpha-2 Adrenergic Agonist	FDA
DB00629	3952	guanabenz	PA	D018663	Adrenergic Agents	MeSH
DB00629	3952	guanabenz	PA	D000322	Adrenergic Agonists	MeSH
DB00629	3952	guanabenz	PA	D058647	Adrenergic alpha-2 Receptor Agonists	MeSH
DB00629	3952	guanabenz	PA	D000316	Adrenergic alpha-Agonists	MeSH
DB00629	3952	guanabenz	PA	D000959	Antihypertensive Agents	MeSH
DB00629	3952	guanabenz	PA	D002317	Cardiovascular Agents	MeSH
DB00629	3952	guanabenz	PA	D018377	Neurotransmitter Agents	MeSH
DB00630	112	alendronic acid	EPC	N0000175579	Bisphosphonate	FDA
DB00630	112	alendronic acid	Chemical/Ingredient	N0000007707	Diphosphonates	FDA
DB00630	112	alendronic acid	has role	CHEBI:50646	bone density conservation agent	CHEBI
DB00630	112	alendronic acid	PA	D050071	Bone Density Conservation Agents	MeSH
DB00631	691	clofarabine	MoA	N0000000233	Nucleic Acid Synthesis Inhibitors	FDA
DB00631	691	clofarabine	EPC	N0000175595	Nucleoside Metabolic Inhibitor	FDA
DB00631	691	clofarabine	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00631	691	clofarabine	PA	D000963	Antimetabolites	MeSH
DB00631	691	clofarabine	PA	D000964	Antimetabolites, Antineoplastic	MeSH
DB00631	691	clofarabine	PA	D000970	Antineoplastic Agents	MeSH
DB00631	691	clofarabine	PA	D009676	Noxae	MeSH
DB00632	940	docosanol	PA	D000890	Anti-Infective Agents	MeSH
DB00632	940	docosanol	PA	D000998	Antiviral Agents	MeSH
DB00633	835	dexmedetomidine	MoA	N0000009918	Adrenergic alpha2-Agonists	FDA
DB00633	835	dexmedetomidine	EPC	N0000175554	Central alpha-2 Adrenergic Agonist	FDA
DB00633	835	dexmedetomidine	PE	N0000175975	General Anesthesia	FDA
DB00633	835	dexmedetomidine	PA	D018663	Adrenergic Agents	MeSH
DB00633	835	dexmedetomidine	PA	D000322	Adrenergic Agonists	MeSH
DB00633	835	dexmedetomidine	PA	D058647	Adrenergic alpha-2 Receptor Agonists	MeSH
DB00633	835	dexmedetomidine	PA	D000316	Adrenergic alpha-Agonists	MeSH
DB00633	835	dexmedetomidine	PA	D000700	Analgesics	MeSH
DB00633	835	dexmedetomidine	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00633	835	dexmedetomidine	has role	CHEBI:35717	sedative	CHEBI
DB00633	835	dexmedetomidine	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB00633	835	dexmedetomidine	has role	CHEBI:35480	analgesic	CHEBI
DB00633	835	dexmedetomidine	has role	CHEBI:35569	alpha-adrenergic agonist	CHEBI
DB00633	835	dexmedetomidine	PA	D002491	Central Nervous System Agents	MeSH
DB00633	835	dexmedetomidine	PA	D002492	Central Nervous System Depressants	MeSH
DB00633	835	dexmedetomidine	PA	D006993	Hypnotics and Sedatives	MeSH
DB00633	835	dexmedetomidine	PA	D018377	Neurotransmitter Agents	MeSH
DB00633	835	dexmedetomidine	PA	D018689	Sensory System Agents	MeSH
DB00634	2497	sulfacetamide	EPC	N0000175503	Sulfonamide Antibacterial	FDA
DB00634	2497	sulfacetamide	Chemical/Ingredient	N0000008048	Sulfonamides	FDA
DB00634	2497	sulfacetamide	PA	D000890	Anti-Infective Agents	MeSH
DB00634	2497	sulfacetamide	PA	D000891	Anti-Infective Agents, Local	MeSH
DB00634	2497	sulfacetamide	PA	D000892	Anti-Infective Agents, Urinary	MeSH
DB00634	2497	sulfacetamide	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00634	2497	sulfacetamide	has role	CHEBI:35441	antiinfective agent	CHEBI
DB00635	2253	prednisone	EPC	N0000175576	Corticosteroid	FDA
DB00635	2253	prednisone	MoA	N0000175450	Corticosteroid Hormone Receptor Agonists	FDA
DB00635	2253	prednisone	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00635	2253	prednisone	has role	CHEBI:50266	prodrug	CHEBI
DB00635	2253	prednisone	has role	CHEBI:35472	anti-inflammatory drug	CHEBI
DB00635	2253	prednisone	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00635	2253	prednisone	has role	CHEBI:37962	adrenergic agent	CHEBI
DB00635	2253	prednisone	has role	CHEBI:35705	immunosuppressive agent	CHEBI
DB00635	2253	prednisone	PA	D000970	Antineoplastic Agents	MeSH
DB00635	2253	prednisone	PA	D018931	Antineoplastic Agents, Hormonal	MeSH
DB00635	2253	prednisone	PA	D005938	Glucocorticoids	MeSH
DB00635	2253	prednisone	PA	D006728	Hormones	MeSH
DB00636	694	clofibrate	has role	CHEBI:35821	anticholesteremic drug	CHEBI
DB00636	694	clofibrate	has role	CHEBI:35679	antilipemic drug	CHEBI
DB00636	694	clofibrate	PA	D000924	Anticholesteremic Agents	MeSH
DB00636	694	clofibrate	PA	D000963	Antimetabolites	MeSH
DB00636	694	clofibrate	PA	D000960	Hypolipidemic Agents	MeSH
DB00637	249	astemizole	PA	D018926	Anti-Allergic Agents	MeSH
DB00637	249	astemizole	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB00637	249	astemizole	has role	CHEBI:50857	anti-allergic agent	CHEBI
DB00637	249	astemizole	PA	D018494	Histamine Agents	MeSH
DB00637	249	astemizole	PA	D006633	Histamine Antagonists	MeSH
DB00637	249	astemizole	PA	D006634	Histamine H1 Antagonists	MeSH
DB00637	249	astemizole	PA	D039563	Histamine H1 Antagonists, Non-Sedating	MeSH
DB00637	249	astemizole	PA	D018377	Neurotransmitter Agents	MeSH
DB00639	450	butoconazole	EPC	N0000175487	Azole Antifungal	FDA
DB00639	450	butoconazole	Chemical/Ingredient	N0000008217	Azoles	FDA
DB00639	450	butoconazole	PA	D000890	Anti-Infective Agents	MeSH
DB00639	450	butoconazole	PA	D000935	Antifungal Agents	MeSH
DB00641	2445	simvastatin	EPC	N0000175589	HMG-CoA Reductase Inhibitor	FDA
DB00641	2445	simvastatin	has role	CHEBI:50266	prodrug	CHEBI
DB00641	2445	simvastatin	PA	D000924	Anticholesteremic Agents	MeSH
DB00641	2445	simvastatin	PA	D000963	Antimetabolites	MeSH
DB00641	2445	simvastatin	PA	D004791	Enzyme Inhibitors	MeSH
DB00641	2445	simvastatin	PA	D019161	Hydroxymethylglutaryl-CoA Reductase Inhibitors	MeSH
DB00641	2445	simvastatin	PA	D000960	Hypolipidemic Agents	MeSH
DB00642	2073	pemetrexed	EPC	N0000175584	Folate Analog Metabolic Inhibitor	FDA
DB00642	2073	pemetrexed	MoA	N0000000111	Folic Acid Metabolism Inhibitors	FDA
DB00642	2073	pemetrexed	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00642	2073	pemetrexed	PA	D000970	Antineoplastic Agents	MeSH
DB00642	2073	pemetrexed	PA	D004791	Enzyme Inhibitors	MeSH
DB00642	2073	pemetrexed	PA	D005493	Folic Acid Antagonists	MeSH
DB00642	2073	pemetrexed	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB00643	1641	mebendazole	EPC	N0000175481	Antihelminthic	FDA
DB00643	1641	mebendazole	PA	D000871	Anthelmintics	MeSH
DB00643	1641	mebendazole	PA	D000890	Anti-Infective Agents	MeSH
DB00643	1641	mebendazole	has role	CHEBI:35444	antinematodal drug	CHEBI
DB00643	1641	mebendazole	PA	D050256	Antimitotic Agents	MeSH
DB00643	1641	mebendazole	PA	D000969	Antinematodal Agents	MeSH
DB00643	1641	mebendazole	PA	D000977	Antiparasitic Agents	MeSH
DB00643	1641	mebendazole	PA	D050257	Tubulin Modulators	MeSH
DB00644	2958	gonadorelin	has role	CHEBI:63533	gonadotropin releasing hormone agonist	CHEBI
DB00645	974	dyclonine	PA	D000777	Anesthetics	MeSH
DB00645	974	dyclonine	PA	D000779	Anesthetics, Local	MeSH
DB00645	974	dyclonine	has role	CHEBI:48425	topical anaesthetic	CHEBI
DB00645	974	dyclonine	PA	D002491	Central Nervous System Agents	MeSH
DB00645	974	dyclonine	PA	D002492	Central Nervous System Depressants	MeSH
DB00645	974	dyclonine	PA	D018689	Sensory System Agents	MeSH
DB00647	844	dextropropoxyphene	MoA	N0000175684	Full Opioid Agonists	FDA
DB00647	844	dextropropoxyphene	EPC	N0000175690	Opioid Agonist	FDA
DB00647	844	dextropropoxyphene	PA	D000700	Analgesics	MeSH
DB00647	844	dextropropoxyphene	PA	D000701	Analgesics, Opioid	MeSH
DB00647	844	dextropropoxyphene	has role	CHEBI:35482	opioid analgesic	CHEBI
DB00647	844	dextropropoxyphene	has role	CHEBI:55322	mu-opioid receptor agonist	CHEBI
DB00647	844	dextropropoxyphene	PA	D002491	Central Nervous System Agents	MeSH
DB00647	844	dextropropoxyphene	PA	D002492	Central Nervous System Depressants	MeSH
DB00647	844	dextropropoxyphene	PA	D009294	Narcotics	MeSH
DB00647	844	dextropropoxyphene	PA	D018689	Sensory System Agents	MeSH
DB00648	1820	mitotane	MoA	N0000185506	Cytochrome P450 3A4 Inducers	FDA
DB00648	1820	mitotane	PA	D000970	Antineoplastic Agents	MeSH
DB00648	1820	mitotane	PA	D018931	Antineoplastic Agents, Hormonal	MeSH
DB00649	2478	stavudine	EPC	N0000175462	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor	FDA
DB00649	2478	stavudine	Chemical/Ingredient	N0000175459	Nucleoside Analog	FDA
DB00649	2478	stavudine	MoA	N0000009947	Nucleoside Reverse Transcriptase Inhibitors	FDA
DB00649	2478	stavudine	PA	D019380	Anti-HIV Agents	MeSH
DB00649	2478	stavudine	PA	D000890	Anti-Infective Agents	MeSH
DB00649	2478	stavudine	PA	D000963	Antimetabolites	MeSH
DB00649	2478	stavudine	PA	D000998	Antiviral Agents	MeSH
DB00649	2478	stavudine	PA	D004791	Enzyme Inhibitors	MeSH
DB00649	2478	stavudine	PA	D009676	Noxae	MeSH
DB00649	2478	stavudine	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB00649	2478	stavudine	PA	D018894	Reverse Transcriptase Inhibitors	MeSH
DB00651	976	diprophylline	PA	D018927	Anti-Asthmatic Agents	MeSH
DB00651	976	diprophylline	has role	CHEBI:35523	bronchodilator agent	CHEBI
DB00651	976	diprophylline	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00651	976	diprophylline	has role	CHEBI:51371	muscle relaxant	CHEBI
DB00651	976	diprophylline	PA	D001993	Bronchodilator Agents	MeSH
DB00651	976	diprophylline	PA	D002317	Cardiovascular Agents	MeSH
DB00651	976	diprophylline	PA	D004791	Enzyme Inhibitors	MeSH
DB00651	976	diprophylline	PA	D010726	Phosphodiesterase Inhibitors	MeSH
DB00651	976	diprophylline	PA	D019141	Respiratory System Agents	MeSH
DB00651	976	diprophylline	PA	D014665	Vasodilator Agents	MeSH
DB00652	3424	pentazocine	MoA	N0000175686	Competitive Opioid Antagonists	FDA
DB00652	3424	pentazocine	EPC	N0000175688	Partial Opioid Agonist/Antagonist	FDA
DB00652	3424	pentazocine	MoA	N0000175685	Partial Opioid Agonists	FDA
DB00652	3424	pentazocine	PA	D000759	Adjuvants, Anesthesia	MeSH
DB00652	3424	pentazocine	PA	D000700	Analgesics	MeSH
DB00652	3424	pentazocine	PA	D000701	Analgesics, Opioid	MeSH
DB00652	3424	pentazocine	PA	D002491	Central Nervous System Agents	MeSH
DB00652	3424	pentazocine	PA	D002492	Central Nervous System Depressants	MeSH
DB00652	3424	pentazocine	PA	D009292	Narcotic Antagonists	MeSH
DB00652	3424	pentazocine	PA	D009294	Narcotics	MeSH
DB00652	3424	pentazocine	PA	D018689	Sensory System Agents	MeSH
DB00654	1551	latanoprost	EPC	N0000175454	Prostaglandin Analog	FDA
DB00654	1551	latanoprost	Chemical/Ingredient	N0000007706	Prostaglandins	FDA
DB00654	1551	latanoprost	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00654	1551	latanoprost	has role	CHEBI:50266	prodrug	CHEBI
DB00654	1551	latanoprost	has role	CHEBI:39456	antiglaucoma drug	CHEBI
DB00654	1551	latanoprost	PA	D000959	Antihypertensive Agents	MeSH
DB00654	1551	latanoprost	PA	D002317	Cardiovascular Agents	MeSH
DB00655	3188	estrone	has role	CHEBI:50646	bone density conservation agent	CHEBI
DB00655	3188	estrone	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00655	3188	estrone	PA	D004967	Estrogens	MeSH
DB00655	3188	estrone	PA	D006728	Hormones	MeSH
DB00656	2717	trazodone	EPC	N0000175696	Serotonin Reuptake Inhibitor	FDA
DB00656	2717	trazodone	PA	D014151	Anti-Anxiety Agents	MeSH
DB00656	2717	trazodone	has role	CHEBI:35469	antidepressant	CHEBI
DB00656	2717	trazodone	has role	CHEBI:35717	sedative	CHEBI
DB00656	2717	trazodone	has role	CHEBI:37887	adrenergic antagonist	CHEBI
DB00656	2717	trazodone	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB00656	2717	trazodone	has role	CHEBI:50949	serotonin uptake inhibitor	CHEBI
DB00656	2717	trazodone	has role	CHEBI:35474	anxiolytic drug	CHEBI
DB00656	2717	trazodone	PA	D000928	Antidepressive Agents	MeSH
DB00656	2717	trazodone	PA	D018687	Antidepressive Agents, Second-Generation	MeSH
DB00656	2717	trazodone	PA	D002491	Central Nervous System Agents	MeSH
DB00656	2717	trazodone	PA	D002492	Central Nervous System Depressants	MeSH
DB00656	2717	trazodone	PA	D049990	Membrane Transport Modulators	MeSH
DB00656	2717	trazodone	PA	D018377	Neurotransmitter Agents	MeSH
DB00656	2717	trazodone	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB00656	2717	trazodone	PA	D011619	Psychotropic Drugs	MeSH
DB00656	2717	trazodone	PA	D018490	Serotonin Agents	MeSH
DB00656	2717	trazodone	PA	D017367	Serotonin Uptake Inhibitors	MeSH
DB00656	2717	trazodone	PA	D014149	Tranquilizing Agents	MeSH
DB00657	1646	mecamylamine	EPC	N0000175641	Autonomic Ganglionic Blocker	FDA
DB00657	1646	mecamylamine	PE	N0000175644	Decreased Autonomic Ganglionic Activity	FDA
DB00657	1646	mecamylamine	PA	D000959	Antihypertensive Agents	MeSH
DB00657	1646	mecamylamine	PA	D002317	Cardiovascular Agents	MeSH
DB00657	1646	mecamylamine	PA	D018678	Cholinergic Agents	MeSH
DB00657	1646	mecamylamine	PA	D018680	Cholinergic Antagonists	MeSH
DB00657	1646	mecamylamine	PA	D005730	Ganglionic Blockers	MeSH
DB00657	1646	mecamylamine	PA	D018377	Neurotransmitter Agents	MeSH
DB00657	1646	mecamylamine	PA	D018733	Nicotinic Antagonists	MeSH
DB00659	38	acamprosate	PA	D000427	Alcohol Deterrents	MeSH
DB00659	38	acamprosate	has role	CHEBI:35942	neurotransmitter agent	CHEBI
DB00659	38	acamprosate	PA	D002491	Central Nervous System Agents	MeSH
DB00661	2815	verapamil	MoA	N0000000069	Calcium Channel Antagonists	FDA
DB00661	2815	verapamil	EPC	N0000175566	Calcium Channel Blocker	FDA
DB00661	2815	verapamil	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB00661	2815	verapamil	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB00661	2815	verapamil	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00661	2815	verapamil	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00661	2815	verapamil	PA	D002121	Calcium Channel Blockers	MeSH
DB00661	2815	verapamil	PA	D002317	Cardiovascular Agents	MeSH
DB00661	2815	verapamil	PA	D049990	Membrane Transport Modulators	MeSH
DB00661	2815	verapamil	PA	D014665	Vasodilator Agents	MeSH
DB00663	1198	flumetasone pivalate	has role	CHEBI:35472	anti-inflammatory drug	CHEBI
DB00663	1198	flumetasone pivalate	has role	CHEBI:59683	antipruritic drug	CHEBI
DB00663	1198	flumetasone pivalate	PA	D005938	Glucocorticoids	MeSH
DB00663	1198	flumetasone pivalate	PA	D006728	Hormones	MeSH
DB00664	2517	sulfalene	PA	D000890	Anti-Infective Agents	MeSH
DB00664	2517	sulfalene	PA	D000892	Anti-Infective Agents, Urinary	MeSH
DB00664	2517	sulfalene	PA	D000962	Antimalarials	MeSH
DB00664	2517	sulfalene	PA	D000977	Antiparasitic Agents	MeSH
DB00664	2517	sulfalene	PA	D000981	Antiprotozoal Agents	MeSH
DB00665	1933	nilutamide	MoA	N0000000243	Androgen Receptor Antagonists	FDA
DB00665	1933	nilutamide	EPC	N0000175560	Androgen Receptor Inhibitor	FDA
DB00665	1933	nilutamide	PA	D000726	Androgen Antagonists	MeSH
DB00665	1933	nilutamide	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00665	1933	nilutamide	has role	CHEBI:35497	androgen antagonist	CHEBI
DB00665	1933	nilutamide	PA	D000970	Antineoplastic Agents	MeSH
DB00665	1933	nilutamide	PA	D006727	Hormone Antagonists	MeSH
DB00667	1375	histamine	PA	D018494	Histamine Agents	MeSH
DB00667	1375	histamine	PA	D017442	Histamine Agonists	MeSH
DB00667	1375	histamine	PA	D018377	Neurotransmitter Agents	MeSH
DB05381	1375	histamine	PA	D018494	Histamine Agents	MeSH
DB05381	1375	histamine	PA	D017442	Histamine Agonists	MeSH
DB05381	1375	histamine	PA	D018377	Neurotransmitter Agents	MeSH
DB05891	1375	histamine	PA	D018494	Histamine Agents	MeSH
DB05891	1375	histamine	PA	D017442	Histamine Agonists	MeSH
DB05891	1375	histamine	PA	D018377	Neurotransmitter Agents	MeSH
DB00668	1028	epinephrine	EPC	N0000175552	alpha-Adrenergic Agonist	FDA
DB00668	1028	epinephrine	EPC	N0000175555	beta-Adrenergic Agonist	FDA
DB00668	1028	epinephrine	EPC	N0000175570	Catecholamine	FDA
DB00668	1028	epinephrine	Chemical/Ingredient	N0000007715	Catecholamines	FDA
DB00668	1028	epinephrine	PA	D018663	Adrenergic Agents	MeSH
DB00668	1028	epinephrine	PA	D000322	Adrenergic Agonists	MeSH
DB00668	1028	epinephrine	PA	D000316	Adrenergic alpha-Agonists	MeSH
DB00668	1028	epinephrine	PA	D000318	Adrenergic beta-Agonists	MeSH
DB00668	1028	epinephrine	PA	D018927	Anti-Asthmatic Agents	MeSH
DB00668	1028	epinephrine	PA	D001993	Bronchodilator Agents	MeSH
DB00668	1028	epinephrine	PA	D002317	Cardiovascular Agents	MeSH
DB00668	1028	epinephrine	PA	D009184	Mydriatics	MeSH
DB00668	1028	epinephrine	PA	D018377	Neurotransmitter Agents	MeSH
DB00668	1028	epinephrine	PA	D019141	Respiratory System Agents	MeSH
DB00668	1028	epinephrine	PA	D013566	Sympathomimetics	MeSH
DB00668	1028	epinephrine	PA	D014662	Vasoconstrictor Agents	MeSH
DB00669	2543	sumatriptan	MoA	N0000175763	Serotonin 1b Receptor Agonists	FDA
DB00669	2543	sumatriptan	MoA	N0000175764	Serotonin 1d Receptor Agonists	FDA
DB00669	2543	sumatriptan	EPC	N0000175765	Serotonin-1b and Serotonin-1d Receptor Agonist	FDA
DB00669	2543	sumatriptan	has role	CHEBI:50514	vasoconstrictor agent	CHEBI
DB00669	2543	sumatriptan	has role	CHEBI:35941	serotonergic agonist	CHEBI
DB00669	2543	sumatriptan	PA	D002317	Cardiovascular Agents	MeSH
DB00669	2543	sumatriptan	PA	D018377	Neurotransmitter Agents	MeSH
DB00669	2543	sumatriptan	PA	D058825	Serotonin 5-HT1 Receptor Agonists	MeSH
DB00669	2543	sumatriptan	PA	D018490	Serotonin Agents	MeSH
DB00669	2543	sumatriptan	PA	D017366	Serotonin Receptor Agonists	MeSH
DB00669	2543	sumatriptan	PA	D014662	Vasoconstrictor Agents	MeSH
DB00670	2200	pirenzepine	has role	CHEBI:49201	anti-ulcer drug	CHEBI
DB00670	2200	pirenzepine	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00670	2200	pirenzepine	has role	CHEBI:53784	antispasmodic drug	CHEBI
DB00670	2200	pirenzepine	PA	D000897	Anti-Ulcer Agents	MeSH
DB00670	2200	pirenzepine	PA	D018678	Cholinergic Agents	MeSH
DB00670	2200	pirenzepine	PA	D018680	Cholinergic Antagonists	MeSH
DB00670	2200	pirenzepine	PA	D005765	Gastrointestinal Agents	MeSH
DB00670	2200	pirenzepine	PA	D018727	Muscarinic Antagonists	MeSH
DB00670	2200	pirenzepine	PA	D018377	Neurotransmitter Agents	MeSH
DB00671	537	cefixime	PA	D000900	Anti-Bacterial Agents	MeSH
DB00671	537	cefixime	PA	D000890	Anti-Infective Agents	MeSH
DB00671	537	cefixime	has role	CHEBI:88188	drug allergen	CHEBI
DB00671	537	cefixime	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00672	622	chlorpropamide	EPC	N0000175608	Sulfonylurea	FDA
DB00672	622	chlorpropamide	Chemical/Ingredient	N0000008054	Sulfonylurea Compounds	FDA
DB00672	622	chlorpropamide	has role	CHEBI:35526	hypoglycemic agent	CHEBI
DB00672	622	chlorpropamide	PA	D007004	Hypoglycemic Agents	MeSH
DB00673	230	aprepitant	has role	CHEBI:35469	antidepressant	CHEBI
DB00673	230	aprepitant	has role	CHEBI:50919	antiemetic	CHEBI
DB00673	230	aprepitant	has role	CHEBI:49110	peripheral nervous system drug	CHEBI
DB00673	230	aprepitant	PA	D000932	Antiemetics	MeSH
DB00673	230	aprepitant	PA	D002491	Central Nervous System Agents	MeSH
DB00673	230	aprepitant	PA	D005765	Gastrointestinal Agents	MeSH
DB00673	230	aprepitant	PA	D064729	Neurokinin-1 Receptor Antagonists	MeSH
DB00673	230	aprepitant	PA	D018377	Neurotransmitter Agents	MeSH
DB00673	230	aprepitant	MoA	N0000010262	Neurokinin 1 Antagonists	FDA
DB00673	230	aprepitant	EPC	N0000175786	Substance P/Neurokinin-1 Receptor Antagonist	FDA
DB00673	230	aprepitant	MoA	N0000182141	Cytochrome P450 3A4 Inhibitors	FDA
DB00673	230	aprepitant	MoA	N0000185507	Cytochrome P450 2C9 Inducers	FDA
DB00673	230	aprepitant	MoA	N0000185506	Cytochrome P450 3A4 Inducers	FDA
DB00674	1272	galantamine	EPC	N0000175723	Cholinesterase Inhibitor	FDA
DB00674	1272	galantamine	has role	CHEBI:74530	antidote to curare poisoning	CHEBI
DB00674	1272	galantamine	has role	CHEBI:38323	cholinergic drug	CHEBI
DB00674	1272	galantamine	PA	D002491	Central Nervous System Agents	MeSH
DB00674	1272	galantamine	PA	D018678	Cholinergic Agents	MeSH
DB00674	1272	galantamine	PA	D002800	Cholinesterase Inhibitors	MeSH
DB00674	1272	galantamine	PA	D004791	Enzyme Inhibitors	MeSH
DB00674	1272	galantamine	PA	D018377	Neurotransmitter Agents	MeSH
DB00674	1272	galantamine	PA	D018697	Nootropic Agents	MeSH
DB00674	1272	galantamine	PA	D010277	Parasympathomimetics	MeSH
DB00675	2561	tamoxifen	EPC	N0000175826	Estrogen Agonist/Antagonist	FDA
DB00675	2561	tamoxifen	has role	CHEBI:50837	estrogen antagonist	CHEBI
DB00675	2561	tamoxifen	has role	CHEBI:50739	estrogen receptor modulator	CHEBI
DB00675	2561	tamoxifen	has role	CHEBI:50646	bone density conservation agent	CHEBI
DB00675	2561	tamoxifen	has role	CHEBI:50792	estrogen receptor antagonist	CHEBI
DB00675	2561	tamoxifen	has role	CHEBI:48422	angiogenesis inhibitor	CHEBI
DB00675	2561	tamoxifen	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00675	2561	tamoxifen	PA	D000970	Antineoplastic Agents	MeSH
DB00675	2561	tamoxifen	PA	D018931	Antineoplastic Agents, Hormonal	MeSH
DB00675	2561	tamoxifen	PA	D050071	Bone Density Conservation Agents	MeSH
DB00675	2561	tamoxifen	PA	D004965	Estrogen Antagonists	MeSH
DB00675	2561	tamoxifen	PA	D020847	Estrogen Receptor Modulators	MeSH
DB00675	2561	tamoxifen	PA	D006727	Hormone Antagonists	MeSH
DB00675	2561	tamoxifen	PA	D020845	Selective Estrogen Receptor Modulators	MeSH
DB00677	1494	fluostigmine	PA	D018678	Cholinergic Agents	MeSH
DB00677	1494	fluostigmine	PA	D002800	Cholinesterase Inhibitors	MeSH
DB00677	1494	fluostigmine	PA	D004791	Enzyme Inhibitors	MeSH
DB00677	1494	fluostigmine	PA	D018377	Neurotransmitter Agents	MeSH
DB00677	1494	fluostigmine	PA	D011480	Protease Inhibitors	MeSH
DB00679	2637	thioridazine	EPC	N0000175746	Phenothiazine	FDA
DB00679	2637	thioridazine	Chemical/Ingredient	N0000007544	Phenothiazines	FDA
DB00679	2637	thioridazine	has role	CHEBI:65190	first generation antipsychotic	CHEBI
DB00679	2637	thioridazine	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB00679	2637	thioridazine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB00679	2637	thioridazine	has role	CHEBI:37890	alpha-adrenergic antagonist	CHEBI
DB00679	2637	thioridazine	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB00679	2637	thioridazine	PA	D014150	Antipsychotic Agents	MeSH
DB00679	2637	thioridazine	PA	D002491	Central Nervous System Agents	MeSH
DB00679	2637	thioridazine	PA	D002492	Central Nervous System Depressants	MeSH
DB00679	2637	thioridazine	PA	D015259	Dopamine Agents	MeSH
DB00679	2637	thioridazine	PA	D018492	Dopamine Antagonists	MeSH
DB00679	2637	thioridazine	PA	D018377	Neurotransmitter Agents	MeSH
DB00679	2637	thioridazine	PA	D011619	Psychotropic Drugs	MeSH
DB00679	2637	thioridazine	PA	D014149	Tranquilizing Agents	MeSH
DB00680	1842	moracizine	EPC	N0000175426	Antiarrhythmic	FDA
DB00680	1842	moracizine	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB00680	1842	moracizine	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB00680	1842	moracizine	PA	D002317	Cardiovascular Agents	MeSH
DB00680	1842	moracizine	PA	D049990	Membrane Transport Modulators	MeSH
DB00680	1842	moracizine	PA	D026941	Sodium Channel Blockers	MeSH
DB00680	1842	moracizine	PA	D061567	Voltage-Gated Sodium Channel Blockers	MeSH
DB00682	2847	warfarin	EPC	N0000175476	Vitamin K Antagonist	FDA
DB00682	2847	warfarin	MoA	N0000175964	Vitamin K Inhibitors	FDA
DB00682	2847	warfarin	has role	CHEBI:50249	anticoagulant	CHEBI
DB00682	2847	warfarin	has role	CHEBI:33288	rodenticide	CHEBI
DB00682	2847	warfarin	PA	D000925	Anticoagulants	MeSH
DB00682	2847	warfarin	PA	D006401	Hematologic Agents	MeSH
DB00682	2847	warfarin	PA	D010575	Pesticides	MeSH
DB00682	2847	warfarin	PA	D012378	Rodenticides	MeSH
DB02507	2847	warfarin	EPC	N0000175476	Vitamin K Antagonist	FDA
DB02507	2847	warfarin	MoA	N0000175964	Vitamin K Inhibitors	FDA
DB02507	2847	warfarin	has role	CHEBI:50249	anticoagulant	CHEBI
DB02507	2847	warfarin	has role	CHEBI:33288	rodenticide	CHEBI
DB02507	2847	warfarin	PA	D000925	Anticoagulants	MeSH
DB02507	2847	warfarin	PA	D006401	Hematologic Agents	MeSH
DB02507	2847	warfarin	PA	D010575	Pesticides	MeSH
DB02507	2847	warfarin	PA	D012378	Rodenticides	MeSH
DB00683	1802	midazolam	EPC	N0000175694	Benzodiazepine	FDA
DB00683	1802	midazolam	Chemical/Ingredient	N0000007542	Benzodiazepines	FDA
DB00683	1802	midazolam	PA	D000759	Adjuvants, Anesthesia	MeSH
DB00683	1802	midazolam	PA	D000777	Anesthetics	MeSH
DB00683	1802	midazolam	PA	D018686	Anesthetics, Intravenous	MeSH
DB00683	1802	midazolam	PA	D014151	Anti-Anxiety Agents	MeSH
DB00683	1802	midazolam	PA	D002491	Central Nervous System Agents	MeSH
DB00683	1802	midazolam	PA	D002492	Central Nervous System Depressants	MeSH
DB00683	1802	midazolam	PA	D018682	GABA Agents	MeSH
DB00683	1802	midazolam	PA	D018757	GABA Modulators	MeSH
DB00683	1802	midazolam	PA	D006993	Hypnotics and Sedatives	MeSH
DB00683	1802	midazolam	PA	D018377	Neurotransmitter Agents	MeSH
DB00683	1802	midazolam	PA	D011619	Psychotropic Drugs	MeSH
DB00683	1802	midazolam	PA	D014149	Tranquilizing Agents	MeSH
DB00685	2777	trovafloxacin	PA	D000890	Anti-Infective Agents	MeSH
DB00685	2777	trovafloxacin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00685	2777	trovafloxacin	PA	D000970	Antineoplastic Agents	MeSH
DB00685	2777	trovafloxacin	PA	D004791	Enzyme Inhibitors	MeSH
DB00685	2777	trovafloxacin	PA	D059005	Topoisomerase II Inhibitors	MeSH
DB00688	1859	mycophenolate mofetil	PA	D004791	Enzyme Inhibitors	MeSH
DB00688	1859	mycophenolate mofetil	PA	D007155	Immunologic Factors	MeSH
DB00688	1859	mycophenolate mofetil	PA	D007166	Immunosuppressive Agents	MeSH
DB00689	572	cefaloglycin	PA	D000900	Anti-Bacterial Agents	MeSH
DB00689	572	cefaloglycin	PA	D000890	Anti-Infective Agents	MeSH
DB00690	1218	flurazepam	EPC	N0000175694	Benzodiazepine	FDA
DB00690	1218	flurazepam	Chemical/Ingredient	N0000007542	Benzodiazepines	FDA
DB00690	1218	flurazepam	PA	D014151	Anti-Anxiety Agents	MeSH
DB00690	1218	flurazepam	PA	D002491	Central Nervous System Agents	MeSH
DB00690	1218	flurazepam	PA	D002492	Central Nervous System Depressants	MeSH
DB00690	1218	flurazepam	PA	D018682	GABA Agents	MeSH
DB00690	1218	flurazepam	PA	D018757	GABA Modulators	MeSH
DB00690	1218	flurazepam	PA	D006993	Hypnotics and Sedatives	MeSH
DB00690	1218	flurazepam	PA	D018377	Neurotransmitter Agents	MeSH
DB00690	1218	flurazepam	PA	D011619	Psychotropic Drugs	MeSH
DB00690	1218	flurazepam	PA	D014149	Tranquilizing Agents	MeSH
DB00691	1827	moexipril	EPC	N0000175562	Angiotensin Converting Enzyme Inhibitor	FDA
DB00691	1827	moexipril	PA	D000806	Angiotensin-Converting Enzyme Inhibitors	MeSH
DB00691	1827	moexipril	PA	D000959	Antihypertensive Agents	MeSH
DB00691	1827	moexipril	PA	D002317	Cardiovascular Agents	MeSH
DB00691	1827	moexipril	PA	D004791	Enzyme Inhibitors	MeSH
DB00691	1827	moexipril	PA	D011480	Protease Inhibitors	MeSH
DB00692	2142	phentolamine	EPC	N0000175553	alpha-Adrenergic Blocker	FDA
DB00692	2142	phentolamine	PA	D018663	Adrenergic Agents	MeSH
DB00692	2142	phentolamine	PA	D000317	Adrenergic alpha-Antagonists	MeSH
DB00692	2142	phentolamine	PA	D018674	Adrenergic Antagonists	MeSH
DB00692	2142	phentolamine	has role	CHEBI:37890	alpha-adrenergic antagonist	CHEBI
DB00692	2142	phentolamine	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00692	2142	phentolamine	PA	D000959	Antihypertensive Agents	MeSH
DB00692	2142	phentolamine	PA	D002317	Cardiovascular Agents	MeSH
DB00692	2142	phentolamine	PA	D018377	Neurotransmitter Agents	MeSH
DB00694	786	daunorubicin	EPC	N0000175414	Anthracycline Topoisomerase Inhibitor	FDA
DB00694	786	daunorubicin	Chemical/Ingredient	N0000007530	Anthracyclines	FDA
DB00694	786	daunorubicin	MoA	N0000000176	Topoisomerase Inhibitors	FDA
DB00694	786	daunorubicin	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00694	786	daunorubicin	PA	D000903	Antibiotics, Antineoplastic	MeSH
DB00694	786	daunorubicin	PA	D000970	Antineoplastic Agents	MeSH
DB00694	786	daunorubicin	PA	D004791	Enzyme Inhibitors	MeSH
DB00694	786	daunorubicin	PA	D059005	Topoisomerase II Inhibitors	MeSH
DB00695	1258	furosemide	PE	N0000175366	Increased Diuresis at Loop of Henle	FDA
DB00695	1258	furosemide	has role	CHEBI:77608	loop diuretic	CHEBI
DB00695	1258	furosemide	PA	D004232	Diuretics	MeSH
DB00695	1258	furosemide	PA	D049990	Membrane Transport Modulators	MeSH
DB00695	1258	furosemide	PA	D045283	Natriuretic Agents	MeSH
DB00695	1258	furosemide	PA	D049994	Sodium Potassium Chloride Symporter Inhibitors	MeSH
DB00696	1043	ergotamine	EPC	N0000175766	Ergotamine Derivative	FDA
DB00696	1043	ergotamine	Chemical/Ingredient	N0000007621	Ergotamines	FDA
DB00696	1043	ergotamine	PA	D018663	Adrenergic Agents	MeSH
DB00696	1043	ergotamine	PA	D000322	Adrenergic Agonists	MeSH
DB00696	1043	ergotamine	PA	D058646	Adrenergic alpha-1 Receptor Agonists	MeSH
DB00696	1043	ergotamine	PA	D000316	Adrenergic alpha-Agonists	MeSH
DB00696	1043	ergotamine	PA	D000700	Analgesics	MeSH
DB00696	1043	ergotamine	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00696	1043	ergotamine	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB00696	1043	ergotamine	has role	CHEBI:50514	vasoconstrictor agent	CHEBI
DB00696	1043	ergotamine	has role	CHEBI:35941	serotonergic agonist	CHEBI
DB00696	1043	ergotamine	has role	CHEBI:35569	alpha-adrenergic agonist	CHEBI
DB00696	1043	ergotamine	PA	D002317	Cardiovascular Agents	MeSH
DB00696	1043	ergotamine	PA	D002491	Central Nervous System Agents	MeSH
DB00696	1043	ergotamine	PA	D018377	Neurotransmitter Agents	MeSH
DB00696	1043	ergotamine	PA	D010120	Oxytocics	MeSH
DB00696	1043	ergotamine	PA	D012102	Reproductive Control Agents	MeSH
DB00696	1043	ergotamine	PA	D018689	Sensory System Agents	MeSH
DB00696	1043	ergotamine	PA	D018490	Serotonin Agents	MeSH
DB00696	1043	ergotamine	PA	D017366	Serotonin Receptor Agonists	MeSH
DB00696	1043	ergotamine	PA	D014662	Vasoconstrictor Agents	MeSH
DB00697	2683	tizanidine	MoA	N0000009918	Adrenergic alpha2-Agonists	FDA
DB00697	2683	tizanidine	EPC	N0000175554	Central alpha-2 Adrenergic Agonist	FDA
DB00697	2683	tizanidine	PA	D018663	Adrenergic Agents	MeSH
DB00697	2683	tizanidine	PA	D000322	Adrenergic Agonists	MeSH
DB00697	2683	tizanidine	PA	D058647	Adrenergic alpha-2 Receptor Agonists	MeSH
DB00697	2683	tizanidine	PA	D000316	Adrenergic alpha-Agonists	MeSH
DB00697	2683	tizanidine	PA	D000700	Analgesics	MeSH
DB00697	2683	tizanidine	has role	CHEBI:35569	alpha-adrenergic agonist	CHEBI
DB00697	2683	tizanidine	has role	CHEBI:51371	muscle relaxant	CHEBI
DB00697	2683	tizanidine	PA	D000927	Anticonvulsants	MeSH
DB00697	2683	tizanidine	PA	D002491	Central Nervous System Agents	MeSH
DB00697	2683	tizanidine	PA	D009125	Muscle Relaxants, Central	MeSH
DB00697	2683	tizanidine	PA	D009465	Neuromuscular Agents	MeSH
DB00697	2683	tizanidine	PA	D018377	Neurotransmitter Agents	MeSH
DB00697	2683	tizanidine	PA	D010276	Parasympatholytics	MeSH
DB00697	2683	tizanidine	PA	D018689	Sensory System Agents	MeSH
DB00700	1032	eplerenone	EPC	N0000175557	Aldosterone Antagonist	FDA
DB00700	1032	eplerenone	MoA	N0000011310	Aldosterone Antagonists	FDA
DB00700	1032	eplerenone	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00700	1032	eplerenone	PA	D004232	Diuretics	MeSH
DB00700	1032	eplerenone	PA	D006727	Hormone Antagonists	MeSH
DB00700	1032	eplerenone	PA	D000451	Mineralocorticoid Receptor Antagonists	MeSH
DB00700	1032	eplerenone	PA	D045283	Natriuretic Agents	MeSH
DB00701	200	amprenavir	EPC	N0000175889	Protease Inhibitor	FDA
DB00701	200	amprenavir	MoA	N0000182141	Cytochrome P450 3A4 Inhibitors	FDA
DB00701	200	amprenavir	MoA	N0000185506	Cytochrome P450 3A4 Inducers	FDA
DB00701	200	amprenavir	MoA	N0000191264	P-Glycoprotein Inducers	FDA
DB00701	200	amprenavir	PA	D000900	Anti-Bacterial Agents	MeSH
DB00701	200	amprenavir	PA	D019380	Anti-HIV Agents	MeSH
DB00701	200	amprenavir	PA	D000890	Anti-Infective Agents	MeSH
DB00701	200	amprenavir	has role	CHEBI:36044	antiviral drug	CHEBI
DB00701	200	amprenavir	PA	D000904	Antibiotics, Antitubercular	MeSH
DB00701	200	amprenavir	PA	D000995	Antitubercular Agents	MeSH
DB00701	200	amprenavir	PA	D000998	Antiviral Agents	MeSH
DB00701	200	amprenavir	PA	D004791	Enzyme Inhibitors	MeSH
DB00701	200	amprenavir	PA	D017320	HIV Protease Inhibitors	MeSH
DB00701	200	amprenavir	PA	D011480	Protease Inhibitors	MeSH
DB00703	1741	methazolamide	PA	D002257	Carbonic Anhydrase Inhibitors	MeSH
DB00703	1741	methazolamide	PA	D004232	Diuretics	MeSH
DB00703	1741	methazolamide	PA	D004791	Enzyme Inhibitors	MeSH
DB00703	1741	methazolamide	PA	D045283	Natriuretic Agents	MeSH
DB00704	1765	naltrexone	EPC	N0000175691	Opioid Antagonist	FDA
DB00704	1765	naltrexone	MoA	N0000000154	Opioid Antagonists	FDA
DB00704	1765	naltrexone	has role	CHEBI:35488	central nervous system depressant	CHEBI
DB00704	1765	naltrexone	has role	CHEBI:90755	antidote to opioid poisoning	CHEBI
DB00704	1765	naltrexone	PA	D002491	Central Nervous System Agents	MeSH
DB00704	1765	naltrexone	PA	D009292	Narcotic Antagonists	MeSH
DB00704	1765	naltrexone	PA	D018689	Sensory System Agents	MeSH
DB05302	1765	naltrexone	EPC	N0000175691	Opioid Antagonist	FDA
DB05302	1765	naltrexone	MoA	N0000000154	Opioid Antagonists	FDA
DB05302	1765	naltrexone	has role	CHEBI:35488	central nervous system depressant	CHEBI
DB05302	1765	naltrexone	has role	CHEBI:90755	antidote to opioid poisoning	CHEBI
DB05302	1765	naltrexone	PA	D002491	Central Nervous System Agents	MeSH
DB05302	1765	naltrexone	PA	D009292	Narcotic Antagonists	MeSH
DB05302	1765	naltrexone	PA	D018689	Sensory System Agents	MeSH
DB05508	1765	naltrexone	EPC	N0000175691	Opioid Antagonist	FDA
DB05508	1765	naltrexone	MoA	N0000000154	Opioid Antagonists	FDA
DB05508	1765	naltrexone	has role	CHEBI:35488	central nervous system depressant	CHEBI
DB05508	1765	naltrexone	has role	CHEBI:90755	antidote to opioid poisoning	CHEBI
DB05508	1765	naltrexone	PA	D002491	Central Nervous System Agents	MeSH
DB05508	1765	naltrexone	PA	D009292	Narcotic Antagonists	MeSH
DB05508	1765	naltrexone	PA	D018689	Sensory System Agents	MeSH
DB00705	799	delavirdine	EPC	N0000175463	Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor	FDA
DB00705	799	delavirdine	Chemical/Ingredient	N0000175460	Non-Nucleoside Analog	FDA
DB00705	799	delavirdine	MoA	N0000009948	Non-Nucleoside Reverse Transcriptase Inhibitors	FDA
DB00705	799	delavirdine	PA	D019380	Anti-HIV Agents	MeSH
DB00705	799	delavirdine	PA	D000890	Anti-Infective Agents	MeSH
DB00705	799	delavirdine	has role	CHEBI:36044	antiviral drug	CHEBI
DB00705	799	delavirdine	PA	D000998	Antiviral Agents	MeSH
DB00705	799	delavirdine	PA	D004791	Enzyme Inhibitors	MeSH
DB00705	799	delavirdine	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB00705	799	delavirdine	PA	D018894	Reverse Transcriptase Inhibitors	MeSH
DB00708	2491	sufentanil	MoA	N0000175684	Full Opioid Agonists	FDA
DB00708	2491	sufentanil	EPC	N0000175690	Opioid Agonist	FDA
DB00708	2491	sufentanil	PA	D000759	Adjuvants, Anesthesia	MeSH
DB00708	2491	sufentanil	PA	D000700	Analgesics	MeSH
DB00708	2491	sufentanil	PA	D000701	Analgesics, Opioid	MeSH
DB00708	2491	sufentanil	PA	D000777	Anesthetics	MeSH
DB00708	2491	sufentanil	PA	D018686	Anesthetics, Intravenous	MeSH
DB00708	2491	sufentanil	has role	CHEBI:35482	opioid analgesic	CHEBI
DB00708	2491	sufentanil	has role	CHEBI:55322	mu-opioid receptor agonist	CHEBI
DB00708	2491	sufentanil	has role	CHEBI:60807	anaesthesia adjuvant	CHEBI
DB00708	2491	sufentanil	has role	CHEBI:38877	intravenous anaesthetic	CHEBI
DB00708	2491	sufentanil	PA	D002491	Central Nervous System Agents	MeSH
DB00708	2491	sufentanil	PA	D002492	Central Nervous System Depressants	MeSH
DB00708	2491	sufentanil	PA	D009294	Narcotics	MeSH
DB00708	2491	sufentanil	PA	D018689	Sensory System Agents	MeSH
DB00709	1539	lamivudine	EPC	N0000175656	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor	FDA
DB00709	1539	lamivudine	EPC	N0000175462	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor	FDA
DB00709	1539	lamivudine	Chemical/Ingredient	N0000175459	Nucleoside Analog	FDA
DB00709	1539	lamivudine	MoA	N0000009947	Nucleoside Reverse Transcriptase Inhibitors	FDA
DB00709	1539	lamivudine	PA	D019380	Anti-HIV Agents	MeSH
DB00709	1539	lamivudine	PA	D000890	Anti-Infective Agents	MeSH
DB00709	1539	lamivudine	has role	CHEBI:36044	antiviral drug	CHEBI
DB00709	1539	lamivudine	PA	D000998	Antiviral Agents	MeSH
DB00709	1539	lamivudine	PA	D004791	Enzyme Inhibitors	MeSH
DB00709	1539	lamivudine	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB00709	1539	lamivudine	PA	D018894	Reverse Transcriptase Inhibitors	MeSH
DB00710	1404	ibandronic acid	EPC	N0000175579	Bisphosphonate	FDA
DB00710	1404	ibandronic acid	Chemical/Ingredient	N0000007707	Diphosphonates	FDA
DB00710	1404	ibandronic acid	PA	D050071	Bone Density Conservation Agents	MeSH
DB00711	873	diethylcarbamazine	EPC	N0000175481	Antihelminthic	FDA
DB00711	873	diethylcarbamazine	PA	D000871	Anthelmintics	MeSH
DB00711	873	diethylcarbamazine	PA	D000890	Anti-Infective Agents	MeSH
DB00711	873	diethylcarbamazine	PA	D000969	Antinematodal Agents	MeSH
DB00711	873	diethylcarbamazine	PA	D000977	Antiparasitic Agents	MeSH
DB00711	873	diethylcarbamazine	PA	D004791	Enzyme Inhibitors	MeSH
DB00711	873	diethylcarbamazine	PA	D005369	Filaricides	MeSH
DB00711	873	diethylcarbamazine	PA	D016859	Lipoxygenase Inhibitors	MeSH
DB00712	1219	flurbiprofen	Chemical/Ingredient	N0000175721	Nonsteroidal Anti-inflammatory Compounds	FDA
DB00712	1219	flurbiprofen	EPC	N0000175722	Nonsteroidal Anti-inflammatory Drug	FDA
DB00712	1219	flurbiprofen	PA	D000700	Analgesics	MeSH
DB00712	1219	flurbiprofen	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00712	1219	flurbiprofen	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00712	1219	flurbiprofen	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00712	1219	flurbiprofen	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00712	1219	flurbiprofen	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB00712	1219	flurbiprofen	PA	D018501	Antirheumatic Agents	MeSH
DB00712	1219	flurbiprofen	PA	D002491	Central Nervous System Agents	MeSH
DB00712	1219	flurbiprofen	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB00712	1219	flurbiprofen	PA	D004791	Enzyme Inhibitors	MeSH
DB00712	1219	flurbiprofen	PA	D018689	Sensory System Agents	MeSH
DB05289	1219	flurbiprofen	Chemical/Ingredient	N0000175721	Nonsteroidal Anti-inflammatory Compounds	FDA
DB05289	1219	flurbiprofen	EPC	N0000175722	Nonsteroidal Anti-inflammatory Drug	FDA
DB05289	1219	flurbiprofen	PA	D000700	Analgesics	MeSH
DB05289	1219	flurbiprofen	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB05289	1219	flurbiprofen	PA	D000893	Anti-Inflammatory Agents	MeSH
DB05289	1219	flurbiprofen	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB05289	1219	flurbiprofen	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB05289	1219	flurbiprofen	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB05289	1219	flurbiprofen	PA	D018501	Antirheumatic Agents	MeSH
DB05289	1219	flurbiprofen	PA	D002491	Central Nervous System Agents	MeSH
DB05289	1219	flurbiprofen	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB05289	1219	flurbiprofen	PA	D004791	Enzyme Inhibitors	MeSH
DB05289	1219	flurbiprofen	PA	D018689	Sensory System Agents	MeSH
DB00713	2006	oxacillin	EPC	N0000175497	Penicillin-class Antibacterial	FDA
DB00713	2006	oxacillin	Chemical/Ingredient	N0000011281	Penicillins	FDA
DB00713	2006	oxacillin	PA	D000900	Anti-Bacterial Agents	MeSH
DB00713	2006	oxacillin	PA	D000890	Anti-Infective Agents	MeSH
DB00713	2006	oxacillin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00714	228	apomorphine	EPC	N0000175580	Dopaminergic Agonist	FDA
DB00714	228	apomorphine	has role	CHEBI:66956	antidyskinesia agent	CHEBI
DB00714	228	apomorphine	has role	CHEBI:48407	antiparkinson drug	CHEBI
DB00714	228	apomorphine	has role	CHEBI:51065	dopamine agonist	CHEBI
DB00714	228	apomorphine	has role	CHEBI:48539	alpha-adrenergic drug	CHEBI
DB00714	228	apomorphine	has role	CHEBI:48278	serotonergic drug	CHEBI
DB00714	228	apomorphine	PA	D002491	Central Nervous System Agents	MeSH
DB00714	228	apomorphine	PA	D015259	Dopamine Agents	MeSH
DB00714	228	apomorphine	PA	D018491	Dopamine Agonists	MeSH
DB00714	228	apomorphine	PA	D004639	Emetics	MeSH
DB00714	228	apomorphine	PA	D005765	Gastrointestinal Agents	MeSH
DB00714	228	apomorphine	PA	D018377	Neurotransmitter Agents	MeSH
DB00715	2068	paroxetine	EPC	N0000175696	Serotonin Reuptake Inhibitor	FDA
DB00715	2068	paroxetine	has role	CHEBI:35474	anxiolytic drug	CHEBI
DB00715	2068	paroxetine	has role	CHEBI:50949	serotonin uptake inhibitor	CHEBI
DB00715	2068	paroxetine	has role	CHEBI:35469	antidepressant	CHEBI
DB00715	2068	paroxetine	PA	D000928	Antidepressive Agents	MeSH
DB00715	2068	paroxetine	PA	D018687	Antidepressive Agents, Second-Generation	MeSH
DB00715	2068	paroxetine	PA	D002491	Central Nervous System Agents	MeSH
DB00715	2068	paroxetine	PA	D065690	Cytochrome P-450 CYP2D6 Inhibitors	MeSH
DB00715	2068	paroxetine	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB00715	2068	paroxetine	PA	D004791	Enzyme Inhibitors	MeSH
DB00715	2068	paroxetine	PA	D049990	Membrane Transport Modulators	MeSH
DB00715	2068	paroxetine	PA	D018377	Neurotransmitter Agents	MeSH
DB00715	2068	paroxetine	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB00715	2068	paroxetine	PA	D011619	Psychotropic Drugs	MeSH
DB00715	2068	paroxetine	PA	D018490	Serotonin Agents	MeSH
DB00715	2068	paroxetine	PA	D017367	Serotonin Uptake Inhibitors	MeSH
DB00717	1963	norethindrone acetate	has role	CHEBI:49326	synthetic oral contraceptive	CHEBI
DB00717	1963	norethindrone acetate	PA	D003270	Contraceptive Agents	MeSH
DB00717	1963	norethindrone acetate	PA	D003271	Contraceptive Agents, Female	MeSH
DB00717	1963	norethindrone acetate	PA	D003276	Contraceptives, Oral	MeSH
DB00717	1963	norethindrone acetate	PA	D003280	Contraceptives, Oral, Synthetic	MeSH
DB00717	1963	norethindrone acetate	PA	D012102	Reproductive Control Agents	MeSH
DB00717	1962	norethisterone	Chemical/Ingredient	N0000011301	Progesterone Congeners	FDA
DB00717	1962	norethisterone	EPC	N0000175602	Progestin	FDA
DB00718	88	adefovir dipivoxil	PA	D000890	Anti-Infective Agents	MeSH
DB00718	88	adefovir dipivoxil	PA	D000998	Antiviral Agents	MeSH
DB00718	88	adefovir dipivoxil	PA	D004791	Enzyme Inhibitors	MeSH
DB00718	88	adefovir dipivoxil	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB00718	88	adefovir dipivoxil	PA	D018894	Reverse Transcriptase Inhibitors	MeSH
DB00719	268	azatadine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB00719	268	azatadine	has role	CHEBI:50857	anti-allergic agent	CHEBI
DB00719	268	azatadine	PA	D018494	Histamine Agents	MeSH
DB00719	268	azatadine	PA	D006633	Histamine Antagonists	MeSH
DB00719	268	azatadine	PA	D006634	Histamine H1 Antagonists	MeSH
DB00719	268	azatadine	PA	D018377	Neurotransmitter Agents	MeSH
DB00721	2271	procaine	PA	D000777	Anesthetics	MeSH
DB00721	2271	procaine	PA	D000779	Anesthetics, Local	MeSH
DB00721	2271	procaine	has role	CHEBI:36333	local anaesthetic	CHEBI
DB00721	2271	procaine	has role	CHEBI:35488	central nervous system depressant	CHEBI
DB00721	2271	procaine	has role	CHEBI:49110	peripheral nervous system drug	CHEBI
DB00721	2271	procaine	PA	D002491	Central Nervous System Agents	MeSH
DB00721	2271	procaine	PA	D002492	Central Nervous System Depressants	MeSH
DB00721	2271	procaine	PA	D018689	Sensory System Agents	MeSH
DB00722	1587	lisinopril	PA	D000806	Angiotensin-Converting Enzyme Inhibitors	MeSH
DB00722	1587	lisinopril	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00722	1587	lisinopril	PA	D000959	Antihypertensive Agents	MeSH
DB00722	1587	lisinopril	PA	D002316	Cardiotonic Agents	MeSH
DB00722	1587	lisinopril	PA	D002317	Cardiovascular Agents	MeSH
DB00722	1587	lisinopril	PA	D004791	Enzyme Inhibitors	MeSH
DB00722	1587	lisinopril	PA	D011480	Protease Inhibitors	MeSH
DB00722	1587	lisinopril	PA	D020011	Protective Agents	MeSH
DB00723	1753	methoxamine	PA	D018663	Adrenergic Agents	MeSH
DB00723	1753	methoxamine	PA	D000322	Adrenergic Agonists	MeSH
DB00723	1753	methoxamine	PA	D058646	Adrenergic alpha-1 Receptor Agonists	MeSH
DB00723	1753	methoxamine	PA	D000316	Adrenergic alpha-Agonists	MeSH
DB00723	1753	methoxamine	PA	D002317	Cardiovascular Agents	MeSH
DB00723	1753	methoxamine	PA	D018377	Neurotransmitter Agents	MeSH
DB00723	1753	methoxamine	PA	D013566	Sympathomimetics	MeSH
DB00723	1753	methoxamine	PA	D014662	Vasoconstrictor Agents	MeSH
DB00724	1429	imiquimod	PE	N0000009267	Increased Cytokine Activity	FDA
DB00724	1429	imiquimod	PE	N0000009269	Increased Cytokine Production	FDA
DB00724	1429	imiquimod	PA	D000276	Adjuvants, Immunologic	MeSH
DB00724	1429	imiquimod	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00724	1429	imiquimod	has role	CHEBI:36710	interferon inducer	CHEBI
DB00724	1429	imiquimod	PA	D000970	Antineoplastic Agents	MeSH
DB00724	1429	imiquimod	PA	D007155	Immunologic Factors	MeSH
DB00724	1429	imiquimod	PA	D007369	Interferon Inducers	MeSH
DB00726	2758	trimipramine	EPC	N0000175752	Tricyclic Antidepressant	FDA
DB00726	2758	trimipramine	PA	D018663	Adrenergic Agents	MeSH
DB00726	2758	trimipramine	PA	D018759	Adrenergic Uptake Inhibitors	MeSH
DB00726	2758	trimipramine	has role	CHEBI:35469	antidepressant	CHEBI
DB00726	2758	trimipramine	PA	D000928	Antidepressive Agents	MeSH
DB00726	2758	trimipramine	PA	D000929	Antidepressive Agents, Tricyclic	MeSH
DB00726	2758	trimipramine	PA	D002491	Central Nervous System Agents	MeSH
DB00726	2758	trimipramine	PA	D049990	Membrane Transport Modulators	MeSH
DB00726	2758	trimipramine	PA	D018377	Neurotransmitter Agents	MeSH
DB00726	2758	trimipramine	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB00726	2758	trimipramine	PA	D011619	Psychotropic Drugs	MeSH
DB00727	1952	glyceryl trinitrate	EPC	N0000175415	Nitrate Vasodilator	FDA
DB00727	1952	glyceryl trinitrate	Chemical/Ingredient	N0000007647	Nitrates	FDA
DB00727	1952	glyceryl trinitrate	PE	N0000009909	Vasodilation	FDA
DB00727	1952	glyceryl trinitrate	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00727	1952	glyceryl trinitrate	has role	CHEBI:66993	tocolytic agent	CHEBI
DB00727	1952	glyceryl trinitrate	has role	CHEBI:51371	muscle relaxant	CHEBI
DB00727	1952	glyceryl trinitrate	has role	CHEBI:50266	prodrug	CHEBI
DB00727	1952	glyceryl trinitrate	PA	D002317	Cardiovascular Agents	MeSH
DB00727	1952	glyceryl trinitrate	PA	D053834	Explosive Agents	MeSH
DB00727	1952	glyceryl trinitrate	PA	D014665	Vasodilator Agents	MeSH
DB00728	2396	rocuronium	PE	N0000175732	Neuromuscular Nondepolarizing Blockade	FDA
DB00728	2396	rocuronium	EPC	N0000175720	Nondepolarizing Neuromuscular Blocker	FDA
DB00728	2396	rocuronium	has role	CHEBI:51372	neuromuscular agent	CHEBI
DB00728	2396	rocuronium	has role	CHEBI:51371	muscle relaxant	CHEBI
DB00728	2396	rocuronium	PA	D009465	Neuromuscular Agents	MeSH
DB00728	2396	rocuronium	PA	D009466	Neuromuscular Blocking Agents	MeSH
DB00728	2396	rocuronium	PA	D003473	Neuromuscular Nondepolarizing Agents	MeSH
DB00729	915	diphemanil	PA	D018927	Anti-Asthmatic Agents	MeSH
DB00729	915	diphemanil	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00729	915	diphemanil	has role	CHEBI:50370	parasympatholytic	CHEBI
DB00729	915	diphemanil	has role	CHEBI:35523	bronchodilator agent	CHEBI
DB00729	915	diphemanil	PA	D001993	Bronchodilator Agents	MeSH
DB00729	915	diphemanil	PA	D010276	Parasympatholytics	MeSH
DB00729	915	diphemanil	PA	D019141	Respiratory System Agents	MeSH
DB00730	2621	thiabendazole	EPC	N0000175481	Antihelminthic	FDA
DB00730	2621	thiabendazole	PA	D000871	Anthelmintics	MeSH
DB00730	2621	thiabendazole	PA	D000890	Anti-Infective Agents	MeSH
DB00730	2621	thiabendazole	has role	CHEBI:86328	antifungal agrochemical	CHEBI
DB00730	2621	thiabendazole	has role	CHEBI:35444	antinematodal drug	CHEBI
DB00730	2621	thiabendazole	PA	D000977	Antiparasitic Agents	MeSH
DB00731	1886	nateglinide	EPC	N0000175428	Glinide	FDA
DB00731	1886	nateglinide	MoA	N0000175448	Potassium Channel Antagonists	FDA
DB00731	1886	nateglinide	has role	CHEBI:35526	hypoglycemic agent	CHEBI
DB00731	1886	nateglinide	PA	D007004	Hypoglycemic Agents	MeSH
DB00733	2231	pralidoxime	EPC	N0000175742	Cholinesterase Reactivator	FDA
DB00733	2231	pralidoxime	has role	CHEBI:38323	cholinergic drug	CHEBI
DB00733	2231	pralidoxime	has role	CHEBI:90753	antidote to organophosphate poisoning	CHEBI
DB00733	2231	pralidoxime	PA	D000931	Antidotes	MeSH
DB00733	2231	pralidoxime	PA	D018678	Cholinergic Agents	MeSH
DB00733	2231	pralidoxime	PA	D002801	Cholinesterase Reactivators	MeSH
DB00733	2231	pralidoxime	PA	D018377	Neurotransmitter Agents	MeSH
DB00733	2231	pralidoxime	PA	D020011	Protective Agents	MeSH
DB00734	2389	risperidone	EPC	N0000175430	Atypical Antipsychotic	FDA
DB00734	2389	risperidone	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB00734	2389	risperidone	has role	CHEBI:35471	psychotropic drug	CHEBI
DB00734	2389	risperidone	has role	CHEBI:65191	second generation antipsychotic	CHEBI
DB00734	2389	risperidone	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB00734	2389	risperidone	has role	CHEBI:37890	alpha-adrenergic antagonist	CHEBI
DB00734	2389	risperidone	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB00734	2389	risperidone	PA	D014150	Antipsychotic Agents	MeSH
DB00734	2389	risperidone	PA	D002491	Central Nervous System Agents	MeSH
DB00734	2389	risperidone	PA	D002492	Central Nervous System Depressants	MeSH
DB00734	2389	risperidone	PA	D015259	Dopamine Agents	MeSH
DB00734	2389	risperidone	PA	D018492	Dopamine Antagonists	MeSH
DB00734	2389	risperidone	PA	D018377	Neurotransmitter Agents	MeSH
DB00734	2389	risperidone	PA	D011619	Psychotropic Drugs	MeSH
DB00734	2389	risperidone	PA	D018490	Serotonin Agents	MeSH
DB00734	2389	risperidone	PA	D012702	Serotonin Antagonists	MeSH
DB00734	2389	risperidone	PA	D014149	Tranquilizing Agents	MeSH
DB00735	1872	naftifine	Chemical/Ingredient	N0000007522	Allylamine	FDA
DB00735	1872	naftifine	EPC	N0000175874	Allylamine Antifungal	FDA
DB00735	1872	naftifine	PA	D000890	Anti-Infective Agents	MeSH
DB00735	1872	naftifine	PA	D000935	Antifungal Agents	MeSH
DB00737	1649	meclozine	EPC	N0000178372	Antiemetic	FDA
DB00737	1649	meclozine	PE	N0000009034	Emesis Suppression	FDA
DB00737	1649	meclozine	PA	D018926	Anti-Allergic Agents	MeSH
DB00737	1649	meclozine	PA	D000932	Antiemetics	MeSH
DB00737	1649	meclozine	PA	D002491	Central Nervous System Agents	MeSH
DB00737	1649	meclozine	PA	D005765	Gastrointestinal Agents	MeSH
DB00737	1649	meclozine	PA	D018494	Histamine Agents	MeSH
DB00737	1649	meclozine	PA	D006633	Histamine Antagonists	MeSH
DB00737	1649	meclozine	PA	D006634	Histamine H1 Antagonists	MeSH
DB00737	1649	meclozine	PA	D018377	Neurotransmitter Agents	MeSH
DB00739	1363	hetacillin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00740	2382	riluzole	EPC	N0000175740	Benzothiazole	FDA
DB00740	2382	riluzole	Chemical/Ingredient	N0000167094	Benzothiazoles	FDA
DB00740	2382	riluzole	PA	D000927	Anticonvulsants	MeSH
DB00740	2382	riluzole	PA	D002491	Central Nervous System Agents	MeSH
DB00740	2382	riluzole	PA	D018691	Excitatory Amino Acid Antagonists	MeSH
DB00740	2382	riluzole	PA	D018696	Neuroprotective Agents	MeSH
DB00740	2382	riluzole	PA	D018377	Neurotransmitter Agents	MeSH
DB00740	2382	riluzole	PA	D020011	Protective Agents	MeSH
DB00741	1388	hydrocortisone	EPC	N0000175576	Corticosteroid	FDA
DB00741	1388	hydrocortisone	MoA	N0000175450	Corticosteroid Hormone Receptor Agonists	FDA
DB00741	1388	hydrocortisone	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00741	1388	hydrocortisone	has role	CHEBI:35472	anti-inflammatory drug	CHEBI
DB00741	1388	hydrocortisone	has role	CHEBI:50857	anti-allergic agent	CHEBI
DB00741	1388	hydrocortisone	has role	CHEBI:49167	anti-asthmatic drug	CHEBI
DB07886	1388	hydrocortisone	EPC	N0000175576	Corticosteroid	FDA
DB07886	1388	hydrocortisone	MoA	N0000175450	Corticosteroid Hormone Receptor Agonists	FDA
DB07886	1388	hydrocortisone	PA	D000893	Anti-Inflammatory Agents	MeSH
DB07886	1388	hydrocortisone	has role	CHEBI:35472	anti-inflammatory drug	CHEBI
DB07886	1388	hydrocortisone	has role	CHEBI:50857	anti-allergic agent	CHEBI
DB07886	1388	hydrocortisone	has role	CHEBI:49167	anti-asthmatic drug	CHEBI
DB00744	2862	zileuton	EPC	N0000175956	5-Lipoxygenase Inhibitor	FDA
DB00744	2862	zileuton	MoA	N0000175955	5-Lipoxygenase Inhibitors	FDA
DB00744	2862	zileuton	PE	N0000008683	Decreased Leukotriene Production	FDA
DB00744	2862	zileuton	PA	D000700	Analgesics	MeSH
DB00744	2862	zileuton	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00744	2862	zileuton	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00744	2862	zileuton	has role	CHEBI:49159	leukotriene antagonist	CHEBI
DB00744	2862	zileuton	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00744	2862	zileuton	has role	CHEBI:49167	anti-asthmatic drug	CHEBI
DB00744	2862	zileuton	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00744	2862	zileuton	PA	D018501	Antirheumatic Agents	MeSH
DB00744	2862	zileuton	PA	D004791	Enzyme Inhibitors	MeSH
DB00744	2862	zileuton	PA	D006727	Hormone Antagonists	MeSH
DB00744	2862	zileuton	PA	D020024	Leukotriene Antagonists	MeSH
DB00744	2862	zileuton	PA	D016859	Lipoxygenase Inhibitors	MeSH
DB00744	2862	zileuton	PA	D018689	Sensory System Agents	MeSH
DB00745	4501	armodafinil	has role	CHEBI:35337	central nervous system stimulant	CHEBI
DB00745	4501	armodafinil	has role	CHEBI:77567	eugeroic	CHEBI
DB00745	4501	armodafinil	PA	D002491	Central Nervous System Agents	MeSH
DB00745	4501	armodafinil	PA	D000697	Central Nervous System Stimulants	MeSH
DB00745	4501	armodafinil	PA	D064690	Wakefulness-Promoting Agents	MeSH
DB00745	1826	modafinil	PE	N0000175729	Central Nervous System Stimulation	FDA
DB00745	1826	modafinil	PE	N0000175651	Increased Sympathetic Activity	FDA
DB00745	1826	modafinil	EPC	N0000175769	Sympathomimetic-like Agent	FDA
DB00745	1826	modafinil	PA	D065701	Cytochrome P-450 CYP3A Inducers	MeSH
DB00747	2424	scopolamine	EPC	N0000175574	Anticholinergic	FDA
DB00747	2424	scopolamine	PA	D000759	Adjuvants, Anesthesia	MeSH
DB00747	2424	scopolamine	has role	CHEBI:60807	anaesthesia adjuvant	CHEBI
DB00747	2424	scopolamine	has role	CHEBI:53784	antispasmodic drug	CHEBI
DB00747	2424	scopolamine	has role	CHEBI:50513	mydriatic agent	CHEBI
DB00747	2424	scopolamine	has role	CHEBI:60809	adjuvant	CHEBI
DB00747	2424	scopolamine	has role	CHEBI:35469	antidepressant	CHEBI
DB00747	2424	scopolamine	has role	CHEBI:50919	antiemetic	CHEBI
DB00747	2424	scopolamine	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00747	2424	scopolamine	PA	D002491	Central Nervous System Agents	MeSH
DB00747	2424	scopolamine	PA	D018678	Cholinergic Agents	MeSH
DB00747	2424	scopolamine	PA	D018680	Cholinergic Antagonists	MeSH
DB00747	2424	scopolamine	PA	D018727	Muscarinic Antagonists	MeSH
DB00747	2424	scopolamine	PA	D009184	Mydriatics	MeSH
DB00747	2424	scopolamine	PA	D018377	Neurotransmitter Agents	MeSH
DB00748	499	carbinoxamine	MoA	N0000000190	Histamine H1 Receptor Antagonists	FDA
DB00748	499	carbinoxamine	EPC	N0000175587	Histamine-1 Receptor Antagonist	FDA
DB00748	499	carbinoxamine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB00748	499	carbinoxamine	has role	CHEBI:50857	anti-allergic agent	CHEBI
DB00748	499	carbinoxamine	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00748	499	carbinoxamine	has role	CHEBI:48407	antiparkinson drug	CHEBI
DB00748	499	carbinoxamine	PA	D018494	Histamine Agents	MeSH
DB00748	499	carbinoxamine	PA	D006633	Histamine Antagonists	MeSH
DB00748	499	carbinoxamine	PA	D006634	Histamine H1 Antagonists	MeSH
DB00748	499	carbinoxamine	PA	D018377	Neurotransmitter Agents	MeSH
DB00749	1103	etodolac	Chemical/Ingredient	N0000175721	Nonsteroidal Anti-inflammatory Compounds	FDA
DB00749	1103	etodolac	EPC	N0000175722	Nonsteroidal Anti-inflammatory Drug	FDA
DB00749	1103	etodolac	PA	D000700	Analgesics	MeSH
DB00749	1103	etodolac	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00749	1103	etodolac	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00749	1103	etodolac	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00749	1103	etodolac	has role	CHEBI:35493	antipyretic	CHEBI
DB00749	1103	etodolac	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00749	1103	etodolac	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB00749	1103	etodolac	PA	D018501	Antirheumatic Agents	MeSH
DB00749	1103	etodolac	PA	D052246	Cyclooxygenase 2 Inhibitors	MeSH
DB00749	1103	etodolac	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB00749	1103	etodolac	PA	D004791	Enzyme Inhibitors	MeSH
DB00749	1103	etodolac	PA	D018689	Sensory System Agents	MeSH
DB00750	2265	prilocaine	EPC	N0000175682	Amide Local Anesthetic	FDA
DB00750	2265	prilocaine	Chemical/Ingredient	N0000007681	Amides	FDA
DB00750	2265	prilocaine	PE	N0000175976	Local Anesthesia	FDA
DB00750	2265	prilocaine	PA	D000777	Anesthetics	MeSH
DB00750	2265	prilocaine	PA	D000779	Anesthetics, Local	MeSH
DB00750	2265	prilocaine	has role	CHEBI:35623	anticonvulsant	CHEBI
DB00750	2265	prilocaine	has role	CHEBI:36333	local anaesthetic	CHEBI
DB00750	2265	prilocaine	PA	D002491	Central Nervous System Agents	MeSH
DB00750	2265	prilocaine	PA	D002492	Central Nervous System Depressants	MeSH
DB00750	2265	prilocaine	PA	D018689	Sensory System Agents	MeSH
DB00751	1027	epinastine	MoA	N0000000122	Adrenergic Agonists	FDA
DB00751	1027	epinastine	EPC	N0000175883	Adrenergic Receptor Agonist	FDA
DB00751	1027	epinastine	PE	N0000175628	Decreased Histamine Release	FDA
DB00751	1027	epinastine	MoA	N0000000190	Histamine H1 Receptor Antagonists	FDA
DB00751	1027	epinastine	EPC	N0000175519	Histamine-1 Receptor Inhibitor	FDA
DB00751	1027	epinastine	has role	CHEBI:50857	anti-allergic agent	CHEBI
DB00751	1027	epinastine	has role	CHEBI:37956	histamine antagonist	CHEBI
DB00751	1027	epinastine	has role	CHEBI:66981	ophthalmology drug	CHEBI
DB00751	1027	epinastine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB00751	1027	epinastine	PA	D018494	Histamine Agents	MeSH
DB00751	1027	epinastine	PA	D006633	Histamine Antagonists	MeSH
DB00751	1027	epinastine	PA	D006634	Histamine H1 Antagonists	MeSH
DB00751	1027	epinastine	PA	D018377	Neurotransmitter Agents	MeSH
DB00752	2715	tranylcypromine	EPC	N0000175744	Monoamine Oxidase Inhibitor	FDA
DB00752	2715	tranylcypromine	PA	D014151	Anti-Anxiety Agents	MeSH
DB00752	2715	tranylcypromine	PA	D000928	Antidepressive Agents	MeSH
DB00752	2715	tranylcypromine	PA	D002491	Central Nervous System Agents	MeSH
DB00752	2715	tranylcypromine	PA	D002492	Central Nervous System Depressants	MeSH
DB00752	2715	tranylcypromine	PA	D004791	Enzyme Inhibitors	MeSH
DB00752	2715	tranylcypromine	PA	D008996	Monoamine Oxidase Inhibitors	MeSH
DB00752	2715	tranylcypromine	PA	D011619	Psychotropic Drugs	MeSH
DB00752	2715	tranylcypromine	PA	D014149	Tranquilizing Agents	MeSH
DB02665	2715	tranylcypromine	EPC	N0000175744	Monoamine Oxidase Inhibitor	FDA
DB02665	2715	tranylcypromine	PA	D014151	Anti-Anxiety Agents	MeSH
DB02665	2715	tranylcypromine	PA	D000928	Antidepressive Agents	MeSH
DB02665	2715	tranylcypromine	PA	D002491	Central Nervous System Agents	MeSH
DB02665	2715	tranylcypromine	PA	D002492	Central Nervous System Depressants	MeSH
DB02665	2715	tranylcypromine	PA	D004791	Enzyme Inhibitors	MeSH
DB02665	2715	tranylcypromine	PA	D008996	Monoamine Oxidase Inhibitors	MeSH
DB02665	2715	tranylcypromine	PA	D011619	Psychotropic Drugs	MeSH
DB02665	2715	tranylcypromine	PA	D014149	Tranquilizing Agents	MeSH
DB00753	1493	isoflurane	PE	N0000175975	General Anesthesia	FDA
DB00753	1493	isoflurane	EPC	N0000175681	General Anesthetic	FDA
DB00753	1493	isoflurane	PA	D000777	Anesthetics	MeSH
DB00753	1493	isoflurane	PA	D018685	Anesthetics, Inhalation	MeSH
DB00753	1493	isoflurane	has role	CHEBI:38870	inhalation anaesthetic	CHEBI
DB00753	1493	isoflurane	PA	D002491	Central Nervous System Agents	MeSH
DB00753	1493	isoflurane	PA	D002492	Central Nervous System Depressants	MeSH
DB00754	1088	ethotoin	EPC	N0000175753	Anti-epileptic Agent	FDA
DB00754	1088	ethotoin	PE	N0000008486	Decreased Central Nervous System Disorganized Electrical Activity	FDA
DB00754	1088	ethotoin	has role	CHEBI:35623	anticonvulsant	CHEBI
DB00754	1088	ethotoin	PA	D000927	Anticonvulsants	MeSH
DB00754	1088	ethotoin	PA	D002491	Central Nervous System Agents	MeSH
DB00756	1364	hexachlorophene	EPC	N0000175486	Antiseptic	FDA
DB00756	1364	hexachlorophene	PA	D000890	Anti-Infective Agents	MeSH
DB00756	1364	hexachlorophene	PA	D000891	Anti-Infective Agents, Local	MeSH
DB00756	1364	hexachlorophene	has role	CHEBI:48218	antiseptic drug	CHEBI
DB00756	1364	hexachlorophene	has role	CHEBI:22153	acaricide	CHEBI
DB00756	1364	hexachlorophene	has role	CHEBI:86328	antifungal agrochemical	CHEBI
DB00757	3931	dolasetron	MoA	N0000175817	Serotonin 3 Receptor Antagonists	FDA
DB00757	3931	dolasetron	EPC	N0000175818	Serotonin-3 Receptor Antagonist	FDA
DB00757	3931	dolasetron	PA	D000932	Antiemetics	MeSH
DB00757	3931	dolasetron	PA	D002491	Central Nervous System Agents	MeSH
DB00757	3931	dolasetron	PA	D005765	Gastrointestinal Agents	MeSH
DB00757	3931	dolasetron	PA	D018377	Neurotransmitter Agents	MeSH
DB00757	3931	dolasetron	PA	D018490	Serotonin Agents	MeSH
DB00757	3931	dolasetron	PA	D012702	Serotonin Antagonists	MeSH
DB00758	708	clopidogrel	PE	N0000008832	Decreased Platelet Aggregation	FDA
DB00758	708	clopidogrel	EPC	N0000182142	P2Y12 Platelet Inhibitor	FDA
DB00758	708	clopidogrel	MoA	N0000182143	P2Y12 Receptor Antagonists	FDA
DB00758	708	clopidogrel	has role	CHEBI:50427	platelet aggregation inhibitor	CHEBI
DB00758	708	clopidogrel	has role	CHEBI:50249	anticoagulant	CHEBI
DB00758	708	clopidogrel	PA	D006401	Hematologic Agents	MeSH
DB00758	708	clopidogrel	PA	D018377	Neurotransmitter Agents	MeSH
DB00758	708	clopidogrel	PA	D010975	Platelet Aggregation Inhibitors	MeSH
DB00758	708	clopidogrel	PA	D058914	Purinergic Antagonists	MeSH
DB00758	708	clopidogrel	PA	D058919	Purinergic P2 Receptor Antagonists	MeSH
DB00758	708	clopidogrel	PA	D058921	Purinergic P2Y Receptor Antagonists	MeSH
DB00760	1709	meropenem	PA	D000900	Anti-Bacterial Agents	MeSH
DB00760	1709	meropenem	PA	D000890	Anti-Infective Agents	MeSH
DB00760	1709	meropenem	has role	CHEBI:88188	drug allergen	CHEBI
DB00760	1709	meropenem	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00762	1482	irinotecan	EPC	N0000175609	Topoisomerase Inhibitor	FDA
DB00762	1482	irinotecan	MoA	N0000000176	Topoisomerase Inhibitors	FDA
DB00762	1482	irinotecan	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00762	1482	irinotecan	has role	CHEBI:50266	prodrug	CHEBI
DB00762	1482	irinotecan	PA	D000970	Antineoplastic Agents	MeSH
DB00762	1482	irinotecan	PA	D000972	Antineoplastic Agents, Phytogenic	MeSH
DB00762	1482	irinotecan	PA	D004791	Enzyme Inhibitors	MeSH
DB00762	1482	irinotecan	PA	D011838	Radiation-Sensitizing Agents	MeSH
DB00762	1482	irinotecan	PA	D059004	Topoisomerase I Inhibitors	MeSH
DB00763	1745	thiamazole	EPC	N0000175918	Thyroid Hormone Synthesis Inhibitor	FDA
DB00763	1745	thiamazole	MoA	N0000175917	Thyroid Hormone Synthesis Inhibitors	FDA
DB00763	1745	thiamazole	has role	CHEBI:50671	antithyroid drug	CHEBI
DB00763	1745	thiamazole	PA	D013956	Antithyroid Agents	MeSH
DB00763	1745	thiamazole	PA	D006727	Hormone Antagonists	MeSH
DB00765	1792	metirosine	EPC	N0000175569	Catecholamine Synthesis Inhibitor	FDA
DB00765	1792	metirosine	MoA	N0000175361	Catecholamine Synthesis Inhibitors	FDA
DB00765	1792	metirosine	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00766	669	clavulanic acid	EPC	N0000175930	beta Lactamase Inhibitor	FDA
DB00766	669	clavulanic acid	MoA	N0000000202	beta Lactamase Inhibitors	FDA
DB00766	669	clavulanic acid	PA	D000900	Anti-Bacterial Agents	MeSH
DB00766	669	clavulanic acid	PA	D000890	Anti-Infective Agents	MeSH
DB00766	669	clavulanic acid	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00766	669	clavulanic acid	has role	CHEBI:35474	anxiolytic drug	CHEBI
DB00766	669	clavulanic acid	PA	D065093	beta-Lactamase Inhibitors	MeSH
DB00766	669	clavulanic acid	PA	D004791	Enzyme Inhibitors	MeSH
DB00767	331	benzquinamide	has role	CHEBI:50919	antiemetic	CHEBI
DB00767	331	benzquinamide	has role	CHEBI:35717	sedative	CHEBI
DB00767	331	benzquinamide	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB00767	331	benzquinamide	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00767	331	benzquinamide	has role	CHEBI:35476	antipsychotic agent	CHEBI
DB00768	1986	olopatadine	PE	N0000175628	Decreased Histamine Release	FDA
DB00768	1986	olopatadine	MoA	N0000000190	Histamine H1 Receptor Antagonists	FDA
DB00768	1986	olopatadine	EPC	N0000175519	Histamine-1 Receptor Inhibitor	FDA
DB00768	1986	olopatadine	PA	D000700	Analgesics	MeSH
DB00768	1986	olopatadine	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00768	1986	olopatadine	PA	D018926	Anti-Allergic Agents	MeSH
DB00768	1986	olopatadine	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00768	1986	olopatadine	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00768	1986	olopatadine	PA	D018501	Antirheumatic Agents	MeSH
DB00768	1986	olopatadine	PA	D018494	Histamine Agents	MeSH
DB00768	1986	olopatadine	PA	D006633	Histamine Antagonists	MeSH
DB00768	1986	olopatadine	PA	D006634	Histamine H1 Antagonists	MeSH
DB00768	1986	olopatadine	PA	D039563	Histamine H1 Antagonists, Non-Sedating	MeSH
DB00768	1986	olopatadine	PA	D018377	Neurotransmitter Agents	MeSH
DB00768	1986	olopatadine	PA	D018689	Sensory System Agents	MeSH
DB00769	1387	hydrocortamate	has role	CHEBI:35705	immunosuppressive agent	CHEBI
DB00769	1387	hydrocortamate	has role	CHEBI:35472	anti-inflammatory drug	CHEBI
DB00770	138	alprostadil	PE	N0000009059	Genitourinary Arterial Vasodilation	FDA
DB00770	138	alprostadil	EPC	N0000175454	Prostaglandin Analog	FDA
DB00770	138	alprostadil	EPC	N0000180189	Prostaglandin E1 Agonist	FDA
DB00770	138	alprostadil	MoA	N0000000106	Prostaglandin Receptor Agonists	FDA
DB00770	138	alprostadil	Chemical/Ingredient	N0000007706	Prostaglandins	FDA
DB00770	138	alprostadil	PE	N0000009911	Venous Vasodilation	FDA
DB00770	138	alprostadil	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00770	138	alprostadil	has role	CHEBI:50427	platelet aggregation inhibitor	CHEBI
DB00770	138	alprostadil	has role	CHEBI:50249	anticoagulant	CHEBI
DB00770	138	alprostadil	PA	D002317	Cardiovascular Agents	MeSH
DB00770	138	alprostadil	PA	D006401	Hematologic Agents	MeSH
DB00770	138	alprostadil	PA	D010975	Platelet Aggregation Inhibitors	MeSH
DB00770	138	alprostadil	PA	D064804	Urological Agents	MeSH
DB00770	138	alprostadil	PA	D014665	Vasodilator Agents	MeSH
DB00771	676	clidinium	EPC	N0000175574	Anticholinergic	FDA
DB00771	676	clidinium	PE	N0000008779	Decreased Parasympathetic Acetylcholine Activity	FDA
DB00771	676	clidinium	PE	N0000009048	GI Motility Alteration	FDA
DB00771	676	clidinium	PE	N0000009022	Digestive/GI System Activity Alteration	FDA
DB00771	676	clidinium	MoA	N0000175370	Cholinergic Antagonists	FDA
DB00771	676	clidinium	has role	CHEBI:50370	parasympatholytic	CHEBI
DB00771	676	clidinium	has role	CHEBI:53784	antispasmodic drug	CHEBI
DB00771	676	clidinium	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB00771	676	clidinium	PA	D010276	Parasympatholytics	MeSH
DB00772	1626	malathion	EPC	N0000175723	Cholinesterase Inhibitor	FDA
DB00772	1626	malathion	has role	CHEBI:24852	insecticide	CHEBI
DB00772	1626	malathion	has role	CHEBI:73333	scabicide	CHEBI
DB00772	1626	malathion	has role	CHEBI:33286	agrochemical	CHEBI
DB00772	1626	malathion	has role	CHEBI:38706	pediculicide	CHEBI
DB00772	1626	malathion	PA	D018678	Cholinergic Agents	MeSH
DB00772	1626	malathion	PA	D002800	Cholinesterase Inhibitors	MeSH
DB00772	1626	malathion	PA	D004791	Enzyme Inhibitors	MeSH
DB00772	1626	malathion	PA	D007306	Insecticides	MeSH
DB00772	1626	malathion	PA	D018377	Neurotransmitter Agents	MeSH
DB00772	1626	malathion	PA	D010575	Pesticides	MeSH
DB00773	1112	etoposide	EPC	N0000175609	Topoisomerase Inhibitor	FDA
DB00773	1112	etoposide	MoA	N0000000176	Topoisomerase Inhibitors	FDA
DB00773	1112	etoposide	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00773	1112	etoposide	PA	D000970	Antineoplastic Agents	MeSH
DB00773	1112	etoposide	PA	D000972	Antineoplastic Agents, Phytogenic	MeSH
DB00773	1112	etoposide	PA	D004791	Enzyme Inhibitors	MeSH
DB00773	1112	etoposide	PA	D059005	Topoisomerase II Inhibitors	MeSH
DB00774	1392	hydroflumethiazide	PE	N0000175359	Increased Diuresis	FDA
DB00774	1392	hydroflumethiazide	EPC	N0000175419	Thiazide Diuretic	FDA
DB00774	1392	hydroflumethiazide	Chemical/Ingredient	N0000166469	Thiazides	FDA
DB00774	1392	hydroflumethiazide	PA	D000959	Antihypertensive Agents	MeSH
DB00774	1392	hydroflumethiazide	PA	D002317	Cardiovascular Agents	MeSH
DB00774	1392	hydroflumethiazide	PA	D004232	Diuretics	MeSH
DB00774	1392	hydroflumethiazide	PA	D049990	Membrane Transport Modulators	MeSH
DB00774	1392	hydroflumethiazide	PA	D045283	Natriuretic Agents	MeSH
DB00774	1392	hydroflumethiazide	PA	D049993	Sodium Chloride Symporter Inhibitors	MeSH
DB00775	2680	tirofiban	PE	N0000008832	Decreased Platelet Aggregation	FDA
DB00775	2680	tirofiban	EPC	N0000175578	Platelet Aggregation Inhibitor	FDA
DB00775	2680	tirofiban	has role	CHEBI:48676	fibrin modulating drug	CHEBI
DB00775	2680	tirofiban	has role	CHEBI:50433	platelet glycoprotein-IIb/IIIa receptor antagonist	CHEBI
DB00775	2680	tirofiban	has role	CHEBI:50249	anticoagulant	CHEBI
DB00775	2680	tirofiban	PA	D002317	Cardiovascular Agents	MeSH
DB00775	2680	tirofiban	PA	D005343	Fibrinolytic Agents	MeSH
DB00775	2680	tirofiban	PA	D006401	Hematologic Agents	MeSH
DB00775	2680	tirofiban	PA	D010975	Platelet Aggregation Inhibitors	MeSH
DB00776	2017	oxcarbazepine	EPC	N0000175753	Anti-epileptic Agent	FDA
DB00776	2017	oxcarbazepine	PE	N0000008486	Decreased Central Nervous System Disorganized Electrical Activity	FDA
DB00776	2017	oxcarbazepine	has role	CHEBI:35623	anticonvulsant	CHEBI
DB00776	2017	oxcarbazepine	PA	D000927	Anticonvulsants	MeSH
DB00776	2017	oxcarbazepine	PA	D002317	Cardiovascular Agents	MeSH
DB00776	2017	oxcarbazepine	PA	D002491	Central Nervous System Agents	MeSH
DB00776	2017	oxcarbazepine	PA	D065701	Cytochrome P-450 CYP3A Inducers	MeSH
DB00776	2017	oxcarbazepine	PA	D049990	Membrane Transport Modulators	MeSH
DB00776	2017	oxcarbazepine	PA	D026941	Sodium Channel Blockers	MeSH
DB00776	2017	oxcarbazepine	PA	D061567	Voltage-Gated Sodium Channel Blockers	MeSH
DB00777	2298	propiomazine	has role	CHEBI:37930	phenothiazine antipsychotic drug	CHEBI
DB00777	2298	propiomazine	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB00777	2298	propiomazine	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB00777	2298	propiomazine	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00777	2298	propiomazine	has role	CHEBI:37956	histamine antagonist	CHEBI
DB00777	2298	propiomazine	has role	CHEBI:35717	sedative	CHEBI
DB00779	1875	nalidixic acid	PA	D000900	Anti-Bacterial Agents	MeSH
DB00779	1875	nalidixic acid	PA	D000890	Anti-Infective Agents	MeSH
DB00779	1875	nalidixic acid	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00779	1875	nalidixic acid	PA	D000970	Antineoplastic Agents	MeSH
DB00779	1875	nalidixic acid	PA	D004791	Enzyme Inhibitors	MeSH
DB00779	1875	nalidixic acid	PA	D059005	Topoisomerase II Inhibitors	MeSH
DB00780	2123	phenelzine	EPC	N0000175744	Monoamine Oxidase Inhibitor	FDA
DB00780	2123	phenelzine	PA	D000928	Antidepressive Agents	MeSH
DB00780	2123	phenelzine	PA	D002491	Central Nervous System Agents	MeSH
DB00780	2123	phenelzine	PA	D004791	Enzyme Inhibitors	MeSH
DB00780	2123	phenelzine	PA	D008996	Monoamine Oxidase Inhibitors	MeSH
DB00780	2123	phenelzine	PA	D011619	Psychotropic Drugs	MeSH
DB00782	2293	propantheline	EPC	N0000175574	Anticholinergic	FDA
DB00782	2293	propantheline	PA	D000897	Anti-Ulcer Agents	MeSH
DB00782	2293	propantheline	PA	D018678	Cholinergic Agents	MeSH
DB00782	2293	propantheline	PA	D018680	Cholinergic Antagonists	MeSH
DB00782	2293	propantheline	PA	D005765	Gastrointestinal Agents	MeSH
DB00782	2293	propantheline	PA	D018727	Muscarinic Antagonists	MeSH
DB00782	2293	propantheline	PA	D018377	Neurotransmitter Agents	MeSH
DB00783	1057	estradiol	Chemical/Ingredient	N0000011402	Estradiol Congeners	FDA
DB00783	1057	estradiol	EPC	N0000175825	Estrogen	FDA
DB00783	1057	estradiol	MoA	N0000000100	Estrogen Receptor Agonists	FDA
DB00783	1057	estradiol	PA	D004967	Estrogens	MeSH
DB00783	1057	estradiol	PA	D006728	Hormones	MeSH
DB00784	1663	mefenamic acid	Chemical/Ingredient	N0000175721	Nonsteroidal Anti-inflammatory Compounds	FDA
DB00784	1663	mefenamic acid	EPC	N0000175722	Nonsteroidal Anti-inflammatory Drug	FDA
DB00784	1663	mefenamic acid	PA	D000700	Analgesics	MeSH
DB00784	1663	mefenamic acid	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00784	1663	mefenamic acid	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00784	1663	mefenamic acid	has role	CHEBI:35480	analgesic	CHEBI
DB00784	1663	mefenamic acid	has role	CHEBI:35842	antirheumatic drug	CHEBI
DB00784	1663	mefenamic acid	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00784	1663	mefenamic acid	has role	CHEBI:35493	antipyretic	CHEBI
DB00784	1663	mefenamic acid	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00784	1663	mefenamic acid	PA	D018501	Antirheumatic Agents	MeSH
DB00784	1663	mefenamic acid	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB00784	1663	mefenamic acid	PA	D004791	Enzyme Inhibitors	MeSH
DB00784	1663	mefenamic acid	PA	D018689	Sensory System Agents	MeSH
DB00787	85	aciclovir	MoA	N0000020060	DNA Polymerase Inhibitors	FDA
DB00787	85	aciclovir	EPC	N0000180187	Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor	FDA
DB00787	85	aciclovir	EPC	N0000180188	Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor	FDA
DB00787	85	aciclovir	EPC	N0000175468	Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor	FDA
DB00787	85	aciclovir	Chemical/Ingredient	N0000175459	Nucleoside Analog	FDA
DB00787	85	aciclovir	PA	D000890	Anti-Infective Agents	MeSH
DB00787	85	aciclovir	has role	CHEBI:36044	antiviral drug	CHEBI
DB00787	85	aciclovir	PA	D000998	Antiviral Agents	MeSH
DB05347	85	aciclovir	MoA	N0000020060	DNA Polymerase Inhibitors	FDA
DB05347	85	aciclovir	EPC	N0000180187	Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor	FDA
DB05347	85	aciclovir	EPC	N0000180188	Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor	FDA
DB05347	85	aciclovir	EPC	N0000175468	Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor	FDA
DB05347	85	aciclovir	Chemical/Ingredient	N0000175459	Nucleoside Analog	FDA
DB05347	85	aciclovir	PA	D000890	Anti-Infective Agents	MeSH
DB05347	85	aciclovir	has role	CHEBI:36044	antiviral drug	CHEBI
DB05347	85	aciclovir	PA	D000998	Antiviral Agents	MeSH
DB00788	1883	naproxen	Chemical/Ingredient	N0000175721	Nonsteroidal Anti-inflammatory Compounds	FDA
DB00788	1883	naproxen	EPC	N0000175722	Nonsteroidal Anti-inflammatory Drug	FDA
DB00788	1883	naproxen	PA	D000700	Analgesics	MeSH
DB00788	1883	naproxen	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00788	1883	naproxen	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00788	1883	naproxen	has role	CHEBI:35845	gout suppressant	CHEBI
DB00788	1883	naproxen	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00788	1883	naproxen	has role	CHEBI:35493	antipyretic	CHEBI
DB00788	1883	naproxen	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB00788	1883	naproxen	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00788	1883	naproxen	PA	D018501	Antirheumatic Agents	MeSH
DB00788	1883	naproxen	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB00788	1883	naproxen	PA	D004791	Enzyme Inhibitors	MeSH
DB00788	1883	naproxen	PA	D006074	Gout Suppressants	MeSH
DB00788	1883	naproxen	PA	D018689	Sensory System Agents	MeSH
DB08298	1883	naproxen	Chemical/Ingredient	N0000175721	Nonsteroidal Anti-inflammatory Compounds	FDA
DB08298	1883	naproxen	EPC	N0000175722	Nonsteroidal Anti-inflammatory Drug	FDA
DB08298	1883	naproxen	PA	D000700	Analgesics	MeSH
DB08298	1883	naproxen	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB08298	1883	naproxen	PA	D000893	Anti-Inflammatory Agents	MeSH
DB08298	1883	naproxen	has role	CHEBI:35845	gout suppressant	CHEBI
DB08298	1883	naproxen	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB08298	1883	naproxen	has role	CHEBI:35493	antipyretic	CHEBI
DB08298	1883	naproxen	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB08298	1883	naproxen	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB08298	1883	naproxen	PA	D018501	Antirheumatic Agents	MeSH
DB08298	1883	naproxen	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB08298	1883	naproxen	PA	D004791	Enzyme Inhibitors	MeSH
DB08298	1883	naproxen	PA	D006074	Gout Suppressants	MeSH
DB08298	1883	naproxen	PA	D018689	Sensory System Agents	MeSH
DB00792	2762	tripelennamine	PA	D018926	Anti-Allergic Agents	MeSH
DB00792	2762	tripelennamine	PA	D018494	Histamine Agents	MeSH
DB00792	2762	tripelennamine	PA	D006633	Histamine Antagonists	MeSH
DB00792	2762	tripelennamine	PA	D006634	Histamine H1 Antagonists	MeSH
DB00792	2762	tripelennamine	PA	D018377	Neurotransmitter Agents	MeSH
DB00794	2267	primidone	EPC	N0000175753	Anti-epileptic Agent	FDA
DB00794	2267	primidone	PE	N0000008486	Decreased Central Nervous System Disorganized Electrical Activity	FDA
DB00794	2267	primidone	has role	CHEBI:35623	anticonvulsant	CHEBI
DB00794	2267	primidone	PA	D000927	Anticonvulsants	MeSH
DB00794	2267	primidone	PA	D002491	Central Nervous System Agents	MeSH
DB00795	2525	sulfasalazine	EPC	N0000175781	Aminosalicylate	FDA
DB00795	2525	sulfasalazine	Chemical/Ingredient	N0000005760	Aminosalicylic Acids	FDA
DB00795	2525	sulfasalazine	PA	D000700	Analgesics	MeSH
DB00795	2525	sulfasalazine	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00795	2525	sulfasalazine	PA	D000890	Anti-Infective Agents	MeSH
DB00795	2525	sulfasalazine	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00795	2525	sulfasalazine	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00795	2525	sulfasalazine	has role	CHEBI:35441	antiinfective agent	CHEBI
DB00795	2525	sulfasalazine	has role	CHEBI:55324	gastrointestinal drug	CHEBI
DB00795	2525	sulfasalazine	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00795	2525	sulfasalazine	PA	D018501	Antirheumatic Agents	MeSH
DB00795	2525	sulfasalazine	PA	D005765	Gastrointestinal Agents	MeSH
DB00795	2525	sulfasalazine	PA	D018689	Sensory System Agents	MeSH
DB00796	475	candesartan cilexetil	PA	D047228	Angiotensin II Type 1 Receptor Blockers	MeSH
DB00796	475	candesartan cilexetil	PA	D057911	Angiotensin Receptor Antagonists	MeSH
DB00796	475	candesartan cilexetil	PA	D000959	Antihypertensive Agents	MeSH
DB00796	475	candesartan cilexetil	PA	D002317	Cardiovascular Agents	MeSH
DB00797	2695	tolazoline	PA	D018663	Adrenergic Agents	MeSH
DB00797	2695	tolazoline	PA	D000317	Adrenergic alpha-Antagonists	MeSH
DB00797	2695	tolazoline	PA	D018674	Adrenergic Antagonists	MeSH
DB00797	2695	tolazoline	has role	CHEBI:37890	alpha-adrenergic antagonist	CHEBI
DB00797	2695	tolazoline	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00797	2695	tolazoline	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00797	2695	tolazoline	PA	D000959	Antihypertensive Agents	MeSH
DB00797	2695	tolazoline	PA	D002317	Cardiovascular Agents	MeSH
DB00797	2695	tolazoline	PA	D018377	Neurotransmitter Agents	MeSH
DB00797	2695	tolazoline	PA	D014665	Vasodilator Agents	MeSH
DB00799	2571	tazarotene	EPC	N0000175607	Retinoid	FDA
DB00799	2571	tazarotene	Chemical/Ingredient	N0000007700	Retinoids	FDA
DB00799	2571	tazarotene	has role	CHEBI:50176	keratolytic drug	CHEBI
DB00799	2571	tazarotene	has role	CHEBI:50266	prodrug	CHEBI
DB00799	2571	tazarotene	PA	D003879	Dermatologic Agents	MeSH
DB00799	2571	tazarotene	PA	D007641	Keratolytic Agents	MeSH
DB00799	2571	tazarotene	PA	D009676	Noxae	MeSH
DB00799	2571	tazarotene	PA	D013723	Teratogens	MeSH
DB00800	1153	fenoldopam	EPC	N0000175580	Dopaminergic Agonist	FDA
DB00800	1153	fenoldopam	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB00800	1153	fenoldopam	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00800	1153	fenoldopam	has role	CHEBI:35569	alpha-adrenergic agonist	CHEBI
DB00800	1153	fenoldopam	has role	CHEBI:51065	dopamine agonist	CHEBI
DB00800	1153	fenoldopam	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00800	1153	fenoldopam	PA	D000959	Antihypertensive Agents	MeSH
DB00800	1153	fenoldopam	PA	D002317	Cardiovascular Agents	MeSH
DB00800	1153	fenoldopam	PA	D015259	Dopamine Agents	MeSH
DB00800	1153	fenoldopam	PA	D018491	Dopamine Agonists	MeSH
DB00800	1153	fenoldopam	PA	D018377	Neurotransmitter Agents	MeSH
DB00800	1153	fenoldopam	PA	D014665	Vasodilator Agents	MeSH
DB00801	1348	halazepam	PA	D014151	Anti-Anxiety Agents	MeSH
DB00801	1348	halazepam	PA	D002491	Central Nervous System Agents	MeSH
DB00801	1348	halazepam	PA	D002492	Central Nervous System Depressants	MeSH
DB00801	1348	halazepam	PA	D011619	Psychotropic Drugs	MeSH
DB00801	1348	halazepam	PA	D014149	Tranquilizing Agents	MeSH
DB00802	114	alfentanil	MoA	N0000175684	Full Opioid Agonists	FDA
DB00802	114	alfentanil	EPC	N0000175690	Opioid Agonist	FDA
DB00802	114	alfentanil	PA	D000700	Analgesics	MeSH
DB00802	114	alfentanil	PA	D000701	Analgesics, Opioid	MeSH
DB00802	114	alfentanil	PA	D000777	Anesthetics	MeSH
DB00802	114	alfentanil	PA	D018686	Anesthetics, Intravenous	MeSH
DB00802	114	alfentanil	has role	CHEBI:35482	opioid analgesic	CHEBI
DB00802	114	alfentanil	has role	CHEBI:55322	mu-opioid receptor agonist	CHEBI
DB00802	114	alfentanil	has role	CHEBI:38877	intravenous anaesthetic	CHEBI
DB00802	114	alfentanil	has role	CHEBI:35488	central nervous system depressant	CHEBI
DB00802	114	alfentanil	has role	CHEBI:49110	peripheral nervous system drug	CHEBI
DB00802	114	alfentanil	PA	D002491	Central Nervous System Agents	MeSH
DB00802	114	alfentanil	PA	D002492	Central Nervous System Depressants	MeSH
DB00802	114	alfentanil	PA	D009294	Narcotics	MeSH
DB00802	114	alfentanil	PA	D018689	Sensory System Agents	MeSH
DB00804	868	dicycloverine	EPC	N0000175574	Anticholinergic	FDA
DB00804	868	dicycloverine	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00804	868	dicycloverine	has role	CHEBI:53784	antispasmodic drug	CHEBI
DB00804	868	dicycloverine	has role	CHEBI:50370	parasympatholytic	CHEBI
DB00804	868	dicycloverine	PA	D018678	Cholinergic Agents	MeSH
DB00804	868	dicycloverine	PA	D018680	Cholinergic Antagonists	MeSH
DB00804	868	dicycloverine	PA	D018727	Muscarinic Antagonists	MeSH
DB00804	868	dicycloverine	PA	D018377	Neurotransmitter Agents	MeSH
DB00804	868	dicycloverine	PA	D010276	Parasympatholytics	MeSH
DB00806	2099	pentoxifylline	EPC	N0000175895	Blood Viscosity Reducer	FDA
DB00806	2099	pentoxifylline	PE	N0000009065	Hematologic Activity Alteration	FDA
DB00806	2099	pentoxifylline	PA	D000975	Antioxidants	MeSH
DB00806	2099	pentoxifylline	PA	D002317	Cardiovascular Agents	MeSH
DB00806	2099	pentoxifylline	PA	D004791	Enzyme Inhibitors	MeSH
DB00806	2099	pentoxifylline	PA	D016166	Free Radical Scavengers	MeSH
DB00806	2099	pentoxifylline	PA	D006401	Hematologic Agents	MeSH
DB00806	2099	pentoxifylline	PA	D010726	Phosphodiesterase Inhibitors	MeSH
DB00806	2099	pentoxifylline	PA	D010975	Platelet Aggregation Inhibitors	MeSH
DB00806	2099	pentoxifylline	PA	D020011	Protective Agents	MeSH
DB00806	2099	pentoxifylline	PA	D011837	Radiation-Protective Agents	MeSH
DB00806	2099	pentoxifylline	PA	D014665	Vasodilator Agents	MeSH
DB00807	2294	proparacaine	PE	N0000175976	Local Anesthesia	FDA
DB00807	2294	proparacaine	EPC	N0000175539	Local Anesthetic	FDA
DB00807	2294	proparacaine	PA	D000777	Anesthetics	MeSH
DB00807	2294	proparacaine	PA	D000779	Anesthetics, Local	MeSH
DB00807	2294	proparacaine	PA	D002491	Central Nervous System Agents	MeSH
DB00807	2294	proparacaine	PA	D002492	Central Nervous System Depressants	MeSH
DB00807	2294	proparacaine	PA	D018689	Sensory System Agents	MeSH
DB00808	1433	indapamide	PE	N0000175359	Increased Diuresis	FDA
DB00808	1433	indapamide	EPC	N0000175420	Thiazide-like Diuretic	FDA
DB00808	1433	indapamide	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00808	1433	indapamide	has role	CHEBI:35498	diuretic	CHEBI
DB00808	1433	indapamide	PA	D000959	Antihypertensive Agents	MeSH
DB00808	1433	indapamide	PA	D002317	Cardiovascular Agents	MeSH
DB00808	1433	indapamide	PA	D004232	Diuretics	MeSH
DB00808	1433	indapamide	PA	D049990	Membrane Transport Modulators	MeSH
DB00808	1433	indapamide	PA	D045283	Natriuretic Agents	MeSH
DB00808	1433	indapamide	PA	D049993	Sodium Chloride Symporter Inhibitors	MeSH
DB07467	1433	indapamide	PE	N0000175359	Increased Diuresis	FDA
DB07467	1433	indapamide	EPC	N0000175420	Thiazide-like Diuretic	FDA
DB07467	1433	indapamide	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB07467	1433	indapamide	has role	CHEBI:35498	diuretic	CHEBI
DB07467	1433	indapamide	PA	D000959	Antihypertensive Agents	MeSH
DB07467	1433	indapamide	PA	D002317	Cardiovascular Agents	MeSH
DB07467	1433	indapamide	PA	D004232	Diuretics	MeSH
DB07467	1433	indapamide	PA	D049990	Membrane Transport Modulators	MeSH
DB07467	1433	indapamide	PA	D045283	Natriuretic Agents	MeSH
DB07467	1433	indapamide	PA	D049993	Sodium Chloride Symporter Inhibitors	MeSH
DB00809	2774	tropicamide	EPC	N0000175574	Anticholinergic	FDA
DB00809	2774	tropicamide	PA	D018678	Cholinergic Agents	MeSH
DB00809	2774	tropicamide	PA	D018680	Cholinergic Antagonists	MeSH
DB00809	2774	tropicamide	PA	D018727	Muscarinic Antagonists	MeSH
DB00809	2774	tropicamide	PA	D009184	Mydriatics	MeSH
DB00809	2774	tropicamide	PA	D018377	Neurotransmitter Agents	MeSH
DB00810	374	biperiden	EPC	N0000175574	Anticholinergic	FDA
DB00810	374	biperiden	PA	D018726	Anti-Dyskinesia Agents	MeSH
DB00810	374	biperiden	has role	CHEBI:66956	antidyskinesia agent	CHEBI
DB00810	374	biperiden	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00810	374	biperiden	has role	CHEBI:50370	parasympatholytic	CHEBI
DB00810	374	biperiden	has role	CHEBI:48407	antiparkinson drug	CHEBI
DB00810	374	biperiden	PA	D000978	Antiparkinson Agents	MeSH
DB00810	374	biperiden	PA	D002491	Central Nervous System Agents	MeSH
DB00810	374	biperiden	PA	D018678	Cholinergic Agents	MeSH
DB00810	374	biperiden	PA	D018680	Cholinergic Antagonists	MeSH
DB00810	374	biperiden	PA	D018727	Muscarinic Antagonists	MeSH
DB00810	374	biperiden	PA	D018377	Neurotransmitter Agents	MeSH
DB00810	374	biperiden	PA	D010276	Parasympatholytics	MeSH
DB00811	2373	ribavirin	Chemical/Ingredient	N0000175459	Nucleoside Analog	FDA
DB00811	2373	ribavirin	EPC	N0000175466	Nucleoside Analog Antiviral	FDA
DB00811	2373	ribavirin	PA	D000890	Anti-Infective Agents	MeSH
DB00811	2373	ribavirin	has role	CHEBI:35441	antiinfective agent	CHEBI
DB00811	2373	ribavirin	PA	D000963	Antimetabolites	MeSH
DB00811	2373	ribavirin	PA	D000998	Antiviral Agents	MeSH
DB00811	2373	ribavirin	PA	D009676	Noxae	MeSH
DB00812	2145	phenylbutazone	PA	D000700	Analgesics	MeSH
DB00812	2145	phenylbutazone	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00812	2145	phenylbutazone	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00812	2145	phenylbutazone	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB00812	2145	phenylbutazone	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00812	2145	phenylbutazone	has role	CHEBI:35842	antirheumatic drug	CHEBI
DB00812	2145	phenylbutazone	has role	CHEBI:49110	peripheral nervous system drug	CHEBI
DB00812	2145	phenylbutazone	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00812	2145	phenylbutazone	PA	D018501	Antirheumatic Agents	MeSH
DB00812	2145	phenylbutazone	PA	D018689	Sensory System Agents	MeSH
DB00813	1164	fentanyl	MoA	N0000175684	Full Opioid Agonists	FDA
DB00813	1164	fentanyl	EPC	N0000175690	Opioid Agonist	FDA
DB00813	1164	fentanyl	PA	D000759	Adjuvants, Anesthesia	MeSH
DB00813	1164	fentanyl	PA	D000700	Analgesics	MeSH
DB00813	1164	fentanyl	PA	D000701	Analgesics, Opioid	MeSH
DB00813	1164	fentanyl	PA	D000777	Anesthetics	MeSH
DB00813	1164	fentanyl	PA	D018686	Anesthetics, Intravenous	MeSH
DB00813	1164	fentanyl	has role	CHEBI:38877	intravenous anaesthetic	CHEBI
DB00813	1164	fentanyl	has role	CHEBI:38867	anaesthetic	CHEBI
DB00813	1164	fentanyl	has role	CHEBI:60809	adjuvant	CHEBI
DB00813	1164	fentanyl	has role	CHEBI:60807	anaesthesia adjuvant	CHEBI
DB00813	1164	fentanyl	has role	CHEBI:35482	opioid analgesic	CHEBI
DB00813	1164	fentanyl	has role	CHEBI:55322	mu-opioid receptor agonist	CHEBI
DB00813	1164	fentanyl	PA	D002491	Central Nervous System Agents	MeSH
DB00813	1164	fentanyl	PA	D002492	Central Nervous System Depressants	MeSH
DB00813	1164	fentanyl	PA	D009294	Narcotics	MeSH
DB00813	1164	fentanyl	PA	D018689	Sensory System Agents	MeSH
DB00814	1676	meloxicam	Chemical/Ingredient	N0000175721	Nonsteroidal Anti-inflammatory Compounds	FDA
DB00814	1676	meloxicam	EPC	N0000175722	Nonsteroidal Anti-inflammatory Drug	FDA
DB00814	1676	meloxicam	PA	D000700	Analgesics	MeSH
DB00814	1676	meloxicam	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00814	1676	meloxicam	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00814	1676	meloxicam	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00814	1676	meloxicam	has role	CHEBI:35842	antirheumatic drug	CHEBI
DB00814	1676	meloxicam	has role	CHEBI:35480	analgesic	CHEBI
DB00814	1676	meloxicam	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00814	1676	meloxicam	PA	D018501	Antirheumatic Agents	MeSH
DB00814	1676	meloxicam	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB00814	1676	meloxicam	PA	D004791	Enzyme Inhibitors	MeSH
DB00814	1676	meloxicam	PA	D018689	Sensory System Agents	MeSH
DB00816	1720	orciprenaline	MoA	N0000009922	Adrenergic beta2-Agonists	FDA
DB00816	1720	orciprenaline	EPC	N0000175779	beta2-Adrenergic Agonist	FDA
DB00816	1720	orciprenaline	PA	D018663	Adrenergic Agents	MeSH
DB00816	1720	orciprenaline	PA	D000322	Adrenergic Agonists	MeSH
DB00816	1720	orciprenaline	PA	D058666	Adrenergic beta-2 Receptor Agonists	MeSH
DB00816	1720	orciprenaline	PA	D000318	Adrenergic beta-Agonists	MeSH
DB00816	1720	orciprenaline	PA	D018927	Anti-Asthmatic Agents	MeSH
DB00816	1720	orciprenaline	has role	CHEBI:35523	bronchodilator agent	CHEBI
DB00816	1720	orciprenaline	has role	CHEBI:35522	beta-adrenergic agonist	CHEBI
DB00816	1720	orciprenaline	has role	CHEBI:49167	anti-asthmatic drug	CHEBI
DB00816	1720	orciprenaline	PA	D001993	Bronchodilator Agents	MeSH
DB00816	1720	orciprenaline	PA	D018377	Neurotransmitter Agents	MeSH
DB00816	1720	orciprenaline	PA	D012102	Reproductive Control Agents	MeSH
DB00816	1720	orciprenaline	PA	D019141	Respiratory System Agents	MeSH
DB00816	1720	orciprenaline	PA	D013566	Sympathomimetics	MeSH
DB00816	1720	orciprenaline	PA	D015149	Tocolytic Agents	MeSH
DB00818	2302	propofol	PE	N0000175975	General Anesthesia	FDA
DB00818	2302	propofol	EPC	N0000175681	General Anesthetic	FDA
DB00818	2302	propofol	PA	D000777	Anesthetics	MeSH
DB00818	2302	propofol	PA	D018686	Anesthetics, Intravenous	MeSH
DB00818	2302	propofol	has role	CHEBI:38877	intravenous anaesthetic	CHEBI
DB00818	2302	propofol	has role	CHEBI:35717	sedative	CHEBI
DB00818	2302	propofol	has role	CHEBI:50919	antiemetic	CHEBI
DB00818	2302	propofol	has role	CHEBI:35623	anticonvulsant	CHEBI
DB00818	2302	propofol	PA	D002491	Central Nervous System Agents	MeSH
DB00818	2302	propofol	PA	D002492	Central Nervous System Depressants	MeSH
DB00818	2302	propofol	PA	D006993	Hypnotics and Sedatives	MeSH
DB00819	56	acetazolamide	EPC	N0000175517	Carbonic Anhydrase Inhibitor	FDA
DB00819	56	acetazolamide	Chemical/Ingredient	N0000008048	Sulfonamides	FDA
DB00819	56	acetazolamide	PA	D000927	Anticonvulsants	MeSH
DB00819	56	acetazolamide	PA	D002257	Carbonic Anhydrase Inhibitors	MeSH
DB00819	56	acetazolamide	PA	D002491	Central Nervous System Agents	MeSH
DB00819	56	acetazolamide	PA	D004232	Diuretics	MeSH
DB00819	56	acetazolamide	PA	D004791	Enzyme Inhibitors	MeSH
DB00819	56	acetazolamide	PA	D045283	Natriuretic Agents	MeSH
DB00820	2553	tadalafil	EPC	N0000175599	Phosphodiesterase 5 Inhibitor	FDA
DB00820	2553	tadalafil	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00820	2553	tadalafil	PA	D002317	Cardiovascular Agents	MeSH
DB00820	2553	tadalafil	PA	D004791	Enzyme Inhibitors	MeSH
DB00820	2553	tadalafil	PA	D058986	Phosphodiesterase 5 Inhibitors	MeSH
DB00820	2553	tadalafil	PA	D010726	Phosphodiesterase Inhibitors	MeSH
DB00820	2553	tadalafil	PA	D064804	Urological Agents	MeSH
DB00820	2553	tadalafil	PA	D014665	Vasodilator Agents	MeSH
DB00821	518	carprofen	PA	D000700	Analgesics	MeSH
DB00821	518	carprofen	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00821	518	carprofen	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00821	518	carprofen	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00821	518	carprofen	has role	CHEBI:47868	photosensitizing agent	CHEBI
DB00821	518	carprofen	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00821	518	carprofen	PA	D018501	Antirheumatic Agents	MeSH
DB00821	518	carprofen	PA	D003879	Dermatologic Agents	MeSH
DB00821	518	carprofen	PA	D017319	Photosensitizing Agents	MeSH
DB00821	518	carprofen	PA	D011838	Radiation-Sensitizing Agents	MeSH
DB00821	518	carprofen	PA	D018689	Sensory System Agents	MeSH
DB00822	928	disulfiram	MoA	N0000000183	Acetyl Aldehyde Dehydrogenase Inhibitors	FDA
DB00822	928	disulfiram	EPC	N0000175679	Aldehyde Dehydrogenase Inhibitor	FDA
DB00822	928	disulfiram	PA	D065086	Acetaldehyde Dehydrogenase Inhibitors	MeSH
DB00822	928	disulfiram	PA	D000427	Alcohol Deterrents	MeSH
DB00822	928	disulfiram	has role	CHEBI:48422	angiogenesis inhibitor	CHEBI
DB00822	928	disulfiram	has role	CHEBI:24127	fungicide	CHEBI
DB00822	928	disulfiram	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00822	928	disulfiram	PA	D002491	Central Nervous System Agents	MeSH
DB00822	928	disulfiram	PA	D004791	Enzyme Inhibitors	MeSH
DB00823	1095	etynodiol	Chemical/Ingredient	N0000011301	Progesterone Congeners	FDA
DB00823	1095	etynodiol	EPC	N0000175602	Progestin	FDA
DB00823	1095	etynodiol	PA	D003270	Contraceptive Agents	MeSH
DB00823	1095	etynodiol	PA	D003271	Contraceptive Agents, Female	MeSH
DB00823	1095	etynodiol	PA	D003276	Contraceptives, Oral	MeSH
DB00823	1095	etynodiol	PA	D003280	Contraceptives, Oral, Synthetic	MeSH
DB00823	1095	etynodiol	PA	D012102	Reproductive Control Agents	MeSH
DB00825	934	levomenthol	has role	CHEBI:51177	antitussive	CHEBI
DB00825	934	levomenthol	has role	CHEBI:53784	antispasmodic drug	CHEBI
DB00825	934	levomenthol	has role	CHEBI:59683	antipruritic drug	CHEBI
DB00825	934	levomenthol	PA	D000982	Antipruritics	MeSH
DB00825	934	levomenthol	PA	D003879	Dermatologic Agents	MeSH
DB00827	657	cinoxacin	PA	D000890	Anti-Infective Agents	MeSH
DB00827	657	cinoxacin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00827	657	cinoxacin	has role	CHEBI:35441	antiinfective agent	CHEBI
DB00827	657	cinoxacin	PA	D000970	Antineoplastic Agents	MeSH
DB00827	657	cinoxacin	PA	D004791	Enzyme Inhibitors	MeSH
DB00827	657	cinoxacin	PA	D059005	Topoisomerase II Inhibitors	MeSH
DB00828	1243	fosfomycin	PA	D000900	Anti-Bacterial Agents	MeSH
DB00828	1243	fosfomycin	PA	D000890	Anti-Infective Agents	MeSH
DB00829	852	diazepam	EPC	N0000175694	Benzodiazepine	FDA
DB00829	852	diazepam	Chemical/Ingredient	N0000007542	Benzodiazepines	FDA
DB00829	852	diazepam	PA	D000759	Adjuvants, Anesthesia	MeSH
DB00829	852	diazepam	PA	D000777	Anesthetics	MeSH
DB00829	852	diazepam	PA	D018686	Anesthetics, Intravenous	MeSH
DB00829	852	diazepam	PA	D014151	Anti-Anxiety Agents	MeSH
DB00829	852	diazepam	has role	CHEBI:35474	anxiolytic drug	CHEBI
DB00829	852	diazepam	has role	CHEBI:35623	anticonvulsant	CHEBI
DB00829	852	diazepam	has role	CHEBI:35717	sedative	CHEBI
DB00829	852	diazepam	PA	D000927	Anticonvulsants	MeSH
DB00829	852	diazepam	PA	D000932	Antiemetics	MeSH
DB00829	852	diazepam	PA	D002491	Central Nervous System Agents	MeSH
DB00829	852	diazepam	PA	D002492	Central Nervous System Depressants	MeSH
DB00829	852	diazepam	PA	D018682	GABA Agents	MeSH
DB00829	852	diazepam	PA	D018757	GABA Modulators	MeSH
DB00829	852	diazepam	PA	D005765	Gastrointestinal Agents	MeSH
DB00829	852	diazepam	PA	D006993	Hypnotics and Sedatives	MeSH
DB00829	852	diazepam	PA	D009125	Muscle Relaxants, Central	MeSH
DB00829	852	diazepam	PA	D009465	Neuromuscular Agents	MeSH
DB00829	852	diazepam	PA	D018377	Neurotransmitter Agents	MeSH
DB00829	852	diazepam	PA	D011619	Psychotropic Drugs	MeSH
DB00829	852	diazepam	PA	D014149	Tranquilizing Agents	MeSH
DB00830	2133	phenmetrazine	PA	D019440	Anti-Obesity Agents	MeSH
DB00830	2133	phenmetrazine	PA	D001067	Appetite Depressants	MeSH
DB00830	2133	phenmetrazine	PA	D002491	Central Nervous System Agents	MeSH
DB00830	2133	phenmetrazine	PA	D000697	Central Nervous System Stimulants	MeSH
DB00830	2133	phenmetrazine	PA	D013566	Sympathomimetics	MeSH
DB00831	2740	trifluoperazine	EPC	N0000175746	Phenothiazine	FDA
DB00831	2740	trifluoperazine	Chemical/Ingredient	N0000007544	Phenothiazines	FDA
DB00831	2740	trifluoperazine	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB00831	2740	trifluoperazine	has role	CHEBI:50919	antiemetic	CHEBI
DB00831	2740	trifluoperazine	has role	CHEBI:37930	phenothiazine antipsychotic drug	CHEBI
DB00831	2740	trifluoperazine	PA	D000932	Antiemetics	MeSH
DB00831	2740	trifluoperazine	PA	D014150	Antipsychotic Agents	MeSH
DB00831	2740	trifluoperazine	PA	D002491	Central Nervous System Agents	MeSH
DB00831	2740	trifluoperazine	PA	D002492	Central Nervous System Depressants	MeSH
DB00831	2740	trifluoperazine	PA	D015259	Dopamine Agents	MeSH
DB00831	2740	trifluoperazine	PA	D018492	Dopamine Antagonists	MeSH
DB00831	2740	trifluoperazine	PA	D005765	Gastrointestinal Agents	MeSH
DB00831	2740	trifluoperazine	PA	D018377	Neurotransmitter Agents	MeSH
DB00831	2740	trifluoperazine	PA	D011619	Psychotropic Drugs	MeSH
DB00831	2740	trifluoperazine	PA	D014149	Tranquilizing Agents	MeSH
DB00833	525	cefaclor	PA	D000900	Anti-Bacterial Agents	MeSH
DB00833	525	cefaclor	PA	D000890	Anti-Infective Agents	MeSH
DB00833	525	cefaclor	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00833	525	cefaclor	has role	CHEBI:88188	drug allergen	CHEBI
DB00834	1805	mifepristone	MoA	N0000000115	Progestational Hormone Receptor Antagonists	FDA
DB00834	1805	mifepristone	EPC	N0000175841	Progestin Antagonist	FDA
DB00834	1805	mifepristone	PA	D000021	Abortifacient Agents, Steroidal	MeSH
DB00834	1805	mifepristone	has role	CHEBI:49020	hormone antagonist	CHEBI
DB00834	1805	mifepristone	has role	CHEBI:49323	contraceptive drug	CHEBI
DB00834	1805	mifepristone	has role	CHEBI:49326	synthetic oral contraceptive	CHEBI
DB00834	1805	mifepristone	has role	CHEBI:50691	abortifacient	CHEBI
DB00834	1805	mifepristone	PA	D003270	Contraceptive Agents	MeSH
DB00834	1805	mifepristone	PA	D003271	Contraceptive Agents, Female	MeSH
DB00834	1805	mifepristone	PA	D003276	Contraceptives, Oral	MeSH
DB00834	1805	mifepristone	PA	D003280	Contraceptives, Oral, Synthetic	MeSH
DB00834	1805	mifepristone	PA	D003281	Contraceptives, Postcoital	MeSH
DB00834	1805	mifepristone	PA	D003283	Contraceptives, Postcoital, Synthetic	MeSH
DB00834	1805	mifepristone	PA	D006727	Hormone Antagonists	MeSH
DB00834	1805	mifepristone	PA	D008186	Luteolytic Agents	MeSH
DB00834	1805	mifepristone	PA	D008600	Menstruation-Inducing Agents	MeSH
DB00834	1805	mifepristone	PA	D012102	Reproductive Control Agents	MeSH
DB00836	1599	loperamide	EPC	N0000175690	Opioid Agonist	FDA
DB00836	1599	loperamide	MoA	N0000000174	Opioid Agonists	FDA
DB00836	1599	loperamide	has role	CHEBI:55322	mu-opioid receptor agonist	CHEBI
DB00836	1599	loperamide	has role	CHEBI:55323	antidiarrhoeal drug	CHEBI
DB00836	1599	loperamide	PA	D000930	Antidiarrheals	MeSH
DB00836	1599	loperamide	PA	D005765	Gastrointestinal Agents	MeSH
DB00839	2694	tolazamide	EPC	N0000175608	Sulfonylurea	FDA
DB00839	2694	tolazamide	Chemical/Ingredient	N0000008054	Sulfonylurea Compounds	FDA
DB00839	2694	tolazamide	has role	CHEBI:35526	hypoglycemic agent	CHEBI
DB00839	2694	tolazamide	PA	D007004	Hypoglycemic Agents	MeSH
DB00841	937	dobutamine	PA	D018663	Adrenergic Agents	MeSH
DB00841	937	dobutamine	PA	D000322	Adrenergic Agonists	MeSH
DB00841	937	dobutamine	PA	D058665	Adrenergic beta-1 Receptor Agonists	MeSH
DB00841	937	dobutamine	PA	D000318	Adrenergic beta-Agonists	MeSH
DB00841	937	dobutamine	has role	CHEBI:38147	cardiotonic drug	CHEBI
DB00841	937	dobutamine	has role	CHEBI:35524	sympathomimetic agent	CHEBI
DB00841	937	dobutamine	has role	CHEBI:35522	beta-adrenergic agonist	CHEBI
DB00841	937	dobutamine	PA	D002316	Cardiotonic Agents	MeSH
DB00841	937	dobutamine	PA	D002317	Cardiovascular Agents	MeSH
DB00841	937	dobutamine	PA	D018377	Neurotransmitter Agents	MeSH
DB00841	937	dobutamine	PA	D020011	Protective Agents	MeSH
DB00841	937	dobutamine	PA	D013566	Sympathomimetics	MeSH
DB00842	2015	oxazepam	EPC	N0000175694	Benzodiazepine	FDA
DB00842	2015	oxazepam	Chemical/Ingredient	N0000007542	Benzodiazepines	FDA
DB00842	2015	oxazepam	PA	D014151	Anti-Anxiety Agents	MeSH
DB00842	2015	oxazepam	has role	CHEBI:35474	anxiolytic drug	CHEBI
DB00842	2015	oxazepam	PA	D002491	Central Nervous System Agents	MeSH
DB00842	2015	oxazepam	PA	D002492	Central Nervous System Depressants	MeSH
DB00842	2015	oxazepam	PA	D018682	GABA Agents	MeSH
DB00842	2015	oxazepam	PA	D018757	GABA Modulators	MeSH
DB00842	2015	oxazepam	PA	D006993	Hypnotics and Sedatives	MeSH
DB00842	2015	oxazepam	PA	D018377	Neurotransmitter Agents	MeSH
DB00842	2015	oxazepam	PA	D011619	Psychotropic Drugs	MeSH
DB00842	2015	oxazepam	PA	D014149	Tranquilizing Agents	MeSH
DB00843	946	donepezil	EPC	N0000175723	Cholinesterase Inhibitor	FDA
DB00843	946	donepezil	has role	CHEBI:66980	nootropic agent	CHEBI
DB00843	946	donepezil	PA	D002491	Central Nervous System Agents	MeSH
DB00843	946	donepezil	PA	D018678	Cholinergic Agents	MeSH
DB00843	946	donepezil	PA	D002800	Cholinesterase Inhibitors	MeSH
DB00843	946	donepezil	PA	D004791	Enzyme Inhibitors	MeSH
DB00843	946	donepezil	PA	D018377	Neurotransmitter Agents	MeSH
DB00843	946	donepezil	PA	D018697	Nootropic Agents	MeSH
DB07701	946	donepezil	EPC	N0000175723	Cholinesterase Inhibitor	FDA
DB07701	946	donepezil	has role	CHEBI:66980	nootropic agent	CHEBI
DB07701	946	donepezil	PA	D002491	Central Nervous System Agents	MeSH
DB07701	946	donepezil	PA	D018678	Cholinergic Agents	MeSH
DB07701	946	donepezil	PA	D002800	Cholinesterase Inhibitors	MeSH
DB07701	946	donepezil	PA	D004791	Enzyme Inhibitors	MeSH
DB07701	946	donepezil	PA	D018377	Neurotransmitter Agents	MeSH
DB07701	946	donepezil	PA	D018697	Nootropic Agents	MeSH
DB00844	1874	nalbuphine	MoA	N0000175686	Competitive Opioid Antagonists	FDA
DB00844	1874	nalbuphine	EPC	N0000175692	Opioid Agonist/Antagonist	FDA
DB00844	1874	nalbuphine	MoA	N0000175685	Partial Opioid Agonists	FDA
DB00844	1874	nalbuphine	PA	D000700	Analgesics	MeSH
DB00844	1874	nalbuphine	PA	D000701	Analgesics, Opioid	MeSH
DB00844	1874	nalbuphine	has role	CHEBI:35482	opioid analgesic	CHEBI
DB00844	1874	nalbuphine	PA	D002491	Central Nervous System Agents	MeSH
DB00844	1874	nalbuphine	PA	D002492	Central Nervous System Depressants	MeSH
DB00844	1874	nalbuphine	PA	D009292	Narcotic Antagonists	MeSH
DB00844	1874	nalbuphine	PA	D009294	Narcotics	MeSH
DB00844	1874	nalbuphine	PA	D018689	Sensory System Agents	MeSH
DB00846	1217	fludroxycortide	EPC	N0000175576	Corticosteroid	FDA
DB00846	1217	fludroxycortide	MoA	N0000175450	Corticosteroid Hormone Receptor Agonists	FDA
DB00846	1217	fludroxycortide	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00846	1217	fludroxycortide	PA	D005938	Glucocorticoids	MeSH
DB00846	1217	fludroxycortide	PA	D006728	Hormones	MeSH
DB00848	1561	levamisole	PA	D000276	Adjuvants, Immunologic	MeSH
DB00848	1561	levamisole	PA	D000871	Anthelmintics	MeSH
DB00848	1561	levamisole	PA	D000890	Anti-Infective Agents	MeSH
DB00848	1561	levamisole	has role	CHEBI:35444	antinematodal drug	CHEBI
DB00848	1561	levamisole	has role	CHEBI:35842	antirheumatic drug	CHEBI
DB00848	1561	levamisole	has role	CHEBI:50846	immunomodulator	CHEBI
DB00848	1561	levamisole	has role	CHEBI:50847	immunological adjuvant	CHEBI
DB00848	1561	levamisole	PA	D000969	Antinematodal Agents	MeSH
DB00848	1561	levamisole	PA	D000977	Antiparasitic Agents	MeSH
DB00848	1561	levamisole	PA	D018501	Antirheumatic Agents	MeSH
DB00848	1561	levamisole	PA	D007155	Immunologic Factors	MeSH
DB00850	2113	perphenazine	EPC	N0000175746	Phenothiazine	FDA
DB00850	2113	perphenazine	Chemical/Ingredient	N0000007544	Phenothiazines	FDA
DB00850	2113	perphenazine	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB00850	2113	perphenazine	has role	CHEBI:50919	antiemetic	CHEBI
DB00850	2113	perphenazine	has role	CHEBI:37930	phenothiazine antipsychotic drug	CHEBI
DB00850	2113	perphenazine	PA	D014150	Antipsychotic Agents	MeSH
DB00850	2113	perphenazine	PA	D002491	Central Nervous System Agents	MeSH
DB00850	2113	perphenazine	PA	D002492	Central Nervous System Depressants	MeSH
DB00850	2113	perphenazine	PA	D015259	Dopamine Agents	MeSH
DB00850	2113	perphenazine	PA	D018492	Dopamine Antagonists	MeSH
DB00850	2113	perphenazine	PA	D018377	Neurotransmitter Agents	MeSH
DB00850	2113	perphenazine	PA	D011619	Psychotropic Drugs	MeSH
DB00850	2113	perphenazine	PA	D014149	Tranquilizing Agents	MeSH
DB00852	1024	ephedrine	PA	D018663	Adrenergic Agents	MeSH
DB00852	1024	ephedrine	has role	CHEBI:35524	sympathomimetic agent	CHEBI
DB00852	1024	ephedrine	has role	CHEBI:50514	vasoconstrictor agent	CHEBI
DB00852	1024	ephedrine	has role	CHEBI:77715	nasal decongestant	CHEBI
DB00852	1024	ephedrine	PA	D002317	Cardiovascular Agents	MeSH
DB00852	1024	ephedrine	PA	D002491	Central Nervous System Agents	MeSH
DB00852	1024	ephedrine	PA	D000697	Central Nervous System Stimulants	MeSH
DB00852	1024	ephedrine	PA	D018377	Neurotransmitter Agents	MeSH
DB00852	1024	ephedrine	PA	D013566	Sympathomimetics	MeSH
DB00852	1024	ephedrine	PA	D014662	Vasoconstrictor Agents	MeSH
DB01364	1024	ephedrine	PA	D018663	Adrenergic Agents	MeSH
DB01364	1024	ephedrine	has role	CHEBI:35524	sympathomimetic agent	CHEBI
DB01364	1024	ephedrine	has role	CHEBI:50514	vasoconstrictor agent	CHEBI
DB01364	1024	ephedrine	has role	CHEBI:77715	nasal decongestant	CHEBI
DB01364	1024	ephedrine	PA	D002317	Cardiovascular Agents	MeSH
DB01364	1024	ephedrine	PA	D002491	Central Nervous System Agents	MeSH
DB01364	1024	ephedrine	PA	D000697	Central Nervous System Stimulants	MeSH
DB01364	1024	ephedrine	PA	D018377	Neurotransmitter Agents	MeSH
DB01364	1024	ephedrine	PA	D013566	Sympathomimetics	MeSH
DB01364	1024	ephedrine	PA	D014662	Vasoconstrictor Agents	MeSH
DB00854	1574	levorphanol	MoA	N0000175684	Full Opioid Agonists	FDA
DB00854	1574	levorphanol	EPC	N0000175690	Opioid Agonist	FDA
DB00854	1574	levorphanol	PA	D000700	Analgesics	MeSH
DB00854	1574	levorphanol	PA	D000701	Analgesics, Opioid	MeSH
DB00854	1574	levorphanol	PA	D002491	Central Nervous System Agents	MeSH
DB00854	1574	levorphanol	PA	D002492	Central Nervous System Depressants	MeSH
DB00854	1574	levorphanol	PA	D009294	Narcotics	MeSH
DB00854	1574	levorphanol	PA	D018689	Sensory System Agents	MeSH
DB00857	2597	terbinafine	Chemical/Ingredient	N0000007522	Allylamine	FDA
DB00857	2597	terbinafine	EPC	N0000175874	Allylamine Antifungal	FDA
DB00857	2597	terbinafine	PA	D000890	Anti-Infective Agents	MeSH
DB00857	2597	terbinafine	PA	D000935	Antifungal Agents	MeSH
DB00857	2597	terbinafine	PA	D004791	Enzyme Inhibitors	MeSH
DB00860	2245	prednisolone	EPC	N0000175576	Corticosteroid	FDA
DB00860	2245	prednisolone	MoA	N0000175450	Corticosteroid Hormone Receptor Agonists	FDA
DB00860	2245	prednisolone	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00860	2245	prednisolone	has role	CHEBI:37962	adrenergic agent	CHEBI
DB00860	2245	prednisolone	has role	CHEBI:35472	anti-inflammatory drug	CHEBI
DB00860	2245	prednisolone	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00860	2245	prednisolone	has role	CHEBI:35705	immunosuppressive agent	CHEBI
DB00860	2245	prednisolone	PA	D000970	Antineoplastic Agents	MeSH
DB00860	2245	prednisolone	PA	D018931	Antineoplastic Agents, Hormonal	MeSH
DB00860	2245	prednisolone	PA	D005938	Glucocorticoids	MeSH
DB00860	2245	prednisolone	PA	D006728	Hormones	MeSH
DB00861	880	diflunisal	Chemical/Ingredient	N0000175721	Nonsteroidal Anti-inflammatory Compounds	FDA
DB00861	880	diflunisal	EPC	N0000175722	Nonsteroidal Anti-inflammatory Drug	FDA
DB00861	880	diflunisal	PA	D000700	Analgesics	MeSH
DB00861	880	diflunisal	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00861	880	diflunisal	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00861	880	diflunisal	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00861	880	diflunisal	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00861	880	diflunisal	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB00861	880	diflunisal	PA	D018501	Antirheumatic Agents	MeSH
DB00861	880	diflunisal	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB00861	880	diflunisal	PA	D004791	Enzyme Inhibitors	MeSH
DB00861	880	diflunisal	PA	D018689	Sensory System Agents	MeSH
DB00862	2809	vardenafil	EPC	N0000175599	Phosphodiesterase 5 Inhibitor	FDA
DB00862	2809	vardenafil	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00862	2809	vardenafil	PA	D002317	Cardiovascular Agents	MeSH
DB00862	2809	vardenafil	PA	D004791	Enzyme Inhibitors	MeSH
DB00862	2809	vardenafil	PA	D058986	Phosphodiesterase 5 Inhibitors	MeSH
DB00862	2809	vardenafil	PA	D010726	Phosphodiesterase Inhibitors	MeSH
DB00862	2809	vardenafil	PA	D064804	Urological Agents	MeSH
DB00862	2809	vardenafil	PA	D014665	Vasodilator Agents	MeSH
DB00863	2358	ranitidine	MoA	N0000000151	Histamine H2 Receptor Antagonists	FDA
DB00863	2358	ranitidine	EPC	N0000175784	Histamine-2 Receptor Antagonist	FDA
DB00863	2358	ranitidine	has role	CHEBI:37961	H2-receptor antagonist	CHEBI
DB00863	2358	ranitidine	has role	CHEBI:49201	anti-ulcer drug	CHEBI
DB00863	2358	ranitidine	has role	CHEBI:88188	drug allergen	CHEBI
DB00863	2358	ranitidine	PA	D000897	Anti-Ulcer Agents	MeSH
DB00863	2358	ranitidine	PA	D005765	Gastrointestinal Agents	MeSH
DB00863	2358	ranitidine	PA	D018494	Histamine Agents	MeSH
DB00863	2358	ranitidine	PA	D006633	Histamine Antagonists	MeSH
DB00863	2358	ranitidine	PA	D006635	Histamine H2 Antagonists	MeSH
DB00863	2358	ranitidine	PA	D018377	Neurotransmitter Agents	MeSH
DB00864	2552	tacrolimus	EPC	N0000175457	Calcineurin Inhibitor Immunosuppressant	FDA
DB00864	2552	tacrolimus	has role	CHEBI:35705	immunosuppressive agent	CHEBI
DB00864	2552	tacrolimus	PA	D065095	Calcineurin Inhibitors	MeSH
DB00864	2552	tacrolimus	PA	D004791	Enzyme Inhibitors	MeSH
DB00864	2552	tacrolimus	PA	D007155	Immunologic Factors	MeSH
DB00864	2552	tacrolimus	PA	D007166	Immunosuppressive Agents	MeSH
DB00865	329	benzphetamine	PE	N0000175372	Appetite Suppression	FDA
DB00865	329	benzphetamine	PE	N0000175651	Increased Sympathetic Activity	FDA
DB00865	329	benzphetamine	EPC	N0000175423	Sympathomimetic Amine Anorectic	FDA
DB00865	329	benzphetamine	PA	D018663	Adrenergic Agents	MeSH
DB00865	329	benzphetamine	PA	D018759	Adrenergic Uptake Inhibitors	MeSH
DB00865	329	benzphetamine	has role	CHEBI:35524	sympathomimetic agent	CHEBI
DB00865	329	benzphetamine	has role	CHEBI:51039	dopamine uptake inhibitor	CHEBI
DB00865	329	benzphetamine	has role	CHEBI:50507	appetite depressant	CHEBI
DB00865	329	benzphetamine	has role	CHEBI:35640	adrenergic uptake inhibitor	CHEBI
DB00865	329	benzphetamine	PA	D002491	Central Nervous System Agents	MeSH
DB00865	329	benzphetamine	PA	D000697	Central Nervous System Stimulants	MeSH
DB00865	329	benzphetamine	PA	D015259	Dopamine Agents	MeSH
DB00865	329	benzphetamine	PA	D018765	Dopamine Uptake Inhibitors	MeSH
DB00865	329	benzphetamine	PA	D049990	Membrane Transport Modulators	MeSH
DB00865	329	benzphetamine	PA	D018377	Neurotransmitter Agents	MeSH
DB00865	329	benzphetamine	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB00865	329	benzphetamine	PA	D013566	Sympathomimetics	MeSH
DB00866	137	alprenolol	PA	D018663	Adrenergic Agents	MeSH
DB00866	137	alprenolol	PA	D018674	Adrenergic Antagonists	MeSH
DB00866	137	alprenolol	PA	D000319	Adrenergic beta-Antagonists	MeSH
DB00866	137	alprenolol	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB00866	137	alprenolol	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB00866	137	alprenolol	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00866	137	alprenolol	has role	CHEBI:35530	beta-adrenergic antagonist	CHEBI
DB00866	137	alprenolol	has role	CHEBI:66991	sympatholytic agent	CHEBI
DB00866	137	alprenolol	PA	D000959	Antihypertensive Agents	MeSH
DB00866	137	alprenolol	PA	D002317	Cardiovascular Agents	MeSH
DB00866	137	alprenolol	PA	D018377	Neurotransmitter Agents	MeSH
DB00866	137	alprenolol	PA	D013565	Sympatholytics	MeSH
DB00867	2390	ritodrine	PA	D018663	Adrenergic Agents	MeSH
DB00867	2390	ritodrine	PA	D000322	Adrenergic Agonists	MeSH
DB00867	2390	ritodrine	PA	D058666	Adrenergic beta-2 Receptor Agonists	MeSH
DB00867	2390	ritodrine	PA	D000318	Adrenergic beta-Agonists	MeSH
DB00867	2390	ritodrine	PA	D018377	Neurotransmitter Agents	MeSH
DB00867	2390	ritodrine	PA	D012102	Reproductive Control Agents	MeSH
DB00867	2390	ritodrine	PA	D013566	Sympathomimetics	MeSH
DB00867	2390	ritodrine	PA	D015149	Tocolytic Agents	MeSH
DB00869	949	dorzolamide	EPC	N0000175517	Carbonic Anhydrase Inhibitor	FDA
DB00869	949	dorzolamide	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00869	949	dorzolamide	has role	CHEBI:39456	antiglaucoma drug	CHEBI
DB00869	949	dorzolamide	PA	D000959	Antihypertensive Agents	MeSH
DB00869	949	dorzolamide	PA	D002257	Carbonic Anhydrase Inhibitors	MeSH
DB00869	949	dorzolamide	PA	D002317	Cardiovascular Agents	MeSH
DB00869	949	dorzolamide	PA	D004791	Enzyme Inhibitors	MeSH
DB00870	2546	suprofen	PA	D000700	Analgesics	MeSH
DB00870	2546	suprofen	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00870	2546	suprofen	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00870	2546	suprofen	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00870	2546	suprofen	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB00870	2546	suprofen	has role	CHEBI:35842	antirheumatic drug	CHEBI
DB00870	2546	suprofen	has role	CHEBI:49110	peripheral nervous system drug	CHEBI
DB00870	2546	suprofen	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00870	2546	suprofen	PA	D018501	Antirheumatic Agents	MeSH
DB00870	2546	suprofen	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB00870	2546	suprofen	PA	D004791	Enzyme Inhibitors	MeSH
DB00870	2546	suprofen	PA	D018689	Sensory System Agents	MeSH
DB00871	2598	terbutaline	PA	D018663	Adrenergic Agents	MeSH
DB00871	2598	terbutaline	PA	D000322	Adrenergic Agonists	MeSH
DB00871	2598	terbutaline	PA	D058666	Adrenergic beta-2 Receptor Agonists	MeSH
DB00871	2598	terbutaline	PA	D000318	Adrenergic beta-Agonists	MeSH
DB00871	2598	terbutaline	PA	D018927	Anti-Asthmatic Agents	MeSH
DB00871	2598	terbutaline	has role	CHEBI:35526	hypoglycemic agent	CHEBI
DB00871	2598	terbutaline	has role	CHEBI:35522	beta-adrenergic agonist	CHEBI
DB00871	2598	terbutaline	has role	CHEBI:49167	anti-asthmatic drug	CHEBI
DB00871	2598	terbutaline	has role	CHEBI:35523	bronchodilator agent	CHEBI
DB00871	2598	terbutaline	has role	CHEBI:35524	sympathomimetic agent	CHEBI
DB00871	2598	terbutaline	has role	CHEBI:66993	tocolytic agent	CHEBI
DB00871	2598	terbutaline	PA	D001993	Bronchodilator Agents	MeSH
DB00871	2598	terbutaline	PA	D018377	Neurotransmitter Agents	MeSH
DB00871	2598	terbutaline	PA	D012102	Reproductive Control Agents	MeSH
DB00871	2598	terbutaline	PA	D019141	Respiratory System Agents	MeSH
DB00871	2598	terbutaline	PA	D013566	Sympathomimetics	MeSH
DB00871	2598	terbutaline	PA	D015149	Tocolytic Agents	MeSH
DB00872	732	conivaptan	MoA	N0000009945	Antidiuretic Hormone Antagonists	FDA
DB00872	732	conivaptan	EPC	N0000178376	Vasopressin Antagonist	FDA
DB00872	732	conivaptan	has role	CHEBI:59680	vasopressin  receptor antagonist	CHEBI
DB00872	732	conivaptan	PA	D065092	Antidiuretic Hormone Receptor Antagonists	MeSH
DB00872	732	conivaptan	PA	D045283	Natriuretic Agents	MeSH
DB00876	1037	eprosartan	MoA	N0000000070	Angiotensin 2 Receptor Antagonists	FDA
DB00876	1037	eprosartan	EPC	N0000175561	Angiotensin 2 Receptor Blocker	FDA
DB00876	1037	eprosartan	PA	D057912	Angiotensin II Type 2 Receptor Blockers	MeSH
DB00876	1037	eprosartan	PA	D057911	Angiotensin Receptor Antagonists	MeSH
DB00876	1037	eprosartan	has role	CHEBI:61016	angiotensin receptor antagonist	CHEBI
DB00876	1037	eprosartan	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00876	1037	eprosartan	PA	D000959	Antihypertensive Agents	MeSH
DB00876	1037	eprosartan	PA	D002317	Cardiovascular Agents	MeSH
DB00877	2446	sirolimus	PE	N0000175550	Decreased Immunologic Activity	FDA
DB00877	2446	sirolimus	EPC	N0000175625	mTOR Inhibitor Immunosuppressant	FDA
DB00877	2446	sirolimus	MoA	N0000175624	mTOR Inhibitors	FDA
DB00877	2446	sirolimus	PA	D000900	Anti-Bacterial Agents	MeSH
DB00877	2446	sirolimus	PA	D000890	Anti-Infective Agents	MeSH
DB00877	2446	sirolimus	has role	CHEBI:35705	immunosuppressive agent	CHEBI
DB00877	2446	sirolimus	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00877	2446	sirolimus	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00877	2446	sirolimus	PA	D000903	Antibiotics, Antineoplastic	MeSH
DB00877	2446	sirolimus	PA	D000935	Antifungal Agents	MeSH
DB00877	2446	sirolimus	PA	D000970	Antineoplastic Agents	MeSH
DB00877	2446	sirolimus	PA	D007155	Immunologic Factors	MeSH
DB00877	2446	sirolimus	PA	D007166	Immunosuppressive Agents	MeSH
DB00879	1003	emtricitabine	EPC	N0000175462	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor	FDA
DB00879	1003	emtricitabine	Chemical/Ingredient	N0000175459	Nucleoside Analog	FDA
DB00879	1003	emtricitabine	MoA	N0000009947	Nucleoside Reverse Transcriptase Inhibitors	FDA
DB00879	1003	emtricitabine	PA	D019380	Anti-HIV Agents	MeSH
DB00879	1003	emtricitabine	PA	D000890	Anti-Infective Agents	MeSH
DB00879	1003	emtricitabine	has role	CHEBI:36044	antiviral drug	CHEBI
DB00879	1003	emtricitabine	PA	D000998	Antiviral Agents	MeSH
DB00879	1003	emtricitabine	PA	D004791	Enzyme Inhibitors	MeSH
DB00879	1003	emtricitabine	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB00879	1003	emtricitabine	PA	D018894	Reverse Transcriptase Inhibitors	MeSH
DB00880	609	chlorothiazide	PE	N0000175359	Increased Diuresis	FDA
DB00880	609	chlorothiazide	EPC	N0000175419	Thiazide Diuretic	FDA
DB00880	609	chlorothiazide	Chemical/Ingredient	N0000166469	Thiazides	FDA
DB00880	609	chlorothiazide	has role	CHEBI:35498	diuretic	CHEBI
DB00880	609	chlorothiazide	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00880	609	chlorothiazide	PA	D000959	Antihypertensive Agents	MeSH
DB00880	609	chlorothiazide	PA	D002317	Cardiovascular Agents	MeSH
DB00880	609	chlorothiazide	PA	D004232	Diuretics	MeSH
DB00880	609	chlorothiazide	PA	D049990	Membrane Transport Modulators	MeSH
DB00880	609	chlorothiazide	PA	D045283	Natriuretic Agents	MeSH
DB00880	609	chlorothiazide	PA	D049993	Sodium Chloride Symporter Inhibitors	MeSH
DB00881	2340	quinapril	EPC	N0000175562	Angiotensin Converting Enzyme Inhibitor	FDA
DB00881	2340	quinapril	PA	D000806	Angiotensin-Converting Enzyme Inhibitors	MeSH
DB00881	2340	quinapril	has role	CHEBI:35457	EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor	CHEBI
DB00881	2340	quinapril	PA	D000959	Antihypertensive Agents	MeSH
DB00881	2340	quinapril	PA	D002317	Cardiovascular Agents	MeSH
DB00881	2340	quinapril	PA	D004791	Enzyme Inhibitors	MeSH
DB00881	2340	quinapril	PA	D011480	Protease Inhibitors	MeSH
DB00882	700	clomifene	EPC	N0000175826	Estrogen Agonist/Antagonist	FDA
DB00882	700	clomifene	has role	CHEBI:50751	anti-estrogen	CHEBI
DB00882	700	clomifene	PA	D004965	Estrogen Antagonists	MeSH
DB00882	700	clomifene	PA	D020847	Estrogen Receptor Modulators	MeSH
DB00882	700	clomifene	PA	D005300	Fertility Agents, Female	MeSH
DB00882	700	clomifene	PA	D006727	Hormone Antagonists	MeSH
DB00882	700	clomifene	PA	D012102	Reproductive Control Agents	MeSH
DB00882	700	clomifene	PA	D020845	Selective Estrogen Receptor Modulators	MeSH
DB00883	1505	isosorbide dinitrate	EPC	N0000175415	Nitrate Vasodilator	FDA
DB00883	1505	isosorbide dinitrate	Chemical/Ingredient	N0000007647	Nitrates	FDA
DB00883	1505	isosorbide dinitrate	PE	N0000009909	Vasodilation	FDA
DB00883	1505	isosorbide dinitrate	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00883	1505	isosorbide dinitrate	PA	D002317	Cardiovascular Agents	MeSH
DB00883	1505	isosorbide dinitrate	PA	D020030	Nitric Oxide Donors	MeSH
DB00883	1505	isosorbide dinitrate	PA	D014665	Vasodilator Agents	MeSH
DB00884	2387	risedronic acid	EPC	N0000175579	Bisphosphonate	FDA
DB00884	2387	risedronic acid	Chemical/Ingredient	N0000007707	Diphosphonates	FDA
DB00884	2387	risedronic acid	PA	D050071	Bone Density Conservation Agents	MeSH
DB00884	2387	risedronic acid	PA	D002121	Calcium Channel Blockers	MeSH
DB00884	2387	risedronic acid	PA	D002317	Cardiovascular Agents	MeSH
DB00884	2387	risedronic acid	PA	D049990	Membrane Transport Modulators	MeSH
DB00887	427	bumetanide	PE	N0000175366	Increased Diuresis at Loop of Henle	FDA
DB00887	427	bumetanide	EPC	N0000175590	Loop Diuretic	FDA
DB00887	427	bumetanide	has role	CHEBI:35498	diuretic	CHEBI
DB00887	427	bumetanide	PA	D004232	Diuretics	MeSH
DB00887	427	bumetanide	PA	D049990	Membrane Transport Modulators	MeSH
DB00887	427	bumetanide	PA	D045283	Natriuretic Agents	MeSH
DB00887	427	bumetanide	PA	D049994	Sodium Potassium Chloride Symporter Inhibitors	MeSH
DB00889	1329	granisetron	MoA	N0000175817	Serotonin 3 Receptor Antagonists	FDA
DB00889	1329	granisetron	EPC	N0000175818	Serotonin-3 Receptor Antagonist	FDA
DB00889	1329	granisetron	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB00889	1329	granisetron	has role	CHEBI:50919	antiemetic	CHEBI
DB00889	1329	granisetron	PA	D000932	Antiemetics	MeSH
DB00889	1329	granisetron	PA	D002491	Central Nervous System Agents	MeSH
DB00889	1329	granisetron	PA	D005765	Gastrointestinal Agents	MeSH
DB00889	1329	granisetron	PA	D018377	Neurotransmitter Agents	MeSH
DB00889	1329	granisetron	PA	D018490	Serotonin Agents	MeSH
DB00889	1329	granisetron	PA	D012702	Serotonin Antagonists	MeSH
DB00890	870	dienestrol	PA	D004967	Estrogens	MeSH
DB00890	870	dienestrol	PA	D004968	Estrogens, Non-Steroidal	MeSH
DB00890	870	dienestrol	PA	D006728	Hormones	MeSH
DB00891	2524	sulfapyridine	PA	D000890	Anti-Infective Agents	MeSH
DB00891	2524	sulfapyridine	has role	CHEBI:35441	antiinfective agent	CHEBI
DB00891	2524	sulfapyridine	has role	CHEBI:50177	dermatologic drug	CHEBI
DB00891	2524	sulfapyridine	PA	D003879	Dermatologic Agents	MeSH
DB00892	3016	oxybuprocaine	PA	D000777	Anesthetics	MeSH
DB00892	3016	oxybuprocaine	PA	D000779	Anesthetics, Local	MeSH
DB00892	3016	oxybuprocaine	has role	CHEBI:36333	local anaesthetic	CHEBI
DB00892	3016	oxybuprocaine	PA	D002491	Central Nervous System Agents	MeSH
DB00892	3016	oxybuprocaine	PA	D002492	Central Nervous System Depressants	MeSH
DB00892	3016	oxybuprocaine	PA	D018689	Sensory System Agents	MeSH
DB00894	2606	testolactone	EPC	N0000175563	Aromatase Inhibitor	FDA
DB00894	2606	testolactone	MoA	N0000175080	Aromatase Inhibitors	FDA
DB00894	2606	testolactone	PA	D000970	Antineoplastic Agents	MeSH
DB00894	2606	testolactone	PA	D018931	Antineoplastic Agents, Hormonal	MeSH
DB00896	2384	rimexolone	EPC	N0000175576	Corticosteroid	FDA
DB00896	2384	rimexolone	MoA	N0000175450	Corticosteroid Hormone Receptor Agonists	FDA
DB00896	2384	rimexolone	PA	D005938	Glucocorticoids	MeSH
DB00896	2384	rimexolone	PA	D006728	Hormones	MeSH
DB00897	2729	triazolam	EPC	N0000175694	Benzodiazepine	FDA
DB00897	2729	triazolam	Chemical/Ingredient	N0000007542	Benzodiazepines	FDA
DB00897	2729	triazolam	PA	D000759	Adjuvants, Anesthesia	MeSH
DB00897	2729	triazolam	PA	D014151	Anti-Anxiety Agents	MeSH
DB00897	2729	triazolam	PA	D002491	Central Nervous System Agents	MeSH
DB00897	2729	triazolam	PA	D002492	Central Nervous System Depressants	MeSH
DB00897	2729	triazolam	PA	D018682	GABA Agents	MeSH
DB00897	2729	triazolam	PA	D018757	GABA Modulators	MeSH
DB00897	2729	triazolam	PA	D018377	Neurotransmitter Agents	MeSH
DB00897	2729	triazolam	PA	D011619	Psychotropic Drugs	MeSH
DB00897	2729	triazolam	PA	D014149	Tranquilizing Agents	MeSH
DB00899	2363	remifentanil	MoA	N0000175684	Full Opioid Agonists	FDA
DB00899	2363	remifentanil	EPC	N0000175690	Opioid Agonist	FDA
DB00899	2363	remifentanil	PA	D000700	Analgesics	MeSH
DB00899	2363	remifentanil	PA	D000701	Analgesics, Opioid	MeSH
DB00899	2363	remifentanil	PA	D000777	Anesthetics	MeSH
DB00899	2363	remifentanil	PA	D018686	Anesthetics, Intravenous	MeSH
DB00899	2363	remifentanil	has role	CHEBI:55322	mu-opioid receptor agonist	CHEBI
DB00899	2363	remifentanil	has role	CHEBI:35482	opioid analgesic	CHEBI
DB00899	2363	remifentanil	has role	CHEBI:38877	intravenous anaesthetic	CHEBI
DB00899	2363	remifentanil	has role	CHEBI:35717	sedative	CHEBI
DB00899	2363	remifentanil	PA	D002491	Central Nervous System Agents	MeSH
DB00899	2363	remifentanil	PA	D002492	Central Nervous System Depressants	MeSH
DB00899	2363	remifentanil	PA	D006993	Hypnotics and Sedatives	MeSH
DB00899	2363	remifentanil	PA	D009294	Narcotics	MeSH
DB00899	2363	remifentanil	PA	D018689	Sensory System Agents	MeSH
DB00900	869	didanosine	EPC	N0000175462	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor	FDA
DB00900	869	didanosine	Chemical/Ingredient	N0000175459	Nucleoside Analog	FDA
DB00900	869	didanosine	MoA	N0000009947	Nucleoside Reverse Transcriptase Inhibitors	FDA
DB00900	869	didanosine	PA	D019380	Anti-HIV Agents	MeSH
DB00900	869	didanosine	PA	D000890	Anti-Infective Agents	MeSH
DB00900	869	didanosine	has role	CHEBI:36044	antiviral drug	CHEBI
DB00900	869	didanosine	PA	D000963	Antimetabolites	MeSH
DB00900	869	didanosine	PA	D000998	Antiviral Agents	MeSH
DB00900	869	didanosine	PA	D004791	Enzyme Inhibitors	MeSH
DB00900	869	didanosine	PA	D009676	Noxae	MeSH
DB00900	869	didanosine	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB00900	869	didanosine	PA	D018894	Reverse Transcriptase Inhibitors	MeSH
DB00901	384	bitolterol	PA	D018663	Adrenergic Agents	MeSH
DB00901	384	bitolterol	PA	D000322	Adrenergic Agonists	MeSH
DB00901	384	bitolterol	PA	D058666	Adrenergic beta-2 Receptor Agonists	MeSH
DB00901	384	bitolterol	PA	D000318	Adrenergic beta-Agonists	MeSH
DB00901	384	bitolterol	PA	D018927	Anti-Asthmatic Agents	MeSH
DB00901	384	bitolterol	has role	CHEBI:35523	bronchodilator agent	CHEBI
DB00901	384	bitolterol	has role	CHEBI:49167	anti-asthmatic drug	CHEBI
DB00901	384	bitolterol	has role	CHEBI:35522	beta-adrenergic agonist	CHEBI
DB00901	384	bitolterol	has role	CHEBI:50266	prodrug	CHEBI
DB00901	384	bitolterol	PA	D001993	Bronchodilator Agents	MeSH
DB00901	384	bitolterol	PA	D018377	Neurotransmitter Agents	MeSH
DB00901	384	bitolterol	PA	D019141	Respiratory System Agents	MeSH
DB00903	1071	ethacrynic acid	PE	N0000175366	Increased Diuresis at Loop of Henle	FDA
DB00903	1071	ethacrynic acid	has role	CHEBI:77608	loop diuretic	CHEBI
DB00903	1071	ethacrynic acid	PA	D004232	Diuretics	MeSH
DB00903	1071	ethacrynic acid	PA	D004791	Enzyme Inhibitors	MeSH
DB00903	1071	ethacrynic acid	PA	D045283	Natriuretic Agents	MeSH
DB00904	1992	ondansetron	MoA	N0000175817	Serotonin 3 Receptor Antagonists	FDA
DB00904	1992	ondansetron	EPC	N0000175818	Serotonin-3 Receptor Antagonist	FDA
DB00904	1992	ondansetron	PA	D014151	Anti-Anxiety Agents	MeSH
DB00904	1992	ondansetron	PA	D000932	Antiemetics	MeSH
DB00904	1992	ondansetron	PA	D000982	Antipruritics	MeSH
DB00904	1992	ondansetron	PA	D014150	Antipsychotic Agents	MeSH
DB00904	1992	ondansetron	PA	D002491	Central Nervous System Agents	MeSH
DB00904	1992	ondansetron	PA	D002492	Central Nervous System Depressants	MeSH
DB00904	1992	ondansetron	PA	D003879	Dermatologic Agents	MeSH
DB00904	1992	ondansetron	PA	D005765	Gastrointestinal Agents	MeSH
DB00904	1992	ondansetron	PA	D018377	Neurotransmitter Agents	MeSH
DB00904	1992	ondansetron	PA	D011619	Psychotropic Drugs	MeSH
DB00904	1992	ondansetron	PA	D018490	Serotonin Agents	MeSH
DB00904	1992	ondansetron	PA	D012702	Serotonin Antagonists	MeSH
DB00904	1992	ondansetron	PA	D014149	Tranquilizing Agents	MeSH
DB00905	371	bimatoprost	EPC	N0000175454	Prostaglandin Analog	FDA
DB00905	371	bimatoprost	Chemical/Ingredient	N0000007706	Prostaglandins	FDA
DB00905	371	bimatoprost	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00905	371	bimatoprost	has role	CHEBI:39456	antiglaucoma drug	CHEBI
DB00905	371	bimatoprost	PA	D000959	Antihypertensive Agents	MeSH
DB00905	371	bimatoprost	PA	D002317	Cardiovascular Agents	MeSH
DB00906	2648	tiagabine	EPC	N0000175753	Anti-epileptic Agent	FDA
DB00906	2648	tiagabine	PE	N0000008486	Decreased Central Nervous System Disorganized Electrical Activity	FDA
DB00906	2648	tiagabine	has role	CHEBI:85384	GABA reuptake inhibitor	CHEBI
DB00906	2648	tiagabine	has role	CHEBI:35623	anticonvulsant	CHEBI
DB00906	2648	tiagabine	PA	D000927	Anticonvulsants	MeSH
DB00906	2648	tiagabine	PA	D002491	Central Nervous System Agents	MeSH
DB00906	2648	tiagabine	PA	D018682	GABA Agents	MeSH
DB00906	2648	tiagabine	PA	D018755	GABA Agonists	MeSH
DB00906	2648	tiagabine	PA	D049990	Membrane Transport Modulators	MeSH
DB00906	2648	tiagabine	PA	D018377	Neurotransmitter Agents	MeSH
DB00906	2648	tiagabine	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB00907	723	cocaine	PA	D000777	Anesthetics	MeSH
DB00907	723	cocaine	PA	D000779	Anesthetics, Local	MeSH
DB00907	723	cocaine	has role	CHEBI:35640	adrenergic uptake inhibitor	CHEBI
DB00907	723	cocaine	has role	CHEBI:51039	dopamine uptake inhibitor	CHEBI
DB00907	723	cocaine	has role	CHEBI:50949	serotonin uptake inhibitor	CHEBI
DB00907	723	cocaine	has role	CHEBI:50514	vasoconstrictor agent	CHEBI
DB00907	723	cocaine	has role	CHEBI:36333	local anaesthetic	CHEBI
DB00907	723	cocaine	has role	CHEBI:35337	central nervous system stimulant	CHEBI
DB00907	723	cocaine	has role	CHEBI:35524	sympathomimetic agent	CHEBI
DB00907	723	cocaine	PA	D002317	Cardiovascular Agents	MeSH
DB00907	723	cocaine	PA	D002491	Central Nervous System Agents	MeSH
DB00907	723	cocaine	PA	D002492	Central Nervous System Depressants	MeSH
DB00907	723	cocaine	PA	D015259	Dopamine Agents	MeSH
DB00907	723	cocaine	PA	D018765	Dopamine Uptake Inhibitors	MeSH
DB00907	723	cocaine	PA	D049990	Membrane Transport Modulators	MeSH
DB00907	723	cocaine	PA	D018377	Neurotransmitter Agents	MeSH
DB00907	723	cocaine	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB00907	723	cocaine	PA	D018689	Sensory System Agents	MeSH
DB00907	723	cocaine	PA	D014662	Vasoconstrictor Agents	MeSH
DB00909	2872	zonisamide	EPC	N0000175753	Anti-epileptic Agent	FDA
DB00909	2872	zonisamide	PE	N0000008486	Decreased Central Nervous System Disorganized Electrical Activity	FDA
DB00909	2872	zonisamide	Chemical/Ingredient	N0000008048	Sulfonamides	FDA
DB00909	2872	zonisamide	MoA	N0000000235	Carbonic Anhydrase Inhibitors	FDA
DB00909	2872	zonisamide	MoA	N0000185503	P-Glycoprotein Inhibitors	FDA
DB00909	2872	zonisamide	has role	CHEBI:35623	anticonvulsant	CHEBI
DB00909	2872	zonisamide	has role	CHEBI:35470	central nervous system drug	CHEBI
DB00909	2872	zonisamide	has role	CHEBI:50267	protective agent	CHEBI
DB00909	2872	zonisamide	PA	D000927	Anticonvulsants	MeSH
DB00909	2872	zonisamide	PA	D000975	Antioxidants	MeSH
DB00909	2872	zonisamide	PA	D002491	Central Nervous System Agents	MeSH
DB00909	2872	zonisamide	PA	D020011	Protective Agents	MeSH
DB00910	2066	paricalcitol	Chemical/Ingredient	N0000006996	Cholecalciferol	FDA
DB00910	2066	paricalcitol	EPC	N0000175908	Vitamin D3 Analog	FDA
DB00910	2066	paricalcitol	has role	CHEBI:50827	antiparathyroid drug	CHEBI
DB00912	2366	repaglinide	EPC	N0000175428	Glinide	FDA
DB00912	2366	repaglinide	MoA	N0000175448	Potassium Channel Antagonists	FDA
DB00912	2366	repaglinide	PA	D007004	Hypoglycemic Agents	MeSH
DB00913	220	anileridine	has role	CHEBI:60606	opioid receptor agonist	CHEBI
DB00913	220	anileridine	has role	CHEBI:35482	opioid analgesic	CHEBI
DB00915	144	amantadine	EPC	N0000175543	Influenza A M2 Protein Inhibitor	FDA
DB00915	144	amantadine	MoA	N0000175542	M2 Protein Inhibitors	FDA
DB00915	144	amantadine	PA	D000700	Analgesics	MeSH
DB00915	144	amantadine	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00915	144	amantadine	PA	D018726	Anti-Dyskinesia Agents	MeSH
DB00915	144	amantadine	PA	D000890	Anti-Infective Agents	MeSH
DB00915	144	amantadine	has role	CHEBI:36044	antiviral drug	CHEBI
DB00915	144	amantadine	has role	CHEBI:48407	antiparkinson drug	CHEBI
DB00915	144	amantadine	has role	CHEBI:48560	dopaminergic agent	CHEBI
DB00915	144	amantadine	has role	CHEBI:35480	analgesic	CHEBI
DB00915	144	amantadine	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB00915	144	amantadine	PA	D000978	Antiparkinson Agents	MeSH
DB00915	144	amantadine	PA	D000998	Antiviral Agents	MeSH
DB00915	144	amantadine	PA	D002491	Central Nervous System Agents	MeSH
DB00915	144	amantadine	PA	D015259	Dopamine Agents	MeSH
DB00915	144	amantadine	PA	D018377	Neurotransmitter Agents	MeSH
DB00915	144	amantadine	PA	D018689	Sensory System Agents	MeSH
DB00917	913	dinoprostone	EPC	N0000175454	Prostaglandin Analog	FDA
DB00917	913	dinoprostone	Chemical/Ingredient	N0000007706	Prostaglandins	FDA
DB00917	913	dinoprostone	has role	CHEBI:36063	oxytocic	CHEBI
DB00917	913	dinoprostone	PA	D010120	Oxytocics	MeSH
DB00917	913	dinoprostone	PA	D012102	Reproductive Control Agents	MeSH
DB00918	128	almotriptan	MoA	N0000175763	Serotonin 1b Receptor Agonists	FDA
DB00918	128	almotriptan	MoA	N0000175764	Serotonin 1d Receptor Agonists	FDA
DB00918	128	almotriptan	EPC	N0000175765	Serotonin-1b and Serotonin-1d Receptor Agonist	FDA
DB00918	128	almotriptan	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00918	128	almotriptan	has role	CHEBI:35941	serotonergic agonist	CHEBI
DB00918	128	almotriptan	has role	CHEBI:50514	vasoconstrictor agent	CHEBI
DB00918	128	almotriptan	PA	D018377	Neurotransmitter Agents	MeSH
DB00918	128	almotriptan	PA	D018490	Serotonin Agents	MeSH
DB00918	128	almotriptan	PA	D017366	Serotonin Receptor Agonists	MeSH
DB00920	1530	ketotifen	MoA	N0000000190	Histamine H1 Receptor Antagonists	FDA
DB00920	1530	ketotifen	EPC	N0000175519	Histamine-1 Receptor Inhibitor	FDA
DB00920	1530	ketotifen	PA	D018926	Anti-Allergic Agents	MeSH
DB00920	1530	ketotifen	PA	D000982	Antipruritics	MeSH
DB00920	1530	ketotifen	PA	D003879	Dermatologic Agents	MeSH
DB00920	1530	ketotifen	PA	D018494	Histamine Agents	MeSH
DB00920	1530	ketotifen	PA	D006633	Histamine Antagonists	MeSH
DB00920	1530	ketotifen	PA	D006634	Histamine H1 Antagonists	MeSH
DB00920	1530	ketotifen	PA	D018377	Neurotransmitter Agents	MeSH
DB00921	434	buprenorphine	EPC	N0000175689	Partial Opioid Agonist	FDA
DB00921	434	buprenorphine	MoA	N0000175685	Partial Opioid Agonists	FDA
DB00921	434	buprenorphine	PA	D000700	Analgesics	MeSH
DB00921	434	buprenorphine	PA	D000701	Analgesics, Opioid	MeSH
DB00921	434	buprenorphine	has role	CHEBI:35482	opioid analgesic	CHEBI
DB00921	434	buprenorphine	has role	CHEBI:55322	mu-opioid receptor agonist	CHEBI
DB00921	434	buprenorphine	has role	CHEBI:59282	kappa-opioid receptor agonist	CHEBI
DB00921	434	buprenorphine	has role	CHEBI:59283	delta-opioid receptor antagonist	CHEBI
DB00921	434	buprenorphine	PA	D002491	Central Nervous System Agents	MeSH
DB00921	434	buprenorphine	PA	D002492	Central Nervous System Depressants	MeSH
DB00921	434	buprenorphine	PA	D009292	Narcotic Antagonists	MeSH
DB00921	434	buprenorphine	PA	D009294	Narcotics	MeSH
DB00921	434	buprenorphine	PA	D018689	Sensory System Agents	MeSH
DB00922	1576	levosimendan	has role	CHEBI:38147	cardiotonic drug	CHEBI
DB00922	1576	levosimendan	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00922	1576	levosimendan	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB00923	544	ceforanide	PA	D000900	Anti-Bacterial Agents	MeSH
DB00923	544	ceforanide	PA	D000890	Anti-Infective Agents	MeSH
DB00923	544	ceforanide	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00924	751	cyclobenzaprine	PE	N0000175730	Centrally-mediated Muscle Relaxation	FDA
DB00924	751	cyclobenzaprine	has role	CHEBI:51371	muscle relaxant	CHEBI
DB00924	751	cyclobenzaprine	has role	CHEBI:35473	tranquilizing drug	CHEBI
DB00924	751	cyclobenzaprine	has role	CHEBI:35469	antidepressant	CHEBI
DB00924	751	cyclobenzaprine	PA	D000928	Antidepressive Agents	MeSH
DB00924	751	cyclobenzaprine	PA	D000929	Antidepressive Agents, Tricyclic	MeSH
DB00924	751	cyclobenzaprine	PA	D002491	Central Nervous System Agents	MeSH
DB00924	751	cyclobenzaprine	PA	D002492	Central Nervous System Depressants	MeSH
DB00924	751	cyclobenzaprine	PA	D009125	Muscle Relaxants, Central	MeSH
DB00924	751	cyclobenzaprine	PA	D009465	Neuromuscular Agents	MeSH
DB00924	751	cyclobenzaprine	PA	D011619	Psychotropic Drugs	MeSH
DB00924	751	cyclobenzaprine	PA	D014149	Tranquilizing Agents	MeSH
DB00925	2136	phenoxybenzamine	EPC	N0000175553	alpha-Adrenergic Blocker	FDA
DB00925	2136	phenoxybenzamine	PA	D018663	Adrenergic Agents	MeSH
DB00925	2136	phenoxybenzamine	PA	D000317	Adrenergic alpha-Antagonists	MeSH
DB00925	2136	phenoxybenzamine	PA	D018674	Adrenergic Antagonists	MeSH
DB00925	2136	phenoxybenzamine	PA	D000959	Antihypertensive Agents	MeSH
DB00925	2136	phenoxybenzamine	PA	D002317	Cardiovascular Agents	MeSH
DB00925	2136	phenoxybenzamine	PA	D018377	Neurotransmitter Agents	MeSH
DB00925	2136	phenoxybenzamine	PA	D014665	Vasodilator Agents	MeSH
DB00926	1116	etretinate	has role	CHEBI:50176	keratolytic drug	CHEBI
DB00926	1116	etretinate	PA	D003879	Dermatologic Agents	MeSH
DB00926	1116	etretinate	PA	D007641	Keratolytic Agents	MeSH
DB00927	1129	famotidine	MoA	N0000000151	Histamine H2 Receptor Antagonists	FDA
DB00927	1129	famotidine	EPC	N0000175784	Histamine-2 Receptor Antagonist	FDA
DB00927	1129	famotidine	has role	CHEBI:37961	H2-receptor antagonist	CHEBI
DB00927	1129	famotidine	has role	CHEBI:49201	anti-ulcer drug	CHEBI
DB00927	1129	famotidine	PA	D000897	Anti-Ulcer Agents	MeSH
DB00927	1129	famotidine	PA	D005765	Gastrointestinal Agents	MeSH
DB00927	1129	famotidine	PA	D018494	Histamine Agents	MeSH
DB00927	1129	famotidine	PA	D006633	Histamine Antagonists	MeSH
DB00927	1129	famotidine	PA	D006635	Histamine H2 Antagonists	MeSH
DB00927	1129	famotidine	PA	D018377	Neurotransmitter Agents	MeSH
DB00928	25	azacitidine	MoA	N0000000233	Nucleic Acid Synthesis Inhibitors	FDA
DB00928	25	azacitidine	EPC	N0000175595	Nucleoside Metabolic Inhibitor	FDA
DB00928	25	azacitidine	PA	D000963	Antimetabolites	MeSH
DB00928	25	azacitidine	PA	D000964	Antimetabolites, Antineoplastic	MeSH
DB00928	25	azacitidine	PA	D000970	Antineoplastic Agents	MeSH
DB00928	25	azacitidine	PA	D004791	Enzyme Inhibitors	MeSH
DB00928	25	azacitidine	PA	D009676	Noxae	MeSH
DB00929	1817	misoprostol	EPC	N0000175785	Prostaglandin E1 Analog	FDA
DB00929	1817	misoprostol	Chemical/Ingredient	N0000007710	Prostaglandins E, Synthetic	FDA
DB00929	1817	misoprostol	PA	D000020	Abortifacient Agents, Nonsteroidal	MeSH
DB00929	1817	misoprostol	has role	CHEBI:49201	anti-ulcer drug	CHEBI
DB00929	1817	misoprostol	has role	CHEBI:36063	oxytocic	CHEBI
DB00929	1817	misoprostol	has role	CHEBI:50691	abortifacient	CHEBI
DB00929	1817	misoprostol	PA	D000897	Anti-Ulcer Agents	MeSH
DB00929	1817	misoprostol	PA	D005765	Gastrointestinal Agents	MeSH
DB00929	1817	misoprostol	PA	D010120	Oxytocics	MeSH
DB00929	1817	misoprostol	PA	D012102	Reproductive Control Agents	MeSH
DB05379	1817	misoprostol	EPC	N0000175785	Prostaglandin E1 Analog	FDA
DB05379	1817	misoprostol	Chemical/Ingredient	N0000007710	Prostaglandins E, Synthetic	FDA
DB05379	1817	misoprostol	PA	D000020	Abortifacient Agents, Nonsteroidal	MeSH
DB05379	1817	misoprostol	has role	CHEBI:49201	anti-ulcer drug	CHEBI
DB05379	1817	misoprostol	has role	CHEBI:36063	oxytocic	CHEBI
DB05379	1817	misoprostol	has role	CHEBI:50691	abortifacient	CHEBI
DB05379	1817	misoprostol	PA	D000897	Anti-Ulcer Agents	MeSH
DB05379	1817	misoprostol	PA	D005765	Gastrointestinal Agents	MeSH
DB05379	1817	misoprostol	PA	D010120	Oxytocics	MeSH
DB05379	1817	misoprostol	PA	D012102	Reproductive Control Agents	MeSH
DB00933	1712	mesoridazine	EPC	N0000175746	Phenothiazine	FDA
DB00933	1712	mesoridazine	Chemical/Ingredient	N0000007544	Phenothiazines	FDA
DB00933	1712	mesoridazine	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB00933	1712	mesoridazine	has role	CHEBI:65190	first generation antipsychotic	CHEBI
DB00933	1712	mesoridazine	PA	D014150	Antipsychotic Agents	MeSH
DB00933	1712	mesoridazine	PA	D002491	Central Nervous System Agents	MeSH
DB00933	1712	mesoridazine	PA	D002492	Central Nervous System Depressants	MeSH
DB00933	1712	mesoridazine	PA	D015259	Dopamine Agents	MeSH
DB00933	1712	mesoridazine	PA	D018492	Dopamine Antagonists	MeSH
DB00933	1712	mesoridazine	PA	D018377	Neurotransmitter Agents	MeSH
DB00933	1712	mesoridazine	PA	D011619	Psychotropic Drugs	MeSH
DB00933	1712	mesoridazine	PA	D014149	Tranquilizing Agents	MeSH
DB00934	1634	maprotiline	PA	D018663	Adrenergic Agents	MeSH
DB00934	1634	maprotiline	PA	D018759	Adrenergic Uptake Inhibitors	MeSH
DB00934	1634	maprotiline	PA	D000928	Antidepressive Agents	MeSH
DB00934	1634	maprotiline	PA	D018687	Antidepressive Agents, Second-Generation	MeSH
DB00934	1634	maprotiline	PA	D002491	Central Nervous System Agents	MeSH
DB00934	1634	maprotiline	PA	D049990	Membrane Transport Modulators	MeSH
DB00934	1634	maprotiline	PA	D018377	Neurotransmitter Agents	MeSH
DB00934	1634	maprotiline	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB00934	1634	maprotiline	PA	D011619	Psychotropic Drugs	MeSH
DB00935	2032	oxymetazoline	PA	D018663	Adrenergic Agents	MeSH
DB00935	2032	oxymetazoline	PA	D000322	Adrenergic Agonists	MeSH
DB00935	2032	oxymetazoline	PA	D000316	Adrenergic alpha-Agonists	MeSH
DB00935	2032	oxymetazoline	has role	CHEBI:35569	alpha-adrenergic agonist	CHEBI
DB00935	2032	oxymetazoline	has role	CHEBI:35524	sympathomimetic agent	CHEBI
DB00935	2032	oxymetazoline	has role	CHEBI:77715	nasal decongestant	CHEBI
DB00935	2032	oxymetazoline	has role	CHEBI:50514	vasoconstrictor agent	CHEBI
DB00935	2032	oxymetazoline	PA	D002317	Cardiovascular Agents	MeSH
DB00935	2032	oxymetazoline	PA	D014663	Nasal Decongestants	MeSH
DB00935	2032	oxymetazoline	PA	D018377	Neurotransmitter Agents	MeSH
DB00935	2032	oxymetazoline	PA	D019141	Respiratory System Agents	MeSH
DB00935	2032	oxymetazoline	PA	D013566	Sympathomimetics	MeSH
DB00935	2032	oxymetazoline	PA	D014662	Vasoconstrictor Agents	MeSH
DB00937	874	diethylpropion	PE	N0000175372	Appetite Suppression	FDA
DB00937	874	diethylpropion	PE	N0000175651	Increased Sympathetic Activity	FDA
DB00937	874	diethylpropion	EPC	N0000175423	Sympathomimetic Amine Anorectic	FDA
DB00937	874	diethylpropion	has role	CHEBI:50507	appetite depressant	CHEBI
DB00937	874	diethylpropion	PA	D019440	Anti-Obesity Agents	MeSH
DB00937	874	diethylpropion	PA	D001067	Appetite Depressants	MeSH
DB00937	874	diethylpropion	PA	D002491	Central Nervous System Agents	MeSH
DB00938	2419	salmeterol	MoA	N0000009922	Adrenergic beta2-Agonists	FDA
DB00938	2419	salmeterol	EPC	N0000175779	beta2-Adrenergic Agonist	FDA
DB00938	2419	salmeterol	PA	D018663	Adrenergic Agents	MeSH
DB00938	2419	salmeterol	PA	D000322	Adrenergic Agonists	MeSH
DB00938	2419	salmeterol	PA	D058666	Adrenergic beta-2 Receptor Agonists	MeSH
DB00938	2419	salmeterol	PA	D000318	Adrenergic beta-Agonists	MeSH
DB00938	2419	salmeterol	PA	D018927	Anti-Asthmatic Agents	MeSH
DB00938	2419	salmeterol	has role	CHEBI:35523	bronchodilator agent	CHEBI
DB00938	2419	salmeterol	has role	CHEBI:35522	beta-adrenergic agonist	CHEBI
DB00938	2419	salmeterol	PA	D001993	Bronchodilator Agents	MeSH
DB00938	2419	salmeterol	PA	D018377	Neurotransmitter Agents	MeSH
DB00938	2419	salmeterol	PA	D019141	Respiratory System Agents	MeSH
DB00939	1650	meclofenamic acid	PA	D000700	Analgesics	MeSH
DB00939	1650	meclofenamic acid	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00939	1650	meclofenamic acid	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00939	1650	meclofenamic acid	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00939	1650	meclofenamic acid	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00939	1650	meclofenamic acid	has role	CHEBI:35842	antirheumatic drug	CHEBI
DB00939	1650	meclofenamic acid	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00939	1650	meclofenamic acid	has role	CHEBI:35623	anticonvulsant	CHEBI
DB00939	1650	meclofenamic acid	has role	CHEBI:35480	analgesic	CHEBI
DB00939	1650	meclofenamic acid	has role	CHEBI:35493	antipyretic	CHEBI
DB00939	1650	meclofenamic acid	PA	D018501	Antirheumatic Agents	MeSH
DB00939	1650	meclofenamic acid	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB00939	1650	meclofenamic acid	PA	D004791	Enzyme Inhibitors	MeSH
DB00939	1650	meclofenamic acid	PA	D018689	Sensory System Agents	MeSH
DB00940	1736	methantheline	PA	D018678	Cholinergic Agents	MeSH
DB00940	1736	methantheline	PA	D018680	Cholinergic Antagonists	MeSH
DB00940	1736	methantheline	PA	D018727	Muscarinic Antagonists	MeSH
DB00940	1736	methantheline	PA	D018377	Neurotransmitter Agents	MeSH
DB00942	763	cycrimine	has role	CHEBI:48407	antiparkinson drug	CHEBI
DB00942	763	cycrimine	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00942	763	cycrimine	has role	CHEBI:66956	antidyskinesia agent	CHEBI
DB00943	2856	zalcitabine	PA	D019380	Anti-HIV Agents	MeSH
DB00943	2856	zalcitabine	PA	D000890	Anti-Infective Agents	MeSH
DB00943	2856	zalcitabine	has role	CHEBI:36044	antiviral drug	CHEBI
DB00943	2856	zalcitabine	PA	D000963	Antimetabolites	MeSH
DB00943	2856	zalcitabine	PA	D000998	Antiviral Agents	MeSH
DB00943	2856	zalcitabine	PA	D004791	Enzyme Inhibitors	MeSH
DB00943	2856	zalcitabine	PA	D009676	Noxae	MeSH
DB00943	2856	zalcitabine	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB00943	2856	zalcitabine	PA	D018894	Reverse Transcriptase Inhibitors	MeSH
DB00944	801	demecarium	PA	D018678	Cholinergic Agents	MeSH
DB00944	801	demecarium	PA	D002800	Cholinesterase Inhibitors	MeSH
DB00944	801	demecarium	PA	D004791	Enzyme Inhibitors	MeSH
DB00944	801	demecarium	PA	D018377	Neurotransmitter Agents	MeSH
DB00945	74	acetylsalicylic acid	PE	N0000008836	Decreased Prostaglandin Production	FDA
DB00945	74	acetylsalicylic acid	Chemical/Ingredient	N0000175721	Nonsteroidal Anti-inflammatory Compounds	FDA
DB00945	74	acetylsalicylic acid	EPC	N0000175722	Nonsteroidal Anti-inflammatory Drug	FDA
DB00945	74	acetylsalicylic acid	PA	D000700	Analgesics	MeSH
DB00945	74	acetylsalicylic acid	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00945	74	acetylsalicylic acid	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00945	74	acetylsalicylic acid	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00945	74	acetylsalicylic acid	has role	CHEBI:73182	plant activator	CHEBI
DB00945	74	acetylsalicylic acid	has role	CHEBI:88188	drug allergen	CHEBI
DB00945	74	acetylsalicylic acid	has role	CHEBI:50427	platelet aggregation inhibitor	CHEBI
DB00945	74	acetylsalicylic acid	has role	CHEBI:35493	antipyretic	CHEBI
DB00945	74	acetylsalicylic acid	has role	CHEBI:49023	prostaglandin antagonist	CHEBI
DB00945	74	acetylsalicylic acid	has role	CHEBI:50249	anticoagulant	CHEBI
DB00945	74	acetylsalicylic acid	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00945	74	acetylsalicylic acid	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB00945	74	acetylsalicylic acid	PA	D058633	Antipyretics	MeSH
DB00945	74	acetylsalicylic acid	PA	D018501	Antirheumatic Agents	MeSH
DB00945	74	acetylsalicylic acid	PA	D002317	Cardiovascular Agents	MeSH
DB00945	74	acetylsalicylic acid	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB00945	74	acetylsalicylic acid	PA	D004791	Enzyme Inhibitors	MeSH
DB00945	74	acetylsalicylic acid	PA	D005343	Fibrinolytic Agents	MeSH
DB00945	74	acetylsalicylic acid	PA	D006401	Hematologic Agents	MeSH
DB00945	74	acetylsalicylic acid	PA	D010975	Platelet Aggregation Inhibitors	MeSH
DB00945	74	acetylsalicylic acid	PA	D018689	Sensory System Agents	MeSH
DB00947	1255	fulvestrant	MoA	N0000000168	Selective Estrogen Receptor Modulators	FDA
DB00947	1255	fulvestrant	has role	CHEBI:50792	estrogen receptor antagonist	CHEBI
DB00947	1255	fulvestrant	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00947	1255	fulvestrant	has role	CHEBI:50837	estrogen antagonist	CHEBI
DB00947	1255	fulvestrant	PA	D000970	Antineoplastic Agents	MeSH
DB00947	1255	fulvestrant	PA	D018931	Antineoplastic Agents, Hormonal	MeSH
DB00947	1255	fulvestrant	PA	D004965	Estrogen Antagonists	MeSH
DB00947	1255	fulvestrant	PA	D065171	Estrogen Receptor Antagonists	MeSH
DB00947	1255	fulvestrant	PA	D006727	Hormone Antagonists	MeSH
DB00948	1795	mezlocillin	PA	D000900	Anti-Bacterial Agents	MeSH
DB00948	1795	mezlocillin	PA	D000890	Anti-Infective Agents	MeSH
DB00948	1795	mezlocillin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB00949	1140	felbamate	EPC	N0000175753	Anti-epileptic Agent	FDA
DB00949	1140	felbamate	PE	N0000008486	Decreased Central Nervous System Disorganized Electrical Activity	FDA
DB00949	1140	felbamate	has role	CHEBI:63726	neuroprotective agent	CHEBI
DB00949	1140	felbamate	has role	CHEBI:35623	anticonvulsant	CHEBI
DB00949	1140	felbamate	PA	D000927	Anticonvulsants	MeSH
DB00949	1140	felbamate	PA	D002491	Central Nervous System Agents	MeSH
DB00950	1170	fexofenadine	MoA	N0000000190	Histamine H1 Receptor Antagonists	FDA
DB00950	1170	fexofenadine	EPC	N0000175587	Histamine-1 Receptor Antagonist	FDA
DB00950	1170	fexofenadine	PA	D018926	Anti-Allergic Agents	MeSH
DB00950	1170	fexofenadine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB00950	1170	fexofenadine	has role	CHEBI:50857	anti-allergic agent	CHEBI
DB00950	1170	fexofenadine	PA	D018494	Histamine Agents	MeSH
DB00950	1170	fexofenadine	PA	D006633	Histamine Antagonists	MeSH
DB00950	1170	fexofenadine	PA	D006634	Histamine H1 Antagonists	MeSH
DB00950	1170	fexofenadine	PA	D039563	Histamine H1 Antagonists, Non-Sedating	MeSH
DB00950	1170	fexofenadine	PA	D018377	Neurotransmitter Agents	MeSH
DB00951	1497	isoniazid	EPC	N0000175483	Antimycobacterial	FDA
DB00951	1497	isoniazid	PA	D000900	Anti-Bacterial Agents	MeSH
DB00951	1497	isoniazid	PA	D000890	Anti-Infective Agents	MeSH
DB00951	1497	isoniazid	has role	CHEBI:88188	drug allergen	CHEBI
DB00951	1497	isoniazid	has role	CHEBI:33231	antitubercular agent	CHEBI
DB00951	1497	isoniazid	PA	D000963	Antimetabolites	MeSH
DB00951	1497	isoniazid	PA	D000995	Antitubercular Agents	MeSH
DB00951	1497	isoniazid	PA	D054872	Fatty Acid Synthesis Inhibitors	MeSH
DB00951	1497	isoniazid	PA	D000960	Hypolipidemic Agents	MeSH
DB00952	1884	naratriptan	MoA	N0000175763	Serotonin 1b Receptor Agonists	FDA
DB00952	1884	naratriptan	MoA	N0000175764	Serotonin 1d Receptor Agonists	FDA
DB00952	1884	naratriptan	EPC	N0000175765	Serotonin-1b and Serotonin-1d Receptor Agonist	FDA
DB00952	1884	naratriptan	has role	CHEBI:35941	serotonergic agonist	CHEBI
DB00952	1884	naratriptan	has role	CHEBI:50514	vasoconstrictor agent	CHEBI
DB00952	1884	naratriptan	PA	D002317	Cardiovascular Agents	MeSH
DB00952	1884	naratriptan	PA	D018377	Neurotransmitter Agents	MeSH
DB00952	1884	naratriptan	PA	D058825	Serotonin 5-HT1 Receptor Agonists	MeSH
DB00952	1884	naratriptan	PA	D018490	Serotonin Agents	MeSH
DB00952	1884	naratriptan	PA	D017366	Serotonin Receptor Agonists	MeSH
DB00952	1884	naratriptan	PA	D014662	Vasoconstrictor Agents	MeSH
DB00953	2393	rizatriptan	MoA	N0000175763	Serotonin 1b Receptor Agonists	FDA
DB00953	2393	rizatriptan	MoA	N0000175764	Serotonin 1d Receptor Agonists	FDA
DB00953	2393	rizatriptan	EPC	N0000175765	Serotonin-1b and Serotonin-1d Receptor Agonist	FDA
DB00953	2393	rizatriptan	has role	CHEBI:50514	vasoconstrictor agent	CHEBI
DB00953	2393	rizatriptan	has role	CHEBI:35472	anti-inflammatory drug	CHEBI
DB00953	2393	rizatriptan	has role	CHEBI:35941	serotonergic agonist	CHEBI
DB00953	2393	rizatriptan	PA	D018377	Neurotransmitter Agents	MeSH
DB00953	2393	rizatriptan	PA	D018490	Serotonin Agents	MeSH
DB00953	2393	rizatriptan	PA	D017366	Serotonin Receptor Agonists	MeSH
DB00956	1386	hydrocodone	EPC	N0000175690	Opioid Agonist	FDA
DB00956	1386	hydrocodone	MoA	N0000000174	Opioid Agonists	FDA
DB00956	1386	hydrocodone	PA	D000700	Analgesics	MeSH
DB00956	1386	hydrocodone	PA	D000701	Analgesics, Opioid	MeSH
DB00956	1386	hydrocodone	has role	CHEBI:55322	mu-opioid receptor agonist	CHEBI
DB00956	1386	hydrocodone	has role	CHEBI:35482	opioid analgesic	CHEBI
DB00956	1386	hydrocodone	has role	CHEBI:51177	antitussive	CHEBI
DB00956	1386	hydrocodone	PA	D000996	Antitussive Agents	MeSH
DB00956	1386	hydrocodone	PA	D002491	Central Nervous System Agents	MeSH
DB00956	1386	hydrocodone	PA	D002492	Central Nervous System Depressants	MeSH
DB00956	1386	hydrocodone	PA	D009294	Narcotics	MeSH
DB00956	1386	hydrocodone	PA	D019141	Respiratory System Agents	MeSH
DB00956	1386	hydrocodone	PA	D018689	Sensory System Agents	MeSH
DB00957	1968	norgestimate	Chemical/Ingredient	N0000011301	Progesterone Congeners	FDA
DB00957	1968	norgestimate	EPC	N0000175602	Progestin	FDA
DB00957	1968	norgestimate	has role	CHEBI:49323	contraceptive drug	CHEBI
DB00957	1968	norgestimate	has role	CHEBI:49326	synthetic oral contraceptive	CHEBI
DB00957	1968	norgestimate	PA	D003270	Contraceptive Agents	MeSH
DB00957	1968	norgestimate	PA	D003271	Contraceptive Agents, Female	MeSH
DB00957	1968	norgestimate	PA	D003276	Contraceptives, Oral	MeSH
DB00957	1968	norgestimate	PA	D003280	Contraceptives, Oral, Synthetic	MeSH
DB00957	1968	norgestimate	PA	D012102	Reproductive Control Agents	MeSH
DB00959	1770	methylprednisolone acetate	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00959	1770	methylprednisolone acetate	has role	CHEBI:35472	anti-inflammatory drug	CHEBI
DB00959	1768	methylprednisolone	EPC	N0000175576	Corticosteroid	FDA
DB00959	1768	methylprednisolone	MoA	N0000175450	Corticosteroid Hormone Receptor Agonists	FDA
DB00959	1768	methylprednisolone	has role	CHEBI:63726	neuroprotective agent	CHEBI
DB00959	1768	methylprednisolone	has role	CHEBI:37962	adrenergic agent	CHEBI
DB00959	1768	methylprednisolone	has role	CHEBI:50919	antiemetic	CHEBI
DB00959	1768	methylprednisolone	PA	D000932	Antiemetics	MeSH
DB00959	1768	methylprednisolone	PA	D002491	Central Nervous System Agents	MeSH
DB00959	1768	methylprednisolone	PA	D005765	Gastrointestinal Agents	MeSH
DB00959	1768	methylprednisolone	PA	D005938	Glucocorticoids	MeSH
DB00959	1768	methylprednisolone	PA	D006728	Hormones	MeSH
DB00959	1768	methylprednisolone	PA	D018696	Neuroprotective Agents	MeSH
DB00959	1768	methylprednisolone	PA	D020011	Protective Agents	MeSH
DB00960	2176	pindolol	EPC	N0000175556	beta-Adrenergic Blocker	FDA
DB00960	2176	pindolol	PA	D018663	Adrenergic Agents	MeSH
DB00960	2176	pindolol	PA	D018674	Adrenergic Antagonists	MeSH
DB00960	2176	pindolol	PA	D000319	Adrenergic beta-Antagonists	MeSH
DB00960	2176	pindolol	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB00960	2176	pindolol	has role	CHEBI:35530	beta-adrenergic antagonist	CHEBI
DB00960	2176	pindolol	has role	CHEBI:39456	antiglaucoma drug	CHEBI
DB00960	2176	pindolol	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00960	2176	pindolol	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00960	2176	pindolol	PA	D000959	Antihypertensive Agents	MeSH
DB00960	2176	pindolol	PA	D002317	Cardiovascular Agents	MeSH
DB00960	2176	pindolol	PA	D018377	Neurotransmitter Agents	MeSH
DB00960	2176	pindolol	PA	D018490	Serotonin Agents	MeSH
DB00960	2176	pindolol	PA	D012702	Serotonin Antagonists	MeSH
DB00960	2176	pindolol	PA	D014665	Vasodilator Agents	MeSH
DB00961	1700	mepivacaine	EPC	N0000175682	Amide Local Anesthetic	FDA
DB00961	1700	mepivacaine	Chemical/Ingredient	N0000007681	Amides	FDA
DB00961	1700	mepivacaine	PE	N0000175976	Local Anesthesia	FDA
DB00961	1700	mepivacaine	PA	D000777	Anesthetics	MeSH
DB00961	1700	mepivacaine	PA	D000779	Anesthetics, Local	MeSH
DB00961	1700	mepivacaine	has role	CHEBI:36333	local anaesthetic	CHEBI
DB00961	1700	mepivacaine	has role	CHEBI:88188	drug allergen	CHEBI
DB00961	1700	mepivacaine	PA	D002491	Central Nervous System Agents	MeSH
DB00961	1700	mepivacaine	PA	D002492	Central Nervous System Depressants	MeSH
DB00961	1700	mepivacaine	PA	D018689	Sensory System Agents	MeSH
DB00962	2857	zaleplon	EPC	N0000183360	gamma-Aminobutyric Acid A Receptor Agonist	FDA
DB00962	2857	zaleplon	MoA	N0000000196	GABA A Agonists	FDA
DB00962	2857	zaleplon	PE	N0000175728	Central Nervous System Depression	FDA
DB00962	2857	zaleplon	has role	CHEBI:35623	anticonvulsant	CHEBI
DB00962	2857	zaleplon	has role	CHEBI:35488	central nervous system depressant	CHEBI
DB00962	2857	zaleplon	has role	CHEBI:35717	sedative	CHEBI
DB00962	2857	zaleplon	has role	CHEBI:35474	anxiolytic drug	CHEBI
DB00962	2857	zaleplon	PA	D000927	Anticonvulsants	MeSH
DB00962	2857	zaleplon	PA	D002491	Central Nervous System Agents	MeSH
DB00962	2857	zaleplon	PA	D002492	Central Nervous System Depressants	MeSH
DB00962	2857	zaleplon	PA	D018682	GABA Agents	MeSH
DB00962	2857	zaleplon	PA	D018757	GABA Modulators	MeSH
DB00962	2857	zaleplon	PA	D006993	Hypnotics and Sedatives	MeSH
DB00962	2857	zaleplon	PA	D018377	Neurotransmitter Agents	MeSH
DB00963	401	bromfenac	MoA	N0000000160	Cyclooxygenase Inhibitors	FDA
DB00963	401	bromfenac	Chemical/Ingredient	N0000175721	Nonsteroidal Anti-inflammatory Compounds	FDA
DB00963	401	bromfenac	EPC	N0000175722	Nonsteroidal Anti-inflammatory Drug	FDA
DB00963	401	bromfenac	PA	D000700	Analgesics	MeSH
DB00963	401	bromfenac	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00963	401	bromfenac	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00963	401	bromfenac	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00963	401	bromfenac	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00963	401	bromfenac	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB00963	401	bromfenac	PA	D018501	Antirheumatic Agents	MeSH
DB00963	401	bromfenac	PA	D018689	Sensory System Agents	MeSH
DB00964	229	apraclonidine	PA	D018663	Adrenergic Agents	MeSH
DB00964	229	apraclonidine	PA	D000322	Adrenergic Agonists	MeSH
DB00964	229	apraclonidine	PA	D058647	Adrenergic alpha-2 Receptor Agonists	MeSH
DB00964	229	apraclonidine	PA	D000316	Adrenergic alpha-Agonists	MeSH
DB00964	229	apraclonidine	has role	CHEBI:66981	ophthalmology drug	CHEBI
DB00964	229	apraclonidine	has role	CHEBI:35569	alpha-adrenergic agonist	CHEBI
DB00964	229	apraclonidine	has role	CHEBI:39456	antiglaucoma drug	CHEBI
DB00964	229	apraclonidine	PA	D018377	Neurotransmitter Agents	MeSH
DB00966	2583	telmisartan	MoA	N0000000070	Angiotensin 2 Receptor Antagonists	FDA
DB00966	2583	telmisartan	EPC	N0000175561	Angiotensin 2 Receptor Blocker	FDA
DB00966	2583	telmisartan	PA	D047228	Angiotensin II Type 1 Receptor Blockers	MeSH
DB00966	2583	telmisartan	PA	D057911	Angiotensin Receptor Antagonists	MeSH
DB00966	2583	telmisartan	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00966	2583	telmisartan	has role	CHEBI:35457	EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor	CHEBI
DB00966	2583	telmisartan	has role	CHEBI:61016	angiotensin receptor antagonist	CHEBI
DB00966	2583	telmisartan	PA	D000959	Antihypertensive Agents	MeSH
DB00966	2583	telmisartan	PA	D002317	Cardiovascular Agents	MeSH
DB00967	814	desloratadine	MoA	N0000000190	Histamine H1 Receptor Antagonists	FDA
DB00967	814	desloratadine	EPC	N0000175587	Histamine-1 Receptor Antagonist	FDA
DB00967	814	desloratadine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB00967	814	desloratadine	has role	CHEBI:50857	anti-allergic agent	CHEBI
DB00967	814	desloratadine	has role	CHEBI:48873	cholinergic antagonist	CHEBI
DB00967	814	desloratadine	PA	D018678	Cholinergic Agents	MeSH
DB00967	814	desloratadine	PA	D018680	Cholinergic Antagonists	MeSH
DB00967	814	desloratadine	PA	D018494	Histamine Agents	MeSH
DB00967	814	desloratadine	PA	D006633	Histamine Antagonists	MeSH
DB00967	814	desloratadine	PA	D006634	Histamine H1 Antagonists	MeSH
DB00967	814	desloratadine	PA	D039563	Histamine H1 Antagonists, Non-Sedating	MeSH
DB00967	814	desloratadine	PA	D018377	Neurotransmitter Agents	MeSH
DB00968	1762	methyldopa	PA	D018663	Adrenergic Agents	MeSH
DB00968	1762	methyldopa	PA	D000322	Adrenergic Agonists	MeSH
DB00968	1762	methyldopa	PA	D058647	Adrenergic alpha-2 Receptor Agonists	MeSH
DB00968	1762	methyldopa	PA	D000316	Adrenergic alpha-Agonists	MeSH
DB00968	1762	methyldopa	has role	CHEBI:66991	sympatholytic agent	CHEBI
DB00968	1762	methyldopa	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00968	1762	methyldopa	has role	CHEBI:35569	alpha-adrenergic agonist	CHEBI
DB00968	1762	methyldopa	has role	CHEBI:49110	peripheral nervous system drug	CHEBI
DB00968	1762	methyldopa	PA	D000959	Antihypertensive Agents	MeSH
DB00968	1762	methyldopa	PA	D002317	Cardiovascular Agents	MeSH
DB00968	1762	methyldopa	PA	D018377	Neurotransmitter Agents	MeSH
DB00968	1762	methyldopa	PA	D013565	Sympatholytics	MeSH
DB00969	129	alosetron	MoA	N0000175817	Serotonin 3 Receptor Antagonists	FDA
DB00969	129	alosetron	EPC	N0000175818	Serotonin-3 Receptor Antagonist	FDA
DB00969	129	alosetron	has role	CHEBI:55324	gastrointestinal drug	CHEBI
DB00969	129	alosetron	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB00969	129	alosetron	has role	CHEBI:50919	antiemetic	CHEBI
DB00969	129	alosetron	PA	D005765	Gastrointestinal Agents	MeSH
DB00969	129	alosetron	PA	D018377	Neurotransmitter Agents	MeSH
DB00969	129	alosetron	PA	D018490	Serotonin Agents	MeSH
DB00969	129	alosetron	PA	D012702	Serotonin Antagonists	MeSH
DB00972	271	azelastine	MoA	N0000000190	Histamine H1 Receptor Antagonists	FDA
DB00972	271	azelastine	EPC	N0000175587	Histamine-1 Receptor Antagonist	FDA
DB00972	271	azelastine	PA	D018926	Anti-Allergic Agents	MeSH
DB00972	271	azelastine	PA	D018927	Anti-Asthmatic Agents	MeSH
DB00972	271	azelastine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB00972	271	azelastine	has role	CHEBI:50857	anti-allergic agent	CHEBI
DB00972	271	azelastine	has role	CHEBI:49167	anti-asthmatic drug	CHEBI
DB00972	271	azelastine	has role	CHEBI:35523	bronchodilator agent	CHEBI
DB00972	271	azelastine	has role	CHEBI:50427	platelet aggregation inhibitor	CHEBI
DB00972	271	azelastine	PA	D001993	Bronchodilator Agents	MeSH
DB00972	271	azelastine	PA	D004791	Enzyme Inhibitors	MeSH
DB00972	271	azelastine	PA	D018494	Histamine Agents	MeSH
DB00972	271	azelastine	PA	D006633	Histamine Antagonists	MeSH
DB00972	271	azelastine	PA	D006634	Histamine H1 Antagonists	MeSH
DB00972	271	azelastine	PA	D039563	Histamine H1 Antagonists, Non-Sedating	MeSH
DB00972	271	azelastine	PA	D016859	Lipoxygenase Inhibitors	MeSH
DB00972	271	azelastine	PA	D018377	Neurotransmitter Agents	MeSH
DB00972	271	azelastine	PA	D019141	Respiratory System Agents	MeSH
DB00973	1125	ezetimibe	PE	N0000008553	Decreased Cholesterol Absorption	FDA
DB00973	1125	ezetimibe	EPC	N0000175911	Dietary Cholesterol Absorption Inhibitor	FDA
DB00973	1125	ezetimibe	has role	CHEBI:35821	anticholesteremic drug	CHEBI
DB00973	1125	ezetimibe	has role	CHEBI:35679	antilipemic drug	CHEBI
DB00973	1125	ezetimibe	PA	D000924	Anticholesteremic Agents	MeSH
DB00973	1125	ezetimibe	PA	D000963	Antimetabolites	MeSH
DB00973	1125	ezetimibe	PA	D000960	Hypolipidemic Agents	MeSH
DB00975	924	dipyridamole	PE	N0000008832	Decreased Platelet Aggregation	FDA
DB00975	924	dipyridamole	has role	CHEBI:50427	platelet aggregation inhibitor	CHEBI
DB00975	924	dipyridamole	has role	CHEBI:35620	vasodilator agent	CHEBI
DB00975	924	dipyridamole	PA	D002317	Cardiovascular Agents	MeSH
DB00975	924	dipyridamole	PA	D004791	Enzyme Inhibitors	MeSH
DB00975	924	dipyridamole	PA	D006401	Hematologic Agents	MeSH
DB00975	924	dipyridamole	PA	D010726	Phosphodiesterase Inhibitors	MeSH
DB00975	924	dipyridamole	PA	D010975	Platelet Aggregation Inhibitors	MeSH
DB00975	924	dipyridamole	PA	D014665	Vasodilator Agents	MeSH
DB00977	1082	ethinylestradiol	EPC	N0000175825	Estrogen	FDA
DB00977	1082	ethinylestradiol	MoA	N0000000100	Estrogen Receptor Agonists	FDA
DB00977	1082	ethinylestradiol	PA	D004967	Estrogens	MeSH
DB00977	1082	ethinylestradiol	PA	D006728	Hormones	MeSH
DB00978	1594	lomefloxacin	PA	D000900	Anti-Bacterial Agents	MeSH
DB00978	1594	lomefloxacin	PA	D000890	Anti-Infective Agents	MeSH
DB00978	1594	lomefloxacin	has role	CHEBI:47868	photosensitizing agent	CHEBI
DB00978	1594	lomefloxacin	has role	CHEBI:33231	antitubercular agent	CHEBI
DB00978	1594	lomefloxacin	PA	D000970	Antineoplastic Agents	MeSH
DB00978	1594	lomefloxacin	PA	D004791	Enzyme Inhibitors	MeSH
DB00978	1594	lomefloxacin	PA	D059005	Topoisomerase II Inhibitors	MeSH
DB00979	757	cyclopentolate	has role	CHEBI:50513	mydriatic agent	CHEBI
DB00979	757	cyclopentolate	has role	CHEBI:50370	parasympatholytic	CHEBI
DB00979	757	cyclopentolate	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00979	757	cyclopentolate	has role	CHEBI:33295	diagnostic agent	CHEBI
DB00979	757	cyclopentolate	PA	D018678	Cholinergic Agents	MeSH
DB00979	757	cyclopentolate	PA	D018680	Cholinergic Antagonists	MeSH
DB00979	757	cyclopentolate	PA	D018727	Muscarinic Antagonists	MeSH
DB00979	757	cyclopentolate	PA	D009184	Mydriatics	MeSH
DB00979	757	cyclopentolate	PA	D018377	Neurotransmitter Agents	MeSH
DB00979	757	cyclopentolate	PA	D010276	Parasympatholytics	MeSH
DB00980	2355	ramelteon	EPC	N0000175743	Melatonin Receptor Agonist	FDA
DB00980	2355	ramelteon	MoA	N0000000250	Melatonin Receptor Agonists	FDA
DB00981	2159	physostigmine	has role	CHEBI:74530	antidote to curare poisoning	CHEBI
DB00981	2159	physostigmine	has role	CHEBI:51068	miotic	CHEBI
DB00981	2159	physostigmine	PA	D018678	Cholinergic Agents	MeSH
DB00981	2159	physostigmine	PA	D002800	Cholinesterase Inhibitors	MeSH
DB00981	2159	physostigmine	PA	D004791	Enzyme Inhibitors	MeSH
DB00981	2159	physostigmine	PA	D008916	Miotics	MeSH
DB00981	2159	physostigmine	PA	D018377	Neurotransmitter Agents	MeSH
DB00983	4943	arformoterol	MoA	N0000009922	Adrenergic beta2-Agonists	FDA
DB00983	4943	arformoterol	EPC	N0000175779	beta2-Adrenergic Agonist	FDA
DB00983	4943	arformoterol	has role	CHEBI:35523	bronchodilator agent	CHEBI
DB00983	4943	arformoterol	has role	CHEBI:49167	anti-asthmatic drug	CHEBI
DB00983	4943	arformoterol	has role	CHEBI:35522	beta-adrenergic agonist	CHEBI
DB01274	4943	arformoterol	MoA	N0000009922	Adrenergic beta2-Agonists	FDA
DB01274	4943	arformoterol	EPC	N0000175779	beta2-Adrenergic Agonist	FDA
DB01274	4943	arformoterol	has role	CHEBI:35523	bronchodilator agent	CHEBI
DB01274	4943	arformoterol	has role	CHEBI:49167	anti-asthmatic drug	CHEBI
DB01274	4943	arformoterol	has role	CHEBI:35522	beta-adrenergic agonist	CHEBI
DB00983	1239	formoterol	PA	D018663	Adrenergic Agents	MeSH
DB00983	1239	formoterol	PA	D000322	Adrenergic Agonists	MeSH
DB00983	1239	formoterol	PA	D058666	Adrenergic beta-2 Receptor Agonists	MeSH
DB00983	1239	formoterol	PA	D000318	Adrenergic beta-Agonists	MeSH
DB00983	1239	formoterol	PA	D018927	Anti-Asthmatic Agents	MeSH
DB00983	1239	formoterol	PA	D001993	Bronchodilator Agents	MeSH
DB00983	1239	formoterol	PA	D018377	Neurotransmitter Agents	MeSH
DB00983	1239	formoterol	PA	D019141	Respiratory System Agents	MeSH
DB01274	1239	formoterol	PA	D018663	Adrenergic Agents	MeSH
DB01274	1239	formoterol	PA	D000322	Adrenergic Agonists	MeSH
DB01274	1239	formoterol	PA	D058666	Adrenergic beta-2 Receptor Agonists	MeSH
DB01274	1239	formoterol	PA	D000318	Adrenergic beta-Agonists	MeSH
DB01274	1239	formoterol	PA	D018927	Anti-Asthmatic Agents	MeSH
DB01274	1239	formoterol	PA	D001993	Bronchodilator Agents	MeSH
DB01274	1239	formoterol	PA	D018377	Neurotransmitter Agents	MeSH
DB01274	1239	formoterol	PA	D019141	Respiratory System Agents	MeSH
DB00984	1882	nandrolone phenpropionate	PA	D045930	Anabolic Agents	MeSH
DB00984	1882	nandrolone phenpropionate	PA	D006728	Hormones	MeSH
DB00985	901	dimenhydrinate	has role	CHEBI:50919	antiemetic	CHEBI
DB00985	901	dimenhydrinate	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB00985	901	dimenhydrinate	PA	D000932	Antiemetics	MeSH
DB00985	901	dimenhydrinate	PA	D002491	Central Nervous System Agents	MeSH
DB00985	901	dimenhydrinate	PA	D005765	Gastrointestinal Agents	MeSH
DB00985	901	dimenhydrinate	PA	D018494	Histamine Agents	MeSH
DB00985	901	dimenhydrinate	PA	D006633	Histamine Antagonists	MeSH
DB00985	901	dimenhydrinate	PA	D006634	Histamine H1 Antagonists	MeSH
DB00985	901	dimenhydrinate	PA	D018377	Neurotransmitter Agents	MeSH
DB01075	901	dimenhydrinate	has role	CHEBI:50919	antiemetic	CHEBI
DB01075	901	dimenhydrinate	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB01075	901	dimenhydrinate	PA	D000932	Antiemetics	MeSH
DB01075	901	dimenhydrinate	PA	D002491	Central Nervous System Agents	MeSH
DB01075	901	dimenhydrinate	PA	D005765	Gastrointestinal Agents	MeSH
DB01075	901	dimenhydrinate	PA	D018494	Histamine Agents	MeSH
DB01075	901	dimenhydrinate	PA	D006633	Histamine Antagonists	MeSH
DB01075	901	dimenhydrinate	PA	D006634	Histamine H1 Antagonists	MeSH
DB01075	901	dimenhydrinate	PA	D018377	Neurotransmitter Agents	MeSH
DB00985	916	diphenhydramine	MoA	N0000000190	Histamine H1 Receptor Antagonists	FDA
DB00985	916	diphenhydramine	EPC	N0000175587	Histamine-1 Receptor Antagonist	FDA
DB00985	916	diphenhydramine	PA	D000777	Anesthetics	MeSH
DB00985	916	diphenhydramine	PA	D000779	Anesthetics, Local	MeSH
DB00985	916	diphenhydramine	PA	D018926	Anti-Allergic Agents	MeSH
DB00985	916	diphenhydramine	has role	CHEBI:35717	sedative	CHEBI
DB00985	916	diphenhydramine	has role	CHEBI:50857	anti-allergic agent	CHEBI
DB00985	916	diphenhydramine	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB00985	916	diphenhydramine	has role	CHEBI:48407	antiparkinson drug	CHEBI
DB00985	916	diphenhydramine	has role	CHEBI:59683	antipruritic drug	CHEBI
DB00985	916	diphenhydramine	has role	CHEBI:36333	local anaesthetic	CHEBI
DB00985	916	diphenhydramine	has role	CHEBI:66956	antidyskinesia agent	CHEBI
DB00985	916	diphenhydramine	has role	CHEBI:51177	antitussive	CHEBI
DB00985	916	diphenhydramine	PA	D002492	Central Nervous System Depressants	MeSH
DB00985	916	diphenhydramine	PA	D006993	Hypnotics and Sedatives	MeSH
DB00985	916	diphenhydramine	PA	D018689	Sensory System Agents	MeSH
DB00985	916	diphenhydramine	PA	D000068776	Sleep Aids, Pharmaceutical	MeSH
DB01075	916	diphenhydramine	MoA	N0000000190	Histamine H1 Receptor Antagonists	FDA
DB01075	916	diphenhydramine	EPC	N0000175587	Histamine-1 Receptor Antagonist	FDA
DB01075	916	diphenhydramine	PA	D000777	Anesthetics	MeSH
DB01075	916	diphenhydramine	PA	D000779	Anesthetics, Local	MeSH
DB01075	916	diphenhydramine	PA	D018926	Anti-Allergic Agents	MeSH
DB01075	916	diphenhydramine	has role	CHEBI:35717	sedative	CHEBI
DB01075	916	diphenhydramine	has role	CHEBI:50857	anti-allergic agent	CHEBI
DB01075	916	diphenhydramine	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB01075	916	diphenhydramine	has role	CHEBI:48407	antiparkinson drug	CHEBI
DB01075	916	diphenhydramine	has role	CHEBI:59683	antipruritic drug	CHEBI
DB01075	916	diphenhydramine	has role	CHEBI:36333	local anaesthetic	CHEBI
DB01075	916	diphenhydramine	has role	CHEBI:66956	antidyskinesia agent	CHEBI
DB01075	916	diphenhydramine	has role	CHEBI:51177	antitussive	CHEBI
DB01075	916	diphenhydramine	PA	D002492	Central Nervous System Depressants	MeSH
DB01075	916	diphenhydramine	PA	D006993	Hypnotics and Sedatives	MeSH
DB01075	916	diphenhydramine	PA	D018689	Sensory System Agents	MeSH
DB01075	916	diphenhydramine	PA	D000068776	Sleep Aids, Pharmaceutical	MeSH
DB00986	4302	glycopyrronium bromide	EPC	N0000175574	Anticholinergic	FDA
DB00986	4302	glycopyrronium bromide	PA	D000759	Adjuvants, Anesthesia	MeSH
DB00986	4302	glycopyrronium bromide	PA	D002491	Central Nervous System Agents	MeSH
DB00986	4302	glycopyrronium bromide	PA	D018678	Cholinergic Agents	MeSH
DB00986	4302	glycopyrronium bromide	PA	D018680	Cholinergic Antagonists	MeSH
DB00986	4302	glycopyrronium bromide	PA	D018727	Muscarinic Antagonists	MeSH
DB00986	4302	glycopyrronium bromide	PA	D018377	Neurotransmitter Agents	MeSH
DB00987	770	cytarabine	MoA	N0000000233	Nucleic Acid Synthesis Inhibitors	FDA
DB00987	770	cytarabine	EPC	N0000175595	Nucleoside Metabolic Inhibitor	FDA
DB00987	770	cytarabine	PA	D000890	Anti-Infective Agents	MeSH
DB00987	770	cytarabine	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00987	770	cytarabine	has role	CHEBI:35705	immunosuppressive agent	CHEBI
DB00987	770	cytarabine	PA	D000963	Antimetabolites	MeSH
DB00987	770	cytarabine	PA	D000964	Antimetabolites, Antineoplastic	MeSH
DB00987	770	cytarabine	PA	D000970	Antineoplastic Agents	MeSH
DB00987	770	cytarabine	PA	D000998	Antiviral Agents	MeSH
DB00987	770	cytarabine	PA	D007155	Immunologic Factors	MeSH
DB00987	770	cytarabine	PA	D007166	Immunosuppressive Agents	MeSH
DB00987	770	cytarabine	PA	D009676	Noxae	MeSH
DB02097	770	cytarabine	MoA	N0000000233	Nucleic Acid Synthesis Inhibitors	FDA
DB02097	770	cytarabine	EPC	N0000175595	Nucleoside Metabolic Inhibitor	FDA
DB02097	770	cytarabine	PA	D000890	Anti-Infective Agents	MeSH
DB02097	770	cytarabine	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB02097	770	cytarabine	has role	CHEBI:35705	immunosuppressive agent	CHEBI
DB02097	770	cytarabine	PA	D000963	Antimetabolites	MeSH
DB02097	770	cytarabine	PA	D000964	Antimetabolites, Antineoplastic	MeSH
DB02097	770	cytarabine	PA	D000970	Antineoplastic Agents	MeSH
DB02097	770	cytarabine	PA	D000998	Antiviral Agents	MeSH
DB02097	770	cytarabine	PA	D007155	Immunologic Factors	MeSH
DB02097	770	cytarabine	PA	D007166	Immunosuppressive Agents	MeSH
DB02097	770	cytarabine	PA	D009676	Noxae	MeSH
DB05494	770	cytarabine	MoA	N0000000233	Nucleic Acid Synthesis Inhibitors	FDA
DB05494	770	cytarabine	EPC	N0000175595	Nucleoside Metabolic Inhibitor	FDA
DB05494	770	cytarabine	PA	D000890	Anti-Infective Agents	MeSH
DB05494	770	cytarabine	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB05494	770	cytarabine	has role	CHEBI:35705	immunosuppressive agent	CHEBI
DB05494	770	cytarabine	PA	D000963	Antimetabolites	MeSH
DB05494	770	cytarabine	PA	D000964	Antimetabolites, Antineoplastic	MeSH
DB05494	770	cytarabine	PA	D000970	Antineoplastic Agents	MeSH
DB05494	770	cytarabine	PA	D000998	Antiviral Agents	MeSH
DB05494	770	cytarabine	PA	D007155	Immunologic Factors	MeSH
DB05494	770	cytarabine	PA	D007166	Immunosuppressive Agents	MeSH
DB05494	770	cytarabine	PA	D009676	Noxae	MeSH
DB00988	947	dopamine	EPC	N0000175570	Catecholamine	FDA
DB00988	947	dopamine	Chemical/Ingredient	N0000007715	Catecholamines	FDA
DB00988	947	dopamine	has role	CHEBI:38147	cardiotonic drug	CHEBI
DB00988	947	dopamine	has role	CHEBI:35522	beta-adrenergic agonist	CHEBI
DB00988	947	dopamine	has role	CHEBI:48560	dopaminergic agent	CHEBI
DB00988	947	dopamine	has role	CHEBI:35524	sympathomimetic agent	CHEBI
DB00988	947	dopamine	PA	D002316	Cardiotonic Agents	MeSH
DB00988	947	dopamine	PA	D002317	Cardiovascular Agents	MeSH
DB00988	947	dopamine	PA	D015259	Dopamine Agents	MeSH
DB00988	947	dopamine	PA	D018377	Neurotransmitter Agents	MeSH
DB00988	947	dopamine	PA	D020011	Protective Agents	MeSH
DB00988	947	dopamine	PA	D013566	Sympathomimetics	MeSH
DB00989	2392	rivastigmine	EPC	N0000175723	Cholinesterase Inhibitor	FDA
DB00989	2392	rivastigmine	has role	CHEBI:63726	neuroprotective agent	CHEBI
DB00989	2392	rivastigmine	has role	CHEBI:38323	cholinergic drug	CHEBI
DB00989	2392	rivastigmine	PA	D002491	Central Nervous System Agents	MeSH
DB00989	2392	rivastigmine	PA	D018678	Cholinergic Agents	MeSH
DB00989	2392	rivastigmine	PA	D002800	Cholinesterase Inhibitors	MeSH
DB00989	2392	rivastigmine	PA	D004791	Enzyme Inhibitors	MeSH
DB00989	2392	rivastigmine	PA	D018696	Neuroprotective Agents	MeSH
DB00989	2392	rivastigmine	PA	D018377	Neurotransmitter Agents	MeSH
DB00989	2392	rivastigmine	PA	D020011	Protective Agents	MeSH
DB00990	1122	exemestane	EPC	N0000175563	Aromatase Inhibitor	FDA
DB00990	1122	exemestane	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB00990	1122	exemestane	PA	D000970	Antineoplastic Agents	MeSH
DB00990	1122	exemestane	PA	D047072	Aromatase Inhibitors	MeSH
DB00990	1122	exemestane	PA	D004791	Enzyme Inhibitors	MeSH
DB00990	1122	exemestane	PA	D004965	Estrogen Antagonists	MeSH
DB00990	1122	exemestane	PA	D006727	Hormone Antagonists	MeSH
DB00990	1122	exemestane	PA	D065088	Steroid Synthesis Inhibitors	MeSH
DB00991	2013	oxaprozin	MoA	N0000000160	Cyclooxygenase Inhibitors	FDA
DB00991	2013	oxaprozin	Chemical/Ingredient	N0000175721	Nonsteroidal Anti-inflammatory Compounds	FDA
DB00991	2013	oxaprozin	EPC	N0000175722	Nonsteroidal Anti-inflammatory Drug	FDA
DB00991	2013	oxaprozin	PA	D000700	Analgesics	MeSH
DB00991	2013	oxaprozin	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB00991	2013	oxaprozin	PA	D000893	Anti-Inflammatory Agents	MeSH
DB00991	2013	oxaprozin	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB00991	2013	oxaprozin	has role	CHEBI:35480	analgesic	CHEBI
DB00991	2013	oxaprozin	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB00991	2013	oxaprozin	PA	D018501	Antirheumatic Agents	MeSH
DB00991	2013	oxaprozin	PA	D018689	Sensory System Agents	MeSH
DB00996	1264	gabapentin	EPC	N0000175753	Anti-epileptic Agent	FDA
DB00996	1264	gabapentin	PE	N0000008486	Decreased Central Nervous System Disorganized Electrical Activity	FDA
DB00996	1264	gabapentin	PA	D000700	Analgesics	MeSH
DB00996	1264	gabapentin	PA	D014151	Anti-Anxiety Agents	MeSH
DB00996	1264	gabapentin	PA	D018726	Anti-Dyskinesia Agents	MeSH
DB00996	1264	gabapentin	has role	CHEBI:35623	anticonvulsant	CHEBI
DB00996	1264	gabapentin	PA	D000927	Anticonvulsants	MeSH
DB00996	1264	gabapentin	PA	D018692	Antimanic Agents	MeSH
DB00996	1264	gabapentin	PA	D000978	Antiparkinson Agents	MeSH
DB00996	1264	gabapentin	PA	D002121	Calcium Channel Blockers	MeSH
DB00996	1264	gabapentin	PA	D002317	Cardiovascular Agents	MeSH
DB00996	1264	gabapentin	PA	D002491	Central Nervous System Agents	MeSH
DB00996	1264	gabapentin	PA	D002492	Central Nervous System Depressants	MeSH
DB00996	1264	gabapentin	PA	D018691	Excitatory Amino Acid Antagonists	MeSH
DB00996	1264	gabapentin	PA	D049990	Membrane Transport Modulators	MeSH
DB00996	1264	gabapentin	PA	D018377	Neurotransmitter Agents	MeSH
DB00996	1264	gabapentin	PA	D011619	Psychotropic Drugs	MeSH
DB00996	1264	gabapentin	PA	D018689	Sensory System Agents	MeSH
DB00996	1264	gabapentin	PA	D014149	Tranquilizing Agents	MeSH
DB00998	1251	frovatriptan	MoA	N0000175763	Serotonin 1b Receptor Agonists	FDA
DB00998	1251	frovatriptan	MoA	N0000175764	Serotonin 1d Receptor Agonists	FDA
DB00998	1251	frovatriptan	EPC	N0000175765	Serotonin-1b and Serotonin-1d Receptor Agonist	FDA
DB00998	1251	frovatriptan	PA	D018377	Neurotransmitter Agents	MeSH
DB00998	1251	frovatriptan	PA	D018490	Serotonin Agents	MeSH
DB00998	1251	frovatriptan	PA	D017366	Serotonin Receptor Agonists	MeSH
DB00999	1385	hydrochlorothiazide	PE	N0000175359	Increased Diuresis	FDA
DB00999	1385	hydrochlorothiazide	EPC	N0000175419	Thiazide Diuretic	FDA
DB00999	1385	hydrochlorothiazide	Chemical/Ingredient	N0000166469	Thiazides	FDA
DB00999	1385	hydrochlorothiazide	has role	CHEBI:35498	diuretic	CHEBI
DB00999	1385	hydrochlorothiazide	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB00999	1385	hydrochlorothiazide	PA	D000959	Antihypertensive Agents	MeSH
DB00999	1385	hydrochlorothiazide	PA	D002317	Cardiovascular Agents	MeSH
DB00999	1385	hydrochlorothiazide	PA	D004232	Diuretics	MeSH
DB00999	1385	hydrochlorothiazide	PA	D049990	Membrane Transport Modulators	MeSH
DB00999	1385	hydrochlorothiazide	PA	D045283	Natriuretic Agents	MeSH
DB00999	1385	hydrochlorothiazide	PA	D049993	Sodium Chloride Symporter Inhibitors	MeSH
DB01000	632	cyclacillin	PA	D000900	Anti-Bacterial Agents	MeSH
DB01000	632	cyclacillin	PA	D000890	Anti-Infective Agents	MeSH
DB01000	632	cyclacillin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB01001	1575	levosalbutamol	MoA	N0000009922	Adrenergic beta2-Agonists	FDA
DB01001	1575	levosalbutamol	EPC	N0000175779	beta2-Adrenergic Agonist	FDA
DB01001	105	salbutamol	PA	D018663	Adrenergic Agents	MeSH
DB01001	105	salbutamol	PA	D000322	Adrenergic Agonists	MeSH
DB01001	105	salbutamol	PA	D058666	Adrenergic beta-2 Receptor Agonists	MeSH
DB01001	105	salbutamol	PA	D000318	Adrenergic beta-Agonists	MeSH
DB01001	105	salbutamol	PA	D018927	Anti-Asthmatic Agents	MeSH
DB01001	105	salbutamol	has role	CHEBI:35522	beta-adrenergic agonist	CHEBI
DB01001	105	salbutamol	has role	CHEBI:35523	bronchodilator agent	CHEBI
DB01001	105	salbutamol	PA	D001993	Bronchodilator Agents	MeSH
DB01001	105	salbutamol	PA	D018377	Neurotransmitter Agents	MeSH
DB01001	105	salbutamol	PA	D012102	Reproductive Control Agents	MeSH
DB01001	105	salbutamol	PA	D019141	Respiratory System Agents	MeSH
DB01001	105	salbutamol	PA	D015149	Tocolytic Agents	MeSH
DB01004	1277	ganciclovir	EPC	N0000175461	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor	FDA
DB01004	1277	ganciclovir	MoA	N0000020060	DNA Polymerase Inhibitors	FDA
DB01004	1277	ganciclovir	Chemical/Ingredient	N0000175459	Nucleoside Analog	FDA
DB01004	1277	ganciclovir	EPC	N0000175466	Nucleoside Analog Antiviral	FDA
DB01004	1277	ganciclovir	PA	D000890	Anti-Infective Agents	MeSH
DB01004	1277	ganciclovir	has role	CHEBI:36044	antiviral drug	CHEBI
DB01004	1277	ganciclovir	has role	CHEBI:35441	antiinfective agent	CHEBI
DB01004	1277	ganciclovir	PA	D000998	Antiviral Agents	MeSH
DB01005	1399	hydroxycarbamide	EPC	N0000180853	Antimetabolite	FDA
DB01005	1399	hydroxycarbamide	Chemical/Ingredient	N0000006999	Urea	FDA
DB01005	1399	hydroxycarbamide	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB01005	1399	hydroxycarbamide	has role	CHEBI:50846	immunomodulator	CHEBI
DB01005	1399	hydroxycarbamide	PA	D000970	Antineoplastic Agents	MeSH
DB01005	1399	hydroxycarbamide	PA	D000986	Antisickling Agents	MeSH
DB01005	1399	hydroxycarbamide	PA	D004791	Enzyme Inhibitors	MeSH
DB01005	1399	hydroxycarbamide	PA	D006401	Hematologic Agents	MeSH
DB01005	1399	hydroxycarbamide	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB01006	1556	letrozole	EPC	N0000175563	Aromatase Inhibitor	FDA
DB01006	1556	letrozole	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB01006	1556	letrozole	PA	D000970	Antineoplastic Agents	MeSH
DB01006	1556	letrozole	PA	D047072	Aromatase Inhibitors	MeSH
DB01006	1556	letrozole	PA	D004791	Enzyme Inhibitors	MeSH
DB01006	1556	letrozole	PA	D004965	Estrogen Antagonists	MeSH
DB01006	1556	letrozole	PA	D006727	Hormone Antagonists	MeSH
DB01006	1556	letrozole	PA	D065088	Steroid Synthesis Inhibitors	MeSH
DB01007	2675	tioconazole	EPC	N0000175487	Azole Antifungal	FDA
DB01007	2675	tioconazole	Chemical/Ingredient	N0000008217	Azoles	FDA
DB01007	2675	tioconazole	PA	D058888	14-alpha Demethylase Inhibitors	MeSH
DB01007	2675	tioconazole	PA	D000890	Anti-Infective Agents	MeSH
DB01007	2675	tioconazole	has role	CHEBI:35441	antiinfective agent	CHEBI
DB01007	2675	tioconazole	PA	D000935	Antifungal Agents	MeSH
DB01007	2675	tioconazole	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB01007	2675	tioconazole	PA	D004791	Enzyme Inhibitors	MeSH
DB01007	2675	tioconazole	PA	D006727	Hormone Antagonists	MeSH
DB01007	2675	tioconazole	PA	D065088	Steroid Synthesis Inhibitors	MeSH
DB01009	1528	ketoprofen	Chemical/Ingredient	N0000175721	Nonsteroidal Anti-inflammatory Compounds	FDA
DB01009	1528	ketoprofen	EPC	N0000175722	Nonsteroidal Anti-inflammatory Drug	FDA
DB01009	1528	ketoprofen	PA	D000700	Analgesics	MeSH
DB01009	1528	ketoprofen	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB01009	1528	ketoprofen	PA	D000893	Anti-Inflammatory Agents	MeSH
DB01009	1528	ketoprofen	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB01009	1528	ketoprofen	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB01009	1528	ketoprofen	has role	CHEBI:35493	antipyretic	CHEBI
DB01009	1528	ketoprofen	PA	D018501	Antirheumatic Agents	MeSH
DB01009	1528	ketoprofen	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB01009	1528	ketoprofen	PA	D004791	Enzyme Inhibitors	MeSH
DB01009	1528	ketoprofen	PA	D018689	Sensory System Agents	MeSH
DB01010	988	edrophonium	EPC	N0000175723	Cholinesterase Inhibitor	FDA
DB01010	988	edrophonium	has role	CHEBI:33295	diagnostic agent	CHEBI
DB01010	988	edrophonium	has role	CHEBI:50247	antidote	CHEBI
DB01010	988	edrophonium	PA	D000931	Antidotes	MeSH
DB01010	988	edrophonium	PA	D018678	Cholinergic Agents	MeSH
DB01010	988	edrophonium	PA	D002800	Cholinesterase Inhibitors	MeSH
DB01010	988	edrophonium	PA	D004791	Enzyme Inhibitors	MeSH
DB01010	988	edrophonium	PA	D018377	Neurotransmitter Agents	MeSH
DB01010	988	edrophonium	PA	D020011	Protective Agents	MeSH
DB01011	1791	metyrapone	EPC	N0000175928	Adrenal Steroid Synthesis Inhibitor	FDA
DB01011	1791	metyrapone	MoA	N0000175921	Adrenal Steroid Synthesis Inhibitors	FDA
DB01011	1791	metyrapone	has role	CHEBI:33295	diagnostic agent	CHEBI
DB01011	1791	metyrapone	PA	D000963	Antimetabolites	MeSH
DB01011	1791	metyrapone	PA	D004791	Enzyme Inhibitors	MeSH
DB01011	1791	metyrapone	PA	D009676	Noxae	MeSH
DB01012	647	cinacalcet	EPC	N0000175902	Calcium-sensing Receptor Agonist	FDA
DB01012	647	cinacalcet	MoA	N0000020081	Increased Calcium-sensing Receptor Sensitivity	FDA
DB01012	647	cinacalcet	has role	CHEBI:48525	calcimimetic	CHEBI
DB01012	647	cinacalcet	PA	D057966	Calcimimetic Agents	MeSH
DB01012	647	cinacalcet	PA	D006727	Hormone Antagonists	MeSH
DB01014	284	balsalazide	EPC	N0000175781	Aminosalicylate	FDA
DB01014	284	balsalazide	Chemical/Ingredient	N0000005760	Aminosalicylic Acids	FDA
DB01014	284	balsalazide	PA	D000700	Analgesics	MeSH
DB01014	284	balsalazide	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB01014	284	balsalazide	PA	D000893	Anti-Inflammatory Agents	MeSH
DB01014	284	balsalazide	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB01014	284	balsalazide	has role	CHEBI:50266	prodrug	CHEBI
DB01014	284	balsalazide	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB01014	284	balsalazide	has role	CHEBI:49201	anti-ulcer drug	CHEBI
DB01014	284	balsalazide	has role	CHEBI:55324	gastrointestinal drug	CHEBI
DB01014	284	balsalazide	PA	D018501	Antirheumatic Agents	MeSH
DB01014	284	balsalazide	PA	D005765	Gastrointestinal Agents	MeSH
DB01014	284	balsalazide	PA	D018689	Sensory System Agents	MeSH
DB01015	2514	sulfamethoxazole	EPC	N0000175504	Sulfonamide Antimicrobial	FDA
DB01015	2514	sulfamethoxazole	Chemical/Ingredient	N0000008048	Sulfonamides	FDA
DB01015	2514	sulfamethoxazole	MoA	N0000185504	Cytochrome P450 2C9 Inhibitors	FDA
DB01015	2514	sulfamethoxazole	PA	D000890	Anti-Infective Agents	MeSH
DB01015	2514	sulfamethoxazole	has role	CHEBI:88188	drug allergen	CHEBI
DB01015	2514	sulfamethoxazole	has role	CHEBI:35441	antiinfective agent	CHEBI
DB01016	1314	glibenclamide	EPC	N0000175608	Sulfonylurea	FDA
DB01016	1314	glibenclamide	Chemical/Ingredient	N0000008054	Sulfonylurea Compounds	FDA
DB01016	1314	glibenclamide	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB01016	1314	glibenclamide	has role	CHEBI:35526	hypoglycemic agent	CHEBI
DB01016	1314	glibenclamide	PA	D007004	Hypoglycemic Agents	MeSH
DB01018	1343	guanfacine	MoA	N0000009918	Adrenergic alpha2-Agonists	FDA
DB01018	1343	guanfacine	EPC	N0000175554	Central alpha-2 Adrenergic Agonist	FDA
DB01018	1343	guanfacine	PA	D018663	Adrenergic Agents	MeSH
DB01018	1343	guanfacine	PA	D000322	Adrenergic Agonists	MeSH
DB01018	1343	guanfacine	PA	D058647	Adrenergic alpha-2 Receptor Agonists	MeSH
DB01018	1343	guanfacine	PA	D000316	Adrenergic alpha-Agonists	MeSH
DB01018	1343	guanfacine	PA	D000959	Antihypertensive Agents	MeSH
DB01018	1343	guanfacine	PA	D002317	Cardiovascular Agents	MeSH
DB01018	1343	guanfacine	PA	D018377	Neurotransmitter Agents	MeSH
DB01019	358	bethanechol	EPC	N0000175840	Cholinergic Muscarinic Agonist	FDA
DB01019	358	bethanechol	MoA	N0000000104	Cholinergic Muscarinic Agonists	FDA
DB01019	358	bethanechol	has role	CHEBI:38325	muscarinic agonist	CHEBI
DB01019	358	bethanechol	PA	D018678	Cholinergic Agents	MeSH
DB01019	358	bethanechol	PA	D018679	Cholinergic Agonists	MeSH
DB01019	358	bethanechol	PA	D018721	Muscarinic Agonists	MeSH
DB01019	358	bethanechol	PA	D018377	Neurotransmitter Agents	MeSH
DB01019	358	bethanechol	PA	D010277	Parasympathomimetics	MeSH
DB01020	1506	isosorbide mononitrate	EPC	N0000175415	Nitrate Vasodilator	FDA
DB01020	1506	isosorbide mononitrate	Chemical/Ingredient	N0000007647	Nitrates	FDA
DB01020	1506	isosorbide mononitrate	PE	N0000009909	Vasodilation	FDA
DB01020	1506	isosorbide mononitrate	has role	CHEBI:35620	vasodilator agent	CHEBI
DB01020	1506	isosorbide mononitrate	PA	D002317	Cardiovascular Agents	MeSH
DB01020	1506	isosorbide mononitrate	PA	D020030	Nitric Oxide Donors	MeSH
DB01020	1506	isosorbide mononitrate	PA	D014665	Vasodilator Agents	MeSH
DB01021	2733	trichlormethiazide	PA	D000959	Antihypertensive Agents	MeSH
DB01021	2733	trichlormethiazide	PA	D002317	Cardiovascular Agents	MeSH
DB01021	2733	trichlormethiazide	PA	D004232	Diuretics	MeSH
DB01021	2733	trichlormethiazide	PA	D049990	Membrane Transport Modulators	MeSH
DB01021	2733	trichlormethiazide	PA	D045283	Natriuretic Agents	MeSH
DB01021	2733	trichlormethiazide	PA	D049993	Sodium Chloride Symporter Inhibitors	MeSH
DB08645	2733	trichlormethiazide	PA	D000959	Antihypertensive Agents	MeSH
DB08645	2733	trichlormethiazide	PA	D002317	Cardiovascular Agents	MeSH
DB08645	2733	trichlormethiazide	PA	D004232	Diuretics	MeSH
DB08645	2733	trichlormethiazide	PA	D049990	Membrane Transport Modulators	MeSH
DB08645	2733	trichlormethiazide	PA	D045283	Natriuretic Agents	MeSH
DB08645	2733	trichlormethiazide	PA	D049993	Sodium Chloride Symporter Inhibitors	MeSH
DB01023	1142	felodipine	MoA	N0000000069	Calcium Channel Antagonists	FDA
DB01023	1142	felodipine	EPC	N0000175421	Dihydropyridine Calcium Channel Blocker	FDA
DB01023	1142	felodipine	Chemical/Ingredient	N0000007556	Dihydropyridines	FDA
DB01023	1142	felodipine	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB01023	1142	felodipine	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB01023	1142	felodipine	has role	CHEBI:35620	vasodilator agent	CHEBI
DB01023	1142	felodipine	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB01023	1142	felodipine	PA	D000959	Antihypertensive Agents	MeSH
DB01023	1142	felodipine	PA	D002121	Calcium Channel Blockers	MeSH
DB01023	1142	felodipine	PA	D002317	Cardiovascular Agents	MeSH
DB01023	1142	felodipine	PA	D049990	Membrane Transport Modulators	MeSH
DB01023	1142	felodipine	PA	D014665	Vasodilator Agents	MeSH
DB01024	1860	mycophenolic acid	EPC	N0000175613	Antimetabolite Immunosuppressant	FDA
DB01024	1860	mycophenolic acid	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB01024	1860	mycophenolic acid	has role	CHEBI:35705	immunosuppressive agent	CHEBI
DB01024	1860	mycophenolic acid	PA	D000903	Antibiotics, Antineoplastic	MeSH
DB01024	1860	mycophenolic acid	PA	D000970	Antineoplastic Agents	MeSH
DB01024	1860	mycophenolic acid	PA	D004791	Enzyme Inhibitors	MeSH
DB01025	182	amlexanox	PE	N0000175628	Decreased Histamine Release	FDA
DB01025	182	amlexanox	PA	D018926	Anti-Allergic Agents	MeSH
DB01025	182	amlexanox	has role	CHEBI:50857	anti-allergic agent	CHEBI
DB01025	182	amlexanox	has role	CHEBI:49201	anti-ulcer drug	CHEBI
DB01025	182	amlexanox	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB01026	1527	ketoconazole	EPC	N0000175487	Azole Antifungal	FDA
DB01026	1527	ketoconazole	Chemical/Ingredient	N0000008217	Azoles	FDA
DB01026	1527	ketoconazole	MoA	N0000182141	Cytochrome P450 3A4 Inhibitors	FDA
DB01026	1527	ketoconazole	MoA	N0000190115	Cytochrome P450 3A5 Inhibitors	FDA
DB01026	1527	ketoconazole	MoA	N0000185503	P-Glycoprotein Inhibitors	FDA
DB01026	1527	ketoconazole	PA	D058888	14-alpha Demethylase Inhibitors	MeSH
DB01026	1527	ketoconazole	PA	D000890	Anti-Infective Agents	MeSH
DB01026	1527	ketoconazole	PA	D000935	Antifungal Agents	MeSH
DB01026	1527	ketoconazole	PA	D065692	Cytochrome P-450 CYP3A Inhibitors	MeSH
DB01026	1527	ketoconazole	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB01026	1527	ketoconazole	PA	D004791	Enzyme Inhibitors	MeSH
DB01026	1527	ketoconazole	PA	D006727	Hormone Antagonists	MeSH
DB01026	1527	ketoconazole	PA	D065088	Steroid Synthesis Inhibitors	MeSH
DB01028	1754	methoxyflurane	PA	D000777	Anesthetics	MeSH
DB01028	1754	methoxyflurane	PA	D018685	Anesthetics, Inhalation	MeSH
DB01028	1754	methoxyflurane	has role	CHEBI:38870	inhalation anaesthetic	CHEBI
DB01028	1754	methoxyflurane	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB01028	1754	methoxyflurane	PA	D002491	Central Nervous System Agents	MeSH
DB01028	1754	methoxyflurane	PA	D002492	Central Nervous System Depressants	MeSH
DB01029	1481	irbesartan	MoA	N0000000070	Angiotensin 2 Receptor Antagonists	FDA
DB01029	1481	irbesartan	EPC	N0000175561	Angiotensin 2 Receptor Blocker	FDA
DB01029	1481	irbesartan	PA	D047228	Angiotensin II Type 1 Receptor Blockers	MeSH
DB01029	1481	irbesartan	PA	D057911	Angiotensin Receptor Antagonists	MeSH
DB01029	1481	irbesartan	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB01029	1481	irbesartan	has role	CHEBI:61016	angiotensin receptor antagonist	CHEBI
DB01029	1481	irbesartan	PA	D000959	Antihypertensive Agents	MeSH
DB01029	1481	irbesartan	PA	D002317	Cardiovascular Agents	MeSH
DB01030	2707	topotecan	EPC	N0000175609	Topoisomerase Inhibitor	FDA
DB01030	2707	topotecan	MoA	N0000000176	Topoisomerase Inhibitors	FDA
DB01030	2707	topotecan	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB01030	2707	topotecan	PA	D000970	Antineoplastic Agents	MeSH
DB01030	2707	topotecan	PA	D004791	Enzyme Inhibitors	MeSH
DB01030	2707	topotecan	PA	D059004	Topoisomerase I Inhibitors	MeSH
DB01032	2268	probenecid	PA	D000277	Adjuvants, Pharmaceutic	MeSH
DB01032	2268	probenecid	has role	CHEBI:35841	uricosuric drug	CHEBI
DB01032	2268	probenecid	PA	D018501	Antirheumatic Agents	MeSH
DB01032	2268	probenecid	PA	D006074	Gout Suppressants	MeSH
DB01032	2268	probenecid	PA	D010592	Pharmaceutic Aids	MeSH
DB01032	2268	probenecid	PA	D014528	Uricosuric Agents	MeSH
DB01033	1708	mercaptopurine	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB01033	1708	mercaptopurine	PA	D000963	Antimetabolites	MeSH
DB01033	1708	mercaptopurine	PA	D000964	Antimetabolites, Antineoplastic	MeSH
DB01033	1708	mercaptopurine	PA	D000970	Antineoplastic Agents	MeSH
DB01033	1708	mercaptopurine	PA	D004791	Enzyme Inhibitors	MeSH
DB01033	1708	mercaptopurine	PA	D007155	Immunologic Factors	MeSH
DB01033	1708	mercaptopurine	PA	D007166	Immunosuppressive Agents	MeSH
DB01033	1708	mercaptopurine	PA	D009676	Noxae	MeSH
DB01033	1708	mercaptopurine	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB01035	2270	procainamide	EPC	N0000175426	Antiarrhythmic	FDA
DB01035	2270	procainamide	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB01035	2270	procainamide	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB01035	2270	procainamide	has role	CHEBI:50427	platelet aggregation inhibitor	CHEBI
DB01035	2270	procainamide	PA	D002317	Cardiovascular Agents	MeSH
DB01035	2270	procainamide	PA	D049990	Membrane Transport Modulators	MeSH
DB01035	2270	procainamide	PA	D026941	Sodium Channel Blockers	MeSH
DB01035	2270	procainamide	PA	D061567	Voltage-Gated Sodium Channel Blockers	MeSH
DB01036	2705	tolterodine	EPC	N0000175700	Cholinergic Muscarinic Antagonist	FDA
DB01036	2705	tolterodine	MoA	N0000000125	Cholinergic Muscarinic Antagonists	FDA
DB01036	2705	tolterodine	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB01036	2705	tolterodine	has role	CHEBI:53784	antispasmodic drug	CHEBI
DB01036	2705	tolterodine	has role	CHEBI:51371	muscle relaxant	CHEBI
DB01036	2705	tolterodine	PA	D018678	Cholinergic Agents	MeSH
DB01036	2705	tolterodine	PA	D018680	Cholinergic Antagonists	MeSH
DB01036	2705	tolterodine	PA	D018727	Muscarinic Antagonists	MeSH
DB01036	2705	tolterodine	PA	D018377	Neurotransmitter Agents	MeSH
DB01036	2705	tolterodine	PA	D064804	Urological Agents	MeSH
DB01037	2429	selegiline	EPC	N0000175744	Monoamine Oxidase Inhibitor	FDA
DB01037	2429	selegiline	EPC	N0000175762	Monoamine Oxidase Type B Inhibitor	FDA
DB01037	2429	selegiline	MoA	N0000175761	Monoamine Oxidase-B Inhibitors	FDA
DB01037	2429	selegiline	PA	D018726	Anti-Dyskinesia Agents	MeSH
DB01037	2429	selegiline	PA	D000978	Antiparkinson Agents	MeSH
DB01037	2429	selegiline	PA	D002491	Central Nervous System Agents	MeSH
DB01037	2429	selegiline	PA	D004791	Enzyme Inhibitors	MeSH
DB01037	2429	selegiline	PA	D008996	Monoamine Oxidase Inhibitors	MeSH
DB01037	2429	selegiline	PA	D018696	Neuroprotective Agents	MeSH
DB01037	2429	selegiline	PA	D020011	Protective Agents	MeSH
DB01039	1152	fenofibrate	EPC	N0000175596	Peroxisome Proliferator Receptor alpha Agonist	FDA
DB01039	1152	fenofibrate	MoA	N0000175375	Peroxisome Proliferator-activated Receptor alpha Agonists	FDA
DB01039	1152	fenofibrate	Chemical/Ingredient	N0000170118	PPAR alpha	FDA
DB01039	1152	fenofibrate	has role	CHEBI:35679	antilipemic drug	CHEBI
DB01039	1152	fenofibrate	PA	D000963	Antimetabolites	MeSH
DB01039	1152	fenofibrate	PA	D000960	Hypolipidemic Agents	MeSH
DB01041	2616	thalidomide	PE	N0000008663	Decreased Immunologically Active Molecule Activity	FDA
DB01041	2616	thalidomide	PA	D020533	Angiogenesis Inhibitors	MeSH
DB01041	2616	thalidomide	PA	D000900	Anti-Bacterial Agents	MeSH
DB01041	2616	thalidomide	PA	D000890	Anti-Infective Agents	MeSH
DB01041	2616	thalidomide	has role	CHEBI:35705	immunosuppressive agent	CHEBI
DB01041	2616	thalidomide	has role	CHEBI:35816	leprostatic drug	CHEBI
DB01041	2616	thalidomide	has role	CHEBI:48422	angiogenesis inhibitor	CHEBI
DB01041	2616	thalidomide	has role	CHEBI:35623	anticonvulsant	CHEBI
DB01041	2616	thalidomide	has role	CHEBI:50919	antiemetic	CHEBI
DB01041	2616	thalidomide	has role	CHEBI:35717	sedative	CHEBI
DB01041	2616	thalidomide	has role	CHEBI:35472	anti-inflammatory drug	CHEBI
DB01041	2616	thalidomide	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB01041	2616	thalidomide	PA	D000970	Antineoplastic Agents	MeSH
DB01041	2616	thalidomide	PA	D006131	Growth Inhibitors	MeSH
DB01041	2616	thalidomide	PA	D006133	Growth Substances	MeSH
DB01041	2616	thalidomide	PA	D007155	Immunologic Factors	MeSH
DB01041	2616	thalidomide	PA	D007166	Immunosuppressive Agents	MeSH
DB01041	2616	thalidomide	PA	D007917	Leprostatic Agents	MeSH
DB01041	2616	thalidomide	PA	D009676	Noxae	MeSH
DB01041	2616	thalidomide	PA	D013723	Teratogens	MeSH
DB01043	1679	memantine	MoA	N0000020015	NMDA Receptor Antagonists	FDA
DB01043	1679	memantine	EPC	N0000175745	N-methyl-D-aspartate Receptor Antagonist	FDA
DB01043	1679	memantine	PA	D018726	Anti-Dyskinesia Agents	MeSH
DB01043	1679	memantine	has role	CHEBI:48560	dopaminergic agent	CHEBI
DB01043	1679	memantine	has role	CHEBI:48407	antiparkinson drug	CHEBI
DB01043	1679	memantine	has role	CHEBI:63726	neuroprotective agent	CHEBI
DB01043	1679	memantine	has role	CHEBI:35469	antidepressant	CHEBI
DB01043	1679	memantine	PA	D000978	Antiparkinson Agents	MeSH
DB01043	1679	memantine	PA	D002491	Central Nervous System Agents	MeSH
DB01043	1679	memantine	PA	D015259	Dopamine Agents	MeSH
DB01043	1679	memantine	PA	D018691	Excitatory Amino Acid Antagonists	MeSH
DB01043	1679	memantine	PA	D018377	Neurotransmitter Agents	MeSH
DB01044	1280	gatifloxacin	PA	D000900	Anti-Bacterial Agents	MeSH
DB01044	1280	gatifloxacin	PA	D000890	Anti-Infective Agents	MeSH
DB01044	1280	gatifloxacin	has role	CHEBI:35441	antiinfective agent	CHEBI
DB01044	1280	gatifloxacin	PA	D000970	Antineoplastic Agents	MeSH
DB01044	1280	gatifloxacin	PA	D004791	Enzyme Inhibitors	MeSH
DB01044	1280	gatifloxacin	PA	D059005	Topoisomerase II Inhibitors	MeSH
DB01045	2377	rifampicin	EPC	N0000175500	Rifamycin Antibacterial	FDA
DB01045	2377	rifampicin	Chemical/Ingredient	N0000007911	Rifamycins	FDA
DB01045	2377	rifampicin	PA	D000900	Anti-Bacterial Agents	MeSH
DB01045	2377	rifampicin	PA	D000890	Anti-Infective Agents	MeSH
DB01045	2377	rifampicin	PA	D000904	Antibiotics, Antitubercular	MeSH
DB01045	2377	rifampicin	PA	D000995	Antitubercular Agents	MeSH
DB01045	2377	rifampicin	PA	D065695	Cytochrome P-450 CYP2B6 Inducers	MeSH
DB01045	2377	rifampicin	PA	D065697	Cytochrome P-450 CYP2C19 Inducers	MeSH
DB01045	2377	rifampicin	PA	D065696	Cytochrome P-450 CYP2C8 Inducers	MeSH
DB01045	2377	rifampicin	PA	D065698	Cytochrome P-450 CYP2C9 Inducers	MeSH
DB01045	2377	rifampicin	PA	D065701	Cytochrome P-450 CYP3A Inducers	MeSH
DB01045	2377	rifampicin	PA	D004791	Enzyme Inhibitors	MeSH
DB01045	2377	rifampicin	PA	D007917	Leprostatic Agents	MeSH
DB01045	2377	rifampicin	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB01046	4123	lubiprostone	EPC	N0000175573	Chloride Channel Activator	FDA
DB01046	4123	lubiprostone	MoA	N0000175456	Chloride Channel Activators	FDA
DB01046	4123	lubiprostone	PA	D065101	Chloride Channel Agonists	MeSH
DB01046	4123	lubiprostone	PA	D049990	Membrane Transport Modulators	MeSH
DB01048	34	abacavir	EPC	N0000175462	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor	FDA
DB01048	34	abacavir	Chemical/Ingredient	N0000175459	Nucleoside Analog	FDA
DB01048	34	abacavir	MoA	N0000009947	Nucleoside Reverse Transcriptase Inhibitors	FDA
DB01048	34	abacavir	PA	D019380	Anti-HIV Agents	MeSH
DB01048	34	abacavir	PA	D000890	Anti-Infective Agents	MeSH
DB01048	34	abacavir	has role	CHEBI:88188	drug allergen	CHEBI
DB01048	34	abacavir	has role	CHEBI:36044	antiviral drug	CHEBI
DB01048	34	abacavir	PA	D000998	Antiviral Agents	MeSH
DB01048	34	abacavir	PA	D004791	Enzyme Inhibitors	MeSH
DB01048	34	abacavir	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB01048	34	abacavir	PA	D018894	Reverse Transcriptase Inhibitors	MeSH
DB01050	1407	ibuprofen	Chemical/Ingredient	N0000175721	Nonsteroidal Anti-inflammatory Compounds	FDA
DB01050	1407	ibuprofen	EPC	N0000175722	Nonsteroidal Anti-inflammatory Drug	FDA
DB01050	1407	ibuprofen	PA	D000700	Analgesics	MeSH
DB01050	1407	ibuprofen	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB01050	1407	ibuprofen	PA	D000893	Anti-Inflammatory Agents	MeSH
DB01050	1407	ibuprofen	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB01050	1407	ibuprofen	has role	CHEBI:35493	antipyretic	CHEBI
DB01050	1407	ibuprofen	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB01050	1407	ibuprofen	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB01050	1407	ibuprofen	PA	D018501	Antirheumatic Agents	MeSH
DB01050	1407	ibuprofen	PA	D002491	Central Nervous System Agents	MeSH
DB01050	1407	ibuprofen	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB01050	1407	ibuprofen	PA	D004791	Enzyme Inhibitors	MeSH
DB01050	1407	ibuprofen	PA	D018689	Sensory System Agents	MeSH
DB01051	1974	novobiocin	PA	D000900	Anti-Bacterial Agents	MeSH
DB01051	1974	novobiocin	PA	D000890	Anti-Infective Agents	MeSH
DB01051	1974	novobiocin	PA	D004791	Enzyme Inhibitors	MeSH
DB01051	1974	novobiocin	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB01053	4347	benzathine benzylpenicillin	PA	D000900	Anti-Bacterial Agents	MeSH
DB01053	4347	benzathine benzylpenicillin	PA	D000890	Anti-Infective Agents	MeSH
DB01053	2082	benzylpenicillin	EPC	N0000175497	Penicillin-class Antibacterial	FDA
DB01053	2082	benzylpenicillin	Chemical/Ingredient	N0000011281	Penicillins	FDA
DB01053	2082	benzylpenicillin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB01054	1947	nitrendipine	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB01054	1947	nitrendipine	has role	CHEBI:35620	vasodilator agent	CHEBI
DB01054	1947	nitrendipine	PA	D000959	Antihypertensive Agents	MeSH
DB01054	1947	nitrendipine	PA	D002121	Calcium Channel Blockers	MeSH
DB01054	1947	nitrendipine	PA	D002317	Cardiovascular Agents	MeSH
DB01054	1947	nitrendipine	PA	D049990	Membrane Transport Modulators	MeSH
DB01054	1947	nitrendipine	PA	D014665	Vasodilator Agents	MeSH
DB01056	2686	tocainide	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB01056	2686	tocainide	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB01056	2686	tocainide	has role	CHEBI:36333	local anaesthetic	CHEBI
DB01056	2686	tocainide	PA	D002317	Cardiovascular Agents	MeSH
DB01056	2686	tocainide	PA	D049990	Membrane Transport Modulators	MeSH
DB01056	2686	tocainide	PA	D026941	Sodium Channel Blockers	MeSH
DB01056	2686	tocainide	PA	D061567	Voltage-Gated Sodium Channel Blockers	MeSH
DB01057	982	echothiophate	EPC	N0000175723	Cholinesterase Inhibitor	FDA
DB01057	982	echothiophate	Chemical/Ingredient	N0000007196	Iodine	FDA
DB01057	982	echothiophate	has role	CHEBI:51068	miotic	CHEBI
DB01057	982	echothiophate	PA	D018678	Cholinergic Agents	MeSH
DB01057	982	echothiophate	PA	D002800	Cholinesterase Inhibitors	MeSH
DB01057	982	echothiophate	PA	D004791	Enzyme Inhibitors	MeSH
DB01057	982	echothiophate	PA	D008916	Miotics	MeSH
DB01057	982	echothiophate	PA	D018377	Neurotransmitter Agents	MeSH
DB01057	982	echothiophate	PA	D010277	Parasympathomimetics	MeSH
DB01058	2241	praziquantel	EPC	N0000175481	Antihelminthic	FDA
DB01058	2241	praziquantel	PA	D000871	Anthelmintics	MeSH
DB01058	2241	praziquantel	PA	D000890	Anti-Infective Agents	MeSH
DB01058	2241	praziquantel	PA	D000977	Antiparasitic Agents	MeSH
DB01060	192	amoxicillin	EPC	N0000175497	Penicillin-class Antibacterial	FDA
DB01060	192	amoxicillin	Chemical/Ingredient	N0000011281	Penicillins	FDA
DB01060	192	amoxicillin	PA	D000900	Anti-Bacterial Agents	MeSH
DB01060	192	amoxicillin	PA	D000890	Anti-Infective Agents	MeSH
DB01060	192	amoxicillin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB01061	277	azlocillin	PA	D000900	Anti-Bacterial Agents	MeSH
DB01061	277	azlocillin	PA	D000890	Anti-Infective Agents	MeSH
DB01061	277	azlocillin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB01062	2028	oxybutynin	EPC	N0000175700	Cholinergic Muscarinic Antagonist	FDA
DB01062	2028	oxybutynin	MoA	N0000000125	Cholinergic Muscarinic Antagonists	FDA
DB01062	2028	oxybutynin	has role	CHEBI:50370	parasympatholytic	CHEBI
DB01062	2028	oxybutynin	has role	CHEBI:53784	antispasmodic drug	CHEBI
DB01062	2028	oxybutynin	has role	CHEBI:51371	muscle relaxant	CHEBI
DB01062	2028	oxybutynin	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB01062	2028	oxybutynin	PA	D018678	Cholinergic Agents	MeSH
DB01062	2028	oxybutynin	PA	D018680	Cholinergic Antagonists	MeSH
DB01062	2028	oxybutynin	PA	D018727	Muscarinic Antagonists	MeSH
DB01062	2028	oxybutynin	PA	D018377	Neurotransmitter Agents	MeSH
DB01062	2028	oxybutynin	PA	D010276	Parasympatholytics	MeSH
DB01062	2028	oxybutynin	PA	D064804	Urological Agents	MeSH
DB01063	59	acetophenazine	has role	CHEBI:37930	phenothiazine antipsychotic drug	CHEBI
DB01064	1499	isoprenaline	PA	D018663	Adrenergic Agents	MeSH
DB01064	1499	isoprenaline	PA	D000322	Adrenergic Agonists	MeSH
DB01064	1499	isoprenaline	PA	D000318	Adrenergic beta-Agonists	MeSH
DB01064	1499	isoprenaline	PA	D018927	Anti-Asthmatic Agents	MeSH
DB01064	1499	isoprenaline	has role	CHEBI:35522	beta-adrenergic agonist	CHEBI
DB01064	1499	isoprenaline	has role	CHEBI:35523	bronchodilator agent	CHEBI
DB01064	1499	isoprenaline	has role	CHEBI:38147	cardiotonic drug	CHEBI
DB01064	1499	isoprenaline	has role	CHEBI:35524	sympathomimetic agent	CHEBI
DB01064	1499	isoprenaline	PA	D001993	Bronchodilator Agents	MeSH
DB01064	1499	isoprenaline	PA	D002316	Cardiotonic Agents	MeSH
DB01064	1499	isoprenaline	PA	D002317	Cardiovascular Agents	MeSH
DB01064	1499	isoprenaline	PA	D018377	Neurotransmitter Agents	MeSH
DB01064	1499	isoprenaline	PA	D020011	Protective Agents	MeSH
DB01064	1499	isoprenaline	PA	D019141	Respiratory System Agents	MeSH
DB01064	1499	isoprenaline	PA	D013566	Sympathomimetics	MeSH
DB01065	1672	melatonin	has role	CHEBI:35623	anticonvulsant	CHEBI
DB01065	1672	melatonin	has role	CHEBI:35488	central nervous system depressant	CHEBI
DB01065	1672	melatonin	has role	CHEBI:50847	immunological adjuvant	CHEBI
DB01065	1672	melatonin	PA	D000975	Antioxidants	MeSH
DB01065	1672	melatonin	PA	D002491	Central Nervous System Agents	MeSH
DB01065	1672	melatonin	PA	D002492	Central Nervous System Depressants	MeSH
DB01065	1672	melatonin	PA	D020011	Protective Agents	MeSH
DB01067	1301	glipizide	EPC	N0000175608	Sulfonylurea	FDA
DB01067	1301	glipizide	Chemical/Ingredient	N0000008054	Sulfonylurea Compounds	FDA
DB01067	1301	glipizide	has role	CHEBI:35526	hypoglycemic agent	CHEBI
DB01067	1301	glipizide	PA	D007004	Hypoglycemic Agents	MeSH
DB01068	703	clonazepam	EPC	N0000175694	Benzodiazepine	FDA
DB01068	703	clonazepam	Chemical/Ingredient	N0000007542	Benzodiazepines	FDA
DB01068	703	clonazepam	has role	CHEBI:35623	anticonvulsant	CHEBI
DB01068	703	clonazepam	has role	CHEBI:50268	GABA modulator	CHEBI
DB01068	703	clonazepam	has role	CHEBI:35474	anxiolytic drug	CHEBI
DB01068	703	clonazepam	PA	D000927	Anticonvulsants	MeSH
DB01068	703	clonazepam	PA	D002491	Central Nervous System Agents	MeSH
DB01068	703	clonazepam	PA	D018682	GABA Agents	MeSH
DB01068	703	clonazepam	PA	D018757	GABA Modulators	MeSH
DB01068	703	clonazepam	PA	D018377	Neurotransmitter Agents	MeSH
DB01069	2286	promethazine	EPC	N0000175746	Phenothiazine	FDA
DB01069	2286	promethazine	Chemical/Ingredient	N0000007544	Phenothiazines	FDA
DB01069	2286	promethazine	PA	D018926	Anti-Allergic Agents	MeSH
DB01069	2286	promethazine	has role	CHEBI:35717	sedative	CHEBI
DB01069	2286	promethazine	has role	CHEBI:50919	antiemetic	CHEBI
DB01069	2286	promethazine	has role	CHEBI:36333	local anaesthetic	CHEBI
DB01069	2286	promethazine	has role	CHEBI:59683	antipruritic drug	CHEBI
DB01069	2286	promethazine	has role	CHEBI:50857	anti-allergic agent	CHEBI
DB01069	2286	promethazine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB01069	2286	promethazine	PA	D000982	Antipruritics	MeSH
DB01069	2286	promethazine	PA	D003879	Dermatologic Agents	MeSH
DB01069	2286	promethazine	PA	D018494	Histamine Agents	MeSH
DB01069	2286	promethazine	PA	D006633	Histamine Antagonists	MeSH
DB01069	2286	promethazine	PA	D006634	Histamine H1 Antagonists	MeSH
DB01069	2286	promethazine	PA	D018377	Neurotransmitter Agents	MeSH
DB01072	254	atazanavir	EPC	N0000175889	Protease Inhibitor	FDA
DB01072	254	atazanavir	MoA	N0000191272	UGT1A1 Inhibitors	FDA
DB01072	254	atazanavir	MoA	N0000191269	UDP Glucuronosyltransferases Inhibitors	FDA
DB01072	254	atazanavir	MoA	N0000182141	Cytochrome P450 3A4 Inhibitors	FDA
DB01072	254	atazanavir	MoA	N0000190114	Cytochrome P450 3A Inhibitors	FDA
DB01072	254	atazanavir	MoA	N0000187062	Cytochrome P450 2C8 Inhibitors	FDA
DB01072	254	atazanavir	PA	D019380	Anti-HIV Agents	MeSH
DB01072	254	atazanavir	PA	D000890	Anti-Infective Agents	MeSH
DB01072	254	atazanavir	has role	CHEBI:36044	antiviral drug	CHEBI
DB01072	254	atazanavir	PA	D000998	Antiviral Agents	MeSH
DB01072	254	atazanavir	PA	D004791	Enzyme Inhibitors	MeSH
DB01072	254	atazanavir	PA	D017320	HIV Protease Inhibitors	MeSH
DB01072	254	atazanavir	PA	D011480	Protease Inhibitors	MeSH
DB01076	257	atorvastatin	EPC	N0000175589	HMG-CoA Reductase Inhibitor	FDA
DB01076	257	atorvastatin	PA	D000924	Anticholesteremic Agents	MeSH
DB01076	257	atorvastatin	PA	D000963	Antimetabolites	MeSH
DB01076	257	atorvastatin	PA	D004791	Enzyme Inhibitors	MeSH
DB01076	257	atorvastatin	PA	D019161	Hydroxymethylglutaryl-CoA Reductase Inhibitors	MeSH
DB01076	257	atorvastatin	PA	D000960	Hypolipidemic Agents	MeSH
DB01078	813	deslanoside	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB01078	813	deslanoside	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB01078	813	deslanoside	has role	CHEBI:38147	cardiotonic drug	CHEBI
DB01078	813	deslanoside	PA	D002316	Cardiotonic Agents	MeSH
DB01078	813	deslanoside	PA	D002317	Cardiovascular Agents	MeSH
DB01078	813	deslanoside	PA	D004791	Enzyme Inhibitors	MeSH
DB01078	813	deslanoside	PA	D020011	Protective Agents	MeSH
DB01080	2819	vigabatrin	EPC	N0000175753	Anti-epileptic Agent	FDA
DB01080	2819	vigabatrin	has role	CHEBI:35623	anticonvulsant	CHEBI
DB01080	2819	vigabatrin	PA	D000927	Anticonvulsants	MeSH
DB01080	2819	vigabatrin	PA	D002491	Central Nervous System Agents	MeSH
DB01080	2819	vigabatrin	PA	D004791	Enzyme Inhibitors	MeSH
DB01080	2819	vigabatrin	PA	D018682	GABA Agents	MeSH
DB01080	2819	vigabatrin	PA	D018377	Neurotransmitter Agents	MeSH
DB01081	918	diphenoxylate	EPC	N0000178374	Antidiarrheal	FDA
DB01081	918	diphenoxylate	PA	D000700	Analgesics	MeSH
DB01081	918	diphenoxylate	PA	D000701	Analgesics, Opioid	MeSH
DB01081	918	diphenoxylate	has role	CHEBI:55323	antidiarrhoeal drug	CHEBI
DB01081	918	diphenoxylate	PA	D000930	Antidiarrheals	MeSH
DB01081	918	diphenoxylate	PA	D002491	Central Nervous System Agents	MeSH
DB01081	918	diphenoxylate	PA	D002492	Central Nervous System Depressants	MeSH
DB01081	918	diphenoxylate	PA	D005765	Gastrointestinal Agents	MeSH
DB01081	918	diphenoxylate	PA	D009294	Narcotics	MeSH
DB01081	918	diphenoxylate	PA	D018689	Sensory System Agents	MeSH
DB01083	1996	orlistat	EPC	N0000175591	Intestinal Lipase Inhibitor	FDA
DB01083	1996	orlistat	MoA	N0000009916	Lipase Inhibitors	FDA
DB01083	1996	orlistat	PA	D019440	Anti-Obesity Agents	MeSH
DB01083	1996	orlistat	PA	D002491	Central Nervous System Agents	MeSH
DB01083	1996	orlistat	PA	D004791	Enzyme Inhibitors	MeSH
DB01084	999	emedastine	MoA	N0000000190	Histamine H1 Receptor Antagonists	FDA
DB01084	999	emedastine	EPC	N0000175519	Histamine-1 Receptor Inhibitor	FDA
DB01084	999	emedastine	PA	D018926	Anti-Allergic Agents	MeSH
DB01084	999	emedastine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB01084	999	emedastine	has role	CHEBI:50857	anti-allergic agent	CHEBI
DB01084	999	emedastine	has role	CHEBI:59683	antipruritic drug	CHEBI
DB01084	999	emedastine	PA	D018494	Histamine Agents	MeSH
DB01084	999	emedastine	PA	D006633	Histamine Antagonists	MeSH
DB01084	999	emedastine	PA	D006634	Histamine H1 Antagonists	MeSH
DB01084	999	emedastine	PA	D018377	Neurotransmitter Agents	MeSH
DB01085	2166	pilocarpine	MoA	N0000000104	Cholinergic Muscarinic Agonists	FDA
DB01085	2166	pilocarpine	EPC	N0000175884	Cholinergic Receptor Agonist	FDA
DB01085	2166	pilocarpine	has role	CHEBI:39456	antiglaucoma drug	CHEBI
DB01085	2166	pilocarpine	PA	D018678	Cholinergic Agents	MeSH
DB01085	2166	pilocarpine	PA	D018679	Cholinergic Agonists	MeSH
DB01085	2166	pilocarpine	PA	D008916	Miotics	MeSH
DB01085	2166	pilocarpine	PA	D018721	Muscarinic Agonists	MeSH
DB01085	2166	pilocarpine	PA	D018377	Neurotransmitter Agents	MeSH
DB01086	323	benzocaine	EPC	N0000185508	Standardized Chemical Allergen	FDA
DB01086	323	benzocaine	PE	N0000175629	Increased Histamine Release	FDA
DB01086	323	benzocaine	PE	N0000184306	Cell-mediated Immunity	FDA
DB01086	323	benzocaine	Chemical/Ingredient	N0000171131	Allergens	FDA
DB01086	323	benzocaine	PA	D000777	Anesthetics	MeSH
DB01086	323	benzocaine	PA	D000779	Anesthetics, Local	MeSH
DB01086	323	benzocaine	has role	CHEBI:59683	antipruritic drug	CHEBI
DB01086	323	benzocaine	has role	CHEBI:48425	topical anaesthetic	CHEBI
DB01086	323	benzocaine	PA	D002491	Central Nervous System Agents	MeSH
DB01086	323	benzocaine	PA	D002492	Central Nervous System Depressants	MeSH
DB01086	323	benzocaine	PA	D018689	Sensory System Agents	MeSH
DB01089	810	deserpidine	EPC	N0000175640	Catecholamine-depleting Sympatholytic	FDA
DB01089	810	deserpidine	PE	N0000175650	Decreased Sympathetic Activity	FDA
DB01090	2096	pentolonium	PA	D000959	Antihypertensive Agents	MeSH
DB01090	2096	pentolonium	PA	D002317	Cardiovascular Agents	MeSH
DB01090	2096	pentolonium	PA	D018678	Cholinergic Agents	MeSH
DB01090	2096	pentolonium	PA	D018680	Cholinergic Antagonists	MeSH
DB01090	2096	pentolonium	PA	D005730	Ganglionic Blockers	MeSH
DB01090	2096	pentolonium	PA	D018377	Neurotransmitter Agents	MeSH
DB01090	2096	pentolonium	PA	D018733	Nicotinic Antagonists	MeSH
DB01091	444	butenafine	EPC	N0000175875	Benzylamine Antifungal	FDA
DB01091	444	butenafine	Chemical/Ingredient	N0000007566	Benzylamines	FDA
DB01091	444	butenafine	PA	D000890	Anti-Infective Agents	MeSH
DB01091	444	butenafine	has role	CHEBI:86327	antifungal drug	CHEBI
DB01091	444	butenafine	PA	D000935	Antifungal Agents	MeSH
DB01095	1229	fluvastatin	EPC	N0000175589	HMG-CoA Reductase Inhibitor	FDA
DB01095	1229	fluvastatin	has role	CHEBI:35821	anticholesteremic drug	CHEBI
DB01095	1229	fluvastatin	PA	D000924	Anticholesteremic Agents	MeSH
DB01095	1229	fluvastatin	PA	D000963	Antimetabolites	MeSH
DB01095	1229	fluvastatin	PA	D004791	Enzyme Inhibitors	MeSH
DB01095	1229	fluvastatin	PA	D019161	Hydroxymethylglutaryl-CoA Reductase Inhibitors	MeSH
DB01095	1229	fluvastatin	PA	D000960	Hypolipidemic Agents	MeSH
DB01097	1552	leflunomide	EPC	N0000175713	Antirheumatic Agent	FDA
DB01097	1552	leflunomide	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB01097	1552	leflunomide	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB01097	1552	leflunomide	has role	CHEBI:35442	antiparasitic agent	CHEBI
DB01097	1552	leflunomide	has role	CHEBI:50266	prodrug	CHEBI
DB01097	1552	leflunomide	has role	CHEBI:35705	immunosuppressive agent	CHEBI
DB01097	1552	leflunomide	PA	D018501	Antirheumatic Agents	MeSH
DB01097	1552	leflunomide	PA	D004791	Enzyme Inhibitors	MeSH
DB01097	1552	leflunomide	PA	D007155	Immunologic Factors	MeSH
DB01097	1552	leflunomide	PA	D007166	Immunosuppressive Agents	MeSH
DB01098	2406	rosuvastatin	EPC	N0000175589	HMG-CoA Reductase Inhibitor	FDA
DB01098	2406	rosuvastatin	has role	CHEBI:35679	antilipemic drug	CHEBI
DB01098	2406	rosuvastatin	has role	CHEBI:67079	anti-inflammatory agent	CHEBI
DB01098	2406	rosuvastatin	has role	CHEBI:77307	cardioprotective agent	CHEBI
DB01098	2406	rosuvastatin	PA	D000924	Anticholesteremic Agents	MeSH
DB01098	2406	rosuvastatin	PA	D000963	Antimetabolites	MeSH
DB01098	2406	rosuvastatin	PA	D004791	Enzyme Inhibitors	MeSH
DB01098	2406	rosuvastatin	PA	D019161	Hydroxymethylglutaryl-CoA Reductase Inhibitors	MeSH
DB01098	2406	rosuvastatin	PA	D000960	Hypolipidemic Agents	MeSH
DB01100	2172	pimozide	EPC	N0000180182	Typical Antipsychotic	FDA
DB01100	2172	pimozide	PA	D018726	Anti-Dyskinesia Agents	MeSH
DB01100	2172	pimozide	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB01100	2172	pimozide	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB01100	2172	pimozide	has role	CHEBI:66956	antidyskinesia agent	CHEBI
DB01100	2172	pimozide	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB01100	2172	pimozide	has role	CHEBI:65190	first generation antipsychotic	CHEBI
DB01100	2172	pimozide	PA	D014150	Antipsychotic Agents	MeSH
DB01100	2172	pimozide	PA	D002491	Central Nervous System Agents	MeSH
DB01100	2172	pimozide	PA	D002492	Central Nervous System Depressants	MeSH
DB01100	2172	pimozide	PA	D015259	Dopamine Agents	MeSH
DB01100	2172	pimozide	PA	D018492	Dopamine Antagonists	MeSH
DB01100	2172	pimozide	PA	D018377	Neurotransmitter Agents	MeSH
DB01100	2172	pimozide	PA	D011619	Psychotropic Drugs	MeSH
DB01100	2172	pimozide	PA	D014149	Tranquilizing Agents	MeSH
DB01101	480	capecitabine	MoA	N0000000233	Nucleic Acid Synthesis Inhibitors	FDA
DB01101	480	capecitabine	EPC	N0000175595	Nucleoside Metabolic Inhibitor	FDA
DB01101	480	capecitabine	has role	CHEBI:50266	prodrug	CHEBI
DB01101	480	capecitabine	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB01101	480	capecitabine	PA	D000963	Antimetabolites	MeSH
DB01101	480	capecitabine	PA	D000964	Antimetabolites, Antineoplastic	MeSH
DB01101	480	capecitabine	PA	D000970	Antineoplastic Agents	MeSH
DB01101	480	capecitabine	PA	D009676	Noxae	MeSH
DB01102	237	arbutamine	PA	D018663	Adrenergic Agents	MeSH
DB01102	237	arbutamine	PA	D000322	Adrenergic Agonists	MeSH
DB01102	237	arbutamine	PA	D000318	Adrenergic beta-Agonists	MeSH
DB01102	237	arbutamine	has role	CHEBI:35522	beta-adrenergic agonist	CHEBI
DB01102	237	arbutamine	has role	CHEBI:38147	cardiotonic drug	CHEBI
DB01102	237	arbutamine	PA	D002316	Cardiotonic Agents	MeSH
DB01102	237	arbutamine	PA	D002317	Cardiovascular Agents	MeSH
DB01102	237	arbutamine	PA	D018377	Neurotransmitter Agents	MeSH
DB01102	237	arbutamine	PA	D020011	Protective Agents	MeSH
DB01104	2436	sertraline	EPC	N0000175696	Serotonin Reuptake Inhibitor	FDA
DB01104	2436	sertraline	has role	CHEBI:50949	serotonin uptake inhibitor	CHEBI
DB01104	2436	sertraline	has role	CHEBI:35469	antidepressant	CHEBI
DB01104	2436	sertraline	PA	D000928	Antidepressive Agents	MeSH
DB01104	2436	sertraline	PA	D002491	Central Nervous System Agents	MeSH
DB01104	2436	sertraline	PA	D049990	Membrane Transport Modulators	MeSH
DB01104	2436	sertraline	PA	D018377	Neurotransmitter Agents	MeSH
DB01104	2436	sertraline	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB01104	2436	sertraline	PA	D011619	Psychotropic Drugs	MeSH
DB01104	2436	sertraline	PA	D018490	Serotonin Agents	MeSH
DB01104	2436	sertraline	PA	D017367	Serotonin Uptake Inhibitors	MeSH
DB08567	2436	sertraline	EPC	N0000175696	Serotonin Reuptake Inhibitor	FDA
DB08567	2436	sertraline	has role	CHEBI:50949	serotonin uptake inhibitor	CHEBI
DB08567	2436	sertraline	has role	CHEBI:35469	antidepressant	CHEBI
DB08567	2436	sertraline	PA	D000928	Antidepressive Agents	MeSH
DB08567	2436	sertraline	PA	D002491	Central Nervous System Agents	MeSH
DB08567	2436	sertraline	PA	D049990	Membrane Transport Modulators	MeSH
DB08567	2436	sertraline	PA	D018377	Neurotransmitter Agents	MeSH
DB08567	2436	sertraline	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB08567	2436	sertraline	PA	D011619	Psychotropic Drugs	MeSH
DB08567	2436	sertraline	PA	D018490	Serotonin Agents	MeSH
DB08567	2436	sertraline	PA	D017367	Serotonin Uptake Inhibitors	MeSH
DB01105	2440	sibutramine	PE	N0000175372	Appetite Suppression	FDA
DB01105	2440	sibutramine	MoA	N0000000114	Dopamine Uptake Inhibitors	FDA
DB01105	2440	sibutramine	MoA	N0000000102	Norepinephrine Uptake Inhibitors	FDA
DB01105	2440	sibutramine	EPC	N0000175424	Norepinephrine, Serotonin, and Dopamine Reuptake Inhibitor Anorectic	FDA
DB01105	2440	sibutramine	MoA	N0000000109	Serotonin Uptake Inhibitors	FDA
DB01105	2440	sibutramine	has role	CHEBI:50949	serotonin uptake inhibitor	CHEBI
DB01105	2440	sibutramine	PA	D019440	Anti-Obesity Agents	MeSH
DB01105	2440	sibutramine	PA	D000928	Antidepressive Agents	MeSH
DB01105	2440	sibutramine	PA	D001067	Appetite Depressants	MeSH
DB01105	2440	sibutramine	PA	D002491	Central Nervous System Agents	MeSH
DB01105	2440	sibutramine	PA	D011619	Psychotropic Drugs	MeSH
DB01106	1564	levocabastine	PA	D018494	Histamine Agents	MeSH
DB01106	1564	levocabastine	PA	D006633	Histamine Antagonists	MeSH
DB01106	1564	levocabastine	PA	D006634	Histamine H1 Antagonists	MeSH
DB01106	1564	levocabastine	PA	D039563	Histamine H1 Antagonists, Non-Sedating	MeSH
DB01106	1564	levocabastine	PA	D018377	Neurotransmitter Agents	MeSH
DB01108	2746	trilostane	PA	D000021	Abortifacient Agents, Steroidal	MeSH
DB01108	2746	trilostane	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB01108	2746	trilostane	has role	CHEBI:50691	abortifacient	CHEBI
DB01108	2746	trilostane	PA	D000970	Antineoplastic Agents	MeSH
DB01108	2746	trilostane	PA	D004791	Enzyme Inhibitors	MeSH
DB01108	2746	trilostane	PA	D012102	Reproductive Control Agents	MeSH
DB01110	1800	miconazole	EPC	N0000175487	Azole Antifungal	FDA
DB01110	1800	miconazole	Chemical/Ingredient	N0000008217	Azoles	FDA
DB01110	1800	miconazole	PA	D058888	14-alpha Demethylase Inhibitors	MeSH
DB01110	1800	miconazole	PA	D000890	Anti-Infective Agents	MeSH
DB01110	1800	miconazole	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB01110	1800	miconazole	PA	D000935	Antifungal Agents	MeSH
DB01110	1800	miconazole	PA	D065688	Cytochrome P-450 CYP2C9 Inhibitors	MeSH
DB01110	1800	miconazole	PA	D065692	Cytochrome P-450 CYP3A Inhibitors	MeSH
DB01110	1800	miconazole	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB01110	1800	miconazole	PA	D004791	Enzyme Inhibitors	MeSH
DB01110	1800	miconazole	PA	D006727	Hormone Antagonists	MeSH
DB01110	1800	miconazole	PA	D065088	Steroid Synthesis Inhibitors	MeSH
DB01112	565	cefuroxime	EPC	N0000175488	Cephalosporin Antibacterial	FDA
DB01112	565	cefuroxime	Chemical/Ingredient	N0000011161	Cephalosporins	FDA
DB01112	565	cefuroxime	PA	D000900	Anti-Bacterial Agents	MeSH
DB01112	565	cefuroxime	PA	D000890	Anti-Infective Agents	MeSH
DB01112	565	cefuroxime	has role	CHEBI:88188	drug allergen	CHEBI
DB01114	4411	dexchlorpheniramine	PA	D018494	Histamine Agents	MeSH
DB01114	4411	dexchlorpheniramine	PA	D006633	Histamine Antagonists	MeSH
DB01114	4411	dexchlorpheniramine	PA	D006634	Histamine H1 Antagonists	MeSH
DB01114	4411	dexchlorpheniramine	PA	D018377	Neurotransmitter Agents	MeSH
DB01114	616	chlorphenamine	MoA	N0000000190	Histamine H1 Receptor Antagonists	FDA
DB01114	616	chlorphenamine	EPC	N0000175587	Histamine-1 Receptor Antagonist	FDA
DB01114	616	chlorphenamine	PA	D018926	Anti-Allergic Agents	MeSH
DB01114	616	chlorphenamine	has role	CHEBI:50949	serotonin uptake inhibitor	CHEBI
DB01114	616	chlorphenamine	has role	CHEBI:35469	antidepressant	CHEBI
DB01114	616	chlorphenamine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB01114	616	chlorphenamine	has role	CHEBI:37956	histamine antagonist	CHEBI
DB01114	616	chlorphenamine	has role	CHEBI:59683	antipruritic drug	CHEBI
DB01114	616	chlorphenamine	has role	CHEBI:50857	anti-allergic agent	CHEBI
DB01114	616	chlorphenamine	PA	D000982	Antipruritics	MeSH
DB01114	616	chlorphenamine	PA	D003879	Dermatologic Agents	MeSH
DB01115	1922	nifedipine	MoA	N0000000069	Calcium Channel Antagonists	FDA
DB01115	1922	nifedipine	EPC	N0000175421	Dihydropyridine Calcium Channel Blocker	FDA
DB01115	1922	nifedipine	Chemical/Ingredient	N0000007556	Dihydropyridines	FDA
DB01115	1922	nifedipine	has role	CHEBI:35620	vasodilator agent	CHEBI
DB01115	1922	nifedipine	has role	CHEBI:66993	tocolytic agent	CHEBI
DB01115	1922	nifedipine	PA	D002121	Calcium Channel Blockers	MeSH
DB01115	1922	nifedipine	PA	D002317	Cardiovascular Agents	MeSH
DB01115	1922	nifedipine	PA	D049990	Membrane Transport Modulators	MeSH
DB01115	1922	nifedipine	PA	D012102	Reproductive Control Agents	MeSH
DB01115	1922	nifedipine	PA	D015149	Tocolytic Agents	MeSH
DB01115	1922	nifedipine	PA	D014665	Vasodilator Agents	MeSH
DB01116	2752	trimetaphan	PA	D000759	Adjuvants, Anesthesia	MeSH
DB01116	2752	trimetaphan	has role	CHEBI:60807	anaesthesia adjuvant	CHEBI
DB01116	2752	trimetaphan	has role	CHEBI:35620	vasodilator agent	CHEBI
DB01116	2752	trimetaphan	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB01116	2752	trimetaphan	has role	CHEBI:48878	nicotinic antagonist	CHEBI
DB01116	2752	trimetaphan	PA	D000959	Antihypertensive Agents	MeSH
DB01116	2752	trimetaphan	PA	D002317	Cardiovascular Agents	MeSH
DB01116	2752	trimetaphan	PA	D002491	Central Nervous System Agents	MeSH
DB01116	2752	trimetaphan	PA	D018678	Cholinergic Agents	MeSH
DB01116	2752	trimetaphan	PA	D018680	Cholinergic Antagonists	MeSH
DB01116	2752	trimetaphan	PA	D005730	Ganglionic Blockers	MeSH
DB01116	2752	trimetaphan	PA	D018377	Neurotransmitter Agents	MeSH
DB01116	2752	trimetaphan	PA	D018733	Nicotinic Antagonists	MeSH
DB01116	2752	trimetaphan	PA	D014665	Vasodilator Agents	MeSH
DB01117	258	atovaquone	EPC	N0000175485	Antiprotozoal	FDA
DB01117	258	atovaquone	PA	D000890	Anti-Infective Agents	MeSH
DB01117	258	atovaquone	has role	CHEBI:38068	antimalarial	CHEBI
DB01117	258	atovaquone	PA	D000962	Antimalarials	MeSH
DB01117	258	atovaquone	PA	D000977	Antiparasitic Agents	MeSH
DB01117	258	atovaquone	PA	D000981	Antiprotozoal Agents	MeSH
DB01117	258	atovaquone	PA	D004791	Enzyme Inhibitors	MeSH
DB01118	176	amiodarone	EPC	N0000175426	Antiarrhythmic	FDA
DB01118	176	amiodarone	MoA	N0000182141	Cytochrome P450 3A4 Inhibitors	FDA
DB01118	176	amiodarone	MoA	N0000185503	P-Glycoprotein Inhibitors	FDA
DB01118	176	amiodarone	MoA	N0000182138	Cytochrome P450 1A2 Inhibitors	FDA
DB01118	176	amiodarone	MoA	N0000185504	Cytochrome P450 2C9 Inhibitors	FDA
DB01118	176	amiodarone	MoA	N0000182137	Cytochrome P450 2D6 Inhibitors	FDA
DB01118	176	amiodarone	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB01118	176	amiodarone	has role	CHEBI:35554	cardiovascular drug	CHEBI
DB01118	176	amiodarone	PA	D002317	Cardiovascular Agents	MeSH
DB01118	176	amiodarone	PA	D065609	Cytochrome P-450 CYP1A2 Inhibitors	MeSH
DB01118	176	amiodarone	PA	D065688	Cytochrome P-450 CYP2C9 Inhibitors	MeSH
DB01118	176	amiodarone	PA	D065690	Cytochrome P-450 CYP2D6 Inhibitors	MeSH
DB01118	176	amiodarone	PA	D065692	Cytochrome P-450 CYP3A Inhibitors	MeSH
DB01118	176	amiodarone	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB01118	176	amiodarone	PA	D004791	Enzyme Inhibitors	MeSH
DB01118	176	amiodarone	PA	D049990	Membrane Transport Modulators	MeSH
DB01118	176	amiodarone	PA	D026902	Potassium Channel Blockers	MeSH
DB01118	176	amiodarone	PA	D026941	Sodium Channel Blockers	MeSH
DB01118	176	amiodarone	PA	D014665	Vasodilator Agents	MeSH
DB01119	854	diazoxide	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB01119	854	diazoxide	has role	CHEBI:35524	sympathomimetic agent	CHEBI
DB01119	854	diazoxide	has role	CHEBI:38147	cardiotonic drug	CHEBI
DB01119	854	diazoxide	has role	CHEBI:35523	bronchodilator agent	CHEBI
DB01119	854	diazoxide	has role	CHEBI:35522	beta-adrenergic agonist	CHEBI
DB01119	854	diazoxide	has role	CHEBI:35498	diuretic	CHEBI
DB01119	854	diazoxide	has role	CHEBI:35620	vasodilator agent	CHEBI
DB01119	854	diazoxide	PA	D000959	Antihypertensive Agents	MeSH
DB01119	854	diazoxide	PA	D002317	Cardiovascular Agents	MeSH
DB01119	854	diazoxide	PA	D014665	Vasodilator Agents	MeSH
DB01120	1299	gliclazide	has role	CHEBI:35526	hypoglycemic agent	CHEBI
DB01120	1299	gliclazide	PA	D007004	Hypoglycemic Agents	MeSH
DB01122	146	ambenonium	EPC	N0000175723	Cholinesterase Inhibitor	FDA
DB01122	146	ambenonium	PA	D018678	Cholinergic Agents	MeSH
DB01122	146	ambenonium	PA	D002800	Cholinesterase Inhibitors	MeSH
DB01122	146	ambenonium	PA	D004791	Enzyme Inhibitors	MeSH
DB01122	146	ambenonium	PA	D018377	Neurotransmitter Agents	MeSH
DB01122	146	ambenonium	PA	D010277	Parasympathomimetics	MeSH
DB01124	2696	tolbutamide	EPC	N0000175608	Sulfonylurea	FDA
DB01124	2696	tolbutamide	Chemical/Ingredient	N0000008054	Sulfonylurea Compounds	FDA
DB01124	2696	tolbutamide	has role	CHEBI:35526	hypoglycemic agent	CHEBI
DB01124	2696	tolbutamide	PA	D007004	Hypoglycemic Agents	MeSH
DB01125	222	anisindione	has role	CHEBI:50249	anticoagulant	CHEBI
DB01126	973	dutasteride	EPC	N0000175836	5-alpha Reductase Inhibitor	FDA
DB01126	973	dutasteride	PA	D058891	5-alpha Reductase Inhibitors	MeSH
DB01126	973	dutasteride	PA	D004791	Enzyme Inhibitors	MeSH
DB01126	973	dutasteride	PA	D006727	Hormone Antagonists	MeSH
DB01126	973	dutasteride	PA	D065088	Steroid Synthesis Inhibitors	MeSH
DB01127	983	econazole	EPC	N0000175487	Azole Antifungal	FDA
DB01127	983	econazole	Chemical/Ingredient	N0000008217	Azoles	FDA
DB01127	983	econazole	PA	D058888	14-alpha Demethylase Inhibitors	MeSH
DB01127	983	econazole	PA	D000890	Anti-Infective Agents	MeSH
DB01127	983	econazole	PA	D000935	Antifungal Agents	MeSH
DB01127	983	econazole	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB01127	983	econazole	PA	D004791	Enzyme Inhibitors	MeSH
DB01127	983	econazole	PA	D006727	Hormone Antagonists	MeSH
DB01127	983	econazole	PA	D065088	Steroid Synthesis Inhibitors	MeSH
DB07705	983	econazole	EPC	N0000175487	Azole Antifungal	FDA
DB07705	983	econazole	Chemical/Ingredient	N0000008217	Azoles	FDA
DB07705	983	econazole	PA	D058888	14-alpha Demethylase Inhibitors	MeSH
DB07705	983	econazole	PA	D000890	Anti-Infective Agents	MeSH
DB07705	983	econazole	PA	D000935	Antifungal Agents	MeSH
DB07705	983	econazole	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB07705	983	econazole	PA	D004791	Enzyme Inhibitors	MeSH
DB07705	983	econazole	PA	D006727	Hormone Antagonists	MeSH
DB07705	983	econazole	PA	D065088	Steroid Synthesis Inhibitors	MeSH
DB01128	367	bicalutamide	MoA	N0000000243	Androgen Receptor Antagonists	FDA
DB01128	367	bicalutamide	EPC	N0000175560	Androgen Receptor Inhibitor	FDA
DB01128	367	bicalutamide	PA	D000726	Androgen Antagonists	MeSH
DB01128	367	bicalutamide	has role	CHEBI:35497	androgen antagonist	CHEBI
DB01128	367	bicalutamide	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB01128	367	bicalutamide	PA	D000970	Antineoplastic Agents	MeSH
DB01128	367	bicalutamide	PA	D006727	Hormone Antagonists	MeSH
DB02932	367	bicalutamide	MoA	N0000000243	Androgen Receptor Antagonists	FDA
DB02932	367	bicalutamide	EPC	N0000175560	Androgen Receptor Inhibitor	FDA
DB02932	367	bicalutamide	PA	D000726	Androgen Antagonists	MeSH
DB02932	367	bicalutamide	has role	CHEBI:35497	androgen antagonist	CHEBI
DB02932	367	bicalutamide	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB02932	367	bicalutamide	PA	D000970	Antineoplastic Agents	MeSH
DB02932	367	bicalutamide	PA	D006727	Hormone Antagonists	MeSH
DB01129	2350	rabeprazole	EPC	N0000175525	Proton Pump Inhibitor	FDA
DB01129	2350	rabeprazole	has role	CHEBI:49201	anti-ulcer drug	CHEBI
DB01129	2350	rabeprazole	PA	D000897	Anti-Ulcer Agents	MeSH
DB01129	2350	rabeprazole	PA	D004791	Enzyme Inhibitors	MeSH
DB01129	2350	rabeprazole	PA	D005765	Gastrointestinal Agents	MeSH
DB01129	2350	rabeprazole	PA	D054328	Proton Pump Inhibitors	MeSH
DB01130	2243	prednicarbate	EPC	N0000175576	Corticosteroid	FDA
DB01130	2243	prednicarbate	MoA	N0000175450	Corticosteroid Hormone Receptor Agonists	FDA
DB01130	2243	prednicarbate	PA	D000893	Anti-Inflammatory Agents	MeSH
DB01130	2243	prednicarbate	PA	D005938	Glucocorticoids	MeSH
DB01130	2243	prednicarbate	PA	D006728	Hormones	MeSH
DB01131	2282	proguanil	MoA	N0000000191	Dihydrofolate Reductase Inhibitors	FDA
DB01131	2282	proguanil	PA	D000890	Anti-Infective Agents	MeSH
DB01131	2282	proguanil	has role	CHEBI:38068	antimalarial	CHEBI
DB01131	2282	proguanil	has role	CHEBI:35820	antiprotozoal drug	CHEBI
DB01131	2282	proguanil	PA	D000962	Antimalarials	MeSH
DB01131	2282	proguanil	PA	D000963	Antimetabolites	MeSH
DB01131	2282	proguanil	PA	D000977	Antiparasitic Agents	MeSH
DB01131	2282	proguanil	PA	D000981	Antiprotozoal Agents	MeSH
DB01131	2282	proguanil	PA	D009676	Noxae	MeSH
DB01132	2179	pioglitazone	EPC	N0000175596	Peroxisome Proliferator Receptor alpha Agonist	FDA
DB01132	2179	pioglitazone	EPC	N0000180186	Peroxisome Proliferator Receptor gamma Agonist	FDA
DB01132	2179	pioglitazone	MoA	N0000175374	Peroxisome Proliferator-activated Receptor Activity	FDA
DB01132	2179	pioglitazone	Chemical/Ingredient	N0000170118	PPAR alpha	FDA
DB01132	2179	pioglitazone	Chemical/Ingredient	N0000170119	PPAR gamma	FDA
DB01132	2179	pioglitazone	EPC	N0000180190	Thiazolidinedione	FDA
DB01132	2179	pioglitazone	Chemical/Ingredient	N0000011272	Thiazolidinediones	FDA
DB01132	2179	pioglitazone	has role	CHEBI:50864	insulin-sensitizing drug	CHEBI
DB01132	2179	pioglitazone	PA	D007004	Hypoglycemic Agents	MeSH
DB01135	2974	doxacurium	has role	CHEBI:51371	muscle relaxant	CHEBI
DB01135	2974	doxacurium	PA	D009465	Neuromuscular Agents	MeSH
DB01135	2974	doxacurium	PA	D009466	Neuromuscular Blocking Agents	MeSH
DB01135	2974	doxacurium	PA	D003473	Neuromuscular Nondepolarizing Agents	MeSH
DB01136	522	carvedilol	MoA	N0000009923	Adrenergic beta1-Antagonists	FDA
DB01136	522	carvedilol	MoA	N0000009924	Adrenergic beta2-Antagonists	FDA
DB01136	522	carvedilol	EPC	N0000175553	alpha-Adrenergic Blocker	FDA
DB01136	522	carvedilol	EPC	N0000175556	beta-Adrenergic Blocker	FDA
DB01136	522	carvedilol	PA	D018663	Adrenergic Agents	MeSH
DB01136	522	carvedilol	PA	D058668	Adrenergic alpha-1 Receptor Antagonists	MeSH
DB01136	522	carvedilol	PA	D000317	Adrenergic alpha-Antagonists	MeSH
DB01136	522	carvedilol	PA	D018674	Adrenergic Antagonists	MeSH
DB01136	522	carvedilol	PA	D000319	Adrenergic beta-Antagonists	MeSH
DB01136	522	carvedilol	has role	CHEBI:35620	vasodilator agent	CHEBI
DB01136	522	carvedilol	has role	CHEBI:35554	cardiovascular drug	CHEBI
DB01136	522	carvedilol	has role	CHEBI:35530	beta-adrenergic antagonist	CHEBI
DB01136	522	carvedilol	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB01136	522	carvedilol	has role	CHEBI:37890	alpha-adrenergic antagonist	CHEBI
DB01136	522	carvedilol	PA	D000959	Antihypertensive Agents	MeSH
DB01136	522	carvedilol	PA	D002317	Cardiovascular Agents	MeSH
DB01136	522	carvedilol	PA	D018377	Neurotransmitter Agents	MeSH
DB01136	522	carvedilol	PA	D014665	Vasodilator Agents	MeSH
DB01137	1967	norfloxacin	EPC	N0000175937	Quinolone Antimicrobial	FDA
DB01137	1967	norfloxacin	Chemical/Ingredient	N0000007606	Quinolones	FDA
DB01137	1967	norfloxacin	PA	D000900	Anti-Bacterial Agents	MeSH
DB01137	1967	norfloxacin	PA	D000890	Anti-Infective Agents	MeSH
DB01137	1967	norfloxacin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB01137	1967	norfloxacin	PA	D000970	Antineoplastic Agents	MeSH
DB01137	1967	norfloxacin	PA	D065609	Cytochrome P-450 CYP1A2 Inhibitors	MeSH
DB01137	1967	norfloxacin	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB01137	1967	norfloxacin	PA	D004791	Enzyme Inhibitors	MeSH
DB01137	1967	norfloxacin	PA	D059005	Topoisomerase II Inhibitors	MeSH
DB01165	1967	norfloxacin	EPC	N0000175937	Quinolone Antimicrobial	FDA
DB01165	1967	norfloxacin	Chemical/Ingredient	N0000007606	Quinolones	FDA
DB01165	1967	norfloxacin	PA	D000900	Anti-Bacterial Agents	MeSH
DB01165	1967	norfloxacin	PA	D000890	Anti-Infective Agents	MeSH
DB01165	1967	norfloxacin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB01165	1967	norfloxacin	PA	D000970	Antineoplastic Agents	MeSH
DB01165	1967	norfloxacin	PA	D065609	Cytochrome P-450 CYP1A2 Inhibitors	MeSH
DB01165	1967	norfloxacin	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB01165	1967	norfloxacin	PA	D004791	Enzyme Inhibitors	MeSH
DB01165	1967	norfloxacin	PA	D059005	Topoisomerase II Inhibitors	MeSH
DB03034	1967	norfloxacin	EPC	N0000175937	Quinolone Antimicrobial	FDA
DB03034	1967	norfloxacin	Chemical/Ingredient	N0000007606	Quinolones	FDA
DB03034	1967	norfloxacin	PA	D000900	Anti-Bacterial Agents	MeSH
DB03034	1967	norfloxacin	PA	D000890	Anti-Infective Agents	MeSH
DB03034	1967	norfloxacin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB03034	1967	norfloxacin	PA	D000970	Antineoplastic Agents	MeSH
DB03034	1967	norfloxacin	PA	D065609	Cytochrome P-450 CYP1A2 Inhibitors	MeSH
DB03034	1967	norfloxacin	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB03034	1967	norfloxacin	PA	D004791	Enzyme Inhibitors	MeSH
DB03034	1967	norfloxacin	PA	D059005	Topoisomerase II Inhibitors	MeSH
DB01137	1569	levofloxacin	PA	D000892	Anti-Infective Agents, Urinary	MeSH
DB01165	1569	levofloxacin	PA	D000892	Anti-Infective Agents, Urinary	MeSH
DB03034	1569	levofloxacin	PA	D000892	Anti-Infective Agents, Urinary	MeSH
DB01137	1981	ofloxacin	has role	CHEBI:35441	antiinfective agent	CHEBI
DB01165	1981	ofloxacin	has role	CHEBI:35441	antiinfective agent	CHEBI
DB03034	1981	ofloxacin	has role	CHEBI:35441	antiinfective agent	CHEBI
DB01138	2528	sulfinpyrazone	has role	CHEBI:35841	uricosuric drug	CHEBI
DB01138	2528	sulfinpyrazone	PA	D018501	Antirheumatic Agents	MeSH
DB01138	2528	sulfinpyrazone	PA	D006074	Gout Suppressants	MeSH
DB01138	2528	sulfinpyrazone	PA	D014528	Uricosuric Agents	MeSH
DB01139	575	cefapirin	PA	D000900	Anti-Bacterial Agents	MeSH
DB01139	575	cefapirin	PA	D000890	Anti-Infective Agents	MeSH
DB01139	575	cefapirin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB01140	526	cefadroxil	PA	D000900	Anti-Bacterial Agents	MeSH
DB01140	526	cefadroxil	PA	D000890	Anti-Infective Agents	MeSH
DB01140	526	cefadroxil	has role	CHEBI:36047	antibacterial drug	CHEBI
DB01141	1798	micafungin	EPC	N0000175507	Echinocandin Antifungal	FDA
DB01141	1798	micafungin	Chemical/Ingredient	N0000175508	Lipopeptides	FDA
DB01141	1798	micafungin	PA	D000890	Anti-Infective Agents	MeSH
DB01141	1798	micafungin	has role	CHEBI:35441	antiinfective agent	CHEBI
DB01141	1798	micafungin	PA	D000935	Antifungal Agents	MeSH
DB01142	956	doxepin	EPC	N0000175752	Tricyclic Antidepressant	FDA
DB01142	956	doxepin	has role	CHEBI:35469	antidepressant	CHEBI
DB01142	956	doxepin	PA	D000928	Antidepressive Agents	MeSH
DB01142	956	doxepin	PA	D000929	Antidepressive Agents, Tricyclic	MeSH
DB01142	956	doxepin	PA	D002491	Central Nervous System Agents	MeSH
DB01142	956	doxepin	PA	D018494	Histamine Agents	MeSH
DB01142	956	doxepin	PA	D006633	Histamine Antagonists	MeSH
DB01142	956	doxepin	PA	D018377	Neurotransmitter Agents	MeSH
DB01142	956	doxepin	PA	D011619	Psychotropic Drugs	MeSH
DB01142	956	doxepin	PA	D000068776	Sleep Aids, Pharmaceutical	MeSH
DB01144	864	dichlorphenamide	has role	CHEBI:39456	antiglaucoma drug	CHEBI
DB01144	864	dichlorphenamide	has role	CHEBI:66981	ophthalmology drug	CHEBI
DB01144	864	dichlorphenamide	PA	D002257	Carbonic Anhydrase Inhibitors	MeSH
DB01144	864	dichlorphenamide	PA	D004791	Enzyme Inhibitors	MeSH
DB01144	864	dichlorphenamide	EPC	N0000175517	Carbonic Anhydrase Inhibitor	FDA
DB01144	864	dichlorphenamide	Chemical/Ingredient	N0000008048	Sulfonamides	FDA
DB01146	920	diphenylpyraline	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB01146	920	diphenylpyraline	has role	CHEBI:48873	cholinergic antagonist	CHEBI
DB01147	720	cloxacillin	PA	D000900	Anti-Bacterial Agents	MeSH
DB01147	720	cloxacillin	PA	D000890	Anti-Infective Agents	MeSH
DB01147	720	cloxacillin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB01148	1175	flavoxate	EPC	N0000175700	Cholinergic Muscarinic Antagonist	FDA
DB01148	1175	flavoxate	MoA	N0000000125	Cholinergic Muscarinic Antagonists	FDA
DB01148	1175	flavoxate	has role	CHEBI:50370	parasympatholytic	CHEBI
DB01148	1175	flavoxate	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB01148	1175	flavoxate	has role	CHEBI:53784	antispasmodic drug	CHEBI
DB01148	1175	flavoxate	PA	D010276	Parasympatholytics	MeSH
DB01148	1175	flavoxate	PA	D064804	Urological Agents	MeSH
DB01149	1890	nefazodone	EPC	N0000175696	Serotonin Reuptake Inhibitor	FDA
DB01149	1890	nefazodone	has role	CHEBI:35469	antidepressant	CHEBI
DB01149	1890	nefazodone	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB01149	1890	nefazodone	has role	CHEBI:50949	serotonin uptake inhibitor	CHEBI
DB01149	1890	nefazodone	has role	CHEBI:37890	alpha-adrenergic antagonist	CHEBI
DB01149	1890	nefazodone	has role	CHEBI:35480	analgesic	CHEBI
DB01149	1890	nefazodone	PA	D000928	Antidepressive Agents	MeSH
DB01149	1890	nefazodone	PA	D018687	Antidepressive Agents, Second-Generation	MeSH
DB01149	1890	nefazodone	PA	D002491	Central Nervous System Agents	MeSH
DB01149	1890	nefazodone	PA	D011619	Psychotropic Drugs	MeSH
DB01151	812	desipramine	EPC	N0000175752	Tricyclic Antidepressant	FDA
DB01151	812	desipramine	PA	D018663	Adrenergic Agents	MeSH
DB01151	812	desipramine	PA	D018759	Adrenergic Uptake Inhibitors	MeSH
DB01151	812	desipramine	has role	CHEBI:35640	adrenergic uptake inhibitor	CHEBI
DB01151	812	desipramine	has role	CHEBI:50949	serotonin uptake inhibitor	CHEBI
DB01151	812	desipramine	has role	CHEBI:48873	cholinergic antagonist	CHEBI
DB01151	812	desipramine	has role	CHEBI:37890	alpha-adrenergic antagonist	CHEBI
DB01151	812	desipramine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB01151	812	desipramine	has role	CHEBI:35469	antidepressant	CHEBI
DB01151	812	desipramine	has role	CHEBI:88188	drug allergen	CHEBI
DB01151	812	desipramine	PA	D000928	Antidepressive Agents	MeSH
DB01151	812	desipramine	PA	D000929	Antidepressive Agents, Tricyclic	MeSH
DB01151	812	desipramine	PA	D002491	Central Nervous System Agents	MeSH
DB01151	812	desipramine	PA	D004791	Enzyme Inhibitors	MeSH
DB01151	812	desipramine	PA	D049990	Membrane Transport Modulators	MeSH
DB01151	812	desipramine	PA	D018377	Neurotransmitter Agents	MeSH
DB01151	812	desipramine	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB01151	812	desipramine	PA	D011619	Psychotropic Drugs	MeSH
DB01153	2434	sertaconazole	EPC	N0000175487	Azole Antifungal	FDA
DB01153	2434	sertaconazole	Chemical/Ingredient	N0000008217	Azoles	FDA
DB01153	2434	sertaconazole	PA	D000890	Anti-Infective Agents	MeSH
DB01153	2434	sertaconazole	has role	CHEBI:36047	antibacterial drug	CHEBI
DB01153	2434	sertaconazole	has role	CHEBI:59683	antipruritic drug	CHEBI
DB01153	2434	sertaconazole	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB01153	2434	sertaconazole	PA	D000935	Antifungal Agents	MeSH
DB01154	2626	thiamylal	PA	D000777	Anesthetics	MeSH
DB01154	2626	thiamylal	PA	D018686	Anesthetics, Intravenous	MeSH
DB01154	2626	thiamylal	has role	CHEBI:35717	sedative	CHEBI
DB01154	2626	thiamylal	PA	D002491	Central Nervous System Agents	MeSH
DB01154	2626	thiamylal	PA	D002492	Central Nervous System Depressants	MeSH
DB01154	2626	thiamylal	PA	D018682	GABA Agents	MeSH
DB01154	2626	thiamylal	PA	D018757	GABA Modulators	MeSH
DB01154	2626	thiamylal	PA	D006993	Hypnotics and Sedatives	MeSH
DB01154	2626	thiamylal	PA	D018377	Neurotransmitter Agents	MeSH
DB01155	1286	gemifloxacin	EPC	N0000175937	Quinolone Antimicrobial	FDA
DB01155	1286	gemifloxacin	Chemical/Ingredient	N0000007606	Quinolones	FDA
DB01155	1286	gemifloxacin	PA	D000900	Anti-Bacterial Agents	MeSH
DB01155	1286	gemifloxacin	PA	D000890	Anti-Infective Agents	MeSH
DB01155	1286	gemifloxacin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB01155	1286	gemifloxacin	PA	D000970	Antineoplastic Agents	MeSH
DB01155	1286	gemifloxacin	PA	D004791	Enzyme Inhibitors	MeSH
DB01155	1286	gemifloxacin	PA	D059005	Topoisomerase II Inhibitors	MeSH
DB01156	435	bupropion	EPC	N0000180855	Aminoketone	FDA
DB01156	435	bupropion	PE	N0000009282	Increased Dopamine Activity	FDA
DB01156	435	bupropion	PE	N0000009456	Increased Norepinephrine Activity	FDA
DB01156	435	bupropion	MoA	N0000000102	Norepinephrine Uptake Inhibitors	FDA
DB01156	435	bupropion	has role	CHEBI:35469	antidepressant	CHEBI
DB01156	435	bupropion	PA	D000928	Antidepressive Agents	MeSH
DB01156	435	bupropion	PA	D018687	Antidepressive Agents, Second-Generation	MeSH
DB01156	435	bupropion	PA	D002491	Central Nervous System Agents	MeSH
DB01156	435	bupropion	PA	D065690	Cytochrome P-450 CYP2D6 Inhibitors	MeSH
DB01156	435	bupropion	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB01156	435	bupropion	PA	D015259	Dopamine Agents	MeSH
DB01156	435	bupropion	PA	D018765	Dopamine Uptake Inhibitors	MeSH
DB01156	435	bupropion	PA	D004791	Enzyme Inhibitors	MeSH
DB01156	435	bupropion	PA	D049990	Membrane Transport Modulators	MeSH
DB01156	435	bupropion	PA	D018377	Neurotransmitter Agents	MeSH
DB01156	435	bupropion	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB01156	435	bupropion	PA	D011619	Psychotropic Drugs	MeSH
DB01157	2757	trimetrexate	PA	D000890	Anti-Infective Agents	MeSH
DB01157	2757	trimetrexate	has role	CHEBI:86327	antifungal drug	CHEBI
DB01157	2757	trimetrexate	PA	D000935	Antifungal Agents	MeSH
DB01157	2757	trimetrexate	PA	D000963	Antimetabolites	MeSH
DB01157	2757	trimetrexate	PA	D000964	Antimetabolites, Antineoplastic	MeSH
DB01157	2757	trimetrexate	PA	D000970	Antineoplastic Agents	MeSH
DB01157	2757	trimetrexate	PA	D004791	Enzyme Inhibitors	MeSH
DB01157	2757	trimetrexate	PA	D005493	Folic Acid Antagonists	MeSH
DB01157	2757	trimetrexate	PA	D009676	Noxae	MeSH
DB01158	394	bretylium	PA	D018663	Adrenergic Agents	MeSH
DB01158	394	bretylium	PA	D018674	Adrenergic Antagonists	MeSH
DB01158	394	bretylium	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB01158	394	bretylium	PA	D000959	Antihypertensive Agents	MeSH
DB01158	394	bretylium	PA	D002317	Cardiovascular Agents	MeSH
DB01158	394	bretylium	PA	D018377	Neurotransmitter Agents	MeSH
DB01159	1356	halothane	PA	D000777	Anesthetics	MeSH
DB01159	1356	halothane	PA	D018685	Anesthetics, Inhalation	MeSH
DB01159	1356	halothane	has role	CHEBI:38870	inhalation anaesthetic	CHEBI
DB01159	1356	halothane	PA	D002491	Central Nervous System Agents	MeSH
DB01159	1356	halothane	PA	D002492	Central Nervous System Depressants	MeSH
DB01160	912	dinoprost	PA	D000020	Abortifacient Agents, Nonsteroidal	MeSH
DB01160	912	dinoprost	PA	D010120	Oxytocics	MeSH
DB01160	912	dinoprost	PA	D012102	Reproductive Control Agents	MeSH
DB01161	605	chloroprocaine	EPC	N0000175683	Ester Local Anesthetic	FDA
DB01161	605	chloroprocaine	Chemical/Ingredient	N0000166743	Esters	FDA
DB01161	605	chloroprocaine	PE	N0000175976	Local Anesthesia	FDA
DB01161	605	chloroprocaine	PA	D000777	Anesthetics	MeSH
DB01161	605	chloroprocaine	PA	D000779	Anesthetics, Local	MeSH
DB01161	605	chloroprocaine	has role	CHEBI:36333	local anaesthetic	CHEBI
DB01161	605	chloroprocaine	has role	CHEBI:49110	peripheral nervous system drug	CHEBI
DB01161	605	chloroprocaine	has role	CHEBI:35488	central nervous system depressant	CHEBI
DB01161	605	chloroprocaine	PA	D002491	Central Nervous System Agents	MeSH
DB01161	605	chloroprocaine	PA	D002492	Central Nervous System Depressants	MeSH
DB01161	605	chloroprocaine	PA	D018689	Sensory System Agents	MeSH
DB01162	3584	terazosin	EPC	N0000175553	alpha-Adrenergic Blocker	FDA
DB01162	3584	terazosin	PA	D018663	Adrenergic Agents	MeSH
DB01162	3584	terazosin	PA	D058668	Adrenergic alpha-1 Receptor Antagonists	MeSH
DB01162	3584	terazosin	PA	D000317	Adrenergic alpha-Antagonists	MeSH
DB01162	3584	terazosin	PA	D018674	Adrenergic Antagonists	MeSH
DB01162	3584	terazosin	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB01162	3584	terazosin	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB01162	3584	terazosin	has role	CHEBI:37890	alpha-adrenergic antagonist	CHEBI
DB01162	3584	terazosin	PA	D018377	Neurotransmitter Agents	MeSH
DB01162	3584	terazosin	PA	D064804	Urological Agents	MeSH
DB01163	1648	mecillinam	PA	D000900	Anti-Bacterial Agents	MeSH
DB01163	1648	mecillinam	PA	D000890	Anti-Infective Agents	MeSH
DB01163	1648	mecillinam	PA	D000892	Anti-Infective Agents, Urinary	MeSH
DB01163	1648	mecillinam	has role	CHEBI:35441	antiinfective agent	CHEBI
DB01163	1648	mecillinam	has role	CHEBI:36047	antibacterial drug	CHEBI
DB01166	644	cilostazol	EPC	N0000175598	Phosphodiesterase 3 Inhibitor	FDA
DB01166	644	cilostazol	PA	D018927	Anti-Asthmatic Agents	MeSH
DB01166	644	cilostazol	has role	CHEBI:50249	anticoagulant	CHEBI
DB01166	644	cilostazol	has role	CHEBI:63726	neuroprotective agent	CHEBI
DB01166	644	cilostazol	has role	CHEBI:35523	bronchodilator agent	CHEBI
DB01166	644	cilostazol	has role	CHEBI:35620	vasodilator agent	CHEBI
DB01166	644	cilostazol	has role	CHEBI:48676	fibrin modulating drug	CHEBI
DB01166	644	cilostazol	has role	CHEBI:50427	platelet aggregation inhibitor	CHEBI
DB01166	644	cilostazol	PA	D001993	Bronchodilator Agents	MeSH
DB01166	644	cilostazol	PA	D002317	Cardiovascular Agents	MeSH
DB01166	644	cilostazol	PA	D002491	Central Nervous System Agents	MeSH
DB01166	644	cilostazol	PA	D004791	Enzyme Inhibitors	MeSH
DB01166	644	cilostazol	PA	D005343	Fibrinolytic Agents	MeSH
DB01166	644	cilostazol	PA	D006401	Hematologic Agents	MeSH
DB01166	644	cilostazol	PA	D018696	Neuroprotective Agents	MeSH
DB01166	644	cilostazol	PA	D058987	Phosphodiesterase 3 Inhibitors	MeSH
DB01166	644	cilostazol	PA	D010726	Phosphodiesterase Inhibitors	MeSH
DB01166	644	cilostazol	PA	D010975	Platelet Aggregation Inhibitors	MeSH
DB01166	644	cilostazol	PA	D020011	Protective Agents	MeSH
DB01166	644	cilostazol	PA	D019141	Respiratory System Agents	MeSH
DB01166	644	cilostazol	PA	D014665	Vasodilator Agents	MeSH
DB01167	1513	itraconazole	EPC	N0000175487	Azole Antifungal	FDA
DB01167	1513	itraconazole	Chemical/Ingredient	N0000008217	Azoles	FDA
DB01167	1513	itraconazole	MoA	N0000182141	Cytochrome P450 3A4 Inhibitors	FDA
DB01167	1513	itraconazole	MoA	N0000185503	P-Glycoprotein Inhibitors	FDA
DB01167	1513	itraconazole	PA	D058888	14-alpha Demethylase Inhibitors	MeSH
DB01167	1513	itraconazole	PA	D000890	Anti-Infective Agents	MeSH
DB01167	1513	itraconazole	PA	D000935	Antifungal Agents	MeSH
DB01167	1513	itraconazole	PA	D065692	Cytochrome P-450 CYP3A Inhibitors	MeSH
DB01167	1513	itraconazole	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB01167	1513	itraconazole	PA	D004791	Enzyme Inhibitors	MeSH
DB01167	1513	itraconazole	PA	D006727	Hormone Antagonists	MeSH
DB01167	1513	itraconazole	PA	D065088	Steroid Synthesis Inhibitors	MeSH
DB01170	1342	guanethidine	PA	D018663	Adrenergic Agents	MeSH
DB01170	1342	guanethidine	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB01170	1342	guanethidine	has role	CHEBI:37887	adrenergic antagonist	CHEBI
DB01170	1342	guanethidine	has role	CHEBI:66991	sympatholytic agent	CHEBI
DB01170	1342	guanethidine	PA	D000959	Antihypertensive Agents	MeSH
DB01170	1342	guanethidine	PA	D002317	Cardiovascular Agents	MeSH
DB01170	1342	guanethidine	PA	D018377	Neurotransmitter Agents	MeSH
DB01170	1342	guanethidine	PA	D013565	Sympatholytics	MeSH
DB01171	1825	moclobemide	has role	CHEBI:35469	antidepressant	CHEBI
DB01171	1825	moclobemide	PA	D000928	Antidepressive Agents	MeSH
DB01171	1825	moclobemide	PA	D002491	Central Nervous System Agents	MeSH
DB01171	1825	moclobemide	PA	D004791	Enzyme Inhibitors	MeSH
DB01171	1825	moclobemide	PA	D008996	Monoamine Oxidase Inhibitors	MeSH
DB01171	1825	moclobemide	PA	D011619	Psychotropic Drugs	MeSH
DB01173	1999	orphenadrine	PE	N0000175730	Centrally-mediated Muscle Relaxation	FDA
DB01173	1999	orphenadrine	PA	D018726	Anti-Dyskinesia Agents	MeSH
DB01173	1999	orphenadrine	has role	CHEBI:66956	antidyskinesia agent	CHEBI
DB01173	1999	orphenadrine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB01173	1999	orphenadrine	has role	CHEBI:48407	antiparkinson drug	CHEBI
DB01173	1999	orphenadrine	has role	CHEBI:50370	parasympatholytic	CHEBI
DB01173	1999	orphenadrine	has role	CHEBI:51371	muscle relaxant	CHEBI
DB01173	1999	orphenadrine	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB01173	1999	orphenadrine	PA	D000978	Antiparkinson Agents	MeSH
DB01173	1999	orphenadrine	PA	D002491	Central Nervous System Agents	MeSH
DB01173	1999	orphenadrine	PA	D018678	Cholinergic Agents	MeSH
DB01173	1999	orphenadrine	PA	D018680	Cholinergic Antagonists	MeSH
DB01173	1999	orphenadrine	PA	D065686	Cytochrome P-450 CYP2B6 Inhibitors	MeSH
DB01173	1999	orphenadrine	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB01173	1999	orphenadrine	PA	D004791	Enzyme Inhibitors	MeSH
DB01173	1999	orphenadrine	PA	D018727	Muscarinic Antagonists	MeSH
DB01173	1999	orphenadrine	PA	D009125	Muscle Relaxants, Central	MeSH
DB01173	1999	orphenadrine	PA	D009465	Neuromuscular Agents	MeSH
DB01173	1999	orphenadrine	PA	D018377	Neurotransmitter Agents	MeSH
DB01173	1999	orphenadrine	PA	D010276	Parasympatholytics	MeSH
DB01176	749	cyclizine	has role	CHEBI:50919	antiemetic	CHEBI
DB01176	749	cyclizine	has role	CHEBI:48873	cholinergic antagonist	CHEBI
DB01176	749	cyclizine	has role	CHEBI:35488	central nervous system depressant	CHEBI
DB01176	749	cyclizine	has role	CHEBI:36333	local anaesthetic	CHEBI
DB01176	749	cyclizine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB01176	749	cyclizine	PA	D000932	Antiemetics	MeSH
DB01176	749	cyclizine	PA	D002491	Central Nervous System Agents	MeSH
DB01176	749	cyclizine	PA	D005765	Gastrointestinal Agents	MeSH
DB01176	749	cyclizine	PA	D018494	Histamine Agents	MeSH
DB01176	749	cyclizine	PA	D006633	Histamine Antagonists	MeSH
DB01176	749	cyclizine	PA	D006634	Histamine H1 Antagonists	MeSH
DB01176	749	cyclizine	PA	D018377	Neurotransmitter Agents	MeSH
DB01177	1414	idarubicin	EPC	N0000175414	Anthracycline Topoisomerase Inhibitor	FDA
DB01177	1414	idarubicin	Chemical/Ingredient	N0000007530	Anthracyclines	FDA
DB01177	1414	idarubicin	MoA	N0000000176	Topoisomerase Inhibitors	FDA
DB01177	1414	idarubicin	PA	D000903	Antibiotics, Antineoplastic	MeSH
DB01177	1414	idarubicin	PA	D000970	Antineoplastic Agents	MeSH
DB01177	1414	idarubicin	PA	D004791	Enzyme Inhibitors	MeSH
DB01177	1414	idarubicin	PA	D059005	Topoisomerase II Inhibitors	MeSH
DB01180	2369	rescinnamine	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB01182	2291	propafenone	EPC	N0000175426	Antiarrhythmic	FDA
DB01182	2291	propafenone	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB01182	2291	propafenone	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB01182	2291	propafenone	PA	D002317	Cardiovascular Agents	MeSH
DB01182	2291	propafenone	PA	D049990	Membrane Transport Modulators	MeSH
DB01182	2291	propafenone	PA	D026941	Sodium Channel Blockers	MeSH
DB01182	2291	propafenone	PA	D061567	Voltage-Gated Sodium Channel Blockers	MeSH
DB01183	1878	naloxone	EPC	N0000175691	Opioid Antagonist	FDA
DB01183	1878	naloxone	MoA	N0000000154	Opioid Antagonists	FDA
DB01183	1878	naloxone	has role	CHEBI:35488	central nervous system depressant	CHEBI
DB01183	1878	naloxone	has role	CHEBI:90755	antidote to opioid poisoning	CHEBI
DB01183	1878	naloxone	PA	D002491	Central Nervous System Agents	MeSH
DB01183	1878	naloxone	PA	D009292	Narcotic Antagonists	MeSH
DB01183	1878	naloxone	PA	D018689	Sensory System Agents	MeSH
DB01184	945	domperidone	has role	CHEBI:50919	antiemetic	CHEBI
DB01184	945	domperidone	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB01184	945	domperidone	PA	D000932	Antiemetics	MeSH
DB01184	945	domperidone	PA	D002491	Central Nervous System Agents	MeSH
DB01184	945	domperidone	PA	D015259	Dopamine Agents	MeSH
DB01184	945	domperidone	PA	D018492	Dopamine Antagonists	MeSH
DB01184	945	domperidone	PA	D005765	Gastrointestinal Agents	MeSH
DB01184	945	domperidone	PA	D018377	Neurotransmitter Agents	MeSH
DB01185	1210	fluoxymesterone	EPC	N0000175824	Androgen	FDA
DB01185	1210	fluoxymesterone	MoA	N0000000146	Androgen Receptor Agonists	FDA
DB01185	1210	fluoxymesterone	Chemical/Ingredient	N0000008241	Androstanes	FDA
DB01185	1210	fluoxymesterone	PA	D045930	Anabolic Agents	MeSH
DB01185	1210	fluoxymesterone	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB01185	1210	fluoxymesterone	PA	D006728	Hormones	MeSH
DB01186	2105	pergolide	Chemical/Ingredient	N0000007620	Ergot Alkaloids	FDA
DB01186	2105	pergolide	EPC	N0000175767	Ergot-derived Dopamine Receptor Agonist	FDA
DB01186	2105	pergolide	has role	CHEBI:48407	antiparkinson drug	CHEBI
DB01186	2105	pergolide	has role	CHEBI:51065	dopamine agonist	CHEBI
DB01186	2105	pergolide	PA	D015259	Dopamine Agents	MeSH
DB01186	2105	pergolide	PA	D018491	Dopamine Agonists	MeSH
DB01186	2105	pergolide	PA	D018377	Neurotransmitter Agents	MeSH
DB01189	811	desflurane	PE	N0000175975	General Anesthesia	FDA
DB01189	811	desflurane	EPC	N0000175681	General Anesthetic	FDA
DB01189	811	desflurane	PA	D000777	Anesthetics	MeSH
DB01189	811	desflurane	PA	D018685	Anesthetics, Inhalation	MeSH
DB01189	811	desflurane	has role	CHEBI:38870	inhalation anaesthetic	CHEBI
DB01189	811	desflurane	PA	D002491	Central Nervous System Agents	MeSH
DB01189	811	desflurane	PA	D002492	Central Nervous System Depressants	MeSH
DB01192	2034	oxymorphone	MoA	N0000175684	Full Opioid Agonists	FDA
DB01192	2034	oxymorphone	EPC	N0000175690	Opioid Agonist	FDA
DB01192	2034	oxymorphone	PA	D000759	Adjuvants, Anesthesia	MeSH
DB01192	2034	oxymorphone	PA	D000700	Analgesics	MeSH
DB01192	2034	oxymorphone	PA	D000701	Analgesics, Opioid	MeSH
DB01192	2034	oxymorphone	PA	D002491	Central Nervous System Agents	MeSH
DB01192	2034	oxymorphone	PA	D002492	Central Nervous System Depressants	MeSH
DB01192	2034	oxymorphone	PA	D009294	Narcotics	MeSH
DB01192	2034	oxymorphone	PA	D018689	Sensory System Agents	MeSH
DB01193	40	acebutolol	EPC	N0000175556	beta-Adrenergic Blocker	FDA
DB01193	40	acebutolol	PA	D018663	Adrenergic Agents	MeSH
DB01193	40	acebutolol	PA	D018674	Adrenergic Antagonists	MeSH
DB01193	40	acebutolol	PA	D058671	Adrenergic beta-1 Receptor Antagonists	MeSH
DB01193	40	acebutolol	PA	D000319	Adrenergic beta-Antagonists	MeSH
DB01193	40	acebutolol	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB01193	40	acebutolol	has role	CHEBI:35530	beta-adrenergic antagonist	CHEBI
DB01193	40	acebutolol	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB01193	40	acebutolol	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB01193	40	acebutolol	has role	CHEBI:35524	sympathomimetic agent	CHEBI
DB01193	40	acebutolol	PA	D000959	Antihypertensive Agents	MeSH
DB01193	40	acebutolol	PA	D002317	Cardiovascular Agents	MeSH
DB01193	40	acebutolol	PA	D018377	Neurotransmitter Agents	MeSH
DB01193	40	acebutolol	PA	D013566	Sympathomimetics	MeSH
DB01194	396	brinzolamide	EPC	N0000175517	Carbonic Anhydrase Inhibitor	FDA
DB01194	396	brinzolamide	has role	CHEBI:39456	antiglaucoma drug	CHEBI
DB01194	396	brinzolamide	PA	D002257	Carbonic Anhydrase Inhibitors	MeSH
DB01194	396	brinzolamide	PA	D004791	Enzyme Inhibitors	MeSH
DB01195	1176	flecainide	EPC	N0000175426	Antiarrhythmic	FDA
DB01195	1176	flecainide	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB01195	1176	flecainide	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB01195	1176	flecainide	PA	D002317	Cardiovascular Agents	MeSH
DB01195	1176	flecainide	PA	D049990	Membrane Transport Modulators	MeSH
DB01195	1176	flecainide	PA	D026941	Sodium Channel Blockers	MeSH
DB01195	1176	flecainide	PA	D061567	Voltage-Gated Sodium Channel Blockers	MeSH
DB01197	484	captopril	EPC	N0000175562	Angiotensin Converting Enzyme Inhibitor	FDA
DB01197	484	captopril	PA	D000806	Angiotensin-Converting Enzyme Inhibitors	MeSH
DB01197	484	captopril	has role	CHEBI:35457	EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor	CHEBI
DB01197	484	captopril	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB01197	484	captopril	PA	D000959	Antihypertensive Agents	MeSH
DB01197	484	captopril	PA	D002317	Cardiovascular Agents	MeSH
DB01197	484	captopril	PA	D004791	Enzyme Inhibitors	MeSH
DB01197	484	captopril	PA	D011480	Protease Inhibitors	MeSH
DB02032	484	captopril	EPC	N0000175562	Angiotensin Converting Enzyme Inhibitor	FDA
DB02032	484	captopril	PA	D000806	Angiotensin-Converting Enzyme Inhibitors	MeSH
DB02032	484	captopril	has role	CHEBI:35457	EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor	CHEBI
DB02032	484	captopril	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB02032	484	captopril	PA	D000959	Antihypertensive Agents	MeSH
DB02032	484	captopril	PA	D002317	Cardiovascular Agents	MeSH
DB02032	484	captopril	PA	D004791	Enzyme Inhibitors	MeSH
DB02032	484	captopril	PA	D011480	Protease Inhibitors	MeSH
DB01199	2781	tubocurarine	has role	CHEBI:48878	nicotinic antagonist	CHEBI
DB01199	2781	tubocurarine	has role	CHEBI:51371	muscle relaxant	CHEBI
DB01199	2781	tubocurarine	PA	D018678	Cholinergic Agents	MeSH
DB01199	2781	tubocurarine	PA	D018680	Cholinergic Antagonists	MeSH
DB01199	2781	tubocurarine	PA	D009465	Neuromuscular Agents	MeSH
DB01199	2781	tubocurarine	PA	D009466	Neuromuscular Blocking Agents	MeSH
DB01199	2781	tubocurarine	PA	D003473	Neuromuscular Nondepolarizing Agents	MeSH
DB01199	2781	tubocurarine	PA	D018377	Neurotransmitter Agents	MeSH
DB01199	2781	tubocurarine	PA	D018733	Nicotinic Antagonists	MeSH
DB01200	403	bromocriptine	Chemical/Ingredient	N0000007618	Ergolines	FDA
DB01200	403	bromocriptine	EPC	N0000175827	Ergot Derivative	FDA
DB01200	403	bromocriptine	PA	D018726	Anti-Dyskinesia Agents	MeSH
DB01200	403	bromocriptine	has role	CHEBI:49020	hormone antagonist	CHEBI
DB01200	403	bromocriptine	has role	CHEBI:48407	antiparkinson drug	CHEBI
DB01200	403	bromocriptine	has role	CHEBI:66956	antidyskinesia agent	CHEBI
DB01200	403	bromocriptine	has role	CHEBI:51065	dopamine agonist	CHEBI
DB01200	403	bromocriptine	PA	D000978	Antiparkinson Agents	MeSH
DB01200	403	bromocriptine	PA	D002491	Central Nervous System Agents	MeSH
DB01200	403	bromocriptine	PA	D015259	Dopamine Agents	MeSH
DB01200	403	bromocriptine	PA	D018491	Dopamine Agonists	MeSH
DB01200	403	bromocriptine	PA	D006727	Hormone Antagonists	MeSH
DB01200	403	bromocriptine	PA	D018377	Neurotransmitter Agents	MeSH
DB01201	2378	rifapentine	EPC	N0000175501	Rifamycin Antimycobacterial	FDA
DB01201	2378	rifapentine	Chemical/Ingredient	N0000007911	Rifamycins	FDA
DB01201	2378	rifapentine	PA	D000900	Anti-Bacterial Agents	MeSH
DB01201	2378	rifapentine	PA	D000890	Anti-Infective Agents	MeSH
DB01201	2378	rifapentine	has role	CHEBI:33231	antitubercular agent	CHEBI
DB01201	2378	rifapentine	has role	CHEBI:35816	leprostatic drug	CHEBI
DB01201	2378	rifapentine	PA	D000904	Antibiotics, Antitubercular	MeSH
DB01201	2378	rifapentine	PA	D000995	Antitubercular Agents	MeSH
DB01201	2378	rifapentine	PA	D007917	Leprostatic Agents	MeSH
DB01202	1563	levetiracetam	PE	N0000008486	Decreased Central Nervous System Disorganized Electrical Activity	FDA
DB01202	1563	levetiracetam	has role	CHEBI:35623	anticonvulsant	CHEBI
DB01203	1865	nadolol	EPC	N0000175556	beta-Adrenergic Blocker	FDA
DB01203	1865	nadolol	PA	D018663	Adrenergic Agents	MeSH
DB01203	1865	nadolol	PA	D018674	Adrenergic Antagonists	MeSH
DB01203	1865	nadolol	PA	D000319	Adrenergic beta-Antagonists	MeSH
DB01203	1865	nadolol	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB01203	1865	nadolol	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB01203	1865	nadolol	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB01203	1865	nadolol	has role	CHEBI:66991	sympatholytic agent	CHEBI
DB01203	1865	nadolol	has role	CHEBI:35530	beta-adrenergic antagonist	CHEBI
DB01203	1865	nadolol	PA	D000959	Antihypertensive Agents	MeSH
DB01203	1865	nadolol	PA	D002317	Cardiovascular Agents	MeSH
DB01203	1865	nadolol	PA	D018377	Neurotransmitter Agents	MeSH
DB01203	1865	nadolol	PA	D013565	Sympatholytics	MeSH
DB01204	1821	mitoxantrone	EPC	N0000175609	Topoisomerase Inhibitor	FDA
DB01204	1821	mitoxantrone	MoA	N0000000176	Topoisomerase Inhibitors	FDA
DB01204	1821	mitoxantrone	PA	D000700	Analgesics	MeSH
DB01204	1821	mitoxantrone	has role	CHEBI:35480	analgesic	CHEBI
DB01204	1821	mitoxantrone	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB01204	1821	mitoxantrone	PA	D000970	Antineoplastic Agents	MeSH
DB01204	1821	mitoxantrone	PA	D002491	Central Nervous System Agents	MeSH
DB01204	1821	mitoxantrone	PA	D004791	Enzyme Inhibitors	MeSH
DB01204	1821	mitoxantrone	PA	D018689	Sensory System Agents	MeSH
DB01204	1821	mitoxantrone	PA	D059005	Topoisomerase II Inhibitors	MeSH
DB01205	1195	flumazenil	EPC	N0000175680	Benzodiazepine Antagonist	FDA
DB01205	1195	flumazenil	has role	CHEBI:65259	GABA antagonist	CHEBI
DB01205	1195	flumazenil	has role	CHEBI:90757	antidote to benzodiazepine poisoning	CHEBI
DB01205	1195	flumazenil	PA	D000931	Antidotes	MeSH
DB01205	1195	flumazenil	PA	D018682	GABA Agents	MeSH
DB01205	1195	flumazenil	PA	D018757	GABA Modulators	MeSH
DB01205	1195	flumazenil	PA	D018377	Neurotransmitter Agents	MeSH
DB01205	1195	flumazenil	PA	D020011	Protective Agents	MeSH
DB01208	2466	sparfloxacin	PA	D000900	Anti-Bacterial Agents	MeSH
DB01208	2466	sparfloxacin	PA	D000890	Anti-Infective Agents	MeSH
DB01208	2466	sparfloxacin	PA	D000970	Antineoplastic Agents	MeSH
DB01208	2466	sparfloxacin	PA	D000995	Antitubercular Agents	MeSH
DB01208	2466	sparfloxacin	PA	D004791	Enzyme Inhibitors	MeSH
DB01208	2466	sparfloxacin	PA	D059005	Topoisomerase II Inhibitors	MeSH
DB01209	847	dezocine	PA	D000700	Analgesics	MeSH
DB01209	847	dezocine	PA	D000701	Analgesics, Opioid	MeSH
DB01209	847	dezocine	has role	CHEBI:35482	opioid analgesic	CHEBI
DB01209	847	dezocine	PA	D002491	Central Nervous System Agents	MeSH
DB01209	847	dezocine	PA	D002492	Central Nervous System Depressants	MeSH
DB01209	847	dezocine	PA	D009294	Narcotics	MeSH
DB01209	847	dezocine	PA	D018689	Sensory System Agents	MeSH
DB01210	431	levobunolol	EPC	N0000175556	beta-Adrenergic Blocker	FDA
DB01210	431	levobunolol	PA	D018663	Adrenergic Agents	MeSH
DB01210	431	levobunolol	PA	D018674	Adrenergic Antagonists	MeSH
DB01210	431	levobunolol	PA	D000319	Adrenergic beta-Antagonists	MeSH
DB01210	431	levobunolol	has role	CHEBI:39456	antiglaucoma drug	CHEBI
DB01210	431	levobunolol	has role	CHEBI:35530	beta-adrenergic antagonist	CHEBI
DB01210	431	levobunolol	PA	D018377	Neurotransmitter Agents	MeSH
DB01210	431	levobunolol	PA	D013565	Sympatholytics	MeSH
DB01212	564	ceftriaxone	EPC	N0000175488	Cephalosporin Antibacterial	FDA
DB01212	564	ceftriaxone	Chemical/Ingredient	N0000011161	Cephalosporins	FDA
DB01212	564	ceftriaxone	PA	D000900	Anti-Bacterial Agents	MeSH
DB01212	564	ceftriaxone	PA	D000890	Anti-Infective Agents	MeSH
DB01212	564	ceftriaxone	has role	CHEBI:36047	antibacterial drug	CHEBI
DB01212	564	ceftriaxone	has role	CHEBI:88188	drug allergen	CHEBI
DB01213	1233	fomepizole	has role	CHEBI:50247	antidote	CHEBI
DB01213	1233	fomepizole	has role	CHEBI:50267	protective agent	CHEBI
DB01213	1233	fomepizole	PA	D000931	Antidotes	MeSH
DB01213	1233	fomepizole	PA	D020011	Protective Agents	MeSH
DB01214	1779	metipranolol	EPC	N0000175556	beta-Adrenergic Blocker	FDA
DB01214	1779	metipranolol	PA	D018663	Adrenergic Agents	MeSH
DB01214	1779	metipranolol	PA	D018674	Adrenergic Antagonists	MeSH
DB01214	1779	metipranolol	PA	D000319	Adrenergic beta-Antagonists	MeSH
DB01214	1779	metipranolol	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB01214	1779	metipranolol	has role	CHEBI:35530	beta-adrenergic antagonist	CHEBI
DB01214	1779	metipranolol	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB01214	1779	metipranolol	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB01214	1779	metipranolol	has role	CHEBI:39456	antiglaucoma drug	CHEBI
DB01214	1779	metipranolol	PA	D000959	Antihypertensive Agents	MeSH
DB01214	1779	metipranolol	PA	D002317	Cardiovascular Agents	MeSH
DB01214	1779	metipranolol	PA	D018377	Neurotransmitter Agents	MeSH
DB01214	1779	metipranolol	PA	D013565	Sympatholytics	MeSH
DB01215	1056	estazolam	EPC	N0000175694	Benzodiazepine	FDA
DB01215	1056	estazolam	Chemical/Ingredient	N0000007542	Benzodiazepines	FDA
DB01215	1056	estazolam	PA	D014151	Anti-Anxiety Agents	MeSH
DB01215	1056	estazolam	has role	CHEBI:35474	anxiolytic drug	CHEBI
DB01215	1056	estazolam	has role	CHEBI:35623	anticonvulsant	CHEBI
DB01215	1056	estazolam	has role	CHEBI:50268	GABA modulator	CHEBI
DB01215	1056	estazolam	PA	D000927	Anticonvulsants	MeSH
DB01215	1056	estazolam	PA	D002491	Central Nervous System Agents	MeSH
DB01215	1056	estazolam	PA	D002492	Central Nervous System Depressants	MeSH
DB01215	1056	estazolam	PA	D018682	GABA Agents	MeSH
DB01215	1056	estazolam	PA	D018757	GABA Modulators	MeSH
DB01215	1056	estazolam	PA	D018377	Neurotransmitter Agents	MeSH
DB01215	1056	estazolam	PA	D011619	Psychotropic Drugs	MeSH
DB01215	1056	estazolam	PA	D014149	Tranquilizing Agents	MeSH
DB01216	1171	finasteride	EPC	N0000175836	5-alpha Reductase Inhibitor	FDA
DB01216	1171	finasteride	PA	D058891	5-alpha Reductase Inhibitors	MeSH
DB01216	1171	finasteride	has role	CHEBI:59844	antihyperplasia drug	CHEBI
DB01216	1171	finasteride	has role	CHEBI:35497	androgen antagonist	CHEBI
DB01216	1171	finasteride	PA	D004791	Enzyme Inhibitors	MeSH
DB01216	1171	finasteride	PA	D006727	Hormone Antagonists	MeSH
DB01216	1171	finasteride	PA	D065088	Steroid Synthesis Inhibitors	MeSH
DB01216	1171	finasteride	PA	D064804	Urological Agents	MeSH
DB01217	210	anastrozole	EPC	N0000175563	Aromatase Inhibitor	FDA
DB01217	210	anastrozole	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB01217	210	anastrozole	PA	D000970	Antineoplastic Agents	MeSH
DB01217	210	anastrozole	PA	D018931	Antineoplastic Agents, Hormonal	MeSH
DB01217	210	anastrozole	PA	D047072	Aromatase Inhibitors	MeSH
DB01217	210	anastrozole	PA	D004791	Enzyme Inhibitors	MeSH
DB01217	210	anastrozole	PA	D004965	Estrogen Antagonists	MeSH
DB01217	210	anastrozole	PA	D006727	Hormone Antagonists	MeSH
DB01217	210	anastrozole	PA	D065088	Steroid Synthesis Inhibitors	MeSH
DB01219	780	dantrolene	PE	N0000008953	Decreased Striated Muscle Contraction	FDA
DB01219	780	dantrolene	PE	N0000175735	Decreased Striated Muscle Tone	FDA
DB01219	780	dantrolene	EPC	N0000175738	Skeletal Muscle Relaxant	FDA
DB01219	780	dantrolene	has role	CHEBI:51371	muscle relaxant	CHEBI
DB01219	780	dantrolene	PA	D002491	Central Nervous System Agents	MeSH
DB01219	780	dantrolene	PA	D009125	Muscle Relaxants, Central	MeSH
DB01219	780	dantrolene	PA	D009465	Neuromuscular Agents	MeSH
DB01220	2379	rifaximin	EPC	N0000175500	Rifamycin Antibacterial	FDA
DB01220	2379	rifaximin	Chemical/Ingredient	N0000007911	Rifamycins	FDA
DB01220	2379	rifaximin	PA	D000890	Anti-Infective Agents	MeSH
DB01220	2379	rifaximin	has role	CHEBI:71031	orphan drug	CHEBI
DB01220	2379	rifaximin	has role	CHEBI:55324	gastrointestinal drug	CHEBI
DB01220	2379	rifaximin	PA	D004791	Enzyme Inhibitors	MeSH
DB01220	2379	rifaximin	PA	D005765	Gastrointestinal Agents	MeSH
DB01220	2379	rifaximin	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB01221	1523	ketamine	PE	N0000175975	General Anesthesia	FDA
DB01221	1523	ketamine	EPC	N0000175681	General Anesthetic	FDA
DB01221	1523	ketamine	PA	D000700	Analgesics	MeSH
DB01221	1523	ketamine	PA	D000777	Anesthetics	MeSH
DB01221	1523	ketamine	PA	D000778	Anesthetics, Dissociative	MeSH
DB01221	1523	ketamine	PA	D018686	Anesthetics, Intravenous	MeSH
DB01221	1523	ketamine	has role	CHEBI:38877	intravenous anaesthetic	CHEBI
DB01221	1523	ketamine	has role	CHEBI:35480	analgesic	CHEBI
DB01221	1523	ketamine	PA	D002491	Central Nervous System Agents	MeSH
DB01221	1523	ketamine	PA	D002492	Central Nervous System Depressants	MeSH
DB01221	1523	ketamine	PA	D018691	Excitatory Amino Acid Antagonists	MeSH
DB01221	1523	ketamine	PA	D018377	Neurotransmitter Agents	MeSH
DB01221	1523	ketamine	PA	D018689	Sensory System Agents	MeSH
DB01222	419	budesonide	EPC	N0000175576	Corticosteroid	FDA
DB01222	419	budesonide	MoA	N0000175450	Corticosteroid Hormone Receptor Agonists	FDA
DB01222	419	budesonide	PA	D018927	Anti-Asthmatic Agents	MeSH
DB01222	419	budesonide	PA	D000893	Anti-Inflammatory Agents	MeSH
DB01222	419	budesonide	has role	CHEBI:35523	bronchodilator agent	CHEBI
DB01222	419	budesonide	has role	CHEBI:35472	anti-inflammatory drug	CHEBI
DB01222	419	budesonide	PA	D001993	Bronchodilator Agents	MeSH
DB01222	419	budesonide	PA	D005938	Glucocorticoids	MeSH
DB01222	419	budesonide	PA	D006728	Hormones	MeSH
DB01222	419	budesonide	PA	D019141	Respiratory System Agents	MeSH
DB01222	294	beclometasone dipropionate	has role	CHEBI:49167	anti-asthmatic drug	CHEBI
DB01222	294	beclometasone dipropionate	has role	CHEBI:50266	prodrug	CHEBI
DB01222	294	beclometasone dipropionate	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB01224	2337	quetiapine	EPC	N0000175430	Atypical Antipsychotic	FDA
DB01224	2337	quetiapine	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB01224	2337	quetiapine	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB01224	2337	quetiapine	has role	CHEBI:37956	histamine antagonist	CHEBI
DB01224	2337	quetiapine	has role	CHEBI:37887	adrenergic antagonist	CHEBI
DB01224	2337	quetiapine	has role	CHEBI:65191	second generation antipsychotic	CHEBI
DB01224	2337	quetiapine	PA	D014150	Antipsychotic Agents	MeSH
DB01224	2337	quetiapine	PA	D002491	Central Nervous System Agents	MeSH
DB01224	2337	quetiapine	PA	D002492	Central Nervous System Depressants	MeSH
DB01224	2337	quetiapine	PA	D011619	Psychotropic Drugs	MeSH
DB01224	2337	quetiapine	PA	D014149	Tranquilizing Agents	MeSH
DB01226	1822	mivacurium	PA	D009465	Neuromuscular Agents	MeSH
DB01226	1822	mivacurium	PA	D009466	Neuromuscular Blocking Agents	MeSH
DB01226	1822	mivacurium	PA	D003473	Neuromuscular Nondepolarizing Agents	MeSH
DB01227	1729	acetylmethadol	PA	D000700	Analgesics	MeSH
DB01227	1729	acetylmethadol	PA	D000701	Analgesics, Opioid	MeSH
DB01227	1729	acetylmethadol	PA	D002491	Central Nervous System Agents	MeSH
DB01227	1729	acetylmethadol	PA	D002492	Central Nervous System Depressants	MeSH
DB01227	1729	acetylmethadol	PA	D009294	Narcotics	MeSH
DB01227	1729	acetylmethadol	PA	D018689	Sensory System Agents	MeSH
DB01433	1729	acetylmethadol	PA	D000700	Analgesics	MeSH
DB01433	1729	acetylmethadol	PA	D000701	Analgesics, Opioid	MeSH
DB01433	1729	acetylmethadol	PA	D002491	Central Nervous System Agents	MeSH
DB01433	1729	acetylmethadol	PA	D002492	Central Nervous System Depressants	MeSH
DB01433	1729	acetylmethadol	PA	D009294	Narcotics	MeSH
DB01433	1729	acetylmethadol	PA	D018689	Sensory System Agents	MeSH
DB01522	1729	acetylmethadol	PA	D000700	Analgesics	MeSH
DB01522	1729	acetylmethadol	PA	D000701	Analgesics, Opioid	MeSH
DB01522	1729	acetylmethadol	PA	D002491	Central Nervous System Agents	MeSH
DB01522	1729	acetylmethadol	PA	D002492	Central Nervous System Depressants	MeSH
DB01522	1729	acetylmethadol	PA	D009294	Narcotics	MeSH
DB01522	1729	acetylmethadol	PA	D018689	Sensory System Agents	MeSH
DB01555	1729	acetylmethadol	PA	D000700	Analgesics	MeSH
DB01555	1729	acetylmethadol	PA	D000701	Analgesics, Opioid	MeSH
DB01555	1729	acetylmethadol	PA	D002491	Central Nervous System Agents	MeSH
DB01555	1729	acetylmethadol	PA	D002492	Central Nervous System Depressants	MeSH
DB01555	1729	acetylmethadol	PA	D009294	Narcotics	MeSH
DB01555	1729	acetylmethadol	PA	D018689	Sensory System Agents	MeSH
DB01229	2044	paclitaxel	PE	N0000175085	Microtubule Inhibition	FDA
DB01229	2044	paclitaxel	EPC	N0000175592	Microtubule Inhibitor	FDA
DB01229	2044	paclitaxel	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB01229	2044	paclitaxel	PA	D050256	Antimitotic Agents	MeSH
DB01229	2044	paclitaxel	PA	D000970	Antineoplastic Agents	MeSH
DB01229	2044	paclitaxel	PA	D000972	Antineoplastic Agents, Phytogenic	MeSH
DB01229	2044	paclitaxel	PA	D050257	Tubulin Modulators	MeSH
DB01231	313	diphenidol	PE	N0000009034	Emesis Suppression	FDA
DB01231	313	diphenidol	has role	CHEBI:50919	antiemetic	CHEBI
DB01231	313	diphenidol	PA	D000932	Antiemetics	MeSH
DB01231	313	diphenidol	PA	D002491	Central Nervous System Agents	MeSH
DB01231	313	diphenidol	PA	D005765	Gastrointestinal Agents	MeSH
DB01232	2422	saquinavir	EPC	N0000175889	Protease Inhibitor	FDA
DB01232	2422	saquinavir	PA	D019380	Anti-HIV Agents	MeSH
DB01232	2422	saquinavir	PA	D000890	Anti-Infective Agents	MeSH
DB01232	2422	saquinavir	has role	CHEBI:36044	antiviral drug	CHEBI
DB01232	2422	saquinavir	PA	D000998	Antiviral Agents	MeSH
DB01232	2422	saquinavir	PA	D065692	Cytochrome P-450 CYP3A Inhibitors	MeSH
DB01232	2422	saquinavir	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB01232	2422	saquinavir	PA	D004791	Enzyme Inhibitors	MeSH
DB01232	2422	saquinavir	PA	D017320	HIV Protease Inhibitors	MeSH
DB01232	2422	saquinavir	PA	D011480	Protease Inhibitors	MeSH
DB01232	2422	saquinavir	MoA	N0000190114	Cytochrome P450 3A Inhibitors	FDA
DB01233	1782	metoclopramide	MoA	N0000175799	Dopamine D2 Antagonists	FDA
DB01233	1782	metoclopramide	EPC	N0000175800	Dopamine-2 Receptor Antagonist	FDA
DB01233	1782	metoclopramide	has role	CHEBI:50919	antiemetic	CHEBI
DB01233	1782	metoclopramide	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB01233	1782	metoclopramide	has role	CHEBI:55324	gastrointestinal drug	CHEBI
DB01233	1782	metoclopramide	PA	D000932	Antiemetics	MeSH
DB01233	1782	metoclopramide	PA	D002491	Central Nervous System Agents	MeSH
DB01233	1782	metoclopramide	PA	D015259	Dopamine Agents	MeSH
DB01233	1782	metoclopramide	PA	D018492	Dopamine Antagonists	MeSH
DB01233	1782	metoclopramide	PA	D065127	Dopamine D2 Receptor Antagonists	MeSH
DB01233	1782	metoclopramide	PA	D005765	Gastrointestinal Agents	MeSH
DB01233	1782	metoclopramide	PA	D018377	Neurotransmitter Agents	MeSH
DB01235	1567	levodopa	EPC	N0000175754	Aromatic Amino Acid Decarboxylation Inhibitor	FDA
DB01235	1567	levodopa	MoA	N0000175755	DOPA Decarboxylase Inhibitors	FDA
DB01235	1567	levodopa	PA	D018726	Anti-Dyskinesia Agents	MeSH
DB01235	1567	levodopa	has role	CHEBI:66956	antidyskinesia agent	CHEBI
DB01235	1567	levodopa	has role	CHEBI:48560	dopaminergic agent	CHEBI
DB01235	1567	levodopa	has role	CHEBI:48407	antiparkinson drug	CHEBI
DB01235	1567	levodopa	has role	CHEBI:50266	prodrug	CHEBI
DB01235	1567	levodopa	PA	D000978	Antiparkinson Agents	MeSH
DB01235	1567	levodopa	PA	D002491	Central Nervous System Agents	MeSH
DB01235	1567	levodopa	PA	D015259	Dopamine Agents	MeSH
DB01235	1567	levodopa	PA	D018377	Neurotransmitter Agents	MeSH
DB01236	2439	sevoflurane	PE	N0000175975	General Anesthesia	FDA
DB01236	2439	sevoflurane	EPC	N0000175681	General Anesthetic	FDA
DB01236	2439	sevoflurane	PA	D000777	Anesthetics	MeSH
DB01236	2439	sevoflurane	PA	D018685	Anesthetics, Inhalation	MeSH
DB01236	2439	sevoflurane	has role	CHEBI:38870	inhalation anaesthetic	CHEBI
DB01236	2439	sevoflurane	has role	CHEBI:50427	platelet aggregation inhibitor	CHEBI
DB01236	2439	sevoflurane	has role	CHEBI:35488	central nervous system depressant	CHEBI
DB01236	2439	sevoflurane	PA	D002491	Central Nervous System Agents	MeSH
DB01236	2439	sevoflurane	PA	D002492	Central Nervous System Depressants	MeSH
DB01236	2439	sevoflurane	PA	D006401	Hematologic Agents	MeSH
DB01236	2439	sevoflurane	PA	D010975	Platelet Aggregation Inhibitors	MeSH
DB01237	404	bromazine	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB01237	404	bromazine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB01238	242	aripiprazole	EPC	N0000175430	Atypical Antipsychotic	FDA
DB01238	242	aripiprazole	has role	CHEBI:65191	second generation antipsychotic	CHEBI
DB01238	242	aripiprazole	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB01238	242	aripiprazole	has role	CHEBI:35941	serotonergic agonist	CHEBI
DB01238	242	aripiprazole	PA	D014150	Antipsychotic Agents	MeSH
DB01238	242	aripiprazole	PA	D002491	Central Nervous System Agents	MeSH
DB01238	242	aripiprazole	PA	D002492	Central Nervous System Depressants	MeSH
DB01238	242	aripiprazole	PA	D011619	Psychotropic Drugs	MeSH
DB01238	242	aripiprazole	PA	D014149	Tranquilizing Agents	MeSH
DB01239	623	chlorprothixene	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB01239	623	chlorprothixene	has role	CHEBI:50919	antiemetic	CHEBI
DB01239	623	chlorprothixene	has role	CHEBI:35717	sedative	CHEBI
DB01239	623	chlorprothixene	has role	CHEBI:48873	cholinergic antagonist	CHEBI
DB01239	623	chlorprothixene	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB01239	623	chlorprothixene	has role	CHEBI:65190	first generation antipsychotic	CHEBI
DB01239	623	chlorprothixene	PA	D014150	Antipsychotic Agents	MeSH
DB01239	623	chlorprothixene	PA	D002491	Central Nervous System Agents	MeSH
DB01239	623	chlorprothixene	PA	D002492	Central Nervous System Depressants	MeSH
DB01239	623	chlorprothixene	PA	D015259	Dopamine Agents	MeSH
DB01239	623	chlorprothixene	PA	D018492	Dopamine Antagonists	MeSH
DB01239	623	chlorprothixene	PA	D018377	Neurotransmitter Agents	MeSH
DB01239	623	chlorprothixene	PA	D011619	Psychotropic Drugs	MeSH
DB01239	623	chlorprothixene	PA	D014149	Tranquilizing Agents	MeSH
DB01240	1034	epoprostenol	EPC	N0000175416	Prostacycline Vasodilator	FDA
DB01240	1034	epoprostenol	Chemical/Ingredient	N0000011280	Prostaglandins I	FDA
DB01240	1034	epoprostenol	PE	N0000009909	Vasodilation	FDA
DB01240	1034	epoprostenol	PA	D000959	Antihypertensive Agents	MeSH
DB01240	1034	epoprostenol	PA	D002317	Cardiovascular Agents	MeSH
DB01240	1034	epoprostenol	PA	D006401	Hematologic Agents	MeSH
DB01240	1034	epoprostenol	PA	D010975	Platelet Aggregation Inhibitors	MeSH
DB01241	1285	gemfibrozil	EPC	N0000175596	Peroxisome Proliferator Receptor alpha Agonist	FDA
DB01241	1285	gemfibrozil	MoA	N0000175375	Peroxisome Proliferator-activated Receptor alpha Agonists	FDA
DB01241	1285	gemfibrozil	Chemical/Ingredient	N0000170118	PPAR alpha	FDA
DB01241	1285	gemfibrozil	has role	CHEBI:35679	antilipemic drug	CHEBI
DB01241	1285	gemfibrozil	PA	D000963	Antimetabolites	MeSH
DB01241	1285	gemfibrozil	PA	D065687	Cytochrome P-450 CYP2C8 Inhibitors	MeSH
DB01241	1285	gemfibrozil	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB01241	1285	gemfibrozil	PA	D004791	Enzyme Inhibitors	MeSH
DB01241	1285	gemfibrozil	PA	D000960	Hypolipidemic Agents	MeSH
DB01242	701	clomipramine	EPC	N0000175752	Tricyclic Antidepressant	FDA
DB01242	701	clomipramine	has role	CHEBI:50949	serotonin uptake inhibitor	CHEBI
DB01242	701	clomipramine	has role	CHEBI:35469	antidepressant	CHEBI
DB01242	701	clomipramine	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB01242	701	clomipramine	has role	CHEBI:48278	serotonergic drug	CHEBI
DB01242	701	clomipramine	PA	D000928	Antidepressive Agents	MeSH
DB01242	701	clomipramine	PA	D000929	Antidepressive Agents, Tricyclic	MeSH
DB01242	701	clomipramine	PA	D002491	Central Nervous System Agents	MeSH
DB01242	701	clomipramine	PA	D049990	Membrane Transport Modulators	MeSH
DB01242	701	clomipramine	PA	D018377	Neurotransmitter Agents	MeSH
DB01242	701	clomipramine	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB01242	701	clomipramine	PA	D011619	Psychotropic Drugs	MeSH
DB01242	701	clomipramine	PA	D018490	Serotonin Agents	MeSH
DB01242	701	clomipramine	PA	D017367	Serotonin Uptake Inhibitors	MeSH
DB01244	342	bepridil	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB01244	342	bepridil	has role	CHEBI:35620	vasodilator agent	CHEBI
DB01244	342	bepridil	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB01244	342	bepridil	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB01244	342	bepridil	PA	D000959	Antihypertensive Agents	MeSH
DB01244	342	bepridil	PA	D002121	Calcium Channel Blockers	MeSH
DB01244	342	bepridil	PA	D002317	Cardiovascular Agents	MeSH
DB01244	342	bepridil	PA	D049990	Membrane Transport Modulators	MeSH
DB01244	342	bepridil	PA	D014665	Vasodilator Agents	MeSH
DB01245	789	decamethonium	has role	CHEBI:47958	nicotinic acetylcholine receptor agonist	CHEBI
DB01245	789	decamethonium	has role	CHEBI:51371	muscle relaxant	CHEBI
DB01245	789	decamethonium	PA	D009465	Neuromuscular Agents	MeSH
DB01245	789	decamethonium	PA	D009466	Neuromuscular Blocking Agents	MeSH
DB01245	789	decamethonium	PA	D009467	Neuromuscular Depolarizing Agents	MeSH
DB01246	2749	alimemazine	PA	D000982	Antipruritics	MeSH
DB01246	2749	alimemazine	PA	D003879	Dermatologic Agents	MeSH
DB01246	2749	alimemazine	PA	D018494	Histamine Agents	MeSH
DB01246	2749	alimemazine	PA	D006633	Histamine Antagonists	MeSH
DB01246	2749	alimemazine	PA	D006634	Histamine H1 Antagonists	MeSH
DB01246	2749	alimemazine	PA	D018377	Neurotransmitter Agents	MeSH
DB01247	1490	isocarboxazid	EPC	N0000175744	Monoamine Oxidase Inhibitor	FDA
DB01247	1490	isocarboxazid	PA	D000928	Antidepressive Agents	MeSH
DB01247	1490	isocarboxazid	PA	D002491	Central Nervous System Agents	MeSH
DB01247	1490	isocarboxazid	PA	D004791	Enzyme Inhibitors	MeSH
DB01247	1490	isocarboxazid	PA	D008996	Monoamine Oxidase Inhibitors	MeSH
DB01247	1490	isocarboxazid	PA	D011619	Psychotropic Drugs	MeSH
DB01248	939	docetaxel	PE	N0000175085	Microtubule Inhibition	FDA
DB01248	939	docetaxel	EPC	N0000175592	Microtubule Inhibitor	FDA
DB01248	939	docetaxel	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB01248	939	docetaxel	has role	CHEBI:47868	photosensitizing agent	CHEBI
DB01248	939	docetaxel	has role	CHEBI:38068	antimalarial	CHEBI
DB01248	939	docetaxel	PA	D050256	Antimitotic Agents	MeSH
DB01248	939	docetaxel	PA	D000970	Antineoplastic Agents	MeSH
DB01248	939	docetaxel	PA	D050257	Tubulin Modulators	MeSH
DB01250	1988	olsalazine	EPC	N0000175781	Aminosalicylate	FDA
DB01250	1988	olsalazine	Chemical/Ingredient	N0000005760	Aminosalicylic Acids	FDA
DB01250	1988	olsalazine	PA	D000700	Analgesics	MeSH
DB01250	1988	olsalazine	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB01250	1988	olsalazine	PA	D000893	Anti-Inflammatory Agents	MeSH
DB01250	1988	olsalazine	has role	CHEBI:50266	prodrug	CHEBI
DB01250	1988	olsalazine	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB01250	1988	olsalazine	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB01250	1988	olsalazine	PA	D018501	Antirheumatic Agents	MeSH
DB01250	1988	olsalazine	PA	D005765	Gastrointestinal Agents	MeSH
DB01250	1988	olsalazine	PA	D018689	Sensory System Agents	MeSH
DB01251	1302	gliquidone	PA	D007004	Hypoglycemic Agents	MeSH
DB01252	1818	mitiglinide	PA	D007004	Hypoglycemic Agents	MeSH
DB01254	785	dasatinib	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB01254	785	dasatinib	PA	D000970	Antineoplastic Agents	MeSH
DB01254	785	dasatinib	PA	D004791	Enzyme Inhibitors	MeSH
DB01254	785	dasatinib	PA	D047428	Protein Kinase Inhibitors	MeSH
DB01255	4135	lisdexamfetamine	EPC	N0000175739	Central Nervous System Stimulant	FDA
DB01255	4135	lisdexamfetamine	PE	N0000175729	Central Nervous System Stimulation	FDA
DB01255	4135	lisdexamfetamine	PA	D002491	Central Nervous System Agents	MeSH
DB01255	4135	lisdexamfetamine	PA	D000697	Central Nervous System Stimulants	MeSH
DB01255	4135	lisdexamfetamine	PA	D015259	Dopamine Agents	MeSH
DB01255	4135	lisdexamfetamine	PA	D018765	Dopamine Uptake Inhibitors	MeSH
DB01255	4135	lisdexamfetamine	PA	D049990	Membrane Transport Modulators	MeSH
DB01255	4135	lisdexamfetamine	PA	D018377	Neurotransmitter Agents	MeSH
DB01255	4135	lisdexamfetamine	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB01259	1548	lapatinib	EPC	N0000175605	Kinase Inhibitor	FDA
DB01259	1548	lapatinib	PA	D000970	Antineoplastic Agents	MeSH
DB01259	1548	lapatinib	PA	D004791	Enzyme Inhibitors	MeSH
DB01259	1548	lapatinib	PA	D047428	Protein Kinase Inhibitors	MeSH
DB01260	3135	desonide	EPC	N0000175576	Corticosteroid	FDA
DB01260	3135	desonide	MoA	N0000175450	Corticosteroid Hormone Receptor Agonists	FDA
DB01260	3135	desonide	PA	D000893	Anti-Inflammatory Agents	MeSH
DB01260	3135	desonide	has role	CHEBI:35472	anti-inflammatory drug	CHEBI
DB01261	2448	sitagliptin	EPC	N0000175913	Dipeptidyl Peptidase 4 Inhibitor	FDA
DB01261	2448	sitagliptin	MoA	N0000175912	Dipeptidyl Peptidase 4 Inhibitors	FDA
DB01261	2448	sitagliptin	has role	CHEBI:35526	hypoglycemic agent	CHEBI
DB01261	2448	sitagliptin	PA	D054873	Dipeptidyl-Peptidase IV Inhibitors	MeSH
DB01261	2448	sitagliptin	PA	D004791	Enzyme Inhibitors	MeSH
DB01261	2448	sitagliptin	PA	D006728	Hormones	MeSH
DB01261	2448	sitagliptin	PA	D007004	Hypoglycemic Agents	MeSH
DB01261	2448	sitagliptin	PA	D054795	Incretins	MeSH
DB01261	2448	sitagliptin	PA	D011480	Protease Inhibitors	MeSH
DB01262	790	decitabine	MoA	N0000000233	Nucleic Acid Synthesis Inhibitors	FDA
DB01262	790	decitabine	EPC	N0000175595	Nucleoside Metabolic Inhibitor	FDA
DB01262	790	decitabine	PA	D000963	Antimetabolites	MeSH
DB01262	790	decitabine	PA	D000964	Antimetabolites, Antineoplastic	MeSH
DB01262	790	decitabine	PA	D000970	Antineoplastic Agents	MeSH
DB01262	790	decitabine	PA	D004791	Enzyme Inhibitors	MeSH
DB01262	790	decitabine	PA	D009676	Noxae	MeSH
DB01262	790	decitabine	PA	D013723	Teratogens	MeSH
DB01263	3483	posaconazole	EPC	N0000175487	Azole Antifungal	FDA
DB01263	3483	posaconazole	Chemical/Ingredient	N0000008217	Azoles	FDA
DB01263	3483	posaconazole	PA	D058888	14-alpha Demethylase Inhibitors	MeSH
DB01263	3483	posaconazole	PA	D000890	Anti-Infective Agents	MeSH
DB01263	3483	posaconazole	has role	CHEBI:36335	trypanocidal drug	CHEBI
DB01263	3483	posaconazole	PA	D000935	Antifungal Agents	MeSH
DB01263	3483	posaconazole	PA	D000977	Antiparasitic Agents	MeSH
DB01263	3483	posaconazole	PA	D000981	Antiprotozoal Agents	MeSH
DB01263	3483	posaconazole	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB01263	3483	posaconazole	PA	D004791	Enzyme Inhibitors	MeSH
DB01263	3483	posaconazole	PA	D006727	Hormone Antagonists	MeSH
DB01263	3483	posaconazole	PA	D065088	Steroid Synthesis Inhibitors	MeSH
DB01263	3483	posaconazole	PA	D014344	Trypanocidal Agents	MeSH
DB01264	4143	darunavir	EPC	N0000175889	Protease Inhibitor	FDA
DB01264	4143	darunavir	MoA	N0000190114	Cytochrome P450 3A Inhibitors	FDA
DB01264	4143	darunavir	PA	D019380	Anti-HIV Agents	MeSH
DB01264	4143	darunavir	PA	D000890	Anti-Infective Agents	MeSH
DB01264	4143	darunavir	has role	CHEBI:36044	antiviral drug	CHEBI
DB01264	4143	darunavir	PA	D000998	Antiviral Agents	MeSH
DB01264	4143	darunavir	PA	D004791	Enzyme Inhibitors	MeSH
DB01264	4143	darunavir	PA	D017320	HIV Protease Inhibitors	MeSH
DB01264	4143	darunavir	PA	D011480	Protease Inhibitors	MeSH
DB01265	4220	telbivudine	EPC	N0000175656	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor	FDA
DB01265	4220	telbivudine	Chemical/Ingredient	N0000175459	Nucleoside Analog	FDA
DB01265	4220	telbivudine	MoA	N0000009947	Nucleoside Reverse Transcriptase Inhibitors	FDA
DB01265	4220	telbivudine	PA	D000890	Anti-Infective Agents	MeSH
DB01265	4220	telbivudine	has role	CHEBI:36044	antiviral drug	CHEBI
DB01265	4220	telbivudine	PA	D000998	Antiviral Agents	MeSH
DB01265	4220	telbivudine	PA	D004791	Enzyme Inhibitors	MeSH
DB01265	4220	telbivudine	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB04485	4220	telbivudine	EPC	N0000175656	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor	FDA
DB04485	4220	telbivudine	Chemical/Ingredient	N0000175459	Nucleoside Analog	FDA
DB04485	4220	telbivudine	MoA	N0000009947	Nucleoside Reverse Transcriptase Inhibitors	FDA
DB04485	4220	telbivudine	PA	D000890	Anti-Infective Agents	MeSH
DB04485	4220	telbivudine	has role	CHEBI:36044	antiviral drug	CHEBI
DB04485	4220	telbivudine	PA	D000998	Antiviral Agents	MeSH
DB04485	4220	telbivudine	PA	D004791	Enzyme Inhibitors	MeSH
DB04485	4220	telbivudine	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB01267	4498	paliperidone palmitate	has role	CHEBI:37890	alpha-adrenergic antagonist	CHEBI
DB01267	4498	paliperidone palmitate	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB01267	4498	paliperidone palmitate	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB01267	4498	paliperidone palmitate	has role	CHEBI:63726	neuroprotective agent	CHEBI
DB01267	4498	paliperidone palmitate	has role	CHEBI:35471	psychotropic drug	CHEBI
DB01267	4498	paliperidone palmitate	has role	CHEBI:65191	second generation antipsychotic	CHEBI
DB01267	4498	paliperidone palmitate	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB01267	4498	paliperidone palmitate	PA	D014150	Antipsychotic Agents	MeSH
DB01267	4498	paliperidone palmitate	PA	D002491	Central Nervous System Agents	MeSH
DB01267	4498	paliperidone palmitate	PA	D002492	Central Nervous System Depressants	MeSH
DB01267	4498	paliperidone palmitate	PA	D015259	Dopamine Agents	MeSH
DB01267	4498	paliperidone palmitate	PA	D018492	Dopamine Antagonists	MeSH
DB01267	4498	paliperidone palmitate	PA	D065127	Dopamine D2 Receptor Antagonists	MeSH
DB01267	4498	paliperidone palmitate	PA	D018377	Neurotransmitter Agents	MeSH
DB01267	4498	paliperidone palmitate	PA	D011619	Psychotropic Drugs	MeSH
DB01267	4498	paliperidone palmitate	PA	D058830	Serotonin 5-HT2 Receptor Antagonists	MeSH
DB01267	4498	paliperidone palmitate	PA	D018490	Serotonin Agents	MeSH
DB01267	4498	paliperidone palmitate	PA	D012702	Serotonin Antagonists	MeSH
DB01267	4498	paliperidone palmitate	PA	D014149	Tranquilizing Agents	MeSH
DB01267	4137	paliperidone	EPC	N0000175430	Atypical Antipsychotic	FDA
DB01268	2544	sunitinib	EPC	N0000175605	Kinase Inhibitor	FDA
DB01268	2544	sunitinib	MoA	N0000175076	Protein Kinase Inhibitors	FDA
DB01268	2544	sunitinib	PA	D020533	Angiogenesis Inhibitors	MeSH
DB01268	2544	sunitinib	has role	CHEBI:48422	angiogenesis inhibitor	CHEBI
DB01268	2544	sunitinib	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB01268	2544	sunitinib	has role	CHEBI:50846	immunomodulator	CHEBI
DB01268	2544	sunitinib	has role	CHEBI:63726	neuroprotective agent	CHEBI
DB01268	2544	sunitinib	PA	D000970	Antineoplastic Agents	MeSH
DB01268	2544	sunitinib	PA	D006131	Growth Inhibitors	MeSH
DB01268	2544	sunitinib	PA	D006133	Growth Substances	MeSH
DB01273	2808	varenicline	EPC	N0000175705	Partial Cholinergic Nicotinic Agonist	FDA
DB01273	2808	varenicline	MoA	N0000175702	Partial Cholinergic Nicotinic Agonists	FDA
DB01273	2808	varenicline	has role	CHEBI:47958	nicotinic acetylcholine receptor agonist	CHEBI
DB01273	2808	varenicline	has role	CHEBI:35941	serotonergic agonist	CHEBI
DB01273	2808	varenicline	PA	D018678	Cholinergic Agents	MeSH
DB01273	2808	varenicline	PA	D018679	Cholinergic Agonists	MeSH
DB01273	2808	varenicline	PA	D018377	Neurotransmitter Agents	MeSH
DB01273	2808	varenicline	PA	D018722	Nicotinic Agonists	MeSH
DB01275	1384	hydralazine	PE	N0000175379	Arteriolar Vasodilation	FDA
DB01275	1384	hydralazine	EPC	N0000175564	Arteriolar Vasodilator	FDA
DB01275	1384	hydralazine	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB01275	1384	hydralazine	has role	CHEBI:35620	vasodilator agent	CHEBI
DB01275	1384	hydralazine	PA	D000959	Antihypertensive Agents	MeSH
DB01275	1384	hydralazine	PA	D002317	Cardiovascular Agents	MeSH
DB01275	1384	hydralazine	PA	D014665	Vasodilator Agents	MeSH
DB01282	495	carbetocin	has role	CHEBI:36063	oxytocic	CHEBI
DB01282	495	carbetocin	PA	D003692	Delayed-Action Preparations	MeSH
DB01282	495	carbetocin	PA	D010120	Oxytocics	MeSH
DB01282	495	carbetocin	PA	D012102	Reproductive Control Agents	MeSH
DB01283	1618	lumiracoxib	PA	D000700	Analgesics	MeSH
DB01283	1618	lumiracoxib	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB01283	1618	lumiracoxib	PA	D000893	Anti-Inflammatory Agents	MeSH
DB01283	1618	lumiracoxib	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB01283	1618	lumiracoxib	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB01283	1618	lumiracoxib	PA	D018501	Antirheumatic Agents	MeSH
DB01283	1618	lumiracoxib	PA	D052246	Cyclooxygenase 2 Inhibitors	MeSH
DB01283	1618	lumiracoxib	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB01283	1618	lumiracoxib	PA	D004791	Enzyme Inhibitors	MeSH
DB01283	1618	lumiracoxib	PA	D018689	Sensory System Agents	MeSH
DB01288	1155	fenoterol	PA	D018663	Adrenergic Agents	MeSH
DB01288	1155	fenoterol	PA	D000322	Adrenergic Agonists	MeSH
DB01288	1155	fenoterol	PA	D058666	Adrenergic beta-2 Receptor Agonists	MeSH
DB01288	1155	fenoterol	PA	D000318	Adrenergic beta-Agonists	MeSH
DB01288	1155	fenoterol	PA	D018927	Anti-Asthmatic Agents	MeSH
DB01288	1155	fenoterol	has role	CHEBI:35523	bronchodilator agent	CHEBI
DB01288	1155	fenoterol	has role	CHEBI:35524	sympathomimetic agent	CHEBI
DB01288	1155	fenoterol	has role	CHEBI:35522	beta-adrenergic agonist	CHEBI
DB01288	1155	fenoterol	has role	CHEBI:66993	tocolytic agent	CHEBI
DB01288	1155	fenoterol	PA	D001993	Bronchodilator Agents	MeSH
DB01288	1155	fenoterol	PA	D018377	Neurotransmitter Agents	MeSH
DB01288	1155	fenoterol	PA	D012102	Reproductive Control Agents	MeSH
DB01288	1155	fenoterol	PA	D019141	Respiratory System Agents	MeSH
DB01288	1155	fenoterol	PA	D013566	Sympathomimetics	MeSH
DB01288	1155	fenoterol	PA	D015149	Tocolytic Agents	MeSH
DB01291	2199	pirbuterol	MoA	N0000009922	Adrenergic beta2-Agonists	FDA
DB01291	2199	pirbuterol	EPC	N0000175779	beta2-Adrenergic Agonist	FDA
DB01291	2199	pirbuterol	PA	D018663	Adrenergic Agents	MeSH
DB01291	2199	pirbuterol	PA	D000322	Adrenergic Agonists	MeSH
DB01291	2199	pirbuterol	PA	D058666	Adrenergic beta-2 Receptor Agonists	MeSH
DB01291	2199	pirbuterol	PA	D000318	Adrenergic beta-Agonists	MeSH
DB01291	2199	pirbuterol	PA	D018927	Anti-Asthmatic Agents	MeSH
DB01291	2199	pirbuterol	PA	D001993	Bronchodilator Agents	MeSH
DB01291	2199	pirbuterol	PA	D002316	Cardiotonic Agents	MeSH
DB01291	2199	pirbuterol	PA	D002317	Cardiovascular Agents	MeSH
DB01291	2199	pirbuterol	PA	D018377	Neurotransmitter Agents	MeSH
DB01291	2199	pirbuterol	PA	D020011	Protective Agents	MeSH
DB01291	2199	pirbuterol	PA	D019141	Respiratory System Agents	MeSH
DB01295	360	bevantolol	PA	D018663	Adrenergic Agents	MeSH
DB01295	360	bevantolol	PA	D018674	Adrenergic Antagonists	MeSH
DB01295	360	bevantolol	PA	D058671	Adrenergic beta-1 Receptor Antagonists	MeSH
DB01295	360	bevantolol	PA	D000319	Adrenergic beta-Antagonists	MeSH
DB01295	360	bevantolol	has role	CHEBI:35530	beta-adrenergic antagonist	CHEBI
DB01295	360	bevantolol	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB01295	360	bevantolol	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB01295	360	bevantolol	PA	D018377	Neurotransmitter Agents	MeSH
DB01297	3486	practolol	PA	D018663	Adrenergic Agents	MeSH
DB01297	3486	practolol	PA	D018674	Adrenergic Antagonists	MeSH
DB01297	3486	practolol	PA	D058671	Adrenergic beta-1 Receptor Antagonists	MeSH
DB01297	3486	practolol	PA	D000319	Adrenergic beta-Antagonists	MeSH
DB01297	3486	practolol	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB01297	3486	practolol	has role	CHEBI:35530	beta-adrenergic antagonist	CHEBI
DB01297	3486	practolol	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB01297	3486	practolol	PA	D002317	Cardiovascular Agents	MeSH
DB01297	3486	practolol	PA	D018377	Neurotransmitter Agents	MeSH
DB01299	2503	sulfadoxine	EPC	N0000175880	Sulfonamide	FDA
DB01299	2503	sulfadoxine	Chemical/Ingredient	N0000008048	Sulfonamides	FDA
DB01299	2503	sulfadoxine	PA	D000890	Anti-Infective Agents	MeSH
DB01299	2503	sulfadoxine	PA	D000892	Anti-Infective Agents, Urinary	MeSH
DB01299	2503	sulfadoxine	has role	CHEBI:36047	antibacterial drug	CHEBI
DB01299	2503	sulfadoxine	has role	CHEBI:38068	antimalarial	CHEBI
DB01299	2503	sulfadoxine	PA	D000962	Antimalarials	MeSH
DB01299	2503	sulfadoxine	PA	D000977	Antiparasitic Agents	MeSH
DB01299	2503	sulfadoxine	PA	D000981	Antiprotozoal Agents	MeSH
DB01319	1240	fosamprenavir	EPC	N0000175889	Protease Inhibitor	FDA
DB01319	1240	fosamprenavir	PA	D019380	Anti-HIV Agents	MeSH
DB01319	1240	fosamprenavir	PA	D000890	Anti-Infective Agents	MeSH
DB01319	1240	fosamprenavir	has role	CHEBI:50266	prodrug	CHEBI
DB01319	1240	fosamprenavir	PA	D000998	Antiviral Agents	MeSH
DB01319	1240	fosamprenavir	PA	D004791	Enzyme Inhibitors	MeSH
DB01319	1240	fosamprenavir	PA	D017320	HIV Protease Inhibitors	MeSH
DB01319	1240	fosamprenavir	PA	D011480	Protease Inhibitors	MeSH
DB01320	1247	fosphenytoin	EPC	N0000175753	Anti-epileptic Agent	FDA
DB01320	1247	fosphenytoin	PE	N0000008486	Decreased Central Nervous System Disorganized Electrical Activity	FDA
DB01320	1247	fosphenytoin	PA	D000927	Anticonvulsants	MeSH
DB01320	1247	fosphenytoin	PA	D002491	Central Nervous System Agents	MeSH
DB01324	2228	polythiazide	PE	N0000175359	Increased Diuresis	FDA
DB01324	2228	polythiazide	EPC	N0000175419	Thiazide Diuretic	FDA
DB01324	2228	polythiazide	Chemical/Ingredient	N0000166469	Thiazides	FDA
DB01324	2228	polythiazide	PA	D000959	Antihypertensive Agents	MeSH
DB01324	2228	polythiazide	PA	D002317	Cardiovascular Agents	MeSH
DB01324	2228	polythiazide	PA	D004232	Diuretics	MeSH
DB01324	2228	polythiazide	PA	D049990	Membrane Transport Modulators	MeSH
DB01324	2228	polythiazide	PA	D045283	Natriuretic Agents	MeSH
DB01324	2228	polythiazide	PA	D049993	Sodium Chloride Symporter Inhibitors	MeSH
DB01325	2343	quinethazone	PA	D004232	Diuretics	MeSH
DB01325	2343	quinethazone	PA	D049990	Membrane Transport Modulators	MeSH
DB01325	2343	quinethazone	PA	D045283	Natriuretic Agents	MeSH
DB01325	2343	quinethazone	PA	D049993	Sodium Chloride Symporter Inhibitors	MeSH
DB01327	530	cefazolin	EPC	N0000175488	Cephalosporin Antibacterial	FDA
DB01327	530	cefazolin	Chemical/Ingredient	N0000011161	Cephalosporins	FDA
DB01327	530	cefazolin	PA	D000900	Anti-Bacterial Agents	MeSH
DB01327	530	cefazolin	PA	D000890	Anti-Infective Agents	MeSH
DB01327	530	cefazolin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB01328	542	cefonicid	PA	D000900	Anti-Bacterial Agents	MeSH
DB01328	542	cefonicid	PA	D000890	Anti-Infective Agents	MeSH
DB01328	542	cefonicid	has role	CHEBI:36047	antibacterial drug	CHEBI
DB01329	543	cefoperazone	EPC	N0000175488	Cephalosporin Antibacterial	FDA
DB01329	543	cefoperazone	Chemical/Ingredient	N0000011161	Cephalosporins	FDA
DB01329	543	cefoperazone	PA	D000900	Anti-Bacterial Agents	MeSH
DB01329	543	cefoperazone	PA	D000890	Anti-Infective Agents	MeSH
DB01329	543	cefoperazone	has role	CHEBI:36047	antibacterial drug	CHEBI
DB01330	547	cefotetan	EPC	N0000175488	Cephalosporin Antibacterial	FDA
DB01330	547	cefotetan	Chemical/Ingredient	N0000011161	Cephalosporins	FDA
DB01330	547	cefotetan	PA	D000900	Anti-Bacterial Agents	MeSH
DB01330	547	cefotetan	PA	D000890	Anti-Infective Agents	MeSH
DB01330	547	cefotetan	has role	CHEBI:36047	antibacterial drug	CHEBI
DB01331	550	cefoxitin	EPC	N0000175488	Cephalosporin Antibacterial	FDA
DB01331	550	cefoxitin	Chemical/Ingredient	N0000011161	Cephalosporins	FDA
DB01331	550	cefoxitin	PA	D000900	Anti-Bacterial Agents	MeSH
DB01331	550	cefoxitin	PA	D000890	Anti-Infective Agents	MeSH
DB01331	550	cefoxitin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB01332	563	ceftizoxime	EPC	N0000175488	Cephalosporin Antibacterial	FDA
DB01332	563	ceftizoxime	Chemical/Ingredient	N0000011161	Cephalosporins	FDA
DB01332	563	ceftizoxime	PA	D000900	Anti-Bacterial Agents	MeSH
DB01332	563	ceftizoxime	PA	D000890	Anti-Infective Agents	MeSH
DB01332	563	ceftizoxime	has role	CHEBI:36047	antibacterial drug	CHEBI
DB01333	576	cefradine	PA	D000900	Anti-Bacterial Agents	MeSH
DB01333	576	cefradine	PA	D000890	Anti-Infective Agents	MeSH
DB01333	576	cefradine	has role	CHEBI:36047	antibacterial drug	CHEBI
DB01337	2052	pancuronium	PE	N0000175732	Neuromuscular Nondepolarizing Blockade	FDA
DB01337	2052	pancuronium	EPC	N0000175720	Nondepolarizing Neuromuscular Blocker	FDA
DB01337	2052	pancuronium	has role	CHEBI:48878	nicotinic antagonist	CHEBI
DB01337	2052	pancuronium	has role	CHEBI:48873	cholinergic antagonist	CHEBI
DB01337	2052	pancuronium	has role	CHEBI:51371	muscle relaxant	CHEBI
DB01337	2052	pancuronium	PA	D018678	Cholinergic Agents	MeSH
DB01337	2052	pancuronium	PA	D018680	Cholinergic Antagonists	MeSH
DB01337	2052	pancuronium	PA	D009465	Neuromuscular Agents	MeSH
DB01337	2052	pancuronium	PA	D009466	Neuromuscular Blocking Agents	MeSH
DB01337	2052	pancuronium	PA	D003473	Neuromuscular Nondepolarizing Agents	MeSH
DB01337	2052	pancuronium	PA	D018377	Neurotransmitter Agents	MeSH
DB01337	2052	pancuronium	PA	D018733	Nicotinic Antagonists	MeSH
DB01338	2183	pipecuronium	PA	D018678	Cholinergic Agents	MeSH
DB01338	2183	pipecuronium	PA	D018680	Cholinergic Antagonists	MeSH
DB01338	2183	pipecuronium	PA	D009465	Neuromuscular Agents	MeSH
DB01338	2183	pipecuronium	PA	D009466	Neuromuscular Blocking Agents	MeSH
DB01338	2183	pipecuronium	PA	D003473	Neuromuscular Nondepolarizing Agents	MeSH
DB01338	2183	pipecuronium	PA	D018377	Neurotransmitter Agents	MeSH
DB01338	2183	pipecuronium	PA	D018733	Nicotinic Antagonists	MeSH
DB01339	2811	vecuronium	PE	N0000175732	Neuromuscular Nondepolarizing Blockade	FDA
DB01339	2811	vecuronium	EPC	N0000175720	Nondepolarizing Neuromuscular Blocker	FDA
DB01339	2811	vecuronium	has role	CHEBI:48878	nicotinic antagonist	CHEBI
DB01339	2811	vecuronium	has role	CHEBI:51372	neuromuscular agent	CHEBI
DB01339	2811	vecuronium	has role	CHEBI:51371	muscle relaxant	CHEBI
DB01339	2811	vecuronium	PA	D018678	Cholinergic Agents	MeSH
DB01339	2811	vecuronium	PA	D018680	Cholinergic Antagonists	MeSH
DB01339	2811	vecuronium	PA	D009465	Neuromuscular Agents	MeSH
DB01339	2811	vecuronium	PA	D009466	Neuromuscular Blocking Agents	MeSH
DB01339	2811	vecuronium	PA	D003473	Neuromuscular Nondepolarizing Agents	MeSH
DB01339	2811	vecuronium	PA	D018377	Neurotransmitter Agents	MeSH
DB01339	2811	vecuronium	PA	D018733	Nicotinic Antagonists	MeSH
DB01340	641	cilazapril	PA	D000806	Angiotensin-Converting Enzyme Inhibitors	MeSH
DB01340	641	cilazapril	PA	D000959	Antihypertensive Agents	MeSH
DB01340	641	cilazapril	PA	D002317	Cardiovascular Agents	MeSH
DB01340	641	cilazapril	PA	D004791	Enzyme Inhibitors	MeSH
DB01340	641	cilazapril	PA	D011480	Protease Inhibitors	MeSH
DB01348	2474	spirapril	PA	D000806	Angiotensin-Converting Enzyme Inhibitors	MeSH
DB01348	2474	spirapril	PA	D000959	Antihypertensive Agents	MeSH
DB01348	2474	spirapril	PA	D002317	Cardiovascular Agents	MeSH
DB01348	2474	spirapril	PA	D004791	Enzyme Inhibitors	MeSH
DB01348	2474	spirapril	PA	D011480	Protease Inhibitors	MeSH
DB01349	3839	tasosartan	PA	D047228	Angiotensin II Type 1 Receptor Blockers	MeSH
DB01349	3839	tasosartan	PA	D057911	Angiotensin Receptor Antagonists	MeSH
DB01357	1714	mestranol	EPC	N0000175825	Estrogen	FDA
DB01357	1714	mestranol	MoA	N0000000100	Estrogen Receptor Agonists	FDA
DB01357	1714	mestranol	has role	CHEBI:50266	prodrug	CHEBI
DB01357	1714	mestranol	PA	D004967	Estrogens	MeSH
DB01357	1714	mestranol	PA	D006728	Hormones	MeSH
DB01359	2078	penbutolol	EPC	N0000175556	beta-Adrenergic Blocker	FDA
DB01359	2078	penbutolol	PA	D018663	Adrenergic Agents	MeSH
DB01359	2078	penbutolol	PA	D018674	Adrenergic Antagonists	MeSH
DB01359	2078	penbutolol	PA	D000319	Adrenergic beta-Antagonists	MeSH
DB01359	2078	penbutolol	PA	D000959	Antihypertensive Agents	MeSH
DB01359	2078	penbutolol	PA	D002317	Cardiovascular Agents	MeSH
DB01359	2078	penbutolol	PA	D018377	Neurotransmitter Agents	MeSH
DB01365	1694	mephentermine	PA	D018663	Adrenergic Agents	MeSH
DB01365	1694	mephentermine	PA	D000322	Adrenergic Agonists	MeSH
DB01365	1694	mephentermine	PA	D058646	Adrenergic alpha-1 Receptor Agonists	MeSH
DB01365	1694	mephentermine	PA	D000316	Adrenergic alpha-Agonists	MeSH
DB01365	1694	mephentermine	PA	D002317	Cardiovascular Agents	MeSH
DB01365	1694	mephentermine	PA	D018377	Neurotransmitter Agents	MeSH
DB01365	1694	mephentermine	PA	D013566	Sympathomimetics	MeSH
DB01365	1694	mephentermine	PA	D014662	Vasoconstrictor Agents	MeSH
DB01366	2273	procaterol	PA	D018663	Adrenergic Agents	MeSH
DB01366	2273	procaterol	PA	D000322	Adrenergic Agonists	MeSH
DB01366	2273	procaterol	PA	D058666	Adrenergic beta-2 Receptor Agonists	MeSH
DB01366	2273	procaterol	PA	D000318	Adrenergic beta-Agonists	MeSH
DB01366	2273	procaterol	PA	D018927	Anti-Asthmatic Agents	MeSH
DB01366	2273	procaterol	PA	D001993	Bronchodilator Agents	MeSH
DB01366	2273	procaterol	PA	D018377	Neurotransmitter Agents	MeSH
DB01366	2273	procaterol	PA	D019141	Respiratory System Agents	MeSH
DB01366	2273	procaterol	PA	D013566	Sympathomimetics	MeSH
DB01367	3521	rasagiline	EPC	N0000175744	Monoamine Oxidase Inhibitor	FDA
DB01367	3521	rasagiline	has role	CHEBI:63726	neuroprotective agent	CHEBI
DB01367	3521	rasagiline	PA	D002491	Central Nervous System Agents	MeSH
DB01367	3521	rasagiline	PA	D004791	Enzyme Inhibitors	MeSH
DB01367	3521	rasagiline	PA	D008996	Monoamine Oxidase Inhibitors	MeSH
DB01367	3521	rasagiline	PA	D018696	Neuroprotective Agents	MeSH
DB01367	3521	rasagiline	PA	D020011	Protective Agents	MeSH
DB03894	3521	rasagiline	EPC	N0000175744	Monoamine Oxidase Inhibitor	FDA
DB03894	3521	rasagiline	has role	CHEBI:63726	neuroprotective agent	CHEBI
DB03894	3521	rasagiline	PA	D002491	Central Nervous System Agents	MeSH
DB03894	3521	rasagiline	PA	D004791	Enzyme Inhibitors	MeSH
DB03894	3521	rasagiline	PA	D008996	Monoamine Oxidase Inhibitors	MeSH
DB03894	3521	rasagiline	PA	D018696	Neuroprotective Agents	MeSH
DB03894	3521	rasagiline	PA	D020011	Protective Agents	MeSH
DB01388	1797	mibefradil	PA	D000959	Antihypertensive Agents	MeSH
DB01388	1797	mibefradil	PA	D002121	Calcium Channel Blockers	MeSH
DB01388	1797	mibefradil	PA	D002317	Cardiovascular Agents	MeSH
DB01388	1797	mibefradil	PA	D065609	Cytochrome P-450 CYP1A2 Inhibitors	MeSH
DB01388	1797	mibefradil	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB01388	1797	mibefradil	PA	D004791	Enzyme Inhibitors	MeSH
DB01388	1797	mibefradil	PA	D049990	Membrane Transport Modulators	MeSH
DB01388	1797	mibefradil	PA	D014665	Vasodilator Agents	MeSH
DB01392	3659	yohimbine	PA	D018663	Adrenergic Agents	MeSH
DB01392	3659	yohimbine	PA	D058669	Adrenergic alpha-2 Receptor Antagonists	MeSH
DB01392	3659	yohimbine	PA	D000317	Adrenergic alpha-Antagonists	MeSH
DB01392	3659	yohimbine	PA	D018674	Adrenergic Antagonists	MeSH
DB01392	3659	yohimbine	has role	CHEBI:37890	alpha-adrenergic antagonist	CHEBI
DB01392	3659	yohimbine	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB01392	3659	yohimbine	PA	D009184	Mydriatics	MeSH
DB01392	3659	yohimbine	PA	D018377	Neurotransmitter Agents	MeSH
DB01392	3659	yohimbine	PA	D064804	Urological Agents	MeSH
DB01393	362	bezafibrate	has role	CHEBI:35679	antilipemic drug	CHEBI
DB01393	362	bezafibrate	PA	D000963	Antimetabolites	MeSH
DB01393	362	bezafibrate	PA	D000960	Hypolipidemic Agents	MeSH
DB01395	968	drospirenone	Chemical/Ingredient	N0000011301	Progesterone Congeners	FDA
DB01395	968	drospirenone	EPC	N0000175602	Progestin	FDA
DB01395	968	drospirenone	has role	CHEBI:49323	contraceptive drug	CHEBI
DB01395	968	drospirenone	PA	D004232	Diuretics	MeSH
DB01395	968	drospirenone	PA	D006727	Hormone Antagonists	MeSH
DB01395	968	drospirenone	PA	D000451	Mineralocorticoid Receptor Antagonists	MeSH
DB01395	968	drospirenone	PA	D045283	Natriuretic Agents	MeSH
DB01396	881	digitoxin	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB01396	881	digitoxin	PA	D002316	Cardiotonic Agents	MeSH
DB01396	881	digitoxin	PA	D002317	Cardiovascular Agents	MeSH
DB01396	881	digitoxin	PA	D004791	Enzyme Inhibitors	MeSH
DB01396	881	digitoxin	PA	D020011	Protective Agents	MeSH
DB01400	1897	neostigmine	EPC	N0000175723	Cholinesterase Inhibitor	FDA
DB01400	1897	neostigmine	PA	D018678	Cholinergic Agents	MeSH
DB01400	1897	neostigmine	PA	D002800	Cholinesterase Inhibitors	MeSH
DB01400	1897	neostigmine	PA	D004791	Enzyme Inhibitors	MeSH
DB01400	1897	neostigmine	PA	D018377	Neurotransmitter Agents	MeSH
DB01400	1897	neostigmine	PA	D010277	Parasympathomimetics	MeSH
DB01406	779	danazol	EPC	N0000175824	Androgen	FDA
DB01406	779	danazol	MoA	N0000000146	Androgen Receptor Agonists	FDA
DB01406	779	danazol	Chemical/Ingredient	N0000008241	Androstanes	FDA
DB01406	779	danazol	has role	CHEBI:50751	anti-estrogen	CHEBI
DB01406	779	danazol	has role	CHEBI:50837	estrogen antagonist	CHEBI
DB01406	779	danazol	PA	D004965	Estrogen Antagonists	MeSH
DB01406	779	danazol	PA	D006727	Hormone Antagonists	MeSH
DB01409	2677	tiotropium bromide	EPC	N0000175574	Anticholinergic	FDA
DB01409	2677	tiotropium bromide	PA	D018927	Anti-Asthmatic Agents	MeSH
DB01409	2677	tiotropium bromide	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB01409	2677	tiotropium bromide	has role	CHEBI:35523	bronchodilator agent	CHEBI
DB01409	2677	tiotropium bromide	PA	D001993	Bronchodilator Agents	MeSH
DB01409	2677	tiotropium bromide	PA	D018678	Cholinergic Agents	MeSH
DB01409	2677	tiotropium bromide	PA	D018680	Cholinergic Antagonists	MeSH
DB01409	2677	tiotropium bromide	PA	D018377	Neurotransmitter Agents	MeSH
DB01409	2677	tiotropium bromide	PA	D010276	Parasympatholytics	MeSH
DB01409	2677	tiotropium bromide	PA	D019141	Respiratory System Agents	MeSH
DB01410	633	ciclesonide	PA	D018926	Anti-Allergic Agents	MeSH
DB01410	633	ciclesonide	PA	D005938	Glucocorticoids	MeSH
DB01410	633	ciclesonide	PA	D006728	Hormones	MeSH
DB01413	535	cefepime	EPC	N0000175488	Cephalosporin Antibacterial	FDA
DB01413	535	cefepime	Chemical/Ingredient	N0000011161	Cephalosporins	FDA
DB01413	535	cefepime	PA	D000900	Anti-Bacterial Agents	MeSH
DB01413	535	cefepime	PA	D000890	Anti-Infective Agents	MeSH
DB01413	535	cefepime	has role	CHEBI:36047	antibacterial drug	CHEBI
DB01415	562	ceftibuten	EPC	N0000175488	Cephalosporin Antibacterial	FDA
DB01415	562	ceftibuten	Chemical/Ingredient	N0000011161	Cephalosporins	FDA
DB01415	562	ceftibuten	PA	D000900	Anti-Bacterial Agents	MeSH
DB01415	562	ceftibuten	PA	D000890	Anti-Infective Agents	MeSH
DB01415	562	ceftibuten	has role	CHEBI:36047	antibacterial drug	CHEBI
DB01418	48	acenocoumarol	has role	CHEBI:50249	anticoagulant	CHEBI
DB01418	48	acenocoumarol	PA	D000925	Anticoagulants	MeSH
DB01418	48	acenocoumarol	PA	D006401	Hematologic Agents	MeSH
DB01427	201	amrinone	PA	D002121	Calcium Channel Blockers	MeSH
DB01427	201	amrinone	PA	D002316	Cardiotonic Agents	MeSH
DB01427	201	amrinone	PA	D002317	Cardiovascular Agents	MeSH
DB01427	201	amrinone	PA	D004791	Enzyme Inhibitors	MeSH
DB01427	201	amrinone	PA	D049990	Membrane Transport Modulators	MeSH
DB01427	201	amrinone	PA	D058987	Phosphodiesterase 3 Inhibitors	MeSH
DB01427	201	amrinone	PA	D010726	Phosphodiesterase Inhibitors	MeSH
DB01427	201	amrinone	PA	D020011	Protective Agents	MeSH
DB01427	201	amrinone	PA	D014665	Vasodilator Agents	MeSH
DB01429	231	aprindine	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB01429	231	aprindine	PA	D002317	Cardiovascular Agents	MeSH
DB01429	231	aprindine	PA	D049990	Membrane Transport Modulators	MeSH
DB01429	231	aprindine	PA	D026941	Sodium Channel Blockers	MeSH
DB01429	231	aprindine	PA	D061567	Voltage-Gated Sodium Channel Blockers	MeSH
DB01436	130	alfacalcidol	has role	CHEBI:50646	bone density conservation agent	CHEBI
DB01436	130	alfacalcidol	PA	D050071	Bone Density Conservation Agents	MeSH
DB01437	1313	glutethimide	PA	D002491	Central Nervous System Agents	MeSH
DB01437	1313	glutethimide	PA	D002492	Central Nervous System Depressants	MeSH
DB01437	1313	glutethimide	PA	D006993	Hypnotics and Sedatives	MeSH
DB01438	2120	phenazopyridine	has role	CHEBI:36333	local anaesthetic	CHEBI
DB01438	2120	phenazopyridine	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB01440	4566	sodium oxybate	PA	D000759	Adjuvants, Anesthesia	MeSH
DB01440	4566	sodium oxybate	PA	D000777	Anesthetics	MeSH
DB01440	4566	sodium oxybate	PA	D018686	Anesthetics, Intravenous	MeSH
DB01440	4566	sodium oxybate	PA	D002491	Central Nervous System Agents	MeSH
DB01440	4566	sodium oxybate	PA	D002492	Central Nervous System Depressants	MeSH
DB01493	1094	ethylestrenol	PA	D045930	Anabolic Agents	MeSH
DB01493	1094	ethylestrenol	PA	D006728	Hormones	MeSH
DB01501	878	difenoxin	EPC	N0000178374	Antidiarrheal	FDA
DB01501	878	difenoxin	has role	CHEBI:55323	antidiarrhoeal drug	CHEBI
DB01544	1202	flunitrazepam	PA	D014151	Anti-Anxiety Agents	MeSH
DB01544	1202	flunitrazepam	PA	D002491	Central Nervous System Agents	MeSH
DB01544	1202	flunitrazepam	PA	D002492	Central Nervous System Depressants	MeSH
DB01544	1202	flunitrazepam	PA	D018682	GABA Agents	MeSH
DB01544	1202	flunitrazepam	PA	D018757	GABA Modulators	MeSH
DB01544	1202	flunitrazepam	PA	D018377	Neurotransmitter Agents	MeSH
DB01544	1202	flunitrazepam	PA	D011619	Psychotropic Drugs	MeSH
DB01544	1202	flunitrazepam	PA	D014149	Tranquilizing Agents	MeSH
DB01551	886	dihydrocodeine	MoA	N0000175684	Full Opioid Agonists	FDA
DB01551	886	dihydrocodeine	EPC	N0000175690	Opioid Agonist	FDA
DB01551	886	dihydrocodeine	PA	D000700	Analgesics	MeSH
DB01551	886	dihydrocodeine	PA	D000701	Analgesics, Opioid	MeSH
DB01551	886	dihydrocodeine	PA	D002491	Central Nervous System Agents	MeSH
DB01551	886	dihydrocodeine	PA	D002492	Central Nervous System Depressants	MeSH
DB01551	886	dihydrocodeine	PA	D009294	Narcotics	MeSH
DB01551	886	dihydrocodeine	PA	D018689	Sensory System Agents	MeSH
DB01556	618	chlorphentermine	PA	D013566	Sympathomimetics	MeSH
DB01577	1732	methamphetamine	EPC	N0000175425	Amphetamine Anorectic	FDA
DB01577	1732	methamphetamine	Chemical/Ingredient	N0000007883	Amphetamines	FDA
DB01577	1732	methamphetamine	PE	N0000175372	Appetite Suppression	FDA
DB01577	1732	methamphetamine	PE	N0000175729	Central Nervous System Stimulation	FDA
DB01577	1732	methamphetamine	PE	N0000175651	Increased Sympathetic Activity	FDA
DB01577	1732	methamphetamine	PA	D018663	Adrenergic Agents	MeSH
DB01577	1732	methamphetamine	PA	D018759	Adrenergic Uptake Inhibitors	MeSH
DB01577	1732	methamphetamine	has role	CHEBI:35471	psychotropic drug	CHEBI
DB01577	1732	methamphetamine	has role	CHEBI:35337	central nervous system stimulant	CHEBI
DB01577	1732	methamphetamine	PA	D002491	Central Nervous System Agents	MeSH
DB01577	1732	methamphetamine	PA	D000697	Central Nervous System Stimulants	MeSH
DB01577	1732	methamphetamine	PA	D015259	Dopamine Agents	MeSH
DB01577	1732	methamphetamine	PA	D018765	Dopamine Uptake Inhibitors	MeSH
DB01577	1732	methamphetamine	PA	D049990	Membrane Transport Modulators	MeSH
DB01577	1732	methamphetamine	PA	D018377	Neurotransmitter Agents	MeSH
DB01577	1732	methamphetamine	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB01577	1732	methamphetamine	PA	D013566	Sympathomimetics	MeSH
DB01579	2122	phendimetrazine	PE	N0000175372	Appetite Suppression	FDA
DB01579	2122	phendimetrazine	PE	N0000175651	Increased Sympathetic Activity	FDA
DB01579	2122	phendimetrazine	EPC	N0000175423	Sympathomimetic Amine Anorectic	FDA
DB01579	2122	phendimetrazine	PA	D002491	Central Nervous System Agents	MeSH
DB01579	2122	phendimetrazine	PA	D000697	Central Nervous System Stimulants	MeSH
DB01580	2027	oxprenolol	PA	D018663	Adrenergic Agents	MeSH
DB01580	2027	oxprenolol	PA	D018674	Adrenergic Antagonists	MeSH
DB01580	2027	oxprenolol	PA	D000319	Adrenergic beta-Antagonists	MeSH
DB01580	2027	oxprenolol	PA	D014151	Anti-Anxiety Agents	MeSH
DB01580	2027	oxprenolol	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB01580	2027	oxprenolol	PA	D000959	Antihypertensive Agents	MeSH
DB01580	2027	oxprenolol	PA	D002317	Cardiovascular Agents	MeSH
DB01580	2027	oxprenolol	PA	D002491	Central Nervous System Agents	MeSH
DB01580	2027	oxprenolol	PA	D002492	Central Nervous System Depressants	MeSH
DB01580	2027	oxprenolol	PA	D018377	Neurotransmitter Agents	MeSH
DB01580	2027	oxprenolol	PA	D011619	Psychotropic Drugs	MeSH
DB01580	2027	oxprenolol	PA	D013565	Sympatholytics	MeSH
DB01580	2027	oxprenolol	PA	D014149	Tranquilizing Agents	MeSH
DB01580	2027	oxprenolol	PA	D014665	Vasodilator Agents	MeSH
DB01581	2510	sulfamerazine	PA	D000900	Anti-Bacterial Agents	MeSH
DB01581	2510	sulfamerazine	PA	D000890	Anti-Infective Agents	MeSH
DB01581	2510	sulfamerazine	has role	CHEBI:35441	antiinfective agent	CHEBI
DB01582	2502	sulfadimidine	PA	D000890	Anti-Infective Agents	MeSH
DB01582	2502	sulfadimidine	has role	CHEBI:35441	antiinfective agent	CHEBI
DB01582	2502	sulfadimidine	has role	CHEBI:36047	antibacterial drug	CHEBI
DB01586	2797	ursodiol	EPC	N0000175802	Bile Acid	FDA
DB01586	2797	ursodiol	Chemical/Ingredient	N0000006801	Bile Acids and Salts	FDA
DB01586	2797	ursodiol	PA	D002756	Cholagogues and Choleretics	MeSH
DB01586	2797	ursodiol	PA	D005765	Gastrointestinal Agents	MeSH
DB06777	2797	ursodiol	EPC	N0000175802	Bile Acid	FDA
DB06777	2797	ursodiol	Chemical/Ingredient	N0000006801	Bile Acids and Salts	FDA
DB06777	2797	ursodiol	PA	D002756	Cholagogues and Choleretics	MeSH
DB06777	2797	ursodiol	PA	D005765	Gastrointestinal Agents	MeSH
DB01586	4361	chenodiol	PA	D002400	Cathartics	MeSH
DB06777	4361	chenodiol	PA	D002400	Cathartics	MeSH
DB01588	2240	prazepam	PA	D014151	Anti-Anxiety Agents	MeSH
DB01588	2240	prazepam	PA	D002491	Central Nervous System Agents	MeSH
DB01588	2240	prazepam	PA	D002492	Central Nervous System Depressants	MeSH
DB01588	2240	prazepam	PA	D018682	GABA Agents	MeSH
DB01588	2240	prazepam	PA	D018757	GABA Modulators	MeSH
DB01588	2240	prazepam	PA	D018377	Neurotransmitter Agents	MeSH
DB01588	2240	prazepam	PA	D011619	Psychotropic Drugs	MeSH
DB01588	2240	prazepam	PA	D014149	Tranquilizing Agents	MeSH
DB01589	2336	quazepam	EPC	N0000175694	Benzodiazepine	FDA
DB01589	2336	quazepam	Chemical/Ingredient	N0000007542	Benzodiazepines	FDA
DB01589	2336	quazepam	PA	D002491	Central Nervous System Agents	MeSH
DB01589	2336	quazepam	PA	D002492	Central Nervous System Depressants	MeSH
DB01589	2336	quazepam	PA	D006993	Hypnotics and Sedatives	MeSH
DB01590	1118	everolimus	EPC	N0000175605	Kinase Inhibitor	FDA
DB01590	1118	everolimus	MoA	N0000175076	Protein Kinase Inhibitors	FDA
DB01590	1118	everolimus	MoA	N0000182141	Cytochrome P450 3A4 Inhibitors	FDA
DB01590	1118	everolimus	MoA	N0000185503	P-Glycoprotein Inhibitors	FDA
DB01590	1118	everolimus	MoA	N0000182137	Cytochrome P450 2D6 Inhibitors	FDA
DB01590	1118	everolimus	has role	CHEBI:35705	immunosuppressive agent	CHEBI
DB01590	1118	everolimus	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB01590	1118	everolimus	PA	D000970	Antineoplastic Agents	MeSH
DB01590	1118	everolimus	PA	D007155	Immunologic Factors	MeSH
DB01590	1118	everolimus	PA	D007166	Immunosuppressive Agents	MeSH
DB01591	2457	solifenacin	EPC	N0000175700	Cholinergic Muscarinic Antagonist	FDA
DB01591	2457	solifenacin	MoA	N0000000125	Cholinergic Muscarinic Antagonists	FDA
DB01591	2457	solifenacin	PA	D018678	Cholinergic Agents	MeSH
DB01591	2457	solifenacin	PA	D018680	Cholinergic Antagonists	MeSH
DB01591	2457	solifenacin	PA	D018727	Muscarinic Antagonists	MeSH
DB01591	2457	solifenacin	PA	D018377	Neurotransmitter Agents	MeSH
DB01591	2457	solifenacin	PA	D064804	Urological Agents	MeSH
DB01595	1945	nitrazepam	PA	D014151	Anti-Anxiety Agents	MeSH
DB01595	1945	nitrazepam	has role	CHEBI:35623	anticonvulsant	CHEBI
DB01595	1945	nitrazepam	has role	CHEBI:53784	antispasmodic drug	CHEBI
DB01595	1945	nitrazepam	has role	CHEBI:50268	GABA modulator	CHEBI
DB01595	1945	nitrazepam	has role	CHEBI:35717	sedative	CHEBI
DB01595	1945	nitrazepam	PA	D000927	Anticonvulsants	MeSH
DB01595	1945	nitrazepam	PA	D002491	Central Nervous System Agents	MeSH
DB01595	1945	nitrazepam	PA	D002492	Central Nervous System Depressants	MeSH
DB01595	1945	nitrazepam	PA	D018682	GABA Agents	MeSH
DB01595	1945	nitrazepam	PA	D018757	GABA Modulators	MeSH
DB01595	1945	nitrazepam	PA	D006993	Hypnotics and Sedatives	MeSH
DB01595	1945	nitrazepam	PA	D018377	Neurotransmitter Agents	MeSH
DB01595	1945	nitrazepam	PA	D011619	Psychotropic Drugs	MeSH
DB01595	1945	nitrazepam	PA	D014149	Tranquilizing Agents	MeSH
DB01597	640	cilastatin	MoA	N0000175513	Dipeptidase Inhibitors	FDA
DB01597	640	cilastatin	EPC	N0000175514	Renal Dehydropeptidase Inhibitor	FDA
DB01597	640	cilastatin	PA	D004791	Enzyme Inhibitors	MeSH
DB01597	640	cilastatin	PA	D011480	Protease Inhibitors	MeSH
DB01598	1426	imipenem	PA	D000900	Anti-Bacterial Agents	MeSH
DB01598	1426	imipenem	PA	D000890	Anti-Infective Agents	MeSH
DB01598	1426	imipenem	has role	CHEBI:36047	antibacterial drug	CHEBI
DB01599	2269	probucol	has role	CHEBI:35472	anti-inflammatory drug	CHEBI
DB01599	2269	probucol	has role	CHEBI:35554	cardiovascular drug	CHEBI
DB01599	2269	probucol	has role	CHEBI:35679	antilipemic drug	CHEBI
DB01599	2269	probucol	has role	CHEBI:35821	anticholesteremic drug	CHEBI
DB01599	2269	probucol	PA	D000924	Anticholesteremic Agents	MeSH
DB01599	2269	probucol	PA	D000963	Antimetabolites	MeSH
DB01599	2269	probucol	PA	D000975	Antioxidants	MeSH
DB01599	2269	probucol	PA	D000960	Hypolipidemic Agents	MeSH
DB01599	2269	probucol	PA	D020011	Protective Agents	MeSH
DB01600	2652	tiaprofenic acid	PA	D000700	Analgesics	MeSH
DB01600	2652	tiaprofenic acid	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB01600	2652	tiaprofenic acid	PA	D000893	Anti-Inflammatory Agents	MeSH
DB01600	2652	tiaprofenic acid	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB01600	2652	tiaprofenic acid	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB01600	2652	tiaprofenic acid	PA	D018501	Antirheumatic Agents	MeSH
DB01600	2652	tiaprofenic acid	PA	D018689	Sensory System Agents	MeSH
DB01601	1601	lopinavir	EPC	N0000175889	Protease Inhibitor	FDA
DB01601	1601	lopinavir	MoA	N0000185503	P-Glycoprotein Inhibitors	FDA
DB01601	1601	lopinavir	MoA	N0000190114	Cytochrome P450 3A Inhibitors	FDA
DB01601	1601	lopinavir	PA	D019380	Anti-HIV Agents	MeSH
DB01601	1601	lopinavir	PA	D000890	Anti-Infective Agents	MeSH
DB01601	1601	lopinavir	has role	CHEBI:36044	antiviral drug	CHEBI
DB01601	1601	lopinavir	PA	D000998	Antiviral Agents	MeSH
DB01601	1601	lopinavir	PA	D065692	Cytochrome P-450 CYP3A Inhibitors	MeSH
DB01601	1601	lopinavir	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB01601	1601	lopinavir	PA	D004791	Enzyme Inhibitors	MeSH
DB01601	1601	lopinavir	PA	D017320	HIV Protease Inhibitors	MeSH
DB01601	1601	lopinavir	PA	D011480	Protease Inhibitors	MeSH
DB01602	280	bacampicillin	PA	D000900	Anti-Bacterial Agents	MeSH
DB01602	280	bacampicillin	PA	D000890	Anti-Infective Agents	MeSH
DB01602	280	bacampicillin	has role	CHEBI:50266	prodrug	CHEBI
DB01603	1744	meticillin	PA	D000900	Anti-Bacterial Agents	MeSH
DB01603	1744	meticillin	PA	D000890	Anti-Infective Agents	MeSH
DB01606	2572	tazobactam	EPC	N0000175930	beta Lactamase Inhibitor	FDA
DB01606	2572	tazobactam	MoA	N0000000202	beta Lactamase Inhibitors	FDA
DB01606	2572	tazobactam	PA	D000900	Anti-Bacterial Agents	MeSH
DB01606	2572	tazobactam	PA	D000890	Anti-Infective Agents	MeSH
DB01606	2572	tazobactam	has role	CHEBI:35441	antiinfective agent	CHEBI
DB01606	2572	tazobactam	PA	D065093	beta-Lactamase Inhibitors	MeSH
DB01606	2572	tazobactam	PA	D004791	Enzyme Inhibitors	MeSH
DB01607	2656	ticarcillin	EPC	N0000175497	Penicillin-class Antibacterial	FDA
DB01607	2656	ticarcillin	Chemical/Ingredient	N0000011281	Penicillins	FDA
DB01607	2656	ticarcillin	PA	D000900	Anti-Bacterial Agents	MeSH
DB01607	2656	ticarcillin	PA	D000890	Anti-Infective Agents	MeSH
DB01607	2656	ticarcillin	has role	CHEBI:36047	antibacterial drug	CHEBI
DB01610	2801	valganciclovir	EPC	N0000175461	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor	FDA
DB01610	2801	valganciclovir	MoA	N0000020060	DNA Polymerase Inhibitors	FDA
DB01610	2801	valganciclovir	Chemical/Ingredient	N0000175459	Nucleoside Analog	FDA
DB01610	2801	valganciclovir	PA	D000890	Anti-Infective Agents	MeSH
DB01610	2801	valganciclovir	has role	CHEBI:50266	prodrug	CHEBI
DB01610	2801	valganciclovir	has role	CHEBI:36044	antiviral drug	CHEBI
DB01610	2801	valganciclovir	PA	D000998	Antiviral Agents	MeSH
DB01611	1395	hydroxychloroquine	EPC	N0000175713	Antirheumatic Agent	FDA
DB01611	1395	hydroxychloroquine	PA	D000890	Anti-Infective Agents	MeSH
DB01611	1395	hydroxychloroquine	has role	CHEBI:35842	antirheumatic drug	CHEBI
DB01611	1395	hydroxychloroquine	has role	CHEBI:50177	dermatologic drug	CHEBI
DB01611	1395	hydroxychloroquine	has role	CHEBI:38068	antimalarial	CHEBI
DB01611	1395	hydroxychloroquine	PA	D000962	Antimalarials	MeSH
DB01611	1395	hydroxychloroquine	PA	D000977	Antiparasitic Agents	MeSH
DB01611	1395	hydroxychloroquine	PA	D000981	Antiprotozoal Agents	MeSH
DB01611	1395	hydroxychloroquine	PA	D018501	Antirheumatic Agents	MeSH
DB01611	1395	hydroxychloroquine	PA	D004791	Enzyme Inhibitors	MeSH
DB01615	50	aceprometazine	has role	CHEBI:35474	anxiolytic drug	CHEBI
DB01615	50	aceprometazine	has role	CHEBI:35717	sedative	CHEBI
DB01615	50	aceprometazine	has role	CHEBI:37956	histamine antagonist	CHEBI
DB01615	50	aceprometazine	PA	D014150	Antipsychotic Agents	MeSH
DB01615	50	aceprometazine	PA	D002491	Central Nervous System Agents	MeSH
DB01615	50	aceprometazine	PA	D002492	Central Nervous System Depressants	MeSH
DB01615	50	aceprometazine	PA	D015259	Dopamine Agents	MeSH
DB01615	50	aceprometazine	PA	D018492	Dopamine Antagonists	MeSH
DB01615	50	aceprometazine	PA	D018377	Neurotransmitter Agents	MeSH
DB01615	50	aceprometazine	PA	D011619	Psychotropic Drugs	MeSH
DB01615	50	aceprometazine	PA	D014149	Tranquilizing Agents	MeSH
DB01618	1830	molindone	EPC	N0000180182	Typical Antipsychotic	FDA
DB01618	1830	molindone	PA	D014150	Antipsychotic Agents	MeSH
DB01618	1830	molindone	PA	D002491	Central Nervous System Agents	MeSH
DB01618	1830	molindone	PA	D002492	Central Nervous System Depressants	MeSH
DB01618	1830	molindone	PA	D011619	Psychotropic Drugs	MeSH
DB01618	1830	molindone	PA	D014149	Tranquilizing Agents	MeSH
DB01620	2132	pheniramine	PA	D018926	Anti-Allergic Agents	MeSH
DB01620	2132	pheniramine	PA	D000982	Antipruritics	MeSH
DB01620	2132	pheniramine	PA	D003879	Dermatologic Agents	MeSH
DB01620	2132	pheniramine	PA	D018494	Histamine Agents	MeSH
DB01620	2132	pheniramine	PA	D006633	Histamine Antagonists	MeSH
DB01620	2132	pheniramine	PA	D006634	Histamine H1 Antagonists	MeSH
DB01620	2132	pheniramine	PA	D018377	Neurotransmitter Agents	MeSH
DB01623	2639	thiothixene	EPC	N0000180182	Typical Antipsychotic	FDA
DB01623	2639	thiothixene	PA	D014150	Antipsychotic Agents	MeSH
DB01623	2639	thiothixene	PA	D002491	Central Nervous System Agents	MeSH
DB01623	2639	thiothixene	PA	D002492	Central Nervous System Depressants	MeSH
DB01623	2639	thiothixene	PA	D015259	Dopamine Agents	MeSH
DB01623	2639	thiothixene	PA	D018492	Dopamine Antagonists	MeSH
DB01623	2639	thiothixene	PA	D018377	Neurotransmitter Agents	MeSH
DB01623	2639	thiothixene	PA	D011619	Psychotropic Drugs	MeSH
DB01623	2639	thiothixene	PA	D014149	Tranquilizing Agents	MeSH
DB01624	2877	zuclopenthixol	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB01624	2877	zuclopenthixol	has role	CHEBI:37890	alpha-adrenergic antagonist	CHEBI
DB01624	2877	zuclopenthixol	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB01624	2877	zuclopenthixol	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB01624	2877	zuclopenthixol	has role	CHEBI:65190	first generation antipsychotic	CHEBI
DB01626	2065	pargyline	PA	D000959	Antihypertensive Agents	MeSH
DB01626	2065	pargyline	PA	D002317	Cardiovascular Agents	MeSH
DB01626	2065	pargyline	PA	D004791	Enzyme Inhibitors	MeSH
DB01626	2065	pargyline	PA	D008996	Monoamine Oxidase Inhibitors	MeSH
DB01628	1113	etoricoxib	PA	D000700	Analgesics	MeSH
DB01628	1113	etoricoxib	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB01628	1113	etoricoxib	PA	D000893	Anti-Inflammatory Agents	MeSH
DB01628	1113	etoricoxib	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB01628	1113	etoricoxib	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB01628	1113	etoricoxib	PA	D018501	Antirheumatic Agents	MeSH
DB01628	1113	etoricoxib	PA	D052246	Cyclooxygenase 2 Inhibitors	MeSH
DB01628	1113	etoricoxib	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB01628	1113	etoricoxib	PA	D004791	Enzyme Inhibitors	MeSH
DB01628	1113	etoricoxib	PA	D018689	Sensory System Agents	MeSH
DB01656	3531	roflumilast	EPC	N0000182961	Phosphodiesterase 4 Inhibitor	FDA
DB01656	3531	roflumilast	MoA	N0000182960	Phosphodiesterase 4 Inhibitors	FDA
DB01656	3531	roflumilast	has role	CHEBI:49167	anti-asthmatic drug	CHEBI
DB02266	1193	flufenamic acid	PA	D000893	Anti-Inflammatory Agents	MeSH
DB02266	1193	flufenamic acid	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB02266	1193	flufenamic acid	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB02266	1193	flufenamic acid	has role	CHEBI:35493	antipyretic	CHEBI
DB02300	465	calcipotriene	Chemical/Ingredient	N0000006277	Vitamin D	FDA
DB02300	465	calcipotriene	EPC	N0000175849	Vitamin D Analog	FDA
DB02300	465	calcipotriene	has role	CHEBI:50748	antipsoriatic	CHEBI
DB02300	465	calcipotriene	PA	D003879	Dermatologic Agents	MeSH
DB02351	385	bivalirudin	EPC	N0000175980	Anti-coagulant	FDA
DB02351	385	bivalirudin	EPC	N0000175518	Direct Thrombin Inhibitor	FDA
DB02351	385	bivalirudin	MoA	N0000009963	Thrombin Inhibitors	FDA
DB02351	385	bivalirudin	has role	CHEBI:35232	radiopharmaceutical	CHEBI
DB02351	385	bivalirudin	has role	CHEBI:50249	anticoagulant	CHEBI
DB02351	385	bivalirudin	PA	D000925	Anticoagulants	MeSH
DB02351	385	bivalirudin	PA	D000991	Antithrombins	MeSH
DB02351	385	bivalirudin	PA	D004791	Enzyme Inhibitors	MeSH
DB02351	385	bivalirudin	PA	D006401	Hematologic Agents	MeSH
DB02351	385	bivalirudin	PA	D011480	Protease Inhibitors	MeSH
DB02351	385	bivalirudin	PA	D015842	Serine Proteinase Inhibitors	MeSH
DB02383	2704	tolrestat	PA	D004791	Enzyme Inhibitors	MeSH
DB02546	4124	vorinostat	EPC	N0000175588	Histone Deacetylase Inhibitor	FDA
DB02546	4124	vorinostat	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB02546	4124	vorinostat	PA	D000970	Antineoplastic Agents	MeSH
DB02546	4124	vorinostat	PA	D004791	Enzyme Inhibitors	MeSH
DB02546	4124	vorinostat	PA	D056572	Histone Deacetylase Inhibitors	MeSH
DB02600	2001	oseltamivir	EPC	N0000175524	Neuraminidase Inhibitor	FDA
DB02600	2001	oseltamivir	MoA	N0000175436	Neuraminidase Inhibitors	FDA
DB02600	2001	oseltamivir	PA	D000890	Anti-Infective Agents	MeSH
DB02600	2001	oseltamivir	has role	CHEBI:50266	prodrug	CHEBI
DB02600	2001	oseltamivir	has role	CHEBI:52425	EC 3.2.1.18 (exo-alpha-sialidase) inhibitor	CHEBI
DB02600	2001	oseltamivir	has role	CHEBI:36044	antiviral drug	CHEBI
DB02600	2001	oseltamivir	PA	D000998	Antiviral Agents	MeSH
DB02600	2001	oseltamivir	PA	D004791	Enzyme Inhibitors	MeSH
DB02631	4893	tipiracil	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB02631	4893	tipiracil	EPC	N0000191870	Thymidine Phosphorylase Inhibitor	FDA
DB02631	4893	tipiracil	MoA	N0000191869	Thymidine Phosphorylase Inhibitors	FDA
DB02925	2201	piretanide	PA	D004232	Diuretics	MeSH
DB02925	2201	piretanide	PA	D049990	Membrane Transport Modulators	MeSH
DB02925	2201	piretanide	PA	D045283	Natriuretic Agents	MeSH
DB02925	2201	piretanide	PA	D049994	Sodium Potassium Chloride Symporter Inhibitors	MeSH
DB03128	65	acetylcholine	EPC	N0000175884	Cholinergic Receptor Agonist	FDA
DB03128	65	acetylcholine	has role	CHEBI:35620	vasodilator agent	CHEBI
DB03128	65	acetylcholine	has role	CHEBI:38325	muscarinic agonist	CHEBI
DB03128	65	acetylcholine	PA	D002317	Cardiovascular Agents	MeSH
DB03128	65	acetylcholine	PA	D018678	Cholinergic Agents	MeSH
DB03128	65	acetylcholine	PA	D018679	Cholinergic Agonists	MeSH
DB03128	65	acetylcholine	PA	D018377	Neurotransmitter Agents	MeSH
DB03128	65	acetylcholine	PA	D014665	Vasodilator Agents	MeSH
DB03496	1174	alvocidib	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB03496	1174	alvocidib	has role	CHEBI:35842	antirheumatic drug	CHEBI
DB03496	1174	alvocidib	PA	D000970	Antineoplastic Agents	MeSH
DB03496	1174	alvocidib	PA	D004791	Enzyme Inhibitors	MeSH
DB03496	1174	alvocidib	PA	D006131	Growth Inhibitors	MeSH
DB03496	1174	alvocidib	PA	D006133	Growth Substances	MeSH
DB03496	1174	alvocidib	PA	D047428	Protein Kinase Inhibitors	MeSH
DB03585	2036	oxyphenbutazone	PA	D000700	Analgesics	MeSH
DB03585	2036	oxyphenbutazone	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB03585	2036	oxyphenbutazone	PA	D000893	Anti-Inflammatory Agents	MeSH
DB03585	2036	oxyphenbutazone	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB03585	2036	oxyphenbutazone	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB03585	2036	oxyphenbutazone	has role	CHEBI:35493	antipyretic	CHEBI
DB03585	2036	oxyphenbutazone	has role	CHEBI:35845	gout suppressant	CHEBI
DB03585	2036	oxyphenbutazone	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB03585	2036	oxyphenbutazone	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB03585	2036	oxyphenbutazone	PA	D018501	Antirheumatic Agents	MeSH
DB03585	2036	oxyphenbutazone	PA	D018689	Sensory System Agents	MeSH
DB03655	4823	peramivir	EPC	N0000175524	Neuraminidase Inhibitor	FDA
DB03655	4823	peramivir	MoA	N0000175436	Neuraminidase Inhibitors	FDA
DB03655	4823	peramivir	PA	D000890	Anti-Infective Agents	MeSH
DB03655	4823	peramivir	has role	CHEBI:52425	EC 3.2.1.18 (exo-alpha-sialidase) inhibitor	CHEBI
DB03655	4823	peramivir	has role	CHEBI:36044	antiviral drug	CHEBI
DB03655	4823	peramivir	PA	D000998	Antiviral Agents	MeSH
DB03655	4823	peramivir	PA	D004791	Enzyme Inhibitors	MeSH
DB06614	4823	peramivir	EPC	N0000175524	Neuraminidase Inhibitor	FDA
DB06614	4823	peramivir	MoA	N0000175436	Neuraminidase Inhibitors	FDA
DB06614	4823	peramivir	PA	D000890	Anti-Infective Agents	MeSH
DB06614	4823	peramivir	has role	CHEBI:52425	EC 3.2.1.18 (exo-alpha-sialidase) inhibitor	CHEBI
DB06614	4823	peramivir	has role	CHEBI:36044	antiviral drug	CHEBI
DB06614	4823	peramivir	PA	D000998	Antiviral Agents	MeSH
DB06614	4823	peramivir	PA	D004791	Enzyme Inhibitors	MeSH
DB03856	990	eflornithine	EPC	N0000175485	Antiprotozoal	FDA
DB03856	990	eflornithine	EPC	N0000175845	Decarboxylase Inhibitor	FDA
DB03856	990	eflornithine	MoA	N0000175844	Decarboxylase Inhibitors	FDA
DB03856	990	eflornithine	PA	D000890	Anti-Infective Agents	MeSH
DB03856	990	eflornithine	PA	D000970	Antineoplastic Agents	MeSH
DB03856	990	eflornithine	PA	D000977	Antiparasitic Agents	MeSH
DB03856	990	eflornithine	PA	D000981	Antiprotozoal Agents	MeSH
DB03856	990	eflornithine	PA	D004791	Enzyme Inhibitors	MeSH
DB03856	990	eflornithine	PA	D065108	Ornithine Decarboxylase Inhibitors	MeSH
DB03856	990	eflornithine	PA	D014344	Trypanocidal Agents	MeSH
DB04342	1851	latamoxef	PA	D000900	Anti-Bacterial Agents	MeSH
DB04342	1851	latamoxef	PA	D000890	Anti-Infective Agents	MeSH
DB04342	1851	latamoxef	has role	CHEBI:36047	antibacterial drug	CHEBI
DB04570	1851	latamoxef	PA	D000900	Anti-Bacterial Agents	MeSH
DB04570	1851	latamoxef	PA	D000890	Anti-Infective Agents	MeSH
DB04570	1851	latamoxef	has role	CHEBI:36047	antibacterial drug	CHEBI
DB04441	1189	fludarabine phosphate	MoA	N0000000233	Nucleic Acid Synthesis Inhibitors	FDA
DB04441	1189	fludarabine phosphate	EPC	N0000175595	Nucleoside Metabolic Inhibitor	FDA
DB04441	1189	fludarabine phosphate	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB04441	1189	fludarabine phosphate	has role	CHEBI:35705	immunosuppressive agent	CHEBI
DB04441	1189	fludarabine phosphate	has role	CHEBI:50266	prodrug	CHEBI
DB04441	1189	fludarabine phosphate	PA	D000963	Antimetabolites	MeSH
DB04441	1189	fludarabine phosphate	PA	D000964	Antimetabolites, Antineoplastic	MeSH
DB04441	1189	fludarabine phosphate	PA	D000970	Antineoplastic Agents	MeSH
DB04441	1189	fludarabine phosphate	PA	D007155	Immunologic Factors	MeSH
DB04441	1189	fludarabine phosphate	PA	D007166	Immunosuppressive Agents	MeSH
DB04441	1189	fludarabine phosphate	PA	D009676	Noxae	MeSH
DB04575	2342	quinestrol	PA	D004967	Estrogens	MeSH
DB04575	2342	quinestrol	PA	D006728	Hormones	MeSH
DB04817	4659	metamizole	PA	D000700	Analgesics	MeSH
DB04817	4659	metamizole	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB04817	4659	metamizole	PA	D000893	Anti-Inflammatory Agents	MeSH
DB04817	4659	metamizole	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB04817	4659	metamizole	has role	CHEBI:50266	prodrug	CHEBI
DB04817	4659	metamizole	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB04817	4659	metamizole	has role	CHEBI:35842	antirheumatic drug	CHEBI
DB04817	4659	metamizole	has role	CHEBI:49110	peripheral nervous system drug	CHEBI
DB04817	4659	metamizole	has role	CHEBI:35493	antipyretic	CHEBI
DB04817	4659	metamizole	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB04817	4659	metamizole	PA	D058633	Antipyretics	MeSH
DB04817	4659	metamizole	PA	D018501	Antirheumatic Agents	MeSH
DB04817	4659	metamizole	PA	D018689	Sensory System Agents	MeSH
DB04818	1480	iproniazid	PA	D000928	Antidepressive Agents	MeSH
DB04818	1480	iproniazid	PA	D002491	Central Nervous System Agents	MeSH
DB04818	1480	iproniazid	PA	D004791	Enzyme Inhibitors	MeSH
DB04818	1480	iproniazid	PA	D008996	Monoamine Oxidase Inhibitors	MeSH
DB04818	1480	iproniazid	PA	D011619	Psychotropic Drugs	MeSH
DB04821	1958	nomifensine	has role	CHEBI:51039	dopamine uptake inhibitor	CHEBI
DB04821	1958	nomifensine	PA	D015259	Dopamine Agents	MeSH
DB04821	1958	nomifensine	PA	D018765	Dopamine Uptake Inhibitors	MeSH
DB04821	1958	nomifensine	PA	D049990	Membrane Transport Modulators	MeSH
DB04821	1958	nomifensine	PA	D018377	Neurotransmitter Agents	MeSH
DB04821	1958	nomifensine	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB04834	3520	rapacuronium	PA	D009465	Neuromuscular Agents	MeSH
DB04834	3520	rapacuronium	PA	D009466	Neuromuscular Blocking Agents	MeSH
DB04834	3520	rapacuronium	PA	D003473	Neuromuscular Nondepolarizing Agents	MeSH
DB04835	1635	maraviroc	EPC	N0000175572	CCR5 Co-receptor Antagonist	FDA
DB04835	1635	maraviroc	MoA	N0000175445	Chemokine Co-receptor 5 Antagonists	FDA
DB04835	1635	maraviroc	PA	D019380	Anti-HIV Agents	MeSH
DB04835	1635	maraviroc	PA	D000890	Anti-Infective Agents	MeSH
DB04835	1635	maraviroc	has role	CHEBI:36044	antiviral drug	CHEBI
DB04835	1635	maraviroc	has role	CHEBI:59886	HIV fusion inhibitor	CHEBI
DB04835	1635	maraviroc	PA	D000998	Antiviral Agents	MeSH
DB04835	1635	maraviroc	PA	D065100	CCR5 Receptor Antagonists	MeSH
DB04839	766	cyproterone acetate	PA	D000726	Androgen Antagonists	MeSH
DB04839	766	cyproterone acetate	has role	CHEBI:35497	androgen antagonist	CHEBI
DB04839	766	cyproterone acetate	PA	D000970	Antineoplastic Agents	MeSH
DB04839	766	cyproterone acetate	PA	D003270	Contraceptive Agents	MeSH
DB04839	766	cyproterone acetate	PA	D003272	Contraceptive Agents, Male	MeSH
DB04839	766	cyproterone acetate	PA	D006727	Hormone Antagonists	MeSH
DB04839	766	cyproterone acetate	PA	D012102	Reproductive Control Agents	MeSH
DB04841	1200	flunarizine	PA	D000927	Anticonvulsants	MeSH
DB04841	1200	flunarizine	PA	D002121	Calcium Channel Blockers	MeSH
DB04841	1200	flunarizine	PA	D002317	Cardiovascular Agents	MeSH
DB04841	1200	flunarizine	PA	D002491	Central Nervous System Agents	MeSH
DB04841	1200	flunarizine	PA	D018494	Histamine Agents	MeSH
DB04841	1200	flunarizine	PA	D006633	Histamine Antagonists	MeSH
DB04841	1200	flunarizine	PA	D006634	Histamine H1 Antagonists	MeSH
DB04841	1200	flunarizine	PA	D049990	Membrane Transport Modulators	MeSH
DB04841	1200	flunarizine	PA	D018377	Neurotransmitter Agents	MeSH
DB04841	1200	flunarizine	PA	D014665	Vasodilator Agents	MeSH
DB04843	1689	mepenzolate	EPC	N0000175574	Anticholinergic	FDA
DB04843	1689	mepenzolate	MoA	N0000175370	Cholinergic Antagonists	FDA
DB04844	2609	tetrabenazine	EPC	N0000190856	Vesicular Monoamine Transporter 2 Inhibitor	FDA
DB04844	2609	tetrabenazine	MoA	N0000190855	Vesicular Monoamine Transporter 2 Inhibitors	FDA
DB04844	2609	tetrabenazine	PA	D018663	Adrenergic Agents	MeSH
DB04844	2609	tetrabenazine	PA	D018759	Adrenergic Uptake Inhibitors	MeSH
DB04844	2609	tetrabenazine	has role	CHEBI:35476	antipsychotic agent	CHEBI
DB04844	2609	tetrabenazine	has role	CHEBI:35640	adrenergic uptake inhibitor	CHEBI
DB04844	2609	tetrabenazine	PA	D049990	Membrane Transport Modulators	MeSH
DB04844	2609	tetrabenazine	PA	D018377	Neurotransmitter Agents	MeSH
DB04844	2609	tetrabenazine	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB04845	1517	ixabepilone	PE	N0000175085	Microtubule Inhibition	FDA
DB04845	1517	ixabepilone	EPC	N0000175592	Microtubule Inhibitor	FDA
DB04845	1517	ixabepilone	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB04855	4112	dronedarone	EPC	N0000175426	Antiarrhythmic	FDA
DB04855	4112	dronedarone	has role	CHEBI:38070	anti-arrhythmia drug	CHEBI
DB04861	1887	nebivolol	PA	D018663	Adrenergic Agents	MeSH
DB04861	1887	nebivolol	PA	D000322	Adrenergic Agonists	MeSH
DB04861	1887	nebivolol	PA	D058665	Adrenergic beta-1 Receptor Agonists	MeSH
DB04861	1887	nebivolol	PA	D000318	Adrenergic beta-Agonists	MeSH
DB04861	1887	nebivolol	has role	CHEBI:35530	beta-adrenergic antagonist	CHEBI
DB04861	1887	nebivolol	has role	CHEBI:35620	vasodilator agent	CHEBI
DB04861	1887	nebivolol	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB04861	1887	nebivolol	PA	D000959	Antihypertensive Agents	MeSH
DB04861	1887	nebivolol	PA	D002317	Cardiovascular Agents	MeSH
DB04861	1887	nebivolol	PA	D018377	Neurotransmitter Agents	MeSH
DB04861	1887	nebivolol	PA	D014665	Vasodilator Agents	MeSH
DB04868	1932	nilotinib	EPC	N0000175605	Kinase Inhibitor	FDA
DB04868	1932	nilotinib	MoA	N0000175076	Protein Kinase Inhibitors	FDA
DB04868	1932	nilotinib	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB04876	3642	vildagliptin	PA	D054873	Dipeptidyl-Peptidase IV Inhibitors	MeSH
DB04876	3642	vildagliptin	PA	D004791	Enzyme Inhibitors	MeSH
DB04876	3642	vildagliptin	PA	D007004	Hypoglycemic Agents	MeSH
DB04876	3642	vildagliptin	PA	D011480	Protease Inhibitors	MeSH
DB04878	2845	voglibose	PA	D004791	Enzyme Inhibitors	MeSH
DB04878	2845	voglibose	PA	D065089	Glycoside Hydrolase Inhibitors	MeSH
DB04878	2845	voglibose	PA	D007004	Hypoglycemic Agents	MeSH
DB04890	341	bepotastine	EPC	N0000175587	Histamine-1 Receptor Antagonist	FDA
DB04890	341	bepotastine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB04890	341	bepotastine	has role	CHEBI:50857	anti-allergic agent	CHEBI
DB04896	1808	milnacipran	MoA	N0000000102	Norepinephrine Uptake Inhibitors	FDA
DB04896	1808	milnacipran	EPC	N0000175749	Serotonin and Norepinephrine Reuptake Inhibitor	FDA
DB04896	1808	milnacipran	PA	D018663	Adrenergic Agents	MeSH
DB04896	1808	milnacipran	PA	D018759	Adrenergic Uptake Inhibitors	MeSH
DB04896	1808	milnacipran	PA	D000928	Antidepressive Agents	MeSH
DB04896	1808	milnacipran	PA	D002491	Central Nervous System Agents	MeSH
DB04896	1808	milnacipran	PA	D049990	Membrane Transport Modulators	MeSH
DB04896	1808	milnacipran	PA	D018377	Neurotransmitter Agents	MeSH
DB04896	1808	milnacipran	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB04896	1808	milnacipran	PA	D011619	Psychotropic Drugs	MeSH
DB04896	1808	milnacipran	PA	D018490	Serotonin Agents	MeSH
DB04896	1808	milnacipran	PA	D017367	Serotonin Uptake Inhibitors	MeSH
DB08918	1808	milnacipran	MoA	N0000000102	Norepinephrine Uptake Inhibitors	FDA
DB08918	1808	milnacipran	EPC	N0000175749	Serotonin and Norepinephrine Reuptake Inhibitor	FDA
DB08918	1808	milnacipran	PA	D018663	Adrenergic Agents	MeSH
DB08918	1808	milnacipran	PA	D018759	Adrenergic Uptake Inhibitors	MeSH
DB08918	1808	milnacipran	PA	D000928	Antidepressive Agents	MeSH
DB08918	1808	milnacipran	PA	D002491	Central Nervous System Agents	MeSH
DB08918	1808	milnacipran	PA	D049990	Membrane Transport Modulators	MeSH
DB08918	1808	milnacipran	PA	D018377	Neurotransmitter Agents	MeSH
DB08918	1808	milnacipran	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB08918	1808	milnacipran	PA	D011619	Psychotropic Drugs	MeSH
DB08918	1808	milnacipran	PA	D018490	Serotonin Agents	MeSH
DB08918	1808	milnacipran	PA	D017367	Serotonin Uptake Inhibitors	MeSH
DB04896	4864	levomilnacipran	MoA	N0000000109	Serotonin Uptake Inhibitors	FDA
DB08918	4864	levomilnacipran	MoA	N0000000109	Serotonin Uptake Inhibitors	FDA
DB04908	5022	flibanserin	MoA	N0000185503	P-Glycoprotein Inhibitors	FDA
DB04908	5022	flibanserin	has role	CHEBI:35941	serotonergic agonist	CHEBI
DB04908	5022	flibanserin	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB04908	5022	flibanserin	has role	CHEBI:35469	antidepressant	CHEBI
DB04920	674	clevidipine	MoA	N0000000069	Calcium Channel Antagonists	FDA
DB04920	674	clevidipine	EPC	N0000175421	Dihydropyridine Calcium Channel Blocker	FDA
DB04920	674	clevidipine	Chemical/Ingredient	N0000007556	Dihydropyridines	FDA
DB04920	674	clevidipine	PA	D002121	Calcium Channel Blockers	MeSH
DB04920	674	clevidipine	PA	D002317	Cardiovascular Agents	MeSH
DB04920	674	clevidipine	PA	D049990	Membrane Transport Modulators	MeSH
DB04930	4152	permethrin	Chemical/Ingredient	N0000006014	Pyrethrins	FDA
DB04930	4152	permethrin	EPC	N0000175847	Pyrethroid	FDA
DB04930	4152	permethrin	has role	CHEBI:73333	scabicide	CHEBI
DB04930	4152	permethrin	has role	CHEBI:39116	pyrethroid ester insecticide	CHEBI
DB04930	4152	permethrin	has role	CHEBI:33286	agrochemical	CHEBI
DB04930	4152	permethrin	has role	CHEBI:38956	ectoparasiticide	CHEBI
DB04930	4152	permethrin	PA	D004791	Enzyme Inhibitors	MeSH
DB04930	4152	permethrin	PA	D007306	Insecticides	MeSH
DB04930	4152	permethrin	PA	D010575	Pesticides	MeSH
DB04938	4749	ospemifene	has role	CHEBI:50739	estrogen receptor modulator	CHEBI
DB04938	4749	ospemifene	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB04938	4749	ospemifene	has role	CHEBI:67079	anti-inflammatory agent	CHEBI
DB04938	4749	ospemifene	EPC	N0000175826	Estrogen Agonist/Antagonist	FDA
DB04938	4749	ospemifene	MoA	N0000000168	Selective Estrogen Receptor Modulators	FDA
DB04946	3294	iloperidone	EPC	N0000175430	Atypical Antipsychotic	FDA
DB04946	3294	iloperidone	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB04946	3294	iloperidone	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB04946	3294	iloperidone	has role	CHEBI:65191	second generation antipsychotic	CHEBI
DB04948	1593	lofexidine	PA	D018663	Adrenergic Agents	MeSH
DB04948	1593	lofexidine	PA	D000322	Adrenergic Agonists	MeSH
DB04948	1593	lofexidine	PA	D058647	Adrenergic alpha-2 Receptor Agonists	MeSH
DB04948	1593	lofexidine	PA	D000316	Adrenergic alpha-Agonists	MeSH
DB04948	1593	lofexidine	has role	CHEBI:35569	alpha-adrenergic agonist	CHEBI
DB04948	1593	lofexidine	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB04948	1593	lofexidine	PA	D000959	Antihypertensive Agents	MeSH
DB04948	1593	lofexidine	PA	D002317	Cardiovascular Agents	MeSH
DB04948	1593	lofexidine	PA	D002491	Central Nervous System Agents	MeSH
DB04948	1593	lofexidine	PA	D009292	Narcotic Antagonists	MeSH
DB04948	1593	lofexidine	PA	D018377	Neurotransmitter Agents	MeSH
DB04948	1593	lofexidine	PA	D018689	Sensory System Agents	MeSH
DB04953	4181	retigabine	MoA	N0000182728	Potassium Channel Openers	FDA
DB04953	4181	retigabine	EPC	N0000182729	Potassium Channel Opener	FDA
DB04953	4181	retigabine	has role	CHEBI:35623	anticonvulsant	CHEBI
DB04953	4181	retigabine	PA	D000927	Anticonvulsants	MeSH
DB04953	4181	retigabine	PA	D002491	Central Nervous System Agents	MeSH
DB04953	4181	retigabine	PA	D049990	Membrane Transport Modulators	MeSH
DB05013	4226	ingenol mebutate	EPC	N0000184015	Cell Death Inducer	FDA
DB05013	4226	ingenol mebutate	PE	N0000009176	Increased Cellular Death	FDA
DB05013	4226	ingenol mebutate	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB05039	4183	indacaterol	has role	CHEBI:35522	beta-adrenergic agonist	CHEBI
DB05039	4183	indacaterol	has role	CHEBI:35523	bronchodilator agent	CHEBI
DB05039	4183	indacaterol	MoA	N0000009922	Adrenergic beta2-Agonists	FDA
DB05039	4183	indacaterol	EPC	N0000175779	beta2-Adrenergic Agonist	FDA
DB05083	4174	rilpivirine	EPC	N0000175463	Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor	FDA
DB05083	4174	rilpivirine	MoA	N0000009948	Non-Nucleoside Reverse Transcriptase Inhibitors	FDA
DB05083	4174	rilpivirine	Chemical/Ingredient	N0000175460	Non-Nucleoside Analog	FDA
DB05083	4174	rilpivirine	PA	D019380	Anti-HIV Agents	MeSH
DB05083	4174	rilpivirine	PA	D000890	Anti-Infective Agents	MeSH
DB05083	4174	rilpivirine	PA	D000998	Antiviral Agents	MeSH
DB05083	4174	rilpivirine	PA	D004791	Enzyme Inhibitors	MeSH
DB05083	4174	rilpivirine	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB05083	4174	rilpivirine	PA	D018894	Reverse Transcriptase Inhibitors	MeSH
DB08592	4174	rilpivirine	EPC	N0000175463	Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor	FDA
DB08592	4174	rilpivirine	MoA	N0000009948	Non-Nucleoside Reverse Transcriptase Inhibitors	FDA
DB08592	4174	rilpivirine	Chemical/Ingredient	N0000175460	Non-Nucleoside Analog	FDA
DB08592	4174	rilpivirine	PA	D019380	Anti-HIV Agents	MeSH
DB08592	4174	rilpivirine	PA	D000890	Anti-Infective Agents	MeSH
DB08592	4174	rilpivirine	PA	D000998	Antiviral Agents	MeSH
DB08592	4174	rilpivirine	PA	D004791	Enzyme Inhibitors	MeSH
DB08592	4174	rilpivirine	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB08592	4174	rilpivirine	PA	D018894	Reverse Transcriptase Inhibitors	MeSH
DB08864	4174	rilpivirine	EPC	N0000175463	Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor	FDA
DB08864	4174	rilpivirine	MoA	N0000009948	Non-Nucleoside Reverse Transcriptase Inhibitors	FDA
DB08864	4174	rilpivirine	Chemical/Ingredient	N0000175460	Non-Nucleoside Analog	FDA
DB08864	4174	rilpivirine	PA	D019380	Anti-HIV Agents	MeSH
DB08864	4174	rilpivirine	PA	D000890	Anti-Infective Agents	MeSH
DB08864	4174	rilpivirine	PA	D000998	Antiviral Agents	MeSH
DB08864	4174	rilpivirine	PA	D004791	Enzyme Inhibitors	MeSH
DB08864	4174	rilpivirine	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB08864	4174	rilpivirine	PA	D018894	Reverse Transcriptase Inhibitors	MeSH
DB05229	343	beraprost	PA	D002317	Cardiovascular Agents	MeSH
DB05229	343	beraprost	PA	D006401	Hematologic Agents	MeSH
DB05229	343	beraprost	PA	D010975	Platelet Aggregation Inhibitors	MeSH
DB05229	343	beraprost	PA	D014665	Vasodilator Agents	MeSH
DB05246	1758	methsuximide	EPC	N0000175753	Anti-epileptic Agent	FDA
DB05246	1758	methsuximide	PE	N0000008486	Decreased Central Nervous System Disorganized Electrical Activity	FDA
DB05246	1758	methsuximide	PA	D000927	Anticonvulsants	MeSH
DB05246	1758	methsuximide	PA	D002491	Central Nervous System Agents	MeSH
DB05286	4167	fingolimod	MoA	N0000181815	Sphingosine 1-Phosphate Receptor Modulators	FDA
DB05286	4167	fingolimod	EPC	N0000181816	Sphingosine 1-phosphate Receptor Modulator	FDA
DB05286	4167	fingolimod	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB05286	4167	fingolimod	has role	CHEBI:35705	immunosuppressive agent	CHEBI
DB05286	4167	fingolimod	has role	CHEBI:50266	prodrug	CHEBI
DB05286	4167	fingolimod	PA	D007155	Immunologic Factors	MeSH
DB05286	4167	fingolimod	PA	D007166	Immunosuppressive Agents	MeSH
DB08868	4167	fingolimod	MoA	N0000181815	Sphingosine 1-Phosphate Receptor Modulators	FDA
DB08868	4167	fingolimod	EPC	N0000181816	Sphingosine 1-phosphate Receptor Modulator	FDA
DB08868	4167	fingolimod	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB08868	4167	fingolimod	has role	CHEBI:35705	immunosuppressive agent	CHEBI
DB08868	4167	fingolimod	has role	CHEBI:50266	prodrug	CHEBI
DB08868	4167	fingolimod	PA	D007155	Immunologic Factors	MeSH
DB08868	4167	fingolimod	PA	D007166	Immunosuppressive Agents	MeSH
DB05294	4178	vandetanib	EPC	N0000175605	Kinase Inhibitor	FDA
DB05294	4178	vandetanib	MoA	N0000175076	Protein Kinase Inhibitors	FDA
DB05294	4178	vandetanib	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB08764	4178	vandetanib	EPC	N0000175605	Kinase Inhibitor	FDA
DB08764	4178	vandetanib	MoA	N0000175076	Protein Kinase Inhibitors	FDA
DB08764	4178	vandetanib	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB05318	3064	capsaicin	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB05318	3064	capsaicin	PA	D000982	Antipruritics	MeSH
DB05318	3064	capsaicin	PA	D003879	Dermatologic Agents	MeSH
DB05318	3064	capsaicin	PA	D018689	Sensory System Agents	MeSH
DB05366	4166	ulipristal	EPC	N0000191263	Progesterone Agonist/Antagonist	FDA
DB05366	4166	ulipristal	MoA	N0000191262	Selective Progesterone Receptor Modulators	FDA
DB05366	4166	ulipristal	has role	CHEBI:49323	contraceptive drug	CHEBI
DB05366	4166	ulipristal	has role	CHEBI:71027	progesterone receptor modulator	CHEBI
DB05521	4173	telaprevir	MoA	N0000182638	HCV NS3/4A Protease Inhibitors	FDA
DB05521	4173	telaprevir	EPC	N0000182639	Hepatitis C Virus NS3/4A Protease Inhibitor	FDA
DB05521	4173	telaprevir	MoA	N0000190114	Cytochrome P450 3A Inhibitors	FDA
DB05521	4173	telaprevir	MoA	N0000185503	P-Glycoprotein Inhibitors	FDA
DB05521	4173	telaprevir	MoA	N0000190107	Organic Anion Transporting Polypeptide 1B1 Inhibitors	FDA
DB05521	4173	telaprevir	MoA	N0000190109	Organic Anion Transporting Polypeptide 2B1 Inhibitors	FDA
DB05521	4173	telaprevir	has role	CHEBI:36044	antiviral drug	CHEBI
DB05665	4172	boceprevir	MoA	N0000182638	HCV NS3/4A Protease Inhibitors	FDA
DB05665	4172	boceprevir	EPC	N0000182639	Hepatitis C Virus NS3/4A Protease Inhibitor	FDA
DB05665	4172	boceprevir	MoA	N0000182141	Cytochrome P450 3A4 Inhibitors	FDA
DB05665	4172	boceprevir	MoA	N0000190115	Cytochrome P450 3A5 Inhibitors	FDA
DB05665	4172	boceprevir	has role	CHEBI:36044	antiviral drug	CHEBI
DB08873	4172	boceprevir	MoA	N0000182638	HCV NS3/4A Protease Inhibitors	FDA
DB08873	4172	boceprevir	EPC	N0000182639	Hepatitis C Virus NS3/4A Protease Inhibitor	FDA
DB08873	4172	boceprevir	MoA	N0000182141	Cytochrome P450 3A4 Inhibitors	FDA
DB08873	4172	boceprevir	MoA	N0000190115	Cytochrome P450 3A5 Inhibitors	FDA
DB08873	4172	boceprevir	has role	CHEBI:36044	antiviral drug	CHEBI
DB05812	4176	abiraterone acetate	has role	CHEBI:50266	prodrug	CHEBI
DB05812	4176	abiraterone acetate	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB05812	4176	abiraterone acetate	PA	D000970	Antineoplastic Agents	MeSH
DB05812	4176	abiraterone acetate	PA	D065607	Cytochrome P-450 Enzyme Inhibitors	MeSH
DB05812	4176	abiraterone acetate	PA	D004791	Enzyme Inhibitors	MeSH
DB05812	4176	abiraterone acetate	PA	D006727	Hormone Antagonists	MeSH
DB05812	4176	abiraterone acetate	PA	D065088	Steroid Synthesis Inhibitors	MeSH
DB06144	2435	sertindole	has role	CHEBI:65191	second generation antipsychotic	CHEBI
DB06144	2435	sertindole	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB06144	2435	sertindole	has role	CHEBI:37890	alpha-adrenergic antagonist	CHEBI
DB06144	2435	sertindole	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB06144	2435	sertindole	PA	D014150	Antipsychotic Agents	MeSH
DB06144	2435	sertindole	PA	D002491	Central Nervous System Agents	MeSH
DB06144	2435	sertindole	PA	D002492	Central Nervous System Depressants	MeSH
DB06144	2435	sertindole	PA	D011619	Psychotropic Drugs	MeSH
DB06144	2435	sertindole	PA	D014149	Tranquilizing Agents	MeSH
DB06147	2527	sulfathiazole	PA	D000890	Anti-Infective Agents	MeSH
DB06147	2527	sulfathiazole	has role	CHEBI:35441	antiinfective agent	CHEBI
DB06148	1796	mianserin	PA	D018663	Adrenergic Agents	MeSH
DB06148	1796	mianserin	PA	D000317	Adrenergic alpha-Antagonists	MeSH
DB06148	1796	mianserin	PA	D018674	Adrenergic Antagonists	MeSH
DB06148	1796	mianserin	has role	CHEBI:35469	antidepressant	CHEBI
DB06148	1796	mianserin	has role	CHEBI:35717	sedative	CHEBI
DB06148	1796	mianserin	has role	CHEBI:37890	alpha-adrenergic antagonist	CHEBI
DB06148	1796	mianserin	has role	CHEBI:35640	adrenergic uptake inhibitor	CHEBI
DB06148	1796	mianserin	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB06148	1796	mianserin	has role	CHEBI:35678	histamine agonist	CHEBI
DB06148	1796	mianserin	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB06148	1796	mianserin	PA	D000928	Antidepressive Agents	MeSH
DB06148	1796	mianserin	PA	D018687	Antidepressive Agents, Second-Generation	MeSH
DB06148	1796	mianserin	PA	D002491	Central Nervous System Agents	MeSH
DB06148	1796	mianserin	PA	D018494	Histamine Agents	MeSH
DB06148	1796	mianserin	PA	D006633	Histamine Antagonists	MeSH
DB06148	1796	mianserin	PA	D006634	Histamine H1 Antagonists	MeSH
DB06148	1796	mianserin	PA	D018377	Neurotransmitter Agents	MeSH
DB06148	1796	mianserin	PA	D011619	Psychotropic Drugs	MeSH
DB06148	1796	mianserin	PA	D018490	Serotonin Agents	MeSH
DB06148	1796	mianserin	PA	D012702	Serotonin Antagonists	MeSH
DB06155	4150	rimonabant	PA	D063387	Cannabinoid Receptor Antagonists	MeSH
DB06155	4150	rimonabant	PA	D063385	Cannabinoid Receptor Modulators	MeSH
DB06155	4150	rimonabant	PA	D006728	Hormones	MeSH
DB06155	4150	rimonabant	PA	D018377	Neurotransmitter Agents	MeSH
DB06196	4186	icatibant	EPC	N0000182965	Bradykinin B2 Receptor Antagonist	FDA
DB06196	4186	icatibant	PA	D000700	Analgesics	MeSH
DB06196	4186	icatibant	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB06196	4186	icatibant	PA	D000893	Anti-Inflammatory Agents	MeSH
DB06196	4186	icatibant	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB06196	4186	icatibant	has role	CHEBI:35530	beta-adrenergic antagonist	CHEBI
DB06196	4186	icatibant	PA	D018501	Antirheumatic Agents	MeSH
DB06196	4186	icatibant	PA	D065094	Bradykinin B2 Receptor Antagonists	MeSH
DB06196	4186	icatibant	PA	D065168	Bradykinin Receptor Antagonists	MeSH
DB06196	4186	icatibant	PA	D051056	Complement Inactivating Agents	MeSH
DB06196	4186	icatibant	PA	D007155	Immunologic Factors	MeSH
DB06196	4186	icatibant	PA	D007166	Immunosuppressive Agents	MeSH
DB06196	4186	icatibant	PA	D018689	Sensory System Agents	MeSH
DB06203	4340	alogliptin	has role	CHEBI:35526	hypoglycemic agent	CHEBI
DB06203	4340	alogliptin	PA	D054873	Dipeptidyl-Peptidase IV Inhibitors	MeSH
DB06203	4340	alogliptin	PA	D004791	Enzyme Inhibitors	MeSH
DB06203	4340	alogliptin	PA	D006728	Hormones	MeSH
DB06203	4340	alogliptin	PA	D007004	Hypoglycemic Agents	MeSH
DB06203	4340	alogliptin	PA	D054795	Incretins	MeSH
DB06203	4340	alogliptin	PA	D011480	Protease Inhibitors	MeSH
DB06203	4340	alogliptin	MoA	N0000175912	Dipeptidyl Peptidase 4 Inhibitors	FDA
DB06203	4340	alogliptin	EPC	N0000175913	Dipeptidyl Peptidase 4 Inhibitor	FDA
DB06204	4283	tapentadol	EPC	N0000175690	Opioid Agonist	FDA
DB06204	4283	tapentadol	MoA	N0000000174	Opioid Agonists	FDA
DB06207	4151	silodosin	EPC	N0000175553	alpha-Adrenergic Blocker	FDA
DB06207	4151	silodosin	PA	D018663	Adrenergic Agents	MeSH
DB06207	4151	silodosin	PA	D058668	Adrenergic alpha-1 Receptor Antagonists	MeSH
DB06207	4151	silodosin	PA	D000317	Adrenergic alpha-Antagonists	MeSH
DB06207	4151	silodosin	PA	D018674	Adrenergic Antagonists	MeSH
DB06207	4151	silodosin	PA	D018377	Neurotransmitter Agents	MeSH
DB06207	4151	silodosin	PA	D064804	Urological Agents	MeSH
DB06209	4113	prasugrel	PE	N0000008832	Decreased Platelet Aggregation	FDA
DB06209	4113	prasugrel	EPC	N0000182142	P2Y12 Platelet Inhibitor	FDA
DB06209	4113	prasugrel	MoA	N0000182143	P2Y12 Receptor Antagonists	FDA
DB06209	4113	prasugrel	has role	CHEBI:50433	platelet glycoprotein-IIb/IIIa receptor antagonist	CHEBI
DB06209	4113	prasugrel	has role	CHEBI:35554	cardiovascular drug	CHEBI
DB06209	4113	prasugrel	has role	CHEBI:50266	prodrug	CHEBI
DB06209	4113	prasugrel	PA	D006401	Hematologic Agents	MeSH
DB06209	4113	prasugrel	PA	D010975	Platelet Aggregation Inhibitors	MeSH
DB06210	4399	eltrombopag	PE	N0000175969	Increased Megakaryocyte Maturation	FDA
DB06210	4399	eltrombopag	PE	N0000175970	Increased Platelet Production	FDA
DB06210	4399	eltrombopag	EPC	N0000178368	Thrombopoiesis Stimulating Agent	FDA
DB06210	4399	eltrombopag	MoA	N0000175968	Thrombopoietin Receptor Agonists	FDA
DB06210	4399	eltrombopag	MoA	N0000175967	Thrombopoietin Receptor Interactions	FDA
DB06210	4399	eltrombopag	EPC	N0000175973	Thrombopoietin Receptor Agonist	FDA
DB06210	4399	eltrombopag	MoA	N0000190107	Organic Anion Transporting Polypeptide 1B1 Inhibitors	FDA
DB06210	4399	eltrombopag	MoA	N0000190113	Breast Cancer Resistance Protein Inhibitors	FDA
DB06210	4399	eltrombopag	MoA	N0000191272	UGT1A1 Inhibitors	FDA
DB06210	4399	eltrombopag	MoA	N0000191275	UGT1A3 Inhibitors	FDA
DB06210	4399	eltrombopag	MoA	N0000191276	UGT1A4 Inhibitors	FDA
DB06210	4399	eltrombopag	MoA	N0000191277	UGT1A6 Inhibitors	FDA
DB06210	4399	eltrombopag	MoA	N0000191278	UGT1A9 Inhibitors	FDA
DB06210	4399	eltrombopag	MoA	N0000191273	UGT2B7 Inhibitors	FDA
DB06210	4399	eltrombopag	MoA	N0000191274	UGT2B15 Inhibitors	FDA
DB06212	4110	tolvaptan	PA	D065092	Antidiuretic Hormone Receptor Antagonists	MeSH
DB06212	4110	tolvaptan	PA	D045283	Natriuretic Agents	MeSH
DB06213	2362	regadenoson	EPC	N0000178375	Adenosine Receptor Agonist	FDA
DB06213	2362	regadenoson	MoA	N0000175788	Adenosine Receptor Agonists	FDA
DB06213	2362	regadenoson	PA	D058908	Adenosine A2 Receptor Agonists	MeSH
DB06213	2362	regadenoson	PA	D018377	Neurotransmitter Agents	MeSH
DB06213	2362	regadenoson	PA	D058906	Purinergic P1 Receptor Agonists	MeSH
DB06216	4115	asenapine	EPC	N0000175430	Atypical Antipsychotic	FDA
DB06216	4115	asenapine	has role	CHEBI:37890	alpha-adrenergic antagonist	CHEBI
DB06216	4115	asenapine	has role	CHEBI:35530	beta-adrenergic antagonist	CHEBI
DB06216	4115	asenapine	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB06216	4115	asenapine	has role	CHEBI:35471	psychotropic drug	CHEBI
DB06216	4115	asenapine	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB06216	4115	asenapine	has role	CHEBI:65191	second generation antipsychotic	CHEBI
DB06216	4115	asenapine	PA	D014150	Antipsychotic Agents	MeSH
DB06216	4115	asenapine	PA	D002491	Central Nervous System Agents	MeSH
DB06216	4115	asenapine	PA	D002492	Central Nervous System Depressants	MeSH
DB06216	4115	asenapine	PA	D011619	Psychotropic Drugs	MeSH
DB06216	4115	asenapine	PA	D014149	Tranquilizing Agents	MeSH
DB06218	4310	lacosamide	EPC	N0000175753	Anti-epileptic Agent	FDA
DB06218	4310	lacosamide	PE	N0000008486	Decreased Central Nervous System Disorganized Electrical Activity	FDA
DB06218	4310	lacosamide	PA	D000927	Anticonvulsants	MeSH
DB06218	4310	lacosamide	PA	D002491	Central Nervous System Agents	MeSH
DB06228	4182	rivaroxaban	EPC	N0000175637	Factor Xa Inhibitor	FDA
DB06228	4182	rivaroxaban	has role	CHEBI:50249	anticoagulant	CHEBI
DB06228	4182	rivaroxaban	PA	D000925	Anticoagulants	MeSH
DB06228	4182	rivaroxaban	PA	D000991	Antithrombins	MeSH
DB06228	4182	rivaroxaban	PA	D004791	Enzyme Inhibitors	MeSH
DB06228	4182	rivaroxaban	PA	D065427	Factor Xa Inhibitors	MeSH
DB06228	4182	rivaroxaban	PA	D006401	Hematologic Agents	MeSH
DB06228	4182	rivaroxaban	PA	D011480	Protease Inhibitors	MeSH
DB06228	4182	rivaroxaban	PA	D015842	Serine Proteinase Inhibitors	MeSH
DB08477	4182	rivaroxaban	EPC	N0000175637	Factor Xa Inhibitor	FDA
DB08477	4182	rivaroxaban	has role	CHEBI:50249	anticoagulant	CHEBI
DB08477	4182	rivaroxaban	PA	D000925	Anticoagulants	MeSH
DB08477	4182	rivaroxaban	PA	D000991	Antithrombins	MeSH
DB08477	4182	rivaroxaban	PA	D004791	Enzyme Inhibitors	MeSH
DB08477	4182	rivaroxaban	PA	D065427	Factor Xa Inhibitors	MeSH
DB08477	4182	rivaroxaban	PA	D006401	Hematologic Agents	MeSH
DB08477	4182	rivaroxaban	PA	D011480	Protease Inhibitors	MeSH
DB08477	4182	rivaroxaban	PA	D015842	Serine Proteinase Inhibitors	MeSH
DB06237	4305	avanafil	EPC	N0000175599	Phosphodiesterase 5 Inhibitor	FDA
DB06237	4305	avanafil	MoA	N0000020026	Phosphodiesterase 5 Inhibitors	FDA
DB06237	4305	avanafil	has role	CHEBI:35620	vasodilator agent	CHEBI
DB06262	971	droxidopa	Chemical/Ingredient	N0000007715	Catecholamines	FDA
DB06262	971	droxidopa	PE	N0000178478	Increased Blood Pressure	FDA
DB06262	971	droxidopa	PA	D018726	Anti-Dyskinesia Agents	MeSH
DB06262	971	droxidopa	has role	CHEBI:50266	prodrug	CHEBI
DB06262	971	droxidopa	has role	CHEBI:50514	vasoconstrictor agent	CHEBI
DB06262	971	droxidopa	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB06262	971	droxidopa	PA	D000978	Antiparkinson Agents	MeSH
DB06262	971	droxidopa	PA	D002491	Central Nervous System Agents	MeSH
DB06267	4141	udenafil	PA	D004791	Enzyme Inhibitors	MeSH
DB06267	4141	udenafil	PA	D058986	Phosphodiesterase 5 Inhibitors	MeSH
DB06267	4141	udenafil	PA	D010726	Phosphodiesterase Inhibitors	MeSH
DB06268	3548	sitaxentan	PA	D065128	Endothelin Receptor Antagonists	MeSH
DB06274	143	alvimopan	PA	D005765	Gastrointestinal Agents	MeSH
DB06287	4161	temsirolimus	EPC	N0000175605	Kinase Inhibitor	FDA
DB06287	4161	temsirolimus	MoA	N0000175076	Protein Kinase Inhibitors	FDA
DB06288	179	amisulpride	has role	CHEBI:65191	second generation antipsychotic	CHEBI
DB06290	4812	simeprevir	EPC	N0000182639	Hepatitis C Virus NS3/4A Protease Inhibitor	FDA
DB06290	4812	simeprevir	MoA	N0000182638	HCV NS3/4A Protease Inhibitors	FDA
DB06290	4812	simeprevir	MoA	N0000182141	Cytochrome P450 3A4 Inhibitors	FDA
DB06290	4812	simeprevir	MoA	N0000185503	P-Glycoprotein Inhibitors	FDA
DB06290	4812	simeprevir	MoA	N0000190107	Organic Anion Transporting Polypeptide 1B1 Inhibitors	FDA
DB06290	4812	simeprevir	MoA	N0000190108	Organic Anion Transporting Polypeptide 1B3 Inhibitors	FDA
DB06290	4812	simeprevir	PA	D000890	Anti-Infective Agents	MeSH
DB06290	4812	simeprevir	PA	D000998	Antiviral Agents	MeSH
DB06290	4812	simeprevir	PA	D004791	Enzyme Inhibitors	MeSH
DB06290	4812	simeprevir	PA	D011480	Protease Inhibitors	MeSH
DB06292	4304	dapagliflozin	EPC	N0000187059	Sodium-Glucose Cotransporter 2 Inhibitor	FDA
DB06292	4304	dapagliflozin	MoA	N0000187058	Sodium-Glucose Transporter 2 Inhibitors	FDA
DB06292	4304	dapagliflozin	has role	CHEBI:35526	hypoglycemic agent	CHEBI
DB06335	4114	saxagliptin	has role	CHEBI:35526	hypoglycemic agent	CHEBI
DB06335	4114	saxagliptin	PA	D054873	Dipeptidyl-Peptidase IV Inhibitors	MeSH
DB06335	4114	saxagliptin	PA	D004791	Enzyme Inhibitors	MeSH
DB06335	4114	saxagliptin	PA	D006728	Hormones	MeSH
DB06335	4114	saxagliptin	PA	D007004	Hypoglycemic Agents	MeSH
DB06335	4114	saxagliptin	PA	D054795	Incretins	MeSH
DB06335	4114	saxagliptin	PA	D011480	Protease Inhibitors	MeSH
DB07465	4114	saxagliptin	has role	CHEBI:35526	hypoglycemic agent	CHEBI
DB07465	4114	saxagliptin	PA	D054873	Dipeptidyl-Peptidase IV Inhibitors	MeSH
DB07465	4114	saxagliptin	PA	D004791	Enzyme Inhibitors	MeSH
DB07465	4114	saxagliptin	PA	D006728	Hormones	MeSH
DB07465	4114	saxagliptin	PA	D007004	Hypoglycemic Agents	MeSH
DB07465	4114	saxagliptin	PA	D054795	Incretins	MeSH
DB07465	4114	saxagliptin	PA	D011480	Protease Inhibitors	MeSH
DB06414	1115	etravirine	EPC	N0000175463	Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor	FDA
DB06414	1115	etravirine	Chemical/Ingredient	N0000175460	Non-Nucleoside Analog	FDA
DB06414	1115	etravirine	MoA	N0000009948	Non-Nucleoside Reverse Transcriptase Inhibitors	FDA
DB06414	1115	etravirine	PA	D000890	Anti-Infective Agents	MeSH
DB06414	1115	etravirine	PA	D000998	Antiviral Agents	MeSH
DB06414	1115	etravirine	PA	D004791	Enzyme Inhibitors	MeSH
DB06414	1115	etravirine	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB06414	1115	etravirine	PA	D018894	Reverse Transcriptase Inhibitors	MeSH
DB07191	1115	etravirine	EPC	N0000175463	Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor	FDA
DB07191	1115	etravirine	Chemical/Ingredient	N0000175460	Non-Nucleoside Analog	FDA
DB07191	1115	etravirine	MoA	N0000009948	Non-Nucleoside Reverse Transcriptase Inhibitors	FDA
DB07191	1115	etravirine	PA	D000890	Anti-Infective Agents	MeSH
DB07191	1115	etravirine	PA	D000998	Antiviral Agents	MeSH
DB07191	1115	etravirine	PA	D004791	Enzyme Inhibitors	MeSH
DB07191	1115	etravirine	PA	D019384	Nucleic Acid Synthesis Inhibitors	MeSH
DB07191	1115	etravirine	PA	D018894	Reverse Transcriptase Inhibitors	MeSH
DB06589	4118	pazopanib	EPC	N0000175605	Kinase Inhibitor	FDA
DB06589	4118	pazopanib	MoA	N0000175076	Protein Kinase Inhibitors	FDA
DB06589	4118	pazopanib	MoA	N0000182141	Cytochrome P450 3A4 Inhibitors	FDA
DB06589	4118	pazopanib	MoA	N0000182137	Cytochrome P450 2D6 Inhibitors	FDA
DB06589	4118	pazopanib	MoA	N0000187062	Cytochrome P450 2C8 Inhibitors	FDA
DB06589	4118	pazopanib	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB06589	4118	pazopanib	has role	CHEBI:67170	anti-angiogenic agent	CHEBI
DB06590	4169	ceftaroline fosamil	has role	CHEBI:50266	prodrug	CHEBI
DB06590	4169	ceftaroline fosamil	has role	CHEBI:36047	antibacterial drug	CHEBI
DB06605	4298	apixaban	EPC	N0000175637	Factor Xa Inhibitor	FDA
DB06605	4298	apixaban	has role	CHEBI:50249	anticoagulant	CHEBI
DB06605	4298	apixaban	PA	D000925	Anticoagulants	MeSH
DB06605	4298	apixaban	PA	D000991	Antithrombins	MeSH
DB06605	4298	apixaban	PA	D004791	Enzyme Inhibitors	MeSH
DB06605	4298	apixaban	PA	D065427	Factor Xa Inhibitors	MeSH
DB06605	4298	apixaban	PA	D006401	Hematologic Agents	MeSH
DB06605	4298	apixaban	PA	D011480	Protease Inhibitors	MeSH
DB06605	4298	apixaban	PA	D015842	Serine Proteinase Inhibitors	MeSH
DB06616	4359	bosutinib	EPC	N0000175605	Kinase Inhibitor	FDA
DB06616	4359	bosutinib	MoA	N0000175076	Protein Kinase Inhibitors	FDA
DB06616	4359	bosutinib	MoA	N0000185503	P-Glycoprotein Inhibitors	FDA
DB06616	4359	bosutinib	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB06637	4163	fampridine	has role	CHEBI:71031	orphan drug	CHEBI
DB06637	4163	fampridine	has role	CHEBI:33289	avicide	CHEBI
DB06637	4163	fampridine	PA	D002317	Cardiovascular Agents	MeSH
DB06637	4163	fampridine	PA	D049990	Membrane Transport Modulators	MeSH
DB06637	4163	fampridine	PA	D026902	Potassium Channel Blockers	MeSH
DB06663	4329	pasireotide	EPC	N0000175904	Somatostatin Analog	FDA
DB06663	4329	pasireotide	MoA	N0000000194	Somatostatin Receptor Agonists	FDA
DB06663	4329	pasireotide	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB06684	4223	vilazodone	has role	CHEBI:35469	antidepressant	CHEBI
DB06684	4223	vilazodone	has role	CHEBI:35941	serotonergic agonist	CHEBI
DB06684	4223	vilazodone	has role	CHEBI:50949	serotonin uptake inhibitor	CHEBI
DB06684	4223	vilazodone	PA	D000928	Antidepressive Agents	MeSH
DB06684	4223	vilazodone	PA	D002491	Central Nervous System Agents	MeSH
DB06684	4223	vilazodone	PA	D049990	Membrane Transport Modulators	MeSH
DB06684	4223	vilazodone	PA	D018377	Neurotransmitter Agents	MeSH
DB06684	4223	vilazodone	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB06684	4223	vilazodone	PA	D011619	Psychotropic Drugs	MeSH
DB06684	4223	vilazodone	PA	D058825	Serotonin 5-HT1 Receptor Agonists	MeSH
DB06684	4223	vilazodone	PA	D018490	Serotonin Agents	MeSH
DB06684	4223	vilazodone	PA	D017366	Serotonin Receptor Agonists	MeSH
DB06684	4223	vilazodone	PA	D017367	Serotonin Uptake Inhibitors	MeSH
DB06691	2331	mepyramine	PA	D018926	Anti-Allergic Agents	MeSH
DB06691	2331	mepyramine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB06691	2331	mepyramine	PA	D018494	Histamine Agents	MeSH
DB06691	2331	mepyramine	PA	D006633	Histamine Antagonists	MeSH
DB06691	2331	mepyramine	PA	D006634	Histamine H1 Antagonists	MeSH
DB06691	2331	mepyramine	PA	D018377	Neurotransmitter Agents	MeSH
DB06691	2331	mepyramine	PA	D000068776	Sleep Aids, Pharmaceutical	MeSH
DB06694	3658	xylometazoline	PA	D002317	Cardiovascular Agents	MeSH
DB06694	3658	xylometazoline	PA	D014663	Nasal Decongestants	MeSH
DB06694	3658	xylometazoline	PA	D019141	Respiratory System Agents	MeSH
DB06694	3658	xylometazoline	PA	D014662	Vasoconstrictor Agents	MeSH
DB06698	346	betahistine	has role	CHEBI:71173	H1-receptor agonist	CHEBI
DB06698	346	betahistine	has role	CHEBI:35620	vasodilator agent	CHEBI
DB06698	346	betahistine	PA	D002317	Cardiovascular Agents	MeSH
DB06698	346	betahistine	PA	D018494	Histamine Agents	MeSH
DB06698	346	betahistine	PA	D017442	Histamine Agonists	MeSH
DB06698	346	betahistine	PA	D018377	Neurotransmitter Agents	MeSH
DB06698	346	betahistine	PA	D014665	Vasodilator Agents	MeSH
DB06700	4380	desvenlafaxine	MoA	N0000000102	Norepinephrine Uptake Inhibitors	FDA
DB06700	4380	desvenlafaxine	EPC	N0000175749	Serotonin and Norepinephrine Reuptake Inhibitor	FDA
DB06700	4380	desvenlafaxine	MoA	N0000000109	Serotonin Uptake Inhibitors	FDA
DB06700	4380	desvenlafaxine	MoA	N0000182137	Cytochrome P450 2D6 Inhibitors	FDA
DB06700	4380	desvenlafaxine	has role	CHEBI:35469	antidepressant	CHEBI
DB06700	4380	desvenlafaxine	PA	D000928	Antidepressive Agents	MeSH
DB06700	4380	desvenlafaxine	PA	D002491	Central Nervous System Agents	MeSH
DB06700	4380	desvenlafaxine	PA	D049990	Membrane Transport Modulators	MeSH
DB06700	4380	desvenlafaxine	PA	D018377	Neurotransmitter Agents	MeSH
DB06700	4380	desvenlafaxine	PA	D014179	Neurotransmitter Uptake Inhibitors	MeSH
DB06700	4380	desvenlafaxine	PA	D011619	Psychotropic Drugs	MeSH
DB06700	4380	desvenlafaxine	PA	D000068760	Serotonin and Noradrenaline Reuptake Inhibitors	MeSH
DB06702	4191	fesoterodine	PA	D018678	Cholinergic Agents	MeSH
DB06702	4191	fesoterodine	PA	D018680	Cholinergic Antagonists	MeSH
DB06702	4191	fesoterodine	PA	D018727	Muscarinic Antagonists	MeSH
DB06702	4191	fesoterodine	PA	D018377	Neurotransmitter Agents	MeSH
DB06702	4191	fesoterodine	PA	D064804	Urological Agents	MeSH
DB06709	1726	methacholine	EPC	N0000175884	Cholinergic Receptor Agonist	FDA
DB06709	1726	methacholine	has role	CHEBI:38325	muscarinic agonist	CHEBI
DB06709	1726	methacholine	has role	CHEBI:50141	bronchoconstrictor agent	CHEBI
DB06709	1726	methacholine	has role	CHEBI:38324	cholinergic agonist	CHEBI
DB06709	1726	methacholine	has role	CHEBI:35620	vasodilator agent	CHEBI
DB06709	1726	methacholine	PA	D016085	Bronchoconstrictor Agents	MeSH
DB06709	1726	methacholine	PA	D018678	Cholinergic Agents	MeSH
DB06709	1726	methacholine	PA	D018679	Cholinergic Agonists	MeSH
DB06709	1726	methacholine	PA	D008916	Miotics	MeSH
DB06709	1726	methacholine	PA	D018721	Muscarinic Agonists	MeSH
DB06709	1726	methacholine	PA	D018377	Neurotransmitter Agents	MeSH
DB06709	1726	methacholine	PA	D010277	Parasympathomimetics	MeSH
DB06709	1726	methacholine	PA	D019141	Respiratory System Agents	MeSH
DB06710	3356	methyltestosterone	EPC	N0000175824	Androgen	FDA
DB06710	3356	methyltestosterone	MoA	N0000000146	Androgen Receptor Agonists	FDA
DB06710	3356	methyltestosterone	Chemical/Ingredient	N0000008241	Androstanes	FDA
DB06710	3356	methyltestosterone	PA	D045930	Anabolic Agents	MeSH
DB06710	3356	methyltestosterone	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB06710	3356	methyltestosterone	PA	D000970	Antineoplastic Agents	MeSH
DB06710	3356	methyltestosterone	PA	D018931	Antineoplastic Agents, Hormonal	MeSH
DB06710	3356	methyltestosterone	PA	D006728	Hormones	MeSH
DB06711	3369	naphazoline	PA	D018663	Adrenergic Agents	MeSH
DB06711	3369	naphazoline	PA	D000322	Adrenergic Agonists	MeSH
DB06711	3369	naphazoline	PA	D000316	Adrenergic alpha-Agonists	MeSH
DB06711	3369	naphazoline	PA	D002317	Cardiovascular Agents	MeSH
DB06711	3369	naphazoline	PA	D014663	Nasal Decongestants	MeSH
DB06711	3369	naphazoline	PA	D018377	Neurotransmitter Agents	MeSH
DB06711	3369	naphazoline	PA	D019141	Respiratory System Agents	MeSH
DB06711	3369	naphazoline	PA	D014662	Vasoconstrictor Agents	MeSH
DB06712	1934	nilvadipine	PA	D000959	Antihypertensive Agents	MeSH
DB06712	1934	nilvadipine	PA	D002121	Calcium Channel Blockers	MeSH
DB06712	1934	nilvadipine	PA	D002317	Cardiovascular Agents	MeSH
DB06712	1934	nilvadipine	PA	D049990	Membrane Transport Modulators	MeSH
DB06713	1959	norelgestromin	Chemical/Ingredient	N0000011301	Progesterone Congeners	FDA
DB06713	1959	norelgestromin	EPC	N0000175602	Progestin	FDA
DB06713	1959	norelgestromin	PA	D003270	Contraceptive Agents	MeSH
DB06713	1959	norelgestromin	PA	D003271	Contraceptive Agents, Female	MeSH
DB06713	1959	norelgestromin	PA	D003276	Contraceptives, Oral	MeSH
DB06713	1959	norelgestromin	PA	D003277	Contraceptives, Oral, Combined	MeSH
DB06713	1959	norelgestromin	PA	D012102	Reproductive Control Agents	MeSH
DB06716	3249	fospropofol	PA	D002491	Central Nervous System Agents	MeSH
DB06716	3249	fospropofol	PA	D002492	Central Nervous System Depressants	MeSH
DB06716	3249	fospropofol	PA	D006993	Hypnotics and Sedatives	MeSH
DB06717	4470	fosaprepitant	MoA	N0000010262	Neurokinin 1 Antagonists	FDA
DB06717	4470	fosaprepitant	EPC	N0000175786	Substance P/Neurokinin-1 Receptor Antagonist	FDA
DB06717	4470	fosaprepitant	has role	CHEBI:50919	antiemetic	CHEBI
DB06717	4470	fosaprepitant	has role	CHEBI:50266	prodrug	CHEBI
DB06717	4470	fosaprepitant	PA	D000932	Antiemetics	MeSH
DB06717	4470	fosaprepitant	PA	D002491	Central Nervous System Agents	MeSH
DB06717	4470	fosaprepitant	PA	D005765	Gastrointestinal Agents	MeSH
DB06717	4470	fosaprepitant	PA	D064729	Neurokinin-1 Receptor Antagonists	MeSH
DB06717	4470	fosaprepitant	PA	D018377	Neurotransmitter Agents	MeSH
DB06718	2477	stanozolol	PA	D045930	Anabolic Agents	MeSH
DB06718	2477	stanozolol	PA	D000728	Androgens	MeSH
DB06718	2477	stanozolol	PA	D006728	Hormones	MeSH
DB06729	2523	sulfaphenazole	PA	D000890	Anti-Infective Agents	MeSH
DB06729	2523	sulfaphenazole	has role	CHEBI:36047	antibacterial drug	CHEBI
DB06766	4165	alcaftadine	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB06766	4165	alcaftadine	has role	CHEBI:50857	anti-allergic agent	CHEBI
DB06766	4165	alcaftadine	PA	D018494	Histamine Agents	MeSH
DB06766	4165	alcaftadine	PA	D006633	Histamine Antagonists	MeSH
DB06766	4165	alcaftadine	PA	D006634	Histamine H1 Antagonists	MeSH
DB06766	4165	alcaftadine	PA	D018377	Neurotransmitter Agents	MeSH
DB06771	4111	besifloxacin	EPC	N0000175937	Quinolone Antimicrobial	FDA
DB06771	4111	besifloxacin	Chemical/Ingredient	N0000007606	Quinolones	FDA
DB06772	4153	cabazitaxel	PE	N0000175085	Microtubule Inhibition	FDA
DB06772	4153	cabazitaxel	EPC	N0000175592	Microtubule Inhibitor	FDA
DB06772	4153	cabazitaxel	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB06775	3068	carglumic acid	EPC	N0000184144	Carbamoyl Phosphate Synthetase 1 Activator	FDA
DB06775	3068	carglumic acid	MoA	N0000184143	Carbamoyl Phosphate Synthetase 1 Activators	FDA
DB06775	3068	carglumic acid	has role	CHEBI:71031	orphan drug	CHEBI
DB06781	3142	difluprednate	PA	D005938	Glucocorticoids	MeSH
DB06781	3142	difluprednate	PA	D006728	Hormones	MeSH
DB06795	1624	mafenide	EPC	N0000175511	Methylated Sulfonamide Antibacterial	FDA
DB06795	1624	mafenide	Chemical/Ingredient	N0000175512	Methylated Sulfonamides	FDA
DB06795	1624	mafenide	PA	D000890	Anti-Infective Agents	MeSH
DB06795	1624	mafenide	PA	D000891	Anti-Infective Agents, Local	MeSH
DB06800	4616	methylnaltrexone	EPC	N0000175691	Opioid Antagonist	FDA
DB06800	4616	methylnaltrexone	MoA	N0000000154	Opioid Antagonists	FDA
DB06800	4616	methylnaltrexone	Chemical/Ingredient	N0000166489	Quaternary Ammonium Compounds	FDA
DB06800	4616	methylnaltrexone	PA	D002491	Central Nervous System Agents	MeSH
DB06800	4616	methylnaltrexone	PA	D009292	Narcotic Antagonists	MeSH
DB06800	4616	methylnaltrexone	PA	D018689	Sensory System Agents	MeSH
DB06802	1899	nepafenac	MoA	N0000000160	Cyclooxygenase Inhibitors	FDA
DB06802	1899	nepafenac	Chemical/Ingredient	N0000175721	Nonsteroidal Anti-inflammatory Compounds	FDA
DB06802	1899	nepafenac	EPC	N0000175722	Nonsteroidal Anti-inflammatory Drug	FDA
DB06802	1899	nepafenac	PA	D000700	Analgesics	MeSH
DB06802	1899	nepafenac	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB06802	1899	nepafenac	PA	D000893	Anti-Inflammatory Agents	MeSH
DB06802	1899	nepafenac	has role	CHEBI:50266	prodrug	CHEBI
DB06802	1899	nepafenac	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB06802	1899	nepafenac	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB06802	1899	nepafenac	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB06802	1899	nepafenac	PA	D018501	Antirheumatic Agents	MeSH
DB06802	1899	nepafenac	PA	D018689	Sensory System Agents	MeSH
DB06809	4410	plerixafor	EPC	N0000178326	Hematopoietic Stem Cell Mobilizer	FDA
DB06809	4410	plerixafor	PE	N0000178324	Increased Hematopoietic Stem Cell Mobilization	FDA
DB06813	4117	pralatrexate	EPC	N0000175584	Folate Analog Metabolic Inhibitor	FDA
DB06813	4117	pralatrexate	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB06817	2352	raltegravir	EPC	N0000175887	Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor	FDA
DB06817	2352	raltegravir	PA	D019380	Anti-HIV Agents	MeSH
DB06817	2352	raltegravir	PA	D000890	Anti-Infective Agents	MeSH
DB06817	2352	raltegravir	PA	D000998	Antiviral Agents	MeSH
DB06817	2352	raltegravir	PA	D004791	Enzyme Inhibitors	MeSH
DB06817	2352	raltegravir	PA	D019428	HIV Integrase Inhibitors	MeSH
DB08162	1132	fasudil	PA	D002121	Calcium Channel Blockers	MeSH
DB08162	1132	fasudil	PA	D002317	Cardiovascular Agents	MeSH
DB08162	1132	fasudil	PA	D004791	Enzyme Inhibitors	MeSH
DB08162	1132	fasudil	PA	D049990	Membrane Transport Modulators	MeSH
DB08162	1132	fasudil	PA	D047428	Protein Kinase Inhibitors	MeSH
DB08162	1132	fasudil	PA	D014665	Vasodilator Agents	MeSH
DB08183	4713	tofacitinib	EPC	N0000190858	Janus Kinase Inhibitor	FDA
DB08183	4713	tofacitinib	MoA	N0000190857	Janus Kinase Inhibitors	FDA
DB08183	4713	tofacitinib	has role	CHEBI:35842	antirheumatic drug	CHEBI
DB08183	4713	tofacitinib	PA	D004791	Enzyme Inhibitors	MeSH
DB08183	4713	tofacitinib	PA	D047428	Protein Kinase Inhibitors	MeSH
DB08439	2063	parecoxib	PA	D000700	Analgesics	MeSH
DB08439	2063	parecoxib	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB08439	2063	parecoxib	PA	D000893	Anti-Inflammatory Agents	MeSH
DB08439	2063	parecoxib	has role	CHEBI:35481	non-narcotic analgesic	CHEBI
DB08439	2063	parecoxib	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB08439	2063	parecoxib	has role	CHEBI:50266	prodrug	CHEBI
DB08439	2063	parecoxib	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB08439	2063	parecoxib	PA	D018501	Antirheumatic Agents	MeSH
DB08439	2063	parecoxib	PA	D052246	Cyclooxygenase 2 Inhibitors	MeSH
DB08439	2063	parecoxib	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB08439	2063	parecoxib	PA	D004791	Enzyme Inhibitors	MeSH
DB08439	2063	parecoxib	PA	D018689	Sensory System Agents	MeSH
DB08604	3631	triclosan	PA	D000890	Anti-Infective Agents	MeSH
DB08604	3631	triclosan	PA	D000891	Anti-Infective Agents, Local	MeSH
DB08604	3631	triclosan	has role	CHEBI:24127	fungicide	CHEBI
DB08604	3631	triclosan	PA	D000963	Antimetabolites	MeSH
DB08604	3631	triclosan	PA	D054872	Fatty Acid Synthesis Inhibitors	MeSH
DB08604	3631	triclosan	PA	D000960	Hypolipidemic Agents	MeSH
DB08700	4187	crizotinib	EPC	N0000175605	Kinase Inhibitor	FDA
DB08700	4187	crizotinib	MoA	N0000190114	Cytochrome P450 3A Inhibitors	FDA
DB08700	4187	crizotinib	MoA	N0000020000	Receptor Tyrosine Kinase Inhibitors	FDA
DB08700	4187	crizotinib	MoA	N0000182139	Cytochrome P450 2B6 Inhibitors	FDA
DB08700	4187	crizotinib	MoA	N0000185503	P-Glycoprotein Inhibitors	FDA
DB08700	4187	crizotinib	MoA	N0000191265	Organic Cation Transporter 1 Inhibitors	FDA
DB08700	4187	crizotinib	MoA	N0000187061	Organic Cation Transporter 2 Inhibitors	FDA
DB08700	4187	crizotinib	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB08700	4187	crizotinib	has role	CHEBI:59163	biomarker	CHEBI
DB08700	4187	crizotinib	PA	D004791	Enzyme Inhibitors	MeSH
DB08700	4187	crizotinib	PA	D047428	Protein Kinase Inhibitors	MeSH
DB08865	4187	crizotinib	EPC	N0000175605	Kinase Inhibitor	FDA
DB08865	4187	crizotinib	MoA	N0000190114	Cytochrome P450 3A Inhibitors	FDA
DB08865	4187	crizotinib	MoA	N0000020000	Receptor Tyrosine Kinase Inhibitors	FDA
DB08865	4187	crizotinib	MoA	N0000182139	Cytochrome P450 2B6 Inhibitors	FDA
DB08865	4187	crizotinib	MoA	N0000185503	P-Glycoprotein Inhibitors	FDA
DB08865	4187	crizotinib	MoA	N0000191265	Organic Cation Transporter 1 Inhibitors	FDA
DB08865	4187	crizotinib	MoA	N0000187061	Organic Cation Transporter 2 Inhibitors	FDA
DB08865	4187	crizotinib	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB08865	4187	crizotinib	has role	CHEBI:59163	biomarker	CHEBI
DB08865	4187	crizotinib	PA	D004791	Enzyme Inhibitors	MeSH
DB08865	4187	crizotinib	PA	D047428	Protein Kinase Inhibitors	MeSH
DB08799	224	antazoline	PA	D018926	Anti-Allergic Agents	MeSH
DB08799	224	antazoline	has role	CHEBI:37955	H1-receptor antagonist	CHEBI
DB08799	224	antazoline	has role	CHEBI:48873	cholinergic antagonist	CHEBI
DB08799	224	antazoline	PA	D018494	Histamine Agents	MeSH
DB08799	224	antazoline	PA	D006633	Histamine Antagonists	MeSH
DB08799	224	antazoline	PA	D006634	Histamine H1 Antagonists	MeSH
DB08799	224	antazoline	PA	D018377	Neurotransmitter Agents	MeSH
DB08806	2408	roxatidine acetate	PA	D000897	Anti-Ulcer Agents	MeSH
DB08806	2408	roxatidine acetate	PA	D005765	Gastrointestinal Agents	MeSH
DB08806	2408	roxatidine acetate	PA	D018494	Histamine Agents	MeSH
DB08806	2408	roxatidine acetate	PA	D006633	Histamine Antagonists	MeSH
DB08806	2408	roxatidine acetate	PA	D006635	Histamine H2 Antagonists	MeSH
DB08806	2408	roxatidine acetate	PA	D018377	Neurotransmitter Agents	MeSH
DB08808	433	bupranolol	PA	D018663	Adrenergic Agents	MeSH
DB08808	433	bupranolol	PA	D018674	Adrenergic Antagonists	MeSH
DB08808	433	bupranolol	PA	D000319	Adrenergic beta-Antagonists	MeSH
DB08808	433	bupranolol	PA	D000889	Anti-Arrhythmia Agents	MeSH
DB08808	433	bupranolol	PA	D000959	Antihypertensive Agents	MeSH
DB08808	433	bupranolol	PA	D002317	Cardiovascular Agents	MeSH
DB08808	433	bupranolol	PA	D018377	Neurotransmitter Agents	MeSH
DB08815	4168	lurasidone	EPC	N0000175430	Atypical Antipsychotic	FDA
DB08815	4168	lurasidone	PA	D018663	Adrenergic Agents	MeSH
DB08815	4168	lurasidone	PA	D058669	Adrenergic alpha-2 Receptor Antagonists	MeSH
DB08815	4168	lurasidone	PA	D000317	Adrenergic alpha-Antagonists	MeSH
DB08815	4168	lurasidone	PA	D018674	Adrenergic Antagonists	MeSH
DB08815	4168	lurasidone	has role	CHEBI:37887	adrenergic antagonist	CHEBI
DB08815	4168	lurasidone	has role	CHEBI:48561	dopaminergic antagonist	CHEBI
DB08815	4168	lurasidone	has role	CHEBI:48279	serotonergic antagonist	CHEBI
DB08815	4168	lurasidone	has role	CHEBI:65191	second generation antipsychotic	CHEBI
DB08815	4168	lurasidone	PA	D014150	Antipsychotic Agents	MeSH
DB08815	4168	lurasidone	PA	D002491	Central Nervous System Agents	MeSH
DB08815	4168	lurasidone	PA	D002492	Central Nervous System Depressants	MeSH
DB08815	4168	lurasidone	PA	D015259	Dopamine Agents	MeSH
DB08815	4168	lurasidone	PA	D018492	Dopamine Antagonists	MeSH
DB08815	4168	lurasidone	PA	D065127	Dopamine D2 Receptor Antagonists	MeSH
DB08815	4168	lurasidone	PA	D018377	Neurotransmitter Agents	MeSH
DB08815	4168	lurasidone	PA	D011619	Psychotropic Drugs	MeSH
DB08815	4168	lurasidone	PA	D058830	Serotonin 5-HT2 Receptor Antagonists	MeSH
DB08815	4168	lurasidone	PA	D018490	Serotonin Agents	MeSH
DB08815	4168	lurasidone	PA	D012702	Serotonin Antagonists	MeSH
DB08815	4168	lurasidone	PA	D014149	Tranquilizing Agents	MeSH
DB08816	4184	ticagrelor	EPC	N0000182142	P2Y12 Platelet Inhibitor	FDA
DB08816	4184	ticagrelor	MoA	N0000190482	Phenylalanine Hydroxylase Activators	FDA
DB08816	4184	ticagrelor	PE	N0000008832	Decreased Platelet Aggregation	FDA
DB08816	4184	ticagrelor	MoA	N0000182143	P2Y12 Receptor Antagonists	FDA
DB08816	4184	ticagrelor	MoA	N0000182141	Cytochrome P450 3A4 Inhibitors	FDA
DB08816	4184	ticagrelor	MoA	N0000190115	Cytochrome P450 3A5 Inhibitors	FDA
DB08816	4184	ticagrelor	MoA	N0000185503	P-Glycoprotein Inhibitors	FDA
DB08816	4184	ticagrelor	has role	CHEBI:50427	platelet aggregation inhibitor	CHEBI
DB08816	4184	ticagrelor	PA	D018377	Neurotransmitter Agents	MeSH
DB08816	4184	ticagrelor	PA	D058914	Purinergic Antagonists	MeSH
DB08816	4184	ticagrelor	PA	D058919	Purinergic P2 Receptor Antagonists	MeSH
DB08816	4184	ticagrelor	PA	D058921	Purinergic P2Y Receptor Antagonists	MeSH
DB08819	4229	tafluprost	EPC	N0000175454	Prostaglandin Analog	FDA
DB08819	4229	tafluprost	MoA	N0000000106	Prostaglandin Receptor Agonists	FDA
DB08819	4229	tafluprost	PE	N0000009526	Increased Prostaglandin Activity	FDA
DB08819	4229	tafluprost	Chemical/Ingredient	N0000007706	Prostaglandins	FDA
DB08820	4228	ivacaftor	EPC	N0000184146	Cystic Fibrosis Transmembrane Conductance Regulator Potentiator	FDA
DB08820	4228	ivacaftor	MoA	N0000184145	Chloride Channel Activation Potentiators	FDA
DB08820	4228	ivacaftor	MoA	N0000182141	Cytochrome P450 3A4 Inhibitors	FDA
DB08820	4228	ivacaftor	MoA	N0000185504	Cytochrome P450 2C9 Inhibitors	FDA
DB08820	4228	ivacaftor	MoA	N0000185503	P-Glycoprotein Inhibitors	FDA
DB08820	4228	ivacaftor	MoA	N0000190114	Cytochrome P450 3A Inhibitors	FDA
DB08820	4228	ivacaftor	has role	CHEBI:71031	orphan drug	CHEBI
DB08827	4721	lomitapide	EPC	N0000186779	Microsomal Triglyceride Transfer Protein Inhibitor	FDA
DB08827	4721	lomitapide	MoA	N0000186778	Microsomal Triglyceride Transfer Protein Inhibitors	FDA
DB08827	4721	lomitapide	MoA	N0000182141	Cytochrome P450 3A4 Inhibitors	FDA
DB08827	4721	lomitapide	MoA	N0000185503	P-Glycoprotein Inhibitors	FDA
DB08827	4721	lomitapide	has role	CHEBI:35821	anticholesteremic drug	CHEBI
DB08828	4227	vismodegib	EPC	N0000184149	Hedgehog Pathway Inhibitor	FDA
DB08828	4227	vismodegib	MoA	N0000184148	Smoothened Receptor Antagonists	FDA
DB08828	4227	vismodegib	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB08860	2214	pitavastatin	EPC	N0000175589	HMG-CoA Reductase Inhibitor	FDA
DB08860	2214	pitavastatin	PA	D000924	Anticholesteremic Agents	MeSH
DB08860	2214	pitavastatin	PA	D000963	Antimetabolites	MeSH
DB08860	2214	pitavastatin	PA	D004791	Enzyme Inhibitors	MeSH
DB08860	2214	pitavastatin	PA	D019161	Hydroxymethylglutaryl-CoA Reductase Inhibitors	MeSH
DB08860	2214	pitavastatin	PA	D000960	Hypolipidemic Agents	MeSH
DB08866	871	dienogest	EPC	N0000175602	Progestin	FDA
DB08866	871	dienogest	Chemical/Ingredient	N0000011301	Progesterone Congeners	FDA
DB08866	871	dienogest	has role	CHEBI:49326	synthetic oral contraceptive	CHEBI
DB08866	871	dienogest	has role	CHEBI:70709	progesterone receptor agonist	CHEBI
DB08866	871	dienogest	PA	D000970	Antineoplastic Agents	MeSH
DB08866	871	dienogest	PA	D018931	Antineoplastic Agents, Hormonal	MeSH
DB08866	871	dienogest	PA	D003270	Contraceptive Agents	MeSH
DB08866	871	dienogest	PA	D003271	Contraceptive Agents, Female	MeSH
DB08866	871	dienogest	PA	D003272	Contraceptive Agents, Male	MeSH
DB08866	871	dienogest	PA	D003276	Contraceptives, Oral	MeSH
DB08866	871	dienogest	PA	D006727	Hormone Antagonists	MeSH
DB08866	871	dienogest	PA	D012102	Reproductive Control Agents	MeSH
DB08871	4171	eribulin	PE	N0000175085	Microtubule Inhibition	FDA
DB08871	4171	eribulin	EPC	N0000175592	Microtubule Inhibitor	FDA
DB08871	4171	eribulin	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB08877	4190	ruxolitinib	EPC	N0000175605	Kinase Inhibitor	FDA
DB08877	4190	ruxolitinib	MoA	N0000175076	Protein Kinase Inhibitors	FDA
DB08877	4190	ruxolitinib	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB08881	4185	vemurafenib	EPC	N0000175605	Kinase Inhibitor	FDA
DB08881	4185	vemurafenib	MoA	N0000175076	Protein Kinase Inhibitors	FDA
DB08881	4185	vemurafenib	MoA	N0000182138	Cytochrome P450 1A2 Inhibitors	FDA
DB08881	4185	vemurafenib	MoA	N0000185503	P-Glycoprotein Inhibitors	FDA
DB08881	4185	vemurafenib	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB08882	4175	linagliptin	MoA	N0000175912	Dipeptidyl Peptidase 4 Inhibitors	FDA
DB08882	4175	linagliptin	EPC	N0000175913	Dipeptidyl Peptidase 4 Inhibitor	FDA
DB08882	4175	linagliptin	has role	CHEBI:35526	hypoglycemic agent	CHEBI
DB08882	4175	linagliptin	PA	D054873	Dipeptidyl-Peptidase IV Inhibitors	MeSH
DB08882	4175	linagliptin	PA	D004791	Enzyme Inhibitors	MeSH
DB08882	4175	linagliptin	PA	D006728	Hormones	MeSH
DB08882	4175	linagliptin	PA	D007004	Hypoglycemic Agents	MeSH
DB08882	4175	linagliptin	PA	D054795	Incretins	MeSH
DB08882	4175	linagliptin	PA	D011480	Protease Inhibitors	MeSH
DB08887	1413	icosapent ethyl	has role	CHEBI:35821	anticholesteremic drug	CHEBI
DB08887	1413	icosapent ethyl	has role	CHEBI:35476	antipsychotic agent	CHEBI
DB08887	1413	icosapent ethyl	has role	CHEBI:35469	antidepressant	CHEBI
DB08887	1413	icosapent ethyl	has role	CHEBI:50266	prodrug	CHEBI
DB08889	4483	carfilzomib	MoA	N0000175075	Proteasome Inhibitors	FDA
DB08889	4483	carfilzomib	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB08889	4483	carfilzomib	has role	CHEBI:52726	proteasome inhibitor	CHEBI
DB08890	4622	linaclotide	EPC	N0000185500	Guanylate Cyclase-C Agonist	FDA
DB08890	4622	linaclotide	MoA	N0000185499	Guanylate Cyclase Activators	FDA
DB08893	4382	mirabegron	EPC	N0000185008	beta3-Adrenergic Agonist	FDA
DB08893	4382	mirabegron	MoA	N0000185007	Adrenergic beta3-Agonists	FDA
DB08893	4382	mirabegron	MoA	N0000182137	Cytochrome P450 2D6 Inhibitors	FDA
DB08893	4382	mirabegron	PA	D018663	Adrenergic Agents	MeSH
DB08893	4382	mirabegron	PA	D000322	Adrenergic Agonists	MeSH
DB08893	4382	mirabegron	PA	D058667	Adrenergic beta-3 Receptor Agonists	MeSH
DB08893	4382	mirabegron	PA	D000318	Adrenergic beta-Agonists	MeSH
DB08893	4382	mirabegron	has role	CHEBI:35522	beta-adrenergic agonist	CHEBI
DB08893	4382	mirabegron	PA	D018377	Neurotransmitter Agents	MeSH
DB08893	4382	mirabegron	PA	D064804	Urological Agents	MeSH
DB08896	4654	regorafenib	EPC	N0000175605	Kinase Inhibitor	FDA
DB08896	4654	regorafenib	MoA	N0000175076	Protein Kinase Inhibitors	FDA
DB08896	4654	regorafenib	MoA	N0000185504	Cytochrome P450 2C9 Inhibitors	FDA
DB08896	4654	regorafenib	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB08897	4484	aclidinium bromide	has role	CHEBI:48876	muscarinic antagonist	CHEBI
DB08897	4484	aclidinium bromide	has role	CHEBI:35523	bronchodilator agent	CHEBI
DB08897	4484	aclidinium bromide	EPC	N0000175574	Anticholinergic	FDA
DB08897	4484	aclidinium bromide	MoA	N0000175370	Cholinergic Antagonists	FDA
DB08899	4628	enzalutamide	EPC	N0000175560	Androgen Receptor Inhibitor	FDA
DB08899	4628	enzalutamide	MoA	N0000000243	Androgen Receptor Antagonists	FDA
DB08899	4628	enzalutamide	MoA	N0000185506	Cytochrome P450 3A4 Inducers	FDA
DB08899	4628	enzalutamide	MoA	N0000185507	Cytochrome P450 2C9 Inducers	FDA
DB08899	4628	enzalutamide	MoA	N0000185607	Cytochrome P450 2C19 Inducers	FDA
DB08899	4628	enzalutamide	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB08899	4628	enzalutamide	has role	CHEBI:35497	androgen antagonist	CHEBI
DB08901	4716	ponatinib	EPC	N0000175605	Kinase Inhibitor	FDA
DB08901	4716	ponatinib	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB08901	4716	ponatinib	PA	D000970	Antineoplastic Agents	MeSH
DB08901	4716	ponatinib	PA	D004791	Enzyme Inhibitors	MeSH
DB08901	4716	ponatinib	PA	D047428	Protein Kinase Inhibitors	MeSH
DB08903	4741	bedaquiline	EPC	N0000186775	Diarylquinoline Antimycobacterial	FDA
DB08903	4741	bedaquiline	Chemical/Ingredient	N0000186774	Diarylquinolines	FDA
DB08903	4741	bedaquiline	PA	D000900	Anti-Bacterial Agents	MeSH
DB08903	4741	bedaquiline	PA	D000890	Anti-Infective Agents	MeSH
DB08903	4741	bedaquiline	has role	CHEBI:33231	antitubercular agent	CHEBI
DB08903	4741	bedaquiline	PA	D000995	Antitubercular Agents	MeSH
DB08906	4554	fluticasone furoate	has role	CHEBI:50266	prodrug	CHEBI
DB08906	4554	fluticasone furoate	has role	CHEBI:50857	anti-allergic agent	CHEBI
DB08906	4554	fluticasone furoate	has role	CHEBI:49167	anti-asthmatic drug	CHEBI
DB08907	4758	canagliflozin	EPC	N0000187059	Sodium-Glucose Cotransporter 2 Inhibitor	FDA
DB08907	4758	canagliflozin	MoA	N0000187058	Sodium-Glucose Transporter 2 Inhibitors	FDA
DB08907	4758	canagliflozin	has role	CHEBI:35526	hypoglycemic agent	CHEBI
DB08907	4758	canagliflozin	PA	D007004	Hypoglycemic Agents	MeSH
DB08910	4746	pomalidomide	EPC	N0000184014	Thalidomide Analog	FDA
DB08910	4746	pomalidomide	PA	D020533	Angiogenesis Inhibitors	MeSH
DB08910	4746	pomalidomide	has role	CHEBI:48422	angiogenesis inhibitor	CHEBI
DB08910	4746	pomalidomide	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB08910	4746	pomalidomide	has role	CHEBI:50846	immunomodulator	CHEBI
DB08910	4746	pomalidomide	PA	D000970	Antineoplastic Agents	MeSH
DB08910	4746	pomalidomide	PA	D006131	Growth Inhibitors	MeSH
DB08910	4746	pomalidomide	PA	D006133	Growth Substances	MeSH
DB08910	4746	pomalidomide	PA	D007155	Immunologic Factors	MeSH
DB08911	4802	trametinib	EPC	N0000175605	Kinase Inhibitor	FDA
DB08911	4802	trametinib	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB08911	4802	trametinib	PA	D000970	Antineoplastic Agents	MeSH
DB08911	4802	trametinib	PA	D004791	Enzyme Inhibitors	MeSH
DB08911	4802	trametinib	PA	D047428	Protein Kinase Inhibitors	MeSH
DB08912	4801	dabrafenib	EPC	N0000175605	Kinase Inhibitor	FDA
DB08912	4801	dabrafenib	MoA	N0000185506	Cytochrome P450 3A4 Inducers	FDA
DB08912	4801	dabrafenib	MoA	N0000187064	Cytochrome P450 2B6 Inducers	FDA
DB08912	4801	dabrafenib	MoA	N0000187063	Cytochrome P450 2C8 Inducers	FDA
DB08912	4801	dabrafenib	MoA	N0000185507	Cytochrome P450 2C9 Inducers	FDA
DB08912	4801	dabrafenib	MoA	N0000185607	Cytochrome P450 2C19 Inducers	FDA
DB08912	4801	dabrafenib	MoA	N0000190107	Organic Anion Transporting Polypeptide 1B1 Inhibitors	FDA
DB08912	4801	dabrafenib	MoA	N0000190108	Organic Anion Transporting Polypeptide 1B3 Inhibitors	FDA
DB08912	4801	dabrafenib	MoA	N0000190110	Organic Anion Transporter 1 Inhibitors	FDA
DB08912	4801	dabrafenib	MoA	N0000190111	Organic Anion Transporter 3 Inhibitors	FDA
DB08912	4801	dabrafenib	MoA	N0000190113	Breast Cancer Resistance Protein Inhibitors	FDA
DB08912	4801	dabrafenib	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB08912	4801	dabrafenib	PA	D000970	Antineoplastic Agents	MeSH
DB08912	4801	dabrafenib	PA	D004791	Enzyme Inhibitors	MeSH
DB08912	4801	dabrafenib	PA	D047428	Protein Kinase Inhibitors	MeSH
DB08916	4318	afatinib	EPC	N0000175605	Kinase Inhibitor	FDA
DB08916	4318	afatinib	MoA	N0000175076	Protein Kinase Inhibitors	FDA
DB08916	4318	afatinib	has role	CHEBI:35610	antineoplastic agent	CHEBI
DB08930	4805	dolutegravir	EPC	N0000175887	Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor	FDA
DB08930	4805	dolutegravir	MoA	N0000191423	Multidrug and Toxin Extrusion Transporter 1 Inhibitors	FDA
DB08930	4805	dolutegravir	MoA	N0000187061	Organic Cation Transporter 2 Inhibitors	FDA
DB08930	4805	dolutegravir	PA	D019380	Anti-HIV Agents	MeSH
DB08930	4805	dolutegravir	PA	D000890	Anti-Infective Agents	MeSH
DB08930	4805	dolutegravir	PA	D000998	Antiviral Agents	MeSH
DB08930	4805	dolutegravir	PA	D004791	Enzyme Inhibitors	MeSH
DB08930	4805	dolutegravir	PA	D019428	HIV Integrase Inhibitors	MeSH
DB08932	4809	macitentan	has role	CHEBI:51451	endothelin receptor antagonist	CHEBI
DB08932	4809	macitentan	has role	CHEBI:35674	antihypertensive agent	CHEBI
DB08932	4809	macitentan	has role	CHEBI:71031	orphan drug	CHEBI
DB08932	4809	macitentan	PA	D065130	Endothelin A Receptor Antagonists	MeSH
DB08932	4809	macitentan	PA	D065131	Endothelin B Receptor Antagonists	MeSH
DB08932	4809	macitentan	PA	D065128	Endothelin Receptor Antagonists	MeSH
DB08933	4813	luliconazole	EPC	N0000175487	Azole Antifungal	FDA
DB08933	4813	luliconazole	Chemical/Ingredient	N0000008217	Azoles	FDA
DB08934	4811	sofosbuvir	EPC	N0000191493	Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor	FDA
DB08934	4811	sofosbuvir	MoA	N0000191258	RNA Replicase Inhibitors	FDA
DB08934	4811	sofosbuvir	Chemical/Ingredient	N0000175459	Nucleoside Analog	FDA
DB08934	4811	sofosbuvir	PA	D000890	Anti-Infective Agents	MeSH
DB08934	4811	sofosbuvir	has role	CHEBI:50266	prodrug	CHEBI
DB08934	4811	sofosbuvir	has role	CHEBI:36044	antiviral drug	CHEBI
DB08934	4811	sofosbuvir	PA	D000998	Antiviral Agents	MeSH
DB08962	1298	glibornuride	PA	D007004	Hypoglycemic Agents	MeSH
DB08976	1178	floctafenine	PA	D000700	Analgesics	MeSH
DB08976	1178	floctafenine	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB08976	1178	floctafenine	PA	D000893	Anti-Inflammatory Agents	MeSH
DB08976	1178	floctafenine	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB08976	1178	floctafenine	PA	D018501	Antirheumatic Agents	MeSH
DB08976	1178	floctafenine	PA	D018689	Sensory System Agents	MeSH
DB08981	1145	fenbufen	PA	D000700	Analgesics	MeSH
DB08981	1145	fenbufen	PA	D018712	Analgesics, Non-Narcotic	MeSH
DB08981	1145	fenbufen	PA	D000893	Anti-Inflammatory Agents	MeSH
DB08981	1145	fenbufen	PA	D000894	Anti-Inflammatory Agents, Non-Steroidal	MeSH
DB08981	1145	fenbufen	has role	CHEBI:35475	non-steroidal anti-inflammatory drug	CHEBI
DB08981	1145	fenbufen	PA	D018501	Antirheumatic Agents	MeSH
DB08981	1145	fenbufen	PA	D016861	Cyclooxygenase Inhibitors	MeSH
DB08981	1145	fenbufen	PA	D004791	Enzyme Inhibitors	MeSH
DB08981	1145	fenbufen	PA	D018689	Sensory System Agents	MeSH
DB08985	1101	etilefrine	PA	D018663	Adrenergic Agents	MeSH
DB08985	1101	etilefrine	PA	D000322	Adrenergic Agonists	MeSH
DB08985	1101	etilefrine	PA	D000316	Adrenergic alpha-Agonists	MeSH
DB08985	1101	etilefrine	PA	D058665	Adrenergic beta-1 Receptor Agonists	MeSH
DB08985	1101	etilefrine	PA	D000318	Adrenergic beta-Agonists	MeSH
DB08985	1101	etilefrine	PA	D002316	Cardiotonic Agents	MeSH
DB08985	1101	etilefrine	PA	D002317	Cardiovascular Agents	MeSH
DB08985	1101	etilefrine	PA	D018377	Neurotransmitter Agents	MeSH
DB08985	1101	etilefrine	PA	D020011	Protective Agents	MeSH
DB08985	1101	etilefrine	PA	D013566	Sympathomimetics	MeSH
DB08985	1101	etilefrine	PA	D014662	Vasoconstrictor Agents	MeSH
DB08987	1097	etidocaine	PA	D000777	Anesthetics	MeSH
DB08987	1097	etidocaine	PA	D000779	Anesthetics, Local	MeSH
DB08987	1097	etidocaine	has role	CHEBI:36333	local anaesthetic	CHEBI
DB08987	1097	etidocaine	PA	D002491	Central Nervous System Agents	MeSH
DB08987	1097	etidocaine	PA	D002492	Central Nervous System Depressants	MeSH
DB08987	1097	etidocaine	PA	D018689	Sensory System Agents	MeSH
DB08997	831	dexetimide	PA	D018726	Anti-Dyskinesia Agents	MeSH
DB08997	831	dexetimide	PA	D000978	Antiparkinson Agents	MeSH
DB08997	831	dexetimide	PA	D002491	Central Nervous System Agents	MeSH
DB08997	831	dexetimide	PA	D018678	Cholinergic Agents	MeSH
DB08997	831	dexetimide	PA	D018680	Cholinergic Antagonists	MeSH
DB08997	831	dexetimide	PA	D018727	Muscarinic Antagonists	MeSH
DB08997	831	dexetimide	PA	D018377	Neurotransmitter Agents	MeSH
DB08997	831	dexetimide	PA	D010276	Parasympatholytics	MeSH
DB09009	3070	articaine	EPC	N0000175682	Amide Local Anesthetic	FDA
DB09009	3070	articaine	Chemical/Ingredient	N0000007681	Amides	FDA
DB09009	3070	articaine	PE	N0000175976	Local Anesthesia	FDA
DB09009	3070	articaine	PA	D000777	Anesthetics	MeSH
DB09009	3070	articaine	PA	D000779	Anesthetics, Local	MeSH
DB09009	3070	articaine	PA	D002491	Central Nervous System Agents	MeSH
DB09009	3070	articaine	PA	D002492	Central Nervous System Depressants	MeSH
DB09009	3070	articaine	PA	D018689	Sensory System Agents	MeSH
